data_1gb4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gb4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.5 m -97.83 104.27 16.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 27.4 m-85 -90.58 152.21 20.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -112.96 -171.85 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.669 -0.645 . . . . 0.0 110.118 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 14.8 tp -164.25 107.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.142 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.68 124.89 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm -89.82 116.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.77 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -103.51 67.74 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 0.0 110.468 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.97 167.92 39.47 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -59.82 -33.84 72.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -1.012 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 p -80.44 133.73 35.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt 58.32 163.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.468 -0.77 . . . . 0.0 110.284 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -177.24 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.55 -163.45 33.99 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -133.41 70.67 1.46 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.932 . . . . 0.0 110.377 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.9 tp -62.31 114.53 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.461 -0.774 . . . . 0.0 109.712 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -83.61 138.47 33.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.651 -0.656 . . . . 0.0 110.499 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.48 149.98 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.573 -0.704 . . . . 0.0 110.369 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 148.68 23.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.18 159.64 23.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.553 -0.717 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.68 -38.83 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.511 -0.743 . . . . 0.0 110.568 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -159.96 175.83 12.57 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.55 -33.81 75.68 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.713 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.82 63.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.455 -0.778 . . . . 0.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.09 -40.47 96.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.36 72.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 0.0 109.479 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -58.29 -36.26 73.04 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -69.11 -50.81 44.66 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.69 -37.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 12.0 m-85 -74.32 -37.34 63.61 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.6 mmmt -76.3 0.23 20.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.738 -0.601 . . . . 0.0 111.563 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -109.24 -45.25 3.77 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 10.7 t80 -53.07 -34.61 57.33 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.028 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.463 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -69.68 -48.14 60.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.193 0.52 . . . . 0.0 110.0 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.41 -46.7 85.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.526 -0.734 . . . . 0.0 110.342 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -54.58 -23.32 16.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.54 -0.725 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.51 -25.86 12.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.627 -0.67 . . . . 0.0 110.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.76 30.68 3.4 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.71 106.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.979 . . . . 0.0 108.788 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.73 111.68 6.75 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.427 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.27 -108.72 0.21 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -109.81 173.37 6.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.396 -1.061 . . . . 0.0 110.39 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.449 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 40.8 m95 -152.06 130.33 12.02 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.543 -0.723 . . . . 0.0 110.26 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.7 p -142.26 134.18 27.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.63 -0.669 . . . . 0.0 109.253 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.6 t80 -97.61 143.7 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.93 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -113.92 97.97 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.817 -0.552 . . . . 0.0 109.536 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -69.69 -6.84 34.41 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.661 -0.649 . . . . 0.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.15 -27.47 17.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.702 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -122.84 5.71 9.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.648 -0.658 . . . . 0.0 110.079 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp 54.19 36.63 25.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -127.97 143.2 51.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.629 -0.669 . . . . 0.0 110.666 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.2 m-85 -95.99 -168.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 109.698 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 92.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -94.18 108.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.902 0.858 . . . . 0.0 110.915 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -89.52 169.68 11.15 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.1 m -61.16 95.17 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.575 -0.703 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 5.7 m-85 -83.68 142.53 30.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.895 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -103.34 -177.24 3.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.584 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 4.9 tp -163.26 110.17 1.17 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.653 -0.654 . . . . 0.0 109.967 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.6 mt -85.8 117.63 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.8 mm -85.72 116.9 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -102.93 63.64 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.88 -132.68 3.26 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -131.32 -40.84 1.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.935 . . . . 0.0 110.465 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -69.89 -47.29 63.12 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.449 -0.782 . . . . 0.0 109.62 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.81 156.89 20.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.811 -0.556 . . . . 0.0 109.829 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -172.34 86.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.432 -0.793 . . . . 0.0 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.55 161.46 27.43 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.71 73.75 9.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.727 -0.867 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.22 120.79 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -99.09 133.47 43.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.797 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.431 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.28 142.1 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.626 -0.671 . . . . 0.0 110.375 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.02 141.21 34.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.619 -0.676 . . . . 0.0 110.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.72 160.14 41.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 110.236 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.9 -32.99 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.242 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -166.13 -176.51 3.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 109.429 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -68.82 -30.29 68.82 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.665 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.19 87.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.706 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -70.33 -39.8 74.52 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.79 85.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.528 -0.732 . . . . 0.0 109.533 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.3 tt0 -58.61 -35.97 73.29 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -71.27 -51.33 25.09 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.0 -36.2 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 8.9 m-85 -75.72 -36.28 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -80.12 4.61 16.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.792 -0.567 . . . . 0.0 111.449 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -110.89 -45.49 3.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 12.2 t80 -55.48 -43.5 75.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.933 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -58.73 -47.26 85.21 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.35 -49.51 75.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.554 -0.716 . . . . 0.0 110.746 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.36 -23.52 38.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -100.8 -24.05 14.47 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.729 -0.607 . . . . 0.0 110.719 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.87 30.89 4.67 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.454 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.51 106.21 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.679 -0.894 . . . . 0.0 108.785 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.53 110.0 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.117 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.94 -106.32 0.2 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 3.2 tt0 -108.63 174.82 5.7 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.483 -1.01 . . . . 0.0 110.524 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.449 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 41.9 m95 -153.53 130.63 11.09 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.638 -0.664 . . . . 0.0 109.99 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -142.48 133.18 25.39 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -99.84 144.24 29.13 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.882 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -114.97 98.56 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.769 -0.582 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.16 -4.94 23.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.713 -0.617 . . . . 0.0 111.664 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 -27.13 18.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.677 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.1 p -127.9 7.38 6.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.658 -0.651 . . . . 0.0 110.175 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt 54.17 40.62 31.85 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -125.83 135.9 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.656 -0.652 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 74.8 m-85 -94.36 -170.36 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.579 -0.701 . . . . 0.0 109.525 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.3 94.15 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.853 -1.154 . . . . 0.0 107.89 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 3.0 p -96.66 107.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.02 0.914 . . . . 0.0 111.173 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -89.07 169.72 11.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.132 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 58.7 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.105 0.479 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 m -71.0 81.93 0.67 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 9.5 m-85 -66.41 144.49 56.49 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.04 179.81 4.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.575 -0.703 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD23 ' CD1' ' A' ' 31' ' ' PHE . 7.0 tp -157.36 112.15 2.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -89.57 122.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD11 ' CG1' ' A' ' 55' ' ' VAL . 3.2 mm -89.06 117.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.664 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -104.95 67.06 0.78 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.474 -0.767 . . . . 0.0 110.091 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.02 166.05 36.76 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -59.89 -28.76 67.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.443 -1.034 . . . . 0.0 110.291 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -92.45 129.59 38.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.622 -0.674 . . . . 0.0 109.619 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 mt 60.33 127.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.378 0.609 . . . . 0.0 110.586 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -148.75 93.6 2.15 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.15 -172.72 45.7 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.22 96.36 5.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.817 -0.813 . . . . 0.0 109.947 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.72 115.51 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 109.95 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -89.44 126.9 35.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.622 . . . . 0.0 110.282 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.87 135.28 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.615 -0.678 . . . . 0.0 110.491 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -73.87 153.1 40.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.592 -0.692 . . . . 0.0 110.134 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.66 160.22 12.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -53.14 -39.46 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.556 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.01 176.83 10.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.671 -0.643 . . . . 0.0 109.575 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.75 -33.35 74.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 109.746 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.2 -43.54 78.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 109.984 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.4 -44.18 68.51 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 -46.29 74.29 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.484 -0.76 . . . . 0.0 109.686 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 2.7 tt0 -58.16 -37.65 75.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.747 -0.596 . . . . 0.0 109.412 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -51.2 43.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.62 -40.39 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 13.2 m-85 -71.8 -34.85 69.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -77.15 0.17 22.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.647 -0.658 . . . . 0.0 111.5 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -108.06 -45.41 3.96 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.6 t80 -54.02 -35.89 62.42 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.139 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.441 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -71.0 -45.76 63.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.81 -0.556 . . . . 0.0 110.343 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -50.23 73.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 111.018 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.82 -21.92 32.61 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.455 -0.778 . . . . 0.0 110.978 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -101.19 -23.71 14.39 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.686 -0.634 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.3 31.09 4.78 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.49 105.34 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.595 -0.944 . . . . 0.0 108.92 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.29 112.22 6.27 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.074 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.46 -104.81 0.18 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 3.3 tt0 -112.19 173.78 6.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -1.022 . . . . 0.0 110.184 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.9 m95 -151.97 128.62 10.8 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.535 -0.728 . . . . 0.0 109.815 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -140.11 132.51 28.46 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.227 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.2 t80 -98.62 147.54 24.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.592 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.46 99.94 7.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.724 -0.61 . . . . 0.0 109.626 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.8 -4.9 26.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.724 -0.61 . . . . 0.0 111.579 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.36 -26.74 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.1 p -129.11 7.54 5.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.6 -0.687 . . . . 0.0 110.17 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.2 mmtp 54.59 40.29 31.75 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -124.7 139.72 53.6 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 76.0 m-85 -97.29 -172.09 2.35 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.556 -0.715 . . . . 0.0 109.741 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.32 91.85 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.0 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -93.0 105.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.897 0.856 . . . . 0.0 110.895 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -88.03 171.75 10.05 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -93.34 103.67 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 28.4 m-85 -88.5 151.33 22.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -115.04 -168.35 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 21.0 tp -166.2 107.37 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.82 105.16 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.2 mm -75.95 106.06 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.523 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 56' ' ' THR . 43.7 t30 -82.04 4.16 24.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.505 -0.747 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.82 -148.05 1.58 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -137.21 32.23 2.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.61 -0.936 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 p -147.23 17.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mt -170.81 36.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.63 97.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 110.994 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.57 177.59 43.63 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -44.33 4.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.702 -0.881 . . . . 0.0 110.181 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.0 mm 53.95 87.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.449 -0.782 . . . . 0.0 110.547 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -84.29 134.36 34.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.736 . . . . 0.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.421 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.49 147.85 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.621 -0.674 . . . . 0.0 110.401 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.17 151.93 22.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.259 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.49 160.71 18.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.342 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.69 -40.17 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -160.87 174.71 13.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -60.18 -27.45 67.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.373 -0.829 . . . . 0.0 109.953 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 -47.45 84.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -0.785 . . . . 0.0 109.748 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -69.88 -41.28 75.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.76 80.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.579 -0.701 . . . . 0.0 109.57 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -57.26 -39.88 76.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.632 -0.667 . . . . 0.0 109.235 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -65.62 -53.1 46.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.508 -0.745 . . . . 0.0 109.379 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -56.29 -39.39 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.523 -0.736 . . . . 0.0 109.102 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 11.8 m-85 -73.67 -36.62 65.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 4.0 mtmp? -79.48 3.32 18.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.701 -0.625 . . . . 0.0 111.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -45.21 3.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 9.4 t80 -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.974 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -62.53 -48.08 81.1 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.867 -0.521 . . . . 0.0 110.181 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.98 -48.52 78.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.539 -0.725 . . . . 0.0 110.622 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.37 -25.55 35.87 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.566 -0.709 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -99.82 -25.56 14.32 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.709 -0.619 . . . . 0.0 110.667 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.17 30.42 4.18 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.454 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 105.82 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.686 -0.891 . . . . 0.0 108.862 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -148.64 102.84 3.34 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.728 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.06 -73.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 29.4 mt-10 -136.0 171.64 14.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.498 -1.001 . . . . 0.0 110.042 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 47.7 m95 -155.26 126.91 7.41 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.65 -0.656 . . . . 0.0 110.045 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 p -144.39 132.79 21.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.4 t80 -95.26 141.65 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.803 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -111.26 100.08 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.736 -0.603 . . . . 0.0 109.739 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.5 -2.79 18.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.686 -0.634 . . . . 0.0 111.657 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.01 -25.93 17.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 109.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.9 p -130.58 8.77 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 110.229 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 56.7 mmtt 54.3 41.65 31.88 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.175 -0.953 . . . . 0.0 110.27 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.4 m -130.56 134.86 47.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 59.1 m-85 -89.28 -168.74 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.521 -0.737 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -155.92 105.3 2.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 108.172 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG23 ' CZ2' ' A' ' 44' ' ' TRP . 5.9 p -115.82 129.86 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.299 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -126.09 -172.04 2.53 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.185 179.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.413 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 52.8 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 m -63.54 85.8 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.713 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 5.3 m-85 -71.21 140.77 50.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.675 -0.641 . . . . 0.0 109.66 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -104.67 168.01 9.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' A' ' 31' ' ' PHE . 17.8 tp -141.9 105.57 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.8 mt -76.89 110.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' CG1' ' A' ' 55' ' ' VAL . 6.8 mm -84.21 112.94 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.121 -1.032 . . . . 0.0 109.79 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -97.86 155.49 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.476 -0.765 . . . . 0.0 110.064 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.7 -138.97 15.32 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -129.07 28.9 5.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.523 -0.986 . . . . 0.0 110.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' LYS . 19.2 p -136.09 145.26 45.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.623 -0.673 . . . . 0.0 109.905 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 mt 60.9 -76.69 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.733 -0.604 . . . . 0.0 111.16 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' THR . 24.6 mtpt 54.99 99.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.343 -0.848 . . . . 0.0 110.708 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.94 -174.22 31.75 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -136.03 86.3 2.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.895 . . . . 0.0 109.729 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -59.39 -25.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.552 -0.717 . . . . 0.0 110.789 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 p 60.69 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 121.43 0.634 . . . . 0.0 110.669 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.58 146.04 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.426 -0.796 . . . . 0.0 110.799 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -81.55 152.95 27.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.33 158.52 9.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 110.398 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.95 -38.92 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -161.26 -177.92 6.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.77 -28.11 68.78 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.46 69.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.23 -41.68 89.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.677 -0.639 . . . . 0.0 109.377 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.23 73.42 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.529 -0.732 . . . . 0.0 109.856 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.5 tt0 -57.94 -38.17 75.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -70.15 -51.91 27.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mt -58.04 -34.91 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.455 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 7.7 m-85 -77.66 -36.6 51.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -74.34 -2.0 23.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.698 -0.626 . . . . 0.0 111.402 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -108.56 -45.38 3.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 8.9 t80 -52.41 -35.44 51.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.936 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -68.11 -47.01 69.33 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.201 0.524 . . . . 0.0 109.987 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.7 -49.31 76.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -54.97 -23.32 18.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.524 -0.735 . . . . 0.0 111.081 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -102.34 -26.84 13.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.658 -0.651 . . . . 0.0 110.624 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.19 30.9 3.46 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.85 107.07 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.647 -0.913 . . . . 0.0 108.928 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -145.12 109.47 4.9 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.162 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -107.2 0.2 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -107.18 176.64 5.1 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.454 -1.027 . . . . 0.0 110.45 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.2 m95 -154.37 130.35 10.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.598 -0.689 . . . . 0.0 109.79 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -143.88 132.25 22.08 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.57 147.61 24.11 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.851 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.44 98.68 6.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.715 -0.615 . . . . 0.0 109.746 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.97 -5.65 27.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.636 -0.665 . . . . 0.0 111.419 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.96 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.555 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -126.59 8.01 6.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.655 . . . . 0.0 110.069 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp 53.57 40.03 30.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.146 -0.971 . . . . 0.0 110.281 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -127.65 142.96 51.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.597 -0.689 . . . . 0.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 72.0 m-85 -98.9 -170.14 1.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.626 -0.671 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.11 94.58 1.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 40' ' ' ILE . 3.0 p -97.43 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.915 0.864 . . . . 0.0 111.173 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 166.25 20.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.257 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.1 m . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.976 0.417 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.6 m 49.86 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 6.4 m-85 -87.36 142.49 27.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.638 -0.664 . . . . 0.0 109.654 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -100.1 -176.45 3.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 1.2 tp -164.43 112.65 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.443 -0.786 . . . . 0.0 110.342 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.45 118.12 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.4 mp -90.21 116.38 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.013 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -92.88 151.99 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.0 110.254 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.52 -155.41 16.27 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.11 31.48 6.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.924 . . . . 0.0 110.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -93.34 -147.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.674 -0.642 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.404 ' CD1' ' N ' ' A' ' 14' ' ' LYS . 4.3 pp -53.91 -36.48 62.78 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 111.309 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 13' ' ' LEU . 4.6 mtpt 50.9 99.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 111.538 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.12 -167.55 37.78 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.334 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -115.74 -64.84 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.814 -0.815 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 17' ' ' ILE . 83.1 mt 52.36 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.372 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.3 p -59.27 150.19 26.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.44 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -143.32 134.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.519 -0.738 . . . . 0.0 110.89 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.99 138.37 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.94 154.65 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -54.44 -38.67 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.78 179.92 8.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.664 . . . . 0.0 109.429 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.29 -34.42 78.29 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.749 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.95 75.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.91 -44.61 65.85 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.06 74.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -59.65 -39.16 83.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.626 -0.671 . . . . 0.0 109.275 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -68.37 -50.06 55.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.184 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.98 -37.49 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 7.3 m-85 -75.97 -38.29 57.66 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.413 0.625 . . . . 0.0 109.321 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.9 mmtp -71.62 -5.09 31.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.777 -0.577 . . . . 0.0 111.479 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.97 -45.16 4.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.284 0.7 OUTLIER -51.22 -38.04 50.25 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.039 176.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -66.89 -47.95 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.252 0.549 . . . . 0.0 110.246 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -56.53 -51.28 69.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.521 -0.737 . . . . 0.0 110.919 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -57.11 -21.13 29.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.548 -0.72 . . . . 0.0 111.082 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -101.61 -25.57 13.83 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.81 28.7 4.94 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.54 105.85 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.653 -0.91 . . . . 0.0 108.581 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -143.24 108.94 5.12 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.53 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.22 -109.89 0.23 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.31 177.75 4.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.41 -1.053 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.446 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 39.8 m95 -155.83 130.52 9.09 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.538 -0.726 . . . . 0.0 109.687 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -145.45 134.89 23.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.454 -0.779 . . . . 0.0 109.202 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.6 t80 -98.81 148.28 24.06 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.28 96.72 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -69.05 -6.68 29.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.699 -0.626 . . . . 0.0 111.403 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.78 20.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 109.605 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -124.76 7.5 8.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.758 -0.589 . . . . 0.0 110.121 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 53.99 38.57 29.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.2 m -128.54 134.76 48.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.691 . . . . 0.0 110.751 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 60.0 m-85 -90.9 -168.97 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.92 97.42 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 3.2 p -101.42 103.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.121 0.962 . . . . 0.0 111.253 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -82.35 171.62 13.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.033 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -84.13 104.29 14.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CZ ' ' CB ' ' A' ' 24' ' ' ALA . 24.3 m-85 -88.83 151.32 22.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -113.19 -170.83 1.76 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 27.1 tp -163.69 99.97 0.9 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 110.233 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.78 115.35 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 13' ' ' LEU . 15.6 mm -82.64 103.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.745 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.8 t30 -71.24 167.06 20.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.496 -0.752 . . . . 0.0 110.238 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 -153.17 26.32 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.76 36.03 4.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.954 . . . . 0.0 109.917 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 -151.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.635 -0.666 . . . . 0.0 110.097 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' CD1' HG13 ' A' ' 8' ' ' ILE . 2.5 pp -48.75 -26.95 2.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 111.027 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.66 103.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.637 -0.664 . . . . 0.0 111.576 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.41 153.36 8.18 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.437 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -108.77 54.73 0.65 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.834 -0.804 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 tt -50.99 128.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.303 -0.873 . . . . 0.0 110.779 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.5 p -99.13 141.05 32.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.332 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.454 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.7 pp -142.99 143.14 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.669 . . . . 0.0 110.548 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -83.85 146.36 28.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.88 159.01 29.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.731 . . . . 0.0 110.454 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.14 -39.32 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.754 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -159.76 176.65 11.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.53 -29.96 70.94 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.738 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.75 80.58 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.819 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.99 -41.35 77.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.08 -44.25 82.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.634 -0.666 . . . . 0.0 109.529 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -59.33 -37.9 78.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.71 -0.619 . . . . 0.0 109.368 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -50.7 46.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.268 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.81 -36.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 8.4 m-85 -77.06 -37.09 55.36 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 6.2 mmmt -77.68 1.69 19.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.662 -0.649 . . . . 0.0 111.351 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -108.8 -45.17 3.87 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 1.5 t80 -53.08 -38.47 62.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.068 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.47 -49.36 71.7 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -57.5 -48.51 79.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.513 -0.742 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.24 -23.55 36.65 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.395 -0.816 . . . . 0.0 110.956 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -101.34 -25.28 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.691 -0.631 . . . . 0.0 110.599 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.63 32.39 3.65 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.21 106.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.69 -0.888 . . . . 0.0 108.765 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -148.65 103.2 3.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.749 -0.594 . . . . 0.0 110.948 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.77 -58.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.5 tp10 -152.19 174.8 13.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.576 -0.955 . . . . 0.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 43.3 m95 -158.42 127.54 5.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.67 -0.644 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -145.03 132.43 20.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.627 -0.671 . . . . 0.0 109.521 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.4 t80 -96.2 146.64 24.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.95 98.43 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.774 -0.579 . . . . 0.0 109.533 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.18 -6.06 31.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.95 -27.07 18.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -124.77 5.81 8.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.603 -0.686 . . . . 0.0 110.05 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.9 mmtt 54.39 40.72 31.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -132.63 137.79 47.13 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.124 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.2 m-85 -92.36 -172.94 3.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.578 -0.701 . . . . 0.0 109.353 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.62 105.12 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 108.548 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 5.9 p -115.22 133.37 61.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.658 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -120.88 -174.35 2.8 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.774 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.144 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 28.8 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.04 0.448 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -66.94 85.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.474 -0.766 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 10.6 m-85 -70.2 142.01 52.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.685 -0.634 . . . . 0.0 109.817 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.3 177.22 4.86 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.541 -0.724 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.441 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 25.6 tp -152.53 109.71 3.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 7' ' ' ILE . 45.3 mm -81.37 108.44 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mm -84.92 118.78 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.957 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -110.95 140.66 45.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.69 -149.66 21.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -121.58 14.64 11.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.005 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -113.57 -56.68 2.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mt -115.01 167.55 10.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.795 -0.566 . . . . 0.0 109.501 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.46 92.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 110.701 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.28 173.99 24.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -100.71 156.76 17.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.799 -0.824 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.77 -16.65 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.601 -0.687 . . . . 0.0 110.53 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 p 46.32 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.579 -0.701 . . . . 0.0 111.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -132.26 132.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.476 -0.765 . . . . 0.0 110.372 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.14 150.45 38.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.644 -0.66 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.17 163.01 28.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.636 . . . . 0.0 110.4 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.55 -34.24 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -166.93 176.26 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.729 -0.607 . . . . 0.0 109.376 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.76 -29.88 71.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.89 87.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.95 -42.71 69.44 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.29 84.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.617 -0.677 . . . . 0.0 109.558 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -59.08 -34.18 71.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 109.487 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -71.09 -52.35 19.93 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.91 -35.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 7.8 m-85 -75.55 -38.95 58.9 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.9 mtpt -79.84 5.25 14.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 111.49 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -110.04 -45.4 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.0 t80 -54.05 -43.72 70.44 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.177 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.0 -49.11 78.95 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.834 -0.541 . . . . 0.0 110.197 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -56.91 -48.39 78.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.727 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.56 -21.57 39.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.599 -0.688 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.09 -27.87 12.31 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.599 -0.688 . . . . 0.0 110.596 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.25 29.63 3.65 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.76 110.49 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.918 . . . . 0.0 109.035 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.22 110.22 3.9 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.335 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.43 -97.69 0.13 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -123.78 129.01 50.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.39 -1.065 . . . . 0.0 111.483 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.452 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 48.1 m95 -107.6 135.9 48.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.428 -0.795 . . . . 0.0 110.405 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p -145.63 131.83 19.45 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -99.19 141.05 32.46 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.774 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -110.9 100.9 9.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.641 -0.662 . . . . 0.0 109.596 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.99 -4.26 23.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.664 -0.648 . . . . 0.0 111.637 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.77 19.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -131.9 8.47 4.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 110.13 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp 54.03 42.94 31.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.216 -0.928 . . . . 0.0 110.233 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -125.75 129.74 50.08 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.626 -0.671 . . . . 0.0 110.787 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 84.2 m-85 -87.46 -173.41 4.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.502 -0.749 . . . . 0.0 109.705 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.32 99.01 1.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -101.77 101.43 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.869 0.843 . . . . 0.0 111.105 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.62 171.96 14.36 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.135 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.485 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.8 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.969 0.414 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m 50.1 72.23 0.34 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.275 -0.891 . . . . 0.0 111.075 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 13.3 m-85 -67.86 139.61 56.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -178.84 3.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -159.52 109.39 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.664 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 7' ' ' ILE . 84.6 mt -85.07 124.89 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 13' ' ' LEU . 1.7 mm -98.71 115.38 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.089 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -93.12 152.58 19.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.74 . . . . 0.0 109.54 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.18 -151.84 18.31 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -116.85 -24.48 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.543 -0.975 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -58.87 -60.52 3.72 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CB ' ' CG2' ' A' ' 8' ' ' ILE . 4.7 mt -120.32 174.52 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.117 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -175.38 75.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.817 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.68 -176.33 34.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -108.61 -28.16 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.779 -0.836 . . . . 0.0 110.381 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt 65.93 -60.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 O-C-N 121.879 -0.513 . . . . 0.0 111.568 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p 61.49 118.63 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.477 -0.764 . . . . 0.0 110.546 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.425 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -148.99 133.93 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.573 -0.704 . . . . 0.0 110.286 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.68 145.22 36.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.595 -0.691 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.03 165.69 34.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.745 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.78 -39.62 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.545 -0.722 . . . . 0.0 110.447 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -161.17 177.26 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.728 -0.608 . . . . 0.0 109.375 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.63 -29.5 70.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 0.0 109.731 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.72 -52.49 63.73 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.02 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -64.13 -42.77 96.7 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.85 75.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 109.601 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 23.6 tt0 -58.73 -37.31 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.315 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -52.64 36.98 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.83 -40.53 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.9 m-85 -72.1 -38.83 69.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 5.9 mmtp -73.88 -2.43 23.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.669 -0.644 . . . . 0.0 111.522 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -107.2 -44.94 4.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 1.4 t80 -52.44 -36.81 55.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.206 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -68.12 -50.98 51.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.758 -0.589 . . . . 0.0 110.23 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -56.25 -49.88 72.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 110.903 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -23.97 41.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.402 -0.811 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -99.16 -26.89 14.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.776 -0.577 . . . . 0.0 110.395 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 30.0 4.0 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.39 107.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.584 -0.95 . . . . 0.0 109.007 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -151.78 100.62 2.69 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.647 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.93 -55.27 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 29.3 tt0 -145.47 169.56 18.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.479 -1.012 . . . . 0.0 110.535 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.461 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 46.6 m95 -159.95 125.62 4.13 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.849 -0.532 . . . . 0.0 109.687 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -145.81 131.68 19.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 109.371 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.4 t80 -96.63 151.19 19.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.702 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -124.73 99.45 6.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.676 -0.64 . . . . 0.0 109.592 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.77 -4.25 22.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.654 . . . . 0.0 111.523 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.94 -27.79 19.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -127.92 7.53 6.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 54.82 42.13 31.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.9 m -130.22 141.79 50.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 110.91 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.5 m-85 -98.44 -173.97 2.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.523 -0.736 . . . . 0.0 109.104 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 102.29 2.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.863 -1.148 . . . . 0.0 108.688 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 7.6 p -117.19 146.24 21.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.165 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -138.12 177.9 7.53 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.231 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.415 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 46.3 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.995 0.426 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 m -62.91 94.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.591 -0.693 . . . . 0.0 110.102 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 24.5 m-85 -78.05 149.25 33.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.067 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -108.71 -174.45 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 110.389 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.436 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 12.7 tp -163.13 97.92 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.16 117.06 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 55' ' ' VAL . 9.9 mm -85.03 110.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.861 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.483 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 41.4 t30 -85.41 7.28 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.72 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.88 -174.67 41.15 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -110.77 26.67 10.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.928 . . . . 0.0 110.379 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 p -125.94 24.51 6.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.617 -0.677 . . . . 0.0 110.284 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mt -172.69 -67.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.76 . . . . 0.0 110.034 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.742 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.67 144.1 3.99 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -102.14 61.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.645 -0.914 . . . . 0.0 110.738 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 34' ' ' TYR . 6.4 pt -57.42 148.08 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.208 -0.932 . . . . 0.0 110.152 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 p -115.72 136.07 53.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.888 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.07 145.78 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.556 -0.715 . . . . 0.0 110.314 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 155.83 24.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.609 -0.682 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.36 159.2 8.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.62 -39.26 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -159.25 173.35 16.47 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -60.55 -35.78 76.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.405 -0.809 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.18 -46.76 72.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.467 -0.771 . . . . 0.0 109.925 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.67 -45.19 79.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.31 -39.48 69.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.419 -0.8 . . . . 0.0 109.819 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -62.12 -39.54 92.89 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.43 -34.48 65.46 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.353 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.489 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 98.0 mt -68.59 -39.66 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 9.9 m-85 -73.31 -36.89 66.31 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 30.1 mttt -75.74 -2.44 29.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.732 -0.605 . . . . 0.0 111.301 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -104.13 -44.97 4.85 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE2' HD12 ' A' ' 17' ' ' ILE 0.293 8.8 t80 -53.56 -42.14 67.23 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.731 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.72 -52.16 58.59 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.813 -0.555 . . . . 0.0 110.135 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.19 -49.14 74.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.725 . . . . 0.0 110.679 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.77 -23.48 18.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.58 -0.7 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -102.31 -28.14 12.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.733 -0.604 . . . . 0.0 110.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 30.08 2.96 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 106.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.985 . . . . 0.0 109.002 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -150.17 105.82 3.41 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.27 0.557 . . . . 0.0 110.715 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.8 -57.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 15.1 tt0 -148.55 171.97 15.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.564 -0.963 . . . . 0.0 110.224 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 45.9 m95 -157.22 128.56 6.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.69 -0.631 . . . . 0.0 109.859 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -145.8 131.96 19.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.615 -0.678 . . . . 0.0 109.409 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.1 t80 -97.49 127.17 43.24 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.59 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.65 98.88 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.651 -0.655 . . . . 0.0 109.316 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.88 -5.41 25.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.65 -0.656 . . . . 0.0 111.583 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.46 21.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 109.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -128.4 8.06 5.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 110.171 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt 54.95 40.38 31.99 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -125.11 125.48 43.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.2 m-85 -80.26 -176.12 5.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.359 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.13 106.67 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.939 -1.1 . . . . 0.0 108.235 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 6.3 p -117.09 133.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.101 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 9' ' ' ASN . 1.3 t -124.41 -170.04 2.08 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.908 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.195 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 95.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.977 0.418 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m 50.24 79.77 0.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.258 -0.901 . . . . 0.0 111.252 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 13.9 m-85 -78.45 147.82 33.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -112.45 -172.25 2.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.511 -0.743 . . . . 0.0 110.17 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 31' ' ' PHE . 19.3 tp -163.08 105.68 1.02 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.444 -0.785 . . . . 0.0 110.204 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.55 114.86 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -89.95 113.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.722 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.37 -161.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.229 -0.919 . . . . 0.0 109.285 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -163.1 13.65 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -114.58 28.18 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.607 -0.937 . . . . 0.0 110.406 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -66.25 -78.21 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 14' ' ' LYS . 4.5 pp -132.21 -27.26 1.82 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.728 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' HD13 ' A' ' 13' ' ' LEU . 70.2 mttt 56.69 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.452 -0.78 . . . . 0.0 111.492 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.37 161.33 20.73 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -130.6 58.31 1.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.884 -0.774 . . . . 0.0 109.711 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.99 110.97 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.549 -0.72 . . . . 0.0 109.755 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.84 144.84 41.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.969 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.407 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.33 133.11 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.6 153.6 35.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.522 -0.736 . . . . 0.0 110.162 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.14 162.3 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.65 -0.656 . . . . 0.0 110.31 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -53.8 -39.1 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.692 . . . . 0.0 110.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -163.51 177.19 9.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 109.526 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -61.43 -29.66 70.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.05 -49.77 72.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 0.0 110.008 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.33 -43.36 81.8 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.49 71.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.57 -0.706 . . . . 0.0 109.856 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.7 tt0 -58.29 -36.75 73.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.64 -0.663 . . . . 0.0 109.332 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.01 -52.24 25.73 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -57.53 -37.58 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.99 -36.69 62.0 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 49.2 mtpt -77.86 2.28 17.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.665 -0.647 . . . . 0.0 111.371 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -105.7 -45.83 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 1.4 t80 -53.38 -46.7 69.73 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.928 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -57.85 -49.25 77.32 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.635 -0.665 . . . . 0.0 110.139 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.81 -50.59 72.78 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.647 -0.658 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -56.46 -24.56 46.52 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.483 -0.761 . . . . 0.0 110.69 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.44 -26.55 14.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.694 -0.628 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.64 33.69 3.26 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -99.11 114.47 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -157.58 104.44 1.99 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.308 0.575 . . . . 0.0 110.945 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.53 -47.15 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 45.0 tt0 -142.2 164.97 28.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.47 -1.017 . . . . 0.0 110.75 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.4 m95 -164.1 112.33 1.15 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 p -137.9 131.05 30.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 109.738 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.9 t80 -93.84 143.66 26.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.78 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -114.7 98.28 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.786 -0.571 . . . . 0.0 109.522 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -70.17 -4.76 23.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.584 -0.697 . . . . 0.0 111.598 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.81 -27.76 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -126.14 7.62 7.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.604 . . . . 0.0 110.087 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp 53.85 41.53 32.02 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.185 -0.947 . . . . 0.0 110.192 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 m -132.31 137.23 47.37 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.68 -0.637 . . . . 0.0 110.762 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 60.2 m-85 -92.0 -172.74 3.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.697 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 103.57 2.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 108.478 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -118.63 152.95 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.198 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.42 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 5.6 t -156.16 -162.44 1.29 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.904 -0.497 . . . . 0.0 109.986 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.049 179.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 72.1 m . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.179 0.514 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -77.42 92.99 4.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.544 -0.722 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 14.2 m-85 -76.74 144.77 39.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.688 -0.633 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -106.6 -179.2 3.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 0.0 110.041 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.441 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -158.09 110.11 2.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.574 -0.704 . . . . 0.0 109.823 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.43 124.81 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.418 HD11 ' CG1' ' A' ' 55' ' ' VAL . 7.0 mm -89.95 108.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.83 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -92.92 54.6 2.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 110.121 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.05 -131.65 2.92 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.43 50.59 0.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.945 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 p -138.72 -59.91 0.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.705 . . . . 0.0 110.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 34' ' ' TYR . 21.8 mt -95.26 -54.58 3.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.367 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.96 82.62 0.07 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.432 -0.792 . . . . 0.0 110.599 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.88 -167.82 37.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.42 -50.88 2.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.915 . . . . 0.0 110.545 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.4 mm 53.7 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.356 -0.84 . . . . 0.0 110.188 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -76.55 133.81 39.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.623 -0.673 . . . . 0.0 110.555 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.439 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -137.32 140.86 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.571 -0.705 . . . . 0.0 110.276 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.32 150.4 28.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.58 161.56 23.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.676 -0.64 . . . . 0.0 110.248 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.66 -39.61 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.557 -0.714 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -158.77 175.99 12.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -63.0 -33.27 75.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.24 69.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.0 109.852 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -63.53 -43.11 98.09 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.36 70.25 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.467 -0.77 . . . . 0.0 109.84 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.2 tt0 -58.71 -36.56 74.47 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.37 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -67.53 -52.97 32.6 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.21 -38.83 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 13.3 m-85 -74.31 -34.57 63.53 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 18.2 mmmt -74.92 -3.25 31.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.75 -0.594 . . . . 0.0 111.22 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -105.74 -45.65 4.34 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 13' ' ' LEU 0.29 6.7 t80 -50.84 -32.46 20.28 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.809 175.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.58 -63.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.74 0.781 . . . . 0.0 109.277 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -55.46 -41.68 73.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.111 0.481 . . . . 0.0 110.914 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.5 -27.2 4.04 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.4 -56.21 2.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.371 0.605 . . . . 0.0 110.049 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.67 61.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -117.97 134.93 59.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.838 -0.801 . . . . 0.0 109.816 -177.536 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.31 106.42 0.57 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.837 . . . . 0.0 111.195 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.08 -107.46 0.2 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -115.84 176.23 5.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.467 -1.019 . . . . 0.0 110.166 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 36.2 m95 -151.72 129.18 11.37 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.638 -0.664 . . . . 0.0 109.881 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -140.74 134.28 30.05 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.301 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.6 t80 -99.41 148.84 23.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -120.71 98.25 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 -6.32 30.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.646 -0.659 . . . . 0.0 111.478 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.6 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 109.557 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 6.54 8.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.624 -0.672 . . . . 0.0 110.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.3 mmtp 54.07 38.25 28.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.0 m -126.39 143.13 51.28 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.038 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.9 m-85 -99.54 -169.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.533 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -157.27 90.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.803 -1.186 . . . . 0.0 108.254 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.7 p -90.4 97.94 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.794 0.806 . . . . 0.0 110.688 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -78.25 170.89 15.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.327 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 38.0 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.113 0.483 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.6 m -69.2 105.7 2.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 110.085 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 43.9 m-85 -88.31 140.26 29.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.672 -0.643 . . . . 0.0 110.443 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -104.98 -174.81 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 7.6 tp -161.21 110.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.86 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' GLY . 74.3 mt -97.64 133.41 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.418 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 21.7 mm -87.66 107.48 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.95 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -75.61 66.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.762 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.62 -135.98 1.95 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -171.19 50.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.518 -0.989 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.3 m -140.2 23.8 2.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.518 -0.739 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.61 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.48 -0.762 . . . . 0.0 111.066 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 55.68 110.19 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.331 -0.855 . . . . 0.0 110.752 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -145.43 135.93 6.23 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.255 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -162.67 28.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 122.08 -0.659 . . . . 0.0 109.67 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.0 -171.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.1 p -138.61 129.12 26.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.424 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -135.56 136.09 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 110.82 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.18 160.17 20.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.613 -0.679 . . . . 0.0 110.043 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.41 171.25 7.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.77 -36.43 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.533 -0.729 . . . . 0.0 110.424 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -166.93 173.38 9.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.67 -0.644 . . . . 0.0 109.336 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.58 -31.39 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -46.83 76.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -45.69 77.76 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.03 -45.02 67.81 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 109.759 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.28 -38.09 76.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.656 -0.652 . . . . 0.0 109.383 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -68.61 -52.83 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.612 -0.68 . . . . 0.0 109.182 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -55.66 -40.38 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 11.5 m-85 -72.29 -32.64 66.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -80.4 4.41 18.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.761 -0.587 . . . . 0.0 111.102 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -104.56 -45.51 4.61 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.299 1.1 t80 -50.34 -40.66 49.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.15 -1.387 . . . . 0.0 108.827 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.53 -44.68 86.15 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.039 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.389 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.0 -23.61 20.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.57 -0.706 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -103.66 -20.68 13.9 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.56 36.55 4.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.477 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -99.03 119.44 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.91 . . . . 0.0 109.186 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -152.16 71.63 0.97 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.373 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -112.22 2.34 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER -108.65 174.13 6.01 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.489 -1.006 . . . . 0.0 110.533 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 43.1 m95 -151.11 134.46 16.15 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.632 -0.667 . . . . 0.0 110.0 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.2 p -142.94 133.0 24.32 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.369 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -97.52 147.29 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.608 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -119.05 102.0 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.617 -0.677 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.4 -5.64 29.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.718 -0.614 . . . . 0.0 111.411 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.59 -28.76 20.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.9 p -127.2 7.17 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.703 . . . . 0.0 110.06 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 54.44 38.26 29.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.188 -0.945 . . . . 0.0 110.203 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -124.49 149.69 46.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.0 110.489 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 68.0 m-85 -102.17 -169.33 1.66 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.515 -0.741 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.7 92.6 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.7 p -91.64 104.8 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.907 0.861 . . . . 0.0 110.649 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -78.13 156.55 29.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.137 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.2 m -72.04 103.04 3.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.568 -0.708 . . . . 0.0 110.18 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 25.9 m-85 -88.44 149.01 23.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -113.63 -173.84 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 110.099 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 16.9 tp -160.47 109.14 1.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.526 -0.734 . . . . 0.0 110.16 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.28 120.12 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.424 HD11 ' CG1' ' A' ' 55' ' ' VAL . 6.2 mm -84.84 114.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.401 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.49 53.47 0.83 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.529 -0.732 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.1 1.9 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -166.34 47.52 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.585 -0.95 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.7 m -140.54 -45.7 0.41 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.67 -0.644 . . . . 0.0 109.995 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 12.3 mt -106.88 -57.71 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 52.84 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.16 172.2 43.14 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -127.58 59.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.888 . . . . 0.0 110.098 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.89 136.4 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.824 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -103.35 136.69 42.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.246 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.429 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.3 135.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -78.3 154.31 31.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.571 -0.706 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.37 164.15 17.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.388 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.82 -39.49 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.48 -0.762 . . . . 0.0 110.518 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -161.44 173.53 14.76 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -61.67 -29.09 69.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 -45.86 85.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 109.631 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.84 -42.24 77.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.51 81.97 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.611 -0.68 . . . . 0.0 109.488 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.4 tt0 -58.63 -37.22 75.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.289 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -68.73 -51.56 40.12 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.93 -40.34 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 13.1 m-85 -71.63 -36.96 70.91 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -77.78 1.9 18.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.62 -0.675 . . . . 0.0 111.43 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -106.5 -45.41 4.26 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.292 8.7 t80 -52.97 -31.74 42.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.743 175.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.455 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -67.26 -63.24 1.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.705 0.764 . . . . 0.0 109.234 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -55.31 -40.99 71.77 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.082 0.468 . . . . 0.0 110.72 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.82 -27.06 4.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.672 -0.642 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -107.15 -53.26 2.64 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.367 0.603 . . . . 0.0 110.192 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.83 62.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -119.24 134.73 61.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.896 -0.767 . . . . 0.0 109.898 -177.352 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -169.68 100.03 0.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.324 -0.86 . . . . 0.0 111.242 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.57 -101.44 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -125.23 134.65 52.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.463 -1.022 . . . . 0.0 110.941 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 43.7 m95 -112.98 132.52 55.32 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -144.43 132.53 21.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.92 137.77 36.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.731 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -107.75 98.72 8.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.69 -0.631 . . . . 0.0 109.524 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -69.07 -6.69 29.82 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.652 -0.655 . . . . 0.0 111.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.25 19.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.9 p -124.62 6.81 8.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.67 . . . . 0.0 110.121 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt 54.41 38.98 30.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.178 -0.952 . . . . 0.0 110.086 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.5 m -126.84 138.39 53.33 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.582 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.9 m-85 -92.45 -171.53 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.475 -0.766 . . . . 0.0 109.574 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.92 98.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.7 p -99.31 90.38 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.697 0.761 . . . . 0.0 111.062 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 170.97 9.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.305 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.453 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.8 m . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.161 0.505 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -63.27 95.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.444 -0.785 . . . . 0.0 109.937 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 12.5 m-85 -79.7 140.53 36.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 110.23 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.06 179.64 4.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 13.3 tp -154.11 108.22 3.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.446 -0.784 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.7 mt -84.31 120.96 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.06 112.6 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.087 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -95.27 148.63 22.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -138.62 14.18 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -132.42 42.74 3.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.976 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' LYS . 1.5 m -150.02 147.22 27.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.603 -0.686 . . . . 0.0 109.702 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 34' ' ' TYR . 6.3 mt 61.59 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.864 -0.522 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' THR . 57.7 mttt 55.4 97.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.311 -0.868 . . . . 0.0 110.51 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.51 -176.42 44.74 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.54 -53.14 2.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.513 -0.992 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.9 mm 52.94 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -79.75 133.8 36.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 110.164 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.435 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.49 137.26 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.56 154.77 32.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.657 -0.652 . . . . 0.0 110.488 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.83 162.82 16.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.99 -38.93 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.592 -0.693 . . . . 0.0 110.425 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -161.61 174.56 13.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -60.26 -28.86 68.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 109.827 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.65 72.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 109.83 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.3 -43.38 98.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.78 80.99 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.645 -0.659 . . . . 0.0 109.553 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.1 tt0 -59.73 -33.74 72.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.704 -0.622 . . . . 0.0 109.48 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -75.98 -45.25 35.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 66.8 mt -62.7 -38.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.7 m-85 -73.23 -37.99 66.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 21.3 mttt -73.64 -2.87 24.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 111.378 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -104.1 -45.33 4.75 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 13' ' ' LEU 0.292 4.4 t80 -50.41 -37.14 36.15 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.103 176.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.53 -47.17 76.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.276 0.56 . . . . 0.0 110.161 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -58.98 -47.17 86.12 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.584 -0.697 . . . . 0.0 110.546 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.47 -19.49 48.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.614 -0.679 . . . . 0.0 110.811 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -104.41 -27.68 11.8 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.559 -0.713 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.3 31.5 3.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -97.17 120.91 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.909 . . . . 0.0 109.402 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -152.47 108.1 3.32 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.317 0.579 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.69 -110.5 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -109.33 177.04 4.87 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -1.012 . . . . 0.0 110.672 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 43.8 m95 -153.15 132.8 13.05 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.605 -0.684 . . . . 0.0 109.803 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.3 p -144.15 132.72 22.23 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 t80 -98.56 138.92 35.06 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.848 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -108.15 100.67 9.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.561 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.12 -5.36 26.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.586 -0.696 . . . . 0.0 111.549 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.28 -28.01 18.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.553 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -126.21 6.89 7.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.665 -0.647 . . . . 0.0 110.213 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 54.3 39.35 30.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.125 -0.984 . . . . 0.0 109.946 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m -124.7 140.99 52.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.655 -0.653 . . . . 0.0 110.549 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 73.8 m-85 -95.79 -171.53 2.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 0.0 109.538 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.28 93.27 1.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -94.16 106.73 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.917 0.865 . . . . 0.0 111.019 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -86.11 170.39 12.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.218 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.867 0.365 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m 50.17 78.01 0.11 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.14 -0.975 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.468 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 10.5 m-85 -75.52 144.57 41.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.552 -0.718 . . . . 0.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -106.39 -174.4 2.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.615 -0.678 . . . . 0.0 109.926 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 17.9 tp -160.77 102.79 1.33 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.47 133.32 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mm -101.85 119.33 49.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.986 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -67.85 -52.15 40.08 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.844 . . . . 0.0 110.255 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -156.08 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.07 15.39 4.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.907 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -60.02 -69.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.212 -0.93 . . . . 0.0 109.438 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD21 ' CE1' ' A' ' 34' ' ' TYR . 1.5 pp -122.47 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 20.5 ptmt -33.74 137.25 0.1 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.13 30.44 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.598 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -140.82 47.57 1.74 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 tp -51.4 115.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -83.76 144.91 29.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.636 -0.665 . . . . 0.0 110.009 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -143.19 134.74 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.56 137.8 39.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.7 -0.625 . . . . 0.0 110.14 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.39 37.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.63 -0.669 . . . . 0.0 110.228 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.77 -39.95 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.0 110.586 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -159.62 179.47 8.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.622 . . . . 0.0 109.398 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.29 -29.15 70.24 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.679 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.0 70.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.19 -41.93 85.04 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -48.32 72.09 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.541 -0.724 . . . . 0.0 109.881 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.566 -0.709 . . . . 0.0 109.368 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -69.04 -52.44 28.57 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -58.49 -36.58 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 7.4 m-85 -75.28 -38.93 60.15 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 24.2 mtpt -76.14 0.4 19.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 111.657 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -105.96 -45.27 4.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CE1' HD21 ' A' ' 13' ' ' LEU 0.287 2.2 t80 -51.12 -38.8 54.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.933 176.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.437 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.62 -48.85 70.83 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -60.47 -48.17 82.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.517 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -55.69 -25.29 39.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.51 -0.743 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -99.51 -27.68 13.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.722 -0.611 . . . . 0.0 110.287 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.36 45.27 1.17 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.437 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -107.87 126.59 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.668 -0.901 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.33 101.97 1.08 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.545 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.48 -57.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 62.5 mt-10 -149.49 169.19 21.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.465 -1.02 . . . . 0.0 110.634 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 50.1 m95 -159.76 121.0 3.18 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -143.08 132.13 23.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.593 -0.692 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.1 t80 -96.8 144.32 26.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.042 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.15 99.76 7.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.0 -5.32 25.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.651 -0.655 . . . . 0.0 111.499 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.86 20.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -129.01 8.22 5.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.625 -0.672 . . . . 0.0 110.131 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 15.9 mmtm 53.78 41.57 32.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m -126.44 130.91 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.596 -0.69 . . . . 0.0 110.69 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 69.6 m-85 -88.32 -173.61 4.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.503 -0.748 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.14 102.57 2.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.99 -1.069 . . . . 0.0 108.664 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.9 p -115.91 141.81 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 111.19 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 2.9 t -141.08 -174.23 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.961 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.242 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.408 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 24.7 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 m -75.85 103.8 6.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.517 -0.739 . . . . 0.0 110.078 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 57.0 m-85 -86.99 140.46 29.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.615 -0.678 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -107.23 -168.01 1.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 110.006 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 11.8 tp -163.56 100.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 110.158 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -83.54 132.46 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 7.1 mm -102.48 119.28 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.141 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -69.16 -26.68 64.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.449 -0.782 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.19 37.49 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -102.56 -23.96 13.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.947 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -59.04 124.7 20.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.354 -0.841 . . . . 0.0 110.011 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 50.63 27.21 2.82 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 110.133 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -46.3 124.56 5.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.217 -0.927 . . . . 0.0 111.873 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.17 -165.92 30.91 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -132.99 67.53 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.727 -0.867 . . . . 0.0 110.049 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mt -60.25 138.48 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.422 -0.799 . . . . 0.0 109.849 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -110.54 138.5 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.663 -0.648 . . . . 0.0 110.833 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.425 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -144.18 142.47 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 157.01 18.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.551 -0.718 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.57 167.15 11.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.55 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -54.41 -39.29 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 110.42 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -162.31 174.62 12.57 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.67 -29.17 69.9 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.44 81.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.03 -42.97 72.25 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.91 78.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.648 -0.657 . . . . 0.0 109.528 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.2 tt0 -58.12 -39.66 79.26 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -50.83 48.27 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.2 -39.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 9.2 m-85 -73.55 -37.5 65.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 11.8 mtpp -81.49 8.16 10.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.676 -0.64 . . . . 0.0 111.367 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -111.65 -46.86 3.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 9.2 t80 -52.99 -41.1 64.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.146 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.25 -49.15 78.12 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.783 -0.573 . . . . 0.0 109.753 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.65 -47.46 81.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.764 -0.585 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -23.46 29.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.578 -0.701 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.88 -30.21 10.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.731 -0.606 . . . . 0.0 110.004 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.68 50.7 0.55 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 13' ' ' LEU . 1.3 mp -115.34 132.63 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.453 -1.028 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -168.12 98.16 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.722 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.31 -56.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 37.2 mt-10 -149.01 169.22 21.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.458 -1.025 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 49.6 m95 -160.39 121.99 3.12 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -145.42 131.61 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.507 -0.746 . . . . 0.0 109.564 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.5 t80 -93.24 144.25 25.48 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.748 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 100.08 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.752 -0.592 . . . . 0.0 109.775 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.24 -4.81 23.56 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.84 -28.94 18.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.509 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -126.77 8.34 6.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.69 -0.631 . . . . 0.0 110.169 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.6 mmtt 53.91 38.6 29.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.146 -0.971 . . . . 0.0 110.318 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -127.53 143.63 51.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.67 -0.644 . . . . 0.0 110.452 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 60.3 m-85 -96.37 -171.64 2.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.48 -0.763 . . . . 0.0 109.74 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.32 102.42 2.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.05 -1.031 . . . . 0.0 108.497 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.7 p -116.34 142.56 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.114 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 3.7 t -140.15 -177.28 4.93 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.283 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 78.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 m -153.06 102.24 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.763 -0.586 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 55.6 m-85 -93.38 154.03 18.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.681 -0.637 . . . . 0.0 110.291 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -113.96 -171.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 16.7 tp -163.42 108.41 1.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.463 -0.773 . . . . 0.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -85.59 120.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.406 HD11 ' CG1' ' A' ' 55' ' ' VAL . 8.6 mm -86.97 109.43 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.784 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -96.65 50.77 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.504 -0.747 . . . . 0.0 110.22 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.59 -118.59 1.99 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.47 47.12 0.19 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.572 -0.957 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -136.45 -62.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.146 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 mt -91.88 -52.64 4.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.99 81.85 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.496 -0.753 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -173.55 46.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.51 66.82 1.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.618 -0.931 . . . . 0.0 110.2 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG23 ' CE2' ' A' ' 34' ' ' TYR . 3.3 tt -60.34 119.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 109.921 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -89.34 140.16 29.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 110.435 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -145.52 149.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.723 . . . . 0.0 110.421 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.7 155.19 19.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.666 -0.646 . . . . 0.0 110.415 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.05 162.47 13.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.577 -0.702 . . . . 0.0 110.208 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.92 -38.11 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.289 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.44 176.88 10.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.36 -29.55 70.55 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.852 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.35 65.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.819 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -63.66 -38.87 92.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.39 78.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.9 tt0 -58.62 -36.25 73.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.638 -0.664 . . . . 0.0 109.355 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -67.71 -52.58 35.99 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.52 -38.5 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 13.1 m-85 -74.04 -35.77 64.34 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -75.98 -1.03 23.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.767 -0.583 . . . . 0.0 111.462 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -109.01 -45.43 3.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.294 12.7 t80 -51.33 -31.97 23.76 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.52 -62.34 1.65 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.874 0.845 . . . . 0.0 108.88 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -55.35 -41.55 72.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.822 -0.549 . . . . 0.0 110.797 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.39 -26.83 5.39 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.626 -0.672 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.5 -54.3 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.98 62.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.46 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.311 1.0 OUTLIER -119.09 134.96 61.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 0.0 109.84 -177.275 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -167.17 104.44 0.54 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.836 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.11 -107.91 0.21 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.6 tp10 -113.24 175.58 5.38 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -1.029 . . . . 0.0 110.398 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 37.9 m95 -152.55 129.04 10.68 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.654 -0.654 . . . . 0.0 109.825 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -142.79 133.65 25.49 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.371 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.3 t80 -97.4 135.15 39.69 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.658 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -103.18 98.96 8.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.356 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.6 -6.1 28.9 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.663 -0.648 . . . . 0.0 111.648 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.94 -27.47 17.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -123.53 5.97 8.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt 54.57 36.31 25.57 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.166 -0.959 . . . . 0.0 110.162 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 m -126.35 140.54 52.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.409 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.6 m-85 -93.24 -169.0 2.04 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.37 94.63 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -95.87 100.12 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.908 0.861 . . . . 0.0 111.023 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -80.44 169.4 17.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.188 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 4' ' ' PHE . 59.9 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.109 0.48 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -76.42 91.0 3.26 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 24.2 m-85 -76.98 143.94 39.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.632 . . . . 0.0 110.073 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -110.51 -171.22 1.79 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.628 -0.67 . . . . 0.0 109.88 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 31' ' ' PHE . 37.3 tp -162.21 112.35 1.53 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -0.87 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.63 106.99 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.6 mm -82.87 110.72 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.153 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -96.32 147.66 23.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.53 -0.731 . . . . 0.0 110.1 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.97 -144.07 14.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -120.02 -33.0 4.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.951 . . . . 0.0 110.484 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -75.15 110.83 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.442 -0.786 . . . . 0.0 110.038 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 59.36 159.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 13' ' ' LEU . 7.5 ptmt -169.99 127.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 179.13 37.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.74 69.37 1.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.704 -0.88 . . . . 0.0 109.941 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.4 pt -61.68 177.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.563 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -139.48 133.1 30.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.529 -0.732 . . . . 0.0 110.509 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -141.97 131.17 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.539 -0.726 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.89 156.08 32.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.11 163.79 13.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.649 -0.657 . . . . 0.0 110.207 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.6 -39.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.44 -0.787 . . . . 0.0 110.521 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.35 174.87 12.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.724 -0.61 . . . . 0.0 109.369 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -59.54 -27.71 66.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.466 -0.771 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -53.3 59.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -42.81 98.0 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.28 -49.29 72.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.624 -0.672 . . . . 0.0 109.618 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.13 -36.24 72.65 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.523 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -69.73 -53.75 16.98 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.7 -36.35 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 6' ' ' LEU . 8.1 m-85 -75.44 -35.76 60.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -80.69 4.56 18.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.705 -0.622 . . . . 0.0 111.401 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -109.95 -45.38 3.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 3.9 t80 -53.51 -43.25 68.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.092 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.446 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -59.82 -49.31 78.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.816 -0.553 . . . . 0.0 110.178 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -57.21 -47.83 80.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.548 -0.72 . . . . 0.0 110.68 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -56.81 -22.6 37.51 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.646 -0.659 . . . . 0.0 110.987 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.9 -26.72 13.01 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.566 -0.709 . . . . 0.0 110.504 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.37 3.68 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.446 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.08 104.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -142.53 106.33 4.69 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.251 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.3 -103.15 0.18 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.9 tt0 -107.46 176.29 5.21 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.44 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 44.1 m95 -156.92 128.79 7.19 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.71 -0.619 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p -144.36 132.56 21.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 t80 -95.84 142.24 28.33 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.696 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -112.69 99.56 8.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.69 -0.632 . . . . 0.0 109.775 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -70.64 -4.6 24.21 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.611 -0.681 . . . . 0.0 111.456 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.67 -27.87 18.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 109.579 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -127.92 7.71 6.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp 54.53 40.68 32.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.165 -0.96 . . . . 0.0 110.194 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.3 m -129.81 139.92 51.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.663 -0.648 . . . . 0.0 110.335 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.2 m-85 -93.42 -168.39 1.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.894 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.13 98.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 3.5 p -102.49 119.43 50.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 122.035 0.921 . . . . 0.0 111.015 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -100.24 169.84 8.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.33 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.413 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 87.3 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.093 0.473 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 m -77.26 90.1 3.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 7.0 m-85 -74.11 141.12 45.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.619 -0.675 . . . . 0.0 109.956 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -104.64 -177.54 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.62 -0.675 . . . . 0.0 110.238 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -164.34 118.16 1.4 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 110.826 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.9 mt -89.77 118.14 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.415 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.2 mm -86.47 108.23 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.692 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.39 144.11 26.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 163.02 18.37 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -60.53 -26.65 67.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.647 -0.914 . . . . 0.0 110.379 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -76.16 125.62 29.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.595 -0.691 . . . . 0.0 110.074 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt 56.09 169.04 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.569 -0.707 . . . . 0.0 110.561 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -179.64 90.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.77 -166.86 34.49 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -105.14 -42.23 5.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.713 -0.875 . . . . 0.0 110.441 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt 53.65 85.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.343 -0.848 . . . . 0.0 110.376 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -84.1 126.23 32.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.601 -0.687 . . . . 0.0 110.338 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -134.91 143.92 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.493 -0.754 . . . . 0.0 110.668 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.86 152.32 25.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.65 7.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.612 -0.68 . . . . 0.0 110.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.32 -39.3 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.357 -0.839 . . . . 0.0 110.582 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.29 178.8 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -63.39 -27.31 69.22 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.806 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.25 -54.93 39.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.552 -0.718 . . . . 0.0 109.854 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.14 -42.92 99.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.726 -0.609 . . . . 0.0 109.371 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.11 -46.01 68.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.359 -0.838 . . . . 0.0 109.836 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.09 -38.21 82.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.665 . . . . 0.0 109.284 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -54.94 -42.29 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 109.391 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 8.1 m-85 -70.52 -37.94 74.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 0.0 109.573 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HD3' ' CE2' ' A' ' 44' ' ' TRP . 11.1 mmtt -76.78 1.09 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.658 -0.651 . . . . 0.0 111.49 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -104.28 -46.54 4.38 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.307 8.1 t80 -46.1 -50.85 14.87 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.206 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.445 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.37 -54.16 47.27 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.64 -46.54 77.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.608 -0.682 . . . . 0.0 110.739 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.45 -16.92 51.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.631 -0.668 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -108.43 -27.87 9.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.464 -0.773 . . . . 0.0 110.691 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.24 30.82 2.37 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.445 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -101.62 113.49 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.473 -1.016 . . . . 0.0 109.031 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.49 109.19 3.46 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.27 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.82 -95.59 0.11 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.04 123.07 37.62 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -1.073 . . . . 0.0 111.55 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.458 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 37.3 m95 -103.5 137.1 42.04 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.583 -0.698 . . . . 0.0 110.403 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -147.38 131.87 17.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.666 . . . . 0.0 109.245 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.8 t80 -95.75 143.43 27.0 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.773 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -113.92 101.52 9.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.647 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.36 -3.81 22.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.619 -0.676 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.36 -27.59 20.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.5 p -130.96 9.5 4.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.617 -0.677 . . . . 0.0 110.162 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.2 mmtt 53.6 41.89 32.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -127.8 140.05 52.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.637 -0.664 . . . . 0.0 110.294 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 67.2 m-85 -93.67 -170.82 2.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 109.708 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.86 99.48 1.54 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -102.61 109.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.999 0.904 . . . . 0.0 111.195 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.49 172.94 9.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.032 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.439 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 79.5 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.153 0.502 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.3 m -72.8 89.39 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.48 -0.763 . . . . 0.0 110.079 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 6.9 m-85 -76.83 143.18 39.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.658 -0.651 . . . . 0.0 109.943 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -104.53 -176.41 3.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 2.2 tp -166.8 108.92 0.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.522 -0.736 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mt -89.06 117.5 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.8 mp -87.32 119.6 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.253 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -96.61 149.58 21.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.11 -127.65 7.06 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.2 -41.23 0.9 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.549 -0.971 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 m -63.16 99.61 0.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 61.57 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.269 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -162.69 105.91 1.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.7 161.94 29.43 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.08 58.45 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.717 -0.872 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.2 pt -52.49 145.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.149 -0.969 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -113.59 139.66 48.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.537 -0.727 . . . . 0.0 110.956 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.72 132.64 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 110.456 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -70.47 154.66 41.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.0 110.186 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.06 157.73 9.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.669 . . . . 0.0 110.354 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -54.89 -34.21 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.549 -0.72 . . . . 0.0 110.502 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -165.72 178.43 6.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.39 -29.74 70.8 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.569 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -47.24 84.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -46.19 81.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.52 -0.738 . . . . 0.0 109.546 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.5 tt0 -58.69 -35.78 73.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.353 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.74 26.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 mt -58.18 -34.77 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 9.6 m-85 -77.48 -36.22 52.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -78.04 1.79 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.778 -0.576 . . . . 0.0 111.219 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.56 -45.4 3.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 177.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 10.9 t80 -53.76 -42.96 68.78 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.753 176.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.22 -47.34 86.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.183 0.516 . . . . 0.0 109.902 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.67 -48.8 78.51 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.634 -0.666 . . . . 0.0 110.549 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.06 -22.47 27.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.571 -0.705 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -103.29 -25.42 13.33 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.639 -0.663 . . . . 0.0 110.671 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.05 30.62 4.13 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.9 107.23 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.68 -0.894 . . . . 0.0 109.004 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -146.08 100.52 3.4 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.23 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.68 -105.48 0.24 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.433 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.2 tp10 -105.28 177.61 4.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.399 -1.059 . . . . 0.0 110.507 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.4 m95 -155.68 130.94 9.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.656 -0.653 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -144.85 132.2 20.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 109.264 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.7 t80 -98.49 138.1 36.19 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.93 99.82 9.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.652 -0.655 . . . . 0.0 109.551 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.31 -4.89 24.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.693 -0.629 . . . . 0.0 111.533 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.86 -28.4 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.654 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -128.76 8.5 5.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 110.234 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 31.6 mmtt 54.08 40.77 31.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.263 -0.898 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -125.17 133.67 52.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 110.628 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 75.1 m-85 -90.57 -172.39 3.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.613 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.12 98.29 1.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 3.6 p -102.02 109.46 26.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 122.122 0.963 . . . . 0.0 111.376 -178.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 169.17 12.45 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.156 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.9 m . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 m -90.55 103.85 16.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.581 -0.699 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 59.8 m-85 -86.32 152.19 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 -164.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.653 -0.655 . . . . 0.0 109.502 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 58.4 tp -168.12 108.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 110.336 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 105.55 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 55' ' ' VAL . 2.7 mm -77.52 99.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.087 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -85.05 63.39 8.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.982 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.7 -129.01 2.63 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 23.66 0.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.636 -0.92 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 10.38 3.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.344 -0.847 . . . . 0.0 110.737 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mt -172.32 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.324 -0.86 . . . . 0.0 110.415 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -52.6 103.82 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.229 -0.92 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.81 -177.83 48.15 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -137.0 64.8 1.52 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.636 -0.92 . . . . 0.0 110.173 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.88 136.41 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.44 -0.787 . . . . 0.0 109.55 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -103.42 136.89 42.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.228 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.421 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.29 136.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.367 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.78 152.49 33.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.131 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.53 159.64 14.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.57 -40.11 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.576 -0.703 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.4 173.08 17.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.43 -29.87 70.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -44.57 84.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.519 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.97 -43.68 71.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.12 77.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.667 . . . . 0.0 109.605 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.0 tt0 -60.27 -39.0 85.29 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.398 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -68.96 -48.84 62.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.58 -37.02 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.517 -0.739 . . . . 0.0 109.018 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 8.3 m-85 -76.89 -38.24 53.93 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.203 0.525 . . . . 0.0 109.652 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -76.79 0.7 19.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.582 -0.699 . . . . 0.0 111.305 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -108.68 -44.72 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.283 6.6 t80 -53.0 -45.53 67.94 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.979 176.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.407 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -57.53 7.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.775 -0.578 . . . . 0.0 109.871 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -58.32 -46.48 86.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.709 -0.619 . . . . 0.0 110.795 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -54.12 -23.93 15.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.5 -0.75 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -105.64 -30.37 9.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 110.155 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.09 32.67 1.48 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.8 mp -102.41 74.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.401 -1.058 . . . . 0.0 108.617 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.95 -164.43 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . 114.41 -173.8 15.09 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.885 -1.15 . . . . 0.0 111.546 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -73.57 -178.09 2.95 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.794 -0.827 . . . . 0.0 109.512 179.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.416 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 24.6 m95 -151.74 128.56 10.92 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.655 -0.653 . . . . 0.0 109.67 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.5 p -142.3 137.36 30.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.7 -0.625 . . . . 0.0 109.442 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.2 t80 -97.37 147.29 24.33 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.548 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -116.35 100.64 8.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.2 -4.65 26.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.613 -0.679 . . . . 0.0 111.33 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.22 -26.81 18.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -128.03 7.02 6.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.66 -0.65 . . . . 0.0 110.13 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 54.74 39.74 31.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.2 -0.937 . . . . 0.0 110.165 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 m -130.27 143.38 50.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 0.0 110.714 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.8 m-85 -96.75 -168.14 1.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -160.96 117.76 2.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.77 -1.206 . . . . 0.0 108.966 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 1.4 p -110.62 110.77 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.135 0.969 . . . . 0.0 109.169 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER -96.36 87.69 4.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.823 0.821 . . . . 0.0 110.125 -178.078 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.501 2.12 0 O-C-N 120.782 -1.199 . . . . 0.0 110.193 -179.636 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.464 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.3 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.045 0.45 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -76.8 103.47 6.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.564 -0.71 . . . . 0.0 110.245 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 53.8 m-85 -84.56 130.5 34.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.597 -0.689 . . . . 0.0 110.182 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -98.83 172.66 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 109.603 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 34.7 tp -143.76 106.06 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.428 -0.795 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 7' ' ' ILE . 87.3 mt -81.64 115.04 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 55' ' ' VAL . 2.1 mm -87.62 113.66 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.461 -178.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -101.21 75.94 1.68 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.453 -0.779 . . . . 0.0 110.544 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.33 -152.02 6.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -110.39 -27.25 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.957 . . . . 0.0 110.262 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 p -79.73 102.24 8.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 109.824 179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.8 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.168 0.508 . . . . 0.0 109.635 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -142.55 137.24 30.0 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.258 -0.901 . . . . 0.0 111.057 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.06 -165.41 22.45 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.26 158.19 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.87 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -116.57 -16.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p 45.53 96.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.557 -0.714 . . . . 0.0 111.655 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -130.14 132.99 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.53 157.46 30.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.531 -0.731 . . . . 0.0 109.937 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.8 168.84 12.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.553 -0.717 . . . . 0.0 110.289 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.37 -35.51 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 0.0 110.487 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 p30 -166.5 172.81 10.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.294 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.98 -31.18 71.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.317 -0.864 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.0 81.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.745 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.16 -43.17 74.82 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.95 77.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.45 -0.782 . . . . 0.0 109.717 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.5 tt0 -59.16 -36.82 75.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.581 -0.699 . . . . 0.0 109.334 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -69.53 -51.4 36.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.7 -39.42 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 9.5 m-85 -72.95 -37.47 67.11 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.52 1.95 17.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.694 -0.629 . . . . 0.0 111.377 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -109.19 -45.54 3.73 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 4.4 t80 -53.21 -40.31 64.37 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.151 176.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.08 -55.13 36.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.846 -0.534 . . . . 0.0 110.191 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.89 -48.79 80.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.709 -0.619 . . . . 0.0 110.662 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.14 -22.8 18.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -0.784 . . . . 0.0 111.06 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -103.1 -35.19 8.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.553 -0.717 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.33 36.32 0.7 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -103.72 119.77 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -1.066 . . . . 0.0 109.06 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -149.1 108.48 3.96 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.264 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.01 -109.64 0.22 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.9 tt0 -111.06 176.58 4.97 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.489 -1.006 . . . . 0.0 110.526 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 40.9 m95 -154.29 130.54 10.41 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.61 -0.682 . . . . 0.0 109.838 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 p -144.28 132.58 21.9 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.485 179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.2 t80 -97.57 132.79 42.91 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.75 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -102.07 99.31 9.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.685 -0.635 . . . . 0.0 109.361 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.21 -7.15 33.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.02 -28.9 18.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -122.02 5.6 9.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.676 -0.64 . . . . 0.0 110.183 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 54.76 35.96 25.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -126.61 143.76 51.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.614 -0.679 . . . . 0.0 110.419 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.9 m-85 -94.93 -170.35 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 0.0 110.036 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -155.72 92.66 1.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.9 p -95.89 104.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.888 0.852 . . . . 0.0 111.053 -178.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 169.73 13.6 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.202 -179.92 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 99.8 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.683 0.278 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 m 50.24 90.64 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.112 -0.992 . . . . 0.0 111.082 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 16.2 m-85 -89.14 139.17 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.089 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -99.22 -173.7 2.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.775 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 12.6 tp -158.99 105.56 1.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.374 -0.829 . . . . 0.0 110.015 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.9 130.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 14.5 mm -95.54 113.83 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.711 -179.011 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -70.69 -23.84 62.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.175 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.28 149.12 46.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.52 -25.01 66.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.685 -0.891 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -86.82 166.72 14.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.745 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' CD2' ' CG1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER 41.0 27.05 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.81 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -52.24 134.8 33.22 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 111.253 -178.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.11 175.42 38.42 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.111 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -140.48 42.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.3 pt -50.26 148.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.522 -0.736 . . . . 0.0 111.165 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -111.97 141.04 46.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.051 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.438 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -138.37 134.75 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.738 . . . . 0.0 110.744 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.99 139.12 42.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.723 -0.611 . . . . 0.0 109.997 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.06 34.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 110.436 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.08 -39.55 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.511 -0.743 . . . . 0.0 110.325 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.02 -179.81 8.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.547 -0.721 . . . . 0.0 109.32 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.02 -31.17 72.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.731 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.15 -57.68 10.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 0.0 109.976 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -59.63 -40.91 89.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.63 -0.669 . . . . 0.0 109.783 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.73 . . . . 0.0 109.732 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 15.4 tt0 -60.54 -47.31 86.75 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.371 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -51.32 69.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.949 . . . . 0.0 109.958 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.51 -45.87 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.46 -0.775 . . . . 0.0 109.415 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 8.7 m-85 -68.85 -37.49 79.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -76.03 1.95 14.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.777 -0.577 . . . . 0.0 111.441 179.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -107.08 -45.12 4.22 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 177.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 2.2 t80 -50.42 -38.28 42.33 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.838 176.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -63.86 -49.55 72.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.248 0.547 . . . . 0.0 109.825 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -60.22 -46.3 90.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.709 -0.619 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.99 -22.86 29.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.51 -0.744 . . . . 0.0 110.826 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -103.8 -24.35 13.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.675 -0.641 . . . . 0.0 110.468 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.33 44.03 1.65 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -104.18 135.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.908 . . . . 0.0 109.705 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -167.61 97.63 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.77 -65.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.445 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 9.0 mt-10 -154.65 173.58 16.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.551 -0.97 . . . . 0.0 110.171 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 52.1 m95 -155.05 123.84 6.13 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.66 -0.65 . . . . 0.0 109.803 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -139.03 133.76 32.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.677 . . . . 0.0 109.289 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.4 t80 -96.15 136.92 35.96 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.851 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -105.15 99.58 9.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.666 . . . . 0.0 109.281 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.7 -4.51 23.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.606 . . . . 0.0 111.603 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.27 -26.58 17.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -126.55 7.82 6.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 110.135 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.6 mmtp 53.4 38.61 28.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.115 -0.99 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.5 m -128.56 135.03 48.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.699 -0.626 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 56.8 m-85 -87.52 -170.5 3.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.348 -0.845 . . . . 0.0 109.795 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.67 104.24 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.031 -1.043 . . . . 0.0 108.211 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.3 p -111.43 132.61 59.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.567 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.66 -177.41 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.268 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.245 0.545 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.8 m -90.23 112.16 23.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 49.7 m-85 -97.8 150.04 21.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.632 -0.668 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.402 ' CG ' ' CG2' ' A' ' 18' ' ' THR . 4.5 mptt -113.24 -167.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.706 -0.621 . . . . 0.0 109.83 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 13.0 tp -167.33 100.38 0.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.487 -0.758 . . . . 0.0 110.145 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.2 mt -82.58 129.18 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG13 ' CG ' ' A' ' 13' ' ' LEU . 10.1 mm -99.91 115.93 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.234 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.75 -158.96 0.21 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.383 -0.823 . . . . 0.0 109.177 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.97 -129.19 47.72 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -148.07 25.54 1.01 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.909 . . . . 0.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 30.4 p -103.74 113.82 27.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 67.43 -51.2 0.5 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.852 -0.53 . . . . 0.0 111.683 179.964 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 11.4 mmmt 49.17 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.616 -1.303 . . . . 0.0 111.543 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.79 170.13 43.24 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.38 55.94 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.77 -0.841 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp -59.32 133.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.519 -0.738 . . . . 0.0 110.373 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.402 ' CG2' ' CG ' ' A' ' 5' ' ' LYS . 53.0 p -98.94 140.13 33.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.647 -0.658 . . . . 0.0 110.079 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.423 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.1 147.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.532 -0.73 . . . . 0.0 110.469 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -90.96 153.36 20.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.592 -0.693 . . . . 0.0 110.152 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.48 164.05 14.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.484 -0.76 . . . . 0.0 110.58 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.22 -39.3 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -162.28 174.33 12.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.92 -30.03 68.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.94 73.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.402 -0.811 . . . . 0.0 109.8 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.89 -40.22 91.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.33 78.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.1 tt0 -58.45 -37.86 76.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.607 -0.683 . . . . 0.0 109.342 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -68.68 -50.64 49.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.27 -39.66 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.3 m-85 -73.36 -36.67 66.17 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 32.9 mtpt -75.62 -0.55 20.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.663 -0.648 . . . . 0.0 111.493 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -105.94 -45.58 4.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 177.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 1.2 t80 -52.81 -40.71 63.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.837 176.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.447 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.73 -47.52 84.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.825 -0.547 . . . . 0.0 109.942 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -59.0 -47.6 84.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.581 -0.7 . . . . 0.0 110.432 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -54.28 -25.15 21.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -101.42 -24.59 14.16 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.784 -0.573 . . . . 0.0 110.535 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.47 36.27 3.11 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.447 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -97.39 116.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.614 -0.933 . . . . 0.0 109.489 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -158.06 101.71 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.13 -64.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 68.8 mm-40 -129.56 169.03 15.53 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.48 -1.012 . . . . 0.0 110.952 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 40.9 m95 -162.85 118.78 1.83 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p -144.44 132.78 21.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -93.56 144.52 25.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.9 97.8 6.61 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.88 -5.84 28.64 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.685 -0.634 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.77 -27.03 17.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -123.98 6.18 8.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.061 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 17.4 mmtt 54.18 39.93 31.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 110.077 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.4 m -134.71 140.29 45.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 0.0 110.744 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 46.3 m-85 -93.62 -170.73 2.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.311 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.04 102.95 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 7.4 p -116.1 144.71 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.92 -178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 2.7 t -143.22 -172.39 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.595 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.436 -0.79 . . . . 0.0 110.199 179.995 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 49.8 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.935 0.398 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.6 m -60.12 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.415 -0.803 . . . . 0.0 109.841 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 4.7 m-85 -85.49 147.51 26.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.715 -0.616 . . . . 0.0 110.129 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 -171.56 1.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.607 -0.683 . . . . 0.0 109.908 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 25.7 tp -160.08 112.43 2.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.305 -0.872 . . . . 0.0 110.841 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mt -85.35 119.91 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 5.4 mm -93.84 114.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.008 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -102.22 144.6 30.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.545 -0.722 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.68 -135.78 9.38 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -131.38 29.66 4.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.93 . . . . 0.0 110.191 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 14' ' ' LYS . 8.7 p -139.4 147.3 41.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt 60.9 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.784 -0.572 . . . . 0.0 111.204 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' THR . 6.1 mtmm 54.72 98.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.47 -0.769 . . . . 0.0 110.56 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.92 177.36 40.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.88 55.76 1.88 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.655 -0.909 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 pt -58.19 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -128.81 138.76 52.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.531 -0.73 . . . . 0.0 110.188 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.51 138.84 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.734 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.61 128.58 33.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 109.538 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.45 -163.06 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.07 -59.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.29 -174.73 4.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . . . -62.22 -35.78 79.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.56 31.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.619 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -56.11 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.635 . . . . 0.0 109.868 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.27 46.65 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.455 -0.778 . . . . 0.0 110.376 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.4 tt0 -60.57 -35.15 75.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.56 -0.713 . . . . 0.0 109.236 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -72.57 -46.82 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -59.31 -36.94 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 7.3 m-85 -76.96 -35.4 57.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 6.1 mtpt -77.3 0.93 20.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.773 -0.579 . . . . 0.0 111.357 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -107.31 -45.46 4.09 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 5.5 t80 -52.46 -35.24 52.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.783 176.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.439 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -71.02 -51.39 25.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.276 0.56 . . . . 0.0 109.946 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.31 -47.43 85.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.635 -0.666 . . . . 0.0 110.396 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -22.64 19.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.571 -0.706 . . . . 0.0 111.11 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -104.52 -31.8 9.28 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.64 1.05 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -102.13 110.18 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.456 -1.026 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -143.36 111.76 6.31 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.25 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.64 -110.03 0.23 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 1.6 tp10 -107.93 179.11 4.32 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.367 -1.078 . . . . 0.0 110.4 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 41.2 m95 -155.19 129.45 8.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.575 -0.703 . . . . 0.0 109.856 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -141.94 133.05 26.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.548 -0.72 . . . . 0.0 109.177 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.5 t80 -98.48 134.48 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.889 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -104.23 98.92 8.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -71.13 -3.81 21.97 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.612 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.75 -25.1 17.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.729 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 p -128.66 5.62 5.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.612 -0.68 . . . . 0.0 110.296 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 74.1 mmtt 55.89 42.81 28.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.164 -0.96 . . . . 0.0 109.679 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 124.89 32.92 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.869 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 82.8 m-85 -81.28 -171.3 3.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -0.75 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.6 90.42 1.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.9 p -92.64 100.25 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.005 0.907 . . . . 0.0 110.927 -178.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -80.12 171.39 15.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.439 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 57.6 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.074 0.464 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -73.3 109.56 6.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.877 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 78.7 m-85 -87.93 145.44 26.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.555 -0.716 . . . . 0.0 110.646 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.94 -173.95 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 6.4 tp -167.65 110.14 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.285 -0.885 . . . . 0.0 110.681 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 52' ' ' THR . 3.6 mp -95.55 113.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.425 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.2 mm -84.13 104.05 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.94 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -86.52 144.6 27.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.554 -0.716 . . . . 0.0 110.17 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.55 -140.77 12.0 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.28 29.74 5.51 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.664 -0.904 . . . . 0.0 110.176 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' LYS . 10.4 p -138.05 138.02 38.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mt 60.9 -77.3 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.762 -0.586 . . . . 0.0 111.027 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' THR . 15.5 mtpt 54.37 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.339 -0.85 . . . . 0.0 110.738 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.62 -175.77 41.58 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -108.43 -57.88 2.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.577 -0.954 . . . . 0.0 110.367 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.9 mm 53.6 72.75 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -69.64 137.36 52.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.598 -0.689 . . . . 0.0 110.112 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -145.51 147.4 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.562 -0.711 . . . . 0.0 110.572 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.73 162.08 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.605 -0.685 . . . . 0.0 109.936 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.35 171.16 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -53.08 -39.06 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.494 -0.754 . . . . 0.0 110.401 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.5 p30 -160.67 -175.18 4.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -70.38 -31.23 68.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.19 -49.3 74.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.593 -0.692 . . . . 0.0 109.921 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.09 -43.64 97.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.403 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -53.35 -45.06 69.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -59.12 -36.27 74.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 109.348 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.72 -54.85 16.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.49 -40.34 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 11.8 m-85 -72.07 -34.7 68.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -78.52 1.25 23.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.693 -0.629 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -104.22 -46.14 4.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 4.4 t80 -47.36 -51.98 17.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.906 175.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.462 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -67.74 -50.19 58.62 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.659 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.06 -49.92 72.41 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.72 . . . . 0.0 110.899 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.86 -21.46 29.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.603 -0.685 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -102.72 -27.76 12.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.572 -0.705 . . . . 0.0 110.576 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.67 29.25 3.67 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.41 106.01 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 108.756 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -141.71 114.89 8.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.35 0.595 . . . . 0.0 111.016 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.76 -100.78 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 5.7 tt0 -115.31 170.74 8.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -1.002 . . . . 0.0 110.035 179.54 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.432 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 40.6 m95 -152.6 122.95 7.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.505 -0.747 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 p -138.22 128.57 26.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.5 t80 -94.24 141.7 28.26 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.654 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -111.82 100.92 9.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.1 -2.68 16.46 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.616 -0.678 . . . . 0.0 111.745 -179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -28.69 21.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -136.69 15.39 3.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.695 . . . . 0.0 109.906 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER 48.28 45.34 20.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.487 179.662 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 7' ' ' ILE . 26.2 m -121.18 120.84 36.38 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.54 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 76.3 m-85 -85.35 172.81 10.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -139.78 97.16 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -97.68 107.53 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 122.007 0.908 . . . . 0.0 110.682 -178.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -92.02 170.1 10.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.286 -179.952 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.4 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.073 0.463 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.5 m 51.03 88.05 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.375 -0.828 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 6.9 m-85 -90.04 149.46 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.228 178.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -173.93 2.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 110.389 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 7.7 tp -160.98 108.97 1.54 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.634 -0.666 . . . . 0.0 109.986 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 7' ' ' ILE . 49.5 mm -87.42 129.89 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.126 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 mm -101.91 116.39 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.67 -179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -76.05 -29.31 57.99 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.84 -175.91 4.92 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -114.85 25.55 10.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.618 -0.931 . . . . 0.0 110.486 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -96.04 -33.72 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.46 -0.775 . . . . 0.0 109.964 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 9.7 mt -121.96 -54.09 1.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.696 -0.628 . . . . 0.0 109.772 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt 52.66 82.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.539 -0.726 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.99 -175.54 46.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.47 -50.07 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.797 -0.825 . . . . 0.0 109.966 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 17' ' ' ILE . 50.0 mm 54.12 83.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.0 p -76.94 142.14 40.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.626 -0.671 . . . . 0.0 109.672 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.429 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -143.69 131.5 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.488 -0.758 . . . . 0.0 111.187 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -66.93 131.15 45.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 110.068 179.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.32 150.11 31.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.26 -39.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.546 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.13 177.18 11.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.386 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -63.68 -33.11 74.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.415 -0.803 . . . . 0.0 109.642 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.09 81.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.562 -0.711 . . . . 0.0 109.723 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 -44.19 67.72 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.98 80.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.571 -0.706 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.8 tt0 -57.98 -37.54 74.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.648 -0.658 . . . . 0.0 109.401 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -51.57 32.62 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.48 -35.56 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 8.7 m-85 -77.24 -35.55 55.36 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 2.1 mtpt -73.85 -2.9 25.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.75 -0.594 . . . . 0.0 111.211 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -103.24 -46.1 4.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.296 2.8 t80 -52.33 -32.43 38.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.692 175.627 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.462 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.49 -60.81 2.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.819 0.818 . . . . 0.0 108.896 178.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -57.19 -40.56 77.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.83 -0.544 . . . . 0.0 110.562 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.09 -27.95 3.78 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.616 -0.678 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -49.31 3.4 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.475 0.655 . . . . 0.0 109.861 179.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.53 64.95 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.295 1.1 mm -118.81 129.3 75.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.949 -0.736 . . . . 0.0 110.389 -176.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.18 94.34 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.511 -0.743 . . . . 0.0 110.154 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.32 -44.95 0.02 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 15.0 tt0 -152.02 167.43 28.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.466 -1.02 . . . . 0.0 110.863 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.8 m95 -163.41 116.56 1.54 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -141.97 130.77 22.9 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.586 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -93.24 146.29 23.81 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.25 100.07 7.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.732 -0.605 . . . . 0.0 109.592 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -71.65 -2.78 18.43 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.668 -0.645 . . . . 0.0 111.505 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -25.82 18.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -131.54 8.74 4.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.482 -0.761 . . . . 0.0 110.174 179.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 54.41 45.11 27.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.193 -0.942 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.9 m -133.52 135.13 44.2 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 63.5 m-85 -90.74 -172.23 3.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.5 -0.75 . . . . 0.0 109.618 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.16 97.68 1.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.98 -1.075 . . . . 0.0 108.712 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.3 p -112.5 146.31 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.138 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 6.2 t -145.28 -172.48 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.936 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.201 179.925 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.415 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 63.5 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.083 0.468 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.1 m -102.76 109.12 20.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.109 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 53.3 m-85 -93.16 141.92 27.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 110.301 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.88 -166.21 1.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 0.0 109.35 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 21.4 tp -166.55 105.69 0.63 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.416 -0.803 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -81.34 118.43 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 HD11 ' CG1' ' A' ' 55' ' ' VAL . 5.2 mm -89.86 101.3 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.609 -178.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -76.1 -3.39 35.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.518 -0.739 . . . . 0.0 111.166 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.8 163.89 33.84 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.83 -27.42 68.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.478 -1.013 . . . . 0.0 110.64 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . 16.7 m -78.46 156.27 29.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.53 -0.731 . . . . 0.0 110.324 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 9.6 mt 59.71 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.865 -0.522 . . . . 0.0 111.188 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' THR . 1.0 OUTLIER 56.3 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.149 -0.969 . . . . 0.0 110.528 -179.766 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.53 -177.69 36.85 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -128.09 67.52 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -1.008 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.72 126.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.735 . . . . 0.0 109.892 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -96.29 137.54 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.485 -0.76 . . . . 0.0 110.424 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -142.37 133.65 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.365 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -78.58 148.99 33.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.672 -0.643 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.63 163.97 32.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.604 -0.685 . . . . 0.0 110.246 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.8 -40.93 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.494 -0.753 . . . . 0.0 110.548 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.42 172.55 18.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.28 -34.48 75.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.299 -0.875 . . . . 0.0 109.704 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.3 -49.47 69.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.62 -0.675 . . . . 0.0 109.796 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -40.87 96.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.53 78.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.424 -0.797 . . . . 0.0 109.665 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 9.6 tt0 -59.82 -35.85 75.56 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -68.33 -51.13 47.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -58.12 -40.96 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.3 m-85 -72.0 -36.66 69.82 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -74.58 -2.44 25.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.615 -0.678 . . . . 0.0 111.182 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -105.41 -42.51 5.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.293 16.4 t80 -55.08 -19.47 7.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.734 175.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -89.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -53.06 -42.42 65.79 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.708 -0.62 . . . . 0.0 111.787 -178.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 39.5 p-10 -46.85 -27.54 1.27 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.461 -0.774 . . . . 0.0 111.612 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -108.74 -59.57 1.86 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.849 -0.532 . . . . 0.0 110.253 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.82 59.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.46 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.297 1.1 mm -116.49 130.52 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.742 -0.858 . . . . 0.0 109.532 -178.363 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -169.9 104.49 0.32 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.407 -0.808 . . . . 0.0 111.079 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.24 -63.22 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 32.7 mt-10 -152.7 171.37 18.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.567 -0.961 . . . . 0.0 110.143 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 47.9 m95 -155.03 124.89 6.57 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.669 -0.644 . . . . 0.0 110.009 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 p -144.45 132.82 21.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.627 -0.671 . . . . 0.0 109.532 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.1 t80 -93.08 148.73 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.67 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.68 100.08 6.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.742 -0.599 . . . . 0.0 109.879 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.79 -4.18 22.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.712 -0.617 . . . . 0.0 111.554 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.24 -28.0 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.9 p -128.82 8.33 5.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 110.083 179.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 15.9 mmtt 54.28 40.1 31.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.5 m -130.49 138.62 50.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 0.0 110.371 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 48.4 m-85 -91.33 -167.41 1.79 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -154.57 102.31 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.99 -1.069 . . . . 0.0 108.474 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.8 p -113.15 128.39 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.796 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.78 -178.69 4.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.769 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.111 0.482 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 m -71.27 93.31 1.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 10.9 m-85 -81.98 139.5 34.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 110.178 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 -170.96 1.83 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.175 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.443 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 2.4 tp -165.04 108.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.601 -0.687 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -84.61 129.41 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.22 114.31 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.082 -178.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.88 40.96 1.16 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.36 -151.17 6.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -114.7 -28.82 6.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -1.013 . . . . 0.0 110.503 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 9.1 p -79.88 113.71 18.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 62.25 144.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.277 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -151.27 140.16 20.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.225 -0.922 . . . . 0.0 111.073 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.53 -163.47 29.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -108.69 -42.76 4.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.883 . . . . 0.0 110.235 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp 53.25 95.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.405 -0.809 . . . . 0.0 110.356 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -90.19 132.11 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.633 -0.667 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.429 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -143.42 130.22 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.512 -0.743 . . . . 0.0 110.478 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -71.22 157.72 37.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.55 161.4 11.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.75 -30.99 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.445 -0.785 . . . . 0.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.8 p30 -171.42 178.3 3.26 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.15 -30.61 71.55 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.612 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.67 81.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.502 -0.749 . . . . 0.0 109.704 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -70.59 -44.64 66.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.54 71.34 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.352 -0.842 . . . . 0.0 109.689 179.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -60.44 -41.13 93.41 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.044 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.11 -35.03 66.49 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.604 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.49 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 52.8 mt -67.72 -40.78 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 12.7 m-85 -73.3 -38.3 65.91 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.7 mmmt -72.96 -4.98 35.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.602 -0.686 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -106.14 -45.12 4.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 5.5 t80 -51.62 -30.62 22.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.091 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -76.08 -50.11 15.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.608 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -57.54 -47.56 81.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 110.678 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -24.74 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -102.75 -27.1 12.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.637 . . . . 0.0 110.426 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 35.15 2.34 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.95 107.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.657 -0.908 . . . . 0.0 108.904 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.25 113.45 9.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.476 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.19 -109.77 0.22 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 5.9 tt0 -114.51 174.39 5.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -1.032 . . . . 0.0 110.347 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 36.5 m95 -151.9 130.71 12.44 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.577 -0.702 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 p -142.89 133.17 24.66 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.298 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.4 t80 -95.12 145.37 25.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -117.8 98.11 6.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.792 -0.568 . . . . 0.0 109.488 179.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.63 -4.62 24.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.659 -0.65 . . . . 0.0 111.659 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -26.71 17.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 109.733 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -125.98 7.05 7.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.609 -0.682 . . . . 0.0 110.194 179.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp 54.15 38.47 29.21 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.184 -0.947 . . . . 0.0 110.101 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.5 m -130.6 134.21 46.8 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.628 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 53.3 m-85 -88.27 -166.84 1.7 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.21 92.71 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -93.92 102.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.933 0.873 . . . . 0.0 111.316 -178.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -82.51 169.44 16.35 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 46.0 m . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 m -68.86 85.31 0.32 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.776 . . . . 0.0 109.983 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 7.6 m-85 -70.42 126.89 30.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.647 -0.658 . . . . 0.0 109.778 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -89.57 175.35 7.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.425 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 2.5 tp -156.54 112.5 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.643 -0.661 . . . . 0.0 109.839 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -90.8 114.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.3 mp -90.08 113.15 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.071 -178.829 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -92.61 149.93 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.432 -0.792 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.51 -108.52 1.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -166.28 47.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.584 -0.951 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.21 119.22 5.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 53.95 23.98 4.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.504 0.669 . . . . 0.0 110.312 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -46.97 109.0 0.16 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.007 -1.058 . . . . 0.0 111.468 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.79 -162.73 29.48 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -109.46 -33.58 6.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.617 -0.931 . . . . 0.0 110.719 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.2 mm 67.05 -61.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 O-C-N 121.699 -0.626 . . . . 0.0 110.834 -179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p 62.37 112.63 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.344 -0.847 . . . . 0.0 110.427 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.43 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -143.24 132.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.765 -0.585 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.51 155.01 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 110.325 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.45 12.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.386 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.5 -39.65 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.535 -0.728 . . . . 0.0 110.617 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.27 177.05 11.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.646 -0.659 . . . . 0.0 109.501 179.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.7 -32.16 73.71 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.383 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.3 82.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.632 -0.667 . . . . 0.0 109.807 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.41 -44.66 82.37 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -45.91 75.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 109.623 178.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 6.1 tt0 -59.26 -37.01 76.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.503 179.08 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -69.14 -51.26 40.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mt -58.26 -38.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 8.4 m-85 -74.65 -39.36 62.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.145 0.498 . . . . 0.0 109.792 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -76.45 0.7 18.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.489 -0.757 . . . . 0.0 111.953 -179.393 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -110.14 -45.32 3.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CE2' HD12 ' A' ' 13' ' ' LEU 0.301 9.5 t80 -53.78 -39.0 65.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.249 176.558 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.22 -54.49 32.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -56.83 -48.35 78.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.679 -0.638 . . . . 0.0 110.712 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.82 -22.23 34.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.0 110.831 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -102.57 -29.02 11.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.681 -0.637 . . . . 0.0 110.217 179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.53 33.55 1.57 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -105.73 115.52 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -1.044 . . . . 0.0 109.229 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.17 105.55 2.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.433 -179.622 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.4 -97.12 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.51 127.55 46.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.334 -1.097 . . . . 0.0 111.067 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 50.4 m95 -105.83 137.09 44.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.533 -0.729 . . . . 0.0 110.904 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -147.01 132.06 18.24 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.3 t80 -98.6 144.8 27.5 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.861 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -115.57 99.34 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.766 -0.584 . . . . 0.0 109.638 179.257 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.31 -6.09 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 111.306 -179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.82 -26.52 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.612 179.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -124.24 5.63 8.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.619 -0.676 . . . . 0.0 110.119 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 54.0 38.55 29.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.143 -0.973 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -128.06 143.53 51.07 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.811 -179.436 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.6 m-85 -98.34 -172.19 2.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.187 179.452 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.41 99.39 1.61 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.713 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -102.79 97.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.774 0.797 . . . . 0.0 111.155 -178.537 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.35 169.62 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.13 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.685 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.981 0.42 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.4 m -67.16 91.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 110.143 179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.468 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 34.2 m-85 -72.43 146.75 46.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.624 -0.672 . . . . 0.0 110.172 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -109.84 -178.1 3.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.94 179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 6.4 tp -160.57 102.48 1.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt -90.71 117.0 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.045 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.0 mp -91.46 120.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.333 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.7 -31.15 59.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.34 -179.293 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 160.12 45.96 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.41 13.66 13.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.611 -0.935 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -63.05 -54.18 42.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.25 -0.906 . . . . 0.0 109.954 179.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.13 -29.08 1.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.677 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt 37.35 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.68 -179.98 47.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.473 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.76 72.54 1.48 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.834 -0.803 . . . . 0.0 109.786 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.66 112.56 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 109.974 -179.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.3 p -88.24 123.27 32.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.642 -0.661 . . . . 0.0 109.692 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.33 139.22 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.781 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -86.51 159.4 19.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.983 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.8 168.92 10.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.711 . . . . 0.0 110.203 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -38.74 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.6 174.65 11.5 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.6 -30.61 70.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.771 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.31 -48.96 70.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.427 -0.796 . . . . 0.0 110.026 179.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.91 -43.43 83.39 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.617 -0.677 . . . . 0.0 109.749 179.105 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 17.9 tt0 -58.02 -40.45 80.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.709 -0.62 . . . . 0.0 109.508 179.175 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -50.12 56.22 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.331 178.984 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.3 mt -58.01 -38.37 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 11.5 m-85 -75.54 -35.28 60.72 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -79.78 3.97 17.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.64 . . . . 0.0 111.32 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -107.23 -45.27 4.15 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.288 6.1 t80 -52.9 -45.51 67.57 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.916 176.218 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.21 -51.56 69.05 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.322 0.582 . . . . 0.0 109.9 179.139 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.83 -49.62 76.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.802 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -57.55 -27.89 63.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.526 -0.733 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.7 -27.52 17.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.887 -0.508 . . . . 0.0 110.307 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.03 38.89 1.92 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -106.44 130.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.656 -0.908 . . . . 0.0 109.375 -179.714 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -168.1 106.61 0.5 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.01 -59.9 0.03 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.0 tt0 -136.75 163.61 30.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.381 -1.07 . . . . 0.0 110.529 -179.479 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.4 m95 -162.65 116.06 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 p -145.64 131.57 19.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.604 -0.685 . . . . 0.0 109.495 179.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.3 t80 -89.05 152.3 21.75 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.821 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.32 102.18 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.721 -0.612 . . . . 0.0 109.643 179.367 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.47 -6.06 33.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.737 -0.602 . . . . 0.0 111.395 -179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.49 -28.13 21.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 p -125.22 6.12 7.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.614 -0.679 . . . . 0.0 109.973 179.103 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt 53.47 39.12 29.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.154 -0.966 . . . . 0.0 110.176 -179.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -133.55 145.87 50.5 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.015 -179.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.6 m-85 -97.68 173.56 7.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.574 -0.704 . . . . 0.0 109.441 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.32 110.2 8.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.097 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -117.94 152.89 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.704 -178.271 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.418 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 5.6 t -160.11 -169.44 2.5 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.7 179.242 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.402 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 53.5 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.131 0.491 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 m -62.75 86.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.531 -0.731 . . . . 0.0 110.074 179.926 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 6.4 m-85 -71.75 137.0 47.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.602 -0.686 . . . . 0.0 109.95 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -99.37 179.72 4.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.635 -0.666 . . . . 0.0 110.269 -179.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -163.14 118.58 1.74 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 110.464 -179.975 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.99 114.35 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.284 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.3 mp -89.84 119.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.529 -179.142 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -102.64 56.76 0.78 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.41 174.2 22.67 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -70.15 -41.14 74.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.505 -0.997 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -76.31 115.44 16.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.469 -0.769 . . . . 0.0 109.946 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.28 156.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.356 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 126.19 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.25 -158.71 23.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -110.03 146.3 35.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.641 -0.917 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 17' ' ' ILE . 49.5 mm -113.64 -16.96 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.669 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.0 p 45.33 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.678 -0.639 . . . . 0.0 112.006 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -126.81 141.04 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.803 . . . . 0.0 110.532 179.35 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.73 151.16 32.25 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.431 -179.835 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.82 158.55 10.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.95 -39.35 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 110.382 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -159.36 178.81 9.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.677 -0.639 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.99 -29.18 70.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.609 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.4 71.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.71 . . . . 0.0 109.878 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -41.97 86.12 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.65 -46.42 77.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.632 -0.668 . . . . 0.0 109.583 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.8 tt0 -58.85 -37.27 76.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -51.44 39.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.515 -0.741 . . . . 0.0 109.046 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.0 mt -58.76 -38.02 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 8.5 m-85 -74.7 -37.98 62.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 179.198 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 9.1 mmmt -75.67 -0.89 22.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 111.448 179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -109.91 -45.49 3.62 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.409 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.59 -39.25 64.71 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.865 176.328 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.36 -54.0 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.344 0.592 . . . . 0.0 109.969 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.8 -47.36 77.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.631 -0.668 . . . . 0.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -51.63 -26.33 8.75 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.527 -0.733 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -103.7 -26.16 12.86 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.887 -0.508 . . . . 0.0 110.318 179.733 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.82 29.35 3.6 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 2.1 mp -100.5 57.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.759 1.266 . . . . 0.0 108.173 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.54 101.75 11.63 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.37 -178.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . -160.38 -127.27 0.88 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.7 tt0 -71.28 168.38 17.45 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.136 -1.214 . . . . 0.0 110.325 -179.786 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 33.9 m95 -158.84 129.03 5.86 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.684 -0.635 . . . . 0.0 109.518 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 p -145.46 133.3 21.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.407 -0.808 . . . . 0.0 109.428 179.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.5 t80 -98.46 144.13 28.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.759 179.597 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.69 98.15 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.07 -7.05 32.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.69 -0.631 . . . . 0.0 111.378 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.24 -27.55 17.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 179.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.0 p -122.21 4.99 9.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.56 -0.713 . . . . 0.0 110.062 179.131 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt 54.41 39.26 30.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 109.938 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -129.87 142.39 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.804 -179.468 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.7 m-85 -97.66 -171.6 2.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -158.51 102.36 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.189 . . . . 0.0 108.088 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.3 p -106.24 108.97 26.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.083 0.944 . . . . 0.0 110.93 -178.711 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.421 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -92.88 98.5 11.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.304 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.324 -179.551 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.101 0.476 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 m -69.59 87.6 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.723 . . . . 0.0 110.143 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 13.5 m-85 -74.79 140.23 43.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.53 -0.731 . . . . 0.0 110.216 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.21 -179.28 3.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.627 -0.67 . . . . 0.0 110.109 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -158.24 114.68 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.441 -0.787 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.36 122.69 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mm -89.64 111.45 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.516 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.47 152.38 19.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.736 179.249 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.67 -142.63 15.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -134.81 21.96 3.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.581 -0.952 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 3.9 m -131.12 111.53 12.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 61.77 137.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.369 0.604 . . . . 0.0 110.158 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -141.83 138.27 32.07 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.65 -176.29 33.24 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.13 -41.49 6.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.701 -0.882 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 mt 53.86 73.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.435 -0.791 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -71.14 130.57 41.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 110.122 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -140.95 135.53 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.498 -0.752 . . . . 0.0 110.625 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.18 156.35 37.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.706 -0.621 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.8 162.28 9.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.552 -0.718 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -54.97 -38.54 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.637 -0.665 . . . . 0.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -160.49 178.98 9.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.8 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.52 -35.91 82.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.487 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.22 -49.28 67.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.412 -0.805 . . . . 0.0 109.948 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -45.8 91.19 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.121 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.07 -44.07 67.2 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.439 -0.788 . . . . 0.0 109.808 179.008 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.1 tt0 -57.96 -35.53 71.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.673 -0.642 . . . . 0.0 109.349 179.032 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -70.15 -53.54 16.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.47 -35.73 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 6' ' ' LEU . 8.7 m-85 -76.26 -34.19 59.14 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.92 1.89 22.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.718 -0.614 . . . . 0.0 111.286 179.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -103.05 -46.47 4.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 176.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 8.3 t80 -45.48 -53.66 8.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.3 175.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.441 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -57.04 -49.92 74.34 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.36 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.83 -47.37 85.99 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.628 -0.67 . . . . 0.0 110.265 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.16 -23.89 15.98 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.595 -0.691 . . . . 0.0 111.16 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.21 -34.43 7.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.633 -0.667 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.21 37.23 0.7 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -102.99 110.85 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 0.0 109.12 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -141.43 109.21 5.69 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.826 -179.679 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.6 -106.63 0.2 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 3.8 tt0 -110.59 173.37 6.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -1.001 . . . . 0.0 110.791 -179.695 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 40.2 m95 -153.75 129.96 10.44 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.648 -0.658 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -143.13 133.84 25.18 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.504 179.799 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.5 t80 -98.73 146.67 25.65 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.881 179.712 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -116.78 100.0 7.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.24 -5.54 28.31 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.657 -0.652 . . . . 0.0 111.513 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.51 -27.61 18.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 179.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -126.06 6.83 7.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt 54.47 38.8 30.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.2 m -126.29 144.78 50.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.2 m-85 -99.15 -169.75 1.81 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 0.0 109.854 179.729 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.69 93.91 1.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.832 -1.167 . . . . 0.0 108.013 179.593 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.9 p -95.73 116.13 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.972 0.892 . . . . 0.0 110.879 -178.634 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -99.25 168.39 10.06 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.146 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.456 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 27.6 m . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 120.949 0.404 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -68.93 106.23 2.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 109.962 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 58.3 m-85 -88.89 145.25 25.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.529 -0.732 . . . . 0.0 110.409 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -112.55 -167.3 1.17 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.672 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 27.4 tp -166.44 108.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.41 -0.806 . . . . 0.0 110.463 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.28 119.81 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.793 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.401 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.1 mm -94.23 113.23 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.596 -179.178 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -105.07 57.9 0.69 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.94 -148.7 6.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 pttp -114.74 -25.07 8.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.598 -0.942 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -80.76 -38.82 27.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 6.5 mt -123.1 168.68 12.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.472 -0.768 . . . . 0.0 110.479 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.42 80.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.009 179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.36 -170.39 38.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.03 107.92 10.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.67 -0.9 . . . . 0.0 110.201 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -93.27 109.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.541 -0.725 . . . . 0.0 109.717 179.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -85.12 124.4 31.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.56 -0.713 . . . . 0.0 110.595 -179.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -143.37 134.23 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -77.47 160.69 28.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.597 -0.689 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.46 165.2 10.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.239 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.13 -38.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.397 -0.814 . . . . 0.0 110.35 -179.979 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.31 174.88 12.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.629 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.29 -30.86 71.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.06 79.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 109.87 179.383 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -71.79 -45.07 62.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.057 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.74 76.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.567 -0.708 . . . . 0.0 109.362 178.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.1 tt0 -60.48 -40.23 90.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.012 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -67.53 -49.12 64.83 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.82 -44.13 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 13.7 m-85 -70.3 -38.92 75.1 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 4.6 mmmt -74.57 0.6 14.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 111.319 179.179 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -106.06 -45.58 4.3 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.425 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.298 17.4 t80 -49.02 -30.05 5.66 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.468 176.037 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -83.74 -48.63 9.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.669 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -68.47 -44.8 74.04 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.606 -0.684 . . . . 0.0 111.419 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -47.46 -28.74 2.3 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.501 -0.75 . . . . 0.0 111.139 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.46 -46.55 4.96 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.499 0.666 . . . . 0.0 109.375 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.3 63.54 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -179.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.454 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.27 1.1 mm -118.72 137.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 O-C-N 121.721 -0.87 . . . . 0.0 110.118 -177.359 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 -172.66 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.067 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 126.53 -177.16 17.38 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.736 179.109 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.89 128.13 36.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.976 -0.72 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 43.4 m95 -97.68 125.01 42.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.56 -0.713 . . . . 0.0 110.407 179.667 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.9 p -138.23 134.75 34.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.843 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -98.15 148.16 23.85 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.452 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.68 101.09 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.39 -4.96 24.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.588 -0.695 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.35 -28.1 18.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.563 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -128.79 8.63 5.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.593 -0.692 . . . . 0.0 110.149 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 7.7 mmtm 54.02 40.8 31.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.119 -0.988 . . . . 0.0 110.255 -179.698 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.8 m -125.73 143.51 51.02 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.122 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.3 m-85 -100.18 -174.15 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.5 m -160.69 122.37 3.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 0.0 109.201 -179.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.4 p -117.24 93.97 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -84.7 90.55 7.74 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.975 0.893 . . . . 0.0 110.008 -178.443 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 14.0 tm-20 . . . . . 0 N--CA 1.499 2.011 0 O-C-N 120.849 -1.157 . . . . 0.0 110.147 -179.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 48.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.946 0.403 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -69.67 103.51 2.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.491 -0.756 . . . . 0.0 110.011 179.799 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 65.7 m-85 -83.0 149.65 26.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.649 -0.657 . . . . 0.0 110.31 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -119.33 179.23 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 179.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 38.9 tp -155.22 112.52 3.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.459 -0.776 . . . . 0.0 110.143 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 7' ' ' ILE . 98.3 mt -82.9 115.99 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.126 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 3.6 mm -94.75 119.9 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.794 -179.171 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -117.54 73.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.749 179.55 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.27 -106.32 0.65 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -149.97 -41.1 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.559 -0.965 . . . . 0.0 110.676 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -71.51 -28.9 64.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 5.6 mt -128.24 170.83 12.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 110.232 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 75.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.182 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.99 -168.87 34.6 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -121.22 135.9 55.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.644 -0.915 . . . . 0.0 110.181 -179.906 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -93.96 -15.65 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.738 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p 54.58 110.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.56 0.695 . . . . 0.0 111.065 179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.413 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.44 138.1 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.653 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.78 156.23 21.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.642 -0.661 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.15 168.99 14.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.673 . . . . 0.0 110.339 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.27 -38.5 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.512 -0.743 . . . . 0.0 110.393 -179.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -161.68 175.08 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.48 -32.39 73.82 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.675 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.771 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.38 -39.63 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.69 86.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.614 -0.679 . . . . 0.0 109.598 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.4 tt0 -59.94 -34.04 72.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.36 -49.74 46.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.45 -35.43 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 10.7 m-85 -77.72 -40.67 40.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.628 179.384 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.0 mmmt -72.33 -3.24 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.0 111.261 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 -44.58 4.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.291 4.5 t80 -49.42 -30.38 7.86 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.326 176.062 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.464 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -82.35 -55.17 4.67 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.718 0.77 . . . . 0.0 108.952 178.602 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.88 -45.8 92.18 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.624 . . . . 0.0 111.457 -178.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.29 -29.23 1.55 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.599 -0.688 . . . . 0.0 111.256 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -46.08 5.08 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.286 178.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.02 64.41 0.1 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.607 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.2 133.9 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.837 -0.802 . . . . 0.0 110.29 -177.068 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.2 -175.16 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 127.63 -173.53 18.69 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.56 -1.305 . . . . 0.0 111.744 179.186 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.8 126.38 36.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.02 -0.694 . . . . 0.0 110.164 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 37.7 m95 -95.84 126.77 41.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.712 . . . . 0.0 110.259 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -141.71 134.96 29.33 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.6 t80 -97.53 141.97 29.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.516 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.49 100.09 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.614 179.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.69 -4.03 21.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.593 -0.692 . . . . 0.0 111.483 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.67 -26.93 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.707 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.2 p -128.53 7.73 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.661 -0.65 . . . . 0.0 110.201 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 54.87 41.95 31.5 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.172 -0.955 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.3 m -130.05 138.58 50.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.587 -0.695 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.4 m-85 -94.46 -173.18 2.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 0.0 109.17 179.245 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -161.38 122.39 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.772 -1.205 . . . . 0.0 109.184 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.5 p -118.99 89.94 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -86.27 99.12 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.957 0.884 . . . . 0.0 110.428 -178.267 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 18.8 tt0 . . . . . 0 N--CA 1.501 2.123 0 O-C-N 120.91 -1.119 . . . . 0.0 110.291 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.416 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 43.2 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 120.975 0.417 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 m -62.55 87.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.459 -0.776 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 13.5 m-85 -72.53 128.12 34.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.735 -0.603 . . . . 0.0 110.228 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.23 171.53 8.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 109.479 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 3.9 tp -150.47 106.6 3.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.66 122.6 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.7 mp -95.89 124.17 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.966 -179.388 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.96 -30.33 39.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.262 -0.898 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.3 149.27 50.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -20.26 49.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.56 -0.965 . . . . 0.0 110.61 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 7.1 p -65.45 116.62 6.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 110.553 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 65.77 -53.62 0.37 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.334 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 43.79 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.779 -1.201 . . . . 0.0 112.682 179.091 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.91 -166.41 38.11 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.664 179.201 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -126.87 153.18 46.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.898 -0.766 . . . . 0.0 109.798 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.56 -14.37 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.426 -0.796 . . . . 0.0 111.242 -179.79 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.7 p 44.14 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.575 -0.703 . . . . 0.0 111.875 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.423 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -128.07 138.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.52 -0.737 . . . . 0.0 110.665 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -81.69 147.89 29.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.9 179.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.98 165.65 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.04 -39.65 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.677 . . . . 0.0 110.601 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -162.32 174.77 12.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.717 -0.614 . . . . 0.0 109.563 179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.51 -32.32 72.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.403 -0.811 . . . . 0.0 109.789 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.0 -41.37 78.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.65 -44.05 57.85 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.131 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.24 80.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.566 -0.709 . . . . 0.0 109.545 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.8 tt0 -58.69 -37.74 76.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.255 178.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -68.62 -52.28 33.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.674 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 mt -56.61 -40.18 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 9.9 m-85 -73.07 -35.72 66.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.881 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 23.7 mttm -76.47 0.34 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.654 -0.654 . . . . 0.0 111.464 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.81 -45.28 3.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 177.455 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 8.3 t80 -55.51 -42.22 74.18 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.882 176.353 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -50.97 71.95 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.261 0.553 . . . . 0.0 110.185 179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.38 -46.51 89.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -54.51 -23.3 15.78 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.17 -34.88 7.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.631 -0.668 . . . . 0.0 110.623 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.63 37.76 0.57 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -107.67 107.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -1.047 . . . . 0.0 108.733 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -157.62 104.41 1.98 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.271 -179.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.72 -50.37 0.04 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 10.1 tt0 -138.0 167.28 22.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -1.064 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 46.7 m95 -161.49 123.94 3.03 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.841 -0.537 . . . . 0.0 109.886 179.514 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 p -146.65 132.23 18.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.501 -0.75 . . . . 0.0 109.36 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.9 t80 -96.37 133.08 41.21 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.85 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 100.3 10.44 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -2.63 16.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.726 -0.609 . . . . 0.0 111.939 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.7 22.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.274 179.406 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -138.34 16.01 2.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.716 -0.615 . . . . 0.0 110.0 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.5 mptt 49.02 42.53 21.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 111.339 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -118.55 110.64 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.936 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 73.5 m-85 -70.86 -175.4 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -156.01 105.61 2.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.947 -1.096 . . . . 0.0 108.369 -179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 8.0 p -120.76 144.5 29.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.418 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 5.7 t -141.3 -165.63 2.01 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.815 179.767 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.294 -179.762 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.427 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 57.9 m . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 78.5 m -67.79 93.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.459 -0.775 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 11.8 m-85 -76.65 159.17 30.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.0 109.707 179.773 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -121.36 -172.99 2.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.396 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 27.5 tp -165.32 104.86 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.263 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.7 126.17 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 13' ' ' LEU . 8.7 mm -99.14 115.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.525 -178.394 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -81.68 -159.04 0.25 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.33 -152.94 5.11 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.943 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -107.44 -18.28 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.771 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.411 ' CG2' ' CD1' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -58.02 94.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 179.743 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.432 ' CD1' HG13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER 58.17 171.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.263 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -162.69 106.9 1.12 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.46 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.93 -166.16 35.62 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.191 -179.823 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.86 -39.12 4.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.798 -0.825 . . . . 0.0 110.517 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.1 mm 54.09 76.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.327 -0.858 . . . . 0.0 110.303 -179.797 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -76.0 129.11 36.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.008 -179.787 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.419 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.17 144.18 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.904 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -83.07 149.66 26.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 109.964 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.81 153.14 14.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.684 . . . . 0.0 110.388 -179.806 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.12 -39.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.399 -0.813 . . . . 0.0 110.458 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.37 173.78 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -61.03 -30.58 70.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.822 . . . . 0.0 109.82 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.89 82.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.813 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -44.79 60.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.594 -0.691 . . . . 0.0 109.689 178.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.1 tt0 -59.79 -38.08 80.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.647 -0.658 . . . . 0.0 109.229 179.088 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -67.99 -51.53 46.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 178.791 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.26 -37.41 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.879 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 8.6 m-85 -75.18 -35.78 61.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.786 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 mmmt -78.32 2.52 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.835 -0.541 . . . . 0.0 111.232 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -106.76 -46.44 3.96 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 177.332 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 23.7 t80 -52.42 -31.79 36.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.938 175.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -67.47 -64.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.676 0.75 . . . . 0.0 109.014 178.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -55.59 -40.08 71.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.925 -0.484 . . . . 0.0 110.767 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -49.32 -27.86 4.33 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.65 -0.656 . . . . 0.0 110.837 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -106.82 -50.72 3.06 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.436 0.636 . . . . 0.0 109.94 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.74 63.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -179.712 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.295 1.1 mm -119.31 130.7 73.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.805 -0.82 . . . . 0.0 109.967 -177.272 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -171.19 100.26 0.21 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 110.724 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.96 -57.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 79.1 mm-40 -140.92 168.42 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.947 . . . . 0.0 110.609 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 40.6 m95 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 p -133.75 130.68 38.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.856 -179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.0 t80 -93.65 129.6 39.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.084 -0.647 . . . . 0.0 109.555 179.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -97.95 97.51 9.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.731 -0.606 . . . . 0.0 109.472 179.185 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.55 -6.32 30.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.561 -0.712 . . . . 0.0 111.527 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.29 -27.26 17.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 179.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 p -124.15 6.82 8.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.557 -0.714 . . . . 0.0 110.142 179.268 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 6.9 mmmt 54.4 38.92 30.48 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 -179.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -130.44 134.17 46.9 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.663 . . . . 0.0 110.761 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 61.1 m-85 -87.88 -173.29 4.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.519 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.74 103.78 2.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.923 -1.111 . . . . 0.0 108.692 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 6.4 p -117.02 146.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.327 -178.64 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 5.9 t -148.06 -171.61 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.999 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.231 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.456 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 59.9 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.15 0.5 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -73.74 109.82 7.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.465 -0.772 . . . . 0.0 110.017 179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 60.2 m-85 -90.56 119.35 30.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 110.391 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -85.84 169.77 13.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.655 -0.653 . . . . 0.0 109.514 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 2.5 tp -148.25 111.06 4.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.986 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -90.72 119.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.508 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.0 mp -93.13 121.05 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.606 -179.144 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.9 162.19 13.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.359 -0.838 . . . . 0.0 110.552 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.07 -168.11 31.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.5 5.54 23.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.503 -0.998 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -164.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.19 -0.944 . . . . 0.0 110.117 179.822 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 pp -52.78 -33.81 50.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.26 -0.9 . . . . 0.0 110.874 -179.506 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.33 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.398 -0.814 . . . . 0.0 111.536 178.985 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.55 -165.85 38.81 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.401 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -148.08 77.56 1.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.821 -0.811 . . . . 0.0 109.334 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 34' ' ' TYR . 41.6 pt -57.82 -26.24 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.46 -0.775 . . . . 0.0 111.118 -179.123 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p 60.31 128.55 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.5 0.666 . . . . 0.0 110.975 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.17 156.88 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.416 -0.802 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.42 159.59 15.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.684 179.432 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.82 168.46 8.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 110.605 -179.952 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.22 -39.83 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 110.676 179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -158.11 177.21 11.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.3 -34.59 78.47 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.471 -179.817 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.42 -52.45 61.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.377 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.29 -42.71 91.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.635 -0.665 . . . . 0.0 109.388 179.095 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.49 69.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.526 -0.734 . . . . 0.0 109.773 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.1 tt0 -59.07 -45.84 89.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.556 -0.715 . . . . 0.0 109.335 179.248 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -50.72 71.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.288 -0.883 . . . . 0.0 109.641 178.654 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.4 -45.86 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.416 -0.803 . . . . 0.0 109.23 179.081 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 10.6 m-85 -69.01 -34.03 74.61 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.923 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 3.9 mmmt -73.72 -4.26 33.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.85 -0.531 . . . . 0.0 111.314 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -107.3 -45.45 4.1 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CE1' HD11 ' A' ' 17' ' ' ILE 0.291 9.4 t80 -51.1 -31.69 20.04 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.821 175.948 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -64.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.837 0.827 . . . . 0.0 108.825 178.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -54.52 -40.42 68.59 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.085 0.469 . . . . 0.0 110.655 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -49.81 -27.15 4.63 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.72 -0.613 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -107.28 -48.75 3.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.382 0.61 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.29 62.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.299 1.1 mm -119.54 136.54 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.821 -0.811 . . . . 0.0 109.495 -177.346 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -169.74 106.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.246 -0.908 . . . . 0.0 111.59 -179.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -108.14 0.21 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 179.054 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 1.5 tt0 -109.2 178.96 4.3 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.414 -1.05 . . . . 0.0 110.4 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.7 m95 -155.17 128.79 8.53 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.667 -0.646 . . . . 0.0 109.539 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -145.17 132.78 20.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.397 -0.814 . . . . 0.0 109.628 179.855 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 19.6 t80 -96.56 131.28 43.34 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -99.98 99.63 10.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.659 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -70.97 -2.83 16.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.692 -0.63 . . . . 0.0 111.87 -179.3 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.66 -28.36 20.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -136.19 14.97 3.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 4.3 mptt 48.8 43.05 20.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 111.578 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -121.01 114.4 21.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.854 -0.529 . . . . 0.0 109.87 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 65.2 m-85 -73.69 -172.96 1.36 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -0.816 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.17 97.55 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.19 . . . . 0.0 107.988 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG1' HG13 ' A' ' 8' ' ' ILE . 2.7 p -99.89 98.88 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.003 0.906 . . . . 0.0 111.012 -178.492 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -76.88 170.47 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.697 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.087 -179.997 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.476 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.0 m . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.041 0.448 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.8 m -72.98 98.01 2.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.733 . . . . 0.0 110.033 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 43.3 m-85 -76.11 122.66 24.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 110.328 -179.923 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.2 169.94 10.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 179.658 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 9.6 tp -150.14 105.21 3.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.953 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -90.66 123.31 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.1 mp -97.5 122.86 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.884 -1.127 . . . . 0.0 109.423 -178.928 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.14 -157.97 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.058 179.542 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.22 -134.52 45.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -144.65 25.71 1.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.688 -0.889 . . . . 0.0 110.413 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -71.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.511 -0.743 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 8' ' ' ILE . 4.6 pp -129.25 -28.69 2.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.631 -0.668 . . . . 0.0 110.688 179.601 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.28 100.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.24 -0.912 . . . . 0.0 111.117 179.538 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.95 48.25 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -117.08 -37.83 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.901 -0.764 . . . . 0.0 109.95 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp 65.52 -58.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.979 -0.451 . . . . 0.0 111.868 179.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p 57.5 107.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.474 -0.766 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.42 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.3 pp -139.08 138.25 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.556 -0.715 . . . . 0.0 110.715 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -84.29 153.49 23.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.36 168.75 19.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.509 -0.744 . . . . 0.0 110.401 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.45 -39.67 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.589 -0.694 . . . . 0.0 110.771 -179.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -162.23 175.41 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.09 -29.33 70.72 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.859 -179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -41.33 78.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.869 179.574 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.65 -45.44 44.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -54.66 -49.15 71.31 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.433 -0.792 . . . . 0.0 109.766 179.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.0 tt0 -58.81 -35.59 73.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.605 -0.685 . . . . 0.0 109.26 179.083 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.77 -50.85 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.722 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mt -59.06 -36.86 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 8.7 m-85 -75.28 -39.29 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.159 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 7.4 mtpm? -76.66 1.73 16.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.58 -0.7 . . . . 0.0 111.535 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -105.81 -45.03 4.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 177.143 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 16.0 t80 -54.02 -34.0 58.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.604 175.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.27 -62.93 1.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.536 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -57.57 -40.68 79.49 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.891 -0.505 . . . . 0.0 110.614 -179.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.88 -27.95 3.43 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.682 -0.636 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.05 -48.87 3.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.406 0.622 . . . . 0.0 109.759 179.113 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.94 63.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.291 1.1 mm -119.24 133.8 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.731 -0.864 . . . . 0.0 109.851 -177.386 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -172.18 103.58 0.17 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.353 -0.842 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.19 -49.04 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 12.8 tt0 -154.6 169.03 24.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -1.062 . . . . 0.0 110.798 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.5 m95 -161.24 115.22 2.0 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.14 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 p -137.81 132.02 32.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.514 -0.741 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.4 t80 -96.68 129.66 44.05 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.854 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -96.94 101.9 13.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.589 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.21 0.09 10.69 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.729 -0.607 . . . . 0.0 111.95 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.23 -26.54 18.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.388 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -140.81 16.85 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.897 179.513 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 49.32 45.63 23.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 111.456 179.591 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 m -120.3 111.64 18.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.087 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 73.8 m-85 -73.71 -176.72 2.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 109.464 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.1 110.84 2.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.82 -1.175 . . . . 0.0 108.525 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -122.35 139.98 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.135 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.426 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 9.3 t -136.37 -171.21 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.212 179.854 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 94.9 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.6 m 49.69 76.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.316 -0.865 . . . . 0.0 111.277 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 10.6 m-85 -73.54 144.63 46.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.535 -0.728 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -109.22 -176.01 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 110.158 -179.8 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 57.2 tp -155.81 118.99 4.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.493 -0.755 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 mt -87.88 108.69 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.043 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG22 ' CB ' ' A' ' 13' ' ' LEU . 4.5 mm -84.64 107.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.643 -179.407 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 25.5 m-20 -76.04 -28.31 57.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.558 -0.713 . . . . 0.0 110.131 179.572 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 166.38 4.72 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.305 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -31.11 27.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.909 . . . . 0.0 110.795 -179.701 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 p -56.51 -31.43 64.07 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.401 -0.812 . . . . 0.0 110.213 -179.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CB ' HG22 ' A' ' 8' ' ' ILE . 4.0 mt -138.37 144.0 40.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.679 -0.638 . . . . 0.0 109.512 179.669 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -146.47 87.68 1.73 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.486 -0.759 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.26 -164.35 31.9 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.652 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.82 149.08 44.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.763 -0.845 . . . . 0.0 110.213 -179.965 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 48.7 mm -103.4 -15.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.716 . . . . 0.0 110.663 179.927 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p 52.67 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.567 0.699 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.412 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -135.81 134.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.39 -0.819 . . . . 0.0 110.733 -179.966 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.47 142.43 40.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.597 -0.689 . . . . 0.0 110.219 179.985 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.48 38.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.705 . . . . 0.0 110.306 179.856 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.38 -39.21 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.511 -0.743 . . . . 0.0 110.694 -179.906 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -160.2 178.33 9.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.689 -0.632 . . . . 0.0 109.469 179.755 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.75 -30.05 71.19 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.797 179.937 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.665 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -65.74 -38.71 89.87 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.79 -44.12 94.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.06 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 16.0 tt0 -59.16 -36.1 74.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.599 . . . . 0.0 109.437 179.085 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -71.88 -49.63 36.34 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 109.109 178.865 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.53 -32.77 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.708 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 6.4 m-85 -80.91 -37.72 29.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.057 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 16.4 mtpp -76.61 1.82 15.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 111.108 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.23 -44.16 4.2 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.423 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.42 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.296 2.6 t80 -52.12 -43.96 64.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.914 176.252 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -62.38 -59.28 5.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.316 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.57 -44.09 80.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.759 -0.588 . . . . 0.0 110.882 -179.509 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -48.31 -28.4 3.11 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.903 -179.786 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -102.36 -43.82 5.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.572 0.701 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.39 59.17 0.1 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 107.391 -2.283 . . . . 0.0 107.391 -179.463 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.293 1.1 mm -120.75 159.41 22.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.95 -0.735 . . . . 0.0 109.563 -177.043 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -176.65 -165.99 0.14 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 -126.5 7.43 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.187 178.373 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' CB ' HG21 ' A' ' 56' ' ' THR . 41.4 tt0 -96.59 109.22 21.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.72 . . . . 0.0 111.973 -177.834 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' THR . 26.0 m95 -97.47 118.03 33.05 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.446 0.641 . . . . 0.0 109.538 178.242 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -131.78 162.03 31.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.329 -179.387 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.8 t80 -123.71 137.37 54.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.46 100.13 9.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.213 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.03 -3.56 20.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.699 -0.626 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.93 -26.29 17.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.96 . . . . 0.0 109.742 179.705 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -129.45 8.28 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.62 -0.675 . . . . 0.0 110.132 179.384 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt 54.24 41.72 31.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 -179.671 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -126.49 137.78 53.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.688 -0.632 . . . . 0.0 110.364 -179.798 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.1 m-85 -96.89 -165.7 1.3 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.467 -0.77 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 6.9 m -154.83 162.86 40.96 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.996 -1.065 . . . . 0.0 108.839 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.35 96.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.738 -0.601 . . . . 0.0 109.523 -179.452 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 56' ' ' THR . 3.8 t -110.83 91.87 3.83 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.296 1.046 . . . . 0.0 111.673 -178.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.504 2.274 0 O-C-N 120.887 -1.133 . . . . 0.0 110.794 -179.666 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 29.8 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.934 0.397 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -68.35 100.03 1.01 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 109.925 179.751 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 58.0 m-85 -80.19 150.7 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -116.4 174.69 5.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 109.333 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.446 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.4 tp -151.54 114.1 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.24 112.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.2 mp -96.59 114.94 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.469 -179.132 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.69 103.21 12.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.747 . . . . 0.0 109.74 179.879 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.77 -103.13 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.955 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -154.64 30.39 0.42 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.946 . . . . 0.0 110.334 -179.968 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -142.74 118.72 10.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.619 -0.676 . . . . 0.0 110.545 -179.813 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 -52.45 0.48 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.986 -0.446 . . . . 0.0 111.57 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 48.83 91.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.712 -1.243 . . . . 0.0 111.473 179.569 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.57 -165.75 29.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.88 154.68 42.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.747 . . . . 0.0 110.02 -179.856 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -118.78 -4.7 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.467 -0.77 . . . . 0.0 111.252 179.861 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p 47.01 102.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.524 -0.735 . . . . 0.0 112.04 179.584 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.433 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -127.56 145.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.406 -0.809 . . . . 0.0 110.541 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.84 155.68 18.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.22 167.49 12.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.595 -0.69 . . . . 0.0 110.445 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.77 -39.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.521 -0.737 . . . . 0.0 110.736 -179.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -161.47 174.91 12.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.88 -31.93 72.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 109.931 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.6 82.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.728 . . . . 0.0 109.831 179.675 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.78 -39.66 84.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.099 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.19 87.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.632 -0.667 . . . . 0.0 109.447 179.049 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.7 tt0 -59.83 -36.86 77.69 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.96 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -70.77 -48.23 55.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.685 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.92 -38.74 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.713 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 10.1 m-85 -74.63 -39.39 62.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.126 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 31.0 mtpt -71.97 -3.36 22.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 111.084 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -107.88 -44.6 4.18 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.903 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 27.5 t80 -52.2 -37.7 55.7 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.355 176.327 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -68.63 -65.65 0.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -56.25 -42.39 77.28 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.721 -0.612 . . . . 0.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.68 -29.35 2.96 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -102.79 -44.96 5.14 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 178.703 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.83 63.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.955 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.81 135.36 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.774 -0.839 . . . . 0.0 110.22 -177.34 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -131.02 170.08 14.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.97 177.83 16.21 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.994 179.376 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -81.31 115.89 20.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.95 -0.735 . . . . 0.0 109.896 179.657 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.438 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 42.1 m95 -79.37 129.34 34.37 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.515 0.674 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -144.44 133.7 23.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.865 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -96.32 145.75 25.32 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.584 179.593 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.52 100.57 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.671 -0.643 . . . . 0.0 109.546 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.4 -5.04 25.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.0 111.588 -179.704 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.68 -27.72 19.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.738 179.619 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -130.03 8.05 5.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.0 110.08 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 54.58 42.13 31.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.3 m -127.03 132.57 50.69 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.419 -179.238 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.0 m-85 -90.12 -179.46 5.67 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.65 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.0 m -162.5 126.38 3.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.772 -1.205 . . . . 0.0 109.95 -179.444 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -116.34 92.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.806 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -84.56 102.94 13.27 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.707 0.765 . . . . 0.0 110.182 -178.54 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.504 2.243 0 O-C-N 121.079 -1.013 . . . . 0.0 110.943 -178.96 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.942 0.401 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 m -109.16 120.85 43.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.73 . . . . 0.0 109.789 179.283 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 35.6 m-85 -114.24 125.46 53.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.568 -0.708 . . . . 0.0 110.256 179.98 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -91.69 172.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.529 -0.732 . . . . 0.0 109.391 179.632 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.425 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -153.99 112.77 3.66 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.233 -179.724 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.2 mt -91.52 115.65 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.941 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.3 mp -87.71 116.81 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.269 -0.973 . . . . 0.0 109.449 -179.229 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.96 60.62 2.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.08 -144.73 4.94 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.36 27.23 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -179.812 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -140.07 27.32 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.491 -0.756 . . . . 0.0 110.183 179.836 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.73 -74.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 110.01 179.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt 51.61 54.07 11.65 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.325 -0.859 . . . . 0.0 110.667 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.95 169.05 28.1 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.782 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.99 64.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.812 . . . . 0.0 110.265 -179.857 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -61.16 143.54 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.0 p -99.4 150.65 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -0.754 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.453 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -116.19 168.58 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.111 0.958 . . . . 0.0 110.963 -179.181 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.16 79.37 1.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.758 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.66 176.68 5.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.678 -0.639 . . . . 0.0 110.5 -177.248 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.3 -40.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.278 -179.592 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -149.36 172.5 14.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.38 -31.27 71.16 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.859 -179.511 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.26 46.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.483 -0.761 . . . . 0.0 110.007 179.517 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.17 -45.57 92.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.0 -45.46 61.15 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.268 -0.895 . . . . 0.0 110.371 179.399 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.82 -34.63 74.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.401 179.348 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.43 -53.39 23.93 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.371 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.4 mt -59.57 -32.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.916 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CZ ' ' HB ' ' A' ' 19' ' ' ILE . 3.9 m-85 -78.89 -38.67 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.463 0.649 . . . . 0.0 109.266 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.3 mmmt -72.93 -4.06 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.796 -0.565 . . . . 0.0 111.429 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -107.84 -44.69 4.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.329 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.293 17.6 t80 -52.62 -34.04 49.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.2 176.43 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -66.58 -49.92 64.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.731 -0.606 . . . . 0.0 109.936 179.253 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -57.85 -46.2 85.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.639 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -55.61 -23.65 28.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.43 -0.794 . . . . 0.0 110.758 179.985 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -102.98 -26.65 13.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.739 -0.601 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.99 29.9 3.37 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.449 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -96.97 106.71 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.622 -0.928 . . . . 0.0 108.855 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -143.96 102.73 3.93 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.409 -179.215 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.42 -105.81 0.2 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.154 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.2 tt0 -105.95 179.73 4.18 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.41 -1.053 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 40.3 m95 -157.17 131.04 8.2 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.654 -0.653 . . . . 0.0 109.757 -179.952 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -146.13 132.29 19.4 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.581 -0.699 . . . . 0.0 109.557 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 19.9 t80 -97.42 121.97 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.667 179.272 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.2 98.82 11.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.554 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.93 -3.05 17.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.573 -0.704 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.08 -28.54 21.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.416 179.369 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -136.53 14.62 3.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.697 -0.627 . . . . 0.0 110.024 179.275 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.6 mptp? 49.46 43.65 23.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.88 . . . . 0.0 111.283 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -119.99 103.41 9.28 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.274 179.774 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 75.6 m-85 -62.3 -177.04 0.12 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.695 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.9 101.68 1.8 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.764 -1.21 . . . . 0.0 107.756 -179.654 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 4.6 p -106.13 115.27 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.209 1.004 . . . . 0.0 111.607 -178.148 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -89.69 171.78 9.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.793 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.216 179.968 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.426 HG21 ' CE2' ' A' ' 4' ' ' PHE . 87.2 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 m -108.0 114.43 28.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.541 -0.725 . . . . 0.0 110.027 179.435 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 27.7 m-85 -113.0 117.91 33.35 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -87.36 171.94 10.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -0.812 . . . . 0.0 110.108 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 29.8 tp -148.48 105.14 3.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.727 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.35 118.36 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.409 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.5 mm -95.35 119.47 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.988 -178.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -113.71 92.03 3.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.55 176.86 45.95 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -34.25 73.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.486 -1.008 . . . . 0.0 110.353 -179.873 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 p -91.09 133.45 35.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.657 -0.652 . . . . 0.0 109.871 179.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mt 58.48 162.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.504 -0.748 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -175.69 94.29 0.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.327 -0.858 . . . . 0.0 110.659 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.54 176.04 14.33 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.586 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -82.06 150.25 27.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.676 -0.896 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.51 -19.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.571 -0.706 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p 61.83 129.59 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.722 -0.611 . . . . 0.0 110.251 -179.636 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -120.53 167.25 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.967 0.889 . . . . 0.0 111.14 -179.445 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.02 71.56 1.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.61 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.1 179.34 4.13 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.797 -0.564 . . . . 0.0 110.403 -177.619 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.5 p -80.01 -41.5 21.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.893 -179.386 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -147.11 171.66 14.97 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.667 -179.338 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.36 72.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.52 -0.737 . . . . 0.0 109.942 179.42 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.43 -49.69 58.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.84 61.64 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.544 -0.723 . . . . 0.0 110.121 179.009 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -60.22 -41.29 92.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.303 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -67.44 -49.85 61.89 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.784 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -59.14 -39.97 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.59 -0.694 . . . . 0.0 109.204 179.023 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 19' ' ' ILE . 5.6 m-85 -73.78 -38.58 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.336 0.588 . . . . 0.0 109.476 179.25 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 0.8 OUTLIER -72.77 -3.35 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.664 -0.647 . . . . 0.0 111.44 -179.99 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -110.41 -45.1 3.6 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 177.721 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.296 3.6 t80 -54.41 -44.49 72.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.85 176.28 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' CB ' HG23 ' A' ' 40' ' ' ILE . . . -64.48 -58.64 5.84 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.196 0.522 . . . . 0.0 109.921 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -54.76 -47.6 73.69 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.595 -0.69 . . . . 0.0 110.916 -179.719 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.32 -28.71 63.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.402 -0.811 . . . . 0.0 110.421 -179.896 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -94.6 -27.8 15.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.809 -0.557 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.33 27.81 4.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.908 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 HG23 ' CB ' ' A' ' 35' ' ' ALA . 1.7 mp -99.77 76.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -1.05 . . . . 0.0 109.075 -179.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -172.3 3.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.042 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 57' ' ' GLU . . . 126.11 -171.13 17.91 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.432 -1.366 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.24 132.14 34.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.983 -0.716 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 32' ' ' LYS . 49.7 m95 -100.57 133.56 44.84 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.573 0.701 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -145.55 133.59 21.44 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.695 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 t80 -98.19 142.2 30.16 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.674 179.688 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -113.2 101.25 9.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.764 -0.585 . . . . 0.0 109.739 179.576 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.87 -5.15 28.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 0.0 111.428 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.8 -28.66 21.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 109.503 179.499 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -129.13 7.64 5.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.676 . . . . 0.0 110.096 179.269 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp 54.42 41.04 32.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.179 -0.951 . . . . 0.0 110.092 -179.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 m -127.98 132.77 49.16 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.044 -179.333 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.7 m-85 -86.92 -173.78 4.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.332 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -157.86 117.76 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.835 -1.166 . . . . 0.0 108.987 -179.878 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' HD11 ' A' ' 8' ' ' ILE . 1.7 p -115.81 93.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.735 0.778 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.6 OUTLIER -87.72 96.78 10.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.892 0.853 . . . . 0.0 110.046 -178.618 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 10.9 tt0 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.131 . . . . 0.0 110.223 -179.131 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.42 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 70.6 m . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.1 m -69.68 91.93 0.64 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 7.9 m-85 -80.98 139.69 35.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.517 -0.739 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.92 -172.31 2.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.528 -0.733 . . . . 0.0 110.208 -179.526 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 3.7 tp -164.05 98.77 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 0.0 109.94 179.912 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 7' ' ' ILE . 89.6 mt -80.52 134.11 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.421 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 5.9 mm -99.03 117.67 44.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.215 -178.925 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -94.07 6.0 49.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.677 -0.639 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.84 -165.89 36.33 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -103.11 27.56 7.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.611 -0.935 . . . . 0.0 109.966 179.614 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -153.92 175.53 13.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 0.0 110.488 -179.63 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' CD2' ' CD1' ' A' ' 40' ' ' ILE . 0.6 OUTLIER 38.74 28.57 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.694 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.44 118.67 2.88 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.198 -0.939 . . . . 0.0 111.7 -179.209 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.95 -174.18 44.71 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -118.56 -32.78 4.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.832 -0.805 . . . . 0.0 110.546 -179.788 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 24.2 pt 36.98 83.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.762 0 CA-C-O 121.558 0.694 . . . . 0.0 112.291 -179.625 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -70.54 140.8 51.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.51 -0.744 . . . . 0.0 110.553 -179.584 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -148.22 134.28 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 179.548 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.68 156.03 35.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 179.974 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.7 158.54 7.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.563 -0.71 . . . . 0.0 110.24 179.968 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -54.0 -39.99 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.544 -0.722 . . . . 0.0 110.555 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -160.5 177.48 10.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.458 -0.776 . . . . 0.0 109.705 179.561 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.79 -34.52 77.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 109.785 -179.985 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.04 -44.73 74.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.494 -0.754 . . . . 0.0 109.77 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.41 -44.48 71.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.826 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.8 -39.92 72.0 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.405 -0.809 . . . . 0.0 109.596 178.871 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.8 tt0 -61.37 -40.1 93.08 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.209 -0.597 . . . . 0.0 110.039 179.595 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.51 -34.44 63.03 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.491 179.478 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 49.4 mt -67.99 -38.76 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.915 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.9 m-85 -75.21 -37.1 61.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.44 2.2 19.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 110.948 179.201 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.19 -44.8 4.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 177.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CZ ' HD12 ' A' ' 17' ' ' ILE 0.291 8.6 t80 -51.54 -39.59 58.05 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.313 176.22 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -73.19 -48.72 32.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.583 0.706 . . . . 0.0 109.583 179.413 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -67.11 -46.38 74.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.774 -0.579 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -48.86 -27.76 3.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 111.03 -179.43 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -100.62 -47.76 4.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.417 0.627 . . . . 0.0 110.007 179.4 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.35 61.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -179.506 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.294 1.1 mm -117.02 141.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.914 -0.756 . . . . 0.0 109.067 -177.298 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -166.66 125.28 1.43 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.735 -179.155 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.4 -102.2 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.525 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 9.6 tt0 -127.98 173.57 9.92 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.455 -1.026 . . . . 0.0 109.582 178.675 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.462 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.5 m95 -150.43 131.35 14.23 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.379 -0.826 . . . . 0.0 110.091 -179.798 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 p -143.96 131.5 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.6 179.507 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -94.87 134.14 37.84 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.211 179.308 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.14 98.77 8.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.627 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.05 -5.31 25.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.655 -0.653 . . . . 0.0 111.425 -179.903 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.59 -27.96 17.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.712 179.616 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.9 p -124.3 7.37 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.655 -0.653 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt 54.56 38.78 30.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.128 -0.982 . . . . 0.0 110.18 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -130.34 140.9 50.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.606 -0.684 . . . . 0.0 110.463 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 57.2 m-85 -92.74 -170.4 2.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 109.609 179.669 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.03 92.84 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.855 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.4 p -92.98 105.71 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.87 0.843 . . . . 0.0 110.458 -178.91 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -84.17 171.6 12.68 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.581 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.253 179.732 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 4' ' ' PHE . 61.7 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 22.6 m 52.39 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.28 -0.888 . . . . 0.0 110.875 -178.784 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 9.5 m-85 -105.03 123.42 47.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.17 174.55 7.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.759 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -151.34 113.51 4.54 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.256 -179.997 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 7' ' ' ILE . 42.4 mm -80.98 119.81 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 13' ' ' LEU . 7.9 mm -96.14 122.64 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.307 -178.738 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -108.84 52.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 109.956 179.458 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.09 -151.72 8.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.808 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 -23.6 9.37 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.598 -0.942 . . . . 0.0 110.722 -179.793 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -82.36 -30.4 30.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.563 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CB ' ' CG2' ' A' ' 8' ' ' ILE . 8.5 mt -119.66 171.66 8.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.723 -0.61 . . . . 0.0 109.358 179.72 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.04 76.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.636 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.23 179.58 27.06 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.512 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.06 -154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.699 -0.883 . . . . 0.0 109.913 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.401 ' O ' ' OG1' ' A' ' 18' ' ' THR . 7.0 tp -175.07 -32.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.501 -0.749 . . . . 0.0 110.25 179.913 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 17' ' ' ILE . 2.2 p 63.49 137.0 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.367 0.603 . . . . 0.0 109.988 -179.831 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -130.77 166.8 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 121.671 0.748 . . . . 0.0 111.057 -178.869 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.41 78.52 1.21 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.305 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 149.43 43.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.577 -0.702 . . . . 0.0 110.381 -177.533 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.55 -39.75 76.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.374 0.607 . . . . 0.0 110.75 -179.63 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -149.8 178.61 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.801 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.57 -29.99 70.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.606 -179.574 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.73 79.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.524 -0.735 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.29 -47.87 66.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.639 -0.663 . . . . 0.0 109.394 179.214 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.01 62.31 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.438 -0.789 . . . . 0.0 110.434 179.486 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.2 tt0 -58.6 -36.45 74.05 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.609 179.423 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -54.13 15.99 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.29 -35.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.527 -0.733 . . . . 0.0 109.184 178.753 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 19' ' ' ILE . 4.5 m-85 -74.65 -39.13 62.24 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.91 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -72.97 -2.79 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 111.442 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -109.28 -44.63 3.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 177.444 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 12.3 t80 -51.44 -33.77 32.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.746 175.954 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -59.95 -57.98 10.52 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.659 0.743 . . . . 0.0 109.118 178.573 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -58.55 -44.4 89.66 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -49.44 -27.19 3.92 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.593 -0.692 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -104.12 -50.07 3.45 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 0.0 110.135 179.402 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.88 62.64 0.05 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -179.653 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.307 1.1 mm -120.3 136.8 56.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.877 -0.778 . . . . 0.0 109.875 -177.042 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -170.07 101.97 0.29 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.325 -0.86 . . . . 0.0 111.237 -179.851 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.01 -104.38 0.18 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.445 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 8.6 tt0 -114.73 174.4 5.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.537 -0.978 . . . . 0.0 110.64 -179.923 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 36.1 m95 -152.87 128.67 10.19 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.709 -0.619 . . . . 0.0 109.615 179.854 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -142.43 132.06 23.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 109.309 179.587 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.5 t80 -96.97 128.25 43.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.53 179.589 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -96.22 98.66 10.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.656 -0.652 . . . . 0.0 109.407 179.207 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -70.59 -4.09 21.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.654 -0.654 . . . . 0.0 111.692 -179.598 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.22 -26.34 17.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.613 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -127.64 7.53 6.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.579 -0.701 . . . . 0.0 110.132 179.333 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 46.8 mmtt 54.53 40.43 31.83 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.21 -0.932 . . . . 0.0 110.134 -179.618 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -127.66 129.82 47.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.728 -0.608 . . . . 0.0 110.425 -179.638 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.5 m-85 -85.29 -171.17 3.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 109.497 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -155.83 95.28 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 3.0 p -98.8 107.5 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.982 0.896 . . . . 0.0 111.18 -178.357 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -88.4 163.72 15.86 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.796 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.305 -179.959 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 88.4 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.112 0.482 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.9 m -84.23 88.61 7.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.158 179.701 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 10.0 m-85 -76.9 137.72 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -102.48 -172.6 2.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.436 -179.533 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 6.0 tp -165.25 107.7 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.659 -0.65 . . . . 0.0 109.939 179.926 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 7' ' ' ILE . 95.3 mt -89.9 115.57 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.264 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.0 mp -97.67 120.55 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.483 -179.499 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -109.24 98.02 7.52 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.499 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.45 -135.02 1.97 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.937 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -32.94 4.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.968 . . . . 0.0 110.325 179.799 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 p -87.29 107.55 18.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 179.512 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.09 148.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -162.91 128.38 3.22 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.236 -0.915 . . . . 0.0 110.647 -179.724 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.07 -174.73 18.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.29 147.89 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.902 . . . . 0.0 110.836 -179.647 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 17' ' ' ILE . 47.8 mm -113.12 -26.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.511 -0.743 . . . . 0.0 110.243 179.729 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 p 56.79 112.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.344 0.592 . . . . 0.0 111.206 179.57 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.97 135.44 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.327 179.188 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.27 149.34 47.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.609 -0.682 . . . . 0.0 110.148 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.67 156.04 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.42 -40.53 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.557 -0.715 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.94 -179.81 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.706 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.92 -32.49 74.24 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.559 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.95 76.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.828 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -45.46 71.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.891 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -42.05 76.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.042 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.5 tt0 -61.62 -41.34 97.33 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.447 179.083 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -69.32 -44.27 72.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.408 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.406 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 87.7 mt -63.21 -42.09 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 8.7 m-85 -70.41 -40.5 73.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.199 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 34.1 mtpt -71.56 -4.06 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 110.963 179.299 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -98.3 -45.6 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.127 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 5.9 t80 -44.36 -54.15 6.11 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.79 175.572 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.78 -51.41 68.41 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.53 -47.3 79.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.641 -0.662 . . . . 0.0 111.364 -178.958 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -48.92 -30.82 6.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.476 -0.765 . . . . 0.0 110.985 -179.275 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -96.01 -46.08 6.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.564 0.697 . . . . 0.0 109.553 179.124 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 62.89 0.16 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -179.373 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.284 1.0 OUTLIER -118.67 139.67 45.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.863 -0.786 . . . . 0.0 110.489 -176.725 . . . . . . . . 4 4 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.98 -178.21 4.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.21 -178.74 17.36 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.716 179.2 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.98 123.1 31.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.982 -0.717 . . . . 0.0 110.328 179.888 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.436 ' CH2' HD12 ' A' ' 6' ' ' LEU . 37.8 m95 -88.62 128.1 35.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -141.04 132.9 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.843 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -96.62 143.44 27.59 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.532 179.714 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.77 99.15 7.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.681 -0.637 . . . . 0.0 109.405 179.233 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.74 -3.84 20.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.664 . . . . 0.0 111.593 -179.641 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.27 -27.05 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.736 179.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -130.17 8.9 5.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.632 -0.668 . . . . 0.0 110.128 179.372 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 53.82 44.22 29.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 0.0 110.154 -179.589 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.2 m -130.07 129.93 44.25 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.113 -179.411 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 69.9 m-85 -89.69 -176.65 5.05 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.934 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 m -162.39 124.58 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.793 -1.192 . . . . 0.0 109.664 179.996 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.13 93.27 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.059 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -82.93 96.44 8.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.026 0.917 . . . . 0.0 110.157 -178.237 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 O-C-N 120.978 -1.076 . . . . 0.0 110.448 -179.243 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.143 0.497 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m -104.78 74.69 1.15 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.5 m -97.83 104.27 16.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 27.4 m-85 -90.58 152.21 20.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -112.96 -171.85 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.669 -0.645 . . . . 0.0 110.118 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 14.8 tp -164.25 107.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.142 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.68 124.89 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.7 mm -89.82 116.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.77 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -103.51 67.74 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 0.0 110.468 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.97 167.92 39.47 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -59.82 -33.84 72.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -1.012 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 p -80.44 133.73 35.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt 58.32 163.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.468 -0.77 . . . . 0.0 110.284 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -177.24 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.55 -163.45 33.99 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -133.41 70.67 1.46 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.932 . . . . 0.0 110.377 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.9 tp -62.31 114.53 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.461 -0.774 . . . . 0.0 109.712 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -83.61 138.47 33.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.651 -0.656 . . . . 0.0 110.499 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.48 149.98 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.573 -0.704 . . . . 0.0 110.369 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 148.68 23.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.18 159.64 23.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.553 -0.717 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.68 -38.83 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.511 -0.743 . . . . 0.0 110.568 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -159.96 175.83 12.57 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.55 -33.81 75.68 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.713 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.82 63.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.455 -0.778 . . . . 0.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.09 -40.47 96.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.36 72.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 0.0 109.479 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -58.29 -36.26 73.04 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -69.11 -50.81 44.66 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.69 -37.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 12.0 m-85 -74.32 -37.34 63.61 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.6 mmmt -76.3 0.23 20.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.738 -0.601 . . . . 0.0 111.563 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -109.24 -45.25 3.77 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 10.7 t80 -53.07 -34.61 57.33 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.028 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.463 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -69.68 -48.14 60.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.193 0.52 . . . . 0.0 110.0 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.41 -46.7 85.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.526 -0.734 . . . . 0.0 110.342 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -54.58 -23.32 16.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.54 -0.725 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.51 -25.86 12.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.627 -0.67 . . . . 0.0 110.557 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.76 30.68 3.4 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.71 106.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.979 . . . . 0.0 108.788 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.73 111.68 6.75 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.427 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.27 -108.72 0.21 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -109.81 173.37 6.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.396 -1.061 . . . . 0.0 110.39 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.449 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 40.8 m95 -152.06 130.33 12.02 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.543 -0.723 . . . . 0.0 110.26 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.7 p -142.26 134.18 27.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.63 -0.669 . . . . 0.0 109.253 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.6 t80 -97.61 143.7 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.93 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -113.92 97.97 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.817 -0.552 . . . . 0.0 109.536 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -69.69 -6.84 34.41 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.661 -0.649 . . . . 0.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.15 -27.47 17.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.702 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -122.84 5.71 9.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.648 -0.658 . . . . 0.0 110.079 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp 54.19 36.63 25.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -127.97 143.2 51.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.629 -0.669 . . . . 0.0 110.666 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.2 m-85 -95.99 -168.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 109.698 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 92.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -94.18 108.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.902 0.858 . . . . 0.0 110.915 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -89.52 169.68 11.15 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.101 0.477 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 m -118.28 34.8 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.713 . . . . 0.0 110.294 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.1 m -61.16 95.17 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.575 -0.703 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 5.7 m-85 -83.68 142.53 30.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.895 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -103.34 -177.24 3.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.584 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 4.9 tp -163.26 110.17 1.17 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.653 -0.654 . . . . 0.0 109.967 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.6 mt -85.8 117.63 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.8 mm -85.72 116.9 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -102.93 63.64 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.88 -132.68 3.26 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -131.32 -40.84 1.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.935 . . . . 0.0 110.465 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -69.89 -47.29 63.12 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.449 -0.782 . . . . 0.0 109.62 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.81 156.89 20.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.811 -0.556 . . . . 0.0 109.829 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -172.34 86.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.432 -0.793 . . . . 0.0 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.55 161.46 27.43 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.71 73.75 9.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.727 -0.867 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.22 120.79 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -99.09 133.47 43.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.797 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.431 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.28 142.1 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.626 -0.671 . . . . 0.0 110.375 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.02 141.21 34.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.619 -0.676 . . . . 0.0 110.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.72 160.14 41.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 110.236 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.9 -32.99 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.242 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -166.13 -176.51 3.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 109.429 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -68.82 -30.29 68.82 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.665 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.19 87.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.706 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -70.33 -39.8 74.52 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.79 85.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.528 -0.732 . . . . 0.0 109.533 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.3 tt0 -58.61 -35.97 73.29 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -71.27 -51.33 25.09 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.0 -36.2 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 8.9 m-85 -75.72 -36.28 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -80.12 4.61 16.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.792 -0.567 . . . . 0.0 111.449 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -110.89 -45.49 3.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 12.2 t80 -55.48 -43.5 75.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.933 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -58.73 -47.26 85.21 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.35 -49.51 75.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.554 -0.716 . . . . 0.0 110.746 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.36 -23.52 38.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -100.8 -24.05 14.47 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.729 -0.607 . . . . 0.0 110.719 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.87 30.89 4.67 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.454 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.51 106.21 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.679 -0.894 . . . . 0.0 108.785 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.53 110.0 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.117 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.94 -106.32 0.2 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 3.2 tt0 -108.63 174.82 5.7 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.483 -1.01 . . . . 0.0 110.524 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.449 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 41.9 m95 -153.53 130.63 11.09 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.638 -0.664 . . . . 0.0 109.99 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -142.48 133.18 25.39 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -99.84 144.24 29.13 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.882 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -114.97 98.56 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.769 -0.582 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.16 -4.94 23.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.713 -0.617 . . . . 0.0 111.664 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 -27.13 18.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.677 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.1 p -127.9 7.38 6.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.658 -0.651 . . . . 0.0 110.175 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt 54.17 40.62 31.85 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -125.83 135.9 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.656 -0.652 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 74.8 m-85 -94.36 -170.36 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.579 -0.701 . . . . 0.0 109.525 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.3 94.15 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.853 -1.154 . . . . 0.0 107.89 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 3.0 p -96.66 107.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.02 0.914 . . . . 0.0 111.173 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -89.07 169.72 11.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.132 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptm . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 58.7 m -131.63 49.1 2.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.518 -0.739 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 m -71.0 81.93 0.67 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 9.5 m-85 -66.41 144.49 56.49 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.04 179.81 4.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.575 -0.703 . . . . 0.0 110.162 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD23 ' CD1' ' A' ' 31' ' ' PHE . 7.0 tp -157.36 112.15 2.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -89.57 122.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD11 ' CG1' ' A' ' 55' ' ' VAL . 3.2 mm -89.06 117.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.664 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -104.95 67.06 0.78 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.474 -0.767 . . . . 0.0 110.091 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.02 166.05 36.76 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -59.89 -28.76 67.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.443 -1.034 . . . . 0.0 110.291 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -92.45 129.59 38.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.622 -0.674 . . . . 0.0 109.619 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 mt 60.33 127.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.378 0.609 . . . . 0.0 110.586 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -148.75 93.6 2.15 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.15 -172.72 45.7 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.22 96.36 5.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.817 -0.813 . . . . 0.0 109.947 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -86.72 115.51 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 109.95 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -89.44 126.9 35.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.622 . . . . 0.0 110.282 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.87 135.28 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.615 -0.678 . . . . 0.0 110.491 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -73.87 153.1 40.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.592 -0.692 . . . . 0.0 110.134 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.66 160.22 12.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -53.14 -39.46 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.556 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.01 176.83 10.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.671 -0.643 . . . . 0.0 109.575 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.75 -33.35 74.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 109.746 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.2 -43.54 78.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 109.984 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.4 -44.18 68.51 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 -46.29 74.29 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.484 -0.76 . . . . 0.0 109.686 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 2.7 tt0 -58.16 -37.65 75.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.747 -0.596 . . . . 0.0 109.412 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -51.2 43.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.62 -40.39 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 13.2 m-85 -71.8 -34.85 69.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -77.15 0.17 22.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.647 -0.658 . . . . 0.0 111.5 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -108.06 -45.41 3.96 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.6 t80 -54.02 -35.89 62.42 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.139 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.441 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -71.0 -45.76 63.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.81 -0.556 . . . . 0.0 110.343 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -50.23 73.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 111.018 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.82 -21.92 32.61 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.455 -0.778 . . . . 0.0 110.978 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -101.19 -23.71 14.39 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.686 -0.634 . . . . 0.0 110.697 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.3 31.09 4.78 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.49 105.34 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.595 -0.944 . . . . 0.0 108.92 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.29 112.22 6.27 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.074 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.46 -104.81 0.18 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 3.3 tt0 -112.19 173.78 6.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -1.022 . . . . 0.0 110.184 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.9 m95 -151.97 128.62 10.8 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.535 -0.728 . . . . 0.0 109.815 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -140.11 132.51 28.46 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.227 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.2 t80 -98.62 147.54 24.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.592 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.46 99.94 7.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.724 -0.61 . . . . 0.0 109.626 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.8 -4.9 26.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.724 -0.61 . . . . 0.0 111.579 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.36 -26.74 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.1 p -129.11 7.54 5.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.6 -0.687 . . . . 0.0 110.17 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.2 mmtp 54.59 40.29 31.75 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -124.7 139.72 53.6 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 76.0 m-85 -97.29 -172.09 2.35 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.556 -0.715 . . . . 0.0 109.741 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.32 91.85 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.0 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -93.0 105.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.897 0.856 . . . . 0.0 110.895 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -88.03 171.75 10.05 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.136 0.494 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 78.2 m -112.17 69.3 0.69 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 110.373 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -93.34 103.67 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 28.4 m-85 -88.5 151.33 22.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -115.04 -168.35 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 21.0 tp -166.2 107.37 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.82 105.16 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.2 mm -75.95 106.06 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.523 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 56' ' ' THR . 43.7 t30 -82.04 4.16 24.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.505 -0.747 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.82 -148.05 1.58 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -137.21 32.23 2.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.61 -0.936 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 p -147.23 17.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mt -170.81 36.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.63 97.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 110.994 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.57 177.59 43.63 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -44.33 4.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.702 -0.881 . . . . 0.0 110.181 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.0 mm 53.95 87.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.449 -0.782 . . . . 0.0 110.547 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -84.29 134.36 34.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.736 . . . . 0.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.421 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.49 147.85 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.621 -0.674 . . . . 0.0 110.401 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.17 151.93 22.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.259 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.49 160.71 18.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.342 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.69 -40.17 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -160.87 174.71 13.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -60.18 -27.45 67.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.373 -0.829 . . . . 0.0 109.953 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 -47.45 84.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -0.785 . . . . 0.0 109.748 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -69.88 -41.28 75.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.76 80.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.579 -0.701 . . . . 0.0 109.57 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -57.26 -39.88 76.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.632 -0.667 . . . . 0.0 109.235 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -65.62 -53.1 46.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.508 -0.745 . . . . 0.0 109.379 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -56.29 -39.39 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.523 -0.736 . . . . 0.0 109.102 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 11.8 m-85 -73.67 -36.62 65.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 4.0 mtmp? -79.48 3.32 18.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.701 -0.625 . . . . 0.0 111.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -45.21 3.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 9.4 t80 -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.974 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -62.53 -48.08 81.1 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.867 -0.521 . . . . 0.0 110.181 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.98 -48.52 78.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.539 -0.725 . . . . 0.0 110.622 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.37 -25.55 35.87 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.566 -0.709 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -99.82 -25.56 14.32 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.709 -0.619 . . . . 0.0 110.667 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.17 30.42 4.18 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.454 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 105.82 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.686 -0.891 . . . . 0.0 108.862 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -148.64 102.84 3.34 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.728 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.06 -73.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 29.4 mt-10 -136.0 171.64 14.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.498 -1.001 . . . . 0.0 110.042 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 47.7 m95 -155.26 126.91 7.41 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.65 -0.656 . . . . 0.0 110.045 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 p -144.39 132.79 21.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.4 t80 -95.26 141.65 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.803 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -111.26 100.08 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.736 -0.603 . . . . 0.0 109.739 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.5 -2.79 18.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.686 -0.634 . . . . 0.0 111.657 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.01 -25.93 17.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 109.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.9 p -130.58 8.77 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 110.229 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 56.7 mmtt 54.3 41.65 31.88 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.175 -0.953 . . . . 0.0 110.27 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.4 m -130.56 134.86 47.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 59.1 m-85 -89.28 -168.74 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.521 -0.737 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -155.92 105.3 2.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 108.172 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG23 ' CZ2' ' A' ' 44' ' ' TRP . 5.9 p -115.82 129.86 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.299 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -126.09 -172.04 2.53 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.185 179.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.626 0.251 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.413 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 52.8 m -104.81 41.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.078 -1.014 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 m -63.54 85.8 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.713 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 5.3 m-85 -71.21 140.77 50.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.675 -0.641 . . . . 0.0 109.66 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -104.67 168.01 9.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' A' ' 31' ' ' PHE . 17.8 tp -141.9 105.57 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.8 mt -76.89 110.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' CG1' ' A' ' 55' ' ' VAL . 6.8 mm -84.21 112.94 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.121 -1.032 . . . . 0.0 109.79 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -97.86 155.49 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.476 -0.765 . . . . 0.0 110.064 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.7 -138.97 15.32 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -129.07 28.9 5.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.523 -0.986 . . . . 0.0 110.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' LYS . 19.2 p -136.09 145.26 45.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.623 -0.673 . . . . 0.0 109.905 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 mt 60.9 -76.69 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.733 -0.604 . . . . 0.0 111.16 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' THR . 24.6 mtpt 54.99 99.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.343 -0.848 . . . . 0.0 110.708 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.94 -174.22 31.75 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -136.03 86.3 2.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.895 . . . . 0.0 109.729 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -59.39 -25.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.552 -0.717 . . . . 0.0 110.789 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 p 60.69 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 121.43 0.634 . . . . 0.0 110.669 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.58 146.04 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.426 -0.796 . . . . 0.0 110.799 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -81.55 152.95 27.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.33 158.52 9.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 110.398 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.95 -38.92 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -161.26 -177.92 6.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.77 -28.11 68.78 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.46 69.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.23 -41.68 89.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.677 -0.639 . . . . 0.0 109.377 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.23 73.42 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.529 -0.732 . . . . 0.0 109.856 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.5 tt0 -57.94 -38.17 75.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -70.15 -51.91 27.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mt -58.04 -34.91 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.455 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 7.7 m-85 -77.66 -36.6 51.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -74.34 -2.0 23.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.698 -0.626 . . . . 0.0 111.402 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -108.56 -45.38 3.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 8.9 t80 -52.41 -35.44 51.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.936 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -68.11 -47.01 69.33 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.201 0.524 . . . . 0.0 109.987 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.7 -49.31 76.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -54.97 -23.32 18.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.524 -0.735 . . . . 0.0 111.081 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -102.34 -26.84 13.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.658 -0.651 . . . . 0.0 110.624 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.19 30.9 3.46 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.85 107.07 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.647 -0.913 . . . . 0.0 108.928 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -145.12 109.47 4.9 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.162 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -107.2 0.2 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -107.18 176.64 5.1 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.454 -1.027 . . . . 0.0 110.45 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.2 m95 -154.37 130.35 10.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.598 -0.689 . . . . 0.0 109.79 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -143.88 132.25 22.08 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.337 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.57 147.61 24.11 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.851 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.44 98.68 6.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.715 -0.615 . . . . 0.0 109.746 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.97 -5.65 27.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.636 -0.665 . . . . 0.0 111.419 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.96 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.555 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -126.59 8.01 6.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.655 . . . . 0.0 110.069 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp 53.57 40.03 30.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.146 -0.971 . . . . 0.0 110.281 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -127.65 142.96 51.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.597 -0.689 . . . . 0.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 72.0 m-85 -98.9 -170.14 1.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.626 -0.671 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.11 94.58 1.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 40' ' ' ILE . 3.0 p -97.43 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.915 0.864 . . . . 0.0 111.173 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 166.25 20.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.257 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.045 0.45 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.1 m -136.61 -71.07 0.45 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.6 m 49.86 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 6.4 m-85 -87.36 142.49 27.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.638 -0.664 . . . . 0.0 109.654 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -100.1 -176.45 3.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 1.2 tp -164.43 112.65 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.443 -0.786 . . . . 0.0 110.342 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.45 118.12 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.4 mp -90.21 116.38 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.013 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -92.88 151.99 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.0 110.254 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.52 -155.41 16.27 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.11 31.48 6.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.924 . . . . 0.0 110.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -93.34 -147.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.674 -0.642 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.404 ' CD1' ' N ' ' A' ' 14' ' ' LYS . 4.3 pp -53.91 -36.48 62.78 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 111.309 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 13' ' ' LEU . 4.6 mtpt 50.9 99.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 111.538 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.12 -167.55 37.78 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.334 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -115.74 -64.84 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.814 -0.815 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 17' ' ' ILE . 83.1 mt 52.36 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.372 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.3 p -59.27 150.19 26.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.44 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -143.32 134.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.519 -0.738 . . . . 0.0 110.89 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.99 138.37 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.94 154.65 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -54.44 -38.67 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.488 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.78 179.92 8.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.664 . . . . 0.0 109.429 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.29 -34.42 78.29 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.749 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.95 75.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.91 -44.61 65.85 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.06 74.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -59.65 -39.16 83.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.626 -0.671 . . . . 0.0 109.275 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -68.37 -50.06 55.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.184 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.98 -37.49 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 7.3 m-85 -75.97 -38.29 57.66 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.413 0.625 . . . . 0.0 109.321 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.9 mmtp -71.62 -5.09 31.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.777 -0.577 . . . . 0.0 111.479 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.97 -45.16 4.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.284 0.7 OUTLIER -51.22 -38.04 50.25 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.039 176.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -66.89 -47.95 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.252 0.549 . . . . 0.0 110.246 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -56.53 -51.28 69.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.521 -0.737 . . . . 0.0 110.919 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -57.11 -21.13 29.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.548 -0.72 . . . . 0.0 111.082 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -101.61 -25.57 13.83 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.81 28.7 4.94 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.54 105.85 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.653 -0.91 . . . . 0.0 108.581 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -143.24 108.94 5.12 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.53 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.22 -109.89 0.23 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.31 177.75 4.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.41 -1.053 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.446 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 39.8 m95 -155.83 130.52 9.09 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.538 -0.726 . . . . 0.0 109.687 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -145.45 134.89 23.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.454 -0.779 . . . . 0.0 109.202 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.6 t80 -98.81 148.28 24.06 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.28 96.72 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -69.05 -6.68 29.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.699 -0.626 . . . . 0.0 111.403 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.78 20.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 109.605 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -124.76 7.5 8.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.758 -0.589 . . . . 0.0 110.121 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 53.99 38.57 29.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.2 m -128.54 134.76 48.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.691 . . . . 0.0 110.751 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 60.0 m-85 -90.9 -168.97 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.92 97.42 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 3.2 p -101.42 103.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.121 0.962 . . . . 0.0 111.253 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -82.35 171.62 13.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.033 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mtp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.006 0.431 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 m -93.76 54.54 2.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -84.13 104.29 14.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CZ ' ' CB ' ' A' ' 24' ' ' ALA . 24.3 m-85 -88.83 151.32 22.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -113.19 -170.83 1.76 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 27.1 tp -163.69 99.97 0.9 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 110.233 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.78 115.35 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 13' ' ' LEU . 15.6 mm -82.64 103.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.745 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.8 t30 -71.24 167.06 20.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.496 -0.752 . . . . 0.0 110.238 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 -153.17 26.32 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.76 36.03 4.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.954 . . . . 0.0 109.917 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 -151.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.635 -0.666 . . . . 0.0 110.097 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' CD1' HG13 ' A' ' 8' ' ' ILE . 2.5 pp -48.75 -26.95 2.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 111.027 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.66 103.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.637 -0.664 . . . . 0.0 111.576 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.41 153.36 8.18 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.437 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -108.77 54.73 0.65 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.834 -0.804 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 tt -50.99 128.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.303 -0.873 . . . . 0.0 110.779 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.5 p -99.13 141.05 32.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.332 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.454 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.7 pp -142.99 143.14 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.669 . . . . 0.0 110.548 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -83.85 146.36 28.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.88 159.01 29.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.731 . . . . 0.0 110.454 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.14 -39.32 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.754 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -159.76 176.65 11.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.53 -29.96 70.94 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.738 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.75 80.58 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.819 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.99 -41.35 77.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.08 -44.25 82.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.634 -0.666 . . . . 0.0 109.529 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -59.33 -37.9 78.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.71 -0.619 . . . . 0.0 109.368 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -50.7 46.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.268 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.81 -36.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 8.4 m-85 -77.06 -37.09 55.36 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 6.2 mmmt -77.68 1.69 19.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.662 -0.649 . . . . 0.0 111.351 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -108.8 -45.17 3.87 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 1.5 t80 -53.08 -38.47 62.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.068 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.47 -49.36 71.7 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -57.5 -48.51 79.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.513 -0.742 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.24 -23.55 36.65 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.395 -0.816 . . . . 0.0 110.956 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -101.34 -25.28 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.691 -0.631 . . . . 0.0 110.599 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.63 32.39 3.65 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.21 106.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.69 -0.888 . . . . 0.0 108.765 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -148.65 103.2 3.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.749 -0.594 . . . . 0.0 110.948 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.77 -58.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.5 tp10 -152.19 174.8 13.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.576 -0.955 . . . . 0.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 43.3 m95 -158.42 127.54 5.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.67 -0.644 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.6 p -145.03 132.43 20.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.627 -0.671 . . . . 0.0 109.521 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.4 t80 -96.2 146.64 24.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.95 98.43 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.774 -0.579 . . . . 0.0 109.533 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.18 -6.06 31.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.95 -27.07 18.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -124.77 5.81 8.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.603 -0.686 . . . . 0.0 110.05 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.9 mmtt 54.39 40.72 31.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -132.63 137.79 47.13 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.124 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.2 m-85 -92.36 -172.94 3.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.578 -0.701 . . . . 0.0 109.353 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.62 105.12 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 108.548 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 5.9 p -115.22 133.37 61.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.658 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -120.88 -174.35 2.8 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.774 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.144 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.085 0.469 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 28.8 m -106.4 42.93 1.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.265 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -66.94 85.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.474 -0.766 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 10.6 m-85 -70.2 142.01 52.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.685 -0.634 . . . . 0.0 109.817 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.3 177.22 4.86 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.541 -0.724 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.441 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 25.6 tp -152.53 109.71 3.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 7' ' ' ILE . 45.3 mm -81.37 108.44 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 mm -84.92 118.78 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.957 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -110.95 140.66 45.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.69 -149.66 21.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -121.58 14.64 11.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.005 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -113.57 -56.68 2.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mt -115.01 167.55 10.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.795 -0.566 . . . . 0.0 109.501 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.46 92.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 110.701 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.28 173.99 24.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -100.71 156.76 17.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.799 -0.824 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.77 -16.65 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.601 -0.687 . . . . 0.0 110.53 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.7 p 46.32 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.579 -0.701 . . . . 0.0 111.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -132.26 132.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.476 -0.765 . . . . 0.0 110.372 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.14 150.45 38.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.644 -0.66 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.17 163.01 28.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.636 . . . . 0.0 110.4 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.55 -34.24 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -166.93 176.26 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.729 -0.607 . . . . 0.0 109.376 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.76 -29.88 71.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.89 87.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.95 -42.71 69.44 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.29 84.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.617 -0.677 . . . . 0.0 109.558 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -59.08 -34.18 71.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 109.487 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -71.09 -52.35 19.93 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.91 -35.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 7.8 m-85 -75.55 -38.95 58.9 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.9 mtpt -79.84 5.25 14.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 111.49 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -110.04 -45.4 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.0 t80 -54.05 -43.72 70.44 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.177 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.0 -49.11 78.95 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.834 -0.541 . . . . 0.0 110.197 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -56.91 -48.39 78.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.727 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.56 -21.57 39.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.599 -0.688 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.09 -27.87 12.31 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.599 -0.688 . . . . 0.0 110.596 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.25 29.63 3.65 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.76 110.49 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.918 . . . . 0.0 109.035 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.22 110.22 3.9 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.335 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.43 -97.69 0.13 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -123.78 129.01 50.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.39 -1.065 . . . . 0.0 111.483 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.452 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 48.1 m95 -107.6 135.9 48.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.428 -0.795 . . . . 0.0 110.405 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p -145.63 131.83 19.45 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -99.19 141.05 32.46 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.774 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -110.9 100.9 9.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.641 -0.662 . . . . 0.0 109.596 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.99 -4.26 23.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.664 -0.648 . . . . 0.0 111.637 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.77 19.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -131.9 8.47 4.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 110.13 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp 54.03 42.94 31.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.216 -0.928 . . . . 0.0 110.233 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -125.75 129.74 50.08 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.626 -0.671 . . . . 0.0 110.787 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 84.2 m-85 -87.46 -173.41 4.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.502 -0.749 . . . . 0.0 109.705 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.32 99.01 1.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -101.77 101.43 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.869 0.843 . . . . 0.0 111.105 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.62 171.96 14.36 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.135 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.108 0.48 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.485 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.8 m -85.07 -72.88 0.46 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.573 -0.704 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m 50.1 72.23 0.34 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.275 -0.891 . . . . 0.0 111.075 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 13.3 m-85 -67.86 139.61 56.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -178.84 3.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -159.52 109.39 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.664 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 7' ' ' ILE . 84.6 mt -85.07 124.89 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 13' ' ' LEU . 1.7 mm -98.71 115.38 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.089 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -93.12 152.58 19.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.74 . . . . 0.0 109.54 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.18 -151.84 18.31 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -116.85 -24.48 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.543 -0.975 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -58.87 -60.52 3.72 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CB ' ' CG2' ' A' ' 8' ' ' ILE . 4.7 mt -120.32 174.52 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.117 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -175.38 75.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.817 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.68 -176.33 34.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -108.61 -28.16 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.779 -0.836 . . . . 0.0 110.381 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt 65.93 -60.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 O-C-N 121.879 -0.513 . . . . 0.0 111.568 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p 61.49 118.63 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.477 -0.764 . . . . 0.0 110.546 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.425 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -148.99 133.93 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.573 -0.704 . . . . 0.0 110.286 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.68 145.22 36.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.595 -0.691 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.03 165.69 34.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.745 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.78 -39.62 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.545 -0.722 . . . . 0.0 110.447 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -161.17 177.26 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.728 -0.608 . . . . 0.0 109.375 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.63 -29.5 70.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 0.0 109.731 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.72 -52.49 63.73 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.02 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -64.13 -42.77 96.7 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.85 75.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 109.601 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 23.6 tt0 -58.73 -37.31 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.315 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -52.64 36.98 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.83 -40.53 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.9 m-85 -72.1 -38.83 69.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 5.9 mmtp -73.88 -2.43 23.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.669 -0.644 . . . . 0.0 111.522 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -107.2 -44.94 4.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 1.4 t80 -52.44 -36.81 55.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.206 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -68.12 -50.98 51.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.758 -0.589 . . . . 0.0 110.23 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -56.25 -49.88 72.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 110.903 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -23.97 41.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.402 -0.811 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -99.16 -26.89 14.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.776 -0.577 . . . . 0.0 110.395 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 30.0 4.0 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.39 107.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.584 -0.95 . . . . 0.0 109.007 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -151.78 100.62 2.69 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.647 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.93 -55.27 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 29.3 tt0 -145.47 169.56 18.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.479 -1.012 . . . . 0.0 110.535 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.461 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 46.6 m95 -159.95 125.62 4.13 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.849 -0.532 . . . . 0.0 109.687 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -145.81 131.68 19.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 109.371 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.4 t80 -96.63 151.19 19.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.702 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -124.73 99.45 6.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.676 -0.64 . . . . 0.0 109.592 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.77 -4.25 22.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.654 . . . . 0.0 111.523 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.94 -27.79 19.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -127.92 7.53 6.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 54.82 42.13 31.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.9 m -130.22 141.79 50.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 110.91 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.5 m-85 -98.44 -173.97 2.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.523 -0.736 . . . . 0.0 109.104 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 102.29 2.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.863 -1.148 . . . . 0.0 108.688 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 7.6 p -117.19 146.24 21.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.165 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -138.12 177.9 7.53 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.231 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.17 0.51 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 46.3 m -110.28 28.08 8.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.739 . . . . 0.0 110.217 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 m -62.91 94.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.591 -0.693 . . . . 0.0 110.102 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 24.5 m-85 -78.05 149.25 33.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.067 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -108.71 -174.45 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 110.389 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 12.7 tp -163.13 97.92 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.16 117.06 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 55' ' ' VAL . 9.9 mm -85.03 110.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.861 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.483 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 41.4 t30 -85.41 7.28 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.72 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.88 -174.67 41.15 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -110.77 26.67 10.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.928 . . . . 0.0 110.379 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 p -125.94 24.51 6.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.617 -0.677 . . . . 0.0 110.284 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mt -172.69 -67.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.76 . . . . 0.0 110.034 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.742 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.67 144.1 3.99 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -102.14 61.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.645 -0.914 . . . . 0.0 110.738 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 34' ' ' TYR . 6.4 pt -57.42 148.08 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.208 -0.932 . . . . 0.0 110.152 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 p -115.72 136.07 53.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.888 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.07 145.78 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.556 -0.715 . . . . 0.0 110.314 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 155.83 24.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.609 -0.682 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.36 159.2 8.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.62 -39.26 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -159.25 173.35 16.47 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -60.55 -35.78 76.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.405 -0.809 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.18 -46.76 72.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.467 -0.771 . . . . 0.0 109.925 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.67 -45.19 79.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.31 -39.48 69.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.419 -0.8 . . . . 0.0 109.819 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -62.12 -39.54 92.89 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.43 -34.48 65.46 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.353 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.489 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 98.0 mt -68.59 -39.66 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 9.9 m-85 -73.31 -36.89 66.31 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 30.1 mttt -75.74 -2.44 29.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.732 -0.605 . . . . 0.0 111.301 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -104.13 -44.97 4.85 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE2' HD12 ' A' ' 17' ' ' ILE 0.293 8.8 t80 -53.56 -42.14 67.23 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.731 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.72 -52.16 58.59 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.813 -0.555 . . . . 0.0 110.135 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.19 -49.14 74.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.725 . . . . 0.0 110.679 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.77 -23.48 18.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.58 -0.7 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -102.31 -28.14 12.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.733 -0.604 . . . . 0.0 110.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 30.08 2.96 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 106.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.985 . . . . 0.0 109.002 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -150.17 105.82 3.41 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.27 0.557 . . . . 0.0 110.715 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.8 -57.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 15.1 tt0 -148.55 171.97 15.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.564 -0.963 . . . . 0.0 110.224 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 45.9 m95 -157.22 128.56 6.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.69 -0.631 . . . . 0.0 109.859 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -145.8 131.96 19.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.615 -0.678 . . . . 0.0 109.409 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.1 t80 -97.49 127.17 43.24 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.59 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.65 98.88 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.651 -0.655 . . . . 0.0 109.316 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.88 -5.41 25.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.65 -0.656 . . . . 0.0 111.583 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.46 21.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 109.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -128.4 8.06 5.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 110.171 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt 54.95 40.38 31.99 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -125.11 125.48 43.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.2 m-85 -80.26 -176.12 5.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.359 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.13 106.67 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.939 -1.1 . . . . 0.0 108.235 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 6.3 p -117.09 133.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.101 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 9' ' ' ASN . 1.3 t -124.41 -170.04 2.08 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.908 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.195 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.064 0.459 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 95.3 m -125.49 -74.42 0.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.1 m 50.24 79.77 0.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.258 -0.901 . . . . 0.0 111.252 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 13.9 m-85 -78.45 147.82 33.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -112.45 -172.25 2.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.511 -0.743 . . . . 0.0 110.17 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 31' ' ' PHE . 19.3 tp -163.08 105.68 1.02 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.444 -0.785 . . . . 0.0 110.204 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.55 114.86 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -89.95 113.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.722 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.37 -161.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.229 -0.919 . . . . 0.0 109.285 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -163.1 13.65 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -114.58 28.18 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.607 -0.937 . . . . 0.0 110.406 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -66.25 -78.21 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 14' ' ' LYS . 4.5 pp -132.21 -27.26 1.82 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.728 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' HD13 ' A' ' 13' ' ' LEU . 70.2 mttt 56.69 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.452 -0.78 . . . . 0.0 111.492 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.37 161.33 20.73 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -130.6 58.31 1.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.884 -0.774 . . . . 0.0 109.711 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.99 110.97 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.549 -0.72 . . . . 0.0 109.755 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.84 144.84 41.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.969 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.407 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.33 133.11 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.6 153.6 35.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.522 -0.736 . . . . 0.0 110.162 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.14 162.3 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.65 -0.656 . . . . 0.0 110.31 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -53.8 -39.1 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.692 . . . . 0.0 110.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -163.51 177.19 9.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 109.526 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -61.43 -29.66 70.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.05 -49.77 72.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 0.0 110.008 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.33 -43.36 81.8 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.49 71.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.57 -0.706 . . . . 0.0 109.856 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.7 tt0 -58.29 -36.75 73.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.64 -0.663 . . . . 0.0 109.332 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.01 -52.24 25.73 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -57.53 -37.58 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.99 -36.69 62.0 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 49.2 mtpt -77.86 2.28 17.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.665 -0.647 . . . . 0.0 111.371 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -105.7 -45.83 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 1.4 t80 -53.38 -46.7 69.73 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.928 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -57.85 -49.25 77.32 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.635 -0.665 . . . . 0.0 110.139 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.81 -50.59 72.78 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.647 -0.658 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -56.46 -24.56 46.52 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.483 -0.761 . . . . 0.0 110.69 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.44 -26.55 14.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.694 -0.628 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.64 33.69 3.26 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -99.11 114.47 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -157.58 104.44 1.99 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.308 0.575 . . . . 0.0 110.945 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.53 -47.15 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 45.0 tt0 -142.2 164.97 28.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.47 -1.017 . . . . 0.0 110.75 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.4 m95 -164.1 112.33 1.15 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 p -137.9 131.05 30.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 109.738 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.9 t80 -93.84 143.66 26.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.78 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -114.7 98.28 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.786 -0.571 . . . . 0.0 109.522 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -70.17 -4.76 23.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.584 -0.697 . . . . 0.0 111.598 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.81 -27.76 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -126.14 7.62 7.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.604 . . . . 0.0 110.087 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp 53.85 41.53 32.02 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.185 -0.947 . . . . 0.0 110.192 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 m -132.31 137.23 47.37 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.68 -0.637 . . . . 0.0 110.762 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 60.2 m-85 -92.0 -172.74 3.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.697 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 103.57 2.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 108.478 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -118.63 152.95 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.198 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.42 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 5.6 t -156.16 -162.44 1.29 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.904 -0.497 . . . . 0.0 109.986 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.049 179.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.05 0.452 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 72.1 m -115.17 55.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.585 -0.697 . . . . 0.0 110.188 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -77.42 92.99 4.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.544 -0.722 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 14.2 m-85 -76.74 144.77 39.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.688 -0.633 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -106.6 -179.2 3.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 0.0 110.041 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.441 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -158.09 110.11 2.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.574 -0.704 . . . . 0.0 109.823 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.43 124.81 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.418 HD11 ' CG1' ' A' ' 55' ' ' VAL . 7.0 mm -89.95 108.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.83 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -92.92 54.6 2.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 110.121 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.05 -131.65 2.92 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.43 50.59 0.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.945 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 p -138.72 -59.91 0.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.705 . . . . 0.0 110.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 34' ' ' TYR . 21.8 mt -95.26 -54.58 3.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.367 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.96 82.62 0.07 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.432 -0.792 . . . . 0.0 110.599 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.88 -167.82 37.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.42 -50.88 2.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.915 . . . . 0.0 110.545 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.4 mm 53.7 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.356 -0.84 . . . . 0.0 110.188 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -76.55 133.81 39.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.623 -0.673 . . . . 0.0 110.555 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.439 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -137.32 140.86 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.571 -0.705 . . . . 0.0 110.276 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.32 150.4 28.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.58 161.56 23.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.676 -0.64 . . . . 0.0 110.248 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.66 -39.61 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.557 -0.714 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -158.77 175.99 12.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -63.0 -33.27 75.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.24 69.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.0 109.852 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -63.53 -43.11 98.09 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.36 70.25 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.467 -0.77 . . . . 0.0 109.84 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.2 tt0 -58.71 -36.56 74.47 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.37 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -67.53 -52.97 32.6 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.21 -38.83 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 13.3 m-85 -74.31 -34.57 63.53 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 18.2 mmmt -74.92 -3.25 31.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.75 -0.594 . . . . 0.0 111.22 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -105.74 -45.65 4.34 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 13' ' ' LEU 0.29 6.7 t80 -50.84 -32.46 20.28 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.809 175.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.58 -63.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.74 0.781 . . . . 0.0 109.277 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -55.46 -41.68 73.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.111 0.481 . . . . 0.0 110.914 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.5 -27.2 4.04 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.4 -56.21 2.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.371 0.605 . . . . 0.0 110.049 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.67 61.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -117.97 134.93 59.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.838 -0.801 . . . . 0.0 109.816 -177.536 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.31 106.42 0.57 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.837 . . . . 0.0 111.195 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.08 -107.46 0.2 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -115.84 176.23 5.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.467 -1.019 . . . . 0.0 110.166 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 36.2 m95 -151.72 129.18 11.37 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.638 -0.664 . . . . 0.0 109.881 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -140.74 134.28 30.05 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.301 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.6 t80 -99.41 148.84 23.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -120.71 98.25 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 -6.32 30.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.646 -0.659 . . . . 0.0 111.478 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.6 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 109.557 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 6.54 8.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.624 -0.672 . . . . 0.0 110.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.3 mmtp 54.07 38.25 28.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.0 m -126.39 143.13 51.28 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.038 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.9 m-85 -99.54 -169.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.533 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -157.27 90.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.803 -1.186 . . . . 0.0 108.254 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.7 p -90.4 97.94 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.794 0.806 . . . . 0.0 110.688 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -78.25 170.89 15.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.327 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 38.0 m -134.48 34.05 3.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.617 -0.677 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.6 m -69.2 105.7 2.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 110.085 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 43.9 m-85 -88.31 140.26 29.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.672 -0.643 . . . . 0.0 110.443 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -104.98 -174.81 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 7.6 tp -161.21 110.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.86 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' GLY . 74.3 mt -97.64 133.41 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.418 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 21.7 mm -87.66 107.48 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.95 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -75.61 66.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.762 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.62 -135.98 1.95 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -171.19 50.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.518 -0.989 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.3 m -140.2 23.8 2.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.518 -0.739 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.61 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.48 -0.762 . . . . 0.0 111.066 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 55.68 110.19 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.331 -0.855 . . . . 0.0 110.752 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -145.43 135.93 6.23 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.255 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -162.67 28.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 122.08 -0.659 . . . . 0.0 109.67 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.0 -171.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.1 p -138.61 129.12 26.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.424 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -135.56 136.09 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 110.82 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.18 160.17 20.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.613 -0.679 . . . . 0.0 110.043 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.41 171.25 7.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.77 -36.43 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.533 -0.729 . . . . 0.0 110.424 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -166.93 173.38 9.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.67 -0.644 . . . . 0.0 109.336 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.58 -31.39 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.48 -46.83 76.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -45.69 77.76 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.03 -45.02 67.81 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 109.759 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.28 -38.09 76.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.656 -0.652 . . . . 0.0 109.383 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -68.61 -52.83 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.612 -0.68 . . . . 0.0 109.182 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -55.66 -40.38 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 11.5 m-85 -72.29 -32.64 66.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -80.4 4.41 18.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.761 -0.587 . . . . 0.0 111.102 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -104.56 -45.51 4.61 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.299 1.1 t80 -50.34 -40.66 49.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.15 -1.387 . . . . 0.0 108.827 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.53 -44.68 86.15 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.039 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.389 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.0 -23.61 20.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.57 -0.706 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -103.66 -20.68 13.9 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.56 36.55 4.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.477 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -99.03 119.44 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.91 . . . . 0.0 109.186 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -152.16 71.63 0.97 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.373 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -112.22 2.34 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 0.4 OUTLIER -108.65 174.13 6.01 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.489 -1.006 . . . . 0.0 110.533 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 43.1 m95 -151.11 134.46 16.15 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.632 -0.667 . . . . 0.0 110.0 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.2 p -142.94 133.0 24.32 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.369 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -97.52 147.29 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.608 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -119.05 102.0 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.617 -0.677 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.4 -5.64 29.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.718 -0.614 . . . . 0.0 111.411 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.59 -28.76 20.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.9 p -127.2 7.17 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.703 . . . . 0.0 110.06 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 54.44 38.26 29.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.188 -0.945 . . . . 0.0 110.203 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -124.49 149.69 46.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.0 110.489 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 68.0 m-85 -102.17 -169.33 1.66 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.515 -0.741 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.7 92.6 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.7 p -91.64 104.8 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.907 0.861 . . . . 0.0 110.649 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -78.13 156.55 29.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.137 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.065 0.46 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.6 m -104.26 40.57 1.44 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.077 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.2 m -72.04 103.04 3.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.568 -0.708 . . . . 0.0 110.18 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 25.9 m-85 -88.44 149.01 23.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -113.63 -173.84 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 110.099 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 16.9 tp -160.47 109.14 1.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.526 -0.734 . . . . 0.0 110.16 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.28 120.12 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 HD11 ' CG1' ' A' ' 55' ' ' VAL . 6.2 mm -84.84 114.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.401 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.49 53.47 0.83 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.529 -0.732 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.1 1.9 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -166.34 47.52 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.585 -0.95 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.7 m -140.54 -45.7 0.41 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.67 -0.644 . . . . 0.0 109.995 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.421 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 12.3 mt -106.88 -57.71 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 52.84 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.16 172.2 43.14 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -127.58 59.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.888 . . . . 0.0 110.098 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.89 136.4 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.824 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -103.35 136.69 42.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.246 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.429 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.3 135.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -78.3 154.31 31.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.571 -0.706 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.37 164.15 17.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.388 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.82 -39.49 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.48 -0.762 . . . . 0.0 110.518 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -161.44 173.53 14.76 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -61.67 -29.09 69.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 -45.86 85.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 109.631 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.84 -42.24 77.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.51 81.97 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.611 -0.68 . . . . 0.0 109.488 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.4 tt0 -58.63 -37.22 75.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.289 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -68.73 -51.56 40.12 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.93 -40.34 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 13.1 m-85 -71.63 -36.96 70.91 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -77.78 1.9 18.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.62 -0.675 . . . . 0.0 111.43 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -106.5 -45.41 4.26 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.292 8.7 t80 -52.97 -31.74 42.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.743 175.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.455 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -67.26 -63.24 1.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.705 0.764 . . . . 0.0 109.234 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -55.31 -40.99 71.77 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.082 0.468 . . . . 0.0 110.72 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.82 -27.06 4.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.672 -0.642 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -107.15 -53.26 2.64 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.367 0.603 . . . . 0.0 110.192 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.83 62.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -119.24 134.73 61.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.896 -0.767 . . . . 0.0 109.898 -177.352 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -169.68 100.03 0.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.324 -0.86 . . . . 0.0 111.242 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.57 -101.44 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -125.23 134.65 52.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.463 -1.022 . . . . 0.0 110.941 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 43.7 m95 -112.98 132.52 55.32 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -144.43 132.53 21.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.92 137.77 36.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.731 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -107.75 98.72 8.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.69 -0.631 . . . . 0.0 109.524 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -69.07 -6.69 29.82 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.652 -0.655 . . . . 0.0 111.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.25 19.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.9 p -124.62 6.81 8.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.67 . . . . 0.0 110.121 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt 54.41 38.98 30.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.178 -0.952 . . . . 0.0 110.086 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.5 m -126.84 138.39 53.33 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.582 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.9 m-85 -92.45 -171.53 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.475 -0.766 . . . . 0.0 109.574 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.92 98.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.7 p -99.31 90.38 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.697 0.761 . . . . 0.0 111.062 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 170.97 9.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.305 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mtt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.141 0.496 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.453 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.8 m -130.96 35.66 3.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.588 -0.695 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -63.27 95.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.444 -0.785 . . . . 0.0 109.937 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 12.5 m-85 -79.7 140.53 36.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 110.23 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.06 179.64 4.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 13.3 tp -154.11 108.22 3.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.446 -0.784 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.7 mt -84.31 120.96 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.06 112.6 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.087 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -95.27 148.63 22.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -138.62 14.18 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -132.42 42.74 3.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.976 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' LYS . 1.5 m -150.02 147.22 27.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.603 -0.686 . . . . 0.0 109.702 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 34' ' ' TYR . 6.3 mt 61.59 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.864 -0.522 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' THR . 57.7 mttt 55.4 97.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.311 -0.868 . . . . 0.0 110.51 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.51 -176.42 44.74 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.54 -53.14 2.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.513 -0.992 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.9 mm 52.94 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -79.75 133.8 36.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 110.164 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.435 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.49 137.26 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.56 154.77 32.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.657 -0.652 . . . . 0.0 110.488 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.83 162.82 16.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -54.99 -38.93 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.592 -0.693 . . . . 0.0 110.425 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -161.61 174.56 13.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -60.26 -28.86 68.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 109.827 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.65 72.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 109.83 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.3 -43.38 98.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.78 80.99 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.645 -0.659 . . . . 0.0 109.553 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.1 tt0 -59.73 -33.74 72.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.704 -0.622 . . . . 0.0 109.48 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -75.98 -45.25 35.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 66.8 mt -62.7 -38.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.7 m-85 -73.23 -37.99 66.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 21.3 mttt -73.64 -2.87 24.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 111.378 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -104.1 -45.33 4.75 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 13' ' ' LEU 0.292 4.4 t80 -50.41 -37.14 36.15 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.103 176.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.53 -47.17 76.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.276 0.56 . . . . 0.0 110.161 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -58.98 -47.17 86.12 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.584 -0.697 . . . . 0.0 110.546 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.47 -19.49 48.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.614 -0.679 . . . . 0.0 110.811 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -104.41 -27.68 11.8 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.559 -0.713 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.3 31.5 3.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -97.17 120.91 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.909 . . . . 0.0 109.402 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -152.47 108.1 3.32 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.317 0.579 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.69 -110.5 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -109.33 177.04 4.87 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -1.012 . . . . 0.0 110.672 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 43.8 m95 -153.15 132.8 13.05 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.605 -0.684 . . . . 0.0 109.803 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.3 p -144.15 132.72 22.23 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.469 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 t80 -98.56 138.92 35.06 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.848 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -108.15 100.67 9.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.561 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.12 -5.36 26.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.586 -0.696 . . . . 0.0 111.549 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.28 -28.01 18.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.553 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -126.21 6.89 7.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.665 -0.647 . . . . 0.0 110.213 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 54.3 39.35 30.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.125 -0.984 . . . . 0.0 109.946 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 m -124.7 140.99 52.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.655 -0.653 . . . . 0.0 110.549 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 73.8 m-85 -95.79 -171.53 2.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 0.0 109.538 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.28 93.27 1.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -94.16 106.73 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.917 0.865 . . . . 0.0 111.019 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -86.11 170.39 12.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.218 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttm . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.097 0.475 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.3 m -104.23 -75.31 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.528 -0.732 . . . . 0.0 110.301 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m 50.17 78.01 0.11 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.14 -0.975 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 10.5 m-85 -75.52 144.57 41.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.552 -0.718 . . . . 0.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -106.39 -174.4 2.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.615 -0.678 . . . . 0.0 109.926 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 17.9 tp -160.77 102.79 1.33 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.47 133.32 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mm -101.85 119.33 49.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.986 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -67.85 -52.15 40.08 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.844 . . . . 0.0 110.255 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -156.08 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.07 15.39 4.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.907 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -60.02 -69.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.212 -0.93 . . . . 0.0 109.438 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD21 ' CE1' ' A' ' 34' ' ' TYR . 1.5 pp -122.47 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 20.5 ptmt -33.74 137.25 0.1 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.13 30.44 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.598 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -140.82 47.57 1.74 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 tp -51.4 115.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -83.76 144.91 29.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.636 -0.665 . . . . 0.0 110.009 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -143.19 134.74 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.56 137.8 39.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.7 -0.625 . . . . 0.0 110.14 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.39 37.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.63 -0.669 . . . . 0.0 110.228 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -53.77 -39.95 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.0 110.586 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -159.62 179.47 8.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.622 . . . . 0.0 109.398 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.29 -29.15 70.24 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.679 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.0 70.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.19 -41.93 85.04 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -48.32 72.09 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.541 -0.724 . . . . 0.0 109.881 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.566 -0.709 . . . . 0.0 109.368 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -69.04 -52.44 28.57 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -58.49 -36.58 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 7.4 m-85 -75.28 -38.93 60.15 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 24.2 mtpt -76.14 0.4 19.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 111.657 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -105.96 -45.27 4.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CE1' HD21 ' A' ' 13' ' ' LEU 0.287 2.2 t80 -51.12 -38.8 54.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.933 176.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.437 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.62 -48.85 70.83 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -60.47 -48.17 82.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.517 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -55.69 -25.29 39.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.51 -0.743 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -99.51 -27.68 13.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.722 -0.611 . . . . 0.0 110.287 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.36 45.27 1.17 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.437 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -107.87 126.59 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.668 -0.901 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.33 101.97 1.08 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.545 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.48 -57.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 62.5 mt-10 -149.49 169.19 21.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.465 -1.02 . . . . 0.0 110.634 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 50.1 m95 -159.76 121.0 3.18 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -143.08 132.13 23.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.593 -0.692 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.1 t80 -96.8 144.32 26.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.042 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.15 99.76 7.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.0 -5.32 25.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.651 -0.655 . . . . 0.0 111.499 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.86 20.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -129.01 8.22 5.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.625 -0.672 . . . . 0.0 110.131 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 15.9 mmtm 53.78 41.57 32.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m -126.44 130.91 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.596 -0.69 . . . . 0.0 110.69 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 69.6 m-85 -88.32 -173.61 4.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.503 -0.748 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.14 102.57 2.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.99 -1.069 . . . . 0.0 108.664 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.9 p -115.91 141.81 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 111.19 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 2.9 t -141.08 -174.23 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.961 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.242 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.408 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 24.7 m -132.95 34.52 3.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.522 -0.736 . . . . 0.0 110.383 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 m -75.85 103.8 6.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.517 -0.739 . . . . 0.0 110.078 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 57.0 m-85 -86.99 140.46 29.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.615 -0.678 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -107.23 -168.01 1.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 110.006 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 11.8 tp -163.56 100.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 110.158 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -83.54 132.46 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 7.1 mm -102.48 119.28 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.141 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -69.16 -26.68 64.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.449 -0.782 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.19 37.49 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -102.56 -23.96 13.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.947 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -59.04 124.7 20.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.354 -0.841 . . . . 0.0 110.011 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 50.63 27.21 2.82 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 110.133 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -46.3 124.56 5.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.217 -0.927 . . . . 0.0 111.873 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.17 -165.92 30.91 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -132.99 67.53 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.727 -0.867 . . . . 0.0 110.049 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mt -60.25 138.48 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.422 -0.799 . . . . 0.0 109.849 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -110.54 138.5 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.663 -0.648 . . . . 0.0 110.833 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.425 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -144.18 142.47 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 157.01 18.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.551 -0.718 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.57 167.15 11.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.55 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -54.41 -39.29 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 110.42 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -162.31 174.62 12.57 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.67 -29.17 69.9 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.44 81.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.03 -42.97 72.25 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.91 78.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.648 -0.657 . . . . 0.0 109.528 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.2 tt0 -58.12 -39.66 79.26 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -50.83 48.27 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.2 -39.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 9.2 m-85 -73.55 -37.5 65.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 11.8 mtpp -81.49 8.16 10.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.676 -0.64 . . . . 0.0 111.367 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -111.65 -46.86 3.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 9.2 t80 -52.99 -41.1 64.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.146 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.25 -49.15 78.12 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.783 -0.573 . . . . 0.0 109.753 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.65 -47.46 81.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.764 -0.585 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -23.46 29.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.578 -0.701 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.88 -30.21 10.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.731 -0.606 . . . . 0.0 110.004 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.68 50.7 0.55 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 13' ' ' LEU . 1.3 mp -115.34 132.63 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.453 -1.028 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -168.12 98.16 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.722 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.31 -56.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 37.2 mt-10 -149.01 169.22 21.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.458 -1.025 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 49.6 m95 -160.39 121.99 3.12 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -145.42 131.61 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.507 -0.746 . . . . 0.0 109.564 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.5 t80 -93.24 144.25 25.48 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.748 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 100.08 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.752 -0.592 . . . . 0.0 109.775 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.24 -4.81 23.56 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.84 -28.94 18.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.509 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -126.77 8.34 6.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.69 -0.631 . . . . 0.0 110.169 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.6 mmtt 53.91 38.6 29.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.146 -0.971 . . . . 0.0 110.318 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -127.53 143.63 51.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.67 -0.644 . . . . 0.0 110.452 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 60.3 m-85 -96.37 -171.64 2.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.48 -0.763 . . . . 0.0 109.74 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.32 102.42 2.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.05 -1.031 . . . . 0.0 108.497 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.7 p -116.34 142.56 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.114 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 3.7 t -140.15 -177.28 4.93 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.283 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.121 0.486 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 78.6 m -134.22 143.06 47.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.715 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 m -153.06 102.24 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.763 -0.586 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 55.6 m-85 -93.38 154.03 18.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.681 -0.637 . . . . 0.0 110.291 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -113.96 -171.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 16.7 tp -163.42 108.41 1.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.463 -0.773 . . . . 0.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -85.59 120.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD11 ' CG1' ' A' ' 55' ' ' VAL . 8.6 mm -86.97 109.43 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.784 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -96.65 50.77 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.504 -0.747 . . . . 0.0 110.22 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.59 -118.59 1.99 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.47 47.12 0.19 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.572 -0.957 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -136.45 -62.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.146 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 mt -91.88 -52.64 4.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.99 81.85 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.496 -0.753 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -173.55 46.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.51 66.82 1.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.618 -0.931 . . . . 0.0 110.2 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG23 ' CE2' ' A' ' 34' ' ' TYR . 3.3 tt -60.34 119.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 109.921 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -89.34 140.16 29.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 110.435 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -145.52 149.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.723 . . . . 0.0 110.421 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.7 155.19 19.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.666 -0.646 . . . . 0.0 110.415 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.05 162.47 13.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.577 -0.702 . . . . 0.0 110.208 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.92 -38.11 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.289 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.44 176.88 10.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.36 -29.55 70.55 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.852 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.35 65.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.819 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -63.66 -38.87 92.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.39 78.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.9 tt0 -58.62 -36.25 73.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.638 -0.664 . . . . 0.0 109.355 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -67.71 -52.58 35.99 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.52 -38.5 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 13.1 m-85 -74.04 -35.77 64.34 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -75.98 -1.03 23.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.767 -0.583 . . . . 0.0 111.462 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -109.01 -45.43 3.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.294 12.7 t80 -51.33 -31.97 23.76 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.52 -62.34 1.65 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.874 0.845 . . . . 0.0 108.88 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -55.35 -41.55 72.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.822 -0.549 . . . . 0.0 110.797 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.39 -26.83 5.39 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.626 -0.672 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.5 -54.3 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.98 62.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.46 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.311 1.0 OUTLIER -119.09 134.96 61.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 0.0 109.84 -177.275 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -167.17 104.44 0.54 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.836 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.11 -107.91 0.21 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.6 tp10 -113.24 175.58 5.38 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -1.029 . . . . 0.0 110.398 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 37.9 m95 -152.55 129.04 10.68 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.654 -0.654 . . . . 0.0 109.825 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -142.79 133.65 25.49 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.371 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.3 t80 -97.4 135.15 39.69 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.658 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -103.18 98.96 8.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.356 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.6 -6.1 28.9 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.663 -0.648 . . . . 0.0 111.648 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.94 -27.47 17.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -123.53 5.97 8.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt 54.57 36.31 25.57 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.166 -0.959 . . . . 0.0 110.162 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 m -126.35 140.54 52.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.409 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.6 m-85 -93.24 -169.0 2.04 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.37 94.63 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -95.87 100.12 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.908 0.861 . . . . 0.0 111.023 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -80.44 169.4 17.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.188 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 tmm? . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.988 0.423 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 4' ' ' PHE . 59.9 m -98.26 45.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.548 -0.72 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -76.42 91.0 3.26 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 24.2 m-85 -76.98 143.94 39.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.632 . . . . 0.0 110.073 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -110.51 -171.22 1.79 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.628 -0.67 . . . . 0.0 109.88 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 31' ' ' PHE . 37.3 tp -162.21 112.35 1.53 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -0.87 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.63 106.99 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 1.6 mm -82.87 110.72 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.153 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -96.32 147.66 23.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.53 -0.731 . . . . 0.0 110.1 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.97 -144.07 14.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -120.02 -33.0 4.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.951 . . . . 0.0 110.484 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -75.15 110.83 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.442 -0.786 . . . . 0.0 110.038 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 59.36 159.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 13' ' ' LEU . 7.5 ptmt -169.99 127.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 179.13 37.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.74 69.37 1.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.704 -0.88 . . . . 0.0 109.941 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.4 pt -61.68 177.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.563 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -139.48 133.1 30.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.529 -0.732 . . . . 0.0 110.509 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -141.97 131.17 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.539 -0.726 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.89 156.08 32.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.11 163.79 13.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.649 -0.657 . . . . 0.0 110.207 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.6 -39.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.44 -0.787 . . . . 0.0 110.521 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.35 174.87 12.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.724 -0.61 . . . . 0.0 109.369 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -59.54 -27.71 66.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.466 -0.771 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -53.3 59.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -42.81 98.0 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.28 -49.29 72.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.624 -0.672 . . . . 0.0 109.618 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.13 -36.24 72.65 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.523 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -69.73 -53.75 16.98 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.7 -36.35 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 6' ' ' LEU . 8.1 m-85 -75.44 -35.76 60.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -80.69 4.56 18.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.705 -0.622 . . . . 0.0 111.401 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -109.95 -45.38 3.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 3.9 t80 -53.51 -43.25 68.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.092 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.446 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -59.82 -49.31 78.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.816 -0.553 . . . . 0.0 110.178 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -57.21 -47.83 80.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.548 -0.72 . . . . 0.0 110.68 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -56.81 -22.6 37.51 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.646 -0.659 . . . . 0.0 110.987 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.9 -26.72 13.01 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.566 -0.709 . . . . 0.0 110.504 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.48 29.37 3.68 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.446 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -96.08 104.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -142.53 106.33 4.69 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.251 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.3 -103.15 0.18 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.9 tt0 -107.46 176.29 5.21 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.44 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 44.1 m95 -156.92 128.79 7.19 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.71 -0.619 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p -144.36 132.56 21.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 t80 -95.84 142.24 28.33 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.696 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -112.69 99.56 8.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.69 -0.632 . . . . 0.0 109.775 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -70.64 -4.6 24.21 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.611 -0.681 . . . . 0.0 111.456 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.67 -27.87 18.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 109.579 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -127.92 7.71 6.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp 54.53 40.68 32.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.165 -0.96 . . . . 0.0 110.194 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.3 m -129.81 139.92 51.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.663 -0.648 . . . . 0.0 110.335 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.2 m-85 -93.42 -168.39 1.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.894 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.13 98.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 3.5 p -102.49 119.43 50.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 122.035 0.921 . . . . 0.0 111.015 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -100.24 169.84 8.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.33 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ptt? . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.413 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 87.3 m -133.43 59.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 110.388 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 m -77.26 90.1 3.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 7.0 m-85 -74.11 141.12 45.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.619 -0.675 . . . . 0.0 109.956 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -104.64 -177.54 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.62 -0.675 . . . . 0.0 110.238 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -164.34 118.16 1.4 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 110.826 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.9 mt -89.77 118.14 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.415 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.2 mm -86.47 108.23 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.692 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.39 144.11 26.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 163.02 18.37 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -60.53 -26.65 67.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.647 -0.914 . . . . 0.0 110.379 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -76.16 125.62 29.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.595 -0.691 . . . . 0.0 110.074 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt 56.09 169.04 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.569 -0.707 . . . . 0.0 110.561 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -179.64 90.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.77 -166.86 34.49 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -105.14 -42.23 5.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.713 -0.875 . . . . 0.0 110.441 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt 53.65 85.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.343 -0.848 . . . . 0.0 110.376 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -84.1 126.23 32.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.601 -0.687 . . . . 0.0 110.338 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -134.91 143.92 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.493 -0.754 . . . . 0.0 110.668 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.86 152.32 25.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.65 7.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.612 -0.68 . . . . 0.0 110.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.32 -39.3 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.357 -0.839 . . . . 0.0 110.582 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.29 178.8 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -63.39 -27.31 69.22 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.806 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.25 -54.93 39.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.552 -0.718 . . . . 0.0 109.854 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.14 -42.92 99.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.726 -0.609 . . . . 0.0 109.371 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.11 -46.01 68.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.359 -0.838 . . . . 0.0 109.836 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.09 -38.21 82.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.665 . . . . 0.0 109.284 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -54.94 -42.29 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 109.391 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 8.1 m-85 -70.52 -37.94 74.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 0.0 109.573 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HD3' ' CE2' ' A' ' 44' ' ' TRP . 11.1 mmtt -76.78 1.09 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.658 -0.651 . . . . 0.0 111.49 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -104.28 -46.54 4.38 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.307 8.1 t80 -46.1 -50.85 14.87 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.206 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.445 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.37 -54.16 47.27 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.64 -46.54 77.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.608 -0.682 . . . . 0.0 110.739 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.45 -16.92 51.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.631 -0.668 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -108.43 -27.87 9.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.464 -0.773 . . . . 0.0 110.691 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.24 30.82 2.37 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.445 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -101.62 113.49 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.473 -1.016 . . . . 0.0 109.031 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.49 109.19 3.46 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.27 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.82 -95.59 0.11 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.04 123.07 37.62 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -1.073 . . . . 0.0 111.55 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.458 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 37.3 m95 -103.5 137.1 42.04 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.583 -0.698 . . . . 0.0 110.403 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -147.38 131.87 17.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.666 . . . . 0.0 109.245 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.8 t80 -95.75 143.43 27.0 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.773 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -113.92 101.52 9.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.647 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.36 -3.81 22.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.619 -0.676 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.36 -27.59 20.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.5 p -130.96 9.5 4.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.617 -0.677 . . . . 0.0 110.162 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.2 mmtt 53.6 41.89 32.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -127.8 140.05 52.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.637 -0.664 . . . . 0.0 110.294 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 67.2 m-85 -93.67 -170.82 2.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 109.708 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.86 99.48 1.54 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -102.61 109.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.999 0.904 . . . . 0.0 111.195 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.49 172.94 9.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.032 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.088 0.47 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.439 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 79.5 m -104.56 54.25 0.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.707 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.3 m -72.8 89.39 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.48 -0.763 . . . . 0.0 110.079 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 6.9 m-85 -76.83 143.18 39.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.658 -0.651 . . . . 0.0 109.943 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -104.53 -176.41 3.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 2.2 tp -166.8 108.92 0.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.522 -0.736 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mt -89.06 117.5 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.8 mp -87.32 119.6 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.253 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -96.61 149.58 21.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.11 -127.65 7.06 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.2 -41.23 0.9 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.549 -0.971 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 m -63.16 99.61 0.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 61.57 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.269 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -162.69 105.91 1.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.7 161.94 29.43 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.08 58.45 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.717 -0.872 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.2 pt -52.49 145.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.149 -0.969 . . . . 0.0 110.382 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -113.59 139.66 48.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.537 -0.727 . . . . 0.0 110.956 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.72 132.64 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 110.456 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -70.47 154.66 41.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.0 110.186 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.06 157.73 9.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.669 . . . . 0.0 110.354 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -54.89 -34.21 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.549 -0.72 . . . . 0.0 110.502 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -165.72 178.43 6.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.39 -29.74 70.8 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.569 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -47.24 84.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -46.19 81.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.52 -0.738 . . . . 0.0 109.546 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.5 tt0 -58.69 -35.78 73.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.353 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.74 26.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 mt -58.18 -34.77 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 9.6 m-85 -77.48 -36.22 52.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -78.04 1.79 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.778 -0.576 . . . . 0.0 111.219 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.56 -45.4 3.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 177.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 10.9 t80 -53.76 -42.96 68.78 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.753 176.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.22 -47.34 86.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.183 0.516 . . . . 0.0 109.902 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.67 -48.8 78.51 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.634 -0.666 . . . . 0.0 110.549 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.06 -22.47 27.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.571 -0.705 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -103.29 -25.42 13.33 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.639 -0.663 . . . . 0.0 110.671 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.05 30.62 4.13 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.9 107.23 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.68 -0.894 . . . . 0.0 109.004 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -146.08 100.52 3.4 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.23 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.68 -105.48 0.24 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.2 tp10 -105.28 177.61 4.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.399 -1.059 . . . . 0.0 110.507 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.4 m95 -155.68 130.94 9.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.656 -0.653 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -144.85 132.2 20.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 109.264 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.7 t80 -98.49 138.1 36.19 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.93 99.82 9.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.652 -0.655 . . . . 0.0 109.551 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.31 -4.89 24.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.693 -0.629 . . . . 0.0 111.533 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.86 -28.4 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.654 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -128.76 8.5 5.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 110.234 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 31.6 mmtt 54.08 40.77 31.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.263 -0.898 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -125.17 133.67 52.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 110.628 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 75.1 m-85 -90.57 -172.39 3.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.613 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.12 98.29 1.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 3.6 p -102.02 109.46 26.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 122.122 0.963 . . . . 0.0 111.376 -178.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 169.17 12.45 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.156 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.077 0.465 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.9 m -139.34 58.46 1.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.531 -0.731 . . . . 0.0 110.25 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 m -90.55 103.85 16.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.581 -0.699 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 59.8 m-85 -86.32 152.19 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.9 -164.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.653 -0.655 . . . . 0.0 109.502 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 58.4 tp -168.12 108.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 110.336 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 105.55 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 55' ' ' VAL . 2.7 mm -77.52 99.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.087 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -85.05 63.39 8.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.982 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.7 -129.01 2.63 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 23.66 0.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.636 -0.92 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 10.38 3.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.344 -0.847 . . . . 0.0 110.737 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mt -172.32 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.324 -0.86 . . . . 0.0 110.415 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -52.6 103.82 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.229 -0.92 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.81 -177.83 48.15 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -137.0 64.8 1.52 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.636 -0.92 . . . . 0.0 110.173 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.88 136.41 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.44 -0.787 . . . . 0.0 109.55 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -103.42 136.89 42.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.228 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.421 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.29 136.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.367 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.78 152.49 33.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.131 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.53 159.64 14.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.57 -40.11 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.576 -0.703 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.4 173.08 17.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.43 -29.87 70.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -44.57 84.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.519 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.97 -43.68 71.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.12 77.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.667 . . . . 0.0 109.605 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.0 tt0 -60.27 -39.0 85.29 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.398 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -68.96 -48.84 62.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.58 -37.02 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.517 -0.739 . . . . 0.0 109.018 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 8.3 m-85 -76.89 -38.24 53.93 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.203 0.525 . . . . 0.0 109.652 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -76.79 0.7 19.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.582 -0.699 . . . . 0.0 111.305 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -108.68 -44.72 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.283 6.6 t80 -53.0 -45.53 67.94 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.979 176.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.407 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -57.53 7.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.775 -0.578 . . . . 0.0 109.871 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -58.32 -46.48 86.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.709 -0.619 . . . . 0.0 110.795 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -54.12 -23.93 15.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.5 -0.75 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -105.64 -30.37 9.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 110.155 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.09 32.67 1.48 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.8 mp -102.41 74.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.401 -1.058 . . . . 0.0 108.617 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.95 -164.43 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . 114.41 -173.8 15.09 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.885 -1.15 . . . . 0.0 111.546 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -73.57 -178.09 2.95 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.794 -0.827 . . . . 0.0 109.512 179.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.416 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 24.6 m95 -151.74 128.56 10.92 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.655 -0.653 . . . . 0.0 109.67 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.5 p -142.3 137.36 30.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.7 -0.625 . . . . 0.0 109.442 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.2 t80 -97.37 147.29 24.33 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.548 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -116.35 100.64 8.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.2 -4.65 26.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.613 -0.679 . . . . 0.0 111.33 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.22 -26.81 18.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -128.03 7.02 6.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.66 -0.65 . . . . 0.0 110.13 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 54.74 39.74 31.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.2 -0.937 . . . . 0.0 110.165 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 m -130.27 143.38 50.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 0.0 110.714 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.8 m-85 -96.75 -168.14 1.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -160.96 117.76 2.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.77 -1.206 . . . . 0.0 108.966 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 1.4 p -110.62 110.77 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.135 0.969 . . . . 0.0 109.169 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER -96.36 87.69 4.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.823 0.821 . . . . 0.0 110.125 -178.078 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.501 2.12 0 O-C-N 120.782 -1.199 . . . . 0.0 110.193 -179.636 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.161 0.505 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.464 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.3 m -115.56 41.34 2.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.567 -0.708 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -76.8 103.47 6.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.564 -0.71 . . . . 0.0 110.245 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 53.8 m-85 -84.56 130.5 34.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.597 -0.689 . . . . 0.0 110.182 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -98.83 172.66 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 109.603 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 34.7 tp -143.76 106.06 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.428 -0.795 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 7' ' ' ILE . 87.3 mt -81.64 115.04 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 55' ' ' VAL . 2.1 mm -87.62 113.66 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.461 -178.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -101.21 75.94 1.68 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.453 -0.779 . . . . 0.0 110.544 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.33 -152.02 6.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -110.39 -27.25 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.957 . . . . 0.0 110.262 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 p -79.73 102.24 8.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 109.824 179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.8 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.168 0.508 . . . . 0.0 109.635 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -142.55 137.24 30.0 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.258 -0.901 . . . . 0.0 111.057 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.06 -165.41 22.45 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.26 158.19 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.87 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 mp -116.57 -16.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p 45.53 96.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.557 -0.714 . . . . 0.0 111.655 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -130.14 132.99 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.53 157.46 30.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.531 -0.731 . . . . 0.0 109.937 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.8 168.84 12.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.553 -0.717 . . . . 0.0 110.289 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.37 -35.51 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 0.0 110.487 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.1 p30 -166.5 172.81 10.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.294 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.98 -31.18 71.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.317 -0.864 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.0 81.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.745 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.16 -43.17 74.82 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.95 77.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.45 -0.782 . . . . 0.0 109.717 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.5 tt0 -59.16 -36.82 75.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.581 -0.699 . . . . 0.0 109.334 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -69.53 -51.4 36.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.7 -39.42 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 9.5 m-85 -72.95 -37.47 67.11 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.52 1.95 17.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.694 -0.629 . . . . 0.0 111.377 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -109.19 -45.54 3.73 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 4.4 t80 -53.21 -40.31 64.37 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.151 176.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.08 -55.13 36.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.846 -0.534 . . . . 0.0 110.191 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.89 -48.79 80.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.709 -0.619 . . . . 0.0 110.662 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.14 -22.8 18.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -0.784 . . . . 0.0 111.06 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -103.1 -35.19 8.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.553 -0.717 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.33 36.32 0.7 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -103.72 119.77 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -1.066 . . . . 0.0 109.06 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -149.1 108.48 3.96 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.264 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.01 -109.64 0.22 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.9 tt0 -111.06 176.58 4.97 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.489 -1.006 . . . . 0.0 110.526 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 40.9 m95 -154.29 130.54 10.41 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.61 -0.682 . . . . 0.0 109.838 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 p -144.28 132.58 21.9 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.485 179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.2 t80 -97.57 132.79 42.91 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.75 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -102.07 99.31 9.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.685 -0.635 . . . . 0.0 109.361 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.21 -7.15 33.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.02 -28.9 18.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -122.02 5.6 9.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.676 -0.64 . . . . 0.0 110.183 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 54.76 35.96 25.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -126.61 143.76 51.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.614 -0.679 . . . . 0.0 110.419 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.9 m-85 -94.93 -170.35 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 0.0 110.036 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -155.72 92.66 1.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.9 p -95.89 104.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.888 0.852 . . . . 0.0 111.053 -178.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 169.73 13.6 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.202 -179.92 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.21 0.529 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 99.8 m -103.13 -82.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.564 -0.71 . . . . 0.0 110.318 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 m 50.24 90.64 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.112 -0.992 . . . . 0.0 111.082 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 16.2 m-85 -89.14 139.17 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.089 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -99.22 -173.7 2.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.775 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 12.6 tp -158.99 105.56 1.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.374 -0.829 . . . . 0.0 110.015 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.9 130.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 14.5 mm -95.54 113.83 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.711 -179.011 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -70.69 -23.84 62.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.175 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.28 149.12 46.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.52 -25.01 66.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.685 -0.891 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -86.82 166.72 14.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.745 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' CD2' ' CG1' ' A' ' 40' ' ' ILE . 0.3 OUTLIER 41.0 27.05 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.81 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -52.24 134.8 33.22 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 111.253 -178.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.11 175.42 38.42 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.111 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -140.48 42.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.3 pt -50.26 148.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.522 -0.736 . . . . 0.0 111.165 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -111.97 141.04 46.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.051 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.438 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -138.37 134.75 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.738 . . . . 0.0 110.744 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.99 139.12 42.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.723 -0.611 . . . . 0.0 109.997 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.06 34.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 110.436 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.08 -39.55 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.511 -0.743 . . . . 0.0 110.325 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -160.02 -179.81 8.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.547 -0.721 . . . . 0.0 109.32 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.02 -31.17 72.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.731 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.15 -57.68 10.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 0.0 109.976 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -59.63 -40.91 89.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.63 -0.669 . . . . 0.0 109.783 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.73 . . . . 0.0 109.732 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 15.4 tt0 -60.54 -47.31 86.75 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.371 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -51.32 69.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.949 . . . . 0.0 109.958 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.51 -45.87 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.46 -0.775 . . . . 0.0 109.415 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 8.7 m-85 -68.85 -37.49 79.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -76.03 1.95 14.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.777 -0.577 . . . . 0.0 111.441 179.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -107.08 -45.12 4.22 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 177.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 2.2 t80 -50.42 -38.28 42.33 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.838 176.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -63.86 -49.55 72.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.248 0.547 . . . . 0.0 109.825 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -60.22 -46.3 90.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.709 -0.619 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.99 -22.86 29.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.51 -0.744 . . . . 0.0 110.826 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -103.8 -24.35 13.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.675 -0.641 . . . . 0.0 110.468 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.33 44.03 1.65 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -104.18 135.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.908 . . . . 0.0 109.705 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -167.61 97.63 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.77 -65.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.445 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 9.0 mt-10 -154.65 173.58 16.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.551 -0.97 . . . . 0.0 110.171 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.445 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 52.1 m95 -155.05 123.84 6.13 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.66 -0.65 . . . . 0.0 109.803 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -139.03 133.76 32.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.677 . . . . 0.0 109.289 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.4 t80 -96.15 136.92 35.96 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.851 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -105.15 99.58 9.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.666 . . . . 0.0 109.281 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.7 -4.51 23.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.606 . . . . 0.0 111.603 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.27 -26.58 17.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -126.55 7.82 6.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 110.135 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.6 mmtp 53.4 38.61 28.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.115 -0.99 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.5 m -128.56 135.03 48.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.699 -0.626 . . . . 0.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 56.8 m-85 -87.52 -170.5 3.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.348 -0.845 . . . . 0.0 109.795 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.67 104.24 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.031 -1.043 . . . . 0.0 108.211 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.3 p -111.43 132.61 59.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.567 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.66 -177.41 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.268 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.132 0.491 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 m -86.44 57.09 4.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 110.2 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.8 m -90.23 112.16 23.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 49.7 m-85 -97.8 150.04 21.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.632 -0.668 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.402 ' CG ' ' CG2' ' A' ' 18' ' ' THR . 4.5 mptt -113.24 -167.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.706 -0.621 . . . . 0.0 109.83 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 13.0 tp -167.33 100.38 0.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.487 -0.758 . . . . 0.0 110.145 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.2 mt -82.58 129.18 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG13 ' CG ' ' A' ' 13' ' ' LEU . 10.1 mm -99.91 115.93 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.234 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.75 -158.96 0.21 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.383 -0.823 . . . . 0.0 109.177 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.97 -129.19 47.72 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -148.07 25.54 1.01 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.909 . . . . 0.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 30.4 p -103.74 113.82 27.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 67.43 -51.2 0.5 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.852 -0.53 . . . . 0.0 111.683 179.964 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 11.4 mmmt 49.17 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.616 -1.303 . . . . 0.0 111.543 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.79 170.13 43.24 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.38 55.94 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.77 -0.841 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp -59.32 133.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.519 -0.738 . . . . 0.0 110.373 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.402 ' CG2' ' CG ' ' A' ' 5' ' ' LYS . 53.0 p -98.94 140.13 33.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.647 -0.658 . . . . 0.0 110.079 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.423 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.1 147.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.532 -0.73 . . . . 0.0 110.469 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -90.96 153.36 20.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.592 -0.693 . . . . 0.0 110.152 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.48 164.05 14.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.484 -0.76 . . . . 0.0 110.58 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.22 -39.3 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -162.28 174.33 12.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.92 -30.03 68.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.94 73.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.402 -0.811 . . . . 0.0 109.8 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.89 -40.22 91.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.33 78.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.1 tt0 -58.45 -37.86 76.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.607 -0.683 . . . . 0.0 109.342 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -68.68 -50.64 49.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.27 -39.66 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.3 m-85 -73.36 -36.67 66.17 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 32.9 mtpt -75.62 -0.55 20.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.663 -0.648 . . . . 0.0 111.493 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -105.94 -45.58 4.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 177.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 1.2 t80 -52.81 -40.71 63.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.837 176.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.73 -47.52 84.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.825 -0.547 . . . . 0.0 109.942 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -59.0 -47.6 84.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.581 -0.7 . . . . 0.0 110.432 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -54.28 -25.15 21.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -101.42 -24.59 14.16 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.784 -0.573 . . . . 0.0 110.535 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.47 36.27 3.11 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.447 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -97.39 116.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.614 -0.933 . . . . 0.0 109.489 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -158.06 101.71 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.13 -64.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 68.8 mm-40 -129.56 169.03 15.53 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.48 -1.012 . . . . 0.0 110.952 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 40.9 m95 -162.85 118.78 1.83 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 p -144.44 132.78 21.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -93.56 144.52 25.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.9 97.8 6.61 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.88 -5.84 28.64 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.685 -0.634 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.77 -27.03 17.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -123.98 6.18 8.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.061 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 17.4 mmtt 54.18 39.93 31.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 110.077 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.4 m -134.71 140.29 45.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 0.0 110.744 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 46.3 m-85 -93.62 -170.73 2.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.311 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.04 102.95 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 7.4 p -116.1 144.71 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.92 -178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 2.7 t -143.22 -172.39 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.595 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.436 -0.79 . . . . 0.0 110.199 179.995 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.058 0.456 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 49.8 m -107.48 37.95 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 110.369 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.6 m -60.12 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.415 -0.803 . . . . 0.0 109.841 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 4.7 m-85 -85.49 147.51 26.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.715 -0.616 . . . . 0.0 110.129 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 -171.56 1.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.607 -0.683 . . . . 0.0 109.908 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 25.7 tp -160.08 112.43 2.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.305 -0.872 . . . . 0.0 110.841 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mt -85.35 119.91 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 5.4 mm -93.84 114.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.008 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -102.22 144.6 30.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.545 -0.722 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.68 -135.78 9.38 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -131.38 29.66 4.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.93 . . . . 0.0 110.191 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 14' ' ' LYS . 8.7 p -139.4 147.3 41.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt 60.9 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.784 -0.572 . . . . 0.0 111.204 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' THR . 6.1 mtmm 54.72 98.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.47 -0.769 . . . . 0.0 110.56 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.92 177.36 40.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.88 55.76 1.88 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.655 -0.909 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 pt -58.19 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -128.81 138.76 52.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.531 -0.73 . . . . 0.0 110.188 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.51 138.84 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.734 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.61 128.58 33.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 109.538 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.45 -163.06 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.07 -59.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.29 -174.73 4.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . . . -62.22 -35.78 79.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.56 31.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.619 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -56.11 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.635 . . . . 0.0 109.868 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.27 46.65 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.455 -0.778 . . . . 0.0 110.376 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.4 tt0 -60.57 -35.15 75.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.56 -0.713 . . . . 0.0 109.236 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -72.57 -46.82 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -59.31 -36.94 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 7.3 m-85 -76.96 -35.4 57.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 6.1 mtpt -77.3 0.93 20.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.773 -0.579 . . . . 0.0 111.357 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -107.31 -45.46 4.09 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 5.5 t80 -52.46 -35.24 52.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.783 176.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -71.02 -51.39 25.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.276 0.56 . . . . 0.0 109.946 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.31 -47.43 85.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.635 -0.666 . . . . 0.0 110.396 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -22.64 19.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.571 -0.706 . . . . 0.0 111.11 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -104.52 -31.8 9.28 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.64 1.05 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -102.13 110.18 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.456 -1.026 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -143.36 111.76 6.31 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.25 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.64 -110.03 0.23 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 1.6 tp10 -107.93 179.11 4.32 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.367 -1.078 . . . . 0.0 110.4 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 41.2 m95 -155.19 129.45 8.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.575 -0.703 . . . . 0.0 109.856 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -141.94 133.05 26.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.548 -0.72 . . . . 0.0 109.177 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.5 t80 -98.48 134.48 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.889 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -104.23 98.92 8.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -71.13 -3.81 21.97 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.612 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.75 -25.1 17.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.729 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 p -128.66 5.62 5.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.612 -0.68 . . . . 0.0 110.296 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 74.1 mmtt 55.89 42.81 28.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.164 -0.96 . . . . 0.0 109.679 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 124.89 32.92 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.869 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 82.8 m-85 -81.28 -171.3 3.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -0.75 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.6 90.42 1.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.9 p -92.64 100.25 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.005 0.907 . . . . 0.0 110.927 -178.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -80.12 171.39 15.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.072 0.463 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.439 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 57.6 m -99.25 29.55 3.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 110.321 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -73.3 109.56 6.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.877 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 78.7 m-85 -87.93 145.44 26.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.555 -0.716 . . . . 0.0 110.646 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.94 -173.95 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 6.4 tp -167.65 110.14 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.285 -0.885 . . . . 0.0 110.681 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 52' ' ' THR . 3.6 mp -95.55 113.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.425 ' HA ' HG11 ' A' ' 55' ' ' VAL . 1.2 mm -84.13 104.05 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.94 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -86.52 144.6 27.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.554 -0.716 . . . . 0.0 110.17 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.55 -140.77 12.0 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.28 29.74 5.51 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.664 -0.904 . . . . 0.0 110.176 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' LYS . 10.4 p -138.05 138.02 38.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mt 60.9 -77.3 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.762 -0.586 . . . . 0.0 111.027 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' THR . 15.5 mtpt 54.37 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.339 -0.85 . . . . 0.0 110.738 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.62 -175.77 41.58 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -108.43 -57.88 2.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.577 -0.954 . . . . 0.0 110.367 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.9 mm 53.6 72.75 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -69.64 137.36 52.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.598 -0.689 . . . . 0.0 110.112 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -145.51 147.4 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.562 -0.711 . . . . 0.0 110.572 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.73 162.08 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.605 -0.685 . . . . 0.0 109.936 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.35 171.16 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -53.08 -39.06 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.494 -0.754 . . . . 0.0 110.401 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.5 p30 -160.67 -175.18 4.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -70.38 -31.23 68.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.19 -49.3 74.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.593 -0.692 . . . . 0.0 109.921 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.09 -43.64 97.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.403 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -53.35 -45.06 69.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -59.12 -36.27 74.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 109.348 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.72 -54.85 16.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.49 -40.34 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 11.8 m-85 -72.07 -34.7 68.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -78.52 1.25 23.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.693 -0.629 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -104.22 -46.14 4.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 4.4 t80 -47.36 -51.98 17.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.906 175.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.462 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -67.74 -50.19 58.62 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.659 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.06 -49.92 72.41 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.72 . . . . 0.0 110.899 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.86 -21.46 29.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.603 -0.685 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -102.72 -27.76 12.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.572 -0.705 . . . . 0.0 110.576 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.67 29.25 3.67 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.462 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.41 106.01 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 108.756 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -141.71 114.89 8.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.35 0.595 . . . . 0.0 111.016 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.76 -100.78 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 5.7 tt0 -115.31 170.74 8.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -1.002 . . . . 0.0 110.035 179.54 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.432 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 40.6 m95 -152.6 122.95 7.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.505 -0.747 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 p -138.22 128.57 26.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.5 t80 -94.24 141.7 28.26 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.654 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -111.82 100.92 9.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.1 -2.68 16.46 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.616 -0.678 . . . . 0.0 111.745 -179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -28.69 21.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -136.69 15.39 3.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.695 . . . . 0.0 109.906 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER 48.28 45.34 20.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.487 179.662 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 7' ' ' ILE . 26.2 m -121.18 120.84 36.38 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.54 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 76.3 m-85 -85.35 172.81 10.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -139.78 97.16 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -97.68 107.53 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 122.007 0.908 . . . . 0.0 110.682 -178.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -92.02 170.1 10.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.286 -179.952 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.122 0.487 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.4 m -141.37 -69.24 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.5 m 51.03 88.05 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.375 -0.828 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 6.9 m-85 -90.04 149.46 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.228 178.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -173.93 2.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 110.389 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 7.7 tp -160.98 108.97 1.54 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.634 -0.666 . . . . 0.0 109.986 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 7' ' ' ILE . 49.5 mm -87.42 129.89 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.126 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 mm -101.91 116.39 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.67 -179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -76.05 -29.31 57.99 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.84 -175.91 4.92 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -114.85 25.55 10.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.618 -0.931 . . . . 0.0 110.486 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -96.04 -33.72 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.46 -0.775 . . . . 0.0 109.964 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 9.7 mt -121.96 -54.09 1.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.696 -0.628 . . . . 0.0 109.772 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt 52.66 82.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.539 -0.726 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.99 -175.54 46.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.47 -50.07 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.797 -0.825 . . . . 0.0 109.966 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 17' ' ' ILE . 50.0 mm 54.12 83.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.0 p -76.94 142.14 40.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.626 -0.671 . . . . 0.0 109.672 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.429 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -143.69 131.5 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.488 -0.758 . . . . 0.0 111.187 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -66.93 131.15 45.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 110.068 179.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.32 150.11 31.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.26 -39.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.546 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.13 177.18 11.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.386 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -63.68 -33.11 74.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.415 -0.803 . . . . 0.0 109.642 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -44.09 81.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.562 -0.711 . . . . 0.0 109.723 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 -44.19 67.72 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.98 80.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.571 -0.706 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.8 tt0 -57.98 -37.54 74.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.648 -0.658 . . . . 0.0 109.401 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -51.57 32.62 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.48 -35.56 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 8.7 m-85 -77.24 -35.55 55.36 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 2.1 mtpt -73.85 -2.9 25.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.75 -0.594 . . . . 0.0 111.211 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -103.24 -46.1 4.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.296 2.8 t80 -52.33 -32.43 38.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.692 175.627 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.462 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.49 -60.81 2.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.819 0.818 . . . . 0.0 108.896 178.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -57.19 -40.56 77.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.83 -0.544 . . . . 0.0 110.562 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.09 -27.95 3.78 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.616 -0.678 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -49.31 3.4 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.475 0.655 . . . . 0.0 109.861 179.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.53 64.95 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.295 1.1 mm -118.81 129.3 75.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.949 -0.736 . . . . 0.0 110.389 -176.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.18 94.34 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.511 -0.743 . . . . 0.0 110.154 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.32 -44.95 0.02 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 15.0 tt0 -152.02 167.43 28.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.466 -1.02 . . . . 0.0 110.863 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.8 m95 -163.41 116.56 1.54 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -141.97 130.77 22.9 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.586 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -93.24 146.29 23.81 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.25 100.07 7.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.732 -0.605 . . . . 0.0 109.592 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -71.65 -2.78 18.43 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.668 -0.645 . . . . 0.0 111.505 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -25.82 18.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -131.54 8.74 4.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.482 -0.761 . . . . 0.0 110.174 179.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 54.41 45.11 27.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.193 -0.942 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.9 m -133.52 135.13 44.2 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 63.5 m-85 -90.74 -172.23 3.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.5 -0.75 . . . . 0.0 109.618 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.16 97.68 1.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.98 -1.075 . . . . 0.0 108.712 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.3 p -112.5 146.31 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.138 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 6.2 t -145.28 -172.48 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.936 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.201 179.925 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.186 0.517 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 63.5 m -120.84 75.55 1.15 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.611 -0.68 . . . . 0.0 110.26 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.1 m -102.76 109.12 20.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.109 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 53.3 m-85 -93.16 141.92 27.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 110.301 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.88 -166.21 1.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 0.0 109.35 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 21.4 tp -166.55 105.69 0.63 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.416 -0.803 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -81.34 118.43 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 HD11 ' CG1' ' A' ' 55' ' ' VAL . 5.2 mm -89.86 101.3 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.609 -178.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -76.1 -3.39 35.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.518 -0.739 . . . . 0.0 111.166 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.8 163.89 33.84 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.83 -27.42 68.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.478 -1.013 . . . . 0.0 110.64 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . 16.7 m -78.46 156.27 29.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.53 -0.731 . . . . 0.0 110.324 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 9.6 mt 59.71 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.865 -0.522 . . . . 0.0 111.188 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' THR . 1.0 OUTLIER 56.3 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.149 -0.969 . . . . 0.0 110.528 -179.766 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.53 -177.69 36.85 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -128.09 67.52 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -1.008 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.72 126.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.735 . . . . 0.0 109.892 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -96.29 137.54 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.485 -0.76 . . . . 0.0 110.424 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -142.37 133.65 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.365 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -78.58 148.99 33.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.672 -0.643 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.63 163.97 32.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.604 -0.685 . . . . 0.0 110.246 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.8 -40.93 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.494 -0.753 . . . . 0.0 110.548 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.42 172.55 18.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.28 -34.48 75.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.299 -0.875 . . . . 0.0 109.704 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.3 -49.47 69.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.62 -0.675 . . . . 0.0 109.796 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -40.87 96.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.53 78.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.424 -0.797 . . . . 0.0 109.665 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 9.6 tt0 -59.82 -35.85 75.56 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -68.33 -51.13 47.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -58.12 -40.96 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 14.3 m-85 -72.0 -36.66 69.82 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -74.58 -2.44 25.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.615 -0.678 . . . . 0.0 111.182 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -105.41 -42.51 5.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.293 16.4 t80 -55.08 -19.47 7.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.734 175.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -89.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -53.06 -42.42 65.79 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.708 -0.62 . . . . 0.0 111.787 -178.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 39.5 p-10 -46.85 -27.54 1.27 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.461 -0.774 . . . . 0.0 111.612 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -108.74 -59.57 1.86 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.849 -0.532 . . . . 0.0 110.253 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.82 59.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.46 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.297 1.1 mm -116.49 130.52 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.742 -0.858 . . . . 0.0 109.532 -178.363 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -169.9 104.49 0.32 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.407 -0.808 . . . . 0.0 111.079 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.24 -63.22 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 32.7 mt-10 -152.7 171.37 18.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.567 -0.961 . . . . 0.0 110.143 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 47.9 m95 -155.03 124.89 6.57 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.669 -0.644 . . . . 0.0 110.009 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 p -144.45 132.82 21.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.627 -0.671 . . . . 0.0 109.532 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.1 t80 -93.08 148.73 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.67 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.68 100.08 6.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.742 -0.599 . . . . 0.0 109.879 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.79 -4.18 22.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.712 -0.617 . . . . 0.0 111.554 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.24 -28.0 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.9 p -128.82 8.33 5.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 110.083 179.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 15.9 mmtt 54.28 40.1 31.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.5 m -130.49 138.62 50.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 0.0 110.371 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 48.4 m-85 -91.33 -167.41 1.79 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -154.57 102.31 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.99 -1.069 . . . . 0.0 108.474 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.8 p -113.15 128.39 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.796 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.78 -178.69 4.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.769 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.8 m -115.85 44.86 1.83 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.568 -0.707 . . . . 0.0 110.157 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 m -71.27 93.31 1.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 10.9 m-85 -81.98 139.5 34.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 110.178 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 -170.96 1.83 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.175 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 2.4 tp -165.04 108.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.601 -0.687 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -84.61 129.41 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.22 114.31 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.082 -178.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.88 40.96 1.16 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.36 -151.17 6.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -114.7 -28.82 6.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -1.013 . . . . 0.0 110.503 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 9.1 p -79.88 113.71 18.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 62.25 144.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.277 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -151.27 140.16 20.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.225 -0.922 . . . . 0.0 111.073 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.53 -163.47 29.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -108.69 -42.76 4.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.883 . . . . 0.0 110.235 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp 53.25 95.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.405 -0.809 . . . . 0.0 110.356 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -90.19 132.11 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.633 -0.667 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.429 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -143.42 130.22 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.512 -0.743 . . . . 0.0 110.478 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -71.22 157.72 37.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.55 161.4 11.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.75 -30.99 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.445 -0.785 . . . . 0.0 110.366 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.8 p30 -171.42 178.3 3.26 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.15 -30.61 71.55 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.612 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.67 81.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.502 -0.749 . . . . 0.0 109.704 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -70.59 -44.64 66.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.54 71.34 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.352 -0.842 . . . . 0.0 109.689 179.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -60.44 -41.13 93.41 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.044 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.11 -35.03 66.49 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.604 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.49 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 52.8 mt -67.72 -40.78 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 12.7 m-85 -73.3 -38.3 65.91 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.7 mmmt -72.96 -4.98 35.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.602 -0.686 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -106.14 -45.12 4.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 5.5 t80 -51.62 -30.62 22.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.091 176.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -76.08 -50.11 15.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.608 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -57.54 -47.56 81.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 110.678 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -24.74 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -102.75 -27.1 12.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.637 . . . . 0.0 110.426 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 35.15 2.34 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -95.95 107.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.657 -0.908 . . . . 0.0 108.904 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.25 113.45 9.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.476 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.19 -109.77 0.22 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 5.9 tt0 -114.51 174.39 5.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -1.032 . . . . 0.0 110.347 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 36.5 m95 -151.9 130.71 12.44 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.577 -0.702 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 p -142.89 133.17 24.66 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.298 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.4 t80 -95.12 145.37 25.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -117.8 98.11 6.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.792 -0.568 . . . . 0.0 109.488 179.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.63 -4.62 24.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.659 -0.65 . . . . 0.0 111.659 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -26.71 17.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 109.733 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -125.98 7.05 7.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.609 -0.682 . . . . 0.0 110.194 179.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp 54.15 38.47 29.21 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.184 -0.947 . . . . 0.0 110.101 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.5 m -130.6 134.21 46.8 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.628 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 53.3 m-85 -88.27 -166.84 1.7 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.21 92.71 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.8 p -93.92 102.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.933 0.873 . . . . 0.0 111.316 -178.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -82.51 169.44 16.35 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.051 0.453 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 46.0 m -124.29 47.16 2.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.294 -179.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 m -68.86 85.31 0.32 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.776 . . . . 0.0 109.983 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 7.6 m-85 -70.42 126.89 30.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.647 -0.658 . . . . 0.0 109.778 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -89.57 175.35 7.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.425 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 2.5 tp -156.54 112.5 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.643 -0.661 . . . . 0.0 109.839 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -90.8 114.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.3 mp -90.08 113.15 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.071 -178.829 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -92.61 149.93 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.432 -0.792 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.51 -108.52 1.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -166.28 47.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.584 -0.951 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.21 119.22 5.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 53.95 23.98 4.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.504 0.669 . . . . 0.0 110.312 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -46.97 109.0 0.16 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.007 -1.058 . . . . 0.0 111.468 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.79 -162.73 29.48 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -109.46 -33.58 6.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.617 -0.931 . . . . 0.0 110.719 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.2 mm 67.05 -61.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 O-C-N 121.699 -0.626 . . . . 0.0 110.834 -179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p 62.37 112.63 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.344 -0.847 . . . . 0.0 110.427 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.43 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -143.24 132.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.765 -0.585 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.51 155.01 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 110.325 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.45 12.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.386 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.5 -39.65 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.535 -0.728 . . . . 0.0 110.617 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.27 177.05 11.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.646 -0.659 . . . . 0.0 109.501 179.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.7 -32.16 73.71 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.383 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.3 82.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.632 -0.667 . . . . 0.0 109.807 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.41 -44.66 82.37 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -45.91 75.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 109.623 178.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 6.1 tt0 -59.26 -37.01 76.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.503 179.08 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -69.14 -51.26 40.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mt -58.26 -38.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 8.4 m-85 -74.65 -39.36 62.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.145 0.498 . . . . 0.0 109.792 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -76.45 0.7 18.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.489 -0.757 . . . . 0.0 111.953 -179.393 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -110.14 -45.32 3.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CE2' HD12 ' A' ' 13' ' ' LEU 0.301 9.5 t80 -53.78 -39.0 65.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.249 176.558 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -64.22 -54.49 32.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -56.83 -48.35 78.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.679 -0.638 . . . . 0.0 110.712 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.82 -22.23 34.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.0 110.831 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -102.57 -29.02 11.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.681 -0.637 . . . . 0.0 110.217 179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.53 33.55 1.57 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -105.73 115.52 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -1.044 . . . . 0.0 109.229 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.17 105.55 2.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.433 -179.622 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.4 -97.12 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.51 127.55 46.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.334 -1.097 . . . . 0.0 111.067 -179.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 50.4 m95 -105.83 137.09 44.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.533 -0.729 . . . . 0.0 110.904 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -147.01 132.06 18.24 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.3 t80 -98.6 144.8 27.5 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.861 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -115.57 99.34 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.766 -0.584 . . . . 0.0 109.638 179.257 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.31 -6.09 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 111.306 -179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.82 -26.52 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.612 179.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -124.24 5.63 8.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.619 -0.676 . . . . 0.0 110.119 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 54.0 38.55 29.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.143 -0.973 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -128.06 143.53 51.07 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.811 -179.436 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.6 m-85 -98.34 -172.19 2.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.187 179.452 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.41 99.39 1.61 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.713 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -102.79 97.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.774 0.797 . . . . 0.0 111.155 -178.537 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.35 169.62 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.13 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.685 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.122 0.487 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 20.3 m -117.64 33.58 5.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.551 -0.718 . . . . 0.0 110.199 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.4 m -67.16 91.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 110.143 179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 34.2 m-85 -72.43 146.75 46.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.624 -0.672 . . . . 0.0 110.172 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -109.84 -178.1 3.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.94 179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 6.4 tp -160.57 102.48 1.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt -90.71 117.0 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.045 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.0 mp -91.46 120.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.333 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.7 -31.15 59.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.34 -179.293 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 160.12 45.96 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.41 13.66 13.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.611 -0.935 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -63.05 -54.18 42.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.25 -0.906 . . . . 0.0 109.954 179.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 pp -131.13 -29.08 1.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.677 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt 37.35 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.68 -179.98 47.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.473 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.76 72.54 1.48 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.834 -0.803 . . . . 0.0 109.786 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.66 112.56 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 109.974 -179.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.3 p -88.24 123.27 32.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.642 -0.661 . . . . 0.0 109.692 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.33 139.22 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.781 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -86.51 159.4 19.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.983 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.8 168.92 10.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.711 . . . . 0.0 110.203 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -38.74 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 110.447 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -163.6 174.65 11.5 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.6 -30.61 70.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.771 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.31 -48.96 70.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.427 -0.796 . . . . 0.0 110.026 179.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.91 -43.43 83.39 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.617 -0.677 . . . . 0.0 109.749 179.105 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 17.9 tt0 -58.02 -40.45 80.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.709 -0.62 . . . . 0.0 109.508 179.175 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -50.12 56.22 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.331 178.984 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.3 mt -58.01 -38.37 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 11.5 m-85 -75.54 -35.28 60.72 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -79.78 3.97 17.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.64 . . . . 0.0 111.32 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -107.23 -45.27 4.15 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.288 6.1 t80 -52.9 -45.51 67.57 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.916 176.218 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.438 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.21 -51.56 69.05 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.322 0.582 . . . . 0.0 109.9 179.139 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.83 -49.62 76.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.802 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -57.55 -27.89 63.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.526 -0.733 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.7 -27.52 17.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.887 -0.508 . . . . 0.0 110.307 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.03 38.89 1.92 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.5 mp -106.44 130.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.656 -0.908 . . . . 0.0 109.375 -179.714 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -168.1 106.61 0.5 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.01 -59.9 0.03 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.0 tt0 -136.75 163.61 30.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.381 -1.07 . . . . 0.0 110.529 -179.479 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.4 m95 -162.65 116.06 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 p -145.64 131.57 19.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.604 -0.685 . . . . 0.0 109.495 179.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.3 t80 -89.05 152.3 21.75 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.821 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.32 102.18 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.721 -0.612 . . . . 0.0 109.643 179.367 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.47 -6.06 33.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.737 -0.602 . . . . 0.0 111.395 -179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.49 -28.13 21.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 p -125.22 6.12 7.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.614 -0.679 . . . . 0.0 109.973 179.103 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt 53.47 39.12 29.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.154 -0.966 . . . . 0.0 110.176 -179.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -133.55 145.87 50.5 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.015 -179.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.6 m-85 -97.68 173.56 7.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.574 -0.704 . . . . 0.0 109.441 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.32 110.2 8.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.097 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -117.94 152.89 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.704 -178.271 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 5.6 t -160.11 -169.44 2.5 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.7 179.242 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.402 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 53.5 m -118.73 37.75 3.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 m -62.75 86.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.531 -0.731 . . . . 0.0 110.074 179.926 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 6.4 m-85 -71.75 137.0 47.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.602 -0.686 . . . . 0.0 109.95 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -99.37 179.72 4.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.635 -0.666 . . . . 0.0 110.269 -179.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -163.14 118.58 1.74 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 110.464 -179.975 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.99 114.35 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.284 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.3 mp -89.84 119.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.529 -179.142 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -102.64 56.76 0.78 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.41 174.2 22.67 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -70.15 -41.14 74.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.505 -0.997 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -76.31 115.44 16.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.469 -0.769 . . . . 0.0 109.946 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.28 156.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.356 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 126.19 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.25 -158.71 23.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -110.03 146.3 35.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.641 -0.917 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 17' ' ' ILE . 49.5 mm -113.64 -16.96 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.669 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.0 p 45.33 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.678 -0.639 . . . . 0.0 112.006 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -126.81 141.04 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.803 . . . . 0.0 110.532 179.35 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.73 151.16 32.25 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.431 -179.835 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.82 158.55 10.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.95 -39.35 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 110.382 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -159.36 178.81 9.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.677 -0.639 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.99 -29.18 70.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.609 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.4 71.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.71 . . . . 0.0 109.878 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -41.97 86.12 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.65 -46.42 77.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.632 -0.668 . . . . 0.0 109.583 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.8 tt0 -58.85 -37.27 76.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -51.44 39.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.515 -0.741 . . . . 0.0 109.046 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.0 mt -58.76 -38.02 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 8.5 m-85 -74.7 -37.98 62.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 179.198 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 9.1 mmmt -75.67 -0.89 22.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 111.448 179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -109.91 -45.49 3.62 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.409 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.59 -39.25 64.71 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.865 176.328 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.36 -54.0 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.344 0.592 . . . . 0.0 109.969 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.8 -47.36 77.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.631 -0.668 . . . . 0.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -51.63 -26.33 8.75 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.527 -0.733 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -103.7 -26.16 12.86 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.887 -0.508 . . . . 0.0 110.318 179.733 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.82 29.35 3.6 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 2.1 mp -100.5 57.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.759 1.266 . . . . 0.0 108.173 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.54 101.75 11.63 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.37 -178.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . -160.38 -127.27 0.88 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.7 tt0 -71.28 168.38 17.45 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.136 -1.214 . . . . 0.0 110.325 -179.786 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 33.9 m95 -158.84 129.03 5.86 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.684 -0.635 . . . . 0.0 109.518 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 p -145.46 133.3 21.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.407 -0.808 . . . . 0.0 109.428 179.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.5 t80 -98.46 144.13 28.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.759 179.597 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.69 98.15 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.07 -7.05 32.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.69 -0.631 . . . . 0.0 111.378 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.24 -27.55 17.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 179.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.0 p -122.21 4.99 9.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.56 -0.713 . . . . 0.0 110.062 179.131 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt 54.41 39.26 30.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 109.938 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -129.87 142.39 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.804 -179.468 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.7 m-85 -97.66 -171.6 2.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -158.51 102.36 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.189 . . . . 0.0 108.088 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.3 p -106.24 108.97 26.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.083 0.944 . . . . 0.0 110.93 -178.711 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.421 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -92.88 98.5 11.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.304 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.324 -179.551 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.132 0.492 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.8 m -126.85 40.74 3.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.724 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 m -69.59 87.6 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.723 . . . . 0.0 110.143 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 13.5 m-85 -74.79 140.23 43.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.53 -0.731 . . . . 0.0 110.216 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.21 -179.28 3.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.627 -0.67 . . . . 0.0 110.109 179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -158.24 114.68 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.441 -0.787 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.36 122.69 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mm -89.64 111.45 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.516 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.47 152.38 19.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.736 179.249 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.67 -142.63 15.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -134.81 21.96 3.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.581 -0.952 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 3.9 m -131.12 111.53 12.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 61.77 137.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.369 0.604 . . . . 0.0 110.158 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -141.83 138.27 32.07 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 -179.605 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.65 -176.29 33.24 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.13 -41.49 6.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.701 -0.882 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 mt 53.86 73.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.435 -0.791 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -71.14 130.57 41.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 110.122 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -140.95 135.53 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.498 -0.752 . . . . 0.0 110.625 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.18 156.35 37.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.706 -0.621 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.8 162.28 9.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.552 -0.718 . . . . 0.0 110.397 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -54.97 -38.54 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.637 -0.665 . . . . 0.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -160.49 178.98 9.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.8 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.52 -35.91 82.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.487 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.22 -49.28 67.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.412 -0.805 . . . . 0.0 109.948 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -45.8 91.19 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.121 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.07 -44.07 67.2 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.439 -0.788 . . . . 0.0 109.808 179.008 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.1 tt0 -57.96 -35.53 71.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.673 -0.642 . . . . 0.0 109.349 179.032 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -70.15 -53.54 16.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.47 -35.73 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 6' ' ' LEU . 8.7 m-85 -76.26 -34.19 59.14 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.92 1.89 22.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.718 -0.614 . . . . 0.0 111.286 179.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -103.05 -46.47 4.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 176.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 8.3 t80 -45.48 -53.66 8.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.3 175.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.441 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -57.04 -49.92 74.34 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.36 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.83 -47.37 85.99 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.628 -0.67 . . . . 0.0 110.265 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.16 -23.89 15.98 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.595 -0.691 . . . . 0.0 111.16 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.21 -34.43 7.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.633 -0.667 . . . . 0.0 110.451 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.21 37.23 0.7 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -102.99 110.85 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 0.0 109.12 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -141.43 109.21 5.69 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.826 -179.679 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.6 -106.63 0.2 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 3.8 tt0 -110.59 173.37 6.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -1.001 . . . . 0.0 110.791 -179.695 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 40.2 m95 -153.75 129.96 10.44 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.648 -0.658 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -143.13 133.84 25.18 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.504 179.799 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.5 t80 -98.73 146.67 25.65 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.881 179.712 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -116.78 100.0 7.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.24 -5.54 28.31 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.657 -0.652 . . . . 0.0 111.513 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.51 -27.61 18.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 179.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -126.06 6.83 7.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt 54.47 38.8 30.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.2 m -126.29 144.78 50.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.2 m-85 -99.15 -169.75 1.81 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 0.0 109.854 179.729 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.69 93.91 1.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.832 -1.167 . . . . 0.0 108.013 179.593 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 2.9 p -95.73 116.13 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.972 0.892 . . . . 0.0 110.879 -178.634 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -99.25 168.39 10.06 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.146 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.031 0.443 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.456 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 27.6 m -122.13 27.28 8.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.579 -0.701 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -68.93 106.23 2.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 109.962 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 58.3 m-85 -88.89 145.25 25.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.529 -0.732 . . . . 0.0 110.409 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -112.55 -167.3 1.17 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.672 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 27.4 tp -166.44 108.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.41 -0.806 . . . . 0.0 110.463 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.28 119.81 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.793 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.401 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.1 mm -94.23 113.23 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.596 -179.178 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -105.07 57.9 0.69 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.94 -148.7 6.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 pttp -114.74 -25.07 8.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.598 -0.942 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -80.76 -38.82 27.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 6.5 mt -123.1 168.68 12.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.472 -0.768 . . . . 0.0 110.479 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.42 80.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.009 179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.36 -170.39 38.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.03 107.92 10.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.67 -0.9 . . . . 0.0 110.201 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -93.27 109.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.541 -0.725 . . . . 0.0 109.717 179.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -85.12 124.4 31.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.56 -0.713 . . . . 0.0 110.595 -179.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -143.37 134.23 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -77.47 160.69 28.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.597 -0.689 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.46 165.2 10.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.239 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.13 -38.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.397 -0.814 . . . . 0.0 110.35 -179.979 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.31 174.88 12.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.629 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.29 -30.86 71.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.06 79.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 109.87 179.383 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -71.79 -45.07 62.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.057 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.74 76.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.567 -0.708 . . . . 0.0 109.362 178.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.1 tt0 -60.48 -40.23 90.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.012 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -67.53 -49.12 64.83 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.82 -44.13 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 19' ' ' ILE . 13.7 m-85 -70.3 -38.92 75.1 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 4.6 mmmt -74.57 0.6 14.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 111.319 179.179 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -106.06 -45.58 4.3 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.425 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.298 17.4 t80 -49.02 -30.05 5.66 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.468 176.037 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -83.74 -48.63 9.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.669 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -68.47 -44.8 74.04 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.606 -0.684 . . . . 0.0 111.419 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -47.46 -28.74 2.3 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.501 -0.75 . . . . 0.0 111.139 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.46 -46.55 4.96 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.499 0.666 . . . . 0.0 109.375 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.3 63.54 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -179.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.454 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.27 1.1 mm -118.72 137.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 O-C-N 121.721 -0.87 . . . . 0.0 110.118 -177.359 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 -172.66 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.067 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 126.53 -177.16 17.38 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.736 179.109 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.89 128.13 36.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.976 -0.72 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 43.4 m95 -97.68 125.01 42.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.56 -0.713 . . . . 0.0 110.407 179.667 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.9 p -138.23 134.75 34.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.843 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -98.15 148.16 23.85 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.452 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.68 101.09 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.39 -4.96 24.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.588 -0.695 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.35 -28.1 18.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.563 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -128.79 8.63 5.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.593 -0.692 . . . . 0.0 110.149 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 7.7 mmtm 54.02 40.8 31.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.119 -0.988 . . . . 0.0 110.255 -179.698 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.8 m -125.73 143.51 51.02 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.122 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.3 m-85 -100.18 -174.15 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.5 m -160.69 122.37 3.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 0.0 109.201 -179.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.4 p -117.24 93.97 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -84.7 90.55 7.74 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.975 0.893 . . . . 0.0 110.008 -178.443 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 14.0 tm-20 . . . . . 0 N--CA 1.499 2.011 0 O-C-N 120.849 -1.157 . . . . 0.0 110.147 -179.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 48.4 m -116.21 25.86 10.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.525 -0.735 . . . . 0.0 110.537 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -69.67 103.51 2.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.491 -0.756 . . . . 0.0 110.011 179.799 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 65.7 m-85 -83.0 149.65 26.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.649 -0.657 . . . . 0.0 110.31 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -119.33 179.23 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 179.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 38.9 tp -155.22 112.52 3.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.459 -0.776 . . . . 0.0 110.143 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 7' ' ' ILE . 98.3 mt -82.9 115.99 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.126 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 55' ' ' VAL . 3.6 mm -94.75 119.9 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.794 -179.171 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -117.54 73.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.749 179.55 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.27 -106.32 0.65 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -149.97 -41.1 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.559 -0.965 . . . . 0.0 110.676 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -71.51 -28.9 64.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 5.6 mt -128.24 170.83 12.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 110.232 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 75.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.182 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.99 -168.87 34.6 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -121.22 135.9 55.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.644 -0.915 . . . . 0.0 110.181 -179.906 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -93.96 -15.65 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.738 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p 54.58 110.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.56 0.695 . . . . 0.0 111.065 179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.413 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.44 138.1 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.653 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.78 156.23 21.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.642 -0.661 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.15 168.99 14.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.673 . . . . 0.0 110.339 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.27 -38.5 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.512 -0.743 . . . . 0.0 110.393 -179.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -161.68 175.08 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.48 -32.39 73.82 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.675 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.771 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.38 -39.63 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.69 86.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.614 -0.679 . . . . 0.0 109.598 179.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.4 tt0 -59.94 -34.04 72.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.36 -49.74 46.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.45 -35.43 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 10.7 m-85 -77.72 -40.67 40.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.628 179.384 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.0 mmmt -72.33 -3.24 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.0 111.261 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 -44.58 4.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' CZ ' HD12 ' A' ' 13' ' ' LEU 0.291 4.5 t80 -49.42 -30.38 7.86 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.326 176.062 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -82.35 -55.17 4.67 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.718 0.77 . . . . 0.0 108.952 178.602 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.88 -45.8 92.18 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.624 . . . . 0.0 111.457 -178.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.29 -29.23 1.55 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.599 -0.688 . . . . 0.0 111.256 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -46.08 5.08 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.286 178.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.02 64.41 0.1 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.607 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.2 133.9 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.837 -0.802 . . . . 0.0 110.29 -177.068 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.2 -175.16 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 127.63 -173.53 18.69 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.56 -1.305 . . . . 0.0 111.744 179.186 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.8 126.38 36.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.02 -0.694 . . . . 0.0 110.164 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 37.7 m95 -95.84 126.77 41.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.712 . . . . 0.0 110.259 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -141.71 134.96 29.33 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.6 t80 -97.53 141.97 29.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.516 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.49 100.09 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.614 179.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.69 -4.03 21.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.593 -0.692 . . . . 0.0 111.483 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.67 -26.93 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.707 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.2 p -128.53 7.73 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.661 -0.65 . . . . 0.0 110.201 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 54.87 41.95 31.5 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.172 -0.955 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.3 m -130.05 138.58 50.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.587 -0.695 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.4 m-85 -94.46 -173.18 2.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 0.0 109.17 179.245 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -161.38 122.39 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.772 -1.205 . . . . 0.0 109.184 -179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.5 p -118.99 89.94 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -86.27 99.12 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.957 0.884 . . . . 0.0 110.428 -178.267 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 18.8 tt0 . . . . . 0 N--CA 1.501 2.123 0 O-C-N 120.91 -1.119 . . . . 0.0 110.291 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.017 0.437 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.416 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 43.2 m -123.49 29.71 6.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 m -62.55 87.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.459 -0.776 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 13.5 m-85 -72.53 128.12 34.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.735 -0.603 . . . . 0.0 110.228 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.23 171.53 8.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 109.479 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 3.9 tp -150.47 106.6 3.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.66 122.6 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.7 mp -95.89 124.17 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.966 -179.388 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.96 -30.33 39.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.262 -0.898 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.3 149.27 50.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.86 -20.26 49.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.56 -0.965 . . . . 0.0 110.61 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 7.1 p -65.45 116.62 6.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 110.553 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 12' ' ' THR . 0.2 OUTLIER 65.77 -53.62 0.37 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.334 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt 43.79 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.779 -1.201 . . . . 0.0 112.682 179.091 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.91 -166.41 38.11 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.664 179.201 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -126.87 153.18 46.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.898 -0.766 . . . . 0.0 109.798 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.56 -14.37 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.426 -0.796 . . . . 0.0 111.242 -179.79 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.7 p 44.14 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.575 -0.703 . . . . 0.0 111.875 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.423 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -128.07 138.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.52 -0.737 . . . . 0.0 110.665 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -81.69 147.89 29.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.9 179.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.98 165.65 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.04 -39.65 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.677 . . . . 0.0 110.601 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -162.32 174.77 12.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.717 -0.614 . . . . 0.0 109.563 179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.51 -32.32 72.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.403 -0.811 . . . . 0.0 109.789 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.0 -41.37 78.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.65 -44.05 57.85 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.131 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.24 80.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.566 -0.709 . . . . 0.0 109.545 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.8 tt0 -58.69 -37.74 76.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.255 178.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -68.62 -52.28 33.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.674 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 mt -56.61 -40.18 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 9.9 m-85 -73.07 -35.72 66.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.881 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 23.7 mttm -76.47 0.34 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.654 -0.654 . . . . 0.0 111.464 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.81 -45.28 3.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 177.455 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 8.3 t80 -55.51 -42.22 74.18 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.882 176.353 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -50.97 71.95 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.261 0.553 . . . . 0.0 110.185 179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.38 -46.51 89.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -54.51 -23.3 15.78 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.17 -34.88 7.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.631 -0.668 . . . . 0.0 110.623 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.63 37.76 0.57 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.7 mp -107.67 107.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -1.047 . . . . 0.0 108.733 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -157.62 104.41 1.98 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.271 -179.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.72 -50.37 0.04 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 10.1 tt0 -138.0 167.28 22.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -1.064 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 46.7 m95 -161.49 123.94 3.03 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.841 -0.537 . . . . 0.0 109.886 179.514 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 p -146.65 132.23 18.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.501 -0.75 . . . . 0.0 109.36 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.9 t80 -96.37 133.08 41.21 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.85 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 100.3 10.44 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -2.63 16.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.726 -0.609 . . . . 0.0 111.939 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.7 22.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.274 179.406 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -138.34 16.01 2.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.716 -0.615 . . . . 0.0 110.0 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.5 mptt 49.02 42.53 21.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 111.339 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -118.55 110.64 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.936 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 73.5 m-85 -70.86 -175.4 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -156.01 105.61 2.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.947 -1.096 . . . . 0.0 108.369 -179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 8.0 p -120.76 144.5 29.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 5.7 t -141.3 -165.63 2.01 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.815 179.767 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.294 -179.762 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.072 0.463 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.427 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 57.9 m -117.42 43.56 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.586 -0.696 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 78.5 m -67.79 93.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.459 -0.775 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 11.8 m-85 -76.65 159.17 30.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.0 109.707 179.773 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -121.36 -172.99 2.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.396 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 27.5 tp -165.32 104.86 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.263 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.7 126.17 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 13' ' ' LEU . 8.7 mm -99.14 115.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.525 -178.394 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -81.68 -159.04 0.25 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.33 -152.94 5.11 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.943 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -107.44 -18.28 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.771 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.411 ' CG2' ' CD1' ' A' ' 40' ' ' ILE . 1.0 OUTLIER -58.02 94.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 179.743 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.432 ' CD1' HG13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER 58.17 171.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.263 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' N ' ' CD1' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -162.69 106.9 1.12 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.46 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.93 -166.16 35.62 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.191 -179.823 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.86 -39.12 4.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.798 -0.825 . . . . 0.0 110.517 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.1 mm 54.09 76.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.327 -0.858 . . . . 0.0 110.303 -179.797 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -76.0 129.11 36.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.008 -179.787 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.419 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.17 144.18 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.904 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -83.07 149.66 26.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 109.964 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.81 153.14 14.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.684 . . . . 0.0 110.388 -179.806 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.12 -39.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.399 -0.813 . . . . 0.0 110.458 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.37 173.78 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -61.03 -30.58 70.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.822 . . . . 0.0 109.82 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.89 82.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.813 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -44.79 60.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.594 -0.691 . . . . 0.0 109.689 178.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.1 tt0 -59.79 -38.08 80.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.647 -0.658 . . . . 0.0 109.229 179.088 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -67.99 -51.53 46.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 178.791 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.26 -37.41 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.879 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 8.6 m-85 -75.18 -35.78 61.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.786 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 mmmt -78.32 2.52 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.835 -0.541 . . . . 0.0 111.232 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -106.76 -46.44 3.96 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 177.332 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 23.7 t80 -52.42 -31.79 36.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.938 175.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -67.47 -64.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.676 0.75 . . . . 0.0 109.014 178.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -55.59 -40.08 71.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.925 -0.484 . . . . 0.0 110.767 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -49.32 -27.86 4.33 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.65 -0.656 . . . . 0.0 110.837 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -106.82 -50.72 3.06 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.436 0.636 . . . . 0.0 109.94 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.74 63.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -179.712 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.295 1.1 mm -119.31 130.7 73.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.805 -0.82 . . . . 0.0 109.967 -177.272 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -171.19 100.26 0.21 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 110.724 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.96 -57.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 79.1 mm-40 -140.92 168.42 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.947 . . . . 0.0 110.609 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 40.6 m95 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 p -133.75 130.68 38.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.856 -179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.0 t80 -93.65 129.6 39.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.084 -0.647 . . . . 0.0 109.555 179.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -97.95 97.51 9.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.731 -0.606 . . . . 0.0 109.472 179.185 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.55 -6.32 30.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.561 -0.712 . . . . 0.0 111.527 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.29 -27.26 17.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 179.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 p -124.15 6.82 8.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.557 -0.714 . . . . 0.0 110.142 179.268 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 6.9 mmmt 54.4 38.92 30.48 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 -179.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -130.44 134.17 46.9 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.663 . . . . 0.0 110.761 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 61.1 m-85 -87.88 -173.29 4.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.519 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.74 103.78 2.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.923 -1.111 . . . . 0.0 108.692 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 6.4 p -117.02 146.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.327 -178.64 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 43' ' ' GLU . 5.9 t -148.06 -171.61 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.999 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.231 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.02 0.438 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.456 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 59.9 m -129.41 34.68 4.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 110.169 -179.884 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -73.74 109.82 7.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.465 -0.772 . . . . 0.0 110.017 179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 60.2 m-85 -90.56 119.35 30.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 110.391 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -85.84 169.77 13.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.655 -0.653 . . . . 0.0 109.514 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 2.5 tp -148.25 111.06 4.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.986 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -90.72 119.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.508 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.0 mp -93.13 121.05 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.606 -179.144 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.9 162.19 13.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.359 -0.838 . . . . 0.0 110.552 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.07 -168.11 31.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.5 5.54 23.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.503 -0.998 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -164.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.19 -0.944 . . . . 0.0 110.117 179.822 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 pp -52.78 -33.81 50.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.26 -0.9 . . . . 0.0 110.874 -179.506 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.33 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.398 -0.814 . . . . 0.0 111.536 178.985 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.55 -165.85 38.81 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.401 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -148.08 77.56 1.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.821 -0.811 . . . . 0.0 109.334 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' CE1' ' A' ' 34' ' ' TYR . 41.6 pt -57.82 -26.24 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.46 -0.775 . . . . 0.0 111.118 -179.123 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p 60.31 128.55 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.5 0.666 . . . . 0.0 110.975 -179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.17 156.88 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.416 -0.802 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.42 159.59 15.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.684 179.432 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.82 168.46 8.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 110.605 -179.952 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.22 -39.83 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 110.676 179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -158.11 177.21 11.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.3 -34.59 78.47 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.471 -179.817 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.42 -52.45 61.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.377 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.29 -42.71 91.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.635 -0.665 . . . . 0.0 109.388 179.095 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.49 69.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.526 -0.734 . . . . 0.0 109.773 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.1 tt0 -59.07 -45.84 89.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.556 -0.715 . . . . 0.0 109.335 179.248 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -50.72 71.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.288 -0.883 . . . . 0.0 109.641 178.654 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.4 -45.86 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.416 -0.803 . . . . 0.0 109.23 179.081 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 10.6 m-85 -69.01 -34.03 74.61 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.923 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 3.9 mmmt -73.72 -4.26 33.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.85 -0.531 . . . . 0.0 111.314 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -107.3 -45.45 4.1 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CE1' HD11 ' A' ' 17' ' ' ILE 0.291 9.4 t80 -51.1 -31.69 20.04 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.821 175.948 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -64.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.837 0.827 . . . . 0.0 108.825 178.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -54.52 -40.42 68.59 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.085 0.469 . . . . 0.0 110.655 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -49.81 -27.15 4.63 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.72 -0.613 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -107.28 -48.75 3.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.382 0.61 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.29 62.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.299 1.1 mm -119.54 136.54 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.821 -0.811 . . . . 0.0 109.495 -177.346 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -169.74 106.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.246 -0.908 . . . . 0.0 111.59 -179.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -108.14 0.21 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 179.054 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 1.5 tt0 -109.2 178.96 4.3 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.414 -1.05 . . . . 0.0 110.4 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.7 m95 -155.17 128.79 8.53 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.667 -0.646 . . . . 0.0 109.539 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 p -145.17 132.78 20.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.397 -0.814 . . . . 0.0 109.628 179.855 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 19.6 t80 -96.56 131.28 43.34 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -99.98 99.63 10.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.659 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -70.97 -2.83 16.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.692 -0.63 . . . . 0.0 111.87 -179.3 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.66 -28.36 20.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -136.19 14.97 3.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 4.3 mptt 48.8 43.05 20.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 111.578 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -121.01 114.4 21.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.854 -0.529 . . . . 0.0 109.87 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 65.2 m-85 -73.69 -172.96 1.36 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -0.816 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.17 97.55 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.19 . . . . 0.0 107.988 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG1' HG13 ' A' ' 8' ' ' ILE . 2.7 p -99.89 98.88 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.003 0.906 . . . . 0.0 111.012 -178.492 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -76.88 170.47 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.697 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.087 -179.997 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.08 0.467 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.476 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.0 m -136.64 42.52 2.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.618 -0.676 . . . . 0.0 110.215 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.8 m -72.98 98.01 2.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.733 . . . . 0.0 110.033 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 43.3 m-85 -76.11 122.66 24.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 110.328 -179.923 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.2 169.94 10.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 179.658 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 9.6 tp -150.14 105.21 3.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.953 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -90.66 123.31 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.1 mp -97.5 122.86 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.884 -1.127 . . . . 0.0 109.423 -178.928 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.14 -157.97 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.058 179.542 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.22 -134.52 45.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -144.65 25.71 1.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.688 -0.889 . . . . 0.0 110.413 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -71.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.511 -0.743 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 8' ' ' ILE . 4.6 pp -129.25 -28.69 2.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.631 -0.668 . . . . 0.0 110.688 179.601 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.28 100.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.24 -0.912 . . . . 0.0 111.117 179.538 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.95 48.25 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -117.08 -37.83 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.901 -0.764 . . . . 0.0 109.95 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp 65.52 -58.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.979 -0.451 . . . . 0.0 111.868 179.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p 57.5 107.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.474 -0.766 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.42 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.3 pp -139.08 138.25 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.556 -0.715 . . . . 0.0 110.715 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -84.29 153.49 23.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.36 168.75 19.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.509 -0.744 . . . . 0.0 110.401 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.45 -39.67 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.589 -0.694 . . . . 0.0 110.771 -179.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -162.23 175.41 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.09 -29.33 70.72 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.859 -179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -41.33 78.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.869 179.574 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.65 -45.44 44.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -54.66 -49.15 71.31 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.433 -0.792 . . . . 0.0 109.766 179.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.0 tt0 -58.81 -35.59 73.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.605 -0.685 . . . . 0.0 109.26 179.083 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.77 -50.85 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.722 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mt -59.06 -36.86 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 8.7 m-85 -75.28 -39.29 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.159 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 7.4 mtpm? -76.66 1.73 16.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.58 -0.7 . . . . 0.0 111.535 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -105.81 -45.03 4.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 177.143 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 16.0 t80 -54.02 -34.0 58.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.604 175.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.27 -62.93 1.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.536 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -57.57 -40.68 79.49 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.891 -0.505 . . . . 0.0 110.614 -179.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.88 -27.95 3.43 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.682 -0.636 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.05 -48.87 3.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.406 0.622 . . . . 0.0 109.759 179.113 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.94 63.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.291 1.1 mm -119.24 133.8 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.731 -0.864 . . . . 0.0 109.851 -177.386 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -172.18 103.58 0.17 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.353 -0.842 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.19 -49.04 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 12.8 tt0 -154.6 169.03 24.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -1.062 . . . . 0.0 110.798 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.5 m95 -161.24 115.22 2.0 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.14 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 p -137.81 132.02 32.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.514 -0.741 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.4 t80 -96.68 129.66 44.05 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.854 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -96.94 101.9 13.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.589 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.21 0.09 10.69 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.729 -0.607 . . . . 0.0 111.95 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.23 -26.54 18.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.388 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -140.81 16.85 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.897 179.513 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 49.32 45.63 23.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 111.456 179.591 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 m -120.3 111.64 18.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.087 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 73.8 m-85 -73.71 -176.72 2.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 109.464 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.1 110.84 2.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.82 -1.175 . . . . 0.0 108.525 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -122.35 139.98 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.135 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.426 ' CG2' ' CB ' ' A' ' 43' ' ' GLU . 9.3 t -136.37 -171.21 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.212 179.854 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 94.9 m -82.74 -71.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 110.22 -179.978 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.6 m 49.69 76.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.316 -0.865 . . . . 0.0 111.277 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 10.6 m-85 -73.54 144.63 46.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.535 -0.728 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -109.22 -176.01 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 110.158 -179.8 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 57.2 tp -155.81 118.99 4.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.493 -0.755 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 mt -87.88 108.69 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.043 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG22 ' CB ' ' A' ' 13' ' ' LEU . 4.5 mm -84.64 107.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.643 -179.407 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 25.5 m-20 -76.04 -28.31 57.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.558 -0.713 . . . . 0.0 110.131 179.572 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 166.38 4.72 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.305 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -31.11 27.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.909 . . . . 0.0 110.795 -179.701 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 p -56.51 -31.43 64.07 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.401 -0.812 . . . . 0.0 110.213 -179.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CB ' HG22 ' A' ' 8' ' ' ILE . 4.0 mt -138.37 144.0 40.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.679 -0.638 . . . . 0.0 109.512 179.669 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -146.47 87.68 1.73 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.486 -0.759 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.26 -164.35 31.9 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.652 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.82 149.08 44.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.763 -0.845 . . . . 0.0 110.213 -179.965 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 48.7 mm -103.4 -15.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.716 . . . . 0.0 110.663 179.927 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p 52.67 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.567 0.699 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.412 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -135.81 134.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.39 -0.819 . . . . 0.0 110.733 -179.966 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.47 142.43 40.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.597 -0.689 . . . . 0.0 110.219 179.985 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.48 38.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.705 . . . . 0.0 110.306 179.856 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.38 -39.21 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.511 -0.743 . . . . 0.0 110.694 -179.906 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -160.2 178.33 9.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.689 -0.632 . . . . 0.0 109.469 179.755 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.75 -30.05 71.19 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.797 179.937 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.665 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -65.74 -38.71 89.87 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.79 -44.12 94.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.06 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 16.0 tt0 -59.16 -36.1 74.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.599 . . . . 0.0 109.437 179.085 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -71.88 -49.63 36.34 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 109.109 178.865 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.53 -32.77 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.708 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 6.4 m-85 -80.91 -37.72 29.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.057 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 16.4 mtpp -76.61 1.82 15.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 111.108 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.23 -44.16 4.2 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.423 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.296 2.6 t80 -52.12 -43.96 64.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.914 176.252 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -62.38 -59.28 5.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.316 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.57 -44.09 80.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.759 -0.588 . . . . 0.0 110.882 -179.509 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -48.31 -28.4 3.11 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.903 -179.786 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -102.36 -43.82 5.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.572 0.701 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.39 59.17 0.1 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 107.391 -2.283 . . . . 0.0 107.391 -179.463 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.293 1.1 mm -120.75 159.41 22.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.95 -0.735 . . . . 0.0 109.563 -177.043 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -176.65 -165.99 0.14 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 -126.5 7.43 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.187 178.373 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' CB ' HG21 ' A' ' 56' ' ' THR . 41.4 tt0 -96.59 109.22 21.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.72 . . . . 0.0 111.973 -177.834 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' THR . 26.0 m95 -97.47 118.03 33.05 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.446 0.641 . . . . 0.0 109.538 178.242 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -131.78 162.03 31.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.329 -179.387 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.8 t80 -123.71 137.37 54.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.46 100.13 9.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.213 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.03 -3.56 20.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.699 -0.626 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.93 -26.29 17.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.96 . . . . 0.0 109.742 179.705 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -129.45 8.28 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.62 -0.675 . . . . 0.0 110.132 179.384 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt 54.24 41.72 31.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 -179.671 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -126.49 137.78 53.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.688 -0.632 . . . . 0.0 110.364 -179.798 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.1 m-85 -96.89 -165.7 1.3 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.467 -0.77 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 6.9 m -154.83 162.86 40.96 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.996 -1.065 . . . . 0.0 108.839 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -164.35 96.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.738 -0.601 . . . . 0.0 109.523 -179.452 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 56' ' ' THR . 3.8 t -110.83 91.87 3.83 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.296 1.046 . . . . 0.0 111.673 -178.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.504 2.274 0 O-C-N 120.887 -1.133 . . . . 0.0 110.794 -179.666 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 29.8 m -129.13 25.83 5.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -68.35 100.03 1.01 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 109.925 179.751 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 58.0 m-85 -80.19 150.7 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -116.4 174.69 5.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 109.333 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.446 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 10.4 tp -151.54 114.1 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.24 112.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.2 mp -96.59 114.94 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.469 -179.132 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.69 103.21 12.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.747 . . . . 0.0 109.74 179.879 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.77 -103.13 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.955 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -154.64 30.39 0.42 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.946 . . . . 0.0 110.334 -179.968 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -142.74 118.72 10.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.619 -0.676 . . . . 0.0 110.545 -179.813 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.31 -52.45 0.48 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.986 -0.446 . . . . 0.0 111.57 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 48.83 91.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.712 -1.243 . . . . 0.0 111.473 179.569 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.57 -165.75 29.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.88 154.68 42.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.747 . . . . 0.0 110.02 -179.856 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 tt -118.78 -4.7 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.467 -0.77 . . . . 0.0 111.252 179.861 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p 47.01 102.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.524 -0.735 . . . . 0.0 112.04 179.584 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.433 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -127.56 145.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.406 -0.809 . . . . 0.0 110.541 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.84 155.68 18.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.22 167.49 12.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.595 -0.69 . . . . 0.0 110.445 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.77 -39.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.521 -0.737 . . . . 0.0 110.736 -179.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -161.47 174.91 12.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.88 -31.93 72.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 109.931 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.6 82.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.728 . . . . 0.0 109.831 179.675 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.78 -39.66 84.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.099 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.19 87.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.632 -0.667 . . . . 0.0 109.447 179.049 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.7 tt0 -59.83 -36.86 77.69 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.96 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -70.77 -48.23 55.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.685 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.92 -38.74 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.713 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 10.1 m-85 -74.63 -39.39 62.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.126 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 31.0 mtpt -71.97 -3.36 22.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 111.084 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -107.88 -44.6 4.18 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.903 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 27.5 t80 -52.2 -37.7 55.7 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.355 176.327 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -68.63 -65.65 0.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -56.25 -42.39 77.28 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.721 -0.612 . . . . 0.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.68 -29.35 2.96 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -102.79 -44.96 5.14 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 178.703 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.83 63.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.955 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.81 135.36 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.774 -0.839 . . . . 0.0 110.22 -177.34 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -131.02 170.08 14.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.97 177.83 16.21 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.994 179.376 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -81.31 115.89 20.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.95 -0.735 . . . . 0.0 109.896 179.657 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.438 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 42.1 m95 -79.37 129.34 34.37 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.515 0.674 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.3 p -144.44 133.7 23.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.865 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -96.32 145.75 25.32 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.584 179.593 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.52 100.57 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.671 -0.643 . . . . 0.0 109.546 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.4 -5.04 25.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.0 111.588 -179.704 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.68 -27.72 19.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.738 179.619 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -130.03 8.05 5.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.0 110.08 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 54.58 42.13 31.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.3 m -127.03 132.57 50.69 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.419 -179.238 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.0 m-85 -90.12 -179.46 5.67 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.65 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.0 m -162.5 126.38 3.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.772 -1.205 . . . . 0.0 109.95 -179.444 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -116.34 92.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.806 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -84.56 102.94 13.27 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.707 0.765 . . . . 0.0 110.182 -178.54 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 N--CA 1.504 2.243 0 O-C-N 121.079 -1.013 . . . . 0.0 110.943 -178.96 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.165 0.507 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.3 m -115.62 87.39 2.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.512 -0.743 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 m -109.16 120.85 43.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.73 . . . . 0.0 109.789 179.283 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CZ ' ' CA ' ' A' ' 24' ' ' ALA . 35.6 m-85 -114.24 125.46 53.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.568 -0.708 . . . . 0.0 110.256 179.98 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -91.69 172.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.529 -0.732 . . . . 0.0 109.391 179.632 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.425 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -153.99 112.77 3.66 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.233 -179.724 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.2 mt -91.52 115.65 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.941 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.3 mp -87.71 116.81 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.269 -0.973 . . . . 0.0 109.449 -179.229 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.96 60.62 2.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.08 -144.73 4.94 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.36 27.23 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -179.812 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -140.07 27.32 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.491 -0.756 . . . . 0.0 110.183 179.836 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.73 -74.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 110.01 179.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt 51.61 54.07 11.65 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.325 -0.859 . . . . 0.0 110.667 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.95 169.05 28.1 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.782 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.99 64.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.812 . . . . 0.0 110.265 -179.857 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -61.16 143.54 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.0 p -99.4 150.65 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -0.754 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.453 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -116.19 168.58 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.111 0.958 . . . . 0.0 110.963 -179.181 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.16 79.37 1.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.758 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.66 176.68 5.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.678 -0.639 . . . . 0.0 110.5 -177.248 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.3 -40.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.278 -179.592 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -149.36 172.5 14.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.38 -31.27 71.16 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.859 -179.511 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.26 46.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.483 -0.761 . . . . 0.0 110.007 179.517 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.17 -45.57 92.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.0 -45.46 61.15 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.268 -0.895 . . . . 0.0 110.371 179.399 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.82 -34.63 74.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.401 179.348 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.43 -53.39 23.93 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.371 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.4 mt -59.57 -32.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.916 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CZ ' ' HB ' ' A' ' 19' ' ' ILE . 3.9 m-85 -78.89 -38.67 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.463 0.649 . . . . 0.0 109.266 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.3 mmmt -72.93 -4.06 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.796 -0.565 . . . . 0.0 111.429 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -107.84 -44.69 4.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.329 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.293 17.6 t80 -52.62 -34.04 49.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.2 176.43 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -66.58 -49.92 64.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.731 -0.606 . . . . 0.0 109.936 179.253 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -57.85 -46.2 85.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.639 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -55.61 -23.65 28.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.43 -0.794 . . . . 0.0 110.758 179.985 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -102.98 -26.65 13.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.739 -0.601 . . . . 0.0 110.453 179.883 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.99 29.9 3.37 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.449 ' HB ' ' CA ' ' A' ' 35' ' ' ALA . 1.6 mp -96.97 106.71 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.622 -0.928 . . . . 0.0 108.855 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -143.96 102.73 3.93 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.409 -179.215 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.42 -105.81 0.2 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.154 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.451 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 2.2 tt0 -105.95 179.73 4.18 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.41 -1.053 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 40.3 m95 -157.17 131.04 8.2 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.654 -0.653 . . . . 0.0 109.757 -179.952 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -146.13 132.29 19.4 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.581 -0.699 . . . . 0.0 109.557 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 19.9 t80 -97.42 121.97 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.667 179.272 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.2 98.82 11.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.554 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.93 -3.05 17.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.573 -0.704 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.08 -28.54 21.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.416 179.369 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -136.53 14.62 3.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.697 -0.627 . . . . 0.0 110.024 179.275 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.6 mptp? 49.46 43.65 23.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.88 . . . . 0.0 111.283 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -119.99 103.41 9.28 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.274 179.774 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 75.6 m-85 -62.3 -177.04 0.12 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.695 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.9 101.68 1.8 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.764 -1.21 . . . . 0.0 107.756 -179.654 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 44' ' ' TRP . 4.6 p -106.13 115.27 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.209 1.004 . . . . 0.0 111.607 -178.148 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -89.69 171.78 9.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.793 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.216 179.968 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.219 0.533 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.426 HG21 ' CE2' ' A' ' 4' ' ' PHE . 87.2 m -87.05 89.98 8.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.95 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 m -108.0 114.43 28.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.541 -0.725 . . . . 0.0 110.027 179.435 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 27.7 m-85 -113.0 117.91 33.35 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -87.36 171.94 10.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -0.812 . . . . 0.0 110.108 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' A' ' 31' ' ' PHE . 29.8 tp -148.48 105.14 3.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.727 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.35 118.36 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.409 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.5 mm -95.35 119.47 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.988 -178.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -113.71 92.03 3.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.55 176.86 45.95 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.41 -34.25 73.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.486 -1.008 . . . . 0.0 110.353 -179.873 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 p -91.09 133.45 35.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.657 -0.652 . . . . 0.0 109.871 179.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mt 58.48 162.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.504 -0.748 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -175.69 94.29 0.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.327 -0.858 . . . . 0.0 110.659 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.54 176.04 14.33 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.586 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -82.06 150.25 27.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.676 -0.896 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.51 -19.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.571 -0.706 . . . . 0.0 110.757 -179.919 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p 61.83 129.59 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.722 -0.611 . . . . 0.0 110.251 -179.636 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -120.53 167.25 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.967 0.889 . . . . 0.0 111.14 -179.445 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.02 71.56 1.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.61 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.1 179.34 4.13 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.797 -0.564 . . . . 0.0 110.403 -177.619 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.5 p -80.01 -41.5 21.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.893 -179.386 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -147.11 171.66 14.97 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.667 -179.338 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.36 72.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.52 -0.737 . . . . 0.0 109.942 179.42 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.43 -49.69 58.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.84 61.64 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.544 -0.723 . . . . 0.0 110.121 179.009 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -60.22 -41.29 92.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.303 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -67.44 -49.85 61.89 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.784 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -59.14 -39.97 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.59 -0.694 . . . . 0.0 109.204 179.023 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 19' ' ' ILE . 5.6 m-85 -73.78 -38.58 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.336 0.588 . . . . 0.0 109.476 179.25 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 0.8 OUTLIER -72.77 -3.35 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.664 -0.647 . . . . 0.0 111.44 -179.99 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -110.41 -45.1 3.6 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 177.721 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.296 3.6 t80 -54.41 -44.49 72.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.85 176.28 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' CB ' HG23 ' A' ' 40' ' ' ILE . . . -64.48 -58.64 5.84 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.196 0.522 . . . . 0.0 109.921 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -54.76 -47.6 73.69 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.595 -0.69 . . . . 0.0 110.916 -179.719 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.32 -28.71 63.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.402 -0.811 . . . . 0.0 110.421 -179.896 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -94.6 -27.8 15.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.809 -0.557 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.33 27.81 4.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.908 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG23 ' CB ' ' A' ' 35' ' ' ALA . 1.7 mp -99.77 76.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -1.05 . . . . 0.0 109.075 -179.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -172.3 3.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.042 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 57' ' ' GLU . . . 126.11 -171.13 17.91 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.432 -1.366 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.24 132.14 34.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.983 -0.716 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 32' ' ' LYS . 49.7 m95 -100.57 133.56 44.84 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.573 0.701 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -145.55 133.59 21.44 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.695 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 t80 -98.19 142.2 30.16 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.674 179.688 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -113.2 101.25 9.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.764 -0.585 . . . . 0.0 109.739 179.576 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.87 -5.15 28.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 0.0 111.428 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.8 -28.66 21.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 109.503 179.499 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -129.13 7.64 5.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.676 . . . . 0.0 110.096 179.269 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp 54.42 41.04 32.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.179 -0.951 . . . . 0.0 110.092 -179.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 m -127.98 132.77 49.16 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.044 -179.333 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.7 m-85 -86.92 -173.78 4.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.332 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -157.86 117.76 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.835 -1.166 . . . . 0.0 108.987 -179.878 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' HD11 ' A' ' 8' ' ' ILE . 1.7 p -115.81 93.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.735 0.778 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.6 OUTLIER -87.72 96.78 10.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.892 0.853 . . . . 0.0 110.046 -178.618 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 10.9 tt0 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.131 . . . . 0.0 110.223 -179.131 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.42 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 70.6 m -114.39 48.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.639 -0.663 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.1 m -69.68 91.93 0.64 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 7.9 m-85 -80.98 139.69 35.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.517 -0.739 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.92 -172.31 2.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.528 -0.733 . . . . 0.0 110.208 -179.526 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 3.7 tp -164.05 98.77 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 0.0 109.94 179.912 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 7' ' ' ILE . 89.6 mt -80.52 134.11 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.421 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 5.9 mm -99.03 117.67 44.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.215 -178.925 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -94.07 6.0 49.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.677 -0.639 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.84 -165.89 36.33 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -103.11 27.56 7.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.611 -0.935 . . . . 0.0 109.966 179.614 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -153.92 175.53 13.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 0.0 110.488 -179.63 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' CD2' ' CD1' ' A' ' 40' ' ' ILE . 0.6 OUTLIER 38.74 28.57 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.694 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.44 118.67 2.88 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.198 -0.939 . . . . 0.0 111.7 -179.209 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.95 -174.18 44.71 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -118.56 -32.78 4.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.832 -0.805 . . . . 0.0 110.546 -179.788 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 24.2 pt 36.98 83.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.762 0 CA-C-O 121.558 0.694 . . . . 0.0 112.291 -179.625 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -70.54 140.8 51.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.51 -0.744 . . . . 0.0 110.553 -179.584 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -148.22 134.28 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 179.548 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.68 156.03 35.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 179.974 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.7 158.54 7.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.563 -0.71 . . . . 0.0 110.24 179.968 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -54.0 -39.99 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.544 -0.722 . . . . 0.0 110.555 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -160.5 177.48 10.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.458 -0.776 . . . . 0.0 109.705 179.561 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -62.79 -34.52 77.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 109.785 -179.985 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.04 -44.73 74.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.494 -0.754 . . . . 0.0 109.77 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.41 -44.48 71.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.826 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.8 -39.92 72.0 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.405 -0.809 . . . . 0.0 109.596 178.871 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.8 tt0 -61.37 -40.1 93.08 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.209 -0.597 . . . . 0.0 110.039 179.595 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.51 -34.44 63.03 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.491 179.478 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 49.4 mt -67.99 -38.76 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.915 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 19' ' ' ILE . 10.9 m-85 -75.21 -37.1 61.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.44 2.2 19.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 110.948 179.201 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.19 -44.8 4.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 177.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CZ ' HD12 ' A' ' 17' ' ' ILE 0.291 8.6 t80 -51.54 -39.59 58.05 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.313 176.22 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.438 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -73.19 -48.72 32.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.583 0.706 . . . . 0.0 109.583 179.413 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -67.11 -46.38 74.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.774 -0.579 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -48.86 -27.76 3.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 111.03 -179.43 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -100.62 -47.76 4.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.417 0.627 . . . . 0.0 110.007 179.4 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.35 61.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -179.506 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.294 1.1 mm -117.02 141.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.914 -0.756 . . . . 0.0 109.067 -177.298 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -166.66 125.28 1.43 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.735 -179.155 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.4 -102.2 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.525 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 9.6 tt0 -127.98 173.57 9.92 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.455 -1.026 . . . . 0.0 109.582 178.675 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.462 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.5 m95 -150.43 131.35 14.23 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.379 -0.826 . . . . 0.0 110.091 -179.798 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 p -143.96 131.5 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.6 179.507 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -94.87 134.14 37.84 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.211 179.308 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.14 98.77 8.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.627 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.05 -5.31 25.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.655 -0.653 . . . . 0.0 111.425 -179.903 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.59 -27.96 17.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.712 179.616 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.9 p -124.3 7.37 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.655 -0.653 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt 54.56 38.78 30.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.128 -0.982 . . . . 0.0 110.18 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -130.34 140.9 50.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.606 -0.684 . . . . 0.0 110.463 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 57.2 m-85 -92.74 -170.4 2.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 109.609 179.669 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.03 92.84 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.855 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' CZ2' ' A' ' 44' ' ' TRP . 2.4 p -92.98 105.71 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.87 0.843 . . . . 0.0 110.458 -178.91 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -84.17 171.6 12.68 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.581 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.253 179.732 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.047 0.451 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 4' ' ' PHE . 61.7 m -110.57 -80.85 0.58 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.65 -0.656 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 22.6 m 52.39 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.28 -0.888 . . . . 0.0 110.875 -178.784 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 9.5 m-85 -105.03 123.42 47.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.17 174.55 7.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.759 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -151.34 113.51 4.54 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.256 -179.997 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 7' ' ' ILE . 42.4 mm -80.98 119.81 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 13' ' ' LEU . 7.9 mm -96.14 122.64 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.307 -178.738 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -108.84 52.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 109.956 179.458 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.09 -151.72 8.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.808 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 -23.6 9.37 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.598 -0.942 . . . . 0.0 110.722 -179.793 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -82.36 -30.4 30.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.563 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CB ' ' CG2' ' A' ' 8' ' ' ILE . 8.5 mt -119.66 171.66 8.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.723 -0.61 . . . . 0.0 109.358 179.72 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.04 76.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.636 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.23 179.58 27.06 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.512 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.06 -154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.699 -0.883 . . . . 0.0 109.913 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.401 ' O ' ' OG1' ' A' ' 18' ' ' THR . 7.0 tp -175.07 -32.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.501 -0.749 . . . . 0.0 110.25 179.913 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 17' ' ' ILE . 2.2 p 63.49 137.0 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.367 0.603 . . . . 0.0 109.988 -179.831 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -130.77 166.8 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 121.671 0.748 . . . . 0.0 111.057 -178.869 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.41 78.52 1.21 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.305 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 149.43 43.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.577 -0.702 . . . . 0.0 110.381 -177.533 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.55 -39.75 76.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.374 0.607 . . . . 0.0 110.75 -179.63 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -149.8 178.61 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.801 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -65.57 -29.99 70.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.606 -179.574 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.73 79.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.524 -0.735 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.29 -47.87 66.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.639 -0.663 . . . . 0.0 109.394 179.214 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.01 62.31 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.438 -0.789 . . . . 0.0 110.434 179.486 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.2 tt0 -58.6 -36.45 74.05 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.609 179.423 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -54.13 15.99 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.29 -35.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.527 -0.733 . . . . 0.0 109.184 178.753 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 19' ' ' ILE . 4.5 m-85 -74.65 -39.13 62.24 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.91 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -72.97 -2.79 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 111.442 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -109.28 -44.63 3.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 177.444 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 12.3 t80 -51.44 -33.77 32.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.746 175.954 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -59.95 -57.98 10.52 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.659 0.743 . . . . 0.0 109.118 178.573 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -58.55 -44.4 89.66 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -49.44 -27.19 3.92 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.593 -0.692 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -104.12 -50.07 3.45 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 0.0 110.135 179.402 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.88 62.64 0.05 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -179.653 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.307 1.1 mm -120.3 136.8 56.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.877 -0.778 . . . . 0.0 109.875 -177.042 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -170.07 101.97 0.29 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.325 -0.86 . . . . 0.0 111.237 -179.851 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.01 -104.38 0.18 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.445 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 44' ' ' TRP . 8.6 tt0 -114.73 174.4 5.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.537 -0.978 . . . . 0.0 110.64 -179.923 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.435 ' CZ2' HG22 ' A' ' 55' ' ' VAL . 36.1 m95 -152.87 128.67 10.19 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.709 -0.619 . . . . 0.0 109.615 179.854 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -142.43 132.06 23.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 109.309 179.587 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.5 t80 -96.97 128.25 43.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.53 179.589 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -96.22 98.66 10.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.656 -0.652 . . . . 0.0 109.407 179.207 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -70.59 -4.09 21.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.654 -0.654 . . . . 0.0 111.692 -179.598 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.22 -26.34 17.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.613 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -127.64 7.53 6.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.579 -0.701 . . . . 0.0 110.132 179.333 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 46.8 mmtt 54.53 40.43 31.83 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.21 -0.932 . . . . 0.0 110.134 -179.618 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -127.66 129.82 47.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.728 -0.608 . . . . 0.0 110.425 -179.638 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.5 m-85 -85.29 -171.17 3.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 109.497 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -155.83 95.28 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 HG22 ' CZ2' ' A' ' 44' ' ' TRP . 3.0 p -98.8 107.5 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.982 0.896 . . . . 0.0 111.18 -178.357 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -88.4 163.72 15.86 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.796 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.305 -179.959 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.032 0.444 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 88.4 m -120.11 67.21 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.675 . . . . 0.0 110.336 -179.848 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.9 m -84.23 88.61 7.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.158 179.701 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CE2' ' N ' ' A' ' 24' ' ' ALA . 10.0 m-85 -76.9 137.72 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -102.48 -172.6 2.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.436 -179.533 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . 6.0 tp -165.25 107.7 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.659 -0.65 . . . . 0.0 109.939 179.926 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 7' ' ' ILE . 95.3 mt -89.9 115.57 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.264 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.0 mp -97.67 120.55 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.483 -179.499 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -109.24 98.02 7.52 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.499 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.45 -135.02 1.97 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.937 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -32.94 4.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.968 . . . . 0.0 110.325 179.799 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 p -87.29 107.55 18.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 179.512 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.09 148.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -162.91 128.38 3.22 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.236 -0.915 . . . . 0.0 110.647 -179.724 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.07 -174.73 18.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.29 147.89 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.902 . . . . 0.0 110.836 -179.647 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 17' ' ' ILE . 47.8 mm -113.12 -26.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.511 -0.743 . . . . 0.0 110.243 179.729 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 p 56.79 112.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.344 0.592 . . . . 0.0 111.206 179.57 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.97 135.44 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.327 179.188 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.27 149.34 47.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.609 -0.682 . . . . 0.0 110.148 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.67 156.04 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -53.42 -40.53 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.557 -0.715 . . . . 0.0 110.832 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.94 -179.81 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.706 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CE2' ' A' ' 4' ' ' PHE . . . -64.92 -32.49 74.24 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.559 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.95 76.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.828 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.59 -45.46 71.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.891 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -42.05 76.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.042 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.5 tt0 -61.62 -41.34 97.33 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.447 179.083 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -69.32 -44.27 72.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.408 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.406 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 87.7 mt -63.21 -42.09 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 6' ' ' LEU . 8.7 m-85 -70.41 -40.5 73.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.199 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 34.1 mtpt -71.56 -4.06 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 110.963 179.299 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -98.3 -45.6 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.127 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 5.9 t80 -44.36 -54.15 6.11 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.79 175.572 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -61.78 -51.41 68.41 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.53 -47.3 79.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.641 -0.662 . . . . 0.0 111.364 -178.958 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -48.92 -30.82 6.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.476 -0.765 . . . . 0.0 110.985 -179.275 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -96.01 -46.08 6.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.564 0.697 . . . . 0.0 109.553 179.124 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 62.89 0.16 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -179.373 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' HB ' ' CB ' ' A' ' 35' ' ' ALA 0.284 1.0 OUTLIER -118.67 139.67 45.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.863 -0.786 . . . . 0.0 110.489 -176.725 . . . . . . . . 4 4 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.98 -178.21 4.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.21 -178.74 17.36 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.716 179.2 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.98 123.1 31.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.982 -0.717 . . . . 0.0 110.328 179.888 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.436 ' CH2' HD12 ' A' ' 6' ' ' LEU . 37.8 m95 -88.62 128.1 35.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -141.04 132.9 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.843 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -96.62 143.44 27.59 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.532 179.714 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.77 99.15 7.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.681 -0.637 . . . . 0.0 109.405 179.233 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.74 -3.84 20.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.664 . . . . 0.0 111.593 -179.641 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.27 -27.05 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.736 179.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -130.17 8.9 5.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.632 -0.668 . . . . 0.0 110.128 179.372 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 53.82 44.22 29.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 0.0 110.154 -179.589 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.2 m -130.07 129.93 44.25 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.113 -179.411 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 69.9 m-85 -89.69 -176.65 5.05 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.934 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 m -162.39 124.58 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.793 -1.192 . . . . 0.0 109.664 179.996 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.13 93.27 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.059 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -82.93 96.44 8.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.026 0.917 . . . . 0.0 110.157 -178.237 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 O-C-N 120.978 -1.076 . . . . 0.0 110.448 -179.243 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.5 m -97.83 104.27 16.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.734 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.4 m-85 -90.58 152.21 20.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.843 ' HG2' HG22 ' A' ' 18' ' ' THR . 33.7 mttt -112.96 -171.85 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.669 -0.645 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.799 HD22 ' CD1' ' A' ' 31' ' ' PHE . 14.8 tp -164.25 107.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.142 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.68 124.89 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.7 mm -89.82 116.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.77 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -103.51 67.74 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 0.0 110.468 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.97 167.92 39.47 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -59.82 -33.84 72.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -1.012 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 p -80.44 133.73 35.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 58.32 163.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.468 -0.77 . . . . 0.0 110.284 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -177.24 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.55 -163.45 33.99 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -133.41 70.67 1.46 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.932 . . . . 0.0 110.377 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -62.31 114.53 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.461 -0.774 . . . . 0.0 109.712 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.843 HG22 ' HG2' ' A' ' 5' ' ' LYS . 75.6 p -83.61 138.47 33.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.651 -0.656 . . . . 0.0 110.499 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.48 149.98 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.573 -0.704 . . . . 0.0 110.369 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 148.68 23.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.18 159.64 23.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.553 -0.717 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -53.68 -38.83 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.511 -0.743 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.5 m-20 -159.96 175.83 12.57 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.55 -33.81 75.68 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.713 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.82 63.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.455 -0.778 . . . . 0.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.09 -40.47 96.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.36 72.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 0.0 109.479 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -58.29 -36.26 73.04 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -69.11 -50.81 44.66 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.69 -37.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.799 ' CD1' HD22 ' A' ' 6' ' ' LEU . 12.0 m-85 -74.32 -37.34 63.61 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.6 mmmt -76.3 0.23 20.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.738 -0.601 . . . . 0.0 111.563 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -109.24 -45.25 3.77 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 10.7 t80 -53.07 -34.61 57.33 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.028 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -69.68 -48.14 60.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.193 0.52 . . . . 0.0 110.0 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.41 -46.7 85.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.526 -0.734 . . . . 0.0 110.342 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -54.58 -23.32 16.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.54 -0.725 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' HD13 ' A' ' 40' ' ' ILE . 1.7 m120 -105.51 -25.86 12.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.627 -0.67 . . . . 0.0 110.557 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.76 30.68 3.4 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.71 106.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.979 . . . . 0.0 108.788 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.73 111.68 6.75 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.427 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.27 -108.72 0.21 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -109.81 173.37 6.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.396 -1.061 . . . . 0.0 110.39 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.476 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.8 m95 -152.06 130.33 12.02 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.543 -0.723 . . . . 0.0 110.26 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 6.7 p -142.26 134.18 27.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.63 -0.669 . . . . 0.0 109.253 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.6 t80 -97.61 143.7 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.93 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -113.92 97.97 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.817 -0.552 . . . . 0.0 109.536 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -69.69 -6.84 34.41 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.661 -0.649 . . . . 0.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.15 -27.47 17.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.702 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -122.84 5.71 9.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.648 -0.658 . . . . 0.0 110.079 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp 54.19 36.63 25.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.7 m -127.97 143.2 51.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.629 -0.669 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HB2' HD12 ' A' ' 6' ' ' LEU . 64.2 m-85 -95.99 -168.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 109.698 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 92.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.18 108.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.902 0.858 . . . . 0.0 110.915 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -89.52 169.68 11.15 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.1 m -61.16 95.17 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.575 -0.703 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.7 m-85 -83.68 142.53 30.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.895 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.811 ' HG2' HG22 ' A' ' 18' ' ' THR . 45.1 mtmt -103.34 -177.24 3.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.584 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.896 HD12 ' HB2' ' A' ' 53' ' ' PHE . 4.9 tp -163.26 110.17 1.17 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.653 -0.654 . . . . 0.0 109.967 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.6 mt -85.8 117.63 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.8 mm -85.72 116.9 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -102.93 63.64 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.88 -132.68 3.26 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -131.32 -40.84 1.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.935 . . . . 0.0 110.465 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -69.89 -47.29 63.12 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.449 -0.782 . . . . 0.0 109.62 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.617 ' CB ' HG21 ' A' ' 8' ' ' ILE . 11.4 mt -110.81 156.89 20.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.811 -0.556 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -172.34 86.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.432 -0.793 . . . . 0.0 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.55 161.46 27.43 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.71 73.75 9.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.727 -0.867 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.646 HD13 ' CE2' ' A' ' 34' ' ' TYR . 7.2 mt -56.22 120.79 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 5' ' ' LYS . 74.2 p -99.09 133.47 43.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.28 142.1 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.626 -0.671 . . . . 0.0 110.375 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.02 141.21 34.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.619 -0.676 . . . . 0.0 110.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.72 160.14 41.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 110.236 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 26' ' ' GLU . 8.6 p -56.9 -32.99 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.242 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 6.5 p30 -166.13 -176.51 3.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 109.429 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -68.82 -30.29 68.82 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.665 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.65 -46.19 87.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.706 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' CB ' HG12 ' A' ' 22' ' ' VAL . 8.2 tp10 -70.33 -39.8 74.52 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.79 85.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.528 -0.732 . . . . 0.0 109.533 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.3 tt0 -58.61 -35.97 73.29 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -71.27 -51.33 25.09 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.0 -36.2 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.9 m-85 -75.72 -36.28 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 12.9 mtpp -80.12 4.61 16.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.792 -0.567 . . . . 0.0 111.449 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' OD2' ' A' ' 37' ' ' ASP . 6.3 tm0? -110.89 -45.49 3.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.646 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.291 12.2 t80 -55.48 -43.5 75.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.933 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.73 -47.26 85.21 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.35 -49.51 75.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.554 -0.716 . . . . 0.0 110.746 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD2' ' NE2' ' A' ' 33' ' ' GLN . 3.0 m-20 -56.36 -23.52 38.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.7 m120 -100.8 -24.05 14.47 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.729 -0.607 . . . . 0.0 110.719 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.87 30.89 4.67 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.749 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.51 106.21 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.679 -0.894 . . . . 0.0 108.785 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.53 110.0 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.117 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.94 -106.32 0.2 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.2 tt0 -108.63 174.82 5.7 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.483 -1.01 . . . . 0.0 110.524 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.473 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.9 m95 -153.53 130.63 11.09 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.638 -0.664 . . . . 0.0 109.99 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.0 p -142.48 133.18 25.39 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -99.84 144.24 29.13 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.882 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -114.97 98.56 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.769 -0.582 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.16 -4.94 23.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.713 -0.617 . . . . 0.0 111.664 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 -27.13 18.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.677 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.1 p -127.9 7.38 6.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.658 -0.651 . . . . 0.0 110.175 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt 54.17 40.62 31.85 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -125.83 135.9 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.656 -0.652 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD12 ' A' ' 6' ' ' LEU . 74.8 m-85 -94.36 -170.36 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.579 -0.701 . . . . 0.0 109.525 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.3 94.15 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.853 -1.154 . . . . 0.0 107.89 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 44' ' ' TRP . 3.0 p -96.66 107.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.02 0.914 . . . . 0.0 111.173 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -89.07 169.72 11.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.132 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 2' ' ' THR . 58.7 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.105 0.479 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.654 HG22 ' HB ' ' A' ' 18' ' ' THR . 2.7 m -71.0 81.93 0.67 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -66.41 144.49 56.49 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.93 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.04 179.81 4.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.575 -0.703 . . . . 0.0 110.162 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.0 tp -157.36 112.15 2.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -89.57 122.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 HD13 ' CG1' ' A' ' 55' ' ' VAL . 3.2 mm -89.06 117.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.664 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -104.95 67.06 0.78 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.474 -0.767 . . . . 0.0 110.091 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.02 166.05 36.76 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 12' ' ' THR . 15.8 pttm -59.89 -28.76 67.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.443 -1.034 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 11' ' ' LYS . 19.2 p -92.45 129.59 38.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.622 -0.674 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 34' ' ' TYR . 8.6 mt 60.33 127.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.378 0.609 . . . . 0.0 110.586 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -148.75 93.6 2.15 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.15 -172.72 45.7 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.22 96.36 5.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.817 -0.813 . . . . 0.0 109.947 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.9 mp -86.72 115.51 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 109.95 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.93 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.7 p -89.44 126.9 35.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.622 . . . . 0.0 110.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.87 135.28 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.615 -0.678 . . . . 0.0 110.491 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -73.87 153.1 40.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.592 -0.692 . . . . 0.0 110.134 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -167.66 160.22 12.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.1 p -53.14 -39.46 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.556 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -162.01 176.83 10.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.671 -0.643 . . . . 0.0 109.575 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.75 -33.35 74.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 109.746 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.2 -43.54 78.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 109.984 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 1.6 tp10 -70.4 -44.18 68.51 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 -46.29 74.29 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.484 -0.76 . . . . 0.0 109.686 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 2.7 tt0 -58.16 -37.65 75.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.747 -0.596 . . . . 0.0 109.412 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -51.2 43.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.62 -40.39 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.2 m-85 -71.8 -34.85 69.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 9.5 mttm -77.15 0.17 22.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.647 -0.658 . . . . 0.0 111.5 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -108.06 -45.41 3.96 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.58 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.292 2.6 t80 -54.02 -35.89 62.42 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.139 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -71.0 -45.76 63.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.81 -0.556 . . . . 0.0 110.343 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -50.23 73.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 111.018 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.82 -21.92 32.61 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.455 -0.778 . . . . 0.0 110.978 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' HD13 ' A' ' 40' ' ' ILE . 6.4 m120 -101.19 -23.71 14.39 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.686 -0.634 . . . . 0.0 110.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.3 31.09 4.78 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.746 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.49 105.34 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.595 -0.944 . . . . 0.0 108.92 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.29 112.22 6.27 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.074 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.46 -104.81 0.18 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.3 tt0 -112.19 173.78 6.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -1.022 . . . . 0.0 110.184 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CE2' HG23 ' A' ' 55' ' ' VAL . 38.9 m95 -151.97 128.62 10.8 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.535 -0.728 . . . . 0.0 109.815 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.11 132.51 28.46 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.227 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.2 t80 -98.62 147.54 24.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.592 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.46 99.94 7.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.724 -0.61 . . . . 0.0 109.626 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.8 -4.9 26.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.724 -0.61 . . . . 0.0 111.579 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.36 -26.74 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.1 p -129.11 7.54 5.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.6 -0.687 . . . . 0.0 110.17 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.2 mmtp 54.59 40.29 31.75 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -124.7 139.72 53.6 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.866 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.0 m-85 -97.29 -172.09 2.35 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.556 -0.715 . . . . 0.0 109.741 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.32 91.85 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.0 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.486 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.0 105.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.897 0.856 . . . . 0.0 110.895 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -88.03 171.75 10.05 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -93.34 103.67 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 28.4 m-85 -88.5 151.33 22.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.808 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.5 mptt -115.04 -168.35 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.671 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.0 tp -166.2 107.37 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.82 105.16 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.626 HD13 ' CG1' ' A' ' 55' ' ' VAL . 1.2 mm -75.95 106.06 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.523 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 56' ' ' THR . 11.2 t-20 -82.04 4.16 24.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.505 -0.747 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.82 -148.05 1.58 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -137.21 32.23 2.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.61 -0.936 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 p -147.23 17.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.6 mt -170.81 36.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.63 97.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 110.994 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.57 177.59 43.63 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -44.33 4.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.702 -0.881 . . . . 0.0 110.181 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.0 mm 53.95 87.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.449 -0.782 . . . . 0.0 110.547 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.808 HG22 ' HG3' ' A' ' 5' ' ' LYS . 70.9 p -84.29 134.36 34.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.736 . . . . 0.0 110.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.49 147.85 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.621 -0.674 . . . . 0.0 110.401 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.17 151.93 22.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.259 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.49 160.71 18.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.342 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.4 p -53.69 -40.17 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.0 m-20 -160.87 174.71 13.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.18 -27.45 67.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.373 -0.829 . . . . 0.0 109.953 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 -47.45 84.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -0.785 . . . . 0.0 109.748 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 22' ' ' VAL . 8.1 tt0 -69.88 -41.28 75.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.55 -46.76 80.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.579 -0.701 . . . . 0.0 109.57 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -57.26 -39.88 76.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.632 -0.667 . . . . 0.0 109.235 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -65.62 -53.1 46.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.508 -0.745 . . . . 0.0 109.379 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -56.29 -39.39 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.523 -0.736 . . . . 0.0 109.102 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -73.67 -36.62 65.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 4.0 mtmp? -79.48 3.32 18.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.701 -0.625 . . . . 0.0 111.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -45.21 3.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.495 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.289 9.4 t80 -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.974 176.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -62.53 -48.08 81.1 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.867 -0.521 . . . . 0.0 110.181 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.98 -48.52 78.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.539 -0.725 . . . . 0.0 110.622 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.37 -25.55 35.87 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.566 -0.709 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.4 m-20 -99.82 -25.56 14.32 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.709 -0.619 . . . . 0.0 110.667 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.17 30.42 4.18 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.752 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 105.82 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.686 -0.891 . . . . 0.0 108.862 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -148.64 102.84 3.34 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.728 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.06 -73.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 56' ' ' THR . 29.4 mt-10 -136.0 171.64 14.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.498 -1.001 . . . . 0.0 110.042 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.7 m95 -155.26 126.91 7.41 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.65 -0.656 . . . . 0.0 110.045 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.6 p -144.39 132.79 21.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.4 t80 -95.26 141.65 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.803 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -111.26 100.08 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.736 -0.603 . . . . 0.0 109.739 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.5 -2.79 18.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.686 -0.634 . . . . 0.0 111.657 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.01 -25.93 17.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 109.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.9 p -130.58 8.77 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 110.229 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 56.7 mmtt 54.3 41.65 31.88 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.175 -0.953 . . . . 0.0 110.27 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 5' ' ' LYS . 35.4 m -130.56 134.86 47.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.49 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HB2' HD12 ' A' ' 6' ' ' LEU . 59.1 m-85 -89.28 -168.74 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.521 -0.737 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -155.92 105.3 2.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 108.172 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.626 ' CG1' HD13 ' A' ' 8' ' ' ILE . 5.9 p -115.82 129.86 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.299 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -126.09 -172.04 2.53 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 56' ' ' THR . 8.9 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.185 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 2' ' ' THR . 52.8 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 m -63.54 85.8 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.713 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.751 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.3 m-85 -71.21 140.77 50.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.675 -0.641 . . . . 0.0 109.66 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HG2' HG22 ' A' ' 18' ' ' THR . 9.5 mtmt -104.67 168.01 9.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.762 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.8 tp -141.9 105.57 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.8 mt -76.89 110.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HD23 ' A' ' 6' ' ' LEU . 6.8 mm -84.21 112.94 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.121 -1.032 . . . . 0.0 109.79 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -97.86 155.49 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.476 -0.765 . . . . 0.0 110.064 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.7 -138.97 15.32 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -129.07 28.9 5.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.523 -0.986 . . . . 0.0 110.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' LYS . 19.2 p -136.09 145.26 45.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.623 -0.673 . . . . 0.0 109.905 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 40' ' ' ILE . 6.2 mt 60.9 -76.69 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.733 -0.604 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' THR . 24.6 mtpt 54.99 99.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.343 -0.848 . . . . 0.0 110.708 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.94 -174.22 31.75 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 18' ' ' THR . 7.6 mt-10 -136.03 86.3 2.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.895 . . . . 0.0 109.729 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -59.39 -25.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.552 -0.717 . . . . 0.0 110.789 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.802 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.6 p 60.69 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 121.43 0.634 . . . . 0.0 110.669 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.58 146.04 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.426 -0.796 . . . . 0.0 110.799 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -81.55 152.95 27.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.33 158.52 9.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 110.398 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.2 p -53.95 -38.92 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.3 m-20 -161.26 -177.92 6.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.751 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.77 -28.11 68.78 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.46 69.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' OE1' HG12 ' A' ' 22' ' ' VAL . 2.5 mt-10 -66.23 -41.68 89.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.677 -0.639 . . . . 0.0 109.377 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.23 73.42 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.529 -0.732 . . . . 0.0 109.856 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.453 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.5 tt0 -57.94 -38.17 75.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -70.15 -51.91 27.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mt -58.04 -34.91 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.7 m-85 -77.66 -36.6 51.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -74.34 -2.0 23.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.698 -0.626 . . . . 0.0 111.402 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -108.56 -45.38 3.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 8.9 t80 -52.41 -35.44 51.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.936 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.761 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.11 -47.01 69.33 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.201 0.524 . . . . 0.0 109.987 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.7 -49.31 76.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -54.97 -23.32 18.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.524 -0.735 . . . . 0.0 111.081 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' HD13 ' A' ' 40' ' ' ILE . 8.4 m-20 -102.34 -26.84 13.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.658 -0.651 . . . . 0.0 110.624 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.19 30.9 3.46 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.807 HG12 HD12 ' A' ' 13' ' ' LEU . 1.7 mp -96.85 107.07 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.647 -0.913 . . . . 0.0 108.928 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -145.12 109.47 4.9 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.162 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -107.2 0.2 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -107.18 176.64 5.1 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.454 -1.027 . . . . 0.0 110.45 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.458 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -154.37 130.35 10.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.598 -0.689 . . . . 0.0 109.79 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.2 p -143.88 132.25 22.08 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.337 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.57 147.61 24.11 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.851 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.44 98.68 6.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.715 -0.615 . . . . 0.0 109.746 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.97 -5.65 27.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.636 -0.665 . . . . 0.0 111.419 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.96 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.555 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -126.59 8.01 6.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.655 . . . . 0.0 110.069 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp 53.57 40.03 30.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.146 -0.971 . . . . 0.0 110.281 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -127.65 142.96 51.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.597 -0.689 . . . . 0.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HD12 ' A' ' 6' ' ' LEU . 72.0 m-85 -98.9 -170.14 1.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.626 -0.671 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.11 94.58 1.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -97.43 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.915 0.864 . . . . 0.0 111.173 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 166.25 20.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.257 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.1 m . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.976 0.417 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 18' ' ' THR . 43.6 m 49.86 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.313 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.718 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -87.36 142.49 27.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.638 -0.664 . . . . 0.0 109.654 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.781 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.1 mtmt -100.1 -176.45 3.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 53' ' ' PHE . 1.2 tp -164.43 112.65 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.443 -0.786 . . . . 0.0 110.342 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.45 118.12 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.882 HD11 HD23 ' A' ' 6' ' ' LEU . 2.4 mp -90.21 116.38 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.013 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -92.88 151.99 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.0 110.254 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.52 -155.41 16.27 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.11 31.48 6.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.924 . . . . 0.0 110.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -93.34 -147.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.674 -0.642 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.3 pp -53.91 -36.48 62.78 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 111.309 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.692 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.6 mtpt 50.9 99.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 111.538 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.12 -167.55 37.78 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.334 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -115.74 -64.84 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.814 -0.815 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.729 HD12 ' OH ' ' A' ' 34' ' ' TYR . 83.1 mt 52.36 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.372 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 5' ' ' LYS . 68.3 p -59.27 150.19 26.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -143.32 134.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.519 -0.738 . . . . 0.0 110.89 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.99 138.37 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -155.94 154.65 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.44 -38.67 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -159.78 179.92 8.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.664 . . . . 0.0 109.429 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.718 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.29 -34.42 78.29 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.749 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.95 75.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -70.91 -44.61 65.85 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.06 74.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -59.65 -39.16 83.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.626 -0.671 . . . . 0.0 109.275 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -68.37 -50.06 55.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.184 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.98 -37.49 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -75.97 -38.29 57.66 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.413 0.625 . . . . 0.0 109.321 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.9 mmtp -71.62 -5.09 31.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.777 -0.577 . . . . 0.0 111.479 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.97 -45.16 4.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.729 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.284 0.7 OUTLIER -51.22 -38.04 50.25 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.039 176.293 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.89 -47.95 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.252 0.549 . . . . 0.0 110.246 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -56.53 -51.28 69.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.521 -0.737 . . . . 0.0 110.919 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -57.11 -21.13 29.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.548 -0.72 . . . . 0.0 111.082 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' HD13 ' A' ' 40' ' ' ILE . 4.3 m120 -101.61 -25.57 13.83 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 106.81 28.7 4.94 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.54 105.85 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.653 -0.91 . . . . 0.0 108.581 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -143.24 108.94 5.12 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.53 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.22 -109.89 0.23 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.31 177.75 4.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.41 -1.053 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' NE1' HG23 ' A' ' 55' ' ' VAL . 39.8 m95 -155.83 130.52 9.09 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.538 -0.726 . . . . 0.0 109.687 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -145.45 134.89 23.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.454 -0.779 . . . . 0.0 109.202 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.6 t80 -98.81 148.28 24.06 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.28 96.72 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -69.05 -6.68 29.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.699 -0.626 . . . . 0.0 111.403 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.78 20.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 109.605 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -124.76 7.5 8.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.758 -0.589 . . . . 0.0 110.121 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 53.99 38.57 29.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.2 m -128.54 134.76 48.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.691 . . . . 0.0 110.751 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.922 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.0 m-85 -90.9 -168.97 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.92 97.42 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.2 p -101.42 103.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.121 0.962 . . . . 0.0 111.253 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -82.35 171.62 13.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.033 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 2' ' ' THR . 80.6 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -84.13 104.29 14.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.3 m-85 -88.83 151.32 22.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.805 ' HG2' HG22 ' A' ' 18' ' ' THR . 42.4 mttt -113.19 -170.83 1.76 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.1 tp -163.69 99.97 0.9 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 110.233 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.78 115.35 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 13' ' ' LEU . 15.6 mm -82.64 103.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.745 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 8.0 t-20 -71.24 167.06 20.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.496 -0.752 . . . . 0.0 110.238 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 -153.17 26.32 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.76 36.03 4.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.954 . . . . 0.0 109.917 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.677 HG21 HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -82.63 -151.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.635 -0.666 . . . . 0.0 110.097 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.677 HD11 HG13 ' A' ' 8' ' ' ILE . 2.5 pp -48.75 -26.95 2.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 111.027 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.66 103.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.637 -0.664 . . . . 0.0 111.576 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.41 153.36 8.18 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.437 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -108.77 54.73 0.65 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.834 -0.804 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.663 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.5 tt -50.99 128.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.303 -0.873 . . . . 0.0 110.779 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.805 HG22 ' HG2' ' A' ' 5' ' ' LYS . 47.5 p -99.13 141.05 32.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.332 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.7 pp -142.99 143.14 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.669 . . . . 0.0 110.548 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -83.85 146.36 28.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.88 159.01 29.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.731 . . . . 0.0 110.454 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.14 -39.32 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.754 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-20 -159.76 176.65 11.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.53 -29.96 70.94 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.738 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.75 80.58 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.819 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.99 -41.35 77.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.08 -44.25 82.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.634 -0.666 . . . . 0.0 109.529 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -59.33 -37.9 78.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.71 -0.619 . . . . 0.0 109.368 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -50.7 46.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.268 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.81 -36.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.739 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -77.06 -37.09 55.36 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.2 mmmt -77.68 1.69 19.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.662 -0.649 . . . . 0.0 111.351 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -108.8 -45.17 3.87 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.08 -38.47 62.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.068 176.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.47 -49.36 71.7 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -57.5 -48.51 79.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.513 -0.742 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.24 -23.55 36.65 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.395 -0.816 . . . . 0.0 110.956 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.3 m-80 -101.34 -25.28 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.691 -0.631 . . . . 0.0 110.599 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.63 32.39 3.65 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.751 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.21 106.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.69 -0.888 . . . . 0.0 108.765 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -148.65 103.2 3.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.749 -0.594 . . . . 0.0 110.948 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.77 -58.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HB2' HG22 ' A' ' 56' ' ' THR . 2.5 tp10 -152.19 174.8 13.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.576 -0.955 . . . . 0.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 43.3 m95 -158.42 127.54 5.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.67 -0.644 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.6 p -145.03 132.43 20.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.627 -0.671 . . . . 0.0 109.521 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.4 t80 -96.2 146.64 24.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.95 98.43 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.774 -0.579 . . . . 0.0 109.533 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.18 -6.06 31.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.95 -27.07 18.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -124.77 5.81 8.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.603 -0.686 . . . . 0.0 110.05 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.9 mmtt 54.39 40.72 31.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -132.63 137.79 47.13 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.124 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.2 m-85 -92.36 -172.94 3.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.578 -0.701 . . . . 0.0 109.353 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.62 105.12 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 108.548 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.9 p -115.22 133.37 61.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.658 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -120.88 -174.35 2.8 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.774 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.144 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 2' ' ' THR . 28.8 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.04 0.448 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -66.94 85.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.474 -0.766 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -70.2 142.01 52.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.685 -0.634 . . . . 0.0 109.817 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.512 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -108.3 177.22 4.86 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.541 -0.724 . . . . 0.0 110.198 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.813 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.6 tp -152.53 109.71 3.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.37 108.44 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.757 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.3 mm -84.92 118.78 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.957 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -110.95 140.66 45.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.69 -149.66 21.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -121.58 14.64 11.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.005 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -113.57 -56.68 2.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.757 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.7 mt -115.01 167.55 10.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.795 -0.566 . . . . 0.0 109.501 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.46 92.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 110.701 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.28 173.99 24.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -100.71 156.76 17.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.799 -0.824 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.77 -16.65 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.601 -0.687 . . . . 0.0 110.53 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.512 HG22 ' CG ' ' A' ' 5' ' ' LYS . 48.7 p 46.32 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.579 -0.701 . . . . 0.0 111.842 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -132.26 132.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.476 -0.765 . . . . 0.0 110.372 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.14 150.45 38.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.644 -0.66 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.17 163.01 28.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.636 . . . . 0.0 110.4 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.4 p -55.55 -34.24 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.2 p30 -166.93 176.26 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.729 -0.607 . . . . 0.0 109.376 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.76 -29.88 71.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.89 87.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' CD ' HG12 ' A' ' 22' ' ' VAL . 17.9 tt0 -70.95 -42.71 69.44 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.29 84.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.617 -0.677 . . . . 0.0 109.558 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -59.08 -34.18 71.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 109.487 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -71.09 -52.35 19.93 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.91 -35.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.813 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.8 m-85 -75.55 -38.95 58.9 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.9 mtpt -79.84 5.25 14.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 111.49 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -110.04 -45.4 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.0 t80 -54.05 -43.72 70.44 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.177 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.0 -49.11 78.95 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.834 -0.541 . . . . 0.0 110.197 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -56.91 -48.39 78.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.727 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.56 -21.57 39.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.599 -0.688 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 40' ' ' ILE . 2.1 m120 -103.09 -27.87 12.31 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.599 -0.688 . . . . 0.0 110.596 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.25 29.63 3.65 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.763 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.76 110.49 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.918 . . . . 0.0 109.035 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.22 110.22 3.9 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.335 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.43 -97.69 0.13 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.5 tt0 -123.78 129.01 50.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.39 -1.065 . . . . 0.0 111.483 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' HG23 ' A' ' 55' ' ' VAL . 48.1 m95 -107.6 135.9 48.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.428 -0.795 . . . . 0.0 110.405 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -145.63 131.83 19.45 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -99.19 141.05 32.46 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.774 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -110.9 100.9 9.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.641 -0.662 . . . . 0.0 109.596 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.99 -4.26 23.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.664 -0.648 . . . . 0.0 111.637 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.77 19.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -131.9 8.47 4.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 110.13 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp 54.03 42.94 31.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.216 -0.928 . . . . 0.0 110.233 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -125.75 129.74 50.08 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.626 -0.671 . . . . 0.0 110.787 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.534 ' HB2' HD12 ' A' ' 6' ' ' LEU . 84.2 m-85 -87.46 -173.41 4.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.502 -0.749 . . . . 0.0 109.705 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.32 99.01 1.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -101.77 101.43 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.869 0.843 . . . . 0.0 111.105 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.62 171.96 14.36 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.135 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.485 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.8 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.969 0.414 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m 50.1 72.23 0.34 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.275 -0.891 . . . . 0.0 111.075 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.726 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.3 m-85 -67.86 139.61 56.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -178.84 3.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.794 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -159.52 109.39 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.664 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.07 124.89 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.802 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.7 mm -98.71 115.38 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.089 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -93.12 152.58 19.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.74 . . . . 0.0 109.54 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.18 -151.84 18.31 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -116.85 -24.48 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.543 -0.975 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -58.87 -60.52 3.72 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.802 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.7 mt -120.32 174.52 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.117 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -175.38 75.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.817 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.68 -176.33 34.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 38.8 mt-10 -108.61 -28.16 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.779 -0.836 . . . . 0.0 110.381 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 16' ' ' GLU . 3.7 mt 65.93 -60.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 O-C-N 121.879 -0.513 . . . . 0.0 111.568 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 19' ' ' ILE . 1.9 p 61.49 118.63 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.477 -0.764 . . . . 0.0 110.546 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -148.99 133.93 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.573 -0.704 . . . . 0.0 110.286 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.68 145.22 36.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.595 -0.691 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.03 165.69 34.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.745 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.78 -39.62 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.545 -0.722 . . . . 0.0 110.447 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 50.9 p30 -161.17 177.26 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.728 -0.608 . . . . 0.0 109.375 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.63 -29.5 70.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 0.0 109.731 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.72 -52.49 63.73 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.02 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -64.13 -42.77 96.7 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.85 75.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 109.601 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 23.6 tt0 -58.73 -37.31 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.315 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -52.64 36.98 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.83 -40.53 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.794 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -72.1 -38.83 69.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 5.9 mmtp -73.88 -2.43 23.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.669 -0.644 . . . . 0.0 111.522 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -107.2 -44.94 4.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 1.4 t80 -52.44 -36.81 55.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.206 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.12 -50.98 51.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.758 -0.589 . . . . 0.0 110.23 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -56.25 -49.88 72.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 110.903 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -23.97 41.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.402 -0.811 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -99.16 -26.89 14.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.776 -0.577 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 30.0 4.0 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.746 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.39 107.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.584 -0.95 . . . . 0.0 109.007 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -151.78 100.62 2.69 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.647 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.93 -55.27 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 29.3 tt0 -145.47 169.56 18.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.479 -1.012 . . . . 0.0 110.535 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.6 m95 -159.95 125.62 4.13 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.849 -0.532 . . . . 0.0 109.687 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.81 131.68 19.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 109.371 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.4 t80 -96.63 151.19 19.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.702 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -124.73 99.45 6.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.676 -0.64 . . . . 0.0 109.592 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.77 -4.25 22.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.654 . . . . 0.0 111.523 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.94 -27.79 19.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -127.92 7.53 6.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 54.82 42.13 31.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.9 m -130.22 141.79 50.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 110.91 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.5 m-85 -98.44 -173.97 2.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.523 -0.736 . . . . 0.0 109.104 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 102.29 2.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.863 -1.148 . . . . 0.0 108.688 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.486 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.6 p -117.19 146.24 21.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.165 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -138.12 177.9 7.53 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.231 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 2' ' ' THR . 46.3 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.995 0.426 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -62.91 94.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.591 -0.693 . . . . 0.0 110.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.5 m-85 -78.05 149.25 33.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.067 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 52' ' ' THR . 12.1 ttpt -108.71 -174.45 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 110.389 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.849 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.7 tp -163.13 97.92 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.16 117.06 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' CB ' ' A' ' 13' ' ' LEU . 9.9 mm -85.03 110.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.861 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 7.2 t-20 -85.41 7.28 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.72 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.88 -174.67 41.15 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -110.77 26.67 10.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.928 . . . . 0.0 110.379 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 p -125.94 24.51 6.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.617 -0.677 . . . . 0.0 110.284 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 HG12 ' A' ' 40' ' ' ILE . 1.5 mt -172.69 -67.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.76 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.742 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.67 144.1 3.99 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -102.14 61.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.645 -0.914 . . . . 0.0 110.738 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -57.42 148.08 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.208 -0.932 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 3' ' ' THR . 7.3 p -115.72 136.07 53.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.888 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.07 145.78 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.556 -0.715 . . . . 0.0 110.314 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 155.83 24.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.609 -0.682 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.36 159.2 8.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.62 -39.26 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.7 m-20 -159.25 173.35 16.47 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.55 -35.78 76.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.405 -0.809 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.18 -46.76 72.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.467 -0.771 . . . . 0.0 109.925 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.763 ' OE1' HD11 ' A' ' 30' ' ' ILE . 1.6 tm-20 -66.67 -45.19 79.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.31 -39.48 69.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.419 -0.8 . . . . 0.0 109.819 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -62.12 -39.54 92.89 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.43 -34.48 65.46 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.353 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.763 HD11 ' OE1' ' A' ' 26' ' ' GLU . 98.0 mt -68.59 -39.66 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.849 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.31 -36.89 66.31 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 30.1 mttt -75.74 -2.44 29.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.732 -0.605 . . . . 0.0 111.301 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -104.13 -44.97 4.85 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.293 8.8 t80 -53.56 -42.14 67.23 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.731 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.72 -52.16 58.59 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.813 -0.555 . . . . 0.0 110.135 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.19 -49.14 74.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.725 . . . . 0.0 110.679 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.77 -23.48 18.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.58 -0.7 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -102.31 -28.14 12.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.733 -0.604 . . . . 0.0 110.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 30.08 2.96 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.754 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 106.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.985 . . . . 0.0 109.002 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -150.17 105.82 3.41 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.27 0.557 . . . . 0.0 110.715 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.8 -57.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' CB ' HG22 ' A' ' 56' ' ' THR . 15.1 tt0 -148.55 171.97 15.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.564 -0.963 . . . . 0.0 110.224 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 45.9 m95 -157.22 128.56 6.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.69 -0.631 . . . . 0.0 109.859 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -145.8 131.96 19.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.615 -0.678 . . . . 0.0 109.409 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.1 t80 -97.49 127.17 43.24 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.59 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.65 98.88 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.651 -0.655 . . . . 0.0 109.316 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.88 -5.41 25.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.65 -0.656 . . . . 0.0 111.583 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.46 21.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 109.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -128.4 8.06 5.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 110.171 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt 54.95 40.38 31.99 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 5' ' ' LYS . 57.6 m -125.11 125.48 43.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.717 ' HB2' HD12 ' A' ' 6' ' ' LEU . 83.2 m-85 -80.26 -176.12 5.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.359 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.13 106.67 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.939 -1.1 . . . . 0.0 108.235 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 6.3 p -117.09 133.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.101 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.605 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -124.41 -170.04 2.08 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.908 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.195 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 95.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.977 0.418 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.597 HG22 ' HB ' ' A' ' 18' ' ' THR . 22.1 m 50.24 79.77 0.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.258 -0.901 . . . . 0.0 111.252 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.9 m-85 -78.45 147.82 33.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 18' ' ' THR . 7.2 mptt -112.45 -172.25 2.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.511 -0.743 . . . . 0.0 110.17 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.729 HD22 ' CD1' ' A' ' 31' ' ' PHE . 19.3 tp -163.08 105.68 1.02 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.444 -0.785 . . . . 0.0 110.204 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.55 114.86 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -89.95 113.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.722 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -83.37 -161.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.229 -0.919 . . . . 0.0 109.285 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -163.1 13.65 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -114.58 28.18 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.607 -0.937 . . . . 0.0 110.406 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -66.25 -78.21 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.801 HD11 HG13 ' A' ' 8' ' ' ILE . 4.5 pp -132.21 -27.26 1.82 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.728 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' N ' HD12 ' A' ' 13' ' ' LEU . 70.2 mttt 56.69 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.452 -0.78 . . . . 0.0 111.492 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.37 161.33 20.73 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -130.6 58.31 1.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.884 -0.774 . . . . 0.0 109.711 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.99 110.97 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.549 -0.72 . . . . 0.0 109.755 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.88 HG22 ' CG ' ' A' ' 5' ' ' LYS . 81.7 p -75.84 144.84 41.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -147.33 133.11 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.6 153.6 35.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.522 -0.736 . . . . 0.0 110.162 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.14 162.3 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.65 -0.656 . . . . 0.0 110.31 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -53.8 -39.1 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.692 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' HG13 ' A' ' 22' ' ' VAL . 40.5 p30 -163.51 177.19 9.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 109.526 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.43 -29.66 70.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.05 -49.77 72.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 0.0 110.008 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.33 -43.36 81.8 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.49 71.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.57 -0.706 . . . . 0.0 109.856 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.7 tt0 -58.29 -36.75 73.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.64 -0.663 . . . . 0.0 109.332 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.01 -52.24 25.73 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -57.53 -37.58 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.729 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.99 -36.69 62.0 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -77.86 2.28 17.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.665 -0.647 . . . . 0.0 111.371 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -105.7 -45.83 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 1.4 t80 -53.38 -46.7 69.73 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.928 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.85 -49.25 77.32 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.635 -0.665 . . . . 0.0 110.139 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.81 -50.59 72.78 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.647 -0.658 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -56.46 -24.56 46.52 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.483 -0.761 . . . . 0.0 110.69 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.44 -26.55 14.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.694 -0.628 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.64 33.69 3.26 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.754 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -99.11 114.47 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -157.58 104.44 1.99 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.308 0.575 . . . . 0.0 110.945 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.53 -47.15 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.908 ' HB3' HG22 ' A' ' 56' ' ' THR . 45.0 tt0 -142.2 164.97 28.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.47 -1.017 . . . . 0.0 110.75 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.489 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 41.4 m95 -164.1 112.33 1.15 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 19.0 p -137.9 131.05 30.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.9 t80 -93.84 143.66 26.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.78 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -114.7 98.28 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.786 -0.571 . . . . 0.0 109.522 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -70.17 -4.76 23.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.584 -0.697 . . . . 0.0 111.598 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.81 -27.76 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -126.14 7.62 7.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.604 . . . . 0.0 110.087 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp 53.85 41.53 32.02 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.185 -0.947 . . . . 0.0 110.192 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.698 HG23 ' HB2' ' A' ' 5' ' ' LYS . 7.3 m -132.31 137.23 47.37 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.68 -0.637 . . . . 0.0 110.762 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.2 m-85 -92.0 -172.74 3.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.697 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 103.57 2.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 108.478 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.515 ' CG1' HD13 ' A' ' 8' ' ' ILE . 7.7 p -118.63 152.95 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.198 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.908 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -156.16 -162.44 1.29 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.904 -0.497 . . . . 0.0 109.986 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.049 179.72 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 2' ' ' THR . 72.1 m . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.179 0.514 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.9 m -77.42 92.99 4.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.544 -0.722 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 14.2 m-85 -76.74 144.77 39.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.688 -0.633 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.829 ' HG2' HG22 ' A' ' 18' ' ' THR . 35.7 mtmt -106.6 -179.2 3.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 0.0 110.041 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.865 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -158.09 110.11 2.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.574 -0.704 . . . . 0.0 109.823 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.43 124.81 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 34' ' ' TYR . 7.0 mm -89.95 108.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.83 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -92.92 54.6 2.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 110.121 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.05 -131.65 2.92 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.43 50.59 0.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.945 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 p -138.72 -59.91 0.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.705 . . . . 0.0 110.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 21.8 mt -95.26 -54.58 3.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.367 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.96 82.62 0.07 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.432 -0.792 . . . . 0.0 110.599 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.88 -167.82 37.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.42 -50.88 2.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.915 . . . . 0.0 110.545 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.4 mm 53.7 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.356 -0.84 . . . . 0.0 110.188 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.829 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.2 p -76.55 133.81 39.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.623 -0.673 . . . . 0.0 110.555 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -137.32 140.86 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.571 -0.705 . . . . 0.0 110.276 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.32 150.4 28.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.58 161.56 23.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.676 -0.64 . . . . 0.0 110.248 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.66 -39.61 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.557 -0.714 . . . . 0.0 110.57 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.0 m-20 -158.77 175.99 12.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.0 -33.27 75.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.24 69.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.0 109.852 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -63.53 -43.11 98.09 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.36 70.25 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.467 -0.77 . . . . 0.0 109.84 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.2 tt0 -58.71 -36.56 74.47 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.37 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -67.53 -52.97 32.6 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.21 -38.83 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.3 m-85 -74.31 -34.57 63.53 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 18.2 mmmt -74.92 -3.25 31.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.75 -0.594 . . . . 0.0 111.22 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -105.74 -45.65 4.34 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.88 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.29 6.7 t80 -50.84 -32.46 20.28 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.809 175.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.711 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.58 -63.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.74 0.781 . . . . 0.0 109.277 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -55.46 -41.68 73.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.111 0.481 . . . . 0.0 110.914 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.5 -27.2 4.04 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.4 -56.21 2.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.371 0.605 . . . . 0.0 110.049 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.67 61.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.711 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -117.97 134.93 59.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.838 -0.801 . . . . 0.0 109.816 -177.536 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.31 106.42 0.57 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.837 . . . . 0.0 111.195 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.08 -107.46 0.2 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -115.84 176.23 5.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.467 -1.019 . . . . 0.0 110.166 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.2 m95 -151.72 129.18 11.37 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.638 -0.664 . . . . 0.0 109.881 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.74 134.28 30.05 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.301 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.6 t80 -99.41 148.84 23.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -120.71 98.25 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 -6.32 30.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.646 -0.659 . . . . 0.0 111.478 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.6 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 109.557 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 6.54 8.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.624 -0.672 . . . . 0.0 110.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.3 mmtp 54.07 38.25 28.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 5' ' ' LYS . 8.0 m -126.39 143.13 51.28 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.038 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.832 ' HB2' HD12 ' A' ' 6' ' ' LEU . 66.9 m-85 -99.54 -169.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.533 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -157.27 90.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.803 -1.186 . . . . 0.0 108.254 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.485 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -90.4 97.94 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.794 0.806 . . . . 0.0 110.688 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -78.25 170.89 15.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.327 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 4' ' ' PHE . 38.0 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.113 0.483 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.62 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 m -69.2 105.7 2.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' HG22 ' A' ' 2' ' ' THR . 43.9 m-85 -88.31 140.26 29.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.672 -0.643 . . . . 0.0 110.443 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.822 ' CG ' HG22 ' A' ' 18' ' ' THR . 5.9 mptt -104.98 -174.81 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.867 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.6 tp -161.21 110.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.86 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' GLY . 74.3 mt -97.64 133.41 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.512 HD13 ' CG1' ' A' ' 55' ' ' VAL . 21.7 mm -87.66 107.48 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.95 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.631 ' HB2' HG22 ' A' ' 54' ' ' THR . 26.9 t-20 -75.61 66.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.762 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.62 -135.98 1.95 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -171.19 50.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.518 -0.989 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 13' ' ' LEU . 52.3 m -140.2 23.8 2.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.518 -0.739 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 12' ' ' THR . 0.4 OUTLIER -177.61 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.48 -0.762 . . . . 0.0 111.066 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 55.68 110.19 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.331 -0.855 . . . . 0.0 110.752 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -145.43 135.93 6.23 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.255 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -162.67 28.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 122.08 -0.659 . . . . 0.0 109.67 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.0 -171.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.822 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.1 p -138.61 129.12 26.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -135.56 136.09 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 110.82 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.18 160.17 20.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.613 -0.679 . . . . 0.0 110.043 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.41 171.25 7.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.682 HG12 ' OE1' ' A' ' 26' ' ' GLU . 7.7 p -53.77 -36.43 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.533 -0.729 . . . . 0.0 110.424 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -166.93 173.38 9.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.67 -0.644 . . . . 0.0 109.336 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -60.58 -31.39 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.48 -46.83 76.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.682 ' OE1' HG12 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -66.76 -45.69 77.76 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.03 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.03 -45.02 67.81 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 109.759 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.28 -38.09 76.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.656 -0.652 . . . . 0.0 109.383 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -68.61 -52.83 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.612 -0.68 . . . . 0.0 109.182 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -55.66 -40.38 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -72.29 -32.64 66.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -80.4 4.41 18.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.761 -0.587 . . . . 0.0 111.102 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -104.56 -45.51 4.61 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.299 1.1 t80 -50.34 -40.66 49.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.15 -1.387 . . . . 0.0 108.827 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -44.68 86.15 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.039 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.389 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.0 -23.61 20.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.57 -0.706 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.66 -20.68 13.9 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 100.56 36.55 4.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.776 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -99.03 119.44 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.91 . . . . 0.0 109.186 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -152.16 71.63 0.97 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.373 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -112.22 2.34 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -108.65 174.13 6.01 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.489 -1.006 . . . . 0.0 110.533 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.1 m95 -151.11 134.46 16.15 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.632 -0.667 . . . . 0.0 110.0 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.2 p -142.94 133.0 24.32 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.369 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -97.52 147.29 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.608 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -119.05 102.0 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.617 -0.677 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.4 -5.64 29.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.718 -0.614 . . . . 0.0 111.411 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.59 -28.76 20.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.9 p -127.2 7.17 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.703 . . . . 0.0 110.06 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 54.44 38.26 29.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.188 -0.945 . . . . 0.0 110.203 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 5' ' ' LYS . 18.6 m -124.49 149.69 46.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 6' ' ' LEU . 68.0 m-85 -102.17 -169.33 1.66 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.515 -0.741 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -157.7 92.6 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.7 p -91.64 104.8 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.907 0.861 . . . . 0.0 110.649 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -78.13 156.55 29.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.137 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 59.6 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 18' ' ' THR . 16.2 m -72.04 103.04 3.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.568 -0.708 . . . . 0.0 110.18 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 25.9 m-85 -88.44 149.01 23.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.868 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -113.63 -173.84 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.9 tp -160.47 109.14 1.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.526 -0.734 . . . . 0.0 110.16 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.28 120.12 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 55' ' ' VAL . 6.2 mm -84.84 114.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.401 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -101.49 53.47 0.83 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.529 -0.732 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.1 1.9 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -166.34 47.52 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.585 -0.95 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.7 m -140.54 -45.7 0.41 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.67 -0.644 . . . . 0.0 109.995 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 12.3 mt -106.88 -57.71 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 52.84 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.16 172.2 43.14 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -127.58 59.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.888 . . . . 0.0 110.098 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.89 136.4 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.824 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.868 HG22 ' CG ' ' A' ' 5' ' ' LYS . 77.8 p -103.35 136.69 42.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.246 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.456 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.3 135.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -78.3 154.31 31.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.571 -0.706 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.37 164.15 17.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.388 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.82 -39.49 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.48 -0.762 . . . . 0.0 110.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.8 m-20 -161.44 173.53 14.76 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.67 -29.09 69.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 -45.86 85.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 109.631 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.84 -42.24 77.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.51 81.97 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.611 -0.68 . . . . 0.0 109.488 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.4 tt0 -58.63 -37.22 75.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.289 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -68.73 -51.56 40.12 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.93 -40.34 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.787 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -71.63 -36.96 70.91 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -77.78 1.9 18.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.62 -0.675 . . . . 0.0 111.43 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -106.5 -45.41 4.26 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.747 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.292 8.7 t80 -52.97 -31.74 42.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.743 175.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.26 -63.24 1.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.705 0.764 . . . . 0.0 109.234 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -55.31 -40.99 71.77 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.082 0.468 . . . . 0.0 110.72 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.82 -27.06 4.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.672 -0.642 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -107.15 -53.26 2.64 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.367 0.603 . . . . 0.0 110.192 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.83 62.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -119.24 134.73 61.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.896 -0.767 . . . . 0.0 109.898 -177.352 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -169.68 100.03 0.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.324 -0.86 . . . . 0.0 111.242 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.57 -101.44 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 4.1 tt0 -125.23 134.65 52.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.463 -1.022 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.468 ' NE1' HG23 ' A' ' 55' ' ' VAL . 43.7 m95 -112.98 132.52 55.32 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.9 p -144.43 132.53 21.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.92 137.77 36.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.731 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -107.75 98.72 8.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.69 -0.631 . . . . 0.0 109.524 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -69.07 -6.69 29.82 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.652 -0.655 . . . . 0.0 111.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.25 19.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.9 p -124.62 6.81 8.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.67 . . . . 0.0 110.121 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt 54.41 38.98 30.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.178 -0.952 . . . . 0.0 110.086 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 5' ' ' LYS . 6.5 m -126.84 138.39 53.33 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.582 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.593 ' HB2' HD12 ' A' ' 6' ' ' LEU . 70.9 m-85 -92.45 -171.53 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.475 -0.766 . . . . 0.0 109.574 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.92 98.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -99.31 90.38 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.697 0.761 . . . . 0.0 111.062 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 170.97 9.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.305 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 2' ' ' THR . 55.8 m . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.161 0.505 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.666 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.3 m -63.27 95.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.444 -0.785 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 12.5 m-85 -79.7 140.53 36.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 110.23 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.858 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.7 OUTLIER -104.06 179.64 4.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 110.071 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.856 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.3 tp -154.11 108.22 3.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.446 -0.784 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.7 mt -84.31 120.96 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.5 mm -90.06 112.6 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.087 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -95.27 148.63 22.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -138.62 14.18 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -132.42 42.74 3.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.976 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 14' ' ' LYS . 1.5 m -150.02 147.22 27.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.603 -0.686 . . . . 0.0 109.702 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.637 HD12 HG12 ' A' ' 40' ' ' ILE . 6.3 mt 61.59 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.864 -0.522 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' THR . 57.7 mttt 55.4 97.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.311 -0.868 . . . . 0.0 110.51 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.51 -176.42 44.74 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.54 -53.14 2.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.513 -0.992 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.9 mm 52.94 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' CG ' ' A' ' 5' ' ' LYS . 63.9 p -79.75 133.8 36.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 110.164 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.49 137.26 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.56 154.77 32.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.657 -0.652 . . . . 0.0 110.488 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.83 162.82 16.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -54.99 -38.93 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.592 -0.693 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.466 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -161.61 174.56 13.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.26 -28.86 68.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 109.827 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.65 72.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 109.83 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.3 -43.38 98.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.78 80.99 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.645 -0.659 . . . . 0.0 109.553 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.1 tt0 -59.73 -33.74 72.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.704 -0.622 . . . . 0.0 109.48 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -75.98 -45.25 35.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 66.8 mt -62.7 -38.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.856 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -73.23 -37.99 66.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -73.64 -2.87 24.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 111.378 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -104.1 -45.33 4.75 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.611 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.292 4.4 t80 -50.41 -37.14 36.15 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.103 176.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -47.17 76.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.276 0.56 . . . . 0.0 110.161 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -58.98 -47.17 86.12 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.584 -0.697 . . . . 0.0 110.546 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.47 -19.49 48.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.614 -0.679 . . . . 0.0 110.811 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -104.41 -27.68 11.8 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.559 -0.713 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.3 31.5 3.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.75 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.17 120.91 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.909 . . . . 0.0 109.402 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -152.47 108.1 3.32 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.317 0.579 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.69 -110.5 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -109.33 177.04 4.87 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -1.012 . . . . 0.0 110.672 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.8 m95 -153.15 132.8 13.05 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.605 -0.684 . . . . 0.0 109.803 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.3 p -144.15 132.72 22.23 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.469 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 t80 -98.56 138.92 35.06 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.848 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -108.15 100.67 9.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.561 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.12 -5.36 26.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.586 -0.696 . . . . 0.0 111.549 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.28 -28.01 18.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.553 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -126.21 6.89 7.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.665 -0.647 . . . . 0.0 110.213 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 54.3 39.35 30.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.125 -0.984 . . . . 0.0 109.946 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.4 m -124.7 140.99 52.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.655 -0.653 . . . . 0.0 110.549 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.785 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -95.79 -171.53 2.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 0.0 109.538 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.28 93.27 1.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.16 106.73 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.917 0.865 . . . . 0.0 111.019 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -86.11 170.39 12.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.218 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.867 0.365 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.6 m 50.17 78.01 0.11 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.14 -0.975 . . . . 0.0 111.111 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.743 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.5 m-85 -75.52 144.57 41.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.552 -0.718 . . . . 0.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -106.39 -174.4 2.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.615 -0.678 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.829 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.9 tp -160.77 102.79 1.33 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.491 ' CD1' HG21 ' A' ' 52' ' ' THR . 22.1 mt -84.47 133.32 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mm -101.85 119.33 49.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.986 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 54' ' ' THR . 32.4 m-20 -67.85 -52.15 40.08 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.844 . . . . 0.0 110.255 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -156.08 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.07 15.39 4.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.907 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -60.02 -69.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.212 -0.93 . . . . 0.0 109.438 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' C ' HD12 ' A' ' 13' ' ' LEU . 1.5 pp -122.47 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 20.5 ptmt -33.74 137.25 0.1 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.13 30.44 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.598 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -140.82 47.57 1.74 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 17' ' ' ILE . 4.6 tp -51.4 115.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.807 HG22 ' HG2' ' A' ' 5' ' ' LYS . 60.4 p -83.76 144.91 29.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.636 -0.665 . . . . 0.0 110.009 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -143.19 134.74 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.56 137.8 39.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.7 -0.625 . . . . 0.0 110.14 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.39 37.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.63 -0.669 . . . . 0.0 110.228 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -53.77 -39.95 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.0 110.586 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.1 m-20 -159.62 179.47 8.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.622 . . . . 0.0 109.398 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.29 -29.15 70.24 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.679 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.0 70.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.19 -41.93 85.04 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -48.32 72.09 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.541 -0.724 . . . . 0.0 109.881 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.566 -0.709 . . . . 0.0 109.368 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -69.04 -52.44 28.57 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -58.49 -36.58 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.4 m-85 -75.28 -38.93 60.15 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -76.14 0.4 19.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 111.657 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -105.96 -45.27 4.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE1' HD22 ' A' ' 13' ' ' LEU 0.287 2.2 t80 -51.12 -38.8 54.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.933 176.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.62 -48.85 70.83 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -60.47 -48.17 82.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.517 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -55.69 -25.29 39.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.51 -0.743 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -99.51 -27.68 13.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.722 -0.611 . . . . 0.0 110.287 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 107.36 45.27 1.17 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.788 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -107.87 126.59 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.668 -0.901 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.33 101.97 1.08 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.545 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.48 -57.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.805 ' HB2' HG22 ' A' ' 56' ' ' THR . 62.5 mt-10 -149.49 169.19 21.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.465 -1.02 . . . . 0.0 110.634 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.521 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 50.1 m95 -159.76 121.0 3.18 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.4 p -143.08 132.13 23.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.593 -0.692 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.1 t80 -96.8 144.32 26.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.042 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.15 99.76 7.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.0 -5.32 25.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.651 -0.655 . . . . 0.0 111.499 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.86 20.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -129.01 8.22 5.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.625 -0.672 . . . . 0.0 110.131 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 15.9 mmtm 53.78 41.57 32.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.2 m -126.44 130.91 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.596 -0.69 . . . . 0.0 110.69 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 69.6 m-85 -88.32 -173.61 4.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.503 -0.748 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -154.14 102.57 2.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.99 -1.069 . . . . 0.0 108.664 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.521 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 5.9 p -115.91 141.81 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 111.19 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.9 t -141.08 -174.23 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.961 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.242 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 ' CE2' ' A' ' 4' ' ' PHE . 24.7 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 m -75.85 103.8 6.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.517 -0.739 . . . . 0.0 110.078 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 57.0 m-85 -86.99 140.46 29.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.615 -0.678 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.919 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.1 mptt -107.23 -168.01 1.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 53' ' ' PHE . 11.8 tp -163.56 100.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 110.158 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CD1' HG21 ' A' ' 52' ' ' THR . 16.4 mt -83.54 132.46 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' VAL . 7.1 mm -102.48 119.28 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.141 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.445 HD21 HG22 ' A' ' 54' ' ' THR . 21.5 m-20 -69.16 -26.68 64.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.449 -0.782 . . . . 0.0 110.307 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.19 37.49 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -102.56 -23.96 13.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.947 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' HD11 ' A' ' 40' ' ' ILE . 70.1 p -59.04 124.7 20.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.354 -0.841 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 50.63 27.21 2.82 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 110.133 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 1.7 ptmm? -46.3 124.56 5.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.217 -0.927 . . . . 0.0 111.873 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.17 -165.92 30.91 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' CG ' ' HB3' ' A' ' 5' ' ' LYS . 29.0 tt0 -132.99 67.53 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.727 -0.867 . . . . 0.0 110.049 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mt -60.25 138.48 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.422 -0.799 . . . . 0.0 109.849 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 5' ' ' LYS . 71.5 p -110.54 138.5 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.663 -0.648 . . . . 0.0 110.833 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -144.18 142.47 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 157.01 18.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.551 -0.718 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.57 167.15 11.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.55 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.41 -39.29 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 110.42 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.1 m-20 -162.31 174.62 12.57 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.67 -29.17 69.9 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.44 81.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.03 -42.97 72.25 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.12 -43.91 78.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.648 -0.657 . . . . 0.0 109.528 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.2 tt0 -58.12 -39.66 79.26 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -50.83 48.27 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.2 -39.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.2 m-85 -73.55 -37.5 65.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 11.8 mtpp -81.49 8.16 10.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.676 -0.64 . . . . 0.0 111.367 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -111.65 -46.86 3.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.442 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.301 9.2 t80 -52.99 -41.1 64.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.146 175.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.804 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.25 -49.15 78.12 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.783 -0.573 . . . . 0.0 109.753 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.65 -47.46 81.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.764 -0.585 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -23.46 29.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.578 -0.701 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.88 -30.21 10.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.731 -0.606 . . . . 0.0 110.004 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 112.68 50.7 0.55 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.804 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.3 mp -115.34 132.63 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.453 -1.028 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -168.12 98.16 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.722 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.31 -56.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.8 ' HB2' HG22 ' A' ' 56' ' ' THR . 37.2 mt-10 -149.01 169.22 21.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.458 -1.025 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.556 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 49.6 m95 -160.39 121.99 3.12 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -145.42 131.61 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.507 -0.746 . . . . 0.0 109.564 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.5 t80 -93.24 144.25 25.48 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.748 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 100.08 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.752 -0.592 . . . . 0.0 109.775 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.24 -4.81 23.56 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.84 -28.94 18.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.509 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -126.77 8.34 6.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.69 -0.631 . . . . 0.0 110.169 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.6 mmtt 53.91 38.6 29.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.146 -0.971 . . . . 0.0 110.318 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.43 HG21 ' CD1' ' A' ' 7' ' ' ILE . 45.5 m -127.53 143.63 51.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.67 -0.644 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.3 m-85 -96.37 -171.64 2.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.48 -0.763 . . . . 0.0 109.74 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.445 HG22 HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER -153.32 102.42 2.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.05 -1.031 . . . . 0.0 108.497 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.579 HG11 HD21 ' A' ' 6' ' ' LEU . 5.7 p -116.34 142.56 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.114 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.8 HG22 ' HB2' ' A' ' 43' ' ' GLU . 3.7 t -140.15 -177.28 4.93 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.283 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 78.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 m -153.06 102.24 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.763 -0.586 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 55.6 m-85 -93.38 154.03 18.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.681 -0.637 . . . . 0.0 110.291 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.879 ' HG2' HG22 ' A' ' 18' ' ' THR . 34.6 mttt -113.96 -171.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.7 tp -163.42 108.41 1.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.463 -0.773 . . . . 0.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -85.59 120.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 HD13 ' CG1' ' A' ' 55' ' ' VAL . 8.6 mm -86.97 109.43 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.784 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -96.65 50.77 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.504 -0.747 . . . . 0.0 110.22 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.59 -118.59 1.99 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.47 47.12 0.19 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.572 -0.957 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -136.45 -62.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.146 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 mt -91.88 -52.64 4.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.99 81.85 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.496 -0.753 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -173.55 46.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.51 66.82 1.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.618 -0.931 . . . . 0.0 110.2 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.3 tt -60.34 119.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 109.921 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.879 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.1 p -89.34 140.16 29.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 110.435 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -145.52 149.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.723 . . . . 0.0 110.421 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.7 155.19 19.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.666 -0.646 . . . . 0.0 110.415 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.05 162.47 13.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.577 -0.702 . . . . 0.0 110.208 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.92 -38.11 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.289 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -162.44 176.88 10.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.36 -29.55 70.55 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.852 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.35 65.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.819 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -63.66 -38.87 92.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.39 78.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.9 tt0 -58.62 -36.25 73.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.638 -0.664 . . . . 0.0 109.355 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -67.71 -52.58 35.99 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.52 -38.5 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -74.04 -35.77 64.34 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.2 mmmt -75.98 -1.03 23.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.767 -0.583 . . . . 0.0 111.462 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -109.01 -45.43 3.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.294 12.7 t80 -51.33 -31.97 23.76 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.52 -62.34 1.65 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.874 0.845 . . . . 0.0 108.88 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -55.35 -41.55 72.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.822 -0.549 . . . . 0.0 110.797 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.39 -26.83 5.39 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.626 -0.672 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.5 -54.3 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.98 62.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.311 1.0 OUTLIER -119.09 134.96 61.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 0.0 109.84 -177.275 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -167.17 104.44 0.54 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.836 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.11 -107.91 0.21 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.6 tp10 -113.24 175.58 5.38 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -1.029 . . . . 0.0 110.398 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.464 ' CE2' HG23 ' A' ' 55' ' ' VAL . 37.9 m95 -152.55 129.04 10.68 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.654 -0.654 . . . . 0.0 109.825 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.79 133.65 25.49 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.371 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.3 t80 -97.4 135.15 39.69 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.658 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -103.18 98.96 8.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.356 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.6 -6.1 28.9 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.663 -0.648 . . . . 0.0 111.648 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.94 -27.47 17.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -123.53 5.97 8.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt 54.57 36.31 25.57 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.166 -0.959 . . . . 0.0 110.162 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 5' ' ' LYS . 17.1 m -126.35 140.54 52.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 62.6 m-85 -93.24 -169.0 2.04 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.37 94.63 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -95.87 100.12 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.908 0.861 . . . . 0.0 111.023 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -80.44 169.4 17.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.188 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 2' ' ' THR . 59.9 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.109 0.48 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.611 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.2 m -76.42 91.0 3.26 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.2 m-85 -76.98 143.94 39.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.632 . . . . 0.0 110.073 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.724 ' HG3' HG22 ' A' ' 18' ' ' THR . 5.0 mptt -110.51 -171.22 1.79 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.628 -0.67 . . . . 0.0 109.88 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.773 HD22 ' CD1' ' A' ' 31' ' ' PHE . 37.3 tp -162.21 112.35 1.53 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -0.87 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.63 106.99 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 13' ' ' LEU . 1.6 mm -82.87 110.72 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.153 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.32 147.66 23.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.53 -0.731 . . . . 0.0 110.1 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.97 -144.07 14.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' THR . 22.3 pttm -120.02 -33.0 4.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.951 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 2.6 m -75.15 110.83 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.442 -0.786 . . . . 0.0 110.038 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 59.36 159.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.922 ' N ' HD12 ' A' ' 13' ' ' LEU . 7.5 ptmt -169.99 127.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 179.13 37.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.74 69.37 1.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.704 -0.88 . . . . 0.0 109.941 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.4 pt -61.68 177.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.563 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.724 HG22 ' HG3' ' A' ' 5' ' ' LYS . 67.0 p -139.48 133.1 30.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.529 -0.732 . . . . 0.0 110.509 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -141.97 131.17 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.539 -0.726 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.89 156.08 32.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.11 163.79 13.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.649 -0.657 . . . . 0.0 110.207 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.6 -39.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.44 -0.787 . . . . 0.0 110.521 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -162.35 174.87 12.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.724 -0.61 . . . . 0.0 109.369 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.54 -27.71 66.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.466 -0.771 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -53.3 59.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HG3' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.67 -42.81 98.0 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.28 -49.29 72.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.624 -0.672 . . . . 0.0 109.618 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.13 -36.24 72.65 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.523 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -69.73 -53.75 16.98 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.7 -36.35 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.1 m-85 -75.44 -35.76 60.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -80.69 4.56 18.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.705 -0.622 . . . . 0.0 111.401 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -109.95 -45.38 3.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 3.9 t80 -53.51 -43.25 68.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.092 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.82 -49.31 78.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.816 -0.553 . . . . 0.0 110.178 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -57.21 -47.83 80.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.548 -0.72 . . . . 0.0 110.68 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -56.81 -22.6 37.51 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.646 -0.659 . . . . 0.0 110.987 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -102.9 -26.72 13.01 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.566 -0.709 . . . . 0.0 110.504 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.48 29.37 3.68 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.757 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.08 104.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -142.53 106.33 4.69 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.251 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.3 -103.15 0.18 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -107.46 176.29 5.21 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.44 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 44.1 m95 -156.92 128.79 7.19 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.71 -0.619 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.36 132.56 21.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 t80 -95.84 142.24 28.33 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.696 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -112.69 99.56 8.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.69 -0.632 . . . . 0.0 109.775 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -70.64 -4.6 24.21 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.611 -0.681 . . . . 0.0 111.456 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.67 -27.87 18.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 109.579 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -127.92 7.71 6.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp 54.53 40.68 32.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.165 -0.96 . . . . 0.0 110.194 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.3 m -129.81 139.92 51.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.663 -0.648 . . . . 0.0 110.335 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.2 m-85 -93.42 -168.39 1.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.894 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.13 98.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.5 p -102.49 119.43 50.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 122.035 0.921 . . . . 0.0 111.015 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -100.24 169.84 8.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.33 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 2' ' ' THR . 87.3 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.093 0.473 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.3 m -77.26 90.1 3.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.0 m-85 -74.11 141.12 45.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.619 -0.675 . . . . 0.0 109.956 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' THR . 21.3 mtmt -104.64 -177.54 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.62 -0.675 . . . . 0.0 110.238 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -164.34 118.16 1.4 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 110.826 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.9 mt -89.77 118.14 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mm -86.47 108.23 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.692 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -90.39 144.11 26.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 163.02 18.37 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -60.53 -26.65 67.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.647 -0.914 . . . . 0.0 110.379 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -76.16 125.62 29.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.595 -0.691 . . . . 0.0 110.074 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.795 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 56.09 169.04 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.569 -0.707 . . . . 0.0 110.561 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -179.64 90.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.77 -166.86 34.49 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -105.14 -42.23 5.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.713 -0.875 . . . . 0.0 110.441 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt 53.65 85.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.343 -0.848 . . . . 0.0 110.376 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.2 p -84.1 126.23 32.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.601 -0.687 . . . . 0.0 110.338 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -134.91 143.92 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.493 -0.754 . . . . 0.0 110.668 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.86 152.32 25.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.65 7.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.612 -0.68 . . . . 0.0 110.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.32 -39.3 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.357 -0.839 . . . . 0.0 110.582 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -159.29 178.8 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.39 -27.31 69.22 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.806 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.25 -54.93 39.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.552 -0.718 . . . . 0.0 109.854 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.14 -42.92 99.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.726 -0.609 . . . . 0.0 109.371 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.11 -46.01 68.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.359 -0.838 . . . . 0.0 109.836 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.09 -38.21 82.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.665 . . . . 0.0 109.284 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -54.94 -42.29 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 109.391 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.1 m-85 -70.52 -37.94 74.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 0.0 109.573 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 44' ' ' TRP . 11.1 mmtt -76.78 1.09 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.658 -0.651 . . . . 0.0 111.49 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -104.28 -46.54 4.38 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.307 8.1 t80 -46.1 -50.85 14.87 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.206 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.744 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.37 -54.16 47.27 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.64 -46.54 77.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.608 -0.682 . . . . 0.0 110.739 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.45 -16.92 51.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.631 -0.668 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' HB3' HD13 ' A' ' 40' ' ' ILE . 20.9 t-20 -108.43 -27.87 9.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.464 -0.773 . . . . 0.0 110.691 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 114.24 30.82 2.37 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -101.62 113.49 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.473 -1.016 . . . . 0.0 109.031 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.49 109.19 3.46 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.27 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.82 -95.59 0.11 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.2 tt0 -126.04 123.07 37.62 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -1.073 . . . . 0.0 111.55 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.55 ' NE1' HG23 ' A' ' 55' ' ' VAL . 37.3 m95 -103.5 137.1 42.04 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.583 -0.698 . . . . 0.0 110.403 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -147.38 131.87 17.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.666 . . . . 0.0 109.245 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.8 t80 -95.75 143.43 27.0 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.773 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -113.92 101.52 9.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.647 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.36 -3.81 22.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.619 -0.676 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.36 -27.59 20.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.5 p -130.96 9.5 4.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.617 -0.677 . . . . 0.0 110.162 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.2 mmtt 53.6 41.89 32.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -127.8 140.05 52.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.637 -0.664 . . . . 0.0 110.294 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 67.2 m-85 -93.67 -170.82 2.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 109.708 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.86 99.48 1.54 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.9 p -102.61 109.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.999 0.904 . . . . 0.0 111.195 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.49 172.94 9.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.032 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 2' ' ' THR . 79.5 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.153 0.502 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 18' ' ' THR . 6.3 m -72.8 89.39 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.48 -0.763 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -76.83 143.18 39.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.658 -0.651 . . . . 0.0 109.943 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.845 ' HG2' HG22 ' A' ' 18' ' ' THR . 32.0 mtmt -104.53 -176.41 3.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 31' ' ' PHE . 2.2 tp -166.8 108.92 0.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.522 -0.736 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mt -89.06 117.5 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.8 mp -87.32 119.6 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.253 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -96.61 149.58 21.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.11 -127.65 7.06 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.2 -41.23 0.9 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.549 -0.971 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 m -63.16 99.61 0.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.57 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.269 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.68 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.5 ptpt -162.69 105.91 1.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.7 161.94 29.43 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.08 58.45 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.717 -0.872 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 11.2 pt -52.49 145.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.149 -0.969 . . . . 0.0 110.382 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.845 HG22 ' HG2' ' A' ' 5' ' ' LYS . 81.4 p -113.59 139.66 48.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.537 -0.727 . . . . 0.0 110.956 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -146.72 132.64 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 110.456 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -70.47 154.66 41.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.0 110.186 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.06 157.73 9.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.669 . . . . 0.0 110.354 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 26' ' ' GLU . 8.9 p -54.89 -34.21 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.549 -0.72 . . . . 0.0 110.502 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.0 p30 -165.72 178.43 6.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.39 -29.74 70.8 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.569 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -47.24 84.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' HD11 ' A' ' 30' ' ' ILE . 30.8 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -46.19 81.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.52 -0.738 . . . . 0.0 109.546 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.5 tt0 -58.69 -35.78 73.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.353 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.74 26.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 26' ' ' GLU . 34.3 mt -58.18 -34.77 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.882 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.6 m-85 -77.48 -36.22 52.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 22.4 mttt -78.04 1.79 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.778 -0.576 . . . . 0.0 111.219 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.56 -45.4 3.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 177.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.294 10.9 t80 -53.76 -42.96 68.78 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.753 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.22 -47.34 86.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.183 0.516 . . . . 0.0 109.902 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.67 -48.8 78.51 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.634 -0.666 . . . . 0.0 110.549 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.06 -22.47 27.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.571 -0.705 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.414 ' CB ' HD13 ' A' ' 40' ' ' ILE . 25.5 m-80 -103.29 -25.42 13.33 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.639 -0.663 . . . . 0.0 110.671 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.05 30.62 4.13 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.9 107.23 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.68 -0.894 . . . . 0.0 109.004 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -146.08 100.52 3.4 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.23 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.68 -105.48 0.24 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tp10 -105.28 177.61 4.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.399 -1.059 . . . . 0.0 110.507 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.4 m95 -155.68 130.94 9.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.656 -0.653 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -144.85 132.2 20.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 109.264 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.7 t80 -98.49 138.1 36.19 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.93 99.82 9.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.652 -0.655 . . . . 0.0 109.551 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.31 -4.89 24.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.693 -0.629 . . . . 0.0 111.533 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.86 -28.4 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.654 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -128.76 8.5 5.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 110.234 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 31.6 mmtt 54.08 40.77 31.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.263 -0.898 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -125.17 133.67 52.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 110.628 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' HD12 ' A' ' 6' ' ' LEU . 75.1 m-85 -90.57 -172.39 3.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.613 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.12 98.29 1.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.6 p -102.02 109.46 26.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 122.122 0.963 . . . . 0.0 111.376 -178.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 169.17 12.45 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.156 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.524 HG22 ' CE2' ' A' ' 4' ' ' PHE . 62.9 m . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.619 HG22 ' HB ' ' A' ' 18' ' ' THR . 11.5 m -90.55 103.85 16.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.581 -0.699 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 59.8 m-85 -86.32 152.19 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.943 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -115.9 -164.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.653 -0.655 . . . . 0.0 109.502 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 31' ' ' PHE . 58.4 tp -168.12 108.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 110.336 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 105.55 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CG1' ' A' ' 55' ' ' VAL . 2.7 mm -77.52 99.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.087 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -85.05 63.39 8.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.982 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.7 -129.01 2.63 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 23.66 0.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.636 -0.92 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 10.38 3.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.344 -0.847 . . . . 0.0 110.737 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.1 mt -172.32 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.324 -0.86 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -52.6 103.82 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.229 -0.92 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.81 -177.83 48.15 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -137.0 64.8 1.52 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.636 -0.92 . . . . 0.0 110.173 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 HD12 ' OH ' ' A' ' 34' ' ' TYR . 95.1 mt -62.88 136.41 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.44 -0.787 . . . . 0.0 109.55 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.943 HG22 ' CG ' ' A' ' 5' ' ' LYS . 64.3 p -103.42 136.89 42.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.228 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.29 136.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.367 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.78 152.49 33.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.131 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -166.53 159.64 14.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.473 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.57 -40.11 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.576 -0.703 . . . . 0.0 110.568 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.4 173.08 17.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.43 -29.87 70.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -44.57 84.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.519 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 2.5 tp10 -69.97 -43.68 71.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.98 -41.12 77.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.667 . . . . 0.0 109.605 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.0 tt0 -60.27 -39.0 85.29 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.398 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -68.96 -48.84 62.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.58 -37.02 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.517 -0.739 . . . . 0.0 109.018 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.3 m-85 -76.89 -38.24 53.93 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.203 0.525 . . . . 0.0 109.652 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 24.5 mtpt -76.79 0.7 19.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.582 -0.699 . . . . 0.0 111.305 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -108.68 -44.72 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.283 6.6 t80 -53.0 -45.53 67.94 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.979 176.17 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -65.65 -57.53 7.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.775 -0.578 . . . . 0.0 109.871 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -58.32 -46.48 86.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.709 -0.619 . . . . 0.0 110.795 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -54.12 -23.93 15.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.5 -0.75 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.439 ' HB3' HD13 ' A' ' 40' ' ' ILE . 23.6 t-20 -105.64 -30.37 9.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 110.155 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 117.09 32.67 1.48 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.731 HG22 HG21 ' A' ' 55' ' ' VAL . 1.8 mp -102.41 74.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.401 -1.058 . . . . 0.0 108.617 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.95 -164.43 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . 114.41 -173.8 15.09 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.885 -1.15 . . . . 0.0 111.546 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -73.57 -178.09 2.95 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.794 -0.827 . . . . 0.0 109.512 179.347 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.415 ' CE2' ' HG2' ' A' ' 32' ' ' LYS . 24.6 m95 -151.74 128.56 10.92 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.655 -0.653 . . . . 0.0 109.67 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.5 p -142.3 137.36 30.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.7 -0.625 . . . . 0.0 109.442 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.2 t80 -97.37 147.29 24.33 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.548 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -116.35 100.64 8.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.2 -4.65 26.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.613 -0.679 . . . . 0.0 111.33 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.22 -26.81 18.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -128.03 7.02 6.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.66 -0.65 . . . . 0.0 110.13 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 54.74 39.74 31.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.2 -0.937 . . . . 0.0 110.165 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 63.9 m -130.27 143.38 50.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 0.0 110.714 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.8 m-85 -96.75 -168.14 1.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -160.96 117.76 2.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.77 -1.206 . . . . 0.0 108.966 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 40' ' ' ILE . 1.4 p -110.62 110.77 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.135 0.969 . . . . 0.0 109.169 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.635 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -96.36 87.69 4.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.823 0.821 . . . . 0.0 110.125 -178.078 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.501 2.12 0 O-C-N 120.782 -1.199 . . . . 0.0 110.193 -179.636 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.3 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.045 0.45 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -76.8 103.47 6.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.564 -0.71 . . . . 0.0 110.245 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.8 m-85 -84.56 130.5 34.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.597 -0.689 . . . . 0.0 110.182 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CG ' HG22 ' A' ' 18' ' ' THR . 6.6 mptt -98.83 172.66 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 109.603 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 ' CD1' ' A' ' 31' ' ' PHE . 34.7 tp -143.76 106.06 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.428 -0.795 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.3 mt -81.64 115.04 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.62 HG13 HD11 ' A' ' 13' ' ' LEU . 2.1 mm -87.62 113.66 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.461 -178.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -101.21 75.94 1.68 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.453 -0.779 . . . . 0.0 110.544 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.33 -152.02 6.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -110.39 -27.25 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.957 . . . . 0.0 110.262 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 7.8 p -79.73 102.24 8.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 109.824 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.8 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.168 0.508 . . . . 0.0 109.635 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 3.0 mtpm? -142.55 137.24 30.0 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.258 -0.901 . . . . 0.0 111.057 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.06 -165.41 22.45 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.26 158.19 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.87 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.8 mp -116.57 -16.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' CG ' ' A' ' 5' ' ' LYS . 60.2 p 45.53 96.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.557 -0.714 . . . . 0.0 111.655 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.453 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -130.14 132.99 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.53 157.46 30.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.531 -0.731 . . . . 0.0 109.937 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.8 168.84 12.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.553 -0.717 . . . . 0.0 110.289 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.37 -35.51 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 0.0 110.487 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 22' ' ' VAL . 32.1 p30 -166.5 172.81 10.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.294 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.74 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.98 -31.18 71.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.317 -0.864 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.0 81.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.745 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.16 -43.17 74.82 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.95 77.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.45 -0.782 . . . . 0.0 109.717 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.5 tt0 -59.16 -36.82 75.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.581 -0.699 . . . . 0.0 109.334 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -69.53 -51.4 36.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.7 -39.42 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.837 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.5 m-85 -72.95 -37.47 67.11 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.52 1.95 17.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.694 -0.629 . . . . 0.0 111.377 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -109.19 -45.54 3.73 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 4.4 t80 -53.21 -40.31 64.37 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.151 176.542 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.08 -55.13 36.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.846 -0.534 . . . . 0.0 110.191 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.89 -48.79 80.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.709 -0.619 . . . . 0.0 110.662 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.14 -22.8 18.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -0.784 . . . . 0.0 111.06 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -103.1 -35.19 8.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.553 -0.717 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 122.33 36.32 0.7 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.788 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -103.72 119.77 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -1.066 . . . . 0.0 109.06 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -149.1 108.48 3.96 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.264 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.01 -109.64 0.22 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -111.06 176.58 4.97 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.489 -1.006 . . . . 0.0 110.526 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.9 m95 -154.29 130.54 10.41 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.61 -0.682 . . . . 0.0 109.838 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.8 p -144.28 132.58 21.9 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.2 t80 -97.57 132.79 42.91 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.75 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -102.07 99.31 9.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.685 -0.635 . . . . 0.0 109.361 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.21 -7.15 33.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.02 -28.9 18.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -122.02 5.6 9.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.676 -0.64 . . . . 0.0 110.183 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 54.76 35.96 25.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 38.4 m -126.61 143.76 51.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.614 -0.679 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.9 m-85 -94.93 -170.35 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 0.0 110.036 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -155.72 92.66 1.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.611 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.9 p -95.89 104.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.888 0.852 . . . . 0.0 111.053 -178.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 169.73 13.6 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 178.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.202 -179.92 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 99.8 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.683 0.278 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 m 50.24 90.64 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.112 -0.992 . . . . 0.0 111.082 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 16.2 m-85 -89.14 139.17 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.089 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.857 ' HG2' HG22 ' A' ' 18' ' ' THR . 23.2 mttt -99.22 -173.7 2.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.775 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.868 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.6 tp -158.99 105.56 1.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.374 -0.829 . . . . 0.0 110.015 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 52' ' ' THR . 12.8 mt -85.9 130.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.683 HG21 ' HG ' ' A' ' 13' ' ' LEU . 14.5 mm -95.54 113.83 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.711 -179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.69 -23.84 62.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.175 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.28 149.12 46.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.52 -25.01 66.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.685 -0.891 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -86.82 166.72 14.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.745 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.683 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.3 OUTLIER 41.0 27.05 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.81 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -52.24 134.8 33.22 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 111.253 -178.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.11 175.42 38.42 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.111 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -140.48 42.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.3 pt -50.26 148.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.522 -0.736 . . . . 0.0 111.165 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.857 HG22 ' HG2' ' A' ' 5' ' ' LYS . 76.0 p -111.97 141.04 46.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.051 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.537 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -138.37 134.75 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.738 . . . . 0.0 110.744 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.99 139.12 42.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.723 -0.611 . . . . 0.0 109.997 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.06 34.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 110.436 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -54.08 -39.55 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.511 -0.743 . . . . 0.0 110.325 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -160.02 -179.81 8.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.547 -0.721 . . . . 0.0 109.32 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.02 -31.17 72.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.731 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -54.15 -57.68 10.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 0.0 109.976 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -59.63 -40.91 89.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.63 -0.669 . . . . 0.0 109.783 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.73 . . . . 0.0 109.732 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 15.4 tt0 -60.54 -47.31 86.75 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.371 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -51.32 69.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.949 . . . . 0.0 109.958 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.51 -45.87 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.46 -0.775 . . . . 0.0 109.415 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.868 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -68.85 -37.49 79.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -76.03 1.95 14.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.777 -0.577 . . . . 0.0 111.441 179.454 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -107.08 -45.12 4.22 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 177.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 2.2 t80 -50.42 -38.28 42.33 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.838 176.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -63.86 -49.55 72.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.248 0.547 . . . . 0.0 109.825 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -60.22 -46.3 90.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.709 -0.619 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.99 -22.86 29.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.51 -0.744 . . . . 0.0 110.826 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -103.8 -24.35 13.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.675 -0.641 . . . . 0.0 110.468 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.33 44.03 1.65 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.797 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -104.18 135.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.908 . . . . 0.0 109.705 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -167.61 97.63 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.77 -65.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.645 ' HB2' HG22 ' A' ' 56' ' ' THR . 9.0 mt-10 -154.65 173.58 16.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.551 -0.97 . . . . 0.0 110.171 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 52.1 m95 -155.05 123.84 6.13 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.66 -0.65 . . . . 0.0 109.803 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -139.03 133.76 32.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.677 . . . . 0.0 109.289 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.4 t80 -96.15 136.92 35.96 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.851 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -105.15 99.58 9.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.666 . . . . 0.0 109.281 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.7 -4.51 23.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.606 . . . . 0.0 111.603 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.27 -26.58 17.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -126.55 7.82 6.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 110.135 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.6 mmtp 53.4 38.61 28.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.115 -0.99 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 7' ' ' ILE . 6.5 m -128.56 135.03 48.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.699 -0.626 . . . . 0.0 110.617 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 56.8 m-85 -87.52 -170.5 3.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.348 -0.845 . . . . 0.0 109.795 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.67 104.24 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.031 -1.043 . . . . 0.0 108.211 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.3 p -111.43 132.61 59.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.567 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -125.66 -177.41 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.268 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.245 0.545 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.8 m -90.23 112.16 23.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 49.7 m-85 -97.8 150.04 21.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.632 -0.668 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.942 ' CG ' HG22 ' A' ' 18' ' ' THR . 4.5 mptt -113.24 -167.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.706 -0.621 . . . . 0.0 109.83 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.736 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -167.33 100.38 0.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.487 -0.758 . . . . 0.0 110.145 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.2 mt -82.58 129.18 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.505 HG13 HD11 ' A' ' 13' ' ' LEU . 10.1 mm -99.91 115.93 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.234 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.491 ' OD1' HG22 ' A' ' 54' ' ' THR . 2.1 m-20 -80.75 -158.96 0.21 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.383 -0.823 . . . . 0.0 109.177 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.97 -129.19 47.72 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -148.07 25.54 1.01 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.909 . . . . 0.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 30.4 p -103.74 113.82 27.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.669 HD23 HG12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 67.43 -51.2 0.5 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.852 -0.53 . . . . 0.0 111.683 179.964 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 11.4 mmmt 49.17 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.616 -1.303 . . . . 0.0 111.543 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.79 170.13 43.24 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.38 55.94 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.77 -0.841 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.523 HG23 ' HE1' ' A' ' 31' ' ' PHE . 4.2 tp -59.32 133.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.519 -0.738 . . . . 0.0 110.373 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.942 HG22 ' CG ' ' A' ' 5' ' ' LYS . 53.0 p -98.94 140.13 33.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.647 -0.658 . . . . 0.0 110.079 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.449 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.1 147.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.532 -0.73 . . . . 0.0 110.469 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -90.96 153.36 20.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.592 -0.693 . . . . 0.0 110.152 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.48 164.05 14.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.484 -0.76 . . . . 0.0 110.58 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.3 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.542 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.5 p30 -162.28 174.33 12.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.92 -30.03 68.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.94 73.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.402 -0.811 . . . . 0.0 109.8 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.89 -40.22 91.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -55.89 -45.33 78.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.1 tt0 -58.45 -37.86 76.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.607 -0.683 . . . . 0.0 109.342 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -68.68 -50.64 49.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.27 -39.66 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.736 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.3 m-85 -73.36 -36.67 66.17 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 32.9 mtpt -75.62 -0.55 20.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.663 -0.648 . . . . 0.0 111.493 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -105.94 -45.58 4.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 177.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 1.2 t80 -52.81 -40.71 63.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.837 176.123 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -61.73 -47.52 84.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.825 -0.547 . . . . 0.0 109.942 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -59.0 -47.6 84.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.581 -0.7 . . . . 0.0 110.432 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -54.28 -25.15 21.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HB2' HD13 ' A' ' 40' ' ' ILE . 10.8 m120 -101.42 -24.59 14.16 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.784 -0.573 . . . . 0.0 110.535 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.47 36.27 3.11 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.777 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.39 116.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.614 -0.933 . . . . 0.0 109.489 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -158.06 101.71 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.13 -64.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.841 ' HB2' HG22 ' A' ' 56' ' ' THR . 68.8 mm-40 -129.56 169.03 15.53 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.48 -1.012 . . . . 0.0 110.952 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.9 m95 -162.85 118.78 1.83 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.44 132.78 21.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.399 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -93.56 144.52 25.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.9 97.8 6.61 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.88 -5.84 28.64 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.685 -0.634 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.77 -27.03 17.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -123.98 6.18 8.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.061 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 17.4 mmtt 54.18 39.93 31.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 110.077 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 5' ' ' LYS . 33.4 m -134.71 140.29 45.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 0.0 110.744 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' A' ' 6' ' ' LEU . 46.3 m-85 -93.62 -170.73 2.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.311 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.491 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.2 OUTLIER -157.04 102.95 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.485 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.4 p -116.1 144.71 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.92 -178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.841 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.7 t -143.22 -172.39 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.595 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.436 -0.79 . . . . 0.0 110.199 179.995 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 2' ' ' THR . 49.8 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.935 0.398 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.571 HG22 ' HB ' ' A' ' 18' ' ' THR . 21.6 m -60.12 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.415 -0.803 . . . . 0.0 109.841 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.528 ' CD2' HG22 ' A' ' 2' ' ' THR . 4.7 m-85 -85.49 147.51 26.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.715 -0.616 . . . . 0.0 110.129 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.847 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.46 -171.56 1.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.607 -0.683 . . . . 0.0 109.908 -179.907 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.733 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.7 tp -160.08 112.43 2.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.305 -0.872 . . . . 0.0 110.841 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mt -85.35 119.91 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 13' ' ' LEU . 5.4 mm -93.84 114.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.008 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -102.22 144.6 30.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.545 -0.722 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.68 -135.78 9.38 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -131.38 29.66 4.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.93 . . . . 0.0 110.191 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 14' ' ' LYS . 8.7 p -139.4 147.3 41.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.813 HD12 HG12 ' A' ' 40' ' ' ILE . 6.5 mt 60.9 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.784 -0.572 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' THR . 6.1 mtmm 54.72 98.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.47 -0.769 . . . . 0.0 110.56 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.92 177.36 40.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.88 55.76 1.88 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.655 -0.909 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 pt -58.19 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.5 p -128.81 138.76 52.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.531 -0.73 . . . . 0.0 110.188 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.51 138.84 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.734 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.61 128.58 33.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 109.538 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.45 -163.06 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.07 -59.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.29 -174.73 4.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.78 79.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.611 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.56 31.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.619 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -56.11 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.635 . . . . 0.0 109.868 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -49.81 -42.27 46.65 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.455 -0.778 . . . . 0.0 110.376 179.24 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.4 tt0 -60.57 -35.15 75.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.56 -0.713 . . . . 0.0 109.236 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -72.57 -46.82 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 27' ' ' ALA . 61.6 mt -59.31 -36.94 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -76.96 -35.4 57.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 6.1 mtpt -77.3 0.93 20.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.773 -0.579 . . . . 0.0 111.357 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -107.31 -45.46 4.09 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.291 5.5 t80 -52.46 -35.24 52.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.783 176.211 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -71.02 -51.39 25.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.276 0.56 . . . . 0.0 109.946 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.31 -47.43 85.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.635 -0.666 . . . . 0.0 110.396 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -22.64 19.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.571 -0.706 . . . . 0.0 111.11 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -104.52 -31.8 9.28 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 118.7 34.64 1.05 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.813 HG12 HD12 ' A' ' 13' ' ' LEU . 1.6 mp -102.13 110.18 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.456 -1.026 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -143.36 111.76 6.31 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.25 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.64 -110.03 0.23 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tp10 -107.93 179.11 4.32 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.367 -1.078 . . . . 0.0 110.4 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -155.19 129.45 8.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.575 -0.703 . . . . 0.0 109.856 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.0 p -141.94 133.05 26.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.548 -0.72 . . . . 0.0 109.177 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.5 t80 -98.48 134.48 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.889 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -104.23 98.92 8.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -71.13 -3.81 21.97 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.612 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.75 -25.1 17.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.729 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 p -128.66 5.62 5.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.612 -0.68 . . . . 0.0 110.296 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 74.1 mmtt 55.89 42.81 28.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.164 -0.96 . . . . 0.0 109.679 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 124.89 32.92 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.869 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 82.8 m-85 -81.28 -171.3 3.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -0.75 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.6 90.42 1.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -92.64 100.25 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.005 0.907 . . . . 0.0 110.927 -178.579 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -80.12 171.39 15.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.67 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.6 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.074 0.464 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -73.3 109.56 6.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.877 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 2' ' ' THR . 78.7 m-85 -87.93 145.44 26.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.555 -0.716 . . . . 0.0 110.646 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.809 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.6 OUTLIER -108.94 -173.95 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.892 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.4 tp -167.65 110.14 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.285 -0.885 . . . . 0.0 110.681 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 52' ' ' THR . 3.6 mp -95.55 113.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' HA ' HG13 ' A' ' 55' ' ' VAL . 1.2 mm -84.13 104.05 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.94 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -86.52 144.6 27.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.554 -0.716 . . . . 0.0 110.17 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.55 -140.77 12.0 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.28 29.74 5.51 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.664 -0.904 . . . . 0.0 110.176 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' LYS . 10.4 p -138.05 138.02 38.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 40' ' ' ILE . 5.7 mt 60.9 -77.3 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.762 -0.586 . . . . 0.0 111.027 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' THR . 15.5 mtpt 54.37 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.339 -0.85 . . . . 0.0 110.738 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.62 -175.77 41.58 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -108.43 -57.88 2.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.577 -0.954 . . . . 0.0 110.367 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.9 mm 53.6 72.75 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.809 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.6 p -69.64 137.36 52.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.598 -0.689 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -145.51 147.4 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.562 -0.711 . . . . 0.0 110.572 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.73 162.08 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.605 -0.685 . . . . 0.0 109.936 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 26' ' ' GLU . . . -169.35 171.16 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.1 p -53.08 -39.06 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.494 -0.754 . . . . 0.0 110.401 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.5 p30 -160.67 -175.18 4.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -70.38 -31.23 68.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.19 -49.3 74.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.593 -0.692 . . . . 0.0 109.921 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tt0 -63.09 -43.64 97.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.403 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.35 -45.06 69.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -59.12 -36.27 74.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 109.348 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.72 -54.85 16.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.52 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.49 -40.34 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.892 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -72.07 -34.7 68.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -78.52 1.25 23.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.693 -0.629 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -104.22 -46.14 4.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 4.4 t80 -47.36 -51.98 17.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.906 175.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.721 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -67.74 -50.19 58.62 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.659 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.06 -49.92 72.41 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.72 . . . . 0.0 110.899 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.86 -21.46 29.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.603 -0.685 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -102.72 -27.76 12.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.572 -0.705 . . . . 0.0 110.576 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.67 29.25 3.67 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.721 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.41 106.01 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 108.756 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -141.71 114.89 8.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.35 0.595 . . . . 0.0 111.016 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.76 -100.78 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.7 tt0 -115.31 170.74 8.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -1.002 . . . . 0.0 110.035 179.54 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 40.6 m95 -152.6 122.95 7.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.505 -0.747 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 25.3 p -138.22 128.57 26.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.5 t80 -94.24 141.7 28.26 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.654 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -111.82 100.92 9.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.1 -2.68 16.46 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.616 -0.678 . . . . 0.0 111.745 -179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -28.69 21.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -136.69 15.39 3.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.695 . . . . 0.0 109.906 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER 48.28 45.34 20.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.487 179.662 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 7' ' ' ILE . 26.2 m -121.18 120.84 36.38 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.54 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.3 m-85 -85.35 172.81 10.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -139.78 97.16 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -97.68 107.53 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 122.007 0.908 . . . . 0.0 110.682 -178.728 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -92.02 170.1 10.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.286 -179.952 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.4 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.073 0.463 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.5 m 51.03 88.05 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.375 -0.828 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -90.04 149.46 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.228 178.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.899 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.5 OUTLIER -110.19 -173.93 2.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 110.389 -179.634 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.7 tp -160.98 108.97 1.54 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.634 -0.666 . . . . 0.0 109.986 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.5 mm -87.42 129.89 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' LEU . 2.1 mm -101.91 116.39 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.67 -179.309 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.637 HD21 HG22 ' A' ' 54' ' ' THR . 15.1 m-20 -76.05 -29.31 57.99 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.84 -175.91 4.92 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -114.85 25.55 10.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.618 -0.931 . . . . 0.0 110.486 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -96.04 -33.72 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.46 -0.775 . . . . 0.0 109.964 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 40' ' ' ILE . 9.7 mt -121.96 -54.09 1.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.696 -0.628 . . . . 0.0 109.772 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt 52.66 82.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.539 -0.726 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.99 -175.54 46.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.47 -50.07 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.797 -0.825 . . . . 0.0 109.966 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.0 mm 54.12 83.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.899 HG22 ' CG ' ' A' ' 5' ' ' LYS . 62.0 p -76.94 142.14 40.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.626 -0.671 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -143.69 131.5 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.488 -0.758 . . . . 0.0 111.187 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -66.93 131.15 45.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 110.068 179.606 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.32 150.11 31.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.0 p -53.26 -39.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.546 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.4 p30 -158.13 177.18 11.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.68 -33.11 74.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.415 -0.803 . . . . 0.0 109.642 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.581 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.71 -44.09 81.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.562 -0.711 . . . . 0.0 109.723 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' OE1' HD11 ' A' ' 30' ' ' ILE . 2.1 tt0 -70.62 -44.19 67.72 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.086 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.98 80.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.571 -0.706 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.8 tt0 -57.98 -37.54 74.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.648 -0.658 . . . . 0.0 109.401 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -51.57 32.62 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.513 HD11 ' OE1' ' A' ' 26' ' ' GLU . 22.3 mt -58.48 -35.56 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -77.24 -35.55 55.36 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -73.85 -2.9 25.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.75 -0.594 . . . . 0.0 111.211 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -103.24 -46.1 4.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.296 2.8 t80 -52.33 -32.43 38.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.692 175.627 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.49 -60.81 2.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.819 0.818 . . . . 0.0 108.896 178.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -57.19 -40.56 77.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.83 -0.544 . . . . 0.0 110.562 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.09 -27.95 3.78 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.616 -0.678 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -49.31 3.4 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.475 0.655 . . . . 0.0 109.861 179.253 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.53 64.95 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.753 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -118.81 129.3 75.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.949 -0.736 . . . . 0.0 110.389 -176.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.18 94.34 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.511 -0.743 . . . . 0.0 110.154 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.32 -44.95 0.02 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 56' ' ' THR . 15.0 tt0 -152.02 167.43 28.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.466 -1.02 . . . . 0.0 110.863 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 43.8 m95 -163.41 116.56 1.54 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -141.97 130.77 22.9 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.586 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -93.24 146.29 23.81 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.25 100.07 7.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.732 -0.605 . . . . 0.0 109.592 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -71.65 -2.78 18.43 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.668 -0.645 . . . . 0.0 111.505 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -25.82 18.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -131.54 8.74 4.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.482 -0.761 . . . . 0.0 110.174 179.36 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 54.41 45.11 27.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.193 -0.942 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.9 m -133.52 135.13 44.2 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.774 ' HB2' HD12 ' A' ' 6' ' ' LEU . 63.5 m-85 -90.74 -172.23 3.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.5 -0.75 . . . . 0.0 109.618 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 HD21 ' A' ' 9' ' ' ASN . 0.6 OUTLIER -156.16 97.68 1.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.98 -1.075 . . . . 0.0 108.712 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.3 p -112.5 146.31 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.138 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.84 HG22 ' HB3' ' A' ' 43' ' ' GLU . 6.2 t -145.28 -172.48 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.936 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.201 179.925 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.438 HG22 ' CE2' ' A' ' 4' ' ' PHE . 63.5 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.083 0.468 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.1 m -102.76 109.12 20.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.109 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.3 m-85 -93.16 141.92 27.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 110.301 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.836 ' HG3' HG22 ' A' ' 18' ' ' THR . 3.8 mptt -105.88 -166.21 1.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 0.0 109.35 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.861 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.4 tp -166.55 105.69 0.63 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.416 -0.803 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -81.34 118.43 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mm -89.86 101.3 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.609 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -76.1 -3.39 35.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.518 -0.739 . . . . 0.0 111.166 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.8 163.89 33.84 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.83 -27.42 68.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.478 -1.013 . . . . 0.0 110.64 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . 16.7 m -78.46 156.27 29.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.53 -0.731 . . . . 0.0 110.324 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.672 HD22 ' OH ' ' A' ' 34' ' ' TYR . 9.6 mt 59.71 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.865 -0.522 . . . . 0.0 111.188 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' THR . 1.0 OUTLIER 56.3 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.149 -0.969 . . . . 0.0 110.528 -179.766 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.53 -177.69 36.85 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -128.09 67.52 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -1.008 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 6.8 tp -62.72 126.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.735 . . . . 0.0 109.892 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.836 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.0 p -96.29 137.54 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.485 -0.76 . . . . 0.0 110.424 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -142.37 133.65 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.365 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -78.58 148.99 33.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.672 -0.643 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.63 163.97 32.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.604 -0.685 . . . . 0.0 110.246 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.8 -40.93 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.494 -0.753 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.42 172.55 18.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.28 -34.48 75.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.299 -0.875 . . . . 0.0 109.704 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.3 -49.47 69.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.62 -0.675 . . . . 0.0 109.796 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -40.87 96.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -56.11 -43.53 78.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.424 -0.797 . . . . 0.0 109.665 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 9.6 tt0 -59.82 -35.85 75.56 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -68.33 -51.13 47.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.3 mt -58.12 -40.96 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.861 ' CD1' HD22 ' A' ' 6' ' ' LEU . 14.3 m-85 -72.0 -36.66 69.82 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.5 mmmt -74.58 -2.44 25.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.615 -0.678 . . . . 0.0 111.182 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -105.41 -42.51 5.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.672 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.293 16.4 t80 -55.08 -19.47 7.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.734 175.785 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -89.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -53.06 -42.42 65.79 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.708 -0.62 . . . . 0.0 111.787 -178.672 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 39.5 p-10 -46.85 -27.54 1.27 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.461 -0.774 . . . . 0.0 111.612 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -108.74 -59.57 1.86 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.849 -0.532 . . . . 0.0 110.253 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.82 59.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.733 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.297 1.1 mm -116.49 130.52 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.742 -0.858 . . . . 0.0 109.532 -178.363 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -169.9 104.49 0.32 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.407 -0.808 . . . . 0.0 111.079 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.24 -63.22 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 32.7 mt-10 -152.7 171.37 18.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.567 -0.961 . . . . 0.0 110.143 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.9 m95 -155.03 124.89 6.57 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.669 -0.644 . . . . 0.0 110.009 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.2 p -144.45 132.82 21.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.627 -0.671 . . . . 0.0 109.532 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.1 t80 -93.08 148.73 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.67 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.68 100.08 6.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.742 -0.599 . . . . 0.0 109.879 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.79 -4.18 22.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.712 -0.617 . . . . 0.0 111.554 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.24 -28.0 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.9 p -128.82 8.33 5.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 110.083 179.304 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 15.9 mmtt 54.28 40.1 31.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.5 m -130.49 138.62 50.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 0.0 110.371 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 48.4 m-85 -91.33 -167.41 1.79 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -154.57 102.31 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.99 -1.069 . . . . 0.0 108.474 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.8 p -113.15 128.39 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.796 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -124.78 -178.69 4.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.769 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 2' ' ' THR . 60.8 m . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.111 0.482 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -71.27 93.31 1.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m-85 -81.98 139.5 34.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 110.178 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.811 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -105.08 -170.96 1.83 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.175 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.4 tp -165.04 108.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.601 -0.687 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -84.61 129.41 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.597 HD11 HD23 ' A' ' 6' ' ' LEU . 9.6 mm -93.22 114.31 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.082 -178.655 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.88 40.96 1.16 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.36 -151.17 6.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 12' ' ' THR . 10.2 ptmt -114.7 -28.82 6.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -1.013 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.1 p -79.88 113.71 18.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.25 144.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.277 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.4 ptpp? -151.27 140.16 20.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.225 -0.922 . . . . 0.0 111.073 -179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.53 -163.47 29.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 17' ' ' ILE . 5.4 mp0 -108.69 -42.76 4.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.883 . . . . 0.0 110.235 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.541 HD12 ' C ' ' A' ' 16' ' ' GLU . 5.3 mp 53.25 95.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.405 -0.809 . . . . 0.0 110.356 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' CG ' ' A' ' 5' ' ' LYS . 80.8 p -90.19 132.11 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.633 -0.667 . . . . 0.0 110.241 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.4 pp -143.42 130.22 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.512 -0.743 . . . . 0.0 110.478 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -71.22 157.72 37.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.55 161.4 11.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 110.165 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -53.75 -30.99 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.445 -0.785 . . . . 0.0 110.366 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.8 p30 -171.42 178.3 3.26 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.15 -30.61 71.55 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.612 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.67 81.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.502 -0.749 . . . . 0.0 109.704 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG3' HD11 ' A' ' 30' ' ' ILE . 19.9 tp10 -70.59 -44.64 66.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.63 -42.54 71.34 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.352 -0.842 . . . . 0.0 109.689 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -60.44 -41.13 93.41 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.044 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.11 -35.03 66.49 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.604 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 26' ' ' GLU . 52.8 mt -67.72 -40.78 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.639 ' HB3' HD13 ' A' ' 6' ' ' LEU . 12.7 m-85 -73.3 -38.3 65.91 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.7 mmmt -72.96 -4.98 35.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.602 -0.686 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -106.14 -45.12 4.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.29 5.5 t80 -51.62 -30.62 22.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.091 176.193 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -76.08 -50.11 15.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.608 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -57.54 -47.56 81.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 110.678 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -24.74 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB2' HD13 ' A' ' 40' ' ' ILE . 52.3 m-20 -102.75 -27.1 12.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.637 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 35.15 2.34 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.769 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.95 107.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.657 -0.908 . . . . 0.0 108.904 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.25 113.45 9.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.476 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.19 -109.77 0.22 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.9 tt0 -114.51 174.39 5.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -1.032 . . . . 0.0 110.347 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CE2' HG23 ' A' ' 55' ' ' VAL . 36.5 m95 -151.9 130.71 12.44 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.577 -0.702 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.2 p -142.89 133.17 24.66 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.298 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.4 t80 -95.12 145.37 25.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -117.8 98.11 6.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.792 -0.568 . . . . 0.0 109.488 179.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.63 -4.62 24.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.659 -0.65 . . . . 0.0 111.659 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -26.71 17.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 109.733 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -125.98 7.05 7.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.609 -0.682 . . . . 0.0 110.194 179.165 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 4' ' ' PHE . 3.9 mmtp 54.15 38.47 29.21 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.184 -0.947 . . . . 0.0 110.101 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.5 m -130.6 134.21 46.8 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.628 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' HD12 ' A' ' 6' ' ' LEU . 53.3 m-85 -88.27 -166.84 1.7 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.21 92.71 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.92 102.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.933 0.873 . . . . 0.0 111.316 -178.379 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -82.51 169.44 16.35 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 2' ' ' THR . 46.0 m . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 m -68.86 85.31 0.32 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.776 . . . . 0.0 109.983 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.6 m-85 -70.42 126.89 30.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.647 -0.658 . . . . 0.0 109.778 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 18' ' ' THR . 30.9 mttm -89.57 175.35 7.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.967 HD23 HD11 ' A' ' 8' ' ' ILE . 2.5 tp -156.54 112.5 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.643 -0.661 . . . . 0.0 109.839 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -90.8 114.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.967 HD11 HD23 ' A' ' 6' ' ' LEU . 2.3 mp -90.08 113.15 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.071 -178.829 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -92.61 149.93 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.432 -0.792 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.51 -108.52 1.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -166.28 47.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.584 -0.951 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.621 ' CG2' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -152.21 119.22 5.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 110.208 179.998 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 53.95 23.98 4.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.504 0.669 . . . . 0.0 110.312 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -46.97 109.0 0.16 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.007 -1.058 . . . . 0.0 111.468 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.79 -162.73 29.48 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.8 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -109.46 -33.58 6.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.617 -0.931 . . . . 0.0 110.719 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.463 ' C ' HG23 ' A' ' 18' ' ' THR . 28.2 mm 67.05 -61.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 O-C-N 121.699 -0.626 . . . . 0.0 110.834 -179.81 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 17' ' ' ILE . 1.3 p 62.37 112.63 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.344 -0.847 . . . . 0.0 110.427 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -143.24 132.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.765 -0.585 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.51 155.01 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 110.325 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.45 12.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.386 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.5 -39.65 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.535 -0.728 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.3 m-20 -159.27 177.05 11.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.646 -0.659 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.7 -32.16 73.71 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.383 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.3 82.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.632 -0.667 . . . . 0.0 109.807 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.41 -44.66 82.37 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -45.91 75.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 109.623 178.926 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 6.1 tt0 -59.26 -37.01 76.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.503 179.08 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -69.14 -51.26 40.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mt -58.26 -38.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.81 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.65 -39.36 62.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.145 0.498 . . . . 0.0 109.792 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -76.45 0.7 18.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.489 -0.757 . . . . 0.0 111.953 -179.393 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -110.14 -45.32 3.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.898 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.301 9.5 t80 -53.78 -39.0 65.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.249 176.558 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.814 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.22 -54.49 32.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -56.83 -48.35 78.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.679 -0.638 . . . . 0.0 110.712 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.82 -22.23 34.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.0 110.831 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -102.57 -29.02 11.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.681 -0.637 . . . . 0.0 110.217 179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 115.53 33.55 1.57 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.814 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -105.73 115.52 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -1.044 . . . . 0.0 109.229 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.17 105.55 2.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.433 -179.622 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.4 -97.12 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.51 127.55 46.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.334 -1.097 . . . . 0.0 111.067 -179.551 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' NE1' HG23 ' A' ' 55' ' ' VAL . 50.4 m95 -105.83 137.09 44.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.533 -0.729 . . . . 0.0 110.904 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.8 p -147.01 132.06 18.24 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.942 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.3 t80 -98.6 144.8 27.5 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.861 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -115.57 99.34 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.766 -0.584 . . . . 0.0 109.638 179.257 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.31 -6.09 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 111.306 -179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.82 -26.52 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.612 179.486 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -124.24 5.63 8.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.619 -0.676 . . . . 0.0 110.119 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 54.0 38.55 29.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.143 -0.973 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -128.06 143.53 51.07 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.811 -179.436 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.901 ' HB2' HD12 ' A' ' 6' ' ' LEU . 78.6 m-85 -98.34 -172.19 2.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.187 179.452 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -158.41 99.39 1.61 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.713 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.466 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -102.79 97.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.774 0.797 . . . . 0.0 111.155 -178.537 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.35 169.62 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.13 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.685 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.59 HG22 ' CE2' ' A' ' 4' ' ' PHE . 20.3 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.981 0.42 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' HB ' ' A' ' 18' ' ' THR . 20.4 m -67.16 91.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 110.143 179.984 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 2' ' ' THR . 34.2 m-85 -72.43 146.75 46.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.624 -0.672 . . . . 0.0 110.172 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 17.1 mtmt -109.84 -178.1 3.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.94 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 53' ' ' PHE . 6.4 tp -160.57 102.48 1.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.401 HG12 ' CG ' ' A' ' 16' ' ' GLU . 18.9 mt -90.71 117.0 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.045 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.766 ' CG1' HD11 ' A' ' 13' ' ' LEU . 2.0 mp -91.46 120.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.333 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.7 -31.15 59.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.34 -179.293 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 160.12 45.96 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.41 13.66 13.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.611 -0.935 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.625 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.2 p -63.05 -54.18 42.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.25 -0.906 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.766 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.6 pp -131.13 -29.08 1.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.677 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.697 ' N ' HD12 ' A' ' 13' ' ' LEU . 16.4 ptmt 37.35 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.667 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.68 -179.98 47.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HG12 ' A' ' 7' ' ' ILE . 2.1 mt-10 -129.76 72.54 1.48 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.834 -0.803 . . . . 0.0 109.786 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.66 112.56 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 109.974 -179.773 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 55.3 p -88.24 123.27 32.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.642 -0.661 . . . . 0.0 109.692 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.33 139.22 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.781 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -86.51 159.4 19.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.983 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.8 168.92 10.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.711 . . . . 0.0 110.203 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.89 -38.74 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -163.6 174.65 11.5 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.711 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.6 -30.61 70.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.771 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.31 -48.96 70.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.427 -0.796 . . . . 0.0 110.026 179.43 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.91 -43.43 83.39 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.891 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.617 -0.677 . . . . 0.0 109.749 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 17.9 tt0 -58.02 -40.45 80.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.709 -0.62 . . . . 0.0 109.508 179.175 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -50.12 56.22 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.331 178.984 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 27' ' ' ALA . 26.3 mt -58.01 -38.37 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.945 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -75.54 -35.28 60.72 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.83 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -79.78 3.97 17.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.64 . . . . 0.0 111.32 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -107.23 -45.27 4.15 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.413 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.288 6.1 t80 -52.9 -45.51 67.57 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.916 176.218 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.21 -51.56 69.05 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.322 0.582 . . . . 0.0 109.9 179.139 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.83 -49.62 76.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.802 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -57.55 -27.89 63.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.526 -0.733 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.7 -27.52 17.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.887 -0.508 . . . . 0.0 110.307 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 108.03 38.89 1.92 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.781 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.8 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -106.44 130.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.656 -0.908 . . . . 0.0 109.375 -179.714 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -168.1 106.61 0.5 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.01 -59.9 0.03 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.852 ' HB3' HG22 ' A' ' 56' ' ' THR . 7.0 tt0 -136.75 163.61 30.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.381 -1.07 . . . . 0.0 110.529 -179.479 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.4 m95 -162.65 116.06 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 p -145.64 131.57 19.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.604 -0.685 . . . . 0.0 109.495 179.47 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.3 t80 -89.05 152.3 21.75 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.821 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.32 102.18 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.721 -0.612 . . . . 0.0 109.643 179.367 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.47 -6.06 33.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.737 -0.602 . . . . 0.0 111.395 -179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.49 -28.13 21.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 p -125.22 6.12 7.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.614 -0.679 . . . . 0.0 109.973 179.103 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt 53.47 39.12 29.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.154 -0.966 . . . . 0.0 110.176 -179.619 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -133.55 145.87 50.5 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.015 -179.493 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 6' ' ' LEU . 49.6 m-85 -97.68 173.56 7.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.574 -0.704 . . . . 0.0 109.441 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.32 110.2 8.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.097 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.694 HG13 HG13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -117.94 152.89 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.704 -178.271 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -160.11 -169.44 2.5 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.7 179.242 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 2' ' ' THR . 53.5 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.131 0.491 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 m -62.75 86.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.531 -0.731 . . . . 0.0 110.074 179.926 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.787 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -71.75 137.0 47.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.602 -0.686 . . . . 0.0 109.95 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 15.9 mttt -99.37 179.72 4.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.635 -0.666 . . . . 0.0 110.269 -179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.823 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -163.14 118.58 1.74 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 110.464 -179.975 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.99 114.35 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.284 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -89.84 119.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.529 -179.142 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.64 56.76 0.78 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.41 174.2 22.67 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -70.15 -41.14 74.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.505 -0.997 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.672 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.3 p -76.31 115.44 16.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.469 -0.769 . . . . 0.0 109.946 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 60.28 156.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.356 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -171.67 126.19 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.25 -158.71 23.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -110.03 146.3 35.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.641 -0.917 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 49.5 mm -113.64 -16.96 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.669 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 65.0 p 45.33 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.678 -0.639 . . . . 0.0 112.006 179.845 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -126.81 141.04 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.803 . . . . 0.0 110.532 179.35 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.73 151.16 32.25 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.431 -179.835 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 2' ' ' THR . . . -167.82 158.55 10.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -55.95 -39.35 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 110.382 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 22' ' ' VAL . 52.6 p30 -159.36 178.81 9.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.677 -0.639 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.99 -29.18 70.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.609 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.4 71.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.71 . . . . 0.0 109.878 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -41.97 86.12 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.65 -46.42 77.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.632 -0.668 . . . . 0.0 109.583 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.8 tt0 -58.85 -37.27 76.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -51.44 39.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.515 -0.741 . . . . 0.0 109.046 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.0 mt -58.76 -38.02 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.823 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.5 m-85 -74.7 -37.98 62.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 179.198 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 9.1 mmmt -75.67 -0.89 22.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 111.448 179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -109.91 -45.49 3.62 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.59 -39.25 64.71 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.865 176.328 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.36 -54.0 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.344 0.592 . . . . 0.0 109.969 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.8 -47.36 77.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.631 -0.668 . . . . 0.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -51.63 -26.33 8.75 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.527 -0.733 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.7 -26.16 12.86 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.887 -0.508 . . . . 0.0 110.318 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.82 29.35 3.6 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' A' ' 12' ' ' THR . 2.1 mp -100.5 57.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.759 1.266 . . . . 0.0 108.173 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.54 101.75 11.63 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.37 -178.92 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . -160.38 -127.27 0.88 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.7 tt0 -71.28 168.38 17.45 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.136 -1.214 . . . . 0.0 110.325 -179.786 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 33.9 m95 -158.84 129.03 5.86 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.684 -0.635 . . . . 0.0 109.518 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.1 p -145.46 133.3 21.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.407 -0.808 . . . . 0.0 109.428 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.5 t80 -98.46 144.13 28.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.759 179.597 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.69 98.15 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.07 -7.05 32.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.69 -0.631 . . . . 0.0 111.378 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.24 -27.55 17.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 179.65 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.0 p -122.21 4.99 9.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.56 -0.713 . . . . 0.0 110.062 179.131 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt 54.41 39.26 30.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 109.938 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -129.87 142.39 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.804 -179.468 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.7 m-85 -97.66 -171.6 2.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -158.51 102.36 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.189 . . . . 0.0 108.088 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 40' ' ' ILE . 3.3 p -106.24 108.97 26.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.083 0.944 . . . . 0.0 110.93 -178.711 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.577 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -92.88 98.5 11.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.304 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.324 -179.551 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 2' ' ' THR . 29.8 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.101 0.476 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.1 m -69.59 87.6 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.723 . . . . 0.0 110.143 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -74.79 140.23 43.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.53 -0.731 . . . . 0.0 110.216 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.936 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.9 OUTLIER -107.21 -179.28 3.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.627 -0.67 . . . . 0.0 110.109 179.9 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -158.24 114.68 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.441 -0.787 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.36 122.69 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.449 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.777 HG21 ' HG ' ' A' ' 13' ' ' LEU . 6.3 mm -89.64 111.45 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.516 -177.957 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -97.47 152.38 19.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.736 179.249 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.67 -142.63 15.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -134.81 21.96 3.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.581 -0.952 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.497 HG22 HD11 ' A' ' 40' ' ' ILE . 3.9 m -131.12 111.53 12.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.777 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 61.77 137.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.369 0.604 . . . . 0.0 110.158 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptpt -141.83 138.27 32.07 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.65 -176.29 33.24 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.13 -41.49 6.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.701 -0.882 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 mt 53.86 73.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.435 -0.791 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.936 HG22 ' CG ' ' A' ' 5' ' ' LYS . 78.8 p -71.14 130.57 41.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -140.95 135.53 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.498 -0.752 . . . . 0.0 110.625 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.18 156.35 37.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.706 -0.621 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 2' ' ' THR . . . -169.8 162.28 9.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.552 -0.718 . . . . 0.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.97 -38.54 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.637 -0.665 . . . . 0.0 110.258 179.78 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.4 m-20 -160.49 178.98 9.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.8 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.52 -35.91 82.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.487 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.22 -49.28 67.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.412 -0.805 . . . . 0.0 109.948 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -45.8 91.19 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.121 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.07 -44.07 67.2 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.439 -0.788 . . . . 0.0 109.808 179.008 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.1 tt0 -57.96 -35.53 71.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.673 -0.642 . . . . 0.0 109.349 179.032 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -70.15 -53.54 16.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.47 -35.73 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.7 m-85 -76.26 -34.19 59.14 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.778 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.92 1.89 22.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.718 -0.614 . . . . 0.0 111.286 179.484 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -103.05 -46.47 4.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 176.63 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 8.3 t80 -45.48 -53.66 8.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.3 175.618 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.766 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.04 -49.92 74.34 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.36 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.83 -47.37 85.99 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.628 -0.67 . . . . 0.0 110.265 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.16 -23.89 15.98 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.595 -0.691 . . . . 0.0 111.16 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -105.21 -34.43 7.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.633 -0.667 . . . . 0.0 110.451 -179.924 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 121.21 37.23 0.7 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.766 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -102.99 110.85 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 0.0 109.12 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -141.43 109.21 5.69 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.826 -179.679 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.6 -106.63 0.2 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 tt0 -110.59 173.37 6.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -1.001 . . . . 0.0 110.791 -179.695 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.2 m95 -153.75 129.96 10.44 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.648 -0.658 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -143.13 133.84 25.18 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.504 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.5 t80 -98.73 146.67 25.65 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.881 179.712 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -116.78 100.0 7.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.24 -5.54 28.31 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.657 -0.652 . . . . 0.0 111.513 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.51 -27.61 18.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 179.642 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -126.06 6.83 7.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt 54.47 38.8 30.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.2 m -126.29 144.78 50.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.2 m-85 -99.15 -169.75 1.81 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 0.0 109.854 179.729 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.69 93.91 1.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.832 -1.167 . . . . 0.0 108.013 179.593 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -95.73 116.13 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.972 0.892 . . . . 0.0 110.879 -178.634 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -99.25 168.39 10.06 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.146 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 4' ' ' PHE . 27.6 m . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 120.949 0.404 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -68.93 106.23 2.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 109.962 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.3 m-85 -88.89 145.25 25.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.529 -0.732 . . . . 0.0 110.409 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.834 ' HG2' HG22 ' A' ' 18' ' ' THR . 26.1 mttt -112.55 -167.3 1.17 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.4 tp -166.44 108.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.41 -0.806 . . . . 0.0 110.463 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.28 119.81 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.793 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.867 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.1 mm -94.23 113.23 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.596 -179.178 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.07 57.9 0.69 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.819 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.94 -148.7 6.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 pttp -114.74 -25.07 8.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.598 -0.942 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -80.76 -38.82 27.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.867 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.5 mt -123.1 168.68 12.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.472 -0.768 . . . . 0.0 110.479 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.42 80.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.009 179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.36 -170.39 38.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.03 107.92 10.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.67 -0.9 . . . . 0.0 110.201 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 17' ' ' ILE . 5.3 mp -93.27 109.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.541 -0.725 . . . . 0.0 109.717 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.834 HG22 ' HG2' ' A' ' 5' ' ' LYS . 82.2 p -85.12 124.4 31.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.56 -0.713 . . . . 0.0 110.595 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -143.37 134.23 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -77.47 160.69 28.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.597 -0.689 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.46 165.2 10.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.239 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.3 p -55.13 -38.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.397 -0.814 . . . . 0.0 110.35 -179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.9 m-20 -162.31 174.88 12.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.629 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.29 -30.86 71.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.06 79.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 109.87 179.383 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' CD ' HG12 ' A' ' 22' ' ' VAL . 6.0 tt0 -71.79 -45.07 62.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.057 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.35 -39.74 76.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.567 -0.708 . . . . 0.0 109.362 178.813 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.1 tt0 -60.48 -40.23 90.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.012 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -67.53 -49.12 64.83 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.806 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.82 -44.13 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.839 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.7 m-85 -70.3 -38.92 75.1 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.982 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 4.6 mmmt -74.57 0.6 14.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 111.319 179.179 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -106.06 -45.58 4.3 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.191 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.298 17.4 t80 -49.02 -30.05 5.66 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.468 176.037 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -83.74 -48.63 9.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.669 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -68.47 -44.8 74.04 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.606 -0.684 . . . . 0.0 111.419 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -47.46 -28.74 2.3 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.501 -0.75 . . . . 0.0 111.139 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.46 -46.55 4.96 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.499 0.666 . . . . 0.0 109.375 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.3 63.54 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -179.698 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.27 1.1 mm -118.72 137.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 O-C-N 121.721 -0.87 . . . . 0.0 110.118 -177.359 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 -172.66 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.067 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 126.53 -177.16 17.38 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.736 179.109 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.89 128.13 36.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.976 -0.72 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 43.4 m95 -97.68 125.01 42.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.56 -0.713 . . . . 0.0 110.407 179.667 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.9 p -138.23 134.75 34.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.843 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -98.15 148.16 23.85 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.452 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.68 101.09 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.39 -4.96 24.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.588 -0.695 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.35 -28.1 18.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.563 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -128.79 8.63 5.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.593 -0.692 . . . . 0.0 110.149 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 7.7 mmtm 54.02 40.8 31.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.119 -0.988 . . . . 0.0 110.255 -179.698 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 5' ' ' LYS . 36.8 m -125.73 143.51 51.02 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.122 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.3 m-85 -100.18 -174.15 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 30.5 m -160.69 122.37 3.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 0.0 109.201 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.4 p -117.24 93.97 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -84.7 90.55 7.74 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.975 0.893 . . . . 0.0 110.008 -178.443 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 . . . . . 0 N--CA 1.499 2.011 0 O-C-N 120.849 -1.157 . . . . 0.0 110.147 -179.522 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 4' ' ' PHE . 48.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.946 0.403 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -69.67 103.51 2.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.491 -0.756 . . . . 0.0 110.011 179.799 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.623 ' CE2' HG22 ' A' ' 2' ' ' THR . 65.7 m-85 -83.0 149.65 26.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.649 -0.657 . . . . 0.0 110.31 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 13.6 mttt -119.33 179.23 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 31' ' ' PHE . 38.9 tp -155.22 112.52 3.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.459 -0.776 . . . . 0.0 110.143 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 98.3 mt -82.9 115.99 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.126 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.733 HG21 ' CB ' ' A' ' 13' ' ' LEU . 3.6 mm -94.75 119.9 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.794 -179.171 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -117.54 73.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.749 179.55 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.27 -106.32 0.65 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -149.97 -41.1 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.559 -0.965 . . . . 0.0 110.676 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -71.51 -28.9 64.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.733 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.6 mt -128.24 170.83 12.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 110.232 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 75.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.182 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.99 -168.87 34.6 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -121.22 135.9 55.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.644 -0.915 . . . . 0.0 110.181 -179.906 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 19' ' ' ILE . 16.4 tt -93.96 -15.65 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.738 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 8.9 p 54.58 110.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.56 0.695 . . . . 0.0 111.065 179.88 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -137.44 138.1 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.653 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.78 156.23 21.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.642 -0.661 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.15 168.99 14.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.673 . . . . 0.0 110.339 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 10.4 p -55.27 -38.5 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.512 -0.743 . . . . 0.0 110.393 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-20 -161.68 175.08 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.48 -32.39 73.82 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.675 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.771 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.38 -39.63 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.06 -42.69 86.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.614 -0.679 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.4 tt0 -59.94 -34.04 72.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.36 -49.74 46.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.45 -35.43 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -77.72 -40.67 40.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.628 179.384 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.0 mmmt -72.33 -3.24 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.0 111.261 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 -44.58 4.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.922 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CE2' HD23 ' A' ' 6' ' ' LEU 0.291 4.5 t80 -49.42 -30.38 7.86 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.326 176.062 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -82.35 -55.17 4.67 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.718 0.77 . . . . 0.0 108.952 178.602 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.88 -45.8 92.18 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.624 . . . . 0.0 111.457 -178.958 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.29 -29.23 1.55 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.599 -0.688 . . . . 0.0 111.256 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.57 -46.08 5.08 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.286 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.02 64.41 0.1 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.607 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.2 133.9 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.837 -0.802 . . . . 0.0 110.29 -177.068 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.2 -175.16 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 127.63 -173.53 18.69 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.56 -1.305 . . . . 0.0 111.744 179.186 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.8 126.38 36.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.02 -0.694 . . . . 0.0 110.164 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 37.7 m95 -95.84 126.77 41.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.712 . . . . 0.0 110.259 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.2 p -141.71 134.96 29.33 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.598 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.6 t80 -97.53 141.97 29.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.516 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.49 100.09 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.614 179.272 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.69 -4.03 21.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.593 -0.692 . . . . 0.0 111.483 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.67 -26.93 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.707 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.2 p -128.53 7.73 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.661 -0.65 . . . . 0.0 110.201 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 54.87 41.95 31.5 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.172 -0.955 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 5' ' ' LYS . 61.3 m -130.05 138.58 50.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.587 -0.695 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.4 m-85 -94.46 -173.18 2.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 0.0 109.17 179.245 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 38.1 m -161.38 122.39 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.772 -1.205 . . . . 0.0 109.184 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.5 p -118.99 89.94 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -86.27 99.12 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.957 0.884 . . . . 0.0 110.428 -178.267 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 18.8 tt0 . . . . . 0 N--CA 1.501 2.123 0 O-C-N 120.91 -1.119 . . . . 0.0 110.291 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 43.2 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 120.975 0.417 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 m -62.55 87.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.459 -0.776 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -72.53 128.12 34.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.735 -0.603 . . . . 0.0 110.228 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.756 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -95.23 171.53 8.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 109.479 179.535 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.9 tp -150.47 106.6 3.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.66 122.6 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -95.89 124.17 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.966 -179.388 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 54' ' ' THR . 3.8 m-20 -79.96 -30.33 39.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.262 -0.898 . . . . 0.0 110.181 -179.688 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.3 149.27 50.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -58.86 -20.26 49.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.56 -0.965 . . . . 0.0 110.61 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.462 ' HB ' HD11 ' A' ' 40' ' ' ILE . 7.1 p -65.45 116.62 6.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 110.553 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 65.77 -53.62 0.37 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.334 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.6 mtmt 43.79 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.779 -1.201 . . . . 0.0 112.682 179.091 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.91 -166.41 38.11 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.664 179.201 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -126.87 153.18 46.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.898 -0.766 . . . . 0.0 109.798 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 17' ' ' ILE . 5.2 mp -120.56 -14.37 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.426 -0.796 . . . . 0.0 111.242 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.756 HG22 ' CG ' ' A' ' 5' ' ' LYS . 40.7 p 44.14 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.575 -0.703 . . . . 0.0 111.875 -179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -128.07 138.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.52 -0.737 . . . . 0.0 110.665 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -81.69 147.89 29.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.9 179.591 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' HG21 ' A' ' 2' ' ' THR . . . -159.98 165.65 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -55.04 -39.65 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.677 . . . . 0.0 110.601 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -162.32 174.77 12.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.717 -0.614 . . . . 0.0 109.563 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.51 -32.32 72.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.403 -0.811 . . . . 0.0 109.789 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.0 -41.37 78.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.65 -44.05 57.85 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.131 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.24 80.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.566 -0.709 . . . . 0.0 109.545 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.8 tt0 -58.69 -37.74 76.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.255 178.96 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -68.62 -52.28 33.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.674 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 mt -56.61 -40.18 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.07 -35.72 66.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.881 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 44' ' ' TRP . 23.7 mttm -76.47 0.34 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.654 -0.654 . . . . 0.0 111.464 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.81 -45.28 3.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 177.455 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 8.3 t80 -55.51 -42.22 74.18 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.882 176.353 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.803 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.28 -50.97 71.95 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.261 0.553 . . . . 0.0 110.185 179.335 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.38 -46.51 89.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -54.51 -23.3 15.78 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -106.17 -34.88 7.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.631 -0.668 . . . . 0.0 110.623 -179.911 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 123.63 37.76 0.57 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.803 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -107.67 107.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -1.047 . . . . 0.0 108.733 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -157.62 104.41 1.98 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.271 -179.399 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.72 -50.37 0.04 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.869 ' CB ' HG22 ' A' ' 56' ' ' THR . 10.1 tt0 -138.0 167.28 22.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -1.064 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.7 m95 -161.49 123.94 3.03 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.841 -0.537 . . . . 0.0 109.886 179.514 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 15.0 p -146.65 132.23 18.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.501 -0.75 . . . . 0.0 109.36 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.9 t80 -96.37 133.08 41.21 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.85 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 100.3 10.44 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -2.63 16.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.726 -0.609 . . . . 0.0 111.939 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.7 22.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.274 179.406 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -138.34 16.01 2.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.716 -0.615 . . . . 0.0 110.0 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.5 mptt 49.02 42.53 21.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 111.339 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -118.55 110.64 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.936 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.882 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.5 m-85 -70.86 -175.4 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 9' ' ' ASN . 0.5 OUTLIER -156.01 105.61 2.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.947 -1.096 . . . . 0.0 108.369 -179.759 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 8.0 p -120.76 144.5 29.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 43' ' ' GLU . 5.7 t -141.3 -165.63 2.01 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.815 179.767 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.294 -179.762 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 2' ' ' THR . 57.9 m . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 78.5 m -67.79 93.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.459 -0.775 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 11.8 m-85 -76.65 159.17 30.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.0 109.707 179.773 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.916 ' HG2' HG22 ' A' ' 18' ' ' THR . 37.7 mtmt -121.36 -172.99 2.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.5 tp -165.32 104.86 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.263 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.7 126.17 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.422 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.642 HG13 HD11 ' A' ' 13' ' ' LEU . 8.7 mm -99.14 115.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.525 -178.394 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.422 HD22 ' CG2' ' A' ' 54' ' ' THR . 1.4 m120 -81.68 -159.04 0.25 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.33 -152.94 5.11 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.943 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -107.44 -18.28 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.771 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.497 ' CG2' HD13 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -58.02 94.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 179.743 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 58.17 171.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.263 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.828 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -162.69 106.9 1.12 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.46 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.93 -166.16 35.62 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.191 -179.823 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.86 -39.12 4.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.798 -0.825 . . . . 0.0 110.517 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.1 mm 54.09 76.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.327 -0.858 . . . . 0.0 110.303 -179.797 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.916 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.8 p -76.0 129.11 36.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.008 -179.787 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.445 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.17 144.18 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.904 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -83.07 149.66 26.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 109.964 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -163.81 153.14 14.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.684 . . . . 0.0 110.388 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -52.12 -39.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.399 -0.813 . . . . 0.0 110.458 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.2 m-20 -159.37 173.78 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.749 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.03 -30.58 70.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.822 . . . . 0.0 109.82 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.89 82.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.813 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.07 -44.79 60.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.594 -0.691 . . . . 0.0 109.689 178.76 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.1 tt0 -59.79 -38.08 80.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.647 -0.658 . . . . 0.0 109.229 179.088 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -67.99 -51.53 46.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 178.791 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.26 -37.41 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.879 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.6 m-85 -75.18 -35.78 61.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.786 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 mmmt -78.32 2.52 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.835 -0.541 . . . . 0.0 111.232 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -106.76 -46.44 3.96 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 177.332 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 23.7 t80 -52.42 -31.79 36.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.938 175.923 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.47 -64.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.676 0.75 . . . . 0.0 109.014 178.988 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -55.59 -40.08 71.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.925 -0.484 . . . . 0.0 110.767 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -49.32 -27.86 4.33 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.65 -0.656 . . . . 0.0 110.837 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -106.82 -50.72 3.06 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.436 0.636 . . . . 0.0 109.94 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.74 63.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -179.712 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.747 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -119.31 130.7 73.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.805 -0.82 . . . . 0.0 109.967 -177.272 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -171.19 100.26 0.21 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 110.724 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.96 -57.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.772 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.858 ' HB2' HG22 ' A' ' 56' ' ' THR . 79.1 mm-40 -140.92 168.42 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.947 . . . . 0.0 110.609 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.6 m95 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.1 p -133.75 130.68 38.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.856 -179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.0 t80 -93.65 129.6 39.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.084 -0.647 . . . . 0.0 109.555 179.434 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -97.95 97.51 9.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.731 -0.606 . . . . 0.0 109.472 179.185 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.55 -6.32 30.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.561 -0.712 . . . . 0.0 111.527 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.29 -27.26 17.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 179.686 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 p -124.15 6.82 8.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.557 -0.714 . . . . 0.0 110.142 179.268 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 6.9 mmmt 54.4 38.92 30.48 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 -179.774 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -130.44 134.17 46.9 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.663 . . . . 0.0 110.761 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 61.1 m-85 -87.88 -173.29 4.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.519 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' HD22 ' A' ' 9' ' ' ASN . 0.8 OUTLIER -155.74 103.78 2.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.923 -1.111 . . . . 0.0 108.692 179.881 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 6.4 p -117.02 146.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.327 -178.64 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' HB2' ' A' ' 43' ' ' GLU . 5.9 t -148.06 -171.61 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.999 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.231 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.627 HG22 ' CE2' ' A' ' 4' ' ' PHE . 59.9 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.15 0.5 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -73.74 109.82 7.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.465 -0.772 . . . . 0.0 110.017 179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.627 ' CE2' HG22 ' A' ' 2' ' ' THR . 60.2 m-85 -90.56 119.35 30.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 110.391 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -85.84 169.77 13.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.655 -0.653 . . . . 0.0 109.514 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.878 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.5 tp -148.25 111.06 4.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.986 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -90.72 119.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.508 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.771 HD11 HD23 ' A' ' 6' ' ' LEU . 2.0 mp -93.13 121.05 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.606 -179.144 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.9 162.19 13.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.359 -0.838 . . . . 0.0 110.552 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.07 -168.11 31.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.5 5.54 23.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.503 -0.998 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.538 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -60.07 -164.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.19 -0.944 . . . . 0.0 110.117 179.822 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.833 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 pp -52.78 -33.81 50.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.26 -0.9 . . . . 0.0 110.874 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.563 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.2 mmtt 52.33 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.398 -0.814 . . . . 0.0 111.536 178.985 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.55 -165.85 38.81 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.401 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' THR . 8.2 mt-10 -148.08 77.56 1.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.821 -0.811 . . . . 0.0 109.334 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 34' ' ' TYR . 41.6 pt -57.82 -26.24 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.46 -0.775 . . . . 0.0 111.118 -179.123 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 16' ' ' GLU . 2.9 p 60.31 128.55 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.5 0.666 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.17 156.88 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.416 -0.802 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.42 159.59 15.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.684 179.432 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.82 168.46 8.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.83 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 110.676 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.5 m-20 -158.11 177.21 11.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -64.3 -34.59 78.47 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.471 -179.817 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.42 -52.45 61.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.377 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -59.29 -42.71 91.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.635 -0.665 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.15 -42.49 69.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.526 -0.734 . . . . 0.0 109.773 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.1 tt0 -59.07 -45.84 89.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.556 -0.715 . . . . 0.0 109.335 179.248 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -50.72 71.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.288 -0.883 . . . . 0.0 109.641 178.654 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.4 -45.86 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.416 -0.803 . . . . 0.0 109.23 179.081 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.6 m-85 -69.01 -34.03 74.61 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.923 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 3.9 mmmt -73.72 -4.26 33.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.85 -0.531 . . . . 0.0 111.314 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -107.3 -45.45 4.1 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.719 ' CE1' HD13 ' A' ' 17' ' ' ILE 0.291 9.4 t80 -51.1 -31.69 20.04 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.821 175.948 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -64.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.837 0.827 . . . . 0.0 108.825 178.771 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -54.52 -40.42 68.59 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.085 0.469 . . . . 0.0 110.655 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -49.81 -27.15 4.63 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.72 -0.613 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -107.28 -48.75 3.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.382 0.61 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.29 62.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.833 HD11 HD23 ' A' ' 13' ' ' LEU 0.299 1.1 mm -119.54 136.54 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.821 -0.811 . . . . 0.0 109.495 -177.346 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -169.74 106.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.246 -0.908 . . . . 0.0 111.59 -179.735 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -108.14 0.21 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 179.054 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.5 tt0 -109.2 178.96 4.3 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.414 -1.05 . . . . 0.0 110.4 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.7 m95 -155.17 128.79 8.53 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.667 -0.646 . . . . 0.0 109.539 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.8 p -145.17 132.78 20.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.397 -0.814 . . . . 0.0 109.628 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 19.6 t80 -96.56 131.28 43.34 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -99.98 99.63 10.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.659 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -70.97 -2.83 16.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.692 -0.63 . . . . 0.0 111.87 -179.3 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.66 -28.36 20.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -136.19 14.97 3.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 4.3 mptt 48.8 43.05 20.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 111.578 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -121.01 114.4 21.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.854 -0.529 . . . . 0.0 109.87 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.878 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.2 m-85 -73.69 -172.96 1.36 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -0.816 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.17 97.55 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.19 . . . . 0.0 107.988 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG1' HG13 ' A' ' 8' ' ' ILE . 2.7 p -99.89 98.88 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.003 0.906 . . . . 0.0 111.012 -178.492 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -76.88 170.47 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.697 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' CG ' HG23 ' A' ' 12' ' ' THR . 5.5 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.087 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.606 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.041 0.448 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.8 m -72.98 98.01 2.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.733 . . . . 0.0 110.033 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 43.3 m-85 -76.11 122.66 24.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 110.328 -179.923 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -92.2 169.94 10.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 179.658 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.903 HD22 ' CD1' ' A' ' 31' ' ' PHE . 9.6 tp -150.14 105.21 3.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.953 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -90.66 123.31 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.1 mp -97.5 122.86 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.884 -1.127 . . . . 0.0 109.423 -178.928 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 54' ' ' THR . 2.3 m-20 -83.14 -157.97 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.22 -134.52 45.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -144.65 25.71 1.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.688 -0.889 . . . . 0.0 110.413 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.6 ' CG2' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -62.82 -71.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.511 -0.743 . . . . 0.0 109.642 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.804 HD23 HD11 ' A' ' 40' ' ' ILE . 4.6 pp -129.25 -28.69 2.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.631 -0.668 . . . . 0.0 110.688 179.601 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER 54.28 100.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.24 -0.912 . . . . 0.0 111.117 179.538 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.95 48.25 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 21.4 mt-10 -117.08 -37.83 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.901 -0.764 . . . . 0.0 109.95 179.815 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 19' ' ' ILE . 2.4 mp 65.52 -58.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.979 -0.451 . . . . 0.0 111.868 179.617 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 5' ' ' LYS . 4.1 p 57.5 107.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.474 -0.766 . . . . 0.0 110.401 -179.51 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 17' ' ' ILE . 2.3 pp -139.08 138.25 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.556 -0.715 . . . . 0.0 110.715 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -84.29 153.49 23.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.36 168.75 19.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.509 -0.744 . . . . 0.0 110.401 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.45 -39.67 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.589 -0.694 . . . . 0.0 110.771 -179.869 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -162.23 175.41 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.09 -29.33 70.72 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.859 -179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -41.33 78.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.869 179.574 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' OE2' HG12 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -74.65 -45.44 44.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.66 -49.15 71.31 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.433 -0.792 . . . . 0.0 109.766 179.149 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.0 tt0 -58.81 -35.59 73.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.605 -0.685 . . . . 0.0 109.26 179.083 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.77 -50.85 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.722 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mt -59.06 -36.86 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.903 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -75.28 -39.29 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.159 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 7.4 mtpm? -76.66 1.73 16.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.58 -0.7 . . . . 0.0 111.535 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -105.81 -45.03 4.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 177.143 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 16.0 t80 -54.02 -34.0 58.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.604 175.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.27 -62.93 1.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.536 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -57.57 -40.68 79.49 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.891 -0.505 . . . . 0.0 110.614 -179.931 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.88 -27.95 3.43 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.682 -0.636 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.05 -48.87 3.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.406 0.622 . . . . 0.0 109.759 179.113 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.94 63.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.786 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.804 HD11 HD23 ' A' ' 13' ' ' LEU 0.291 1.1 mm -119.24 133.8 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.731 -0.864 . . . . 0.0 109.851 -177.386 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -172.18 103.58 0.17 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.353 -0.842 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.19 -49.04 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.884 ' HB3' HG22 ' A' ' 56' ' ' THR . 12.8 tt0 -154.6 169.03 24.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -1.062 . . . . 0.0 110.798 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 48.5 m95 -161.24 115.22 2.0 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.14 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.4 p -137.81 132.02 32.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.514 -0.741 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.4 t80 -96.68 129.66 44.05 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.854 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -96.94 101.9 13.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.589 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.21 0.09 10.69 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.729 -0.607 . . . . 0.0 111.95 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.23 -26.54 18.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.388 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -140.81 16.85 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.897 179.513 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 49.32 45.63 23.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 111.456 179.591 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 m -120.3 111.64 18.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.087 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -73.71 -176.72 2.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 109.464 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.506 HG22 HD21 ' A' ' 9' ' ' ASN . 1.4 m -157.1 110.84 2.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.82 -1.175 . . . . 0.0 108.525 -179.784 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -122.35 139.98 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.135 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.884 HG22 ' HB3' ' A' ' 43' ' ' GLU . 9.3 t -136.37 -171.21 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.212 179.854 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 94.9 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.6 m 49.69 76.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.316 -0.865 . . . . 0.0 111.277 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.738 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -73.54 144.63 46.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.535 -0.728 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 18' ' ' THR . 7.2 mttp -109.22 -176.01 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 110.158 -179.8 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 31' ' ' PHE . 57.2 tp -155.81 118.99 4.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.493 -0.755 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 mt -87.88 108.69 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.043 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.901 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.5 mm -84.64 107.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.643 -179.407 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 25.5 m-20 -76.04 -28.31 57.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.558 -0.713 . . . . 0.0 110.131 179.572 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 166.38 4.72 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.305 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -31.11 27.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.909 . . . . 0.0 110.795 -179.701 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 p -56.51 -31.43 64.07 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.401 -0.812 . . . . 0.0 110.213 -179.956 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.901 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.0 mt -138.37 144.0 40.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.679 -0.638 . . . . 0.0 109.512 179.669 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -146.47 87.68 1.73 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.486 -0.759 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.26 -164.35 31.9 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.652 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.82 149.08 44.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.763 -0.845 . . . . 0.0 110.213 -179.965 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 48.7 mm -103.4 -15.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.716 . . . . 0.0 110.663 179.927 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' HG2' ' A' ' 5' ' ' LYS . 17.2 p 52.67 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.567 0.699 . . . . 0.0 111.018 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -135.81 134.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.39 -0.819 . . . . 0.0 110.733 -179.966 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.47 142.43 40.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.597 -0.689 . . . . 0.0 110.219 179.985 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.48 38.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.705 . . . . 0.0 110.306 179.856 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.38 -39.21 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.511 -0.743 . . . . 0.0 110.694 -179.906 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.1 m-20 -160.2 178.33 9.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.689 -0.632 . . . . 0.0 109.469 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.738 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.75 -30.05 71.19 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.797 179.937 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.665 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -65.74 -38.71 89.87 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.982 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.79 -44.12 94.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.06 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 16.0 tt0 -59.16 -36.1 74.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.599 . . . . 0.0 109.437 179.085 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -71.88 -49.63 36.34 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 109.109 178.865 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.53 -32.77 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.708 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' CD1' HD22 ' A' ' 6' ' ' LEU . 6.4 m-85 -80.91 -37.72 29.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.057 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -76.61 1.82 15.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 111.108 179.169 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -108.23 -44.16 4.2 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.423 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.296 2.6 t80 -52.12 -43.96 64.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.914 176.252 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.38 -59.28 5.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.316 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.57 -44.09 80.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.759 -0.588 . . . . 0.0 110.882 -179.509 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -48.31 -28.4 3.11 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.903 -179.786 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -102.36 -43.82 5.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.572 0.701 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.39 59.17 0.1 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 107.391 -2.283 . . . . 0.0 107.391 -179.463 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.791 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.293 1.1 mm -120.75 159.41 22.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.95 -0.735 . . . . 0.0 109.563 -177.043 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -176.65 -165.99 0.14 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 -126.5 7.43 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.187 178.373 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.902 ' HB3' HG22 ' A' ' 56' ' ' THR . 41.4 tt0 -96.59 109.22 21.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.72 . . . . 0.0 111.973 -177.834 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' THR . 26.0 m95 -97.47 118.03 33.05 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.446 0.641 . . . . 0.0 109.538 178.242 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -131.78 162.03 31.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.329 -179.387 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.8 t80 -123.71 137.37 54.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.878 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.46 100.13 9.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.213 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.03 -3.56 20.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.699 -0.626 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.93 -26.29 17.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.96 . . . . 0.0 109.742 179.705 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -129.45 8.28 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.62 -0.675 . . . . 0.0 110.132 179.384 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt 54.24 41.72 31.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 -179.671 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.6 m -126.49 137.78 53.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.688 -0.632 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.1 m-85 -96.89 -165.7 1.3 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.467 -0.77 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 6.9 m -154.83 162.86 40.96 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.996 -1.065 . . . . 0.0 108.839 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 40' ' ' ILE . 2.5 p -164.35 96.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.738 -0.601 . . . . 0.0 109.523 -179.452 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.902 HG22 ' HB3' ' A' ' 43' ' ' GLU . 3.8 t -110.83 91.87 3.83 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.296 1.046 . . . . 0.0 111.673 -178.794 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.504 2.274 0 O-C-N 120.887 -1.133 . . . . 0.0 110.794 -179.666 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.618 HG22 ' CE2' ' A' ' 4' ' ' PHE . 29.8 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.934 0.397 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -68.35 100.03 1.01 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 109.925 179.751 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.0 m-85 -80.19 150.7 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.841 ' HG2' HG22 ' A' ' 18' ' ' THR . 16.3 mtmm -116.4 174.69 5.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.76 HD23 HD11 ' A' ' 8' ' ' ILE . 10.4 tp -151.54 114.1 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.24 112.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.76 HD11 HD23 ' A' ' 6' ' ' LEU . 3.2 mp -96.59 114.94 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.469 -179.132 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -106.69 103.21 12.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.747 . . . . 0.0 109.74 179.879 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.77 -103.13 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.955 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -154.64 30.39 0.42 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.946 . . . . 0.0 110.334 -179.968 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.494 ' OG1' HD13 ' A' ' 40' ' ' ILE . 1.2 p -142.74 118.72 10.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.619 -0.676 . . . . 0.0 110.545 -179.813 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 67.31 -52.45 0.48 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.986 -0.446 . . . . 0.0 111.57 179.85 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.8 mttt 48.83 91.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.712 -1.243 . . . . 0.0 111.473 179.569 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.57 -165.75 29.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.88 154.68 42.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.747 . . . . 0.0 110.02 -179.856 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 19' ' ' ILE . 15.8 tt -118.78 -4.7 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.467 -0.77 . . . . 0.0 111.252 179.861 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.841 HG22 ' HG2' ' A' ' 5' ' ' LYS . 42.9 p 47.01 102.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.524 -0.735 . . . . 0.0 112.04 179.584 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -127.56 145.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.406 -0.809 . . . . 0.0 110.541 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.84 155.68 18.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.22 167.49 12.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.595 -0.69 . . . . 0.0 110.445 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.77 -39.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.521 -0.737 . . . . 0.0 110.736 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.474 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -161.47 174.91 12.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.88 -31.93 72.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 109.931 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.6 82.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.728 . . . . 0.0 109.831 179.675 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.78 -39.66 84.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.099 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.67 -42.19 87.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.632 -0.667 . . . . 0.0 109.447 179.049 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.7 tt0 -59.83 -36.86 77.69 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.96 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -70.77 -48.23 55.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.685 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 27' ' ' ALA . 46.5 mt -59.92 -38.74 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.713 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.1 m-85 -74.63 -39.39 62.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.126 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 31.0 mtpt -71.97 -3.36 22.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 111.084 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -107.88 -44.6 4.18 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.903 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 27.5 t80 -52.2 -37.7 55.7 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.355 176.327 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.63 -65.65 0.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -56.25 -42.39 77.28 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.721 -0.612 . . . . 0.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.68 -29.35 2.96 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -102.79 -44.96 5.14 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 178.703 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 12' ' ' THR . . . 132.83 63.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.955 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.81 135.36 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.774 -0.839 . . . . 0.0 110.22 -177.34 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -131.02 170.08 14.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 139.97 177.83 16.21 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.994 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -81.31 115.89 20.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.95 -0.735 . . . . 0.0 109.896 179.657 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.411 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 42.1 m95 -79.37 129.34 34.37 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.515 0.674 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 18.3 p -144.44 133.7 23.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.865 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -96.32 145.75 25.32 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.584 179.593 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.52 100.57 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.671 -0.643 . . . . 0.0 109.546 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.4 -5.04 25.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.0 111.588 -179.704 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.68 -27.72 19.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.738 179.619 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -130.03 8.05 5.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.0 110.08 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 54.58 42.13 31.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.3 m -127.03 132.57 50.69 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.419 -179.238 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.0 m-85 -90.12 -179.46 5.67 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.65 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 62.0 m -162.5 126.38 3.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.772 -1.205 . . . . 0.0 109.95 -179.444 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.34 92.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.806 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -84.56 102.94 13.27 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.707 0.765 . . . . 0.0 110.182 -178.54 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 27.0 tt0 . . . . . 0 N--CA 1.504 2.243 0 O-C-N 121.079 -1.013 . . . . 0.0 110.943 -178.96 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.942 0.401 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 m -109.16 120.85 43.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.73 . . . . 0.0 109.789 179.283 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 35.6 m-85 -114.24 125.46 53.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.568 -0.708 . . . . 0.0 110.256 179.98 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.806 ' HG3' HG22 ' A' ' 18' ' ' THR . 1.2 mtmt -91.69 172.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.529 -0.732 . . . . 0.0 109.391 179.632 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.911 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -153.99 112.77 3.66 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.233 -179.724 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.2 mt -91.52 115.65 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.941 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.71 116.81 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.269 -0.973 . . . . 0.0 109.449 -179.229 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -94.96 60.62 2.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.08 -144.73 4.94 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.36 27.23 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -179.812 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -140.07 27.32 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.491 -0.756 . . . . 0.0 110.183 179.836 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -173.73 -74.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 110.01 179.669 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt 51.61 54.07 11.65 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.325 -0.859 . . . . 0.0 110.667 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.95 169.05 28.1 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.782 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.99 64.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.812 . . . . 0.0 110.265 -179.857 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -61.16 143.54 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.806 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.0 p -99.4 150.65 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -0.754 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -116.19 168.58 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.111 0.958 . . . . 0.0 110.963 -179.181 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 19' ' ' ILE . 2.7 tp10 -132.16 79.37 1.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.758 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.66 176.68 5.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.678 -0.639 . . . . 0.0 110.5 -177.248 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 14.7 p -75.3 -40.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.278 -179.592 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 5.9 p30 -149.36 172.5 14.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.367 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.38 -31.27 71.16 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.859 -179.511 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.76 -54.26 46.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.483 -0.761 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' OE1' HG12 ' A' ' 22' ' ' VAL . 1.5 mt-10 -62.17 -45.57 92.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.0 -45.46 61.15 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.268 -0.895 . . . . 0.0 110.371 179.399 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.82 -34.63 74.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.401 179.348 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.43 -53.39 23.93 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.371 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 19' ' ' ILE . 19.4 mt -59.57 -32.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.916 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD12 ' A' ' 6' ' ' LEU . 3.9 m-85 -78.89 -38.67 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.463 0.649 . . . . 0.0 109.266 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.3 mmmt -72.93 -4.06 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.796 -0.565 . . . . 0.0 111.429 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -107.84 -44.69 4.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.329 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.476 ' OH ' HD21 ' A' ' 13' ' ' LEU 0.293 17.6 t80 -52.62 -34.04 49.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.2 176.43 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.58 -49.92 64.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.731 -0.606 . . . . 0.0 109.936 179.253 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -57.85 -46.2 85.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.639 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -55.61 -23.65 28.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.43 -0.794 . . . . 0.0 110.758 179.985 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.538 ' O ' HG21 ' A' ' 12' ' ' THR . 1.8 m-80 -102.98 -26.65 13.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.739 -0.601 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.99 29.9 3.37 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.79 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -96.97 106.71 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.622 -0.928 . . . . 0.0 108.855 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -143.96 102.73 3.93 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.409 -179.215 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.42 -105.81 0.2 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.154 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tt0 -105.95 179.73 4.18 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.41 -1.053 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' NE1' HG23 ' A' ' 55' ' ' VAL . 40.3 m95 -157.17 131.04 8.2 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.654 -0.653 . . . . 0.0 109.757 -179.952 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.2 p -146.13 132.29 19.4 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.581 -0.699 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 19.9 t80 -97.42 121.97 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.667 179.272 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.2 98.82 11.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.554 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.93 -3.05 17.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.573 -0.704 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.08 -28.54 21.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.416 179.369 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -136.53 14.62 3.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.697 -0.627 . . . . 0.0 110.024 179.275 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.6 mptp? 49.46 43.65 23.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.88 . . . . 0.0 111.283 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -119.99 103.41 9.28 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.274 179.774 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 75.6 m-85 -62.3 -177.04 0.12 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.695 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.9 101.68 1.8 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.764 -1.21 . . . . 0.0 107.756 -179.654 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.6 p -106.13 115.27 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.209 1.004 . . . . 0.0 111.607 -178.148 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -89.69 171.78 9.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.793 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.216 179.968 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 m -108.0 114.43 28.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.541 -0.725 . . . . 0.0 110.027 179.435 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.7 m-85 -113.0 117.91 33.35 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG2' HG22 ' A' ' 18' ' ' THR . 24.4 mtmt -87.36 171.94 10.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -0.812 . . . . 0.0 110.108 -179.655 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.899 HD22 ' CD1' ' A' ' 31' ' ' PHE . 29.8 tp -148.48 105.14 3.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.727 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.35 118.36 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mm -95.35 119.47 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.988 -178.991 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' THR . 28.5 t-20 -113.71 92.03 3.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.333 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.55 176.86 45.95 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -60.41 -34.25 73.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.486 -1.008 . . . . 0.0 110.353 -179.873 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.505 HG23 ' HG3' ' A' ' 11' ' ' LYS . 23.9 p -91.09 133.45 35.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.657 -0.652 . . . . 0.0 109.871 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 8' ' ' ILE . 4.9 mt 58.48 162.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.504 -0.748 . . . . 0.0 110.274 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -175.69 94.29 0.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.327 -0.858 . . . . 0.0 110.659 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.54 176.04 14.33 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.586 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -82.06 150.25 27.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.676 -0.896 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.652 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 57.7 mt -117.51 -19.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.571 -0.706 . . . . 0.0 110.757 -179.919 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.494 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.2 p 61.83 129.59 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.722 -0.611 . . . . 0.0 110.251 -179.636 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.681 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -120.53 167.25 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.967 0.889 . . . . 0.0 111.14 -179.445 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.02 71.56 1.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.61 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.1 179.34 4.13 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.797 -0.564 . . . . 0.0 110.403 -177.619 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 13.5 p -80.01 -41.5 21.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.893 -179.386 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 19.0 m-20 -147.11 171.66 14.97 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.831 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.667 -179.338 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.36 72.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.52 -0.737 . . . . 0.0 109.942 179.42 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.43 -49.69 58.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.84 61.64 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.544 -0.723 . . . . 0.0 110.121 179.009 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -60.22 -41.29 92.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.303 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -67.44 -49.85 61.89 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.784 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 19' ' ' ILE . 47.7 mt -59.14 -39.97 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.59 -0.694 . . . . 0.0 109.204 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.899 ' CD1' HD22 ' A' ' 6' ' ' LEU . 5.6 m-85 -73.78 -38.58 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.336 0.588 . . . . 0.0 109.476 179.25 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 0.8 OUTLIER -72.77 -3.35 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.664 -0.647 . . . . 0.0 111.44 -179.99 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -110.41 -45.1 3.6 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 177.721 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.652 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.296 3.6 t80 -54.41 -44.49 72.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.85 176.28 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.479 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.48 -58.64 5.84 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.196 0.522 . . . . 0.0 109.921 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -54.76 -47.6 73.69 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.595 -0.69 . . . . 0.0 110.916 -179.719 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.32 -28.71 63.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.402 -0.811 . . . . 0.0 110.421 -179.896 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -94.6 -27.8 15.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.809 -0.557 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 111.33 27.81 4.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.728 HG22 HG21 ' A' ' 55' ' ' VAL . 1.7 mp -99.77 76.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -1.05 . . . . 0.0 109.075 -179.972 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -172.3 3.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.042 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 126.11 -171.13 17.91 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.432 -1.366 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.24 132.14 34.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.983 -0.716 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.448 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 49.7 m95 -100.57 133.56 44.84 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.573 0.701 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.55 133.59 21.44 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 t80 -98.19 142.2 30.16 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.674 179.688 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -113.2 101.25 9.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.764 -0.585 . . . . 0.0 109.739 179.576 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.87 -5.15 28.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 0.0 111.428 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.8 -28.66 21.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 109.503 179.499 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -129.13 7.64 5.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.676 . . . . 0.0 110.096 179.269 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp 54.42 41.04 32.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.179 -0.951 . . . . 0.0 110.092 -179.717 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 m -127.98 132.77 49.16 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.044 -179.333 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.7 m-85 -86.92 -173.78 4.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.332 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 2.0 m -157.86 117.76 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.835 -1.166 . . . . 0.0 108.987 -179.878 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.728 HG21 HG22 ' A' ' 40' ' ' ILE . 1.7 p -115.81 93.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.735 0.778 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -87.72 96.78 10.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.892 0.853 . . . . 0.0 110.046 -178.618 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 10.9 tt0 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.131 . . . . 0.0 110.223 -179.131 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 2' ' ' THR . 70.6 m . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.1 m -69.68 91.93 0.64 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.9 m-85 -80.98 139.69 35.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.517 -0.739 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.858 ' HG2' HG22 ' A' ' 18' ' ' THR . 78.6 mttt -103.92 -172.31 2.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.528 -0.733 . . . . 0.0 110.208 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.7 tp -164.05 98.77 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 0.0 109.94 179.912 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.435 HG13 HG21 ' A' ' 52' ' ' THR . 89.6 mt -80.52 134.11 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.421 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.807 HG21 ' HG ' ' A' ' 13' ' ' LEU . 5.9 mm -99.03 117.67 44.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.215 -178.925 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -94.07 6.0 49.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.677 -0.639 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.84 -165.89 36.33 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -103.11 27.56 7.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.611 -0.935 . . . . 0.0 109.966 179.614 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.668 ' C ' HD23 ' A' ' 13' ' ' LEU . 2.8 m -153.92 175.53 13.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 40' ' ' ILE . 0.6 OUTLIER 38.74 28.57 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.694 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.44 118.67 2.88 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.198 -0.939 . . . . 0.0 111.7 -179.209 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.95 -174.18 44.71 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 9.6 mt-10 -118.56 -32.78 4.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.832 -0.805 . . . . 0.0 110.546 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 pt 36.98 83.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.762 0 CA-C-O 121.558 0.694 . . . . 0.0 112.291 -179.625 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' HG2' ' A' ' 5' ' ' LYS . 72.9 p -70.54 140.8 51.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.51 -0.744 . . . . 0.0 110.553 -179.584 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -148.22 134.28 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 179.548 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.68 156.03 35.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 179.974 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.7 158.54 7.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.563 -0.71 . . . . 0.0 110.24 179.968 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.9 p -54.0 -39.99 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.544 -0.722 . . . . 0.0 110.555 179.926 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -160.5 177.48 10.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.458 -0.776 . . . . 0.0 109.705 179.561 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.79 -34.52 77.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 109.785 -179.985 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.611 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.04 -44.73 74.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.494 -0.754 . . . . 0.0 109.77 179.442 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -69.41 -44.48 71.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.826 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -55.8 -39.92 72.0 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.405 -0.809 . . . . 0.0 109.596 178.871 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.8 tt0 -61.37 -40.1 93.08 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.209 -0.597 . . . . 0.0 110.039 179.595 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.51 -34.44 63.03 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.491 179.478 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.4 mt -67.99 -38.76 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.915 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -75.21 -37.1 61.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.437 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.44 2.2 19.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 110.948 179.201 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.19 -44.8 4.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 177.386 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 8.6 t80 -51.54 -39.59 58.05 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.313 176.22 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.19 -48.72 32.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.583 0.706 . . . . 0.0 109.583 179.413 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -67.11 -46.38 74.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.774 -0.579 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -48.86 -27.76 3.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 111.03 -179.43 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -100.62 -47.76 4.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.417 0.627 . . . . 0.0 110.007 179.4 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.35 61.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -179.506 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.954 ' CD1' HD22 ' A' ' 13' ' ' LEU 0.294 1.1 mm -117.02 141.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.914 -0.756 . . . . 0.0 109.067 -177.298 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -166.66 125.28 1.43 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.735 -179.155 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.4 -102.2 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.525 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 9.6 tt0 -127.98 173.57 9.92 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.455 -1.026 . . . . 0.0 109.582 178.675 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.462 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.5 m95 -150.43 131.35 14.23 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.379 -0.826 . . . . 0.0 110.091 -179.798 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.4 p -143.96 131.5 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.6 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -94.87 134.14 37.84 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.211 179.308 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.14 98.77 8.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.627 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.05 -5.31 25.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.655 -0.653 . . . . 0.0 111.425 -179.903 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.59 -27.96 17.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.712 179.616 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.9 p -124.3 7.37 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.655 -0.653 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt 54.56 38.78 30.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.128 -0.982 . . . . 0.0 110.18 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -130.34 140.9 50.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.606 -0.684 . . . . 0.0 110.463 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.873 ' HB2' HD12 ' A' ' 6' ' ' LEU . 57.2 m-85 -92.74 -170.4 2.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 109.609 179.669 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.03 92.84 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.855 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 8' ' ' ILE . 2.4 p -92.98 105.71 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.87 0.843 . . . . 0.0 110.458 -178.91 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 43' ' ' GLU . 1.1 m -84.17 171.6 12.68 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.581 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.253 179.732 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.769 HG21 ' O ' ' A' ' 21' ' ' ALA . 61.7 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 22.6 m 52.39 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.28 -0.888 . . . . 0.0 110.875 -178.784 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -105.03 123.42 47.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.17 174.55 7.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.759 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.828 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -151.34 113.51 4.54 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.256 -179.997 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -80.98 119.81 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.969 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.855 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.9 mm -96.14 122.64 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.307 -178.738 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -108.84 52.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 109.956 179.458 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.09 -151.72 8.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.808 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 -23.6 9.37 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.598 -0.942 . . . . 0.0 110.722 -179.793 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -82.36 -30.4 30.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.563 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.855 ' HB2' HG21 ' A' ' 8' ' ' ILE . 8.5 mt -119.66 171.66 8.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.723 -0.61 . . . . 0.0 109.358 179.72 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.04 76.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.636 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.23 179.58 27.06 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.512 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.06 -154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.699 -0.883 . . . . 0.0 109.913 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 31' ' ' PHE . 7.0 tp -175.07 -32.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.501 -0.749 . . . . 0.0 110.25 179.913 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p 63.49 137.0 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.367 0.603 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -130.77 166.8 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 121.671 0.748 . . . . 0.0 111.057 -178.869 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.41 78.52 1.21 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.305 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.769 ' O ' HG21 ' A' ' 2' ' ' THR . . . -122.08 149.43 43.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.577 -0.702 . . . . 0.0 110.381 -177.533 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -58.55 -39.75 76.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.374 0.607 . . . . 0.0 110.75 -179.63 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' N ' HG13 ' A' ' 22' ' ' VAL . 49.1 p-10 -149.8 178.61 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.801 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.57 -29.99 70.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.606 -179.574 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.73 79.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.524 -0.735 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HG3' HG12 ' A' ' 22' ' ' VAL . 1.3 mm-40 -68.29 -47.87 66.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.639 -0.663 . . . . 0.0 109.394 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.26 -48.01 62.31 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.438 -0.789 . . . . 0.0 110.434 179.486 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.2 tt0 -58.6 -36.45 74.05 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.609 179.423 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -54.13 15.99 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.29 -35.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.527 -0.733 . . . . 0.0 109.184 178.753 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 6' ' ' LEU . 4.5 m-85 -74.65 -39.13 62.24 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.91 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -72.97 -2.79 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 111.442 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -109.28 -44.63 3.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 177.444 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 12.3 t80 -51.44 -33.77 32.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.746 175.954 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.95 -57.98 10.52 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.659 0.743 . . . . 0.0 109.118 178.573 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -58.55 -44.4 89.66 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -49.44 -27.19 3.92 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.593 -0.692 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -104.12 -50.07 3.45 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 0.0 110.135 179.402 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.88 62.64 0.05 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -179.653 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.307 1.1 mm -120.3 136.8 56.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.877 -0.778 . . . . 0.0 109.875 -177.042 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -170.07 101.97 0.29 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.325 -0.86 . . . . 0.0 111.237 -179.851 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.01 -104.38 0.18 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.445 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 8.6 tt0 -114.73 174.4 5.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.537 -0.978 . . . . 0.0 110.64 -179.923 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.447 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.1 m95 -152.87 128.67 10.19 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.709 -0.619 . . . . 0.0 109.615 179.854 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.43 132.06 23.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 109.309 179.587 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.5 t80 -96.97 128.25 43.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.53 179.589 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -96.22 98.66 10.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.656 -0.652 . . . . 0.0 109.407 179.207 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -70.59 -4.09 21.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.654 -0.654 . . . . 0.0 111.692 -179.598 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.22 -26.34 17.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.613 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -127.64 7.53 6.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.579 -0.701 . . . . 0.0 110.132 179.333 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 46.8 mmtt 54.53 40.43 31.83 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.21 -0.932 . . . . 0.0 110.134 -179.618 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -127.66 129.82 47.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.728 -0.608 . . . . 0.0 110.425 -179.638 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.5 m-85 -85.29 -171.17 3.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 109.497 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -155.83 95.28 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -98.8 107.5 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.982 0.896 . . . . 0.0 111.18 -178.357 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -88.4 163.72 15.86 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.796 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.305 -179.959 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 88.4 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.112 0.482 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.9 m -84.23 88.61 7.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.158 179.701 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.747 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 m-85 -76.9 137.72 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -102.48 -172.6 2.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.436 -179.533 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.0 tp -165.25 107.7 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.659 -0.65 . . . . 0.0 109.939 179.926 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -89.9 115.57 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.264 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 HD23 ' A' ' 6' ' ' LEU . 3.0 mp -97.67 120.55 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.483 -179.499 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -109.24 98.02 7.52 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.499 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.45 -135.02 1.97 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.937 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -32.94 4.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.968 . . . . 0.0 110.325 179.799 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 p -87.29 107.55 18.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 179.512 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.09 148.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.521 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.67 ' N ' HD12 ' A' ' 13' ' ' LEU . 15.2 ptmt -162.91 128.38 3.22 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.236 -0.915 . . . . 0.0 110.647 -179.724 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.07 -174.73 18.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.29 147.89 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.902 . . . . 0.0 110.836 -179.647 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.8 mm -113.12 -26.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.511 -0.743 . . . . 0.0 110.243 179.729 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 3.2 p 56.79 112.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.344 0.592 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -141.97 135.44 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.327 179.188 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.27 149.34 47.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.609 -0.682 . . . . 0.0 110.148 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.67 156.04 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.3 p -53.42 -40.53 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.557 -0.715 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -159.94 -179.81 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.706 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.92 -32.49 74.24 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.559 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.95 76.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.828 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -68.59 -45.46 71.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.891 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -42.05 76.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.042 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.5 tt0 -61.62 -41.34 97.33 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.447 179.083 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -69.32 -44.27 72.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.408 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 87.7 mt -63.21 -42.09 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.839 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -70.41 -40.5 73.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.199 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 34.1 mtpt -71.56 -4.06 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 110.963 179.299 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -98.3 -45.6 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.127 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 5.9 t80 -44.36 -54.15 6.11 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.79 175.572 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.78 -51.41 68.41 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.53 -47.3 79.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.641 -0.662 . . . . 0.0 111.364 -178.958 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -48.92 -30.82 6.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.476 -0.765 . . . . 0.0 110.985 -179.275 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -96.01 -46.08 6.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.564 0.697 . . . . 0.0 109.553 179.124 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 62.89 0.16 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -179.373 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.284 1.0 OUTLIER -118.67 139.67 45.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.863 -0.786 . . . . 0.0 110.489 -176.725 . . . . . . . . 4 4 . 1 . 047 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.98 -178.21 4.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.21 -178.74 17.36 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.716 179.2 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.98 123.1 31.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.982 -0.717 . . . . 0.0 110.328 179.888 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' THR . 37.8 m95 -88.62 128.1 35.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -141.04 132.9 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -96.62 143.44 27.59 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.532 179.714 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.77 99.15 7.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.681 -0.637 . . . . 0.0 109.405 179.233 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.74 -3.84 20.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.664 . . . . 0.0 111.593 -179.641 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.27 -27.05 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.736 179.677 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -130.17 8.9 5.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.632 -0.668 . . . . 0.0 110.128 179.372 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 53.82 44.22 29.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 0.0 110.154 -179.589 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.2 m -130.07 129.93 44.25 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.113 -179.411 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.794 ' HB2' HD12 ' A' ' 6' ' ' LEU . 69.9 m-85 -89.69 -176.65 5.05 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.934 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 34.5 m -162.39 124.58 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.793 -1.192 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 8' ' ' ILE . 1.2 p -118.13 93.27 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.059 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -82.93 96.44 8.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.026 0.917 . . . . 0.0 110.157 -178.237 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 O-C-N 120.978 -1.076 . . . . 0.0 110.448 -179.243 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.143 0.497 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m -104.78 74.69 1.15 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.5 m -97.83 104.27 16.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.734 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.4 m-85 -90.58 152.21 20.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.843 ' HG2' HG22 ' A' ' 18' ' ' THR . 33.7 mttt -112.96 -171.85 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.669 -0.645 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.799 HD22 ' CD1' ' A' ' 31' ' ' PHE . 14.8 tp -164.25 107.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.142 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.68 124.89 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.7 mm -89.82 116.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.77 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -103.51 67.74 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 0.0 110.468 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.97 167.92 39.47 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -59.82 -33.84 72.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -1.012 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 p -80.44 133.73 35.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 58.32 163.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.468 -0.77 . . . . 0.0 110.284 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -177.24 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.55 -163.45 33.99 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -133.41 70.67 1.46 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.932 . . . . 0.0 110.377 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -62.31 114.53 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.461 -0.774 . . . . 0.0 109.712 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.843 HG22 ' HG2' ' A' ' 5' ' ' LYS . 75.6 p -83.61 138.47 33.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.651 -0.656 . . . . 0.0 110.499 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.48 149.98 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.573 -0.704 . . . . 0.0 110.369 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 148.68 23.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.18 159.64 23.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.553 -0.717 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -53.68 -38.83 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.511 -0.743 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.5 m-20 -159.96 175.83 12.57 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.55 -33.81 75.68 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.713 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.82 63.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.455 -0.778 . . . . 0.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.09 -40.47 96.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.36 72.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 0.0 109.479 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -58.29 -36.26 73.04 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -69.11 -50.81 44.66 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.69 -37.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.799 ' CD1' HD22 ' A' ' 6' ' ' LEU . 12.0 m-85 -74.32 -37.34 63.61 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.6 mmmt -76.3 0.23 20.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.738 -0.601 . . . . 0.0 111.563 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -109.24 -45.25 3.77 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 10.7 t80 -53.07 -34.61 57.33 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.028 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -69.68 -48.14 60.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.193 0.52 . . . . 0.0 110.0 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.41 -46.7 85.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.526 -0.734 . . . . 0.0 110.342 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -54.58 -23.32 16.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.54 -0.725 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' HD13 ' A' ' 40' ' ' ILE . 1.7 m120 -105.51 -25.86 12.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.627 -0.67 . . . . 0.0 110.557 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.76 30.68 3.4 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.71 106.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.979 . . . . 0.0 108.788 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.73 111.68 6.75 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.427 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.27 -108.72 0.21 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -109.81 173.37 6.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.396 -1.061 . . . . 0.0 110.39 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.476 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.8 m95 -152.06 130.33 12.02 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.543 -0.723 . . . . 0.0 110.26 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 6.7 p -142.26 134.18 27.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.63 -0.669 . . . . 0.0 109.253 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.6 t80 -97.61 143.7 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.93 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -113.92 97.97 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.817 -0.552 . . . . 0.0 109.536 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -69.69 -6.84 34.41 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.661 -0.649 . . . . 0.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.15 -27.47 17.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.702 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -122.84 5.71 9.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.648 -0.658 . . . . 0.0 110.079 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp 54.19 36.63 25.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.7 m -127.97 143.2 51.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.629 -0.669 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HB2' HD12 ' A' ' 6' ' ' LEU . 64.2 m-85 -95.99 -168.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 109.698 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 92.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.18 108.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.902 0.858 . . . . 0.0 110.915 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -89.52 169.68 11.15 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.101 0.477 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m -118.28 34.8 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.713 . . . . 0.0 110.294 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.1 m -61.16 95.17 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.575 -0.703 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.7 m-85 -83.68 142.53 30.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.895 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.811 ' HG2' HG22 ' A' ' 18' ' ' THR . 45.1 mtmt -103.34 -177.24 3.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.584 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.896 HD12 ' HB2' ' A' ' 53' ' ' PHE . 4.9 tp -163.26 110.17 1.17 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.653 -0.654 . . . . 0.0 109.967 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.6 mt -85.8 117.63 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.8 mm -85.72 116.9 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -102.93 63.64 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.88 -132.68 3.26 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -131.32 -40.84 1.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.935 . . . . 0.0 110.465 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -69.89 -47.29 63.12 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.449 -0.782 . . . . 0.0 109.62 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.617 ' CB ' HG21 ' A' ' 8' ' ' ILE . 11.4 mt -110.81 156.89 20.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.811 -0.556 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -172.34 86.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.432 -0.793 . . . . 0.0 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.55 161.46 27.43 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.71 73.75 9.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.727 -0.867 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.646 HD13 ' CE2' ' A' ' 34' ' ' TYR . 7.2 mt -56.22 120.79 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 5' ' ' LYS . 74.2 p -99.09 133.47 43.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.28 142.1 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.626 -0.671 . . . . 0.0 110.375 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.02 141.21 34.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.619 -0.676 . . . . 0.0 110.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.72 160.14 41.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 110.236 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 26' ' ' GLU . 8.6 p -56.9 -32.99 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.242 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 6.5 p30 -166.13 -176.51 3.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 109.429 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -68.82 -30.29 68.82 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.665 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.65 -46.19 87.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.706 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' CB ' HG12 ' A' ' 22' ' ' VAL . 8.2 tp10 -70.33 -39.8 74.52 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.79 85.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.528 -0.732 . . . . 0.0 109.533 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.3 tt0 -58.61 -35.97 73.29 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -71.27 -51.33 25.09 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.0 -36.2 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.9 m-85 -75.72 -36.28 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 12.9 mtpp -80.12 4.61 16.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.792 -0.567 . . . . 0.0 111.449 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' OD2' ' A' ' 37' ' ' ASP . 6.3 tm0? -110.89 -45.49 3.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.646 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.291 12.2 t80 -55.48 -43.5 75.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.933 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.73 -47.26 85.21 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.35 -49.51 75.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.554 -0.716 . . . . 0.0 110.746 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD2' ' NE2' ' A' ' 33' ' ' GLN . 3.0 m-20 -56.36 -23.52 38.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.7 m120 -100.8 -24.05 14.47 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.729 -0.607 . . . . 0.0 110.719 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.87 30.89 4.67 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.749 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.51 106.21 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.679 -0.894 . . . . 0.0 108.785 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.53 110.0 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.117 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.94 -106.32 0.2 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.2 tt0 -108.63 174.82 5.7 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.483 -1.01 . . . . 0.0 110.524 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.473 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.9 m95 -153.53 130.63 11.09 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.638 -0.664 . . . . 0.0 109.99 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.0 p -142.48 133.18 25.39 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -99.84 144.24 29.13 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.882 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -114.97 98.56 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.769 -0.582 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.16 -4.94 23.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.713 -0.617 . . . . 0.0 111.664 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 -27.13 18.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.677 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.1 p -127.9 7.38 6.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.658 -0.651 . . . . 0.0 110.175 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt 54.17 40.62 31.85 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -125.83 135.9 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.656 -0.652 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD12 ' A' ' 6' ' ' LEU . 74.8 m-85 -94.36 -170.36 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.579 -0.701 . . . . 0.0 109.525 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.3 94.15 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.853 -1.154 . . . . 0.0 107.89 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 44' ' ' TRP . 3.0 p -96.66 107.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.02 0.914 . . . . 0.0 111.173 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -89.07 169.72 11.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.132 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptm . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 2' ' ' THR . 58.7 m -131.63 49.1 2.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.518 -0.739 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.654 HG22 ' HB ' ' A' ' 18' ' ' THR . 2.7 m -71.0 81.93 0.67 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -66.41 144.49 56.49 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.93 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.04 179.81 4.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.575 -0.703 . . . . 0.0 110.162 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.0 tp -157.36 112.15 2.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -89.57 122.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 HD13 ' CG1' ' A' ' 55' ' ' VAL . 3.2 mm -89.06 117.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.664 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -104.95 67.06 0.78 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.474 -0.767 . . . . 0.0 110.091 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.02 166.05 36.76 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 12' ' ' THR . 15.8 pttm -59.89 -28.76 67.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.443 -1.034 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 11' ' ' LYS . 19.2 p -92.45 129.59 38.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.622 -0.674 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 34' ' ' TYR . 8.6 mt 60.33 127.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.378 0.609 . . . . 0.0 110.586 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -148.75 93.6 2.15 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.15 -172.72 45.7 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.22 96.36 5.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.817 -0.813 . . . . 0.0 109.947 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.9 mp -86.72 115.51 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 109.95 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.93 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.7 p -89.44 126.9 35.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.622 . . . . 0.0 110.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.87 135.28 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.615 -0.678 . . . . 0.0 110.491 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -73.87 153.1 40.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.592 -0.692 . . . . 0.0 110.134 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -167.66 160.22 12.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.1 p -53.14 -39.46 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.556 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -162.01 176.83 10.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.671 -0.643 . . . . 0.0 109.575 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.75 -33.35 74.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 109.746 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.2 -43.54 78.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 109.984 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 1.6 tp10 -70.4 -44.18 68.51 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 -46.29 74.29 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.484 -0.76 . . . . 0.0 109.686 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 2.7 tt0 -58.16 -37.65 75.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.747 -0.596 . . . . 0.0 109.412 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -51.2 43.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.62 -40.39 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.2 m-85 -71.8 -34.85 69.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 9.5 mttm -77.15 0.17 22.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.647 -0.658 . . . . 0.0 111.5 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -108.06 -45.41 3.96 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.58 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.292 2.6 t80 -54.02 -35.89 62.42 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.139 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -71.0 -45.76 63.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.81 -0.556 . . . . 0.0 110.343 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -50.23 73.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 111.018 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.82 -21.92 32.61 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.455 -0.778 . . . . 0.0 110.978 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' HD13 ' A' ' 40' ' ' ILE . 6.4 m120 -101.19 -23.71 14.39 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.686 -0.634 . . . . 0.0 110.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.3 31.09 4.78 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.746 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.49 105.34 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.595 -0.944 . . . . 0.0 108.92 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.29 112.22 6.27 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.074 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.46 -104.81 0.18 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.3 tt0 -112.19 173.78 6.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -1.022 . . . . 0.0 110.184 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CE2' HG23 ' A' ' 55' ' ' VAL . 38.9 m95 -151.97 128.62 10.8 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.535 -0.728 . . . . 0.0 109.815 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.11 132.51 28.46 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.227 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.2 t80 -98.62 147.54 24.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.592 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.46 99.94 7.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.724 -0.61 . . . . 0.0 109.626 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.8 -4.9 26.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.724 -0.61 . . . . 0.0 111.579 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.36 -26.74 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.1 p -129.11 7.54 5.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.6 -0.687 . . . . 0.0 110.17 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.2 mmtp 54.59 40.29 31.75 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -124.7 139.72 53.6 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.866 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.0 m-85 -97.29 -172.09 2.35 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.556 -0.715 . . . . 0.0 109.741 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.32 91.85 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.0 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.486 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.0 105.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.897 0.856 . . . . 0.0 110.895 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -88.03 171.75 10.05 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.136 0.494 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 78.2 m -112.17 69.3 0.69 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 110.373 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -93.34 103.67 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 28.4 m-85 -88.5 151.33 22.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.808 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.5 mptt -115.04 -168.35 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.671 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.0 tp -166.2 107.37 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.82 105.16 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.626 HD13 ' CG1' ' A' ' 55' ' ' VAL . 1.2 mm -75.95 106.06 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.523 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 56' ' ' THR . 11.2 t-20 -82.04 4.16 24.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.505 -0.747 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.82 -148.05 1.58 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -137.21 32.23 2.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.61 -0.936 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 p -147.23 17.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.6 mt -170.81 36.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.63 97.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 110.994 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.57 177.59 43.63 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -44.33 4.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.702 -0.881 . . . . 0.0 110.181 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.0 mm 53.95 87.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.449 -0.782 . . . . 0.0 110.547 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.808 HG22 ' HG3' ' A' ' 5' ' ' LYS . 70.9 p -84.29 134.36 34.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.736 . . . . 0.0 110.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.49 147.85 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.621 -0.674 . . . . 0.0 110.401 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.17 151.93 22.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.259 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.49 160.71 18.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.342 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.4 p -53.69 -40.17 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.0 m-20 -160.87 174.71 13.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.18 -27.45 67.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.373 -0.829 . . . . 0.0 109.953 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 -47.45 84.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -0.785 . . . . 0.0 109.748 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 22' ' ' VAL . 8.1 tt0 -69.88 -41.28 75.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.55 -46.76 80.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.579 -0.701 . . . . 0.0 109.57 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -57.26 -39.88 76.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.632 -0.667 . . . . 0.0 109.235 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -65.62 -53.1 46.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.508 -0.745 . . . . 0.0 109.379 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -56.29 -39.39 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.523 -0.736 . . . . 0.0 109.102 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -73.67 -36.62 65.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 4.0 mtmp? -79.48 3.32 18.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.701 -0.625 . . . . 0.0 111.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -45.21 3.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.495 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.289 9.4 t80 -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.974 176.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -62.53 -48.08 81.1 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.867 -0.521 . . . . 0.0 110.181 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.98 -48.52 78.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.539 -0.725 . . . . 0.0 110.622 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.37 -25.55 35.87 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.566 -0.709 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.4 m-20 -99.82 -25.56 14.32 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.709 -0.619 . . . . 0.0 110.667 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.17 30.42 4.18 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.752 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 105.82 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.686 -0.891 . . . . 0.0 108.862 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -148.64 102.84 3.34 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.728 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.06 -73.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 56' ' ' THR . 29.4 mt-10 -136.0 171.64 14.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.498 -1.001 . . . . 0.0 110.042 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.7 m95 -155.26 126.91 7.41 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.65 -0.656 . . . . 0.0 110.045 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.6 p -144.39 132.79 21.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.4 t80 -95.26 141.65 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.803 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -111.26 100.08 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.736 -0.603 . . . . 0.0 109.739 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.5 -2.79 18.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.686 -0.634 . . . . 0.0 111.657 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.01 -25.93 17.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 109.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.9 p -130.58 8.77 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 110.229 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 56.7 mmtt 54.3 41.65 31.88 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.175 -0.953 . . . . 0.0 110.27 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 5' ' ' LYS . 35.4 m -130.56 134.86 47.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.49 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HB2' HD12 ' A' ' 6' ' ' LEU . 59.1 m-85 -89.28 -168.74 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.521 -0.737 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -155.92 105.3 2.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 108.172 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.626 ' CG1' HD13 ' A' ' 8' ' ' ILE . 5.9 p -115.82 129.86 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.299 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -126.09 -172.04 2.53 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 56' ' ' THR . 8.9 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.185 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.626 0.251 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 2' ' ' THR . 52.8 m -104.81 41.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.078 -1.014 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 m -63.54 85.8 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.713 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.751 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.3 m-85 -71.21 140.77 50.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.675 -0.641 . . . . 0.0 109.66 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HG2' HG22 ' A' ' 18' ' ' THR . 9.5 mtmt -104.67 168.01 9.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.762 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.8 tp -141.9 105.57 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.8 mt -76.89 110.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HD23 ' A' ' 6' ' ' LEU . 6.8 mm -84.21 112.94 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.121 -1.032 . . . . 0.0 109.79 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -97.86 155.49 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.476 -0.765 . . . . 0.0 110.064 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.7 -138.97 15.32 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -129.07 28.9 5.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.523 -0.986 . . . . 0.0 110.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' LYS . 19.2 p -136.09 145.26 45.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.623 -0.673 . . . . 0.0 109.905 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 40' ' ' ILE . 6.2 mt 60.9 -76.69 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.733 -0.604 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' THR . 24.6 mtpt 54.99 99.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.343 -0.848 . . . . 0.0 110.708 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.94 -174.22 31.75 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 18' ' ' THR . 7.6 mt-10 -136.03 86.3 2.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.895 . . . . 0.0 109.729 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -59.39 -25.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.552 -0.717 . . . . 0.0 110.789 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.802 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.6 p 60.69 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 121.43 0.634 . . . . 0.0 110.669 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.58 146.04 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.426 -0.796 . . . . 0.0 110.799 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -81.55 152.95 27.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.33 158.52 9.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 110.398 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.2 p -53.95 -38.92 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.3 m-20 -161.26 -177.92 6.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.751 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.77 -28.11 68.78 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.46 69.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' OE1' HG12 ' A' ' 22' ' ' VAL . 2.5 mt-10 -66.23 -41.68 89.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.677 -0.639 . . . . 0.0 109.377 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.23 73.42 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.529 -0.732 . . . . 0.0 109.856 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.453 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.5 tt0 -57.94 -38.17 75.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -70.15 -51.91 27.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mt -58.04 -34.91 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.7 m-85 -77.66 -36.6 51.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -74.34 -2.0 23.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.698 -0.626 . . . . 0.0 111.402 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -108.56 -45.38 3.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 8.9 t80 -52.41 -35.44 51.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.936 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.761 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.11 -47.01 69.33 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.201 0.524 . . . . 0.0 109.987 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.7 -49.31 76.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -54.97 -23.32 18.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.524 -0.735 . . . . 0.0 111.081 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' HD13 ' A' ' 40' ' ' ILE . 8.4 m-20 -102.34 -26.84 13.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.658 -0.651 . . . . 0.0 110.624 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.19 30.9 3.46 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.807 HG12 HD12 ' A' ' 13' ' ' LEU . 1.7 mp -96.85 107.07 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.647 -0.913 . . . . 0.0 108.928 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -145.12 109.47 4.9 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.162 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -107.2 0.2 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -107.18 176.64 5.1 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.454 -1.027 . . . . 0.0 110.45 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.458 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -154.37 130.35 10.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.598 -0.689 . . . . 0.0 109.79 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.2 p -143.88 132.25 22.08 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.337 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.57 147.61 24.11 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.851 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.44 98.68 6.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.715 -0.615 . . . . 0.0 109.746 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.97 -5.65 27.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.636 -0.665 . . . . 0.0 111.419 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.96 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.555 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -126.59 8.01 6.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.655 . . . . 0.0 110.069 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp 53.57 40.03 30.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.146 -0.971 . . . . 0.0 110.281 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -127.65 142.96 51.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.597 -0.689 . . . . 0.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HD12 ' A' ' 6' ' ' LEU . 72.0 m-85 -98.9 -170.14 1.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.626 -0.671 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.11 94.58 1.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -97.43 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.915 0.864 . . . . 0.0 111.173 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 166.25 20.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.257 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.045 0.45 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.1 m -136.61 -71.07 0.45 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 18' ' ' THR . 43.6 m 49.86 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.313 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.718 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -87.36 142.49 27.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.638 -0.664 . . . . 0.0 109.654 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.781 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.1 mtmt -100.1 -176.45 3.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 53' ' ' PHE . 1.2 tp -164.43 112.65 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.443 -0.786 . . . . 0.0 110.342 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.45 118.12 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.882 HD11 HD23 ' A' ' 6' ' ' LEU . 2.4 mp -90.21 116.38 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.013 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -92.88 151.99 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.0 110.254 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.52 -155.41 16.27 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.11 31.48 6.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.924 . . . . 0.0 110.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -93.34 -147.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.674 -0.642 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.3 pp -53.91 -36.48 62.78 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 111.309 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.692 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.6 mtpt 50.9 99.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 111.538 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.12 -167.55 37.78 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.334 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -115.74 -64.84 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.814 -0.815 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.729 HD12 ' OH ' ' A' ' 34' ' ' TYR . 83.1 mt 52.36 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.372 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 5' ' ' LYS . 68.3 p -59.27 150.19 26.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -143.32 134.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.519 -0.738 . . . . 0.0 110.89 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.99 138.37 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -155.94 154.65 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.44 -38.67 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -159.78 179.92 8.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.664 . . . . 0.0 109.429 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.718 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.29 -34.42 78.29 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.749 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.95 75.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -70.91 -44.61 65.85 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.06 74.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -59.65 -39.16 83.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.626 -0.671 . . . . 0.0 109.275 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -68.37 -50.06 55.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.184 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.98 -37.49 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -75.97 -38.29 57.66 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.413 0.625 . . . . 0.0 109.321 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.9 mmtp -71.62 -5.09 31.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.777 -0.577 . . . . 0.0 111.479 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.97 -45.16 4.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.729 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.284 0.7 OUTLIER -51.22 -38.04 50.25 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.039 176.293 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.89 -47.95 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.252 0.549 . . . . 0.0 110.246 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -56.53 -51.28 69.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.521 -0.737 . . . . 0.0 110.919 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -57.11 -21.13 29.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.548 -0.72 . . . . 0.0 111.082 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' HD13 ' A' ' 40' ' ' ILE . 4.3 m120 -101.61 -25.57 13.83 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 106.81 28.7 4.94 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.54 105.85 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.653 -0.91 . . . . 0.0 108.581 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -143.24 108.94 5.12 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.53 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.22 -109.89 0.23 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.31 177.75 4.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.41 -1.053 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' NE1' HG23 ' A' ' 55' ' ' VAL . 39.8 m95 -155.83 130.52 9.09 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.538 -0.726 . . . . 0.0 109.687 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -145.45 134.89 23.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.454 -0.779 . . . . 0.0 109.202 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.6 t80 -98.81 148.28 24.06 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.28 96.72 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -69.05 -6.68 29.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.699 -0.626 . . . . 0.0 111.403 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.78 20.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 109.605 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -124.76 7.5 8.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.758 -0.589 . . . . 0.0 110.121 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 53.99 38.57 29.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.2 m -128.54 134.76 48.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.691 . . . . 0.0 110.751 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.922 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.0 m-85 -90.9 -168.97 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.92 97.42 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.2 p -101.42 103.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.121 0.962 . . . . 0.0 111.253 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -82.35 171.62 13.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.033 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mtp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.006 0.431 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 2' ' ' THR . 80.6 m -93.76 54.54 2.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -84.13 104.29 14.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.3 m-85 -88.83 151.32 22.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.805 ' HG2' HG22 ' A' ' 18' ' ' THR . 42.4 mttt -113.19 -170.83 1.76 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.1 tp -163.69 99.97 0.9 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 110.233 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.78 115.35 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 13' ' ' LEU . 15.6 mm -82.64 103.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.745 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 8.0 t-20 -71.24 167.06 20.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.496 -0.752 . . . . 0.0 110.238 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 -153.17 26.32 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.76 36.03 4.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.954 . . . . 0.0 109.917 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.677 HG21 HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -82.63 -151.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.635 -0.666 . . . . 0.0 110.097 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.677 HD11 HG13 ' A' ' 8' ' ' ILE . 2.5 pp -48.75 -26.95 2.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 111.027 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.66 103.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.637 -0.664 . . . . 0.0 111.576 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.41 153.36 8.18 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.437 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -108.77 54.73 0.65 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.834 -0.804 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.663 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.5 tt -50.99 128.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.303 -0.873 . . . . 0.0 110.779 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.805 HG22 ' HG2' ' A' ' 5' ' ' LYS . 47.5 p -99.13 141.05 32.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.332 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.7 pp -142.99 143.14 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.669 . . . . 0.0 110.548 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -83.85 146.36 28.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.88 159.01 29.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.731 . . . . 0.0 110.454 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.14 -39.32 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.754 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-20 -159.76 176.65 11.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.53 -29.96 70.94 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.738 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.75 80.58 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.819 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.99 -41.35 77.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.08 -44.25 82.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.634 -0.666 . . . . 0.0 109.529 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -59.33 -37.9 78.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.71 -0.619 . . . . 0.0 109.368 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -50.7 46.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.268 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.81 -36.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.739 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -77.06 -37.09 55.36 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.2 mmmt -77.68 1.69 19.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.662 -0.649 . . . . 0.0 111.351 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -108.8 -45.17 3.87 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.08 -38.47 62.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.068 176.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.47 -49.36 71.7 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -57.5 -48.51 79.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.513 -0.742 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.24 -23.55 36.65 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.395 -0.816 . . . . 0.0 110.956 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.3 m-80 -101.34 -25.28 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.691 -0.631 . . . . 0.0 110.599 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.63 32.39 3.65 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.751 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.21 106.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.69 -0.888 . . . . 0.0 108.765 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -148.65 103.2 3.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.749 -0.594 . . . . 0.0 110.948 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.77 -58.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HB2' HG22 ' A' ' 56' ' ' THR . 2.5 tp10 -152.19 174.8 13.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.576 -0.955 . . . . 0.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 43.3 m95 -158.42 127.54 5.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.67 -0.644 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.6 p -145.03 132.43 20.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.627 -0.671 . . . . 0.0 109.521 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.4 t80 -96.2 146.64 24.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.95 98.43 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.774 -0.579 . . . . 0.0 109.533 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.18 -6.06 31.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.95 -27.07 18.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -124.77 5.81 8.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.603 -0.686 . . . . 0.0 110.05 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.9 mmtt 54.39 40.72 31.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -132.63 137.79 47.13 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.124 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.2 m-85 -92.36 -172.94 3.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.578 -0.701 . . . . 0.0 109.353 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.62 105.12 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 108.548 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.9 p -115.22 133.37 61.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.658 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -120.88 -174.35 2.8 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.774 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.144 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.085 0.469 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 2' ' ' THR . 28.8 m -106.4 42.93 1.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.265 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -66.94 85.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.474 -0.766 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -70.2 142.01 52.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.685 -0.634 . . . . 0.0 109.817 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.512 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -108.3 177.22 4.86 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.541 -0.724 . . . . 0.0 110.198 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.813 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.6 tp -152.53 109.71 3.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.37 108.44 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.757 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.3 mm -84.92 118.78 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.957 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -110.95 140.66 45.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.69 -149.66 21.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -121.58 14.64 11.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.005 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -113.57 -56.68 2.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.757 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.7 mt -115.01 167.55 10.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.795 -0.566 . . . . 0.0 109.501 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.46 92.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 110.701 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.28 173.99 24.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -100.71 156.76 17.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.799 -0.824 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.77 -16.65 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.601 -0.687 . . . . 0.0 110.53 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.512 HG22 ' CG ' ' A' ' 5' ' ' LYS . 48.7 p 46.32 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.579 -0.701 . . . . 0.0 111.842 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -132.26 132.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.476 -0.765 . . . . 0.0 110.372 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.14 150.45 38.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.644 -0.66 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.17 163.01 28.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.636 . . . . 0.0 110.4 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.4 p -55.55 -34.24 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.2 p30 -166.93 176.26 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.729 -0.607 . . . . 0.0 109.376 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.76 -29.88 71.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.89 87.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' CD ' HG12 ' A' ' 22' ' ' VAL . 17.9 tt0 -70.95 -42.71 69.44 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.29 84.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.617 -0.677 . . . . 0.0 109.558 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -59.08 -34.18 71.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 109.487 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -71.09 -52.35 19.93 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.91 -35.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.813 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.8 m-85 -75.55 -38.95 58.9 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.9 mtpt -79.84 5.25 14.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 111.49 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -110.04 -45.4 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.0 t80 -54.05 -43.72 70.44 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.177 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.0 -49.11 78.95 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.834 -0.541 . . . . 0.0 110.197 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -56.91 -48.39 78.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.727 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.56 -21.57 39.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.599 -0.688 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 40' ' ' ILE . 2.1 m120 -103.09 -27.87 12.31 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.599 -0.688 . . . . 0.0 110.596 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.25 29.63 3.65 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.763 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.76 110.49 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.918 . . . . 0.0 109.035 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.22 110.22 3.9 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.335 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.43 -97.69 0.13 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.5 tt0 -123.78 129.01 50.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.39 -1.065 . . . . 0.0 111.483 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' HG23 ' A' ' 55' ' ' VAL . 48.1 m95 -107.6 135.9 48.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.428 -0.795 . . . . 0.0 110.405 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -145.63 131.83 19.45 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -99.19 141.05 32.46 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.774 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -110.9 100.9 9.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.641 -0.662 . . . . 0.0 109.596 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.99 -4.26 23.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.664 -0.648 . . . . 0.0 111.637 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.77 19.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -131.9 8.47 4.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 110.13 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp 54.03 42.94 31.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.216 -0.928 . . . . 0.0 110.233 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -125.75 129.74 50.08 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.626 -0.671 . . . . 0.0 110.787 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.534 ' HB2' HD12 ' A' ' 6' ' ' LEU . 84.2 m-85 -87.46 -173.41 4.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.502 -0.749 . . . . 0.0 109.705 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.32 99.01 1.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -101.77 101.43 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.869 0.843 . . . . 0.0 111.105 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.62 171.96 14.36 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.135 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.108 0.48 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.485 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.8 m -85.07 -72.88 0.46 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.573 -0.704 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m 50.1 72.23 0.34 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.275 -0.891 . . . . 0.0 111.075 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.726 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.3 m-85 -67.86 139.61 56.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -178.84 3.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.794 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -159.52 109.39 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.664 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.07 124.89 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.802 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.7 mm -98.71 115.38 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.089 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -93.12 152.58 19.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.74 . . . . 0.0 109.54 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.18 -151.84 18.31 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -116.85 -24.48 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.543 -0.975 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -58.87 -60.52 3.72 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.802 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.7 mt -120.32 174.52 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.117 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -175.38 75.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.817 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.68 -176.33 34.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 38.8 mt-10 -108.61 -28.16 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.779 -0.836 . . . . 0.0 110.381 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 16' ' ' GLU . 3.7 mt 65.93 -60.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 O-C-N 121.879 -0.513 . . . . 0.0 111.568 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 19' ' ' ILE . 1.9 p 61.49 118.63 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.477 -0.764 . . . . 0.0 110.546 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -148.99 133.93 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.573 -0.704 . . . . 0.0 110.286 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.68 145.22 36.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.595 -0.691 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.03 165.69 34.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.745 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.78 -39.62 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.545 -0.722 . . . . 0.0 110.447 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 50.9 p30 -161.17 177.26 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.728 -0.608 . . . . 0.0 109.375 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.63 -29.5 70.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 0.0 109.731 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.72 -52.49 63.73 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.02 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -64.13 -42.77 96.7 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.85 75.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 109.601 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 23.6 tt0 -58.73 -37.31 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.315 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -52.64 36.98 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.83 -40.53 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.794 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -72.1 -38.83 69.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 5.9 mmtp -73.88 -2.43 23.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.669 -0.644 . . . . 0.0 111.522 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -107.2 -44.94 4.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 1.4 t80 -52.44 -36.81 55.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.206 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.12 -50.98 51.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.758 -0.589 . . . . 0.0 110.23 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -56.25 -49.88 72.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 110.903 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -23.97 41.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.402 -0.811 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -99.16 -26.89 14.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.776 -0.577 . . . . 0.0 110.395 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 30.0 4.0 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.746 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.39 107.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.584 -0.95 . . . . 0.0 109.007 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -151.78 100.62 2.69 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.647 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.93 -55.27 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 29.3 tt0 -145.47 169.56 18.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.479 -1.012 . . . . 0.0 110.535 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.6 m95 -159.95 125.62 4.13 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.849 -0.532 . . . . 0.0 109.687 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.81 131.68 19.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 109.371 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.4 t80 -96.63 151.19 19.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.702 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -124.73 99.45 6.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.676 -0.64 . . . . 0.0 109.592 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.77 -4.25 22.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.654 . . . . 0.0 111.523 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.94 -27.79 19.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -127.92 7.53 6.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 54.82 42.13 31.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.9 m -130.22 141.79 50.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 110.91 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.5 m-85 -98.44 -173.97 2.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.523 -0.736 . . . . 0.0 109.104 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 102.29 2.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.863 -1.148 . . . . 0.0 108.688 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.486 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.6 p -117.19 146.24 21.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.165 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -138.12 177.9 7.53 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.231 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.17 0.51 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 2' ' ' THR . 46.3 m -110.28 28.08 8.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.739 . . . . 0.0 110.217 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -62.91 94.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.591 -0.693 . . . . 0.0 110.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.5 m-85 -78.05 149.25 33.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.067 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 52' ' ' THR . 12.1 ttpt -108.71 -174.45 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 110.389 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.849 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.7 tp -163.13 97.92 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.16 117.06 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' CB ' ' A' ' 13' ' ' LEU . 9.9 mm -85.03 110.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.861 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 7.2 t-20 -85.41 7.28 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.72 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.88 -174.67 41.15 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -110.77 26.67 10.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.928 . . . . 0.0 110.379 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 p -125.94 24.51 6.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.617 -0.677 . . . . 0.0 110.284 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 HG12 ' A' ' 40' ' ' ILE . 1.5 mt -172.69 -67.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.76 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.742 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.67 144.1 3.99 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -102.14 61.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.645 -0.914 . . . . 0.0 110.738 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -57.42 148.08 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.208 -0.932 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 3' ' ' THR . 7.3 p -115.72 136.07 53.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.888 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.07 145.78 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.556 -0.715 . . . . 0.0 110.314 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 155.83 24.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.609 -0.682 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.36 159.2 8.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.62 -39.26 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.7 m-20 -159.25 173.35 16.47 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.55 -35.78 76.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.405 -0.809 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.18 -46.76 72.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.467 -0.771 . . . . 0.0 109.925 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.763 ' OE1' HD11 ' A' ' 30' ' ' ILE . 1.6 tm-20 -66.67 -45.19 79.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.31 -39.48 69.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.419 -0.8 . . . . 0.0 109.819 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -62.12 -39.54 92.89 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.43 -34.48 65.46 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.353 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.763 HD11 ' OE1' ' A' ' 26' ' ' GLU . 98.0 mt -68.59 -39.66 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.849 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.31 -36.89 66.31 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 30.1 mttt -75.74 -2.44 29.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.732 -0.605 . . . . 0.0 111.301 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -104.13 -44.97 4.85 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.293 8.8 t80 -53.56 -42.14 67.23 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.731 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.72 -52.16 58.59 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.813 -0.555 . . . . 0.0 110.135 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.19 -49.14 74.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.725 . . . . 0.0 110.679 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.77 -23.48 18.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.58 -0.7 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -102.31 -28.14 12.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.733 -0.604 . . . . 0.0 110.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 30.08 2.96 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.754 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 106.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.985 . . . . 0.0 109.002 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -150.17 105.82 3.41 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.27 0.557 . . . . 0.0 110.715 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.8 -57.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' CB ' HG22 ' A' ' 56' ' ' THR . 15.1 tt0 -148.55 171.97 15.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.564 -0.963 . . . . 0.0 110.224 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 45.9 m95 -157.22 128.56 6.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.69 -0.631 . . . . 0.0 109.859 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -145.8 131.96 19.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.615 -0.678 . . . . 0.0 109.409 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.1 t80 -97.49 127.17 43.24 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.59 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.65 98.88 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.651 -0.655 . . . . 0.0 109.316 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.88 -5.41 25.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.65 -0.656 . . . . 0.0 111.583 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.46 21.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 109.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -128.4 8.06 5.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 110.171 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt 54.95 40.38 31.99 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 5' ' ' LYS . 57.6 m -125.11 125.48 43.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.717 ' HB2' HD12 ' A' ' 6' ' ' LEU . 83.2 m-85 -80.26 -176.12 5.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.359 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.13 106.67 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.939 -1.1 . . . . 0.0 108.235 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 6.3 p -117.09 133.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.101 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.605 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -124.41 -170.04 2.08 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.908 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.195 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.064 0.459 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 95.3 m -125.49 -74.42 0.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.597 HG22 ' HB ' ' A' ' 18' ' ' THR . 22.1 m 50.24 79.77 0.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.258 -0.901 . . . . 0.0 111.252 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.9 m-85 -78.45 147.82 33.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 18' ' ' THR . 7.2 mptt -112.45 -172.25 2.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.511 -0.743 . . . . 0.0 110.17 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.729 HD22 ' CD1' ' A' ' 31' ' ' PHE . 19.3 tp -163.08 105.68 1.02 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.444 -0.785 . . . . 0.0 110.204 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.55 114.86 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -89.95 113.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.722 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -83.37 -161.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.229 -0.919 . . . . 0.0 109.285 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -163.1 13.65 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -114.58 28.18 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.607 -0.937 . . . . 0.0 110.406 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -66.25 -78.21 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.801 HD11 HG13 ' A' ' 8' ' ' ILE . 4.5 pp -132.21 -27.26 1.82 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.728 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' N ' HD12 ' A' ' 13' ' ' LEU . 70.2 mttt 56.69 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.452 -0.78 . . . . 0.0 111.492 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.37 161.33 20.73 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -130.6 58.31 1.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.884 -0.774 . . . . 0.0 109.711 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.99 110.97 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.549 -0.72 . . . . 0.0 109.755 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.88 HG22 ' CG ' ' A' ' 5' ' ' LYS . 81.7 p -75.84 144.84 41.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -147.33 133.11 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.6 153.6 35.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.522 -0.736 . . . . 0.0 110.162 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.14 162.3 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.65 -0.656 . . . . 0.0 110.31 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -53.8 -39.1 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.692 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' HG13 ' A' ' 22' ' ' VAL . 40.5 p30 -163.51 177.19 9.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 109.526 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.43 -29.66 70.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.05 -49.77 72.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 0.0 110.008 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.33 -43.36 81.8 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.49 71.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.57 -0.706 . . . . 0.0 109.856 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.7 tt0 -58.29 -36.75 73.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.64 -0.663 . . . . 0.0 109.332 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.01 -52.24 25.73 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -57.53 -37.58 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.729 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.99 -36.69 62.0 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -77.86 2.28 17.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.665 -0.647 . . . . 0.0 111.371 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -105.7 -45.83 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 1.4 t80 -53.38 -46.7 69.73 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.928 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.85 -49.25 77.32 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.635 -0.665 . . . . 0.0 110.139 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.81 -50.59 72.78 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.647 -0.658 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -56.46 -24.56 46.52 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.483 -0.761 . . . . 0.0 110.69 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.44 -26.55 14.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.694 -0.628 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.64 33.69 3.26 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.754 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -99.11 114.47 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -157.58 104.44 1.99 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.308 0.575 . . . . 0.0 110.945 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.53 -47.15 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.908 ' HB3' HG22 ' A' ' 56' ' ' THR . 45.0 tt0 -142.2 164.97 28.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.47 -1.017 . . . . 0.0 110.75 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.489 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 41.4 m95 -164.1 112.33 1.15 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 19.0 p -137.9 131.05 30.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.9 t80 -93.84 143.66 26.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.78 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -114.7 98.28 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.786 -0.571 . . . . 0.0 109.522 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -70.17 -4.76 23.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.584 -0.697 . . . . 0.0 111.598 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.81 -27.76 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -126.14 7.62 7.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.604 . . . . 0.0 110.087 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp 53.85 41.53 32.02 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.185 -0.947 . . . . 0.0 110.192 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.698 HG23 ' HB2' ' A' ' 5' ' ' LYS . 7.3 m -132.31 137.23 47.37 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.68 -0.637 . . . . 0.0 110.762 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.2 m-85 -92.0 -172.74 3.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.697 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 103.57 2.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 108.478 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 ' CG1' HD13 ' A' ' 8' ' ' ILE . 7.7 p -118.63 152.95 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.198 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.908 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -156.16 -162.44 1.29 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.904 -0.497 . . . . 0.0 109.986 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.049 179.72 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.05 0.452 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 2' ' ' THR . 72.1 m -115.17 55.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.585 -0.697 . . . . 0.0 110.188 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.9 m -77.42 92.99 4.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.544 -0.722 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 14.2 m-85 -76.74 144.77 39.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.688 -0.633 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.829 ' HG2' HG22 ' A' ' 18' ' ' THR . 35.7 mtmt -106.6 -179.2 3.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 0.0 110.041 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.865 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -158.09 110.11 2.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.574 -0.704 . . . . 0.0 109.823 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.43 124.81 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 34' ' ' TYR . 7.0 mm -89.95 108.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.83 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -92.92 54.6 2.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 110.121 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.05 -131.65 2.92 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.43 50.59 0.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.945 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 p -138.72 -59.91 0.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.705 . . . . 0.0 110.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 21.8 mt -95.26 -54.58 3.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.367 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.96 82.62 0.07 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.432 -0.792 . . . . 0.0 110.599 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.88 -167.82 37.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.42 -50.88 2.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.915 . . . . 0.0 110.545 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.4 mm 53.7 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.356 -0.84 . . . . 0.0 110.188 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.829 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.2 p -76.55 133.81 39.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.623 -0.673 . . . . 0.0 110.555 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -137.32 140.86 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.571 -0.705 . . . . 0.0 110.276 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.32 150.4 28.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.58 161.56 23.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.676 -0.64 . . . . 0.0 110.248 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.66 -39.61 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.557 -0.714 . . . . 0.0 110.57 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.0 m-20 -158.77 175.99 12.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.0 -33.27 75.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.24 69.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.0 109.852 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -63.53 -43.11 98.09 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.36 70.25 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.467 -0.77 . . . . 0.0 109.84 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.2 tt0 -58.71 -36.56 74.47 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.37 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -67.53 -52.97 32.6 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.21 -38.83 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.3 m-85 -74.31 -34.57 63.53 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 18.2 mmmt -74.92 -3.25 31.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.75 -0.594 . . . . 0.0 111.22 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -105.74 -45.65 4.34 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.88 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.29 6.7 t80 -50.84 -32.46 20.28 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.809 175.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.711 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.58 -63.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.74 0.781 . . . . 0.0 109.277 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -55.46 -41.68 73.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.111 0.481 . . . . 0.0 110.914 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.5 -27.2 4.04 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.4 -56.21 2.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.371 0.605 . . . . 0.0 110.049 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.67 61.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.711 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -117.97 134.93 59.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.838 -0.801 . . . . 0.0 109.816 -177.536 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.31 106.42 0.57 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.837 . . . . 0.0 111.195 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.08 -107.46 0.2 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -115.84 176.23 5.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.467 -1.019 . . . . 0.0 110.166 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.2 m95 -151.72 129.18 11.37 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.638 -0.664 . . . . 0.0 109.881 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.74 134.28 30.05 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.301 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.6 t80 -99.41 148.84 23.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -120.71 98.25 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 -6.32 30.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.646 -0.659 . . . . 0.0 111.478 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.6 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 109.557 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 6.54 8.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.624 -0.672 . . . . 0.0 110.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.3 mmtp 54.07 38.25 28.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 5' ' ' LYS . 8.0 m -126.39 143.13 51.28 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.038 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.832 ' HB2' HD12 ' A' ' 6' ' ' LEU . 66.9 m-85 -99.54 -169.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.533 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -157.27 90.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.803 -1.186 . . . . 0.0 108.254 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.485 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -90.4 97.94 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.794 0.806 . . . . 0.0 110.688 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -78.25 170.89 15.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.327 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 4' ' ' PHE . 38.0 m -134.48 34.05 3.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.617 -0.677 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.62 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 m -69.2 105.7 2.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' HG22 ' A' ' 2' ' ' THR . 43.9 m-85 -88.31 140.26 29.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.672 -0.643 . . . . 0.0 110.443 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.822 ' CG ' HG22 ' A' ' 18' ' ' THR . 5.9 mptt -104.98 -174.81 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.867 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.6 tp -161.21 110.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.86 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' GLY . 74.3 mt -97.64 133.41 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.512 HD13 ' CG1' ' A' ' 55' ' ' VAL . 21.7 mm -87.66 107.48 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.95 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.631 ' HB2' HG22 ' A' ' 54' ' ' THR . 26.9 t-20 -75.61 66.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.762 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.62 -135.98 1.95 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -171.19 50.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.518 -0.989 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 13' ' ' LEU . 52.3 m -140.2 23.8 2.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.518 -0.739 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 12' ' ' THR . 0.4 OUTLIER -177.61 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.48 -0.762 . . . . 0.0 111.066 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 55.68 110.19 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.331 -0.855 . . . . 0.0 110.752 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -145.43 135.93 6.23 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.255 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -162.67 28.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 122.08 -0.659 . . . . 0.0 109.67 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.0 -171.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.822 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.1 p -138.61 129.12 26.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -135.56 136.09 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 110.82 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.18 160.17 20.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.613 -0.679 . . . . 0.0 110.043 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.41 171.25 7.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG12 ' OE1' ' A' ' 26' ' ' GLU . 7.7 p -53.77 -36.43 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.533 -0.729 . . . . 0.0 110.424 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -166.93 173.38 9.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.67 -0.644 . . . . 0.0 109.336 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -60.58 -31.39 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.48 -46.83 76.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.682 ' OE1' HG12 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -66.76 -45.69 77.76 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.03 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.03 -45.02 67.81 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 109.759 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.28 -38.09 76.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.656 -0.652 . . . . 0.0 109.383 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -68.61 -52.83 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.612 -0.68 . . . . 0.0 109.182 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -55.66 -40.38 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -72.29 -32.64 66.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -80.4 4.41 18.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.761 -0.587 . . . . 0.0 111.102 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -104.56 -45.51 4.61 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.299 1.1 t80 -50.34 -40.66 49.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.15 -1.387 . . . . 0.0 108.827 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -44.68 86.15 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.039 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.389 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.0 -23.61 20.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.57 -0.706 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.66 -20.68 13.9 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 100.56 36.55 4.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.776 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -99.03 119.44 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.91 . . . . 0.0 109.186 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -152.16 71.63 0.97 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.373 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -112.22 2.34 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -108.65 174.13 6.01 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.489 -1.006 . . . . 0.0 110.533 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.1 m95 -151.11 134.46 16.15 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.632 -0.667 . . . . 0.0 110.0 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.2 p -142.94 133.0 24.32 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.369 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -97.52 147.29 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.608 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -119.05 102.0 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.617 -0.677 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.4 -5.64 29.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.718 -0.614 . . . . 0.0 111.411 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.59 -28.76 20.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.9 p -127.2 7.17 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.703 . . . . 0.0 110.06 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 54.44 38.26 29.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.188 -0.945 . . . . 0.0 110.203 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 5' ' ' LYS . 18.6 m -124.49 149.69 46.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 6' ' ' LEU . 68.0 m-85 -102.17 -169.33 1.66 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.515 -0.741 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -157.7 92.6 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.7 p -91.64 104.8 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.907 0.861 . . . . 0.0 110.649 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -78.13 156.55 29.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.137 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.065 0.46 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 59.6 m -104.26 40.57 1.44 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.077 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 18' ' ' THR . 16.2 m -72.04 103.04 3.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.568 -0.708 . . . . 0.0 110.18 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 25.9 m-85 -88.44 149.01 23.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.868 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -113.63 -173.84 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.9 tp -160.47 109.14 1.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.526 -0.734 . . . . 0.0 110.16 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.28 120.12 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 55' ' ' VAL . 6.2 mm -84.84 114.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.401 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -101.49 53.47 0.83 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.529 -0.732 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.1 1.9 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -166.34 47.52 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.585 -0.95 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.7 m -140.54 -45.7 0.41 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.67 -0.644 . . . . 0.0 109.995 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 12.3 mt -106.88 -57.71 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 52.84 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.16 172.2 43.14 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -127.58 59.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.888 . . . . 0.0 110.098 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.89 136.4 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.824 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.868 HG22 ' CG ' ' A' ' 5' ' ' LYS . 77.8 p -103.35 136.69 42.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.246 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.456 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.3 135.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -78.3 154.31 31.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.571 -0.706 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.37 164.15 17.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.388 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.82 -39.49 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.48 -0.762 . . . . 0.0 110.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.8 m-20 -161.44 173.53 14.76 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.67 -29.09 69.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 -45.86 85.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 109.631 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.84 -42.24 77.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.51 81.97 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.611 -0.68 . . . . 0.0 109.488 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.4 tt0 -58.63 -37.22 75.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.289 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -68.73 -51.56 40.12 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.93 -40.34 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.787 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -71.63 -36.96 70.91 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -77.78 1.9 18.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.62 -0.675 . . . . 0.0 111.43 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -106.5 -45.41 4.26 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.747 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.292 8.7 t80 -52.97 -31.74 42.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.743 175.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.26 -63.24 1.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.705 0.764 . . . . 0.0 109.234 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -55.31 -40.99 71.77 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.082 0.468 . . . . 0.0 110.72 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.82 -27.06 4.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.672 -0.642 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -107.15 -53.26 2.64 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.367 0.603 . . . . 0.0 110.192 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.83 62.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -119.24 134.73 61.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.896 -0.767 . . . . 0.0 109.898 -177.352 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -169.68 100.03 0.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.324 -0.86 . . . . 0.0 111.242 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.57 -101.44 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 4.1 tt0 -125.23 134.65 52.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.463 -1.022 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.468 ' NE1' HG23 ' A' ' 55' ' ' VAL . 43.7 m95 -112.98 132.52 55.32 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.9 p -144.43 132.53 21.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.92 137.77 36.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.731 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -107.75 98.72 8.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.69 -0.631 . . . . 0.0 109.524 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -69.07 -6.69 29.82 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.652 -0.655 . . . . 0.0 111.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.25 19.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.9 p -124.62 6.81 8.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.67 . . . . 0.0 110.121 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt 54.41 38.98 30.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.178 -0.952 . . . . 0.0 110.086 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 5' ' ' LYS . 6.5 m -126.84 138.39 53.33 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.582 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.593 ' HB2' HD12 ' A' ' 6' ' ' LEU . 70.9 m-85 -92.45 -171.53 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.475 -0.766 . . . . 0.0 109.574 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.92 98.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -99.31 90.38 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.697 0.761 . . . . 0.0 111.062 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 170.97 9.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.305 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mtt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.141 0.496 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 2' ' ' THR . 55.8 m -130.96 35.66 3.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.588 -0.695 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.666 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.3 m -63.27 95.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.444 -0.785 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 12.5 m-85 -79.7 140.53 36.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 110.23 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.858 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.7 OUTLIER -104.06 179.64 4.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 110.071 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.856 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.3 tp -154.11 108.22 3.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.446 -0.784 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.7 mt -84.31 120.96 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.5 mm -90.06 112.6 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.087 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -95.27 148.63 22.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -138.62 14.18 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -132.42 42.74 3.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.976 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 14' ' ' LYS . 1.5 m -150.02 147.22 27.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.603 -0.686 . . . . 0.0 109.702 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.637 HD12 HG12 ' A' ' 40' ' ' ILE . 6.3 mt 61.59 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.864 -0.522 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' THR . 57.7 mttt 55.4 97.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.311 -0.868 . . . . 0.0 110.51 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.51 -176.42 44.74 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.54 -53.14 2.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.513 -0.992 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.9 mm 52.94 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' CG ' ' A' ' 5' ' ' LYS . 63.9 p -79.75 133.8 36.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 110.164 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.49 137.26 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.56 154.77 32.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.657 -0.652 . . . . 0.0 110.488 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.83 162.82 16.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -54.99 -38.93 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.592 -0.693 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -161.61 174.56 13.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.26 -28.86 68.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 109.827 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.65 72.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 109.83 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.3 -43.38 98.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.78 80.99 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.645 -0.659 . . . . 0.0 109.553 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.1 tt0 -59.73 -33.74 72.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.704 -0.622 . . . . 0.0 109.48 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -75.98 -45.25 35.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 66.8 mt -62.7 -38.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.856 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -73.23 -37.99 66.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -73.64 -2.87 24.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 111.378 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -104.1 -45.33 4.75 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.611 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.292 4.4 t80 -50.41 -37.14 36.15 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.103 176.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -47.17 76.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.276 0.56 . . . . 0.0 110.161 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -58.98 -47.17 86.12 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.584 -0.697 . . . . 0.0 110.546 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.47 -19.49 48.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.614 -0.679 . . . . 0.0 110.811 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -104.41 -27.68 11.8 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.559 -0.713 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.3 31.5 3.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.75 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.17 120.91 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.909 . . . . 0.0 109.402 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -152.47 108.1 3.32 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.317 0.579 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.69 -110.5 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -109.33 177.04 4.87 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -1.012 . . . . 0.0 110.672 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.8 m95 -153.15 132.8 13.05 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.605 -0.684 . . . . 0.0 109.803 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.3 p -144.15 132.72 22.23 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.469 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 t80 -98.56 138.92 35.06 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.848 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -108.15 100.67 9.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.561 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.12 -5.36 26.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.586 -0.696 . . . . 0.0 111.549 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.28 -28.01 18.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.553 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -126.21 6.89 7.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.665 -0.647 . . . . 0.0 110.213 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 54.3 39.35 30.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.125 -0.984 . . . . 0.0 109.946 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.4 m -124.7 140.99 52.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.655 -0.653 . . . . 0.0 110.549 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.785 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -95.79 -171.53 2.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 0.0 109.538 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.28 93.27 1.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.16 106.73 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.917 0.865 . . . . 0.0 111.019 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -86.11 170.39 12.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.218 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttm . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.097 0.475 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.3 m -104.23 -75.31 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.528 -0.732 . . . . 0.0 110.301 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.6 m 50.17 78.01 0.11 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.14 -0.975 . . . . 0.0 111.111 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.743 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.5 m-85 -75.52 144.57 41.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.552 -0.718 . . . . 0.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -106.39 -174.4 2.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.615 -0.678 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.829 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.9 tp -160.77 102.79 1.33 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' CD1' HG21 ' A' ' 52' ' ' THR . 22.1 mt -84.47 133.32 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mm -101.85 119.33 49.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.986 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 54' ' ' THR . 32.4 m-20 -67.85 -52.15 40.08 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.844 . . . . 0.0 110.255 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -156.08 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.07 15.39 4.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.907 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -60.02 -69.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.212 -0.93 . . . . 0.0 109.438 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' C ' HD12 ' A' ' 13' ' ' LEU . 1.5 pp -122.47 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 20.5 ptmt -33.74 137.25 0.1 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.13 30.44 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.598 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -140.82 47.57 1.74 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 17' ' ' ILE . 4.6 tp -51.4 115.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.807 HG22 ' HG2' ' A' ' 5' ' ' LYS . 60.4 p -83.76 144.91 29.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.636 -0.665 . . . . 0.0 110.009 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -143.19 134.74 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.56 137.8 39.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.7 -0.625 . . . . 0.0 110.14 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.39 37.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.63 -0.669 . . . . 0.0 110.228 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -53.77 -39.95 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.0 110.586 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.1 m-20 -159.62 179.47 8.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.622 . . . . 0.0 109.398 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.29 -29.15 70.24 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.679 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.0 70.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.19 -41.93 85.04 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -48.32 72.09 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.541 -0.724 . . . . 0.0 109.881 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.566 -0.709 . . . . 0.0 109.368 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -69.04 -52.44 28.57 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -58.49 -36.58 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.4 m-85 -75.28 -38.93 60.15 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -76.14 0.4 19.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 111.657 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -105.96 -45.27 4.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE1' HD22 ' A' ' 13' ' ' LEU 0.287 2.2 t80 -51.12 -38.8 54.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.933 176.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.62 -48.85 70.83 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -60.47 -48.17 82.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.517 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -55.69 -25.29 39.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.51 -0.743 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -99.51 -27.68 13.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.722 -0.611 . . . . 0.0 110.287 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 107.36 45.27 1.17 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.788 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -107.87 126.59 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.668 -0.901 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.33 101.97 1.08 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.545 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.48 -57.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.805 ' HB2' HG22 ' A' ' 56' ' ' THR . 62.5 mt-10 -149.49 169.19 21.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.465 -1.02 . . . . 0.0 110.634 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.521 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 50.1 m95 -159.76 121.0 3.18 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.4 p -143.08 132.13 23.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.593 -0.692 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.1 t80 -96.8 144.32 26.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.042 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.15 99.76 7.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.0 -5.32 25.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.651 -0.655 . . . . 0.0 111.499 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.86 20.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -129.01 8.22 5.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.625 -0.672 . . . . 0.0 110.131 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 15.9 mmtm 53.78 41.57 32.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.2 m -126.44 130.91 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.596 -0.69 . . . . 0.0 110.69 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 69.6 m-85 -88.32 -173.61 4.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.503 -0.748 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -154.14 102.57 2.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.99 -1.069 . . . . 0.0 108.664 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.521 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 5.9 p -115.91 141.81 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 111.19 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.9 t -141.08 -174.23 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.961 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.242 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 ' CE2' ' A' ' 4' ' ' PHE . 24.7 m -132.95 34.52 3.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.522 -0.736 . . . . 0.0 110.383 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 m -75.85 103.8 6.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.517 -0.739 . . . . 0.0 110.078 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 57.0 m-85 -86.99 140.46 29.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.615 -0.678 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.919 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.1 mptt -107.23 -168.01 1.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 53' ' ' PHE . 11.8 tp -163.56 100.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 110.158 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CD1' HG21 ' A' ' 52' ' ' THR . 16.4 mt -83.54 132.46 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' VAL . 7.1 mm -102.48 119.28 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.141 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.445 HD21 HG22 ' A' ' 54' ' ' THR . 21.5 m-20 -69.16 -26.68 64.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.449 -0.782 . . . . 0.0 110.307 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.19 37.49 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -102.56 -23.96 13.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.947 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' HD11 ' A' ' 40' ' ' ILE . 70.1 p -59.04 124.7 20.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.354 -0.841 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 50.63 27.21 2.82 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 110.133 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 1.7 ptmm? -46.3 124.56 5.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.217 -0.927 . . . . 0.0 111.873 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.17 -165.92 30.91 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' CG ' ' HB3' ' A' ' 5' ' ' LYS . 29.0 tt0 -132.99 67.53 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.727 -0.867 . . . . 0.0 110.049 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mt -60.25 138.48 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.422 -0.799 . . . . 0.0 109.849 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 5' ' ' LYS . 71.5 p -110.54 138.5 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.663 -0.648 . . . . 0.0 110.833 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -144.18 142.47 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 157.01 18.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.551 -0.718 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.57 167.15 11.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.55 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.41 -39.29 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 110.42 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.1 m-20 -162.31 174.62 12.57 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.67 -29.17 69.9 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.44 81.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.03 -42.97 72.25 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.12 -43.91 78.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.648 -0.657 . . . . 0.0 109.528 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.2 tt0 -58.12 -39.66 79.26 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -50.83 48.27 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.2 -39.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.2 m-85 -73.55 -37.5 65.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 11.8 mtpp -81.49 8.16 10.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.676 -0.64 . . . . 0.0 111.367 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -111.65 -46.86 3.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.442 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.301 9.2 t80 -52.99 -41.1 64.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.146 175.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.804 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.25 -49.15 78.12 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.783 -0.573 . . . . 0.0 109.753 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.65 -47.46 81.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.764 -0.585 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -23.46 29.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.578 -0.701 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.88 -30.21 10.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.731 -0.606 . . . . 0.0 110.004 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 112.68 50.7 0.55 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.804 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.3 mp -115.34 132.63 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.453 -1.028 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -168.12 98.16 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.722 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.31 -56.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.8 ' HB2' HG22 ' A' ' 56' ' ' THR . 37.2 mt-10 -149.01 169.22 21.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.458 -1.025 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.556 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 49.6 m95 -160.39 121.99 3.12 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -145.42 131.61 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.507 -0.746 . . . . 0.0 109.564 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.5 t80 -93.24 144.25 25.48 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.748 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 100.08 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.752 -0.592 . . . . 0.0 109.775 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.24 -4.81 23.56 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.84 -28.94 18.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.509 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -126.77 8.34 6.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.69 -0.631 . . . . 0.0 110.169 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.6 mmtt 53.91 38.6 29.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.146 -0.971 . . . . 0.0 110.318 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.43 HG21 ' CD1' ' A' ' 7' ' ' ILE . 45.5 m -127.53 143.63 51.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.67 -0.644 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.3 m-85 -96.37 -171.64 2.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.48 -0.763 . . . . 0.0 109.74 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.445 HG22 HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER -153.32 102.42 2.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.05 -1.031 . . . . 0.0 108.497 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.579 HG11 HD21 ' A' ' 6' ' ' LEU . 5.7 p -116.34 142.56 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.114 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.8 HG22 ' HB2' ' A' ' 43' ' ' GLU . 3.7 t -140.15 -177.28 4.93 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.283 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.121 0.486 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 78.6 m -134.22 143.06 47.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.715 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 m -153.06 102.24 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.763 -0.586 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 55.6 m-85 -93.38 154.03 18.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.681 -0.637 . . . . 0.0 110.291 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.879 ' HG2' HG22 ' A' ' 18' ' ' THR . 34.6 mttt -113.96 -171.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.7 tp -163.42 108.41 1.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.463 -0.773 . . . . 0.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -85.59 120.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 HD13 ' CG1' ' A' ' 55' ' ' VAL . 8.6 mm -86.97 109.43 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.784 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -96.65 50.77 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.504 -0.747 . . . . 0.0 110.22 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.59 -118.59 1.99 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.47 47.12 0.19 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.572 -0.957 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -136.45 -62.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.146 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 mt -91.88 -52.64 4.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.99 81.85 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.496 -0.753 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -173.55 46.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.51 66.82 1.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.618 -0.931 . . . . 0.0 110.2 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.3 tt -60.34 119.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 109.921 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.879 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.1 p -89.34 140.16 29.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 110.435 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -145.52 149.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.723 . . . . 0.0 110.421 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.7 155.19 19.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.666 -0.646 . . . . 0.0 110.415 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.05 162.47 13.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.577 -0.702 . . . . 0.0 110.208 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.92 -38.11 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.289 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -162.44 176.88 10.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.36 -29.55 70.55 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.852 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.35 65.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.819 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -63.66 -38.87 92.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.39 78.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.9 tt0 -58.62 -36.25 73.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.638 -0.664 . . . . 0.0 109.355 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -67.71 -52.58 35.99 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.52 -38.5 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -74.04 -35.77 64.34 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.2 mmmt -75.98 -1.03 23.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.767 -0.583 . . . . 0.0 111.462 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -109.01 -45.43 3.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.294 12.7 t80 -51.33 -31.97 23.76 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.52 -62.34 1.65 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.874 0.845 . . . . 0.0 108.88 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -55.35 -41.55 72.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.822 -0.549 . . . . 0.0 110.797 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.39 -26.83 5.39 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.626 -0.672 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.5 -54.3 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.98 62.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.311 1.0 OUTLIER -119.09 134.96 61.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 0.0 109.84 -177.275 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -167.17 104.44 0.54 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.836 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.11 -107.91 0.21 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.6 tp10 -113.24 175.58 5.38 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -1.029 . . . . 0.0 110.398 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.464 ' CE2' HG23 ' A' ' 55' ' ' VAL . 37.9 m95 -152.55 129.04 10.68 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.654 -0.654 . . . . 0.0 109.825 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.79 133.65 25.49 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.371 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.3 t80 -97.4 135.15 39.69 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.658 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -103.18 98.96 8.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.356 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.6 -6.1 28.9 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.663 -0.648 . . . . 0.0 111.648 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.94 -27.47 17.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -123.53 5.97 8.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt 54.57 36.31 25.57 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.166 -0.959 . . . . 0.0 110.162 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 5' ' ' LYS . 17.1 m -126.35 140.54 52.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 62.6 m-85 -93.24 -169.0 2.04 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.37 94.63 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -95.87 100.12 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.908 0.861 . . . . 0.0 111.023 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -80.44 169.4 17.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.188 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 tmm? . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.988 0.423 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 2' ' ' THR . 59.9 m -98.26 45.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.548 -0.72 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.611 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.2 m -76.42 91.0 3.26 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.2 m-85 -76.98 143.94 39.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.632 . . . . 0.0 110.073 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.724 ' HG3' HG22 ' A' ' 18' ' ' THR . 5.0 mptt -110.51 -171.22 1.79 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.628 -0.67 . . . . 0.0 109.88 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.773 HD22 ' CD1' ' A' ' 31' ' ' PHE . 37.3 tp -162.21 112.35 1.53 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -0.87 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.63 106.99 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 13' ' ' LEU . 1.6 mm -82.87 110.72 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.153 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.32 147.66 23.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.53 -0.731 . . . . 0.0 110.1 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.97 -144.07 14.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' THR . 22.3 pttm -120.02 -33.0 4.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.951 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 2.6 m -75.15 110.83 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.442 -0.786 . . . . 0.0 110.038 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 59.36 159.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.922 ' N ' HD12 ' A' ' 13' ' ' LEU . 7.5 ptmt -169.99 127.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 179.13 37.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.74 69.37 1.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.704 -0.88 . . . . 0.0 109.941 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.4 pt -61.68 177.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.563 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.724 HG22 ' HG3' ' A' ' 5' ' ' LYS . 67.0 p -139.48 133.1 30.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.529 -0.732 . . . . 0.0 110.509 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -141.97 131.17 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.539 -0.726 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.89 156.08 32.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.11 163.79 13.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.649 -0.657 . . . . 0.0 110.207 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.6 -39.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.44 -0.787 . . . . 0.0 110.521 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -162.35 174.87 12.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.724 -0.61 . . . . 0.0 109.369 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.54 -27.71 66.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.466 -0.771 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -53.3 59.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HG3' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.67 -42.81 98.0 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.28 -49.29 72.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.624 -0.672 . . . . 0.0 109.618 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.13 -36.24 72.65 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.523 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -69.73 -53.75 16.98 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.7 -36.35 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.1 m-85 -75.44 -35.76 60.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -80.69 4.56 18.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.705 -0.622 . . . . 0.0 111.401 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -109.95 -45.38 3.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 3.9 t80 -53.51 -43.25 68.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.092 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.82 -49.31 78.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.816 -0.553 . . . . 0.0 110.178 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -57.21 -47.83 80.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.548 -0.72 . . . . 0.0 110.68 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -56.81 -22.6 37.51 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.646 -0.659 . . . . 0.0 110.987 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -102.9 -26.72 13.01 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.566 -0.709 . . . . 0.0 110.504 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.48 29.37 3.68 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.757 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.08 104.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -142.53 106.33 4.69 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.251 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.3 -103.15 0.18 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -107.46 176.29 5.21 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.44 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 44.1 m95 -156.92 128.79 7.19 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.71 -0.619 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.36 132.56 21.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 t80 -95.84 142.24 28.33 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.696 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -112.69 99.56 8.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.69 -0.632 . . . . 0.0 109.775 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -70.64 -4.6 24.21 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.611 -0.681 . . . . 0.0 111.456 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.67 -27.87 18.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 109.579 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -127.92 7.71 6.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp 54.53 40.68 32.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.165 -0.96 . . . . 0.0 110.194 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.3 m -129.81 139.92 51.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.663 -0.648 . . . . 0.0 110.335 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.2 m-85 -93.42 -168.39 1.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.894 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.13 98.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.5 p -102.49 119.43 50.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 122.035 0.921 . . . . 0.0 111.015 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -100.24 169.84 8.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.33 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ptt? . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 2' ' ' THR . 87.3 m -133.43 59.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 110.388 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.3 m -77.26 90.1 3.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.0 m-85 -74.11 141.12 45.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.619 -0.675 . . . . 0.0 109.956 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' THR . 21.3 mtmt -104.64 -177.54 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.62 -0.675 . . . . 0.0 110.238 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -164.34 118.16 1.4 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 110.826 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.9 mt -89.77 118.14 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mm -86.47 108.23 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.692 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -90.39 144.11 26.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 163.02 18.37 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -60.53 -26.65 67.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.647 -0.914 . . . . 0.0 110.379 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -76.16 125.62 29.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.595 -0.691 . . . . 0.0 110.074 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.795 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 56.09 169.04 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.569 -0.707 . . . . 0.0 110.561 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -179.64 90.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.77 -166.86 34.49 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -105.14 -42.23 5.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.713 -0.875 . . . . 0.0 110.441 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt 53.65 85.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.343 -0.848 . . . . 0.0 110.376 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.2 p -84.1 126.23 32.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.601 -0.687 . . . . 0.0 110.338 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -134.91 143.92 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.493 -0.754 . . . . 0.0 110.668 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.86 152.32 25.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.65 7.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.612 -0.68 . . . . 0.0 110.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.32 -39.3 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.357 -0.839 . . . . 0.0 110.582 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -159.29 178.8 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.39 -27.31 69.22 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.806 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.25 -54.93 39.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.552 -0.718 . . . . 0.0 109.854 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.14 -42.92 99.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.726 -0.609 . . . . 0.0 109.371 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.11 -46.01 68.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.359 -0.838 . . . . 0.0 109.836 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.09 -38.21 82.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.665 . . . . 0.0 109.284 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -54.94 -42.29 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 109.391 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.1 m-85 -70.52 -37.94 74.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 0.0 109.573 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 44' ' ' TRP . 11.1 mmtt -76.78 1.09 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.658 -0.651 . . . . 0.0 111.49 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -104.28 -46.54 4.38 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.307 8.1 t80 -46.1 -50.85 14.87 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.206 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.744 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.37 -54.16 47.27 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.64 -46.54 77.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.608 -0.682 . . . . 0.0 110.739 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.45 -16.92 51.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.631 -0.668 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' HB3' HD13 ' A' ' 40' ' ' ILE . 20.9 t-20 -108.43 -27.87 9.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.464 -0.773 . . . . 0.0 110.691 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 114.24 30.82 2.37 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -101.62 113.49 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.473 -1.016 . . . . 0.0 109.031 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.49 109.19 3.46 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.27 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.82 -95.59 0.11 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.2 tt0 -126.04 123.07 37.62 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -1.073 . . . . 0.0 111.55 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.55 ' NE1' HG23 ' A' ' 55' ' ' VAL . 37.3 m95 -103.5 137.1 42.04 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.583 -0.698 . . . . 0.0 110.403 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -147.38 131.87 17.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.666 . . . . 0.0 109.245 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.8 t80 -95.75 143.43 27.0 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.773 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -113.92 101.52 9.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.647 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.36 -3.81 22.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.619 -0.676 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.36 -27.59 20.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.5 p -130.96 9.5 4.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.617 -0.677 . . . . 0.0 110.162 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.2 mmtt 53.6 41.89 32.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -127.8 140.05 52.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.637 -0.664 . . . . 0.0 110.294 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 67.2 m-85 -93.67 -170.82 2.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 109.708 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.86 99.48 1.54 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.9 p -102.61 109.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.999 0.904 . . . . 0.0 111.195 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.49 172.94 9.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.032 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.088 0.47 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 2' ' ' THR . 79.5 m -104.56 54.25 0.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.707 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 18' ' ' THR . 6.3 m -72.8 89.39 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.48 -0.763 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -76.83 143.18 39.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.658 -0.651 . . . . 0.0 109.943 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.845 ' HG2' HG22 ' A' ' 18' ' ' THR . 32.0 mtmt -104.53 -176.41 3.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 31' ' ' PHE . 2.2 tp -166.8 108.92 0.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.522 -0.736 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mt -89.06 117.5 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.8 mp -87.32 119.6 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.253 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -96.61 149.58 21.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.11 -127.65 7.06 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.2 -41.23 0.9 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.549 -0.971 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 m -63.16 99.61 0.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.57 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.269 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.68 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.5 ptpt -162.69 105.91 1.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.7 161.94 29.43 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.08 58.45 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.717 -0.872 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 11.2 pt -52.49 145.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.149 -0.969 . . . . 0.0 110.382 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.845 HG22 ' HG2' ' A' ' 5' ' ' LYS . 81.4 p -113.59 139.66 48.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.537 -0.727 . . . . 0.0 110.956 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -146.72 132.64 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 110.456 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -70.47 154.66 41.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.0 110.186 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.06 157.73 9.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.669 . . . . 0.0 110.354 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 26' ' ' GLU . 8.9 p -54.89 -34.21 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.549 -0.72 . . . . 0.0 110.502 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.0 p30 -165.72 178.43 6.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.39 -29.74 70.8 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.569 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -47.24 84.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' HD11 ' A' ' 30' ' ' ILE . 30.8 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -46.19 81.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.52 -0.738 . . . . 0.0 109.546 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.5 tt0 -58.69 -35.78 73.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.353 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.74 26.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 26' ' ' GLU . 34.3 mt -58.18 -34.77 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.882 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.6 m-85 -77.48 -36.22 52.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 22.4 mttt -78.04 1.79 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.778 -0.576 . . . . 0.0 111.219 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.56 -45.4 3.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 177.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.294 10.9 t80 -53.76 -42.96 68.78 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.753 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.22 -47.34 86.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.183 0.516 . . . . 0.0 109.902 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.67 -48.8 78.51 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.634 -0.666 . . . . 0.0 110.549 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.06 -22.47 27.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.571 -0.705 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.414 ' CB ' HD13 ' A' ' 40' ' ' ILE . 25.5 m-80 -103.29 -25.42 13.33 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.639 -0.663 . . . . 0.0 110.671 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.05 30.62 4.13 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.9 107.23 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.68 -0.894 . . . . 0.0 109.004 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -146.08 100.52 3.4 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.23 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.68 -105.48 0.24 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tp10 -105.28 177.61 4.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.399 -1.059 . . . . 0.0 110.507 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.4 m95 -155.68 130.94 9.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.656 -0.653 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -144.85 132.2 20.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 109.264 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.7 t80 -98.49 138.1 36.19 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.93 99.82 9.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.652 -0.655 . . . . 0.0 109.551 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.31 -4.89 24.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.693 -0.629 . . . . 0.0 111.533 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.86 -28.4 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.654 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -128.76 8.5 5.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 110.234 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 31.6 mmtt 54.08 40.77 31.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.263 -0.898 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -125.17 133.67 52.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 110.628 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' HD12 ' A' ' 6' ' ' LEU . 75.1 m-85 -90.57 -172.39 3.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.613 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.12 98.29 1.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.6 p -102.02 109.46 26.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 122.122 0.963 . . . . 0.0 111.376 -178.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 169.17 12.45 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.156 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.077 0.465 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.524 HG22 ' CE2' ' A' ' 4' ' ' PHE . 62.9 m -139.34 58.46 1.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.531 -0.731 . . . . 0.0 110.25 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.619 HG22 ' HB ' ' A' ' 18' ' ' THR . 11.5 m -90.55 103.85 16.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.581 -0.699 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 59.8 m-85 -86.32 152.19 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.943 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -115.9 -164.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.653 -0.655 . . . . 0.0 109.502 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 31' ' ' PHE . 58.4 tp -168.12 108.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 110.336 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 105.55 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CG1' ' A' ' 55' ' ' VAL . 2.7 mm -77.52 99.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.087 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -85.05 63.39 8.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.982 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.7 -129.01 2.63 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 23.66 0.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.636 -0.92 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 10.38 3.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.344 -0.847 . . . . 0.0 110.737 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.1 mt -172.32 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.324 -0.86 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -52.6 103.82 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.229 -0.92 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.81 -177.83 48.15 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -137.0 64.8 1.52 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.636 -0.92 . . . . 0.0 110.173 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 HD12 ' OH ' ' A' ' 34' ' ' TYR . 95.1 mt -62.88 136.41 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.44 -0.787 . . . . 0.0 109.55 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.943 HG22 ' CG ' ' A' ' 5' ' ' LYS . 64.3 p -103.42 136.89 42.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.228 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.29 136.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.367 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.78 152.49 33.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.131 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -166.53 159.64 14.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.473 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.57 -40.11 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.576 -0.703 . . . . 0.0 110.568 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.4 173.08 17.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.43 -29.87 70.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -44.57 84.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.519 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 2.5 tp10 -69.97 -43.68 71.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.98 -41.12 77.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.667 . . . . 0.0 109.605 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.0 tt0 -60.27 -39.0 85.29 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.398 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -68.96 -48.84 62.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.58 -37.02 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.517 -0.739 . . . . 0.0 109.018 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.3 m-85 -76.89 -38.24 53.93 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.203 0.525 . . . . 0.0 109.652 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 24.5 mtpt -76.79 0.7 19.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.582 -0.699 . . . . 0.0 111.305 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -108.68 -44.72 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.283 6.6 t80 -53.0 -45.53 67.94 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.979 176.17 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -65.65 -57.53 7.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.775 -0.578 . . . . 0.0 109.871 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -58.32 -46.48 86.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.709 -0.619 . . . . 0.0 110.795 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -54.12 -23.93 15.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.5 -0.75 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.439 ' HB3' HD13 ' A' ' 40' ' ' ILE . 23.6 t-20 -105.64 -30.37 9.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 110.155 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 117.09 32.67 1.48 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.731 HG22 HG21 ' A' ' 55' ' ' VAL . 1.8 mp -102.41 74.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.401 -1.058 . . . . 0.0 108.617 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.95 -164.43 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . 114.41 -173.8 15.09 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.885 -1.15 . . . . 0.0 111.546 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -73.57 -178.09 2.95 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.794 -0.827 . . . . 0.0 109.512 179.347 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.415 ' CE2' ' HG2' ' A' ' 32' ' ' LYS . 24.6 m95 -151.74 128.56 10.92 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.655 -0.653 . . . . 0.0 109.67 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.5 p -142.3 137.36 30.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.7 -0.625 . . . . 0.0 109.442 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.2 t80 -97.37 147.29 24.33 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.548 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -116.35 100.64 8.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.2 -4.65 26.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.613 -0.679 . . . . 0.0 111.33 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.22 -26.81 18.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -128.03 7.02 6.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.66 -0.65 . . . . 0.0 110.13 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 54.74 39.74 31.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.2 -0.937 . . . . 0.0 110.165 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 63.9 m -130.27 143.38 50.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 0.0 110.714 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.8 m-85 -96.75 -168.14 1.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -160.96 117.76 2.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.77 -1.206 . . . . 0.0 108.966 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 40' ' ' ILE . 1.4 p -110.62 110.77 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.135 0.969 . . . . 0.0 109.169 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.635 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -96.36 87.69 4.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.823 0.821 . . . . 0.0 110.125 -178.078 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.501 2.12 0 O-C-N 120.782 -1.199 . . . . 0.0 110.193 -179.636 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.161 0.505 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.3 m -115.56 41.34 2.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.567 -0.708 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -76.8 103.47 6.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.564 -0.71 . . . . 0.0 110.245 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.8 m-85 -84.56 130.5 34.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.597 -0.689 . . . . 0.0 110.182 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CG ' HG22 ' A' ' 18' ' ' THR . 6.6 mptt -98.83 172.66 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 109.603 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 ' CD1' ' A' ' 31' ' ' PHE . 34.7 tp -143.76 106.06 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.428 -0.795 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.3 mt -81.64 115.04 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.62 HG13 HD11 ' A' ' 13' ' ' LEU . 2.1 mm -87.62 113.66 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.461 -178.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -101.21 75.94 1.68 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.453 -0.779 . . . . 0.0 110.544 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.33 -152.02 6.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -110.39 -27.25 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.957 . . . . 0.0 110.262 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 7.8 p -79.73 102.24 8.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 109.824 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.8 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.168 0.508 . . . . 0.0 109.635 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 3.0 mtpm? -142.55 137.24 30.0 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.258 -0.901 . . . . 0.0 111.057 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.06 -165.41 22.45 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.26 158.19 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.87 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.8 mp -116.57 -16.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' CG ' ' A' ' 5' ' ' LYS . 60.2 p 45.53 96.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.557 -0.714 . . . . 0.0 111.655 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.453 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -130.14 132.99 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.53 157.46 30.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.531 -0.731 . . . . 0.0 109.937 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.8 168.84 12.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.553 -0.717 . . . . 0.0 110.289 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.37 -35.51 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 0.0 110.487 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 22' ' ' VAL . 32.1 p30 -166.5 172.81 10.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.294 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.74 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.98 -31.18 71.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.317 -0.864 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.0 81.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.745 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.16 -43.17 74.82 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.95 77.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.45 -0.782 . . . . 0.0 109.717 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.5 tt0 -59.16 -36.82 75.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.581 -0.699 . . . . 0.0 109.334 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -69.53 -51.4 36.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.7 -39.42 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.837 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.5 m-85 -72.95 -37.47 67.11 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.52 1.95 17.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.694 -0.629 . . . . 0.0 111.377 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -109.19 -45.54 3.73 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 4.4 t80 -53.21 -40.31 64.37 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.151 176.542 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.08 -55.13 36.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.846 -0.534 . . . . 0.0 110.191 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.89 -48.79 80.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.709 -0.619 . . . . 0.0 110.662 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.14 -22.8 18.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -0.784 . . . . 0.0 111.06 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -103.1 -35.19 8.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.553 -0.717 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 122.33 36.32 0.7 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.788 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -103.72 119.77 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -1.066 . . . . 0.0 109.06 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -149.1 108.48 3.96 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.264 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.01 -109.64 0.22 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -111.06 176.58 4.97 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.489 -1.006 . . . . 0.0 110.526 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.9 m95 -154.29 130.54 10.41 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.61 -0.682 . . . . 0.0 109.838 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.8 p -144.28 132.58 21.9 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.2 t80 -97.57 132.79 42.91 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.75 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -102.07 99.31 9.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.685 -0.635 . . . . 0.0 109.361 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.21 -7.15 33.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.02 -28.9 18.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -122.02 5.6 9.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.676 -0.64 . . . . 0.0 110.183 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 54.76 35.96 25.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 38.4 m -126.61 143.76 51.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.614 -0.679 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.9 m-85 -94.93 -170.35 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 0.0 110.036 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -155.72 92.66 1.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.611 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.9 p -95.89 104.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.888 0.852 . . . . 0.0 111.053 -178.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 169.73 13.6 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 178.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.202 -179.92 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.21 0.529 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 99.8 m -103.13 -82.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.564 -0.71 . . . . 0.0 110.318 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 m 50.24 90.64 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.112 -0.992 . . . . 0.0 111.082 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 16.2 m-85 -89.14 139.17 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.089 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.857 ' HG2' HG22 ' A' ' 18' ' ' THR . 23.2 mttt -99.22 -173.7 2.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.775 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.868 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.6 tp -158.99 105.56 1.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.374 -0.829 . . . . 0.0 110.015 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 52' ' ' THR . 12.8 mt -85.9 130.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.683 HG21 ' HG ' ' A' ' 13' ' ' LEU . 14.5 mm -95.54 113.83 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.711 -179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.69 -23.84 62.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.175 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.28 149.12 46.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.52 -25.01 66.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.685 -0.891 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -86.82 166.72 14.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.745 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.683 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.3 OUTLIER 41.0 27.05 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.81 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -52.24 134.8 33.22 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 111.253 -178.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.11 175.42 38.42 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.111 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -140.48 42.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.3 pt -50.26 148.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.522 -0.736 . . . . 0.0 111.165 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.857 HG22 ' HG2' ' A' ' 5' ' ' LYS . 76.0 p -111.97 141.04 46.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.051 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.537 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -138.37 134.75 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.738 . . . . 0.0 110.744 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.99 139.12 42.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.723 -0.611 . . . . 0.0 109.997 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.06 34.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 110.436 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -54.08 -39.55 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.511 -0.743 . . . . 0.0 110.325 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -160.02 -179.81 8.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.547 -0.721 . . . . 0.0 109.32 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.02 -31.17 72.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.731 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -54.15 -57.68 10.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 0.0 109.976 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -59.63 -40.91 89.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.63 -0.669 . . . . 0.0 109.783 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.73 . . . . 0.0 109.732 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 15.4 tt0 -60.54 -47.31 86.75 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.371 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -51.32 69.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.949 . . . . 0.0 109.958 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.51 -45.87 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.46 -0.775 . . . . 0.0 109.415 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.868 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -68.85 -37.49 79.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -76.03 1.95 14.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.777 -0.577 . . . . 0.0 111.441 179.454 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -107.08 -45.12 4.22 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 177.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 2.2 t80 -50.42 -38.28 42.33 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.838 176.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -63.86 -49.55 72.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.248 0.547 . . . . 0.0 109.825 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -60.22 -46.3 90.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.709 -0.619 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.99 -22.86 29.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.51 -0.744 . . . . 0.0 110.826 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -103.8 -24.35 13.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.675 -0.641 . . . . 0.0 110.468 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.33 44.03 1.65 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.797 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -104.18 135.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.908 . . . . 0.0 109.705 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -167.61 97.63 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.77 -65.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.645 ' HB2' HG22 ' A' ' 56' ' ' THR . 9.0 mt-10 -154.65 173.58 16.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.551 -0.97 . . . . 0.0 110.171 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 52.1 m95 -155.05 123.84 6.13 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.66 -0.65 . . . . 0.0 109.803 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -139.03 133.76 32.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.677 . . . . 0.0 109.289 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.4 t80 -96.15 136.92 35.96 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.851 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -105.15 99.58 9.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.666 . . . . 0.0 109.281 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.7 -4.51 23.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.606 . . . . 0.0 111.603 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.27 -26.58 17.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -126.55 7.82 6.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 110.135 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.6 mmtp 53.4 38.61 28.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.115 -0.99 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 7' ' ' ILE . 6.5 m -128.56 135.03 48.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.699 -0.626 . . . . 0.0 110.617 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 56.8 m-85 -87.52 -170.5 3.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.348 -0.845 . . . . 0.0 109.795 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.67 104.24 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.031 -1.043 . . . . 0.0 108.211 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.3 p -111.43 132.61 59.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.567 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -125.66 -177.41 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.268 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.132 0.491 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m -86.44 57.09 4.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 110.2 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.8 m -90.23 112.16 23.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 49.7 m-85 -97.8 150.04 21.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.632 -0.668 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.942 ' CG ' HG22 ' A' ' 18' ' ' THR . 4.5 mptt -113.24 -167.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.706 -0.621 . . . . 0.0 109.83 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.736 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -167.33 100.38 0.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.487 -0.758 . . . . 0.0 110.145 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.2 mt -82.58 129.18 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.505 HG13 HD11 ' A' ' 13' ' ' LEU . 10.1 mm -99.91 115.93 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.234 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.491 ' OD1' HG22 ' A' ' 54' ' ' THR . 2.1 m-20 -80.75 -158.96 0.21 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.383 -0.823 . . . . 0.0 109.177 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.97 -129.19 47.72 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -148.07 25.54 1.01 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.909 . . . . 0.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 30.4 p -103.74 113.82 27.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.669 HD23 HG12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 67.43 -51.2 0.5 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.852 -0.53 . . . . 0.0 111.683 179.964 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 11.4 mmmt 49.17 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.616 -1.303 . . . . 0.0 111.543 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.79 170.13 43.24 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.38 55.94 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.77 -0.841 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.523 HG23 ' HE1' ' A' ' 31' ' ' PHE . 4.2 tp -59.32 133.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.519 -0.738 . . . . 0.0 110.373 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.942 HG22 ' CG ' ' A' ' 5' ' ' LYS . 53.0 p -98.94 140.13 33.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.647 -0.658 . . . . 0.0 110.079 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.449 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.1 147.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.532 -0.73 . . . . 0.0 110.469 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -90.96 153.36 20.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.592 -0.693 . . . . 0.0 110.152 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.48 164.05 14.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.484 -0.76 . . . . 0.0 110.58 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.3 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.542 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.5 p30 -162.28 174.33 12.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.92 -30.03 68.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.94 73.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.402 -0.811 . . . . 0.0 109.8 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.89 -40.22 91.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -55.89 -45.33 78.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.1 tt0 -58.45 -37.86 76.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.607 -0.683 . . . . 0.0 109.342 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -68.68 -50.64 49.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.27 -39.66 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.736 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.3 m-85 -73.36 -36.67 66.17 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 32.9 mtpt -75.62 -0.55 20.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.663 -0.648 . . . . 0.0 111.493 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -105.94 -45.58 4.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 177.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 1.2 t80 -52.81 -40.71 63.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.837 176.123 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -61.73 -47.52 84.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.825 -0.547 . . . . 0.0 109.942 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -59.0 -47.6 84.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.581 -0.7 . . . . 0.0 110.432 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -54.28 -25.15 21.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HB2' HD13 ' A' ' 40' ' ' ILE . 10.8 m120 -101.42 -24.59 14.16 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.784 -0.573 . . . . 0.0 110.535 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.47 36.27 3.11 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.777 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.39 116.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.614 -0.933 . . . . 0.0 109.489 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -158.06 101.71 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.13 -64.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.841 ' HB2' HG22 ' A' ' 56' ' ' THR . 68.8 mm-40 -129.56 169.03 15.53 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.48 -1.012 . . . . 0.0 110.952 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.9 m95 -162.85 118.78 1.83 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.44 132.78 21.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.399 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -93.56 144.52 25.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.9 97.8 6.61 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.88 -5.84 28.64 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.685 -0.634 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.77 -27.03 17.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -123.98 6.18 8.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.061 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 17.4 mmtt 54.18 39.93 31.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 110.077 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 5' ' ' LYS . 33.4 m -134.71 140.29 45.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 0.0 110.744 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' A' ' 6' ' ' LEU . 46.3 m-85 -93.62 -170.73 2.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.311 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.491 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.2 OUTLIER -157.04 102.95 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.485 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.4 p -116.1 144.71 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.92 -178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.841 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.7 t -143.22 -172.39 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.595 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.436 -0.79 . . . . 0.0 110.199 179.995 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.058 0.456 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 2' ' ' THR . 49.8 m -107.48 37.95 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 110.369 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.571 HG22 ' HB ' ' A' ' 18' ' ' THR . 21.6 m -60.12 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.415 -0.803 . . . . 0.0 109.841 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.528 ' CD2' HG22 ' A' ' 2' ' ' THR . 4.7 m-85 -85.49 147.51 26.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.715 -0.616 . . . . 0.0 110.129 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.847 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.46 -171.56 1.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.607 -0.683 . . . . 0.0 109.908 -179.907 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.733 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.7 tp -160.08 112.43 2.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.305 -0.872 . . . . 0.0 110.841 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mt -85.35 119.91 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 13' ' ' LEU . 5.4 mm -93.84 114.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.008 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -102.22 144.6 30.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.545 -0.722 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.68 -135.78 9.38 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -131.38 29.66 4.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.93 . . . . 0.0 110.191 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 14' ' ' LYS . 8.7 p -139.4 147.3 41.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.813 HD12 HG12 ' A' ' 40' ' ' ILE . 6.5 mt 60.9 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.784 -0.572 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' THR . 6.1 mtmm 54.72 98.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.47 -0.769 . . . . 0.0 110.56 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.92 177.36 40.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.88 55.76 1.88 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.655 -0.909 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 pt -58.19 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.5 p -128.81 138.76 52.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.531 -0.73 . . . . 0.0 110.188 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.51 138.84 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.734 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.61 128.58 33.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 109.538 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.45 -163.06 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.07 -59.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.29 -174.73 4.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.78 79.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.611 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.56 31.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.619 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -56.11 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.635 . . . . 0.0 109.868 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -49.81 -42.27 46.65 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.455 -0.778 . . . . 0.0 110.376 179.24 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.4 tt0 -60.57 -35.15 75.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.56 -0.713 . . . . 0.0 109.236 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -72.57 -46.82 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 27' ' ' ALA . 61.6 mt -59.31 -36.94 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -76.96 -35.4 57.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 6.1 mtpt -77.3 0.93 20.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.773 -0.579 . . . . 0.0 111.357 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -107.31 -45.46 4.09 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.291 5.5 t80 -52.46 -35.24 52.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.783 176.211 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -71.02 -51.39 25.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.276 0.56 . . . . 0.0 109.946 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.31 -47.43 85.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.635 -0.666 . . . . 0.0 110.396 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -22.64 19.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.571 -0.706 . . . . 0.0 111.11 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -104.52 -31.8 9.28 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 118.7 34.64 1.05 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.813 HG12 HD12 ' A' ' 13' ' ' LEU . 1.6 mp -102.13 110.18 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.456 -1.026 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -143.36 111.76 6.31 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.25 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.64 -110.03 0.23 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tp10 -107.93 179.11 4.32 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.367 -1.078 . . . . 0.0 110.4 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -155.19 129.45 8.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.575 -0.703 . . . . 0.0 109.856 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.0 p -141.94 133.05 26.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.548 -0.72 . . . . 0.0 109.177 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.5 t80 -98.48 134.48 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.889 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -104.23 98.92 8.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -71.13 -3.81 21.97 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.612 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.75 -25.1 17.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.729 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 p -128.66 5.62 5.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.612 -0.68 . . . . 0.0 110.296 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 74.1 mmtt 55.89 42.81 28.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.164 -0.96 . . . . 0.0 109.679 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 124.89 32.92 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.869 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 82.8 m-85 -81.28 -171.3 3.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -0.75 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.6 90.42 1.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -92.64 100.25 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.005 0.907 . . . . 0.0 110.927 -178.579 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -80.12 171.39 15.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.072 0.463 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.67 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.6 m -99.25 29.55 3.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 110.321 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -73.3 109.56 6.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.877 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 2' ' ' THR . 78.7 m-85 -87.93 145.44 26.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.555 -0.716 . . . . 0.0 110.646 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.809 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.6 OUTLIER -108.94 -173.95 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.892 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.4 tp -167.65 110.14 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.285 -0.885 . . . . 0.0 110.681 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 52' ' ' THR . 3.6 mp -95.55 113.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' HA ' HG13 ' A' ' 55' ' ' VAL . 1.2 mm -84.13 104.05 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.94 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -86.52 144.6 27.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.554 -0.716 . . . . 0.0 110.17 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.55 -140.77 12.0 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.28 29.74 5.51 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.664 -0.904 . . . . 0.0 110.176 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' LYS . 10.4 p -138.05 138.02 38.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 40' ' ' ILE . 5.7 mt 60.9 -77.3 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.762 -0.586 . . . . 0.0 111.027 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' THR . 15.5 mtpt 54.37 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.339 -0.85 . . . . 0.0 110.738 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.62 -175.77 41.58 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -108.43 -57.88 2.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.577 -0.954 . . . . 0.0 110.367 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.9 mm 53.6 72.75 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.809 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.6 p -69.64 137.36 52.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.598 -0.689 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -145.51 147.4 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.562 -0.711 . . . . 0.0 110.572 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.73 162.08 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.605 -0.685 . . . . 0.0 109.936 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 26' ' ' GLU . . . -169.35 171.16 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.1 p -53.08 -39.06 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.494 -0.754 . . . . 0.0 110.401 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.5 p30 -160.67 -175.18 4.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -70.38 -31.23 68.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.19 -49.3 74.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.593 -0.692 . . . . 0.0 109.921 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tt0 -63.09 -43.64 97.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.403 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.35 -45.06 69.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -59.12 -36.27 74.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 109.348 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.72 -54.85 16.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.52 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.49 -40.34 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.892 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -72.07 -34.7 68.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -78.52 1.25 23.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.693 -0.629 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -104.22 -46.14 4.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 4.4 t80 -47.36 -51.98 17.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.906 175.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.721 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -67.74 -50.19 58.62 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.659 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.06 -49.92 72.41 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.72 . . . . 0.0 110.899 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.86 -21.46 29.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.603 -0.685 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -102.72 -27.76 12.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.572 -0.705 . . . . 0.0 110.576 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.67 29.25 3.67 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.721 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.41 106.01 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 108.756 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -141.71 114.89 8.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.35 0.595 . . . . 0.0 111.016 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.76 -100.78 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.7 tt0 -115.31 170.74 8.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -1.002 . . . . 0.0 110.035 179.54 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 40.6 m95 -152.6 122.95 7.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.505 -0.747 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 25.3 p -138.22 128.57 26.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.5 t80 -94.24 141.7 28.26 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.654 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -111.82 100.92 9.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.1 -2.68 16.46 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.616 -0.678 . . . . 0.0 111.745 -179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -28.69 21.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -136.69 15.39 3.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.695 . . . . 0.0 109.906 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER 48.28 45.34 20.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.487 179.662 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 7' ' ' ILE . 26.2 m -121.18 120.84 36.38 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.54 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.3 m-85 -85.35 172.81 10.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -139.78 97.16 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -97.68 107.53 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 122.007 0.908 . . . . 0.0 110.682 -178.728 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -92.02 170.1 10.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.286 -179.952 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.122 0.487 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.4 m -141.37 -69.24 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.5 m 51.03 88.05 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.375 -0.828 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -90.04 149.46 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.228 178.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.899 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.5 OUTLIER -110.19 -173.93 2.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 110.389 -179.634 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.7 tp -160.98 108.97 1.54 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.634 -0.666 . . . . 0.0 109.986 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.5 mm -87.42 129.89 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' LEU . 2.1 mm -101.91 116.39 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.67 -179.309 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.637 HD21 HG22 ' A' ' 54' ' ' THR . 15.1 m-20 -76.05 -29.31 57.99 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.84 -175.91 4.92 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -114.85 25.55 10.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.618 -0.931 . . . . 0.0 110.486 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -96.04 -33.72 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.46 -0.775 . . . . 0.0 109.964 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 40' ' ' ILE . 9.7 mt -121.96 -54.09 1.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.696 -0.628 . . . . 0.0 109.772 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt 52.66 82.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.539 -0.726 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.99 -175.54 46.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.47 -50.07 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.797 -0.825 . . . . 0.0 109.966 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.0 mm 54.12 83.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.899 HG22 ' CG ' ' A' ' 5' ' ' LYS . 62.0 p -76.94 142.14 40.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.626 -0.671 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -143.69 131.5 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.488 -0.758 . . . . 0.0 111.187 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -66.93 131.15 45.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 110.068 179.606 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.32 150.11 31.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.0 p -53.26 -39.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.546 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.4 p30 -158.13 177.18 11.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.68 -33.11 74.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.415 -0.803 . . . . 0.0 109.642 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.581 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.71 -44.09 81.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.562 -0.711 . . . . 0.0 109.723 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' OE1' HD11 ' A' ' 30' ' ' ILE . 2.1 tt0 -70.62 -44.19 67.72 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.086 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.98 80.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.571 -0.706 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.8 tt0 -57.98 -37.54 74.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.648 -0.658 . . . . 0.0 109.401 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -51.57 32.62 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.513 HD11 ' OE1' ' A' ' 26' ' ' GLU . 22.3 mt -58.48 -35.56 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -77.24 -35.55 55.36 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -73.85 -2.9 25.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.75 -0.594 . . . . 0.0 111.211 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -103.24 -46.1 4.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.296 2.8 t80 -52.33 -32.43 38.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.692 175.627 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.49 -60.81 2.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.819 0.818 . . . . 0.0 108.896 178.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -57.19 -40.56 77.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.83 -0.544 . . . . 0.0 110.562 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.09 -27.95 3.78 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.616 -0.678 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -49.31 3.4 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.475 0.655 . . . . 0.0 109.861 179.253 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.53 64.95 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.753 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -118.81 129.3 75.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.949 -0.736 . . . . 0.0 110.389 -176.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.18 94.34 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.511 -0.743 . . . . 0.0 110.154 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.32 -44.95 0.02 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 56' ' ' THR . 15.0 tt0 -152.02 167.43 28.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.466 -1.02 . . . . 0.0 110.863 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 43.8 m95 -163.41 116.56 1.54 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -141.97 130.77 22.9 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.586 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -93.24 146.29 23.81 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.25 100.07 7.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.732 -0.605 . . . . 0.0 109.592 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -71.65 -2.78 18.43 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.668 -0.645 . . . . 0.0 111.505 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -25.82 18.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -131.54 8.74 4.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.482 -0.761 . . . . 0.0 110.174 179.36 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 54.41 45.11 27.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.193 -0.942 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.9 m -133.52 135.13 44.2 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.774 ' HB2' HD12 ' A' ' 6' ' ' LEU . 63.5 m-85 -90.74 -172.23 3.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.5 -0.75 . . . . 0.0 109.618 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 HD21 ' A' ' 9' ' ' ASN . 0.6 OUTLIER -156.16 97.68 1.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.98 -1.075 . . . . 0.0 108.712 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.3 p -112.5 146.31 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.138 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.84 HG22 ' HB3' ' A' ' 43' ' ' GLU . 6.2 t -145.28 -172.48 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.936 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.201 179.925 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.186 0.517 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.438 HG22 ' CE2' ' A' ' 4' ' ' PHE . 63.5 m -120.84 75.55 1.15 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.611 -0.68 . . . . 0.0 110.26 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.1 m -102.76 109.12 20.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.109 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.3 m-85 -93.16 141.92 27.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 110.301 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.836 ' HG3' HG22 ' A' ' 18' ' ' THR . 3.8 mptt -105.88 -166.21 1.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 0.0 109.35 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.861 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.4 tp -166.55 105.69 0.63 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.416 -0.803 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -81.34 118.43 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mm -89.86 101.3 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.609 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -76.1 -3.39 35.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.518 -0.739 . . . . 0.0 111.166 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.8 163.89 33.84 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.83 -27.42 68.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.478 -1.013 . . . . 0.0 110.64 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . 16.7 m -78.46 156.27 29.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.53 -0.731 . . . . 0.0 110.324 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.672 HD22 ' OH ' ' A' ' 34' ' ' TYR . 9.6 mt 59.71 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.865 -0.522 . . . . 0.0 111.188 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' THR . 1.0 OUTLIER 56.3 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.149 -0.969 . . . . 0.0 110.528 -179.766 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.53 -177.69 36.85 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -128.09 67.52 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -1.008 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 6.8 tp -62.72 126.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.735 . . . . 0.0 109.892 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.836 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.0 p -96.29 137.54 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.485 -0.76 . . . . 0.0 110.424 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -142.37 133.65 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.365 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -78.58 148.99 33.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.672 -0.643 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.63 163.97 32.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.604 -0.685 . . . . 0.0 110.246 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.8 -40.93 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.494 -0.753 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.42 172.55 18.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.28 -34.48 75.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.299 -0.875 . . . . 0.0 109.704 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.3 -49.47 69.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.62 -0.675 . . . . 0.0 109.796 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -40.87 96.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -56.11 -43.53 78.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.424 -0.797 . . . . 0.0 109.665 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 9.6 tt0 -59.82 -35.85 75.56 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -68.33 -51.13 47.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.3 mt -58.12 -40.96 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.861 ' CD1' HD22 ' A' ' 6' ' ' LEU . 14.3 m-85 -72.0 -36.66 69.82 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.5 mmmt -74.58 -2.44 25.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.615 -0.678 . . . . 0.0 111.182 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -105.41 -42.51 5.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.672 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.293 16.4 t80 -55.08 -19.47 7.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.734 175.785 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -89.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -53.06 -42.42 65.79 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.708 -0.62 . . . . 0.0 111.787 -178.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 39.5 p-10 -46.85 -27.54 1.27 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.461 -0.774 . . . . 0.0 111.612 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -108.74 -59.57 1.86 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.849 -0.532 . . . . 0.0 110.253 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.82 59.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.733 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.297 1.1 mm -116.49 130.52 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.742 -0.858 . . . . 0.0 109.532 -178.363 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -169.9 104.49 0.32 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.407 -0.808 . . . . 0.0 111.079 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.24 -63.22 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 32.7 mt-10 -152.7 171.37 18.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.567 -0.961 . . . . 0.0 110.143 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.9 m95 -155.03 124.89 6.57 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.669 -0.644 . . . . 0.0 110.009 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.2 p -144.45 132.82 21.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.627 -0.671 . . . . 0.0 109.532 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.1 t80 -93.08 148.73 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.67 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.68 100.08 6.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.742 -0.599 . . . . 0.0 109.879 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.79 -4.18 22.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.712 -0.617 . . . . 0.0 111.554 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.24 -28.0 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.9 p -128.82 8.33 5.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 110.083 179.304 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 15.9 mmtt 54.28 40.1 31.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.5 m -130.49 138.62 50.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 0.0 110.371 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 48.4 m-85 -91.33 -167.41 1.79 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -154.57 102.31 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.99 -1.069 . . . . 0.0 108.474 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.8 p -113.15 128.39 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.796 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -124.78 -178.69 4.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.769 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 2' ' ' THR . 60.8 m -115.85 44.86 1.83 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.568 -0.707 . . . . 0.0 110.157 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -71.27 93.31 1.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m-85 -81.98 139.5 34.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 110.178 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.811 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -105.08 -170.96 1.83 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.175 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.4 tp -165.04 108.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.601 -0.687 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -84.61 129.41 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.597 HD11 HD23 ' A' ' 6' ' ' LEU . 9.6 mm -93.22 114.31 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.082 -178.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.88 40.96 1.16 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.36 -151.17 6.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 12' ' ' THR . 10.2 ptmt -114.7 -28.82 6.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -1.013 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.1 p -79.88 113.71 18.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.25 144.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.277 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.4 ptpp? -151.27 140.16 20.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.225 -0.922 . . . . 0.0 111.073 -179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.53 -163.47 29.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 17' ' ' ILE . 5.4 mp0 -108.69 -42.76 4.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.883 . . . . 0.0 110.235 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.541 HD12 ' C ' ' A' ' 16' ' ' GLU . 5.3 mp 53.25 95.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.405 -0.809 . . . . 0.0 110.356 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' CG ' ' A' ' 5' ' ' LYS . 80.8 p -90.19 132.11 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.633 -0.667 . . . . 0.0 110.241 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.4 pp -143.42 130.22 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.512 -0.743 . . . . 0.0 110.478 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -71.22 157.72 37.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.55 161.4 11.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 110.165 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -53.75 -30.99 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.445 -0.785 . . . . 0.0 110.366 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.8 p30 -171.42 178.3 3.26 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.15 -30.61 71.55 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.612 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.67 81.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.502 -0.749 . . . . 0.0 109.704 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG3' HD11 ' A' ' 30' ' ' ILE . 19.9 tp10 -70.59 -44.64 66.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.63 -42.54 71.34 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.352 -0.842 . . . . 0.0 109.689 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -60.44 -41.13 93.41 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.044 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.11 -35.03 66.49 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.604 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 26' ' ' GLU . 52.8 mt -67.72 -40.78 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.639 ' HB3' HD13 ' A' ' 6' ' ' LEU . 12.7 m-85 -73.3 -38.3 65.91 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.7 mmmt -72.96 -4.98 35.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.602 -0.686 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -106.14 -45.12 4.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.29 5.5 t80 -51.62 -30.62 22.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.091 176.193 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -76.08 -50.11 15.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.608 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -57.54 -47.56 81.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 110.678 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -24.74 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB2' HD13 ' A' ' 40' ' ' ILE . 52.3 m-20 -102.75 -27.1 12.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.637 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 35.15 2.34 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.769 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.95 107.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.657 -0.908 . . . . 0.0 108.904 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.25 113.45 9.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.476 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.19 -109.77 0.22 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.9 tt0 -114.51 174.39 5.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -1.032 . . . . 0.0 110.347 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CE2' HG23 ' A' ' 55' ' ' VAL . 36.5 m95 -151.9 130.71 12.44 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.577 -0.702 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.2 p -142.89 133.17 24.66 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.298 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.4 t80 -95.12 145.37 25.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -117.8 98.11 6.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.792 -0.568 . . . . 0.0 109.488 179.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.63 -4.62 24.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.659 -0.65 . . . . 0.0 111.659 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -26.71 17.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 109.733 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -125.98 7.05 7.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.609 -0.682 . . . . 0.0 110.194 179.165 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 4' ' ' PHE . 3.9 mmtp 54.15 38.47 29.21 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.184 -0.947 . . . . 0.0 110.101 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.5 m -130.6 134.21 46.8 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.628 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' HD12 ' A' ' 6' ' ' LEU . 53.3 m-85 -88.27 -166.84 1.7 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.21 92.71 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.92 102.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.933 0.873 . . . . 0.0 111.316 -178.379 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -82.51 169.44 16.35 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.051 0.453 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 2' ' ' THR . 46.0 m -124.29 47.16 2.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.294 -179.965 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 m -68.86 85.31 0.32 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.776 . . . . 0.0 109.983 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.6 m-85 -70.42 126.89 30.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.647 -0.658 . . . . 0.0 109.778 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 18' ' ' THR . 30.9 mttm -89.57 175.35 7.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.967 HD23 HD11 ' A' ' 8' ' ' ILE . 2.5 tp -156.54 112.5 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.643 -0.661 . . . . 0.0 109.839 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -90.8 114.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.967 HD11 HD23 ' A' ' 6' ' ' LEU . 2.3 mp -90.08 113.15 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.071 -178.829 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -92.61 149.93 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.432 -0.792 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.51 -108.52 1.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -166.28 47.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.584 -0.951 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.621 ' CG2' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -152.21 119.22 5.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 110.208 179.998 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 53.95 23.98 4.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.504 0.669 . . . . 0.0 110.312 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -46.97 109.0 0.16 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.007 -1.058 . . . . 0.0 111.468 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.79 -162.73 29.48 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -109.46 -33.58 6.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.617 -0.931 . . . . 0.0 110.719 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.463 ' C ' HG23 ' A' ' 18' ' ' THR . 28.2 mm 67.05 -61.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 O-C-N 121.699 -0.626 . . . . 0.0 110.834 -179.81 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 17' ' ' ILE . 1.3 p 62.37 112.63 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.344 -0.847 . . . . 0.0 110.427 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -143.24 132.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.765 -0.585 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.51 155.01 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 110.325 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.45 12.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.386 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.5 -39.65 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.535 -0.728 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.3 m-20 -159.27 177.05 11.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.646 -0.659 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.7 -32.16 73.71 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.383 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.3 82.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.632 -0.667 . . . . 0.0 109.807 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.41 -44.66 82.37 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -45.91 75.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 109.623 178.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 6.1 tt0 -59.26 -37.01 76.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.503 179.08 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -69.14 -51.26 40.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mt -58.26 -38.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.81 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.65 -39.36 62.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.145 0.498 . . . . 0.0 109.792 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -76.45 0.7 18.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.489 -0.757 . . . . 0.0 111.953 -179.393 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -110.14 -45.32 3.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.898 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.301 9.5 t80 -53.78 -39.0 65.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.249 176.558 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.814 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.22 -54.49 32.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -56.83 -48.35 78.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.679 -0.638 . . . . 0.0 110.712 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.82 -22.23 34.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.0 110.831 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -102.57 -29.02 11.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.681 -0.637 . . . . 0.0 110.217 179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 115.53 33.55 1.57 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.814 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -105.73 115.52 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -1.044 . . . . 0.0 109.229 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.17 105.55 2.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.433 -179.622 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.4 -97.12 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.51 127.55 46.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.334 -1.097 . . . . 0.0 111.067 -179.551 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' NE1' HG23 ' A' ' 55' ' ' VAL . 50.4 m95 -105.83 137.09 44.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.533 -0.729 . . . . 0.0 110.904 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.8 p -147.01 132.06 18.24 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.942 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.3 t80 -98.6 144.8 27.5 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.861 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -115.57 99.34 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.766 -0.584 . . . . 0.0 109.638 179.257 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.31 -6.09 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 111.306 -179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.82 -26.52 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.612 179.486 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -124.24 5.63 8.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.619 -0.676 . . . . 0.0 110.119 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 54.0 38.55 29.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.143 -0.973 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -128.06 143.53 51.07 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.811 -179.436 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.901 ' HB2' HD12 ' A' ' 6' ' ' LEU . 78.6 m-85 -98.34 -172.19 2.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.187 179.452 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -158.41 99.39 1.61 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.713 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -102.79 97.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.774 0.797 . . . . 0.0 111.155 -178.537 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.35 169.62 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.13 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.685 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.122 0.487 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.59 HG22 ' CE2' ' A' ' 4' ' ' PHE . 20.3 m -117.64 33.58 5.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.551 -0.718 . . . . 0.0 110.199 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' HB ' ' A' ' 18' ' ' THR . 20.4 m -67.16 91.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 110.143 179.984 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 2' ' ' THR . 34.2 m-85 -72.43 146.75 46.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.624 -0.672 . . . . 0.0 110.172 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 17.1 mtmt -109.84 -178.1 3.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.94 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 53' ' ' PHE . 6.4 tp -160.57 102.48 1.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG12 ' CG ' ' A' ' 16' ' ' GLU . 18.9 mt -90.71 117.0 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.045 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.766 ' CG1' HD11 ' A' ' 13' ' ' LEU . 2.0 mp -91.46 120.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.333 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.7 -31.15 59.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.34 -179.293 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 160.12 45.96 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.41 13.66 13.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.611 -0.935 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.625 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.2 p -63.05 -54.18 42.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.25 -0.906 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.766 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.6 pp -131.13 -29.08 1.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.677 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.697 ' N ' HD12 ' A' ' 13' ' ' LEU . 16.4 ptmt 37.35 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.667 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.68 -179.98 47.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HG12 ' A' ' 7' ' ' ILE . 2.1 mt-10 -129.76 72.54 1.48 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.834 -0.803 . . . . 0.0 109.786 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.66 112.56 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 109.974 -179.773 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 55.3 p -88.24 123.27 32.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.642 -0.661 . . . . 0.0 109.692 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.33 139.22 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.781 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -86.51 159.4 19.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.983 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.8 168.92 10.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.711 . . . . 0.0 110.203 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.89 -38.74 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -163.6 174.65 11.5 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.711 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.6 -30.61 70.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.771 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.31 -48.96 70.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.427 -0.796 . . . . 0.0 110.026 179.43 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.91 -43.43 83.39 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.891 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.617 -0.677 . . . . 0.0 109.749 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 17.9 tt0 -58.02 -40.45 80.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.709 -0.62 . . . . 0.0 109.508 179.175 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -50.12 56.22 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.331 178.984 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 27' ' ' ALA . 26.3 mt -58.01 -38.37 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.945 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -75.54 -35.28 60.72 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.83 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -79.78 3.97 17.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.64 . . . . 0.0 111.32 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -107.23 -45.27 4.15 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.413 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.288 6.1 t80 -52.9 -45.51 67.57 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.916 176.218 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.21 -51.56 69.05 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.322 0.582 . . . . 0.0 109.9 179.139 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.83 -49.62 76.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.802 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -57.55 -27.89 63.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.526 -0.733 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.7 -27.52 17.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.887 -0.508 . . . . 0.0 110.307 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 108.03 38.89 1.92 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.781 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.8 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -106.44 130.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.656 -0.908 . . . . 0.0 109.375 -179.714 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -168.1 106.61 0.5 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.01 -59.9 0.03 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.852 ' HB3' HG22 ' A' ' 56' ' ' THR . 7.0 tt0 -136.75 163.61 30.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.381 -1.07 . . . . 0.0 110.529 -179.479 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.4 m95 -162.65 116.06 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 p -145.64 131.57 19.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.604 -0.685 . . . . 0.0 109.495 179.47 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.3 t80 -89.05 152.3 21.75 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.821 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.32 102.18 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.721 -0.612 . . . . 0.0 109.643 179.367 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.47 -6.06 33.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.737 -0.602 . . . . 0.0 111.395 -179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.49 -28.13 21.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 p -125.22 6.12 7.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.614 -0.679 . . . . 0.0 109.973 179.103 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt 53.47 39.12 29.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.154 -0.966 . . . . 0.0 110.176 -179.619 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -133.55 145.87 50.5 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.015 -179.493 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 6' ' ' LEU . 49.6 m-85 -97.68 173.56 7.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.574 -0.704 . . . . 0.0 109.441 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.32 110.2 8.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.097 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.694 HG13 HG13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -117.94 152.89 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.704 -178.271 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -160.11 -169.44 2.5 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.7 179.242 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 2' ' ' THR . 53.5 m -118.73 37.75 3.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 m -62.75 86.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.531 -0.731 . . . . 0.0 110.074 179.926 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.787 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -71.75 137.0 47.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.602 -0.686 . . . . 0.0 109.95 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 15.9 mttt -99.37 179.72 4.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.635 -0.666 . . . . 0.0 110.269 -179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.823 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -163.14 118.58 1.74 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 110.464 -179.975 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.99 114.35 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.284 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -89.84 119.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.529 -179.142 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.64 56.76 0.78 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.41 174.2 22.67 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -70.15 -41.14 74.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.505 -0.997 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.672 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.3 p -76.31 115.44 16.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.469 -0.769 . . . . 0.0 109.946 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 60.28 156.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.356 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -171.67 126.19 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.25 -158.71 23.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -110.03 146.3 35.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.641 -0.917 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 49.5 mm -113.64 -16.96 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.669 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 65.0 p 45.33 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.678 -0.639 . . . . 0.0 112.006 179.845 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -126.81 141.04 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.803 . . . . 0.0 110.532 179.35 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.73 151.16 32.25 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.431 -179.835 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 2' ' ' THR . . . -167.82 158.55 10.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -55.95 -39.35 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 110.382 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 22' ' ' VAL . 52.6 p30 -159.36 178.81 9.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.677 -0.639 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.99 -29.18 70.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.609 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.4 71.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.71 . . . . 0.0 109.878 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -41.97 86.12 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.65 -46.42 77.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.632 -0.668 . . . . 0.0 109.583 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.8 tt0 -58.85 -37.27 76.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -51.44 39.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.515 -0.741 . . . . 0.0 109.046 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.0 mt -58.76 -38.02 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.823 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.5 m-85 -74.7 -37.98 62.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 179.198 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 9.1 mmmt -75.67 -0.89 22.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 111.448 179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -109.91 -45.49 3.62 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.59 -39.25 64.71 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.865 176.328 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.36 -54.0 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.344 0.592 . . . . 0.0 109.969 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.8 -47.36 77.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.631 -0.668 . . . . 0.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -51.63 -26.33 8.75 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.527 -0.733 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.7 -26.16 12.86 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.887 -0.508 . . . . 0.0 110.318 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.82 29.35 3.6 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' A' ' 12' ' ' THR . 2.1 mp -100.5 57.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.759 1.266 . . . . 0.0 108.173 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.54 101.75 11.63 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.37 -178.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . -160.38 -127.27 0.88 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.7 tt0 -71.28 168.38 17.45 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.136 -1.214 . . . . 0.0 110.325 -179.786 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 33.9 m95 -158.84 129.03 5.86 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.684 -0.635 . . . . 0.0 109.518 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.1 p -145.46 133.3 21.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.407 -0.808 . . . . 0.0 109.428 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.5 t80 -98.46 144.13 28.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.759 179.597 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.69 98.15 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.07 -7.05 32.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.69 -0.631 . . . . 0.0 111.378 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.24 -27.55 17.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 179.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.0 p -122.21 4.99 9.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.56 -0.713 . . . . 0.0 110.062 179.131 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt 54.41 39.26 30.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 109.938 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -129.87 142.39 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.804 -179.468 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.7 m-85 -97.66 -171.6 2.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -158.51 102.36 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.189 . . . . 0.0 108.088 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 40' ' ' ILE . 3.3 p -106.24 108.97 26.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.083 0.944 . . . . 0.0 110.93 -178.711 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.577 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -92.88 98.5 11.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.304 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.324 -179.551 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.132 0.492 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 2' ' ' THR . 29.8 m -126.85 40.74 3.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.724 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.1 m -69.59 87.6 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.723 . . . . 0.0 110.143 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -74.79 140.23 43.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.53 -0.731 . . . . 0.0 110.216 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.936 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.9 OUTLIER -107.21 -179.28 3.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.627 -0.67 . . . . 0.0 110.109 179.9 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -158.24 114.68 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.441 -0.787 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.36 122.69 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.449 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.777 HG21 ' HG ' ' A' ' 13' ' ' LEU . 6.3 mm -89.64 111.45 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.516 -177.957 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -97.47 152.38 19.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.736 179.249 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.67 -142.63 15.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -134.81 21.96 3.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.581 -0.952 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.497 HG22 HD11 ' A' ' 40' ' ' ILE . 3.9 m -131.12 111.53 12.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.777 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 61.77 137.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.369 0.604 . . . . 0.0 110.158 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptpt -141.83 138.27 32.07 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.65 -176.29 33.24 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.13 -41.49 6.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.701 -0.882 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 mt 53.86 73.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.435 -0.791 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.936 HG22 ' CG ' ' A' ' 5' ' ' LYS . 78.8 p -71.14 130.57 41.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -140.95 135.53 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.498 -0.752 . . . . 0.0 110.625 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.18 156.35 37.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.706 -0.621 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 2' ' ' THR . . . -169.8 162.28 9.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.552 -0.718 . . . . 0.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.97 -38.54 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.637 -0.665 . . . . 0.0 110.258 179.78 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.462 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.4 m-20 -160.49 178.98 9.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.8 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.52 -35.91 82.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.487 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.22 -49.28 67.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.412 -0.805 . . . . 0.0 109.948 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -45.8 91.19 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.121 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.07 -44.07 67.2 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.439 -0.788 . . . . 0.0 109.808 179.008 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.1 tt0 -57.96 -35.53 71.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.673 -0.642 . . . . 0.0 109.349 179.032 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -70.15 -53.54 16.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.47 -35.73 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.7 m-85 -76.26 -34.19 59.14 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.778 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.92 1.89 22.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.718 -0.614 . . . . 0.0 111.286 179.484 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -103.05 -46.47 4.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 176.63 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 8.3 t80 -45.48 -53.66 8.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.3 175.618 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.766 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.04 -49.92 74.34 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.36 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.83 -47.37 85.99 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.628 -0.67 . . . . 0.0 110.265 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.16 -23.89 15.98 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.595 -0.691 . . . . 0.0 111.16 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -105.21 -34.43 7.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.633 -0.667 . . . . 0.0 110.451 -179.924 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 121.21 37.23 0.7 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.766 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -102.99 110.85 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 0.0 109.12 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -141.43 109.21 5.69 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.826 -179.679 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.6 -106.63 0.2 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 tt0 -110.59 173.37 6.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -1.001 . . . . 0.0 110.791 -179.695 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.2 m95 -153.75 129.96 10.44 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.648 -0.658 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -143.13 133.84 25.18 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.504 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.5 t80 -98.73 146.67 25.65 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.881 179.712 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -116.78 100.0 7.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.24 -5.54 28.31 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.657 -0.652 . . . . 0.0 111.513 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.51 -27.61 18.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 179.642 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -126.06 6.83 7.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt 54.47 38.8 30.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.2 m -126.29 144.78 50.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.2 m-85 -99.15 -169.75 1.81 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 0.0 109.854 179.729 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.69 93.91 1.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.832 -1.167 . . . . 0.0 108.013 179.593 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -95.73 116.13 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.972 0.892 . . . . 0.0 110.879 -178.634 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -99.25 168.39 10.06 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.146 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.031 0.443 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 4' ' ' PHE . 27.6 m -122.13 27.28 8.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.579 -0.701 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -68.93 106.23 2.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 109.962 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.3 m-85 -88.89 145.25 25.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.529 -0.732 . . . . 0.0 110.409 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.834 ' HG2' HG22 ' A' ' 18' ' ' THR . 26.1 mttt -112.55 -167.3 1.17 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.4 tp -166.44 108.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.41 -0.806 . . . . 0.0 110.463 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.28 119.81 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.793 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.867 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.1 mm -94.23 113.23 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.596 -179.178 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.07 57.9 0.69 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.819 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.94 -148.7 6.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 pttp -114.74 -25.07 8.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.598 -0.942 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -80.76 -38.82 27.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.867 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.5 mt -123.1 168.68 12.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.472 -0.768 . . . . 0.0 110.479 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.42 80.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.009 179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.36 -170.39 38.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.03 107.92 10.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.67 -0.9 . . . . 0.0 110.201 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 17' ' ' ILE . 5.3 mp -93.27 109.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.541 -0.725 . . . . 0.0 109.717 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.834 HG22 ' HG2' ' A' ' 5' ' ' LYS . 82.2 p -85.12 124.4 31.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.56 -0.713 . . . . 0.0 110.595 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -143.37 134.23 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -77.47 160.69 28.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.597 -0.689 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.46 165.2 10.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.239 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.3 p -55.13 -38.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.397 -0.814 . . . . 0.0 110.35 -179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.9 m-20 -162.31 174.88 12.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.629 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.29 -30.86 71.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.06 79.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 109.87 179.383 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' CD ' HG12 ' A' ' 22' ' ' VAL . 6.0 tt0 -71.79 -45.07 62.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.057 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.35 -39.74 76.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.567 -0.708 . . . . 0.0 109.362 178.813 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.1 tt0 -60.48 -40.23 90.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.012 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -67.53 -49.12 64.83 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.806 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.82 -44.13 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.7 m-85 -70.3 -38.92 75.1 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 4.6 mmmt -74.57 0.6 14.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 111.319 179.179 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -106.06 -45.58 4.3 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.191 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.298 17.4 t80 -49.02 -30.05 5.66 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.468 176.037 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -83.74 -48.63 9.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.669 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -68.47 -44.8 74.04 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.606 -0.684 . . . . 0.0 111.419 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -47.46 -28.74 2.3 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.501 -0.75 . . . . 0.0 111.139 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.46 -46.55 4.96 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.499 0.666 . . . . 0.0 109.375 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.3 63.54 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -179.698 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.27 1.1 mm -118.72 137.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 O-C-N 121.721 -0.87 . . . . 0.0 110.118 -177.359 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 -172.66 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.067 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 126.53 -177.16 17.38 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.736 179.109 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.89 128.13 36.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.976 -0.72 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 43.4 m95 -97.68 125.01 42.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.56 -0.713 . . . . 0.0 110.407 179.667 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.9 p -138.23 134.75 34.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.843 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -98.15 148.16 23.85 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.452 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.68 101.09 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.39 -4.96 24.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.588 -0.695 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.35 -28.1 18.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.563 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -128.79 8.63 5.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.593 -0.692 . . . . 0.0 110.149 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 7.7 mmtm 54.02 40.8 31.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.119 -0.988 . . . . 0.0 110.255 -179.698 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 5' ' ' LYS . 36.8 m -125.73 143.51 51.02 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.122 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.3 m-85 -100.18 -174.15 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 30.5 m -160.69 122.37 3.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 0.0 109.201 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.4 p -117.24 93.97 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -84.7 90.55 7.74 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.975 0.893 . . . . 0.0 110.008 -178.443 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 . . . . . 0 N--CA 1.499 2.011 0 O-C-N 120.849 -1.157 . . . . 0.0 110.147 -179.522 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 4' ' ' PHE . 48.4 m -116.21 25.86 10.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.525 -0.735 . . . . 0.0 110.537 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -69.67 103.51 2.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.491 -0.756 . . . . 0.0 110.011 179.799 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.623 ' CE2' HG22 ' A' ' 2' ' ' THR . 65.7 m-85 -83.0 149.65 26.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.649 -0.657 . . . . 0.0 110.31 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 13.6 mttt -119.33 179.23 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 31' ' ' PHE . 38.9 tp -155.22 112.52 3.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.459 -0.776 . . . . 0.0 110.143 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 98.3 mt -82.9 115.99 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.126 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.733 HG21 ' CB ' ' A' ' 13' ' ' LEU . 3.6 mm -94.75 119.9 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.794 -179.171 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -117.54 73.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.749 179.55 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.27 -106.32 0.65 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -149.97 -41.1 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.559 -0.965 . . . . 0.0 110.676 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -71.51 -28.9 64.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.733 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.6 mt -128.24 170.83 12.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 110.232 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 75.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.182 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.99 -168.87 34.6 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -121.22 135.9 55.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.644 -0.915 . . . . 0.0 110.181 -179.906 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 19' ' ' ILE . 16.4 tt -93.96 -15.65 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.738 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 8.9 p 54.58 110.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.56 0.695 . . . . 0.0 111.065 179.88 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -137.44 138.1 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.653 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.78 156.23 21.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.642 -0.661 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.15 168.99 14.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.673 . . . . 0.0 110.339 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 10.4 p -55.27 -38.5 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.512 -0.743 . . . . 0.0 110.393 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-20 -161.68 175.08 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.48 -32.39 73.82 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.675 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.771 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.38 -39.63 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.06 -42.69 86.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.614 -0.679 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.4 tt0 -59.94 -34.04 72.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.36 -49.74 46.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.45 -35.43 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -77.72 -40.67 40.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.628 179.384 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.0 mmmt -72.33 -3.24 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.0 111.261 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 -44.58 4.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.922 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CE2' HD23 ' A' ' 6' ' ' LEU 0.291 4.5 t80 -49.42 -30.38 7.86 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.326 176.062 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -82.35 -55.17 4.67 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.718 0.77 . . . . 0.0 108.952 178.602 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.88 -45.8 92.18 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.624 . . . . 0.0 111.457 -178.958 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.29 -29.23 1.55 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.599 -0.688 . . . . 0.0 111.256 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -101.57 -46.08 5.08 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.286 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.02 64.41 0.1 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.607 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.2 133.9 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.837 -0.802 . . . . 0.0 110.29 -177.068 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.2 -175.16 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 127.63 -173.53 18.69 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.56 -1.305 . . . . 0.0 111.744 179.186 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.8 126.38 36.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.02 -0.694 . . . . 0.0 110.164 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 37.7 m95 -95.84 126.77 41.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.712 . . . . 0.0 110.259 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.2 p -141.71 134.96 29.33 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.598 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.6 t80 -97.53 141.97 29.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.516 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.49 100.09 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.614 179.272 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.69 -4.03 21.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.593 -0.692 . . . . 0.0 111.483 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.67 -26.93 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.707 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.2 p -128.53 7.73 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.661 -0.65 . . . . 0.0 110.201 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 54.87 41.95 31.5 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.172 -0.955 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 5' ' ' LYS . 61.3 m -130.05 138.58 50.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.587 -0.695 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.4 m-85 -94.46 -173.18 2.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 0.0 109.17 179.245 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 38.1 m -161.38 122.39 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.772 -1.205 . . . . 0.0 109.184 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.5 p -118.99 89.94 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -86.27 99.12 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.957 0.884 . . . . 0.0 110.428 -178.267 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 18.8 tt0 . . . . . 0 N--CA 1.501 2.123 0 O-C-N 120.91 -1.119 . . . . 0.0 110.291 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.017 0.437 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 43.2 m -123.49 29.71 6.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 m -62.55 87.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.459 -0.776 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -72.53 128.12 34.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.735 -0.603 . . . . 0.0 110.228 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.756 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -95.23 171.53 8.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 109.479 179.535 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.9 tp -150.47 106.6 3.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.66 122.6 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -95.89 124.17 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.966 -179.388 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 54' ' ' THR . 3.8 m-20 -79.96 -30.33 39.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.262 -0.898 . . . . 0.0 110.181 -179.688 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.3 149.27 50.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -58.86 -20.26 49.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.56 -0.965 . . . . 0.0 110.61 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.462 ' HB ' HD11 ' A' ' 40' ' ' ILE . 7.1 p -65.45 116.62 6.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 110.553 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 65.77 -53.62 0.37 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.334 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.6 mtmt 43.79 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.779 -1.201 . . . . 0.0 112.682 179.091 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.91 -166.41 38.11 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.664 179.201 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -126.87 153.18 46.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.898 -0.766 . . . . 0.0 109.798 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 17' ' ' ILE . 5.2 mp -120.56 -14.37 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.426 -0.796 . . . . 0.0 111.242 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.756 HG22 ' CG ' ' A' ' 5' ' ' LYS . 40.7 p 44.14 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.575 -0.703 . . . . 0.0 111.875 -179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -128.07 138.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.52 -0.737 . . . . 0.0 110.665 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -81.69 147.89 29.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.9 179.591 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' HG21 ' A' ' 2' ' ' THR . . . -159.98 165.65 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -55.04 -39.65 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.677 . . . . 0.0 110.601 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -162.32 174.77 12.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.717 -0.614 . . . . 0.0 109.563 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.51 -32.32 72.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.403 -0.811 . . . . 0.0 109.789 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.0 -41.37 78.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.65 -44.05 57.85 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.131 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.24 80.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.566 -0.709 . . . . 0.0 109.545 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.8 tt0 -58.69 -37.74 76.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.255 178.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -68.62 -52.28 33.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.674 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 mt -56.61 -40.18 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.07 -35.72 66.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.881 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 44' ' ' TRP . 23.7 mttm -76.47 0.34 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.654 -0.654 . . . . 0.0 111.464 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.81 -45.28 3.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 177.455 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 8.3 t80 -55.51 -42.22 74.18 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.882 176.353 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.803 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.28 -50.97 71.95 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.261 0.553 . . . . 0.0 110.185 179.335 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.38 -46.51 89.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -54.51 -23.3 15.78 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -106.17 -34.88 7.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.631 -0.668 . . . . 0.0 110.623 -179.911 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 123.63 37.76 0.57 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.803 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -107.67 107.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -1.047 . . . . 0.0 108.733 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -157.62 104.41 1.98 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.271 -179.399 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.72 -50.37 0.04 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.869 ' CB ' HG22 ' A' ' 56' ' ' THR . 10.1 tt0 -138.0 167.28 22.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -1.064 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.7 m95 -161.49 123.94 3.03 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.841 -0.537 . . . . 0.0 109.886 179.514 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 15.0 p -146.65 132.23 18.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.501 -0.75 . . . . 0.0 109.36 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.9 t80 -96.37 133.08 41.21 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.85 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 100.3 10.44 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -2.63 16.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.726 -0.609 . . . . 0.0 111.939 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.7 22.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.274 179.406 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -138.34 16.01 2.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.716 -0.615 . . . . 0.0 110.0 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.5 mptt 49.02 42.53 21.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 111.339 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -118.55 110.64 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.936 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.882 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.5 m-85 -70.86 -175.4 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 9' ' ' ASN . 0.5 OUTLIER -156.01 105.61 2.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.947 -1.096 . . . . 0.0 108.369 -179.759 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 8.0 p -120.76 144.5 29.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 43' ' ' GLU . 5.7 t -141.3 -165.63 2.01 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.815 179.767 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.294 -179.762 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.072 0.463 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 2' ' ' THR . 57.9 m -117.42 43.56 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.586 -0.696 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 78.5 m -67.79 93.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.459 -0.775 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 11.8 m-85 -76.65 159.17 30.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.0 109.707 179.773 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.916 ' HG2' HG22 ' A' ' 18' ' ' THR . 37.7 mtmt -121.36 -172.99 2.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.5 tp -165.32 104.86 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.263 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.7 126.17 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.422 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.642 HG13 HD11 ' A' ' 13' ' ' LEU . 8.7 mm -99.14 115.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.525 -178.394 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.422 HD22 ' CG2' ' A' ' 54' ' ' THR . 1.4 m120 -81.68 -159.04 0.25 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.33 -152.94 5.11 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.943 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -107.44 -18.28 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.771 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.497 ' CG2' HD13 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -58.02 94.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 179.743 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 58.17 171.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.263 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.828 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -162.69 106.9 1.12 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.46 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.93 -166.16 35.62 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.191 -179.823 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.86 -39.12 4.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.798 -0.825 . . . . 0.0 110.517 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.1 mm 54.09 76.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.327 -0.858 . . . . 0.0 110.303 -179.797 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.916 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.8 p -76.0 129.11 36.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.008 -179.787 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.17 144.18 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.904 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -83.07 149.66 26.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 109.964 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -163.81 153.14 14.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.684 . . . . 0.0 110.388 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -52.12 -39.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.399 -0.813 . . . . 0.0 110.458 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.2 m-20 -159.37 173.78 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.749 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.03 -30.58 70.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.822 . . . . 0.0 109.82 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.89 82.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.813 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.07 -44.79 60.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.594 -0.691 . . . . 0.0 109.689 178.76 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.1 tt0 -59.79 -38.08 80.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.647 -0.658 . . . . 0.0 109.229 179.088 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -67.99 -51.53 46.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 178.791 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.26 -37.41 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.879 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.6 m-85 -75.18 -35.78 61.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.786 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 mmmt -78.32 2.52 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.835 -0.541 . . . . 0.0 111.232 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -106.76 -46.44 3.96 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 177.332 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 23.7 t80 -52.42 -31.79 36.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.938 175.923 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.47 -64.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.676 0.75 . . . . 0.0 109.014 178.988 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -55.59 -40.08 71.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.925 -0.484 . . . . 0.0 110.767 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -49.32 -27.86 4.33 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.65 -0.656 . . . . 0.0 110.837 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -106.82 -50.72 3.06 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.436 0.636 . . . . 0.0 109.94 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.74 63.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -179.712 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.747 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -119.31 130.7 73.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.805 -0.82 . . . . 0.0 109.967 -177.272 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -171.19 100.26 0.21 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 110.724 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.96 -57.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.772 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.858 ' HB2' HG22 ' A' ' 56' ' ' THR . 79.1 mm-40 -140.92 168.42 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.947 . . . . 0.0 110.609 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.6 m95 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.1 p -133.75 130.68 38.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.856 -179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.0 t80 -93.65 129.6 39.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.084 -0.647 . . . . 0.0 109.555 179.434 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -97.95 97.51 9.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.731 -0.606 . . . . 0.0 109.472 179.185 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.55 -6.32 30.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.561 -0.712 . . . . 0.0 111.527 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.29 -27.26 17.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 179.686 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 p -124.15 6.82 8.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.557 -0.714 . . . . 0.0 110.142 179.268 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 6.9 mmmt 54.4 38.92 30.48 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 -179.774 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -130.44 134.17 46.9 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.663 . . . . 0.0 110.761 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 61.1 m-85 -87.88 -173.29 4.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.519 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' HD22 ' A' ' 9' ' ' ASN . 0.8 OUTLIER -155.74 103.78 2.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.923 -1.111 . . . . 0.0 108.692 179.881 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 6.4 p -117.02 146.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.327 -178.64 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' HB2' ' A' ' 43' ' ' GLU . 5.9 t -148.06 -171.61 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.999 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.231 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.02 0.438 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.627 HG22 ' CE2' ' A' ' 4' ' ' PHE . 59.9 m -129.41 34.68 4.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 110.169 -179.884 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -73.74 109.82 7.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.465 -0.772 . . . . 0.0 110.017 179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.627 ' CE2' HG22 ' A' ' 2' ' ' THR . 60.2 m-85 -90.56 119.35 30.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 110.391 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -85.84 169.77 13.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.655 -0.653 . . . . 0.0 109.514 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.878 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.5 tp -148.25 111.06 4.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.986 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -90.72 119.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.508 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.771 HD11 HD23 ' A' ' 6' ' ' LEU . 2.0 mp -93.13 121.05 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.606 -179.144 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.9 162.19 13.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.359 -0.838 . . . . 0.0 110.552 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.07 -168.11 31.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.5 5.54 23.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.503 -0.998 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.538 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -60.07 -164.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.19 -0.944 . . . . 0.0 110.117 179.822 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.833 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 pp -52.78 -33.81 50.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.26 -0.9 . . . . 0.0 110.874 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.2 mmtt 52.33 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.398 -0.814 . . . . 0.0 111.536 178.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.55 -165.85 38.81 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.401 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' THR . 8.2 mt-10 -148.08 77.56 1.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.821 -0.811 . . . . 0.0 109.334 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 34' ' ' TYR . 41.6 pt -57.82 -26.24 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.46 -0.775 . . . . 0.0 111.118 -179.123 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 16' ' ' GLU . 2.9 p 60.31 128.55 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.5 0.666 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.17 156.88 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.416 -0.802 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.42 159.59 15.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.684 179.432 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.82 168.46 8.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.83 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 110.676 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.5 m-20 -158.11 177.21 11.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -64.3 -34.59 78.47 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.471 -179.817 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.42 -52.45 61.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.377 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -59.29 -42.71 91.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.635 -0.665 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.15 -42.49 69.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.526 -0.734 . . . . 0.0 109.773 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.1 tt0 -59.07 -45.84 89.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.556 -0.715 . . . . 0.0 109.335 179.248 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -50.72 71.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.288 -0.883 . . . . 0.0 109.641 178.654 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.4 -45.86 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.416 -0.803 . . . . 0.0 109.23 179.081 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.6 m-85 -69.01 -34.03 74.61 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.923 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 3.9 mmmt -73.72 -4.26 33.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.85 -0.531 . . . . 0.0 111.314 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -107.3 -45.45 4.1 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.719 ' CE1' HD13 ' A' ' 17' ' ' ILE 0.291 9.4 t80 -51.1 -31.69 20.04 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.821 175.948 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -64.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.837 0.827 . . . . 0.0 108.825 178.771 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -54.52 -40.42 68.59 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.085 0.469 . . . . 0.0 110.655 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -49.81 -27.15 4.63 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.72 -0.613 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -107.28 -48.75 3.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.382 0.61 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.29 62.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.833 HD11 HD23 ' A' ' 13' ' ' LEU 0.299 1.1 mm -119.54 136.54 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.821 -0.811 . . . . 0.0 109.495 -177.346 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -169.74 106.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.246 -0.908 . . . . 0.0 111.59 -179.735 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -108.14 0.21 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 179.054 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.5 tt0 -109.2 178.96 4.3 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.414 -1.05 . . . . 0.0 110.4 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.7 m95 -155.17 128.79 8.53 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.667 -0.646 . . . . 0.0 109.539 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.8 p -145.17 132.78 20.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.397 -0.814 . . . . 0.0 109.628 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 19.6 t80 -96.56 131.28 43.34 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -99.98 99.63 10.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.659 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -70.97 -2.83 16.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.692 -0.63 . . . . 0.0 111.87 -179.3 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.66 -28.36 20.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -136.19 14.97 3.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 4.3 mptt 48.8 43.05 20.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 111.578 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -121.01 114.4 21.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.854 -0.529 . . . . 0.0 109.87 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.878 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.2 m-85 -73.69 -172.96 1.36 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -0.816 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.17 97.55 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.19 . . . . 0.0 107.988 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG1' HG13 ' A' ' 8' ' ' ILE . 2.7 p -99.89 98.88 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.003 0.906 . . . . 0.0 111.012 -178.492 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -76.88 170.47 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.697 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' CG ' HG23 ' A' ' 12' ' ' THR . 5.5 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.087 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.08 0.467 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.606 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m -136.64 42.52 2.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.618 -0.676 . . . . 0.0 110.215 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.8 m -72.98 98.01 2.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.733 . . . . 0.0 110.033 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 43.3 m-85 -76.11 122.66 24.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 110.328 -179.923 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -92.2 169.94 10.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 179.658 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.903 HD22 ' CD1' ' A' ' 31' ' ' PHE . 9.6 tp -150.14 105.21 3.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.953 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -90.66 123.31 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.1 mp -97.5 122.86 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.884 -1.127 . . . . 0.0 109.423 -178.928 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 54' ' ' THR . 2.3 m-20 -83.14 -157.97 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.22 -134.52 45.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -144.65 25.71 1.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.688 -0.889 . . . . 0.0 110.413 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.6 ' CG2' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -62.82 -71.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.511 -0.743 . . . . 0.0 109.642 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.804 HD23 HD11 ' A' ' 40' ' ' ILE . 4.6 pp -129.25 -28.69 2.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.631 -0.668 . . . . 0.0 110.688 179.601 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER 54.28 100.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.24 -0.912 . . . . 0.0 111.117 179.538 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.95 48.25 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 21.4 mt-10 -117.08 -37.83 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.901 -0.764 . . . . 0.0 109.95 179.815 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 19' ' ' ILE . 2.4 mp 65.52 -58.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.979 -0.451 . . . . 0.0 111.868 179.617 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 5' ' ' LYS . 4.1 p 57.5 107.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.474 -0.766 . . . . 0.0 110.401 -179.51 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 17' ' ' ILE . 2.3 pp -139.08 138.25 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.556 -0.715 . . . . 0.0 110.715 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -84.29 153.49 23.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.36 168.75 19.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.509 -0.744 . . . . 0.0 110.401 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.45 -39.67 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.589 -0.694 . . . . 0.0 110.771 -179.869 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -162.23 175.41 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.09 -29.33 70.72 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.859 -179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -41.33 78.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.869 179.574 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' OE2' HG12 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -74.65 -45.44 44.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.66 -49.15 71.31 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.433 -0.792 . . . . 0.0 109.766 179.149 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.0 tt0 -58.81 -35.59 73.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.605 -0.685 . . . . 0.0 109.26 179.083 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.77 -50.85 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.722 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mt -59.06 -36.86 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.903 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -75.28 -39.29 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.159 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 7.4 mtpm? -76.66 1.73 16.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.58 -0.7 . . . . 0.0 111.535 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -105.81 -45.03 4.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 177.143 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 16.0 t80 -54.02 -34.0 58.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.604 175.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.27 -62.93 1.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.536 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -57.57 -40.68 79.49 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.891 -0.505 . . . . 0.0 110.614 -179.931 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.88 -27.95 3.43 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.682 -0.636 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.05 -48.87 3.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.406 0.622 . . . . 0.0 109.759 179.113 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.94 63.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.786 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.804 HD11 HD23 ' A' ' 13' ' ' LEU 0.291 1.1 mm -119.24 133.8 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.731 -0.864 . . . . 0.0 109.851 -177.386 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -172.18 103.58 0.17 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.353 -0.842 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.19 -49.04 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.884 ' HB3' HG22 ' A' ' 56' ' ' THR . 12.8 tt0 -154.6 169.03 24.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -1.062 . . . . 0.0 110.798 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 48.5 m95 -161.24 115.22 2.0 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.14 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.4 p -137.81 132.02 32.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.514 -0.741 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.4 t80 -96.68 129.66 44.05 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.854 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -96.94 101.9 13.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.589 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.21 0.09 10.69 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.729 -0.607 . . . . 0.0 111.95 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.23 -26.54 18.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.388 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -140.81 16.85 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.897 179.513 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 49.32 45.63 23.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 111.456 179.591 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 m -120.3 111.64 18.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.087 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -73.71 -176.72 2.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 109.464 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.506 HG22 HD21 ' A' ' 9' ' ' ASN . 1.4 m -157.1 110.84 2.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.82 -1.175 . . . . 0.0 108.525 -179.784 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -122.35 139.98 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.135 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.884 HG22 ' HB3' ' A' ' 43' ' ' GLU . 9.3 t -136.37 -171.21 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.212 179.854 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 94.9 m -82.74 -71.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 110.22 -179.978 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.6 m 49.69 76.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.316 -0.865 . . . . 0.0 111.277 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.738 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -73.54 144.63 46.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.535 -0.728 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 18' ' ' THR . 7.2 mttp -109.22 -176.01 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 110.158 -179.8 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 31' ' ' PHE . 57.2 tp -155.81 118.99 4.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.493 -0.755 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 mt -87.88 108.69 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.043 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.901 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.5 mm -84.64 107.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.643 -179.407 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 25.5 m-20 -76.04 -28.31 57.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.558 -0.713 . . . . 0.0 110.131 179.572 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 166.38 4.72 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.305 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -31.11 27.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.909 . . . . 0.0 110.795 -179.701 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 p -56.51 -31.43 64.07 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.401 -0.812 . . . . 0.0 110.213 -179.956 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.901 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.0 mt -138.37 144.0 40.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.679 -0.638 . . . . 0.0 109.512 179.669 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -146.47 87.68 1.73 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.486 -0.759 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.26 -164.35 31.9 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.652 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.82 149.08 44.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.763 -0.845 . . . . 0.0 110.213 -179.965 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 48.7 mm -103.4 -15.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.716 . . . . 0.0 110.663 179.927 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' HG2' ' A' ' 5' ' ' LYS . 17.2 p 52.67 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.567 0.699 . . . . 0.0 111.018 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.5 pp -135.81 134.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.39 -0.819 . . . . 0.0 110.733 -179.966 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.47 142.43 40.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.597 -0.689 . . . . 0.0 110.219 179.985 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.48 38.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.705 . . . . 0.0 110.306 179.856 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.38 -39.21 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.511 -0.743 . . . . 0.0 110.694 -179.906 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.1 m-20 -160.2 178.33 9.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.689 -0.632 . . . . 0.0 109.469 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.738 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.75 -30.05 71.19 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.797 179.937 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.665 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -65.74 -38.71 89.87 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.982 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.79 -44.12 94.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.06 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 16.0 tt0 -59.16 -36.1 74.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.599 . . . . 0.0 109.437 179.085 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -71.88 -49.63 36.34 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 109.109 178.865 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.53 -32.77 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.708 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' CD1' HD22 ' A' ' 6' ' ' LEU . 6.4 m-85 -80.91 -37.72 29.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.057 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -76.61 1.82 15.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 111.108 179.169 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -108.23 -44.16 4.2 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.423 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.296 2.6 t80 -52.12 -43.96 64.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.914 176.252 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.38 -59.28 5.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.316 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.57 -44.09 80.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.759 -0.588 . . . . 0.0 110.882 -179.509 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -48.31 -28.4 3.11 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.903 -179.786 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -102.36 -43.82 5.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.572 0.701 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.39 59.17 0.1 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 107.391 -2.283 . . . . 0.0 107.391 -179.463 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.791 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.293 1.1 mm -120.75 159.41 22.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.95 -0.735 . . . . 0.0 109.563 -177.043 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -176.65 -165.99 0.14 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 -126.5 7.43 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.187 178.373 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.902 ' HB3' HG22 ' A' ' 56' ' ' THR . 41.4 tt0 -96.59 109.22 21.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.72 . . . . 0.0 111.973 -177.834 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' THR . 26.0 m95 -97.47 118.03 33.05 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.446 0.641 . . . . 0.0 109.538 178.242 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -131.78 162.03 31.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.329 -179.387 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.8 t80 -123.71 137.37 54.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.878 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.46 100.13 9.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.213 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.03 -3.56 20.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.699 -0.626 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.93 -26.29 17.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.96 . . . . 0.0 109.742 179.705 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -129.45 8.28 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.62 -0.675 . . . . 0.0 110.132 179.384 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt 54.24 41.72 31.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 -179.671 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.6 m -126.49 137.78 53.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.688 -0.632 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.1 m-85 -96.89 -165.7 1.3 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.467 -0.77 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 6.9 m -154.83 162.86 40.96 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.996 -1.065 . . . . 0.0 108.839 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 40' ' ' ILE . 2.5 p -164.35 96.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.738 -0.601 . . . . 0.0 109.523 -179.452 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.902 HG22 ' HB3' ' A' ' 43' ' ' GLU . 3.8 t -110.83 91.87 3.83 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.296 1.046 . . . . 0.0 111.673 -178.794 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.504 2.274 0 O-C-N 120.887 -1.133 . . . . 0.0 110.794 -179.666 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.618 HG22 ' CE2' ' A' ' 4' ' ' PHE . 29.8 m -129.13 25.83 5.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -68.35 100.03 1.01 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 109.925 179.751 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.0 m-85 -80.19 150.7 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.841 ' HG2' HG22 ' A' ' 18' ' ' THR . 16.3 mtmm -116.4 174.69 5.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.76 HD23 HD11 ' A' ' 8' ' ' ILE . 10.4 tp -151.54 114.1 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.24 112.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.76 HD11 HD23 ' A' ' 6' ' ' LEU . 3.2 mp -96.59 114.94 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.469 -179.132 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -106.69 103.21 12.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.747 . . . . 0.0 109.74 179.879 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.77 -103.13 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.955 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -154.64 30.39 0.42 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.946 . . . . 0.0 110.334 -179.968 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.494 ' OG1' HD13 ' A' ' 40' ' ' ILE . 1.2 p -142.74 118.72 10.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.619 -0.676 . . . . 0.0 110.545 -179.813 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 67.31 -52.45 0.48 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.986 -0.446 . . . . 0.0 111.57 179.85 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.8 mttt 48.83 91.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.712 -1.243 . . . . 0.0 111.473 179.569 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.57 -165.75 29.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.88 154.68 42.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.747 . . . . 0.0 110.02 -179.856 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 19' ' ' ILE . 15.8 tt -118.78 -4.7 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.467 -0.77 . . . . 0.0 111.252 179.861 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.841 HG22 ' HG2' ' A' ' 5' ' ' LYS . 42.9 p 47.01 102.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.524 -0.735 . . . . 0.0 112.04 179.584 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -127.56 145.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.406 -0.809 . . . . 0.0 110.541 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.84 155.68 18.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.22 167.49 12.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.595 -0.69 . . . . 0.0 110.445 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.77 -39.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.521 -0.737 . . . . 0.0 110.736 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.474 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -161.47 174.91 12.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.88 -31.93 72.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 109.931 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.6 82.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.728 . . . . 0.0 109.831 179.675 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.78 -39.66 84.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.099 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.67 -42.19 87.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.632 -0.667 . . . . 0.0 109.447 179.049 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.7 tt0 -59.83 -36.86 77.69 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.96 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -70.77 -48.23 55.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.685 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 27' ' ' ALA . 46.5 mt -59.92 -38.74 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.713 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.1 m-85 -74.63 -39.39 62.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.126 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 31.0 mtpt -71.97 -3.36 22.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 111.084 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -107.88 -44.6 4.18 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.903 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 27.5 t80 -52.2 -37.7 55.7 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.355 176.327 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.63 -65.65 0.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -56.25 -42.39 77.28 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.721 -0.612 . . . . 0.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.68 -29.35 2.96 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -102.79 -44.96 5.14 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 178.703 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 12' ' ' THR . . . 132.83 63.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.955 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.81 135.36 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.774 -0.839 . . . . 0.0 110.22 -177.34 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -131.02 170.08 14.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 139.97 177.83 16.21 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.994 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -81.31 115.89 20.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.95 -0.735 . . . . 0.0 109.896 179.657 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.411 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 42.1 m95 -79.37 129.34 34.37 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.515 0.674 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 18.3 p -144.44 133.7 23.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.865 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -96.32 145.75 25.32 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.584 179.593 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.52 100.57 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.671 -0.643 . . . . 0.0 109.546 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.4 -5.04 25.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.0 111.588 -179.704 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.68 -27.72 19.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.738 179.619 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -130.03 8.05 5.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.0 110.08 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 54.58 42.13 31.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.3 m -127.03 132.57 50.69 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.419 -179.238 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.0 m-85 -90.12 -179.46 5.67 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.65 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 62.0 m -162.5 126.38 3.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.772 -1.205 . . . . 0.0 109.95 -179.444 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.34 92.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.806 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -84.56 102.94 13.27 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.707 0.765 . . . . 0.0 110.182 -178.54 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 27.0 tt0 . . . . . 0 N--CA 1.504 2.243 0 O-C-N 121.079 -1.013 . . . . 0.0 110.943 -178.96 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.165 0.507 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.3 m -115.62 87.39 2.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.512 -0.743 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 m -109.16 120.85 43.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.73 . . . . 0.0 109.789 179.283 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 35.6 m-85 -114.24 125.46 53.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.568 -0.708 . . . . 0.0 110.256 179.98 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.806 ' HG3' HG22 ' A' ' 18' ' ' THR . 1.2 mtmt -91.69 172.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.529 -0.732 . . . . 0.0 109.391 179.632 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.911 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -153.99 112.77 3.66 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.233 -179.724 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.2 mt -91.52 115.65 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.941 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.71 116.81 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.269 -0.973 . . . . 0.0 109.449 -179.229 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -94.96 60.62 2.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.08 -144.73 4.94 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.36 27.23 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -179.812 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -140.07 27.32 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.491 -0.756 . . . . 0.0 110.183 179.836 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -173.73 -74.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 110.01 179.669 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt 51.61 54.07 11.65 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.325 -0.859 . . . . 0.0 110.667 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.95 169.05 28.1 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.782 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.99 64.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.812 . . . . 0.0 110.265 -179.857 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -61.16 143.54 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.806 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.0 p -99.4 150.65 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -0.754 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -116.19 168.58 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.111 0.958 . . . . 0.0 110.963 -179.181 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 19' ' ' ILE . 2.7 tp10 -132.16 79.37 1.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.758 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.66 176.68 5.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.678 -0.639 . . . . 0.0 110.5 -177.248 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 14.7 p -75.3 -40.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.278 -179.592 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 5.9 p30 -149.36 172.5 14.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.367 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.38 -31.27 71.16 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.859 -179.511 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.76 -54.26 46.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.483 -0.761 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' OE1' HG12 ' A' ' 22' ' ' VAL . 1.5 mt-10 -62.17 -45.57 92.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.0 -45.46 61.15 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.268 -0.895 . . . . 0.0 110.371 179.399 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.82 -34.63 74.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.401 179.348 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.43 -53.39 23.93 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.371 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 19' ' ' ILE . 19.4 mt -59.57 -32.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.916 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD12 ' A' ' 6' ' ' LEU . 3.9 m-85 -78.89 -38.67 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.463 0.649 . . . . 0.0 109.266 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.3 mmmt -72.93 -4.06 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.796 -0.565 . . . . 0.0 111.429 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -107.84 -44.69 4.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.329 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.476 ' OH ' HD21 ' A' ' 13' ' ' LEU 0.293 17.6 t80 -52.62 -34.04 49.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.2 176.43 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.58 -49.92 64.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.731 -0.606 . . . . 0.0 109.936 179.253 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -57.85 -46.2 85.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.639 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -55.61 -23.65 28.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.43 -0.794 . . . . 0.0 110.758 179.985 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.538 ' O ' HG21 ' A' ' 12' ' ' THR . 1.8 m-80 -102.98 -26.65 13.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.739 -0.601 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.99 29.9 3.37 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.79 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -96.97 106.71 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.622 -0.928 . . . . 0.0 108.855 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -143.96 102.73 3.93 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.409 -179.215 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.42 -105.81 0.2 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.154 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tt0 -105.95 179.73 4.18 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.41 -1.053 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' NE1' HG23 ' A' ' 55' ' ' VAL . 40.3 m95 -157.17 131.04 8.2 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.654 -0.653 . . . . 0.0 109.757 -179.952 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.2 p -146.13 132.29 19.4 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.581 -0.699 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 19.9 t80 -97.42 121.97 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.667 179.272 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.2 98.82 11.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.554 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.93 -3.05 17.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.573 -0.704 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.08 -28.54 21.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.416 179.369 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -136.53 14.62 3.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.697 -0.627 . . . . 0.0 110.024 179.275 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.6 mptp? 49.46 43.65 23.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.88 . . . . 0.0 111.283 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -119.99 103.41 9.28 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.274 179.774 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 75.6 m-85 -62.3 -177.04 0.12 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.695 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.9 101.68 1.8 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.764 -1.21 . . . . 0.0 107.756 -179.654 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.6 p -106.13 115.27 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.209 1.004 . . . . 0.0 111.607 -178.148 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -89.69 171.78 9.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.793 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.216 179.968 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.219 0.533 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.2 m -87.05 89.98 8.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 m -108.0 114.43 28.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.541 -0.725 . . . . 0.0 110.027 179.435 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.7 m-85 -113.0 117.91 33.35 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG2' HG22 ' A' ' 18' ' ' THR . 24.4 mtmt -87.36 171.94 10.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -0.812 . . . . 0.0 110.108 -179.655 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.899 HD22 ' CD1' ' A' ' 31' ' ' PHE . 29.8 tp -148.48 105.14 3.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.727 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.35 118.36 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mm -95.35 119.47 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.988 -178.991 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' THR . 28.5 t-20 -113.71 92.03 3.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.333 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.55 176.86 45.95 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -60.41 -34.25 73.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.486 -1.008 . . . . 0.0 110.353 -179.873 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.505 HG23 ' HG3' ' A' ' 11' ' ' LYS . 23.9 p -91.09 133.45 35.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.657 -0.652 . . . . 0.0 109.871 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 8' ' ' ILE . 4.9 mt 58.48 162.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.504 -0.748 . . . . 0.0 110.274 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -175.69 94.29 0.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.327 -0.858 . . . . 0.0 110.659 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.54 176.04 14.33 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.586 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -82.06 150.25 27.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.676 -0.896 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.652 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 57.7 mt -117.51 -19.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.571 -0.706 . . . . 0.0 110.757 -179.919 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.494 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.2 p 61.83 129.59 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.722 -0.611 . . . . 0.0 110.251 -179.636 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.681 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -120.53 167.25 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.967 0.889 . . . . 0.0 111.14 -179.445 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.02 71.56 1.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.61 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.1 179.34 4.13 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.797 -0.564 . . . . 0.0 110.403 -177.619 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 13.5 p -80.01 -41.5 21.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.893 -179.386 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 19.0 m-20 -147.11 171.66 14.97 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.831 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.667 -179.338 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.36 72.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.52 -0.737 . . . . 0.0 109.942 179.42 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.43 -49.69 58.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.84 61.64 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.544 -0.723 . . . . 0.0 110.121 179.009 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -60.22 -41.29 92.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.303 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -67.44 -49.85 61.89 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.784 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 19' ' ' ILE . 47.7 mt -59.14 -39.97 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.59 -0.694 . . . . 0.0 109.204 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.899 ' CD1' HD22 ' A' ' 6' ' ' LEU . 5.6 m-85 -73.78 -38.58 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.336 0.588 . . . . 0.0 109.476 179.25 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 0.8 OUTLIER -72.77 -3.35 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.664 -0.647 . . . . 0.0 111.44 -179.99 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -110.41 -45.1 3.6 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 177.721 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.652 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.296 3.6 t80 -54.41 -44.49 72.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.85 176.28 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.479 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.48 -58.64 5.84 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.196 0.522 . . . . 0.0 109.921 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -54.76 -47.6 73.69 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.595 -0.69 . . . . 0.0 110.916 -179.719 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.32 -28.71 63.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.402 -0.811 . . . . 0.0 110.421 -179.896 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -94.6 -27.8 15.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.809 -0.557 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 111.33 27.81 4.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.728 HG22 HG21 ' A' ' 55' ' ' VAL . 1.7 mp -99.77 76.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -1.05 . . . . 0.0 109.075 -179.972 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -172.3 3.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.042 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 126.11 -171.13 17.91 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.432 -1.366 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.24 132.14 34.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.983 -0.716 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.448 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 49.7 m95 -100.57 133.56 44.84 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.573 0.701 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.55 133.59 21.44 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 t80 -98.19 142.2 30.16 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.674 179.688 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -113.2 101.25 9.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.764 -0.585 . . . . 0.0 109.739 179.576 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.87 -5.15 28.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 0.0 111.428 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.8 -28.66 21.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 109.503 179.499 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -129.13 7.64 5.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.676 . . . . 0.0 110.096 179.269 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp 54.42 41.04 32.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.179 -0.951 . . . . 0.0 110.092 -179.717 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 m -127.98 132.77 49.16 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.044 -179.333 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.7 m-85 -86.92 -173.78 4.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.332 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 2.0 m -157.86 117.76 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.835 -1.166 . . . . 0.0 108.987 -179.878 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.728 HG21 HG22 ' A' ' 40' ' ' ILE . 1.7 p -115.81 93.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.735 0.778 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -87.72 96.78 10.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.892 0.853 . . . . 0.0 110.046 -178.618 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 10.9 tt0 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.131 . . . . 0.0 110.223 -179.131 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 2' ' ' THR . 70.6 m -114.39 48.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.639 -0.663 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.1 m -69.68 91.93 0.64 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.9 m-85 -80.98 139.69 35.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.517 -0.739 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.858 ' HG2' HG22 ' A' ' 18' ' ' THR . 78.6 mttt -103.92 -172.31 2.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.528 -0.733 . . . . 0.0 110.208 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.7 tp -164.05 98.77 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 0.0 109.94 179.912 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG13 HG21 ' A' ' 52' ' ' THR . 89.6 mt -80.52 134.11 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.421 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.807 HG21 ' HG ' ' A' ' 13' ' ' LEU . 5.9 mm -99.03 117.67 44.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.215 -178.925 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -94.07 6.0 49.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.677 -0.639 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.84 -165.89 36.33 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -103.11 27.56 7.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.611 -0.935 . . . . 0.0 109.966 179.614 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.668 ' C ' HD23 ' A' ' 13' ' ' LEU . 2.8 m -153.92 175.53 13.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 40' ' ' ILE . 0.6 OUTLIER 38.74 28.57 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.694 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.44 118.67 2.88 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.198 -0.939 . . . . 0.0 111.7 -179.209 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.95 -174.18 44.71 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 9.6 mt-10 -118.56 -32.78 4.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.832 -0.805 . . . . 0.0 110.546 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 pt 36.98 83.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.762 0 CA-C-O 121.558 0.694 . . . . 0.0 112.291 -179.625 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' HG2' ' A' ' 5' ' ' LYS . 72.9 p -70.54 140.8 51.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.51 -0.744 . . . . 0.0 110.553 -179.584 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -148.22 134.28 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 179.548 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.68 156.03 35.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 179.974 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.7 158.54 7.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.563 -0.71 . . . . 0.0 110.24 179.968 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.9 p -54.0 -39.99 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.544 -0.722 . . . . 0.0 110.555 179.926 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -160.5 177.48 10.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.458 -0.776 . . . . 0.0 109.705 179.561 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.79 -34.52 77.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 109.785 -179.985 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.611 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.04 -44.73 74.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.494 -0.754 . . . . 0.0 109.77 179.442 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -69.41 -44.48 71.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.826 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -55.8 -39.92 72.0 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.405 -0.809 . . . . 0.0 109.596 178.871 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.8 tt0 -61.37 -40.1 93.08 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.209 -0.597 . . . . 0.0 110.039 179.595 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.51 -34.44 63.03 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.491 179.478 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.4 mt -67.99 -38.76 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.915 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -75.21 -37.1 61.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.437 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.44 2.2 19.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 110.948 179.201 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.19 -44.8 4.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 177.386 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 8.6 t80 -51.54 -39.59 58.05 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.313 176.22 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.19 -48.72 32.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.583 0.706 . . . . 0.0 109.583 179.413 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -67.11 -46.38 74.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.774 -0.579 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -48.86 -27.76 3.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 111.03 -179.43 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -100.62 -47.76 4.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.417 0.627 . . . . 0.0 110.007 179.4 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.35 61.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -179.506 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.954 ' CD1' HD22 ' A' ' 13' ' ' LEU 0.294 1.1 mm -117.02 141.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.914 -0.756 . . . . 0.0 109.067 -177.298 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -166.66 125.28 1.43 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.735 -179.155 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.4 -102.2 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.525 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 9.6 tt0 -127.98 173.57 9.92 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.455 -1.026 . . . . 0.0 109.582 178.675 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.462 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.5 m95 -150.43 131.35 14.23 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.379 -0.826 . . . . 0.0 110.091 -179.798 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.4 p -143.96 131.5 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.6 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -94.87 134.14 37.84 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.211 179.308 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.14 98.77 8.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.627 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.05 -5.31 25.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.655 -0.653 . . . . 0.0 111.425 -179.903 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.59 -27.96 17.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.712 179.616 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.9 p -124.3 7.37 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.655 -0.653 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt 54.56 38.78 30.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.128 -0.982 . . . . 0.0 110.18 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -130.34 140.9 50.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.606 -0.684 . . . . 0.0 110.463 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.873 ' HB2' HD12 ' A' ' 6' ' ' LEU . 57.2 m-85 -92.74 -170.4 2.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 109.609 179.669 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.03 92.84 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.855 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 8' ' ' ILE . 2.4 p -92.98 105.71 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.87 0.843 . . . . 0.0 110.458 -178.91 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 43' ' ' GLU . 1.1 m -84.17 171.6 12.68 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.581 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.253 179.732 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.047 0.451 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.769 HG21 ' O ' ' A' ' 21' ' ' ALA . 61.7 m -110.57 -80.85 0.58 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.65 -0.656 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 22.6 m 52.39 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.28 -0.888 . . . . 0.0 110.875 -178.784 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -105.03 123.42 47.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.17 174.55 7.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.759 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.828 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -151.34 113.51 4.54 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.256 -179.997 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -80.98 119.81 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.969 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.855 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.9 mm -96.14 122.64 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.307 -178.738 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -108.84 52.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 109.956 179.458 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.09 -151.72 8.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.808 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 -23.6 9.37 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.598 -0.942 . . . . 0.0 110.722 -179.793 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -82.36 -30.4 30.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.563 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.855 ' HB2' HG21 ' A' ' 8' ' ' ILE . 8.5 mt -119.66 171.66 8.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.723 -0.61 . . . . 0.0 109.358 179.72 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.04 76.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.636 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.23 179.58 27.06 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.512 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.06 -154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.699 -0.883 . . . . 0.0 109.913 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 31' ' ' PHE . 7.0 tp -175.07 -32.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.501 -0.749 . . . . 0.0 110.25 179.913 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p 63.49 137.0 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.367 0.603 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -130.77 166.8 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 121.671 0.748 . . . . 0.0 111.057 -178.869 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.41 78.52 1.21 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.305 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.769 ' O ' HG21 ' A' ' 2' ' ' THR . . . -122.08 149.43 43.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.577 -0.702 . . . . 0.0 110.381 -177.533 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -58.55 -39.75 76.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.374 0.607 . . . . 0.0 110.75 -179.63 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' N ' HG13 ' A' ' 22' ' ' VAL . 49.1 p-10 -149.8 178.61 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.801 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.57 -29.99 70.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.606 -179.574 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.73 79.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.524 -0.735 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HG3' HG12 ' A' ' 22' ' ' VAL . 1.3 mm-40 -68.29 -47.87 66.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.639 -0.663 . . . . 0.0 109.394 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.26 -48.01 62.31 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.438 -0.789 . . . . 0.0 110.434 179.486 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.2 tt0 -58.6 -36.45 74.05 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.609 179.423 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -54.13 15.99 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.29 -35.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.527 -0.733 . . . . 0.0 109.184 178.753 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 6' ' ' LEU . 4.5 m-85 -74.65 -39.13 62.24 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.91 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -72.97 -2.79 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 111.442 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -109.28 -44.63 3.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 177.444 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 12.3 t80 -51.44 -33.77 32.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.746 175.954 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.95 -57.98 10.52 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.659 0.743 . . . . 0.0 109.118 178.573 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -58.55 -44.4 89.66 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -49.44 -27.19 3.92 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.593 -0.692 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -104.12 -50.07 3.45 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 0.0 110.135 179.402 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.88 62.64 0.05 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -179.653 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.307 1.1 mm -120.3 136.8 56.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.877 -0.778 . . . . 0.0 109.875 -177.042 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -170.07 101.97 0.29 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.325 -0.86 . . . . 0.0 111.237 -179.851 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.01 -104.38 0.18 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.445 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 8.6 tt0 -114.73 174.4 5.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.537 -0.978 . . . . 0.0 110.64 -179.923 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.447 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.1 m95 -152.87 128.67 10.19 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.709 -0.619 . . . . 0.0 109.615 179.854 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.43 132.06 23.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 109.309 179.587 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.5 t80 -96.97 128.25 43.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.53 179.589 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -96.22 98.66 10.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.656 -0.652 . . . . 0.0 109.407 179.207 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -70.59 -4.09 21.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.654 -0.654 . . . . 0.0 111.692 -179.598 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.22 -26.34 17.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.613 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -127.64 7.53 6.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.579 -0.701 . . . . 0.0 110.132 179.333 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 46.8 mmtt 54.53 40.43 31.83 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.21 -0.932 . . . . 0.0 110.134 -179.618 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -127.66 129.82 47.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.728 -0.608 . . . . 0.0 110.425 -179.638 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.5 m-85 -85.29 -171.17 3.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 109.497 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -155.83 95.28 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -98.8 107.5 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.982 0.896 . . . . 0.0 111.18 -178.357 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -88.4 163.72 15.86 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.796 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.305 -179.959 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.032 0.444 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 88.4 m -120.11 67.21 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.675 . . . . 0.0 110.336 -179.848 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.9 m -84.23 88.61 7.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.158 179.701 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.747 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 m-85 -76.9 137.72 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -102.48 -172.6 2.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.436 -179.533 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.0 tp -165.25 107.7 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.659 -0.65 . . . . 0.0 109.939 179.926 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -89.9 115.57 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.264 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 HD23 ' A' ' 6' ' ' LEU . 3.0 mp -97.67 120.55 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.483 -179.499 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -109.24 98.02 7.52 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.499 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.45 -135.02 1.97 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.937 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -32.94 4.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.968 . . . . 0.0 110.325 179.799 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 p -87.29 107.55 18.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 179.512 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.09 148.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.521 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.67 ' N ' HD12 ' A' ' 13' ' ' LEU . 15.2 ptmt -162.91 128.38 3.22 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.236 -0.915 . . . . 0.0 110.647 -179.724 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.07 -174.73 18.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.29 147.89 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.902 . . . . 0.0 110.836 -179.647 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.8 mm -113.12 -26.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.511 -0.743 . . . . 0.0 110.243 179.729 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 3.2 p 56.79 112.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.344 0.592 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.6 pp -141.97 135.44 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.327 179.188 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.27 149.34 47.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.609 -0.682 . . . . 0.0 110.148 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.67 156.04 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.3 p -53.42 -40.53 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.557 -0.715 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -159.94 -179.81 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.706 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.92 -32.49 74.24 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.559 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.95 76.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.828 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -68.59 -45.46 71.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.891 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -42.05 76.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.042 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.5 tt0 -61.62 -41.34 97.33 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.447 179.083 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -69.32 -44.27 72.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.408 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 87.7 mt -63.21 -42.09 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.839 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -70.41 -40.5 73.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.199 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 34.1 mtpt -71.56 -4.06 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 110.963 179.299 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -98.3 -45.6 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.127 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 5.9 t80 -44.36 -54.15 6.11 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.79 175.572 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.78 -51.41 68.41 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.53 -47.3 79.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.641 -0.662 . . . . 0.0 111.364 -178.958 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -48.92 -30.82 6.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.476 -0.765 . . . . 0.0 110.985 -179.275 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -96.01 -46.08 6.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.564 0.697 . . . . 0.0 109.553 179.124 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 62.89 0.16 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -179.373 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.284 1.0 OUTLIER -118.67 139.67 45.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.863 -0.786 . . . . 0.0 110.489 -176.725 . . . . . . . . 4 4 . 1 . 047 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.98 -178.21 4.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.21 -178.74 17.36 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.716 179.2 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.98 123.1 31.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.982 -0.717 . . . . 0.0 110.328 179.888 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' THR . 37.8 m95 -88.62 128.1 35.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -141.04 132.9 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -96.62 143.44 27.59 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.532 179.714 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.77 99.15 7.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.681 -0.637 . . . . 0.0 109.405 179.233 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.74 -3.84 20.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.664 . . . . 0.0 111.593 -179.641 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.27 -27.05 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.736 179.677 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -130.17 8.9 5.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.632 -0.668 . . . . 0.0 110.128 179.372 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 53.82 44.22 29.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 0.0 110.154 -179.589 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.2 m -130.07 129.93 44.25 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.113 -179.411 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.794 ' HB2' HD12 ' A' ' 6' ' ' LEU . 69.9 m-85 -89.69 -176.65 5.05 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.934 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 34.5 m -162.39 124.58 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.793 -1.192 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 8' ' ' ILE . 1.2 p -118.13 93.27 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.059 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -82.93 96.44 8.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.026 0.917 . . . . 0.0 110.157 -178.237 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 O-C-N 120.978 -1.076 . . . . 0.0 110.448 -179.243 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.128 0.49 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.5 m -97.83 104.27 16.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.734 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.4 m-85 -90.58 152.21 20.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.843 ' HG2' HG22 ' A' ' 18' ' ' THR . 33.7 mttt -112.96 -171.85 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.669 -0.645 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.799 HD22 ' CD1' ' A' ' 31' ' ' PHE . 14.8 tp -164.25 107.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.142 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.68 124.89 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.7 mm -89.82 116.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.77 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -103.51 67.74 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 0.0 110.468 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.97 167.92 39.47 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -59.82 -33.84 72.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -1.012 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 p -80.44 133.73 35.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 58.32 163.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.468 -0.77 . . . . 0.0 110.284 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -177.24 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.55 -163.45 33.99 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -133.41 70.67 1.46 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.932 . . . . 0.0 110.377 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -62.31 114.53 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.461 -0.774 . . . . 0.0 109.712 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.843 HG22 ' HG2' ' A' ' 5' ' ' LYS . 75.6 p -83.61 138.47 33.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.651 -0.656 . . . . 0.0 110.499 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.48 149.98 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.573 -0.704 . . . . 0.0 110.369 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 148.68 23.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.18 159.64 23.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.553 -0.717 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -53.68 -38.83 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.511 -0.743 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.5 m-20 -159.96 175.83 12.57 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.55 -33.81 75.68 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.713 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.82 63.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.455 -0.778 . . . . 0.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.09 -40.47 96.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.36 72.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 0.0 109.479 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -58.29 -36.26 73.04 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -69.11 -50.81 44.66 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.69 -37.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.799 ' CD1' HD22 ' A' ' 6' ' ' LEU . 12.0 m-85 -74.32 -37.34 63.61 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.6 mmmt -76.3 0.23 20.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.738 -0.601 . . . . 0.0 111.563 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -109.24 -45.25 3.77 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 10.7 t80 -53.07 -34.61 57.33 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.028 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -69.68 -48.14 60.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.193 0.52 . . . . 0.0 110.0 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.41 -46.7 85.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.526 -0.734 . . . . 0.0 110.342 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -54.58 -23.32 16.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.54 -0.725 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' HD13 ' A' ' 40' ' ' ILE . 1.7 m120 -105.51 -25.86 12.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.627 -0.67 . . . . 0.0 110.557 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.76 30.68 3.4 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.71 106.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.979 . . . . 0.0 108.788 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.73 111.68 6.75 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.427 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.27 -108.72 0.21 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -109.81 173.37 6.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.396 -1.061 . . . . 0.0 110.39 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.476 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.8 m95 -152.06 130.33 12.02 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.543 -0.723 . . . . 0.0 110.26 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 6.7 p -142.26 134.18 27.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.63 -0.669 . . . . 0.0 109.253 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.6 t80 -97.61 143.7 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.93 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -113.92 97.97 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.817 -0.552 . . . . 0.0 109.536 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -69.69 -6.84 34.41 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.661 -0.649 . . . . 0.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.15 -27.47 17.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.702 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -122.84 5.71 9.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.648 -0.658 . . . . 0.0 110.079 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp 54.19 36.63 25.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.7 m -127.97 143.2 51.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.629 -0.669 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HB2' HD12 ' A' ' 6' ' ' LEU . 64.2 m-85 -95.99 -168.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 109.698 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 92.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.18 108.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.902 0.858 . . . . 0.0 110.915 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -89.52 169.68 11.15 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.055 0.455 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.1 m -61.16 95.17 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.575 -0.703 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.7 m-85 -83.68 142.53 30.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.895 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.811 ' HG2' HG22 ' A' ' 18' ' ' THR . 45.1 mtmt -103.34 -177.24 3.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.584 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.896 HD12 ' HB2' ' A' ' 53' ' ' PHE . 4.9 tp -163.26 110.17 1.17 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.653 -0.654 . . . . 0.0 109.967 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.6 mt -85.8 117.63 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.8 mm -85.72 116.9 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -102.93 63.64 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.88 -132.68 3.26 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -131.32 -40.84 1.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.935 . . . . 0.0 110.465 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -69.89 -47.29 63.12 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.449 -0.782 . . . . 0.0 109.62 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.617 ' CB ' HG21 ' A' ' 8' ' ' ILE . 11.4 mt -110.81 156.89 20.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.811 -0.556 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -172.34 86.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.432 -0.793 . . . . 0.0 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.55 161.46 27.43 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.71 73.75 9.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.727 -0.867 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.646 HD13 ' CE2' ' A' ' 34' ' ' TYR . 7.2 mt -56.22 120.79 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 5' ' ' LYS . 74.2 p -99.09 133.47 43.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.28 142.1 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.626 -0.671 . . . . 0.0 110.375 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.02 141.21 34.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.619 -0.676 . . . . 0.0 110.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.72 160.14 41.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 110.236 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 26' ' ' GLU . 8.6 p -56.9 -32.99 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.242 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 6.5 p30 -166.13 -176.51 3.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 109.429 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -68.82 -30.29 68.82 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.665 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.65 -46.19 87.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.706 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' CB ' HG12 ' A' ' 22' ' ' VAL . 8.2 tp10 -70.33 -39.8 74.52 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.79 85.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.528 -0.732 . . . . 0.0 109.533 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.3 tt0 -58.61 -35.97 73.29 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -71.27 -51.33 25.09 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.0 -36.2 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.9 m-85 -75.72 -36.28 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 12.9 mtpp -80.12 4.61 16.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.792 -0.567 . . . . 0.0 111.449 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -110.89 -45.49 3.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.646 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.291 12.2 t80 -55.48 -43.5 75.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.933 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.73 -47.26 85.21 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.35 -49.51 75.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.554 -0.716 . . . . 0.0 110.746 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.36 -23.52 38.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.7 m120 -100.8 -24.05 14.47 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.729 -0.607 . . . . 0.0 110.719 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.87 30.89 4.67 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.749 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.51 106.21 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.679 -0.894 . . . . 0.0 108.785 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.53 110.0 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.117 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.94 -106.32 0.2 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.2 tt0 -108.63 174.82 5.7 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.483 -1.01 . . . . 0.0 110.524 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.473 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.9 m95 -153.53 130.63 11.09 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.638 -0.664 . . . . 0.0 109.99 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.0 p -142.48 133.18 25.39 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -99.84 144.24 29.13 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.882 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -114.97 98.56 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.769 -0.582 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.16 -4.94 23.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.713 -0.617 . . . . 0.0 111.664 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 -27.13 18.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.677 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.1 p -127.9 7.38 6.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.658 -0.651 . . . . 0.0 110.175 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt 54.17 40.62 31.85 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -125.83 135.9 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.656 -0.652 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD12 ' A' ' 6' ' ' LEU . 74.8 m-85 -94.36 -170.36 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.579 -0.701 . . . . 0.0 109.525 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.3 94.15 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.853 -1.154 . . . . 0.0 107.89 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 44' ' ' TRP . 3.0 p -96.66 107.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.02 0.914 . . . . 0.0 111.173 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -89.07 169.72 11.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.132 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 2' ' ' THR . 58.7 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.105 0.479 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.654 HG22 ' HB ' ' A' ' 18' ' ' THR . 2.7 m -71.0 81.93 0.67 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -66.41 144.49 56.49 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.93 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.04 179.81 4.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.575 -0.703 . . . . 0.0 110.162 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.0 tp -157.36 112.15 2.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -89.57 122.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 HD13 ' CG1' ' A' ' 55' ' ' VAL . 3.2 mm -89.06 117.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.664 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -104.95 67.06 0.78 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.474 -0.767 . . . . 0.0 110.091 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.02 166.05 36.76 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 12' ' ' THR . 15.8 pttm -59.89 -28.76 67.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.443 -1.034 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 11' ' ' LYS . 19.2 p -92.45 129.59 38.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.622 -0.674 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 34' ' ' TYR . 8.6 mt 60.33 127.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.378 0.609 . . . . 0.0 110.586 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -148.75 93.6 2.15 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.15 -172.72 45.7 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.22 96.36 5.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.817 -0.813 . . . . 0.0 109.947 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.9 mp -86.72 115.51 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 109.95 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.93 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.7 p -89.44 126.9 35.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.622 . . . . 0.0 110.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.87 135.28 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.615 -0.678 . . . . 0.0 110.491 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -73.87 153.1 40.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.592 -0.692 . . . . 0.0 110.134 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -167.66 160.22 12.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.1 p -53.14 -39.46 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.556 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -162.01 176.83 10.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.671 -0.643 . . . . 0.0 109.575 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.75 -33.35 74.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 109.746 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.2 -43.54 78.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 109.984 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 1.6 tp10 -70.4 -44.18 68.51 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 -46.29 74.29 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.484 -0.76 . . . . 0.0 109.686 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 2.7 tt0 -58.16 -37.65 75.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.747 -0.596 . . . . 0.0 109.412 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -51.2 43.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.62 -40.39 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.2 m-85 -71.8 -34.85 69.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 9.5 mttm -77.15 0.17 22.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.647 -0.658 . . . . 0.0 111.5 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -108.06 -45.41 3.96 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.58 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.292 2.6 t80 -54.02 -35.89 62.42 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.139 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -71.0 -45.76 63.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.81 -0.556 . . . . 0.0 110.343 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -50.23 73.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 111.018 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.82 -21.92 32.61 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.455 -0.778 . . . . 0.0 110.978 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' HD13 ' A' ' 40' ' ' ILE . 6.4 m120 -101.19 -23.71 14.39 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.686 -0.634 . . . . 0.0 110.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.3 31.09 4.78 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.746 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.49 105.34 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.595 -0.944 . . . . 0.0 108.92 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.29 112.22 6.27 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.074 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.46 -104.81 0.18 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.3 tt0 -112.19 173.78 6.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -1.022 . . . . 0.0 110.184 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CE2' HG23 ' A' ' 55' ' ' VAL . 38.9 m95 -151.97 128.62 10.8 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.535 -0.728 . . . . 0.0 109.815 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.11 132.51 28.46 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.227 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.2 t80 -98.62 147.54 24.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.592 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.46 99.94 7.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.724 -0.61 . . . . 0.0 109.626 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.8 -4.9 26.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.724 -0.61 . . . . 0.0 111.579 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.36 -26.74 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.1 p -129.11 7.54 5.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.6 -0.687 . . . . 0.0 110.17 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.2 mmtp 54.59 40.29 31.75 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -124.7 139.72 53.6 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.866 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.0 m-85 -97.29 -172.09 2.35 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.556 -0.715 . . . . 0.0 109.741 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.32 91.85 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.0 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.486 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.0 105.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.897 0.856 . . . . 0.0 110.895 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -88.03 171.75 10.05 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.158 0.504 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -93.34 103.67 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 28.4 m-85 -88.5 151.33 22.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.808 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.5 mptt -115.04 -168.35 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.671 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.0 tp -166.2 107.37 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.82 105.16 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.626 HD13 ' CG1' ' A' ' 55' ' ' VAL . 1.2 mm -75.95 106.06 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.523 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 56' ' ' THR . 43.7 t30 -82.04 4.16 24.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.505 -0.747 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.82 -148.05 1.58 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -137.21 32.23 2.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.61 -0.936 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 p -147.23 17.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.6 mt -170.81 36.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.63 97.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 110.994 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.57 177.59 43.63 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -44.33 4.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.702 -0.881 . . . . 0.0 110.181 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.0 mm 53.95 87.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.449 -0.782 . . . . 0.0 110.547 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.808 HG22 ' HG3' ' A' ' 5' ' ' LYS . 70.9 p -84.29 134.36 34.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.736 . . . . 0.0 110.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.49 147.85 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.621 -0.674 . . . . 0.0 110.401 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.17 151.93 22.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.259 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.49 160.71 18.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.342 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.4 p -53.69 -40.17 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.0 m-20 -160.87 174.71 13.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.18 -27.45 67.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.373 -0.829 . . . . 0.0 109.953 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 -47.45 84.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -0.785 . . . . 0.0 109.748 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 22' ' ' VAL . 8.1 tt0 -69.88 -41.28 75.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.55 -46.76 80.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.579 -0.701 . . . . 0.0 109.57 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -57.26 -39.88 76.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.632 -0.667 . . . . 0.0 109.235 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -65.62 -53.1 46.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.508 -0.745 . . . . 0.0 109.379 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -56.29 -39.39 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.523 -0.736 . . . . 0.0 109.102 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -73.67 -36.62 65.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 4.0 mtmp? -79.48 3.32 18.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.701 -0.625 . . . . 0.0 111.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -45.21 3.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.495 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.289 9.4 t80 -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.974 176.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -62.53 -48.08 81.1 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.867 -0.521 . . . . 0.0 110.181 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.98 -48.52 78.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.539 -0.725 . . . . 0.0 110.622 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.37 -25.55 35.87 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.566 -0.709 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.4 m-20 -99.82 -25.56 14.32 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.709 -0.619 . . . . 0.0 110.667 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.17 30.42 4.18 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.752 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 105.82 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.686 -0.891 . . . . 0.0 108.862 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -148.64 102.84 3.34 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.728 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.06 -73.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 56' ' ' THR . 29.4 mt-10 -136.0 171.64 14.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.498 -1.001 . . . . 0.0 110.042 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.7 m95 -155.26 126.91 7.41 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.65 -0.656 . . . . 0.0 110.045 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.6 p -144.39 132.79 21.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.4 t80 -95.26 141.65 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.803 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -111.26 100.08 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.736 -0.603 . . . . 0.0 109.739 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.5 -2.79 18.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.686 -0.634 . . . . 0.0 111.657 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.01 -25.93 17.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 109.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.9 p -130.58 8.77 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 110.229 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 56.7 mmtt 54.3 41.65 31.88 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.175 -0.953 . . . . 0.0 110.27 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 5' ' ' LYS . 35.4 m -130.56 134.86 47.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.49 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HB2' HD12 ' A' ' 6' ' ' LEU . 59.1 m-85 -89.28 -168.74 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.521 -0.737 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -155.92 105.3 2.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 108.172 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.626 ' CG1' HD13 ' A' ' 8' ' ' ILE . 5.9 p -115.82 129.86 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.299 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -126.09 -172.04 2.53 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 56' ' ' THR . 8.9 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.185 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 2' ' ' THR . 52.8 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 m -63.54 85.8 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.713 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.751 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.3 m-85 -71.21 140.77 50.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.675 -0.641 . . . . 0.0 109.66 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HG2' HG22 ' A' ' 18' ' ' THR . 9.5 mtmt -104.67 168.01 9.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.762 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.8 tp -141.9 105.57 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.8 mt -76.89 110.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HD23 ' A' ' 6' ' ' LEU . 6.8 mm -84.21 112.94 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.121 -1.032 . . . . 0.0 109.79 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -97.86 155.49 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.476 -0.765 . . . . 0.0 110.064 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.7 -138.97 15.32 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -129.07 28.9 5.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.523 -0.986 . . . . 0.0 110.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' LYS . 19.2 p -136.09 145.26 45.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.623 -0.673 . . . . 0.0 109.905 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 40' ' ' ILE . 6.2 mt 60.9 -76.69 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.733 -0.604 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' THR . 24.6 mtpt 54.99 99.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.343 -0.848 . . . . 0.0 110.708 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.94 -174.22 31.75 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 18' ' ' THR . 7.6 mt-10 -136.03 86.3 2.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.895 . . . . 0.0 109.729 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -59.39 -25.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.552 -0.717 . . . . 0.0 110.789 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.802 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.6 p 60.69 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 121.43 0.634 . . . . 0.0 110.669 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.58 146.04 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.426 -0.796 . . . . 0.0 110.799 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -81.55 152.95 27.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.33 158.52 9.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 110.398 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.2 p -53.95 -38.92 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.3 m-20 -161.26 -177.92 6.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.751 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.77 -28.11 68.78 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.46 69.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' OE1' HG12 ' A' ' 22' ' ' VAL . 2.5 mt-10 -66.23 -41.68 89.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.677 -0.639 . . . . 0.0 109.377 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.23 73.42 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.529 -0.732 . . . . 0.0 109.856 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.453 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.5 tt0 -57.94 -38.17 75.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -70.15 -51.91 27.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mt -58.04 -34.91 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.7 m-85 -77.66 -36.6 51.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -74.34 -2.0 23.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.698 -0.626 . . . . 0.0 111.402 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -108.56 -45.38 3.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 8.9 t80 -52.41 -35.44 51.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.936 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.761 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.11 -47.01 69.33 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.201 0.524 . . . . 0.0 109.987 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.7 -49.31 76.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -54.97 -23.32 18.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.524 -0.735 . . . . 0.0 111.081 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' HD13 ' A' ' 40' ' ' ILE . 8.4 m-20 -102.34 -26.84 13.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.658 -0.651 . . . . 0.0 110.624 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.19 30.9 3.46 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.807 HG12 HD12 ' A' ' 13' ' ' LEU . 1.7 mp -96.85 107.07 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.647 -0.913 . . . . 0.0 108.928 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -145.12 109.47 4.9 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.162 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -107.2 0.2 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -107.18 176.64 5.1 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.454 -1.027 . . . . 0.0 110.45 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.458 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -154.37 130.35 10.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.598 -0.689 . . . . 0.0 109.79 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.2 p -143.88 132.25 22.08 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.337 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.57 147.61 24.11 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.851 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.44 98.68 6.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.715 -0.615 . . . . 0.0 109.746 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.97 -5.65 27.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.636 -0.665 . . . . 0.0 111.419 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.96 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.555 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -126.59 8.01 6.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.655 . . . . 0.0 110.069 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp 53.57 40.03 30.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.146 -0.971 . . . . 0.0 110.281 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -127.65 142.96 51.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.597 -0.689 . . . . 0.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HD12 ' A' ' 6' ' ' LEU . 72.0 m-85 -98.9 -170.14 1.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.626 -0.671 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.11 94.58 1.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -97.43 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.915 0.864 . . . . 0.0 111.173 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 166.25 20.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.257 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.1 m . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.976 0.417 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 18' ' ' THR . 43.6 m 49.86 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.313 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.718 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -87.36 142.49 27.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.638 -0.664 . . . . 0.0 109.654 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.781 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.1 mtmt -100.1 -176.45 3.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 53' ' ' PHE . 1.2 tp -164.43 112.65 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.443 -0.786 . . . . 0.0 110.342 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.45 118.12 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.882 HD11 HD23 ' A' ' 6' ' ' LEU . 2.4 mp -90.21 116.38 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.013 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -92.88 151.99 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.0 110.254 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.52 -155.41 16.27 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.11 31.48 6.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.924 . . . . 0.0 110.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -93.34 -147.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.674 -0.642 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.3 pp -53.91 -36.48 62.78 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 111.309 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.692 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.6 mtpt 50.9 99.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 111.538 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.12 -167.55 37.78 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.334 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -115.74 -64.84 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.814 -0.815 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.729 HD12 ' OH ' ' A' ' 34' ' ' TYR . 83.1 mt 52.36 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.372 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 5' ' ' LYS . 68.3 p -59.27 150.19 26.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -143.32 134.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.519 -0.738 . . . . 0.0 110.89 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.99 138.37 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -155.94 154.65 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.44 -38.67 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -159.78 179.92 8.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.664 . . . . 0.0 109.429 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.718 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.29 -34.42 78.29 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.749 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.95 75.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -70.91 -44.61 65.85 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.06 74.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -59.65 -39.16 83.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.626 -0.671 . . . . 0.0 109.275 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -68.37 -50.06 55.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.184 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.98 -37.49 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -75.97 -38.29 57.66 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.413 0.625 . . . . 0.0 109.321 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.9 mmtp -71.62 -5.09 31.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.777 -0.577 . . . . 0.0 111.479 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.97 -45.16 4.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.729 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.284 0.7 OUTLIER -51.22 -38.04 50.25 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.039 176.293 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.89 -47.95 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.252 0.549 . . . . 0.0 110.246 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -56.53 -51.28 69.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.521 -0.737 . . . . 0.0 110.919 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -57.11 -21.13 29.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.548 -0.72 . . . . 0.0 111.082 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' HD13 ' A' ' 40' ' ' ILE . 4.3 m120 -101.61 -25.57 13.83 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 106.81 28.7 4.94 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.54 105.85 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.653 -0.91 . . . . 0.0 108.581 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -143.24 108.94 5.12 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.53 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.22 -109.89 0.23 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.31 177.75 4.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.41 -1.053 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.453 ' NE1' HG23 ' A' ' 55' ' ' VAL . 39.8 m95 -155.83 130.52 9.09 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.538 -0.726 . . . . 0.0 109.687 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -145.45 134.89 23.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.454 -0.779 . . . . 0.0 109.202 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.6 t80 -98.81 148.28 24.06 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.28 96.72 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -69.05 -6.68 29.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.699 -0.626 . . . . 0.0 111.403 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.78 20.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 109.605 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -124.76 7.5 8.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.758 -0.589 . . . . 0.0 110.121 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 53.99 38.57 29.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.2 m -128.54 134.76 48.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.691 . . . . 0.0 110.751 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.922 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.0 m-85 -90.9 -168.97 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.92 97.42 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.2 p -101.42 103.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.121 0.962 . . . . 0.0 111.253 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -82.35 171.62 13.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.033 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 2' ' ' THR . 80.6 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -84.13 104.29 14.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.3 m-85 -88.83 151.32 22.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.805 ' HG2' HG22 ' A' ' 18' ' ' THR . 42.4 mttt -113.19 -170.83 1.76 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.1 tp -163.69 99.97 0.9 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 110.233 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.78 115.35 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 13' ' ' LEU . 15.6 mm -82.64 103.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.745 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.8 t30 -71.24 167.06 20.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.496 -0.752 . . . . 0.0 110.238 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 -153.17 26.32 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.76 36.03 4.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.954 . . . . 0.0 109.917 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.677 HG21 HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -82.63 -151.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.635 -0.666 . . . . 0.0 110.097 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.677 HD11 HG13 ' A' ' 8' ' ' ILE . 2.5 pp -48.75 -26.95 2.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 111.027 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.66 103.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.637 -0.664 . . . . 0.0 111.576 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.41 153.36 8.18 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.437 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -108.77 54.73 0.65 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.834 -0.804 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.663 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.5 tt -50.99 128.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.303 -0.873 . . . . 0.0 110.779 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.805 HG22 ' HG2' ' A' ' 5' ' ' LYS . 47.5 p -99.13 141.05 32.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.332 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.7 pp -142.99 143.14 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.669 . . . . 0.0 110.548 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -83.85 146.36 28.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.88 159.01 29.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.731 . . . . 0.0 110.454 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.14 -39.32 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.754 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-20 -159.76 176.65 11.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.53 -29.96 70.94 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.738 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.75 80.58 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.819 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.99 -41.35 77.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.08 -44.25 82.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.634 -0.666 . . . . 0.0 109.529 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -59.33 -37.9 78.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.71 -0.619 . . . . 0.0 109.368 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -50.7 46.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.268 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.81 -36.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.739 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -77.06 -37.09 55.36 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.2 mmmt -77.68 1.69 19.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.662 -0.649 . . . . 0.0 111.351 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -108.8 -45.17 3.87 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.08 -38.47 62.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.068 176.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.47 -49.36 71.7 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -57.5 -48.51 79.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.513 -0.742 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.24 -23.55 36.65 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.395 -0.816 . . . . 0.0 110.956 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.3 m-80 -101.34 -25.28 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.691 -0.631 . . . . 0.0 110.599 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.63 32.39 3.65 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.751 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.21 106.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.69 -0.888 . . . . 0.0 108.765 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -148.65 103.2 3.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.749 -0.594 . . . . 0.0 110.948 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.77 -58.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HB2' HG22 ' A' ' 56' ' ' THR . 2.5 tp10 -152.19 174.8 13.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.576 -0.955 . . . . 0.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 43.3 m95 -158.42 127.54 5.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.67 -0.644 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.6 p -145.03 132.43 20.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.627 -0.671 . . . . 0.0 109.521 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.4 t80 -96.2 146.64 24.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.95 98.43 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.774 -0.579 . . . . 0.0 109.533 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.18 -6.06 31.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.95 -27.07 18.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -124.77 5.81 8.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.603 -0.686 . . . . 0.0 110.05 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.9 mmtt 54.39 40.72 31.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -132.63 137.79 47.13 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.124 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.2 m-85 -92.36 -172.94 3.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.578 -0.701 . . . . 0.0 109.353 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.62 105.12 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 108.548 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.9 p -115.22 133.37 61.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.658 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -120.88 -174.35 2.8 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.774 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.144 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 2' ' ' THR . 28.8 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.04 0.448 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -66.94 85.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.474 -0.766 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -70.2 142.01 52.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.685 -0.634 . . . . 0.0 109.817 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.512 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -108.3 177.22 4.86 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.541 -0.724 . . . . 0.0 110.198 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.813 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.6 tp -152.53 109.71 3.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.37 108.44 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.757 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.3 mm -84.92 118.78 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.957 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -110.95 140.66 45.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.69 -149.66 21.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -121.58 14.64 11.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.005 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -113.57 -56.68 2.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.757 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.7 mt -115.01 167.55 10.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.795 -0.566 . . . . 0.0 109.501 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.46 92.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 110.701 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.28 173.99 24.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -100.71 156.76 17.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.799 -0.824 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.77 -16.65 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.601 -0.687 . . . . 0.0 110.53 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.512 HG22 ' CG ' ' A' ' 5' ' ' LYS . 48.7 p 46.32 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.579 -0.701 . . . . 0.0 111.842 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -132.26 132.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.476 -0.765 . . . . 0.0 110.372 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.14 150.45 38.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.644 -0.66 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.17 163.01 28.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.636 . . . . 0.0 110.4 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.4 p -55.55 -34.24 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.2 p30 -166.93 176.26 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.729 -0.607 . . . . 0.0 109.376 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.76 -29.88 71.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.89 87.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' CD ' HG12 ' A' ' 22' ' ' VAL . 17.9 tt0 -70.95 -42.71 69.44 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.29 84.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.617 -0.677 . . . . 0.0 109.558 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -59.08 -34.18 71.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 109.487 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -71.09 -52.35 19.93 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.91 -35.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.813 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.8 m-85 -75.55 -38.95 58.9 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.9 mtpt -79.84 5.25 14.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 111.49 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -110.04 -45.4 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.0 t80 -54.05 -43.72 70.44 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.177 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.0 -49.11 78.95 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.834 -0.541 . . . . 0.0 110.197 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -56.91 -48.39 78.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.727 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.56 -21.57 39.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.599 -0.688 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 40' ' ' ILE . 2.1 m120 -103.09 -27.87 12.31 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.599 -0.688 . . . . 0.0 110.596 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.25 29.63 3.65 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.763 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.76 110.49 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.918 . . . . 0.0 109.035 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.22 110.22 3.9 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.335 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.43 -97.69 0.13 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.5 tt0 -123.78 129.01 50.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.39 -1.065 . . . . 0.0 111.483 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' HG23 ' A' ' 55' ' ' VAL . 48.1 m95 -107.6 135.9 48.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.428 -0.795 . . . . 0.0 110.405 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -145.63 131.83 19.45 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -99.19 141.05 32.46 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.774 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -110.9 100.9 9.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.641 -0.662 . . . . 0.0 109.596 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.99 -4.26 23.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.664 -0.648 . . . . 0.0 111.637 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.77 19.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -131.9 8.47 4.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 110.13 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp 54.03 42.94 31.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.216 -0.928 . . . . 0.0 110.233 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -125.75 129.74 50.08 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.626 -0.671 . . . . 0.0 110.787 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.534 ' HB2' HD12 ' A' ' 6' ' ' LEU . 84.2 m-85 -87.46 -173.41 4.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.502 -0.749 . . . . 0.0 109.705 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.32 99.01 1.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -101.77 101.43 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.869 0.843 . . . . 0.0 111.105 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.62 171.96 14.36 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.135 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.485 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.8 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.969 0.414 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m 50.1 72.23 0.34 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.275 -0.891 . . . . 0.0 111.075 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.726 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.3 m-85 -67.86 139.61 56.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -178.84 3.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.794 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -159.52 109.39 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.664 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.07 124.89 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.802 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.7 mm -98.71 115.38 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.089 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -93.12 152.58 19.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.74 . . . . 0.0 109.54 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.18 -151.84 18.31 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -116.85 -24.48 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.543 -0.975 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -58.87 -60.52 3.72 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.802 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.7 mt -120.32 174.52 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.117 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -175.38 75.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.817 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.68 -176.33 34.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 38.8 mt-10 -108.61 -28.16 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.779 -0.836 . . . . 0.0 110.381 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 16' ' ' GLU . 3.7 mt 65.93 -60.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 O-C-N 121.879 -0.513 . . . . 0.0 111.568 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 19' ' ' ILE . 1.9 p 61.49 118.63 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.477 -0.764 . . . . 0.0 110.546 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -148.99 133.93 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.573 -0.704 . . . . 0.0 110.286 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.68 145.22 36.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.595 -0.691 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.03 165.69 34.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.745 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.78 -39.62 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.545 -0.722 . . . . 0.0 110.447 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 50.9 p30 -161.17 177.26 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.728 -0.608 . . . . 0.0 109.375 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.63 -29.5 70.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 0.0 109.731 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.72 -52.49 63.73 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.02 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -64.13 -42.77 96.7 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.85 75.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 109.601 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 23.6 tt0 -58.73 -37.31 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.315 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -52.64 36.98 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.83 -40.53 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.794 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -72.1 -38.83 69.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 5.9 mmtp -73.88 -2.43 23.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.669 -0.644 . . . . 0.0 111.522 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -107.2 -44.94 4.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 1.4 t80 -52.44 -36.81 55.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.206 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.12 -50.98 51.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.758 -0.589 . . . . 0.0 110.23 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -56.25 -49.88 72.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 110.903 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -23.97 41.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.402 -0.811 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.489 HD22 HD11 ' A' ' 13' ' ' LEU . 3.8 m-20 -99.16 -26.89 14.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.776 -0.577 . . . . 0.0 110.395 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 30.0 4.0 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.746 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.39 107.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.584 -0.95 . . . . 0.0 109.007 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -151.78 100.62 2.69 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.647 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.93 -55.27 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 29.3 tt0 -145.47 169.56 18.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.479 -1.012 . . . . 0.0 110.535 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.6 m95 -159.95 125.62 4.13 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.849 -0.532 . . . . 0.0 109.687 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.81 131.68 19.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 109.371 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.4 t80 -96.63 151.19 19.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.702 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -124.73 99.45 6.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.676 -0.64 . . . . 0.0 109.592 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.77 -4.25 22.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.654 . . . . 0.0 111.523 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.94 -27.79 19.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -127.92 7.53 6.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 54.82 42.13 31.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.9 m -130.22 141.79 50.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 110.91 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.5 m-85 -98.44 -173.97 2.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.523 -0.736 . . . . 0.0 109.104 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 102.29 2.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.863 -1.148 . . . . 0.0 108.688 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.486 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.6 p -117.19 146.24 21.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.165 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -138.12 177.9 7.53 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.231 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 2' ' ' THR . 46.3 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.995 0.426 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -62.91 94.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.591 -0.693 . . . . 0.0 110.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.5 m-85 -78.05 149.25 33.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.067 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 52' ' ' THR . 12.1 ttpt -108.71 -174.45 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 110.389 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.849 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.7 tp -163.13 97.92 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.16 117.06 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' CB ' ' A' ' 13' ' ' LEU . 9.9 mm -85.03 110.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.861 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 41.4 t30 -85.41 7.28 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.72 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.88 -174.67 41.15 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -110.77 26.67 10.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.928 . . . . 0.0 110.379 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 p -125.94 24.51 6.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.617 -0.677 . . . . 0.0 110.284 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 HG12 ' A' ' 40' ' ' ILE . 1.5 mt -172.69 -67.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.76 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.742 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.67 144.1 3.99 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -102.14 61.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.645 -0.914 . . . . 0.0 110.738 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -57.42 148.08 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.208 -0.932 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 3' ' ' THR . 7.3 p -115.72 136.07 53.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.888 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.07 145.78 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.556 -0.715 . . . . 0.0 110.314 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 155.83 24.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.609 -0.682 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.36 159.2 8.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.62 -39.26 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.7 m-20 -159.25 173.35 16.47 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.55 -35.78 76.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.405 -0.809 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.18 -46.76 72.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.467 -0.771 . . . . 0.0 109.925 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.763 ' OE1' HD11 ' A' ' 30' ' ' ILE . 1.6 tm-20 -66.67 -45.19 79.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.31 -39.48 69.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.419 -0.8 . . . . 0.0 109.819 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -62.12 -39.54 92.89 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.43 -34.48 65.46 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.353 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.763 HD11 ' OE1' ' A' ' 26' ' ' GLU . 98.0 mt -68.59 -39.66 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.849 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.31 -36.89 66.31 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 30.1 mttt -75.74 -2.44 29.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.732 -0.605 . . . . 0.0 111.301 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -104.13 -44.97 4.85 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.293 8.8 t80 -53.56 -42.14 67.23 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.731 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.72 -52.16 58.59 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.813 -0.555 . . . . 0.0 110.135 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.19 -49.14 74.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.725 . . . . 0.0 110.679 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.77 -23.48 18.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.58 -0.7 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -102.31 -28.14 12.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.733 -0.604 . . . . 0.0 110.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 30.08 2.96 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.754 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 106.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.985 . . . . 0.0 109.002 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -150.17 105.82 3.41 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.27 0.557 . . . . 0.0 110.715 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.8 -57.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' CB ' HG22 ' A' ' 56' ' ' THR . 15.1 tt0 -148.55 171.97 15.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.564 -0.963 . . . . 0.0 110.224 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 45.9 m95 -157.22 128.56 6.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.69 -0.631 . . . . 0.0 109.859 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -145.8 131.96 19.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.615 -0.678 . . . . 0.0 109.409 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.1 t80 -97.49 127.17 43.24 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.59 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.65 98.88 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.651 -0.655 . . . . 0.0 109.316 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.88 -5.41 25.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.65 -0.656 . . . . 0.0 111.583 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.46 21.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 109.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -128.4 8.06 5.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 110.171 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt 54.95 40.38 31.99 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 5' ' ' LYS . 57.6 m -125.11 125.48 43.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.717 ' HB2' HD12 ' A' ' 6' ' ' LEU . 83.2 m-85 -80.26 -176.12 5.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.359 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.13 106.67 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.939 -1.1 . . . . 0.0 108.235 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 6.3 p -117.09 133.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.101 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.605 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -124.41 -170.04 2.08 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.908 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.195 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 95.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.977 0.418 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.597 HG22 ' HB ' ' A' ' 18' ' ' THR . 22.1 m 50.24 79.77 0.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.258 -0.901 . . . . 0.0 111.252 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.9 m-85 -78.45 147.82 33.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 18' ' ' THR . 7.2 mptt -112.45 -172.25 2.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.511 -0.743 . . . . 0.0 110.17 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.729 HD22 ' CD1' ' A' ' 31' ' ' PHE . 19.3 tp -163.08 105.68 1.02 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.444 -0.785 . . . . 0.0 110.204 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.55 114.86 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -89.95 113.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.722 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 54' ' ' THR . 2.3 m-20 -83.37 -161.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.229 -0.919 . . . . 0.0 109.285 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -163.1 13.65 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -114.58 28.18 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.607 -0.937 . . . . 0.0 110.406 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -66.25 -78.21 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.801 HD11 HG13 ' A' ' 8' ' ' ILE . 4.5 pp -132.21 -27.26 1.82 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.728 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' N ' HD12 ' A' ' 13' ' ' LEU . 70.2 mttt 56.69 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.452 -0.78 . . . . 0.0 111.492 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.37 161.33 20.73 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -130.6 58.31 1.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.884 -0.774 . . . . 0.0 109.711 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.99 110.97 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.549 -0.72 . . . . 0.0 109.755 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.88 HG22 ' CG ' ' A' ' 5' ' ' LYS . 81.7 p -75.84 144.84 41.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -147.33 133.11 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.6 153.6 35.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.522 -0.736 . . . . 0.0 110.162 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.14 162.3 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.65 -0.656 . . . . 0.0 110.31 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -53.8 -39.1 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.692 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' HG13 ' A' ' 22' ' ' VAL . 40.5 p30 -163.51 177.19 9.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 109.526 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.43 -29.66 70.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.05 -49.77 72.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 0.0 110.008 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.33 -43.36 81.8 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.49 71.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.57 -0.706 . . . . 0.0 109.856 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.7 tt0 -58.29 -36.75 73.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.64 -0.663 . . . . 0.0 109.332 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.01 -52.24 25.73 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -57.53 -37.58 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.729 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.99 -36.69 62.0 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -77.86 2.28 17.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.665 -0.647 . . . . 0.0 111.371 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -105.7 -45.83 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 1.4 t80 -53.38 -46.7 69.73 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.928 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.85 -49.25 77.32 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.635 -0.665 . . . . 0.0 110.139 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.81 -50.59 72.78 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.647 -0.658 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -56.46 -24.56 46.52 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.483 -0.761 . . . . 0.0 110.69 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.44 -26.55 14.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.694 -0.628 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.64 33.69 3.26 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.754 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -99.11 114.47 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -157.58 104.44 1.99 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.308 0.575 . . . . 0.0 110.945 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.53 -47.15 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.908 ' HB3' HG22 ' A' ' 56' ' ' THR . 45.0 tt0 -142.2 164.97 28.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.47 -1.017 . . . . 0.0 110.75 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.489 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 41.4 m95 -164.1 112.33 1.15 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 19.0 p -137.9 131.05 30.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.9 t80 -93.84 143.66 26.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.78 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -114.7 98.28 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.786 -0.571 . . . . 0.0 109.522 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -70.17 -4.76 23.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.584 -0.697 . . . . 0.0 111.598 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.81 -27.76 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -126.14 7.62 7.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.604 . . . . 0.0 110.087 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp 53.85 41.53 32.02 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.185 -0.947 . . . . 0.0 110.192 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.698 HG23 ' HB2' ' A' ' 5' ' ' LYS . 7.3 m -132.31 137.23 47.37 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.68 -0.637 . . . . 0.0 110.762 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.2 m-85 -92.0 -172.74 3.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.697 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.697 HG22 HD21 ' A' ' 9' ' ' ASN . 0.2 OUTLIER -155.41 103.57 2.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 108.478 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.515 ' CG1' HD13 ' A' ' 8' ' ' ILE . 7.7 p -118.63 152.95 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.198 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.908 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -156.16 -162.44 1.29 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.904 -0.497 . . . . 0.0 109.986 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.049 179.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 2' ' ' THR . 72.1 m . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.179 0.514 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.9 m -77.42 92.99 4.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.544 -0.722 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 14.2 m-85 -76.74 144.77 39.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.688 -0.633 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.829 ' HG2' HG22 ' A' ' 18' ' ' THR . 35.7 mtmt -106.6 -179.2 3.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 0.0 110.041 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.865 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -158.09 110.11 2.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.574 -0.704 . . . . 0.0 109.823 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.43 124.81 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 34' ' ' TYR . 7.0 mm -89.95 108.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.83 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -92.92 54.6 2.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 110.121 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.05 -131.65 2.92 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.43 50.59 0.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.945 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 p -138.72 -59.91 0.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.705 . . . . 0.0 110.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 21.8 mt -95.26 -54.58 3.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.367 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.96 82.62 0.07 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.432 -0.792 . . . . 0.0 110.599 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.88 -167.82 37.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.42 -50.88 2.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.915 . . . . 0.0 110.545 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.4 mm 53.7 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.356 -0.84 . . . . 0.0 110.188 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.829 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.2 p -76.55 133.81 39.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.623 -0.673 . . . . 0.0 110.555 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -137.32 140.86 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.571 -0.705 . . . . 0.0 110.276 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.32 150.4 28.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.58 161.56 23.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.676 -0.64 . . . . 0.0 110.248 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.66 -39.61 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.557 -0.714 . . . . 0.0 110.57 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.0 m-20 -158.77 175.99 12.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.0 -33.27 75.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.24 69.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.0 109.852 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -63.53 -43.11 98.09 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.36 70.25 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.467 -0.77 . . . . 0.0 109.84 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.2 tt0 -58.71 -36.56 74.47 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.37 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -67.53 -52.97 32.6 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.21 -38.83 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.3 m-85 -74.31 -34.57 63.53 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 18.2 mmmt -74.92 -3.25 31.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.75 -0.594 . . . . 0.0 111.22 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -105.74 -45.65 4.34 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.88 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.29 6.7 t80 -50.84 -32.46 20.28 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.809 175.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.711 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.58 -63.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.74 0.781 . . . . 0.0 109.277 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -55.46 -41.68 73.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.111 0.481 . . . . 0.0 110.914 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.5 -27.2 4.04 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.4 -56.21 2.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.371 0.605 . . . . 0.0 110.049 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.67 61.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.711 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -117.97 134.93 59.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.838 -0.801 . . . . 0.0 109.816 -177.536 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.31 106.42 0.57 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.837 . . . . 0.0 111.195 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.08 -107.46 0.2 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -115.84 176.23 5.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.467 -1.019 . . . . 0.0 110.166 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.2 m95 -151.72 129.18 11.37 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.638 -0.664 . . . . 0.0 109.881 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.74 134.28 30.05 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.301 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.6 t80 -99.41 148.84 23.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -120.71 98.25 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 -6.32 30.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.646 -0.659 . . . . 0.0 111.478 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.6 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 109.557 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 6.54 8.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.624 -0.672 . . . . 0.0 110.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.3 mmtp 54.07 38.25 28.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 5' ' ' LYS . 8.0 m -126.39 143.13 51.28 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.038 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.832 ' HB2' HD12 ' A' ' 6' ' ' LEU . 66.9 m-85 -99.54 -169.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.533 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -157.27 90.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.803 -1.186 . . . . 0.0 108.254 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.485 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -90.4 97.94 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.794 0.806 . . . . 0.0 110.688 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -78.25 170.89 15.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.327 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 4' ' ' PHE . 38.0 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.113 0.483 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.62 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 m -69.2 105.7 2.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' HG22 ' A' ' 2' ' ' THR . 43.9 m-85 -88.31 140.26 29.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.672 -0.643 . . . . 0.0 110.443 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.822 ' CG ' HG22 ' A' ' 18' ' ' THR . 5.9 mptt -104.98 -174.81 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.867 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.6 tp -161.21 110.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.86 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' GLY . 74.3 mt -97.64 133.41 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.512 HD13 ' CG1' ' A' ' 55' ' ' VAL . 21.7 mm -87.66 107.48 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.95 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.631 ' HB2' HG22 ' A' ' 54' ' ' THR . 8.3 t30 -75.61 66.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.762 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.62 -135.98 1.95 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -171.19 50.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.518 -0.989 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 13' ' ' LEU . 52.3 m -140.2 23.8 2.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.518 -0.739 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 12' ' ' THR . 0.4 OUTLIER -177.61 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.48 -0.762 . . . . 0.0 111.066 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 55.68 110.19 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.331 -0.855 . . . . 0.0 110.752 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -145.43 135.93 6.23 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.255 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -162.67 28.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 122.08 -0.659 . . . . 0.0 109.67 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.0 -171.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.822 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.1 p -138.61 129.12 26.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -135.56 136.09 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 110.82 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.18 160.17 20.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.613 -0.679 . . . . 0.0 110.043 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.41 171.25 7.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.682 HG12 ' OE1' ' A' ' 26' ' ' GLU . 7.7 p -53.77 -36.43 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.533 -0.729 . . . . 0.0 110.424 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -166.93 173.38 9.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.67 -0.644 . . . . 0.0 109.336 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -60.58 -31.39 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.48 -46.83 76.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.682 ' OE1' HG12 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -66.76 -45.69 77.76 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.03 -45.02 67.81 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 109.759 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.28 -38.09 76.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.656 -0.652 . . . . 0.0 109.383 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -68.61 -52.83 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.612 -0.68 . . . . 0.0 109.182 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -55.66 -40.38 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -72.29 -32.64 66.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -80.4 4.41 18.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.761 -0.587 . . . . 0.0 111.102 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -104.56 -45.51 4.61 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.299 1.1 t80 -50.34 -40.66 49.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.15 -1.387 . . . . 0.0 108.827 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -44.68 86.15 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.039 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.389 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.0 -23.61 20.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.57 -0.706 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.66 -20.68 13.9 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 100.56 36.55 4.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.776 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -99.03 119.44 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.91 . . . . 0.0 109.186 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -152.16 71.63 0.97 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.373 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -112.22 2.34 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -108.65 174.13 6.01 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.489 -1.006 . . . . 0.0 110.533 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.1 m95 -151.11 134.46 16.15 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.632 -0.667 . . . . 0.0 110.0 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.2 p -142.94 133.0 24.32 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.369 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -97.52 147.29 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.608 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -119.05 102.0 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.617 -0.677 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.4 -5.64 29.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.718 -0.614 . . . . 0.0 111.411 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.59 -28.76 20.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.9 p -127.2 7.17 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.703 . . . . 0.0 110.06 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 54.44 38.26 29.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.188 -0.945 . . . . 0.0 110.203 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 5' ' ' LYS . 18.6 m -124.49 149.69 46.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 6' ' ' LEU . 68.0 m-85 -102.17 -169.33 1.66 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.515 -0.741 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -157.7 92.6 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.7 p -91.64 104.8 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.907 0.861 . . . . 0.0 110.649 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -78.13 156.55 29.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.137 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 59.6 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.055 0.455 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 18' ' ' THR . 16.2 m -72.04 103.04 3.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.568 -0.708 . . . . 0.0 110.18 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 25.9 m-85 -88.44 149.01 23.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.868 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -113.63 -173.84 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.9 tp -160.47 109.14 1.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.526 -0.734 . . . . 0.0 110.16 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.28 120.12 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 55' ' ' VAL . 6.2 mm -84.84 114.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.401 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.49 53.47 0.83 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.529 -0.732 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.1 1.9 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -166.34 47.52 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.585 -0.95 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.7 m -140.54 -45.7 0.41 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.67 -0.644 . . . . 0.0 109.995 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 12.3 mt -106.88 -57.71 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 52.84 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.16 172.2 43.14 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -127.58 59.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.888 . . . . 0.0 110.098 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.89 136.4 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.824 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.868 HG22 ' CG ' ' A' ' 5' ' ' LYS . 77.8 p -103.35 136.69 42.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.246 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.456 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.3 135.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -78.3 154.31 31.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.571 -0.706 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.37 164.15 17.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.388 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.82 -39.49 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.48 -0.762 . . . . 0.0 110.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.8 m-20 -161.44 173.53 14.76 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.67 -29.09 69.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 -45.86 85.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 109.631 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.84 -42.24 77.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.51 81.97 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.611 -0.68 . . . . 0.0 109.488 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.4 tt0 -58.63 -37.22 75.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.289 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -68.73 -51.56 40.12 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.93 -40.34 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.787 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -71.63 -36.96 70.91 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -77.78 1.9 18.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.62 -0.675 . . . . 0.0 111.43 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -106.5 -45.41 4.26 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.747 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.292 8.7 t80 -52.97 -31.74 42.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.743 175.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.26 -63.24 1.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.705 0.764 . . . . 0.0 109.234 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -55.31 -40.99 71.77 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.082 0.468 . . . . 0.0 110.72 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.82 -27.06 4.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.672 -0.642 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -107.15 -53.26 2.64 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.367 0.603 . . . . 0.0 110.192 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.83 62.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -119.24 134.73 61.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.896 -0.767 . . . . 0.0 109.898 -177.352 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -169.68 100.03 0.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.324 -0.86 . . . . 0.0 111.242 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.57 -101.44 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 4.1 tt0 -125.23 134.65 52.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.463 -1.022 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.468 ' NE1' HG23 ' A' ' 55' ' ' VAL . 43.7 m95 -112.98 132.52 55.32 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.9 p -144.43 132.53 21.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.92 137.77 36.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.731 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -107.75 98.72 8.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.69 -0.631 . . . . 0.0 109.524 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -69.07 -6.69 29.82 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.652 -0.655 . . . . 0.0 111.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.25 19.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.9 p -124.62 6.81 8.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.67 . . . . 0.0 110.121 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt 54.41 38.98 30.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.178 -0.952 . . . . 0.0 110.086 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 5' ' ' LYS . 6.5 m -126.84 138.39 53.33 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.582 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.593 ' HB2' HD12 ' A' ' 6' ' ' LEU . 70.9 m-85 -92.45 -171.53 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.475 -0.766 . . . . 0.0 109.574 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.92 98.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -99.31 90.38 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.697 0.761 . . . . 0.0 111.062 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 170.97 9.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.305 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 2' ' ' THR . 55.8 m . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.161 0.505 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.666 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.3 m -63.27 95.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.444 -0.785 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 12.5 m-85 -79.7 140.53 36.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 110.23 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.858 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.7 OUTLIER -104.06 179.64 4.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 110.071 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.856 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.3 tp -154.11 108.22 3.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.446 -0.784 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.7 mt -84.31 120.96 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.5 mm -90.06 112.6 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.087 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -95.27 148.63 22.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -138.62 14.18 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -132.42 42.74 3.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.976 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 14' ' ' LYS . 1.5 m -150.02 147.22 27.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.603 -0.686 . . . . 0.0 109.702 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.637 HD12 HG12 ' A' ' 40' ' ' ILE . 6.3 mt 61.59 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.864 -0.522 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' THR . 57.7 mttt 55.4 97.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.311 -0.868 . . . . 0.0 110.51 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.51 -176.42 44.74 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.54 -53.14 2.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.513 -0.992 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.9 mm 52.94 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' CG ' ' A' ' 5' ' ' LYS . 63.9 p -79.75 133.8 36.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 110.164 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.49 137.26 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.56 154.77 32.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.657 -0.652 . . . . 0.0 110.488 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.83 162.82 16.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -54.99 -38.93 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.592 -0.693 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.466 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -161.61 174.56 13.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.26 -28.86 68.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 109.827 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.65 72.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 109.83 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.3 -43.38 98.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.78 80.99 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.645 -0.659 . . . . 0.0 109.553 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.1 tt0 -59.73 -33.74 72.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.704 -0.622 . . . . 0.0 109.48 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -75.98 -45.25 35.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 66.8 mt -62.7 -38.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.856 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -73.23 -37.99 66.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -73.64 -2.87 24.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 111.378 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -104.1 -45.33 4.75 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.611 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.292 4.4 t80 -50.41 -37.14 36.15 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.103 176.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -47.17 76.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.276 0.56 . . . . 0.0 110.161 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -58.98 -47.17 86.12 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.584 -0.697 . . . . 0.0 110.546 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.47 -19.49 48.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.614 -0.679 . . . . 0.0 110.811 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -104.41 -27.68 11.8 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.559 -0.713 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.3 31.5 3.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.75 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.17 120.91 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.909 . . . . 0.0 109.402 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -152.47 108.1 3.32 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.317 0.579 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.69 -110.5 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -109.33 177.04 4.87 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -1.012 . . . . 0.0 110.672 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.8 m95 -153.15 132.8 13.05 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.605 -0.684 . . . . 0.0 109.803 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.3 p -144.15 132.72 22.23 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.469 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 t80 -98.56 138.92 35.06 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.848 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -108.15 100.67 9.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.561 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.12 -5.36 26.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.586 -0.696 . . . . 0.0 111.549 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.28 -28.01 18.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.553 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -126.21 6.89 7.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.665 -0.647 . . . . 0.0 110.213 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 54.3 39.35 30.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.125 -0.984 . . . . 0.0 109.946 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.4 m -124.7 140.99 52.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.655 -0.653 . . . . 0.0 110.549 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.785 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -95.79 -171.53 2.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 0.0 109.538 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.28 93.27 1.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.16 106.73 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.917 0.865 . . . . 0.0 111.019 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -86.11 170.39 12.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.218 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.3 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.867 0.365 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.6 m 50.17 78.01 0.11 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.14 -0.975 . . . . 0.0 111.111 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.743 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.5 m-85 -75.52 144.57 41.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.552 -0.718 . . . . 0.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -106.39 -174.4 2.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.615 -0.678 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.829 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.9 tp -160.77 102.79 1.33 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.491 ' CD1' HG21 ' A' ' 52' ' ' THR . 22.1 mt -84.47 133.32 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mm -101.85 119.33 49.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.986 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 54' ' ' THR . 32.4 m-20 -67.85 -52.15 40.08 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.844 . . . . 0.0 110.255 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -156.08 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.07 15.39 4.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.907 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -60.02 -69.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.212 -0.93 . . . . 0.0 109.438 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' C ' HD12 ' A' ' 13' ' ' LEU . 1.5 pp -122.47 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 20.5 ptmt -33.74 137.25 0.1 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.13 30.44 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.598 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -140.82 47.57 1.74 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 17' ' ' ILE . 4.6 tp -51.4 115.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.807 HG22 ' HG2' ' A' ' 5' ' ' LYS . 60.4 p -83.76 144.91 29.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.636 -0.665 . . . . 0.0 110.009 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.512 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -143.19 134.74 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.56 137.8 39.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.7 -0.625 . . . . 0.0 110.14 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.39 37.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.63 -0.669 . . . . 0.0 110.228 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -53.77 -39.95 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.0 110.586 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.1 m-20 -159.62 179.47 8.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.622 . . . . 0.0 109.398 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.29 -29.15 70.24 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.679 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.0 70.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.19 -41.93 85.04 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -48.32 72.09 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.541 -0.724 . . . . 0.0 109.881 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.566 -0.709 . . . . 0.0 109.368 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -69.04 -52.44 28.57 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -58.49 -36.58 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.4 m-85 -75.28 -38.93 60.15 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -76.14 0.4 19.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 111.657 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -105.96 -45.27 4.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE1' HD22 ' A' ' 13' ' ' LEU 0.287 2.2 t80 -51.12 -38.8 54.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.933 176.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.62 -48.85 70.83 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -60.47 -48.17 82.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.517 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -55.69 -25.29 39.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.51 -0.743 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -99.51 -27.68 13.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.722 -0.611 . . . . 0.0 110.287 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 107.36 45.27 1.17 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.788 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -107.87 126.59 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.668 -0.901 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.33 101.97 1.08 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.545 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.48 -57.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.805 ' HB2' HG22 ' A' ' 56' ' ' THR . 62.5 mt-10 -149.49 169.19 21.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.465 -1.02 . . . . 0.0 110.634 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.521 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 50.1 m95 -159.76 121.0 3.18 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.4 p -143.08 132.13 23.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.593 -0.692 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.1 t80 -96.8 144.32 26.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.042 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.15 99.76 7.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.0 -5.32 25.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.651 -0.655 . . . . 0.0 111.499 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.86 20.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -129.01 8.22 5.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.625 -0.672 . . . . 0.0 110.131 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 15.9 mmtm 53.78 41.57 32.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.2 m -126.44 130.91 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.596 -0.69 . . . . 0.0 110.69 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 6' ' ' LEU . 69.6 m-85 -88.32 -173.61 4.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.503 -0.748 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -154.14 102.57 2.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.99 -1.069 . . . . 0.0 108.664 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.521 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 5.9 p -115.91 141.81 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 111.19 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.9 t -141.08 -174.23 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.961 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.242 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 ' CE2' ' A' ' 4' ' ' PHE . 24.7 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 m -75.85 103.8 6.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.517 -0.739 . . . . 0.0 110.078 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 57.0 m-85 -86.99 140.46 29.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.615 -0.678 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.919 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.1 mptt -107.23 -168.01 1.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 53' ' ' PHE . 11.8 tp -163.56 100.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 110.158 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CD1' HG21 ' A' ' 52' ' ' THR . 16.4 mt -83.54 132.46 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' VAL . 7.1 mm -102.48 119.28 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.141 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.445 HD21 HG22 ' A' ' 54' ' ' THR . 21.5 m-20 -69.16 -26.68 64.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.449 -0.782 . . . . 0.0 110.307 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.19 37.49 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -102.56 -23.96 13.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.947 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' HD11 ' A' ' 40' ' ' ILE . 70.1 p -59.04 124.7 20.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.354 -0.841 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 50.63 27.21 2.82 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 110.133 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 1.7 ptmm? -46.3 124.56 5.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.217 -0.927 . . . . 0.0 111.873 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.17 -165.92 30.91 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' CG ' ' HB3' ' A' ' 5' ' ' LYS . 29.0 tt0 -132.99 67.53 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.727 -0.867 . . . . 0.0 110.049 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mt -60.25 138.48 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.422 -0.799 . . . . 0.0 109.849 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 5' ' ' LYS . 71.5 p -110.54 138.5 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.663 -0.648 . . . . 0.0 110.833 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -144.18 142.47 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 157.01 18.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.551 -0.718 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.57 167.15 11.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.55 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.41 -39.29 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 110.42 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.1 m-20 -162.31 174.62 12.57 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.67 -29.17 69.9 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.44 81.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.03 -42.97 72.25 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.12 -43.91 78.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.648 -0.657 . . . . 0.0 109.528 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.2 tt0 -58.12 -39.66 79.26 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -50.83 48.27 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.2 -39.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.2 m-85 -73.55 -37.5 65.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 11.8 mtpp -81.49 8.16 10.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.676 -0.64 . . . . 0.0 111.367 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -111.65 -46.86 3.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.442 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.301 9.2 t80 -52.99 -41.1 64.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.146 175.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.804 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.25 -49.15 78.12 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.783 -0.573 . . . . 0.0 109.753 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.65 -47.46 81.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.764 -0.585 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -23.46 29.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.578 -0.701 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.88 -30.21 10.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.731 -0.606 . . . . 0.0 110.004 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 112.68 50.7 0.55 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.804 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.3 mp -115.34 132.63 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.453 -1.028 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -168.12 98.16 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.722 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.31 -56.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.8 ' HB2' HG22 ' A' ' 56' ' ' THR . 37.2 mt-10 -149.01 169.22 21.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.458 -1.025 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.556 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 49.6 m95 -160.39 121.99 3.12 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -145.42 131.61 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.507 -0.746 . . . . 0.0 109.564 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.5 t80 -93.24 144.25 25.48 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.748 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 100.08 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.752 -0.592 . . . . 0.0 109.775 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.24 -4.81 23.56 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.84 -28.94 18.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.509 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -126.77 8.34 6.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.69 -0.631 . . . . 0.0 110.169 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.6 mmtt 53.91 38.6 29.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.146 -0.971 . . . . 0.0 110.318 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.43 HG21 ' CD1' ' A' ' 7' ' ' ILE . 45.5 m -127.53 143.63 51.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.67 -0.644 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.3 m-85 -96.37 -171.64 2.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.48 -0.763 . . . . 0.0 109.74 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.445 HG22 HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER -153.32 102.42 2.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.05 -1.031 . . . . 0.0 108.497 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.579 HG11 HD21 ' A' ' 6' ' ' LEU . 5.7 p -116.34 142.56 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.114 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.8 HG22 ' HB2' ' A' ' 43' ' ' GLU . 3.7 t -140.15 -177.28 4.93 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.283 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 78.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 m -153.06 102.24 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.763 -0.586 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 55.6 m-85 -93.38 154.03 18.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.681 -0.637 . . . . 0.0 110.291 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.879 ' HG2' HG22 ' A' ' 18' ' ' THR . 34.6 mttt -113.96 -171.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.7 tp -163.42 108.41 1.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.463 -0.773 . . . . 0.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -85.59 120.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 HD13 ' CG1' ' A' ' 55' ' ' VAL . 8.6 mm -86.97 109.43 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.784 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -96.65 50.77 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.504 -0.747 . . . . 0.0 110.22 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.59 -118.59 1.99 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.47 47.12 0.19 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.572 -0.957 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -136.45 -62.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.146 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 mt -91.88 -52.64 4.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.99 81.85 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.496 -0.753 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -173.55 46.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.51 66.82 1.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.618 -0.931 . . . . 0.0 110.2 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.3 tt -60.34 119.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 109.921 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.879 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.1 p -89.34 140.16 29.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 110.435 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -145.52 149.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.723 . . . . 0.0 110.421 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.7 155.19 19.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.666 -0.646 . . . . 0.0 110.415 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.05 162.47 13.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.577 -0.702 . . . . 0.0 110.208 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.92 -38.11 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.289 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -162.44 176.88 10.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.36 -29.55 70.55 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.852 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.35 65.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.819 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -63.66 -38.87 92.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.39 78.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.9 tt0 -58.62 -36.25 73.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.638 -0.664 . . . . 0.0 109.355 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -67.71 -52.58 35.99 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.52 -38.5 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -74.04 -35.77 64.34 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.2 mmmt -75.98 -1.03 23.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.767 -0.583 . . . . 0.0 111.462 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -109.01 -45.43 3.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.294 12.7 t80 -51.33 -31.97 23.76 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.52 -62.34 1.65 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.874 0.845 . . . . 0.0 108.88 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -55.35 -41.55 72.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.822 -0.549 . . . . 0.0 110.797 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.39 -26.83 5.39 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.626 -0.672 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.5 -54.3 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.98 62.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.311 1.0 OUTLIER -119.09 134.96 61.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 0.0 109.84 -177.275 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -167.17 104.44 0.54 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.836 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.11 -107.91 0.21 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.6 tp10 -113.24 175.58 5.38 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -1.029 . . . . 0.0 110.398 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.464 ' CE2' HG23 ' A' ' 55' ' ' VAL . 37.9 m95 -152.55 129.04 10.68 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.654 -0.654 . . . . 0.0 109.825 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.79 133.65 25.49 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.371 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.3 t80 -97.4 135.15 39.69 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.658 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -103.18 98.96 8.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.356 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.6 -6.1 28.9 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.663 -0.648 . . . . 0.0 111.648 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.94 -27.47 17.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -123.53 5.97 8.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt 54.57 36.31 25.57 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.166 -0.959 . . . . 0.0 110.162 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 5' ' ' LYS . 17.1 m -126.35 140.54 52.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 62.6 m-85 -93.24 -169.0 2.04 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.37 94.63 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 2.8 p -95.87 100.12 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.908 0.861 . . . . 0.0 111.023 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -80.44 169.4 17.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.188 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 2' ' ' THR . 59.9 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.109 0.48 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.611 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.2 m -76.42 91.0 3.26 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.2 m-85 -76.98 143.94 39.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.632 . . . . 0.0 110.073 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.724 ' HG3' HG22 ' A' ' 18' ' ' THR . 5.0 mptt -110.51 -171.22 1.79 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.628 -0.67 . . . . 0.0 109.88 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.773 HD22 ' CD1' ' A' ' 31' ' ' PHE . 37.3 tp -162.21 112.35 1.53 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -0.87 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.63 106.99 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 13' ' ' LEU . 1.6 mm -82.87 110.72 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.153 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -96.32 147.66 23.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.53 -0.731 . . . . 0.0 110.1 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.97 -144.07 14.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' THR . 22.3 pttm -120.02 -33.0 4.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.951 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 2.6 m -75.15 110.83 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.442 -0.786 . . . . 0.0 110.038 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 59.36 159.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.922 ' N ' HD12 ' A' ' 13' ' ' LEU . 7.5 ptmt -169.99 127.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 179.13 37.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.74 69.37 1.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.704 -0.88 . . . . 0.0 109.941 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.4 pt -61.68 177.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.563 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.724 HG22 ' HG3' ' A' ' 5' ' ' LYS . 67.0 p -139.48 133.1 30.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.529 -0.732 . . . . 0.0 110.509 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -141.97 131.17 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.539 -0.726 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.89 156.08 32.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.11 163.79 13.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.649 -0.657 . . . . 0.0 110.207 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.6 -39.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.44 -0.787 . . . . 0.0 110.521 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -162.35 174.87 12.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.724 -0.61 . . . . 0.0 109.369 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.54 -27.71 66.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.466 -0.771 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -53.3 59.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HG3' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.67 -42.81 98.0 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.28 -49.29 72.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.624 -0.672 . . . . 0.0 109.618 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.13 -36.24 72.65 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.523 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -69.73 -53.75 16.98 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.7 -36.35 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.1 m-85 -75.44 -35.76 60.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -80.69 4.56 18.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.705 -0.622 . . . . 0.0 111.401 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -109.95 -45.38 3.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 3.9 t80 -53.51 -43.25 68.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.092 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.82 -49.31 78.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.816 -0.553 . . . . 0.0 110.178 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -57.21 -47.83 80.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.548 -0.72 . . . . 0.0 110.68 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -56.81 -22.6 37.51 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.646 -0.659 . . . . 0.0 110.987 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -102.9 -26.72 13.01 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.566 -0.709 . . . . 0.0 110.504 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.48 29.37 3.68 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.757 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.08 104.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -142.53 106.33 4.69 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.251 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.3 -103.15 0.18 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -107.46 176.29 5.21 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.44 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 44.1 m95 -156.92 128.79 7.19 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.71 -0.619 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.36 132.56 21.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 t80 -95.84 142.24 28.33 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.696 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -112.69 99.56 8.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.69 -0.632 . . . . 0.0 109.775 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -70.64 -4.6 24.21 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.611 -0.681 . . . . 0.0 111.456 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.67 -27.87 18.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 109.579 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -127.92 7.71 6.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp 54.53 40.68 32.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.165 -0.96 . . . . 0.0 110.194 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.3 m -129.81 139.92 51.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.663 -0.648 . . . . 0.0 110.335 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.2 m-85 -93.42 -168.39 1.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.894 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.13 98.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.5 p -102.49 119.43 50.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 122.035 0.921 . . . . 0.0 111.015 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -100.24 169.84 8.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.33 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 2' ' ' THR . 87.3 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.093 0.473 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.3 m -77.26 90.1 3.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.0 m-85 -74.11 141.12 45.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.619 -0.675 . . . . 0.0 109.956 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' THR . 21.3 mtmt -104.64 -177.54 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.62 -0.675 . . . . 0.0 110.238 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -164.34 118.16 1.4 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 110.826 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.9 mt -89.77 118.14 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mm -86.47 108.23 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.692 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.39 144.11 26.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 163.02 18.37 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -60.53 -26.65 67.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.647 -0.914 . . . . 0.0 110.379 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -76.16 125.62 29.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.595 -0.691 . . . . 0.0 110.074 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.795 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 56.09 169.04 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.569 -0.707 . . . . 0.0 110.561 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -179.64 90.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.77 -166.86 34.49 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -105.14 -42.23 5.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.713 -0.875 . . . . 0.0 110.441 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt 53.65 85.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.343 -0.848 . . . . 0.0 110.376 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.2 p -84.1 126.23 32.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.601 -0.687 . . . . 0.0 110.338 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -134.91 143.92 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.493 -0.754 . . . . 0.0 110.668 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.86 152.32 25.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.65 7.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.612 -0.68 . . . . 0.0 110.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.32 -39.3 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.357 -0.839 . . . . 0.0 110.582 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -159.29 178.8 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.39 -27.31 69.22 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.806 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.25 -54.93 39.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.552 -0.718 . . . . 0.0 109.854 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.14 -42.92 99.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.726 -0.609 . . . . 0.0 109.371 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.11 -46.01 68.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.359 -0.838 . . . . 0.0 109.836 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.09 -38.21 82.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.665 . . . . 0.0 109.284 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -54.94 -42.29 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 109.391 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.1 m-85 -70.52 -37.94 74.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 0.0 109.573 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 44' ' ' TRP . 11.1 mmtt -76.78 1.09 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.658 -0.651 . . . . 0.0 111.49 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -104.28 -46.54 4.38 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.307 8.1 t80 -46.1 -50.85 14.87 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.206 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.744 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.37 -54.16 47.27 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.64 -46.54 77.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.608 -0.682 . . . . 0.0 110.739 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.45 -16.92 51.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.631 -0.668 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' HB3' HD13 ' A' ' 40' ' ' ILE . 20.9 t-20 -108.43 -27.87 9.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.464 -0.773 . . . . 0.0 110.691 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 114.24 30.82 2.37 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -101.62 113.49 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.473 -1.016 . . . . 0.0 109.031 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.49 109.19 3.46 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.27 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.82 -95.59 0.11 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.2 tt0 -126.04 123.07 37.62 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -1.073 . . . . 0.0 111.55 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.55 ' NE1' HG23 ' A' ' 55' ' ' VAL . 37.3 m95 -103.5 137.1 42.04 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.583 -0.698 . . . . 0.0 110.403 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -147.38 131.87 17.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.666 . . . . 0.0 109.245 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.8 t80 -95.75 143.43 27.0 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.773 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -113.92 101.52 9.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.647 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.36 -3.81 22.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.619 -0.676 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.36 -27.59 20.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.5 p -130.96 9.5 4.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.617 -0.677 . . . . 0.0 110.162 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.2 mmtt 53.6 41.89 32.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -127.8 140.05 52.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.637 -0.664 . . . . 0.0 110.294 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 67.2 m-85 -93.67 -170.82 2.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 109.708 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.86 99.48 1.54 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.9 p -102.61 109.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.999 0.904 . . . . 0.0 111.195 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.49 172.94 9.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.032 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 2' ' ' THR . 79.5 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.153 0.502 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 18' ' ' THR . 6.3 m -72.8 89.39 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.48 -0.763 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -76.83 143.18 39.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.658 -0.651 . . . . 0.0 109.943 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.845 ' HG2' HG22 ' A' ' 18' ' ' THR . 32.0 mtmt -104.53 -176.41 3.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 31' ' ' PHE . 2.2 tp -166.8 108.92 0.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.522 -0.736 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mt -89.06 117.5 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.8 mp -87.32 119.6 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.253 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -96.61 149.58 21.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.11 -127.65 7.06 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.2 -41.23 0.9 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.549 -0.971 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 m -63.16 99.61 0.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.57 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.269 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.68 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.5 ptpt -162.69 105.91 1.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.7 161.94 29.43 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.08 58.45 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.717 -0.872 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 11.2 pt -52.49 145.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.149 -0.969 . . . . 0.0 110.382 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.845 HG22 ' HG2' ' A' ' 5' ' ' LYS . 81.4 p -113.59 139.66 48.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.537 -0.727 . . . . 0.0 110.956 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.583 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -146.72 132.64 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 110.456 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -70.47 154.66 41.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.0 110.186 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.06 157.73 9.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.669 . . . . 0.0 110.354 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 26' ' ' GLU . 8.9 p -54.89 -34.21 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.549 -0.72 . . . . 0.0 110.502 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.0 p30 -165.72 178.43 6.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.39 -29.74 70.8 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.569 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -47.24 84.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' HD11 ' A' ' 30' ' ' ILE . 30.8 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -46.19 81.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.52 -0.738 . . . . 0.0 109.546 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.5 tt0 -58.69 -35.78 73.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.353 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.74 26.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 26' ' ' GLU . 34.3 mt -58.18 -34.77 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.882 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.6 m-85 -77.48 -36.22 52.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 22.4 mttt -78.04 1.79 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.778 -0.576 . . . . 0.0 111.219 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.56 -45.4 3.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 177.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.294 10.9 t80 -53.76 -42.96 68.78 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.753 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.22 -47.34 86.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.183 0.516 . . . . 0.0 109.902 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.67 -48.8 78.51 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.634 -0.666 . . . . 0.0 110.549 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.06 -22.47 27.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.571 -0.705 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.414 ' CB ' HD13 ' A' ' 40' ' ' ILE . 25.5 m-80 -103.29 -25.42 13.33 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.639 -0.663 . . . . 0.0 110.671 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.05 30.62 4.13 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.9 107.23 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.68 -0.894 . . . . 0.0 109.004 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -146.08 100.52 3.4 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.23 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.68 -105.48 0.24 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tp10 -105.28 177.61 4.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.399 -1.059 . . . . 0.0 110.507 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.4 m95 -155.68 130.94 9.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.656 -0.653 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -144.85 132.2 20.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 109.264 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.7 t80 -98.49 138.1 36.19 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.93 99.82 9.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.652 -0.655 . . . . 0.0 109.551 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.31 -4.89 24.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.693 -0.629 . . . . 0.0 111.533 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.86 -28.4 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.654 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -128.76 8.5 5.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 110.234 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 31.6 mmtt 54.08 40.77 31.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.263 -0.898 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -125.17 133.67 52.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 110.628 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' HD12 ' A' ' 6' ' ' LEU . 75.1 m-85 -90.57 -172.39 3.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.613 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.12 98.29 1.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.6 p -102.02 109.46 26.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 122.122 0.963 . . . . 0.0 111.376 -178.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 169.17 12.45 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.156 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.524 HG22 ' CE2' ' A' ' 4' ' ' PHE . 62.9 m . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.169 0.509 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.619 HG22 ' HB ' ' A' ' 18' ' ' THR . 11.5 m -90.55 103.85 16.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.581 -0.699 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 59.8 m-85 -86.32 152.19 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.943 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -115.9 -164.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.653 -0.655 . . . . 0.0 109.502 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 31' ' ' PHE . 58.4 tp -168.12 108.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 110.336 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 105.55 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CG1' ' A' ' 55' ' ' VAL . 2.7 mm -77.52 99.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.087 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -85.05 63.39 8.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.982 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.7 -129.01 2.63 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 23.66 0.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.636 -0.92 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 10.38 3.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.344 -0.847 . . . . 0.0 110.737 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.1 mt -172.32 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.324 -0.86 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -52.6 103.82 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.229 -0.92 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.81 -177.83 48.15 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -137.0 64.8 1.52 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.636 -0.92 . . . . 0.0 110.173 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 HD12 ' OH ' ' A' ' 34' ' ' TYR . 95.1 mt -62.88 136.41 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.44 -0.787 . . . . 0.0 109.55 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.943 HG22 ' CG ' ' A' ' 5' ' ' LYS . 64.3 p -103.42 136.89 42.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.228 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.29 136.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.367 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.78 152.49 33.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.131 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -166.53 159.64 14.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.473 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.57 -40.11 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.576 -0.703 . . . . 0.0 110.568 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.4 173.08 17.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.43 -29.87 70.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -44.57 84.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.519 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 2.5 tp10 -69.97 -43.68 71.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.98 -41.12 77.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.667 . . . . 0.0 109.605 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.0 tt0 -60.27 -39.0 85.29 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.398 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -68.96 -48.84 62.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.58 -37.02 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.517 -0.739 . . . . 0.0 109.018 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.3 m-85 -76.89 -38.24 53.93 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.203 0.525 . . . . 0.0 109.652 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 24.5 mtpt -76.79 0.7 19.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.582 -0.699 . . . . 0.0 111.305 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -108.68 -44.72 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.283 6.6 t80 -53.0 -45.53 67.94 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.979 176.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -65.65 -57.53 7.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.775 -0.578 . . . . 0.0 109.871 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -58.32 -46.48 86.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.709 -0.619 . . . . 0.0 110.795 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -54.12 -23.93 15.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.5 -0.75 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.439 ' HB3' HD13 ' A' ' 40' ' ' ILE . 23.6 t-20 -105.64 -30.37 9.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 110.155 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 117.09 32.67 1.48 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.731 HG22 HG21 ' A' ' 55' ' ' VAL . 1.8 mp -102.41 74.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.401 -1.058 . . . . 0.0 108.617 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.95 -164.43 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . 114.41 -173.8 15.09 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.885 -1.15 . . . . 0.0 111.546 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -73.57 -178.09 2.95 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.794 -0.827 . . . . 0.0 109.512 179.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.415 ' CE2' ' HG2' ' A' ' 32' ' ' LYS . 24.6 m95 -151.74 128.56 10.92 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.655 -0.653 . . . . 0.0 109.67 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.5 p -142.3 137.36 30.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.7 -0.625 . . . . 0.0 109.442 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.2 t80 -97.37 147.29 24.33 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.548 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -116.35 100.64 8.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.2 -4.65 26.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.613 -0.679 . . . . 0.0 111.33 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.22 -26.81 18.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -128.03 7.02 6.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.66 -0.65 . . . . 0.0 110.13 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 54.74 39.74 31.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.2 -0.937 . . . . 0.0 110.165 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 63.9 m -130.27 143.38 50.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 0.0 110.714 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.8 m-85 -96.75 -168.14 1.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -160.96 117.76 2.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.77 -1.206 . . . . 0.0 108.966 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 40' ' ' ILE . 1.4 p -110.62 110.77 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.135 0.969 . . . . 0.0 109.169 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.635 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -96.36 87.69 4.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.823 0.821 . . . . 0.0 110.125 -178.078 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.501 2.12 0 O-C-N 120.782 -1.199 . . . . 0.0 110.193 -179.636 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.3 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.045 0.45 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -76.8 103.47 6.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.564 -0.71 . . . . 0.0 110.245 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.8 m-85 -84.56 130.5 34.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.597 -0.689 . . . . 0.0 110.182 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CG ' HG22 ' A' ' 18' ' ' THR . 6.6 mptt -98.83 172.66 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 109.603 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 ' CD1' ' A' ' 31' ' ' PHE . 34.7 tp -143.76 106.06 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.428 -0.795 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.3 mt -81.64 115.04 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.62 HG13 HD11 ' A' ' 13' ' ' LEU . 2.1 mm -87.62 113.66 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.461 -178.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -101.21 75.94 1.68 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.453 -0.779 . . . . 0.0 110.544 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.33 -152.02 6.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -110.39 -27.25 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.957 . . . . 0.0 110.262 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 7.8 p -79.73 102.24 8.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 109.824 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.8 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.168 0.508 . . . . 0.0 109.635 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 3.0 mtpm? -142.55 137.24 30.0 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.258 -0.901 . . . . 0.0 111.057 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.06 -165.41 22.45 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.26 158.19 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.87 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.8 mp -116.57 -16.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' CG ' ' A' ' 5' ' ' LYS . 60.2 p 45.53 96.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.557 -0.714 . . . . 0.0 111.655 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.453 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -130.14 132.99 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.53 157.46 30.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.531 -0.731 . . . . 0.0 109.937 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.8 168.84 12.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.553 -0.717 . . . . 0.0 110.289 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.37 -35.51 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 0.0 110.487 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 22' ' ' VAL . 32.1 p30 -166.5 172.81 10.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.294 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.74 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.98 -31.18 71.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.317 -0.864 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.0 81.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.745 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.16 -43.17 74.82 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.95 77.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.45 -0.782 . . . . 0.0 109.717 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.5 tt0 -59.16 -36.82 75.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.581 -0.699 . . . . 0.0 109.334 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -69.53 -51.4 36.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.7 -39.42 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.837 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.5 m-85 -72.95 -37.47 67.11 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.52 1.95 17.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.694 -0.629 . . . . 0.0 111.377 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -109.19 -45.54 3.73 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 4.4 t80 -53.21 -40.31 64.37 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.151 176.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.08 -55.13 36.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.846 -0.534 . . . . 0.0 110.191 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.89 -48.79 80.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.709 -0.619 . . . . 0.0 110.662 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.14 -22.8 18.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -0.784 . . . . 0.0 111.06 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -103.1 -35.19 8.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.553 -0.717 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 122.33 36.32 0.7 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.788 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -103.72 119.77 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -1.066 . . . . 0.0 109.06 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -149.1 108.48 3.96 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.264 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.01 -109.64 0.22 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -111.06 176.58 4.97 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.489 -1.006 . . . . 0.0 110.526 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.9 m95 -154.29 130.54 10.41 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.61 -0.682 . . . . 0.0 109.838 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.8 p -144.28 132.58 21.9 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.2 t80 -97.57 132.79 42.91 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.75 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -102.07 99.31 9.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.685 -0.635 . . . . 0.0 109.361 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.21 -7.15 33.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.02 -28.9 18.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -122.02 5.6 9.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.676 -0.64 . . . . 0.0 110.183 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 54.76 35.96 25.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 38.4 m -126.61 143.76 51.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.614 -0.679 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.9 m-85 -94.93 -170.35 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 0.0 110.036 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -155.72 92.66 1.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.611 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.9 p -95.89 104.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.888 0.852 . . . . 0.0 111.053 -178.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 169.73 13.6 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 178.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.202 -179.92 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 99.8 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.683 0.278 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 m 50.24 90.64 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.112 -0.992 . . . . 0.0 111.082 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 16.2 m-85 -89.14 139.17 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.089 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.857 ' HG2' HG22 ' A' ' 18' ' ' THR . 23.2 mttt -99.22 -173.7 2.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.775 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.868 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.6 tp -158.99 105.56 1.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.374 -0.829 . . . . 0.0 110.015 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 52' ' ' THR . 12.8 mt -85.9 130.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.683 HG21 ' HG ' ' A' ' 13' ' ' LEU . 14.5 mm -95.54 113.83 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.711 -179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -70.69 -23.84 62.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.175 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.28 149.12 46.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.52 -25.01 66.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.685 -0.891 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -86.82 166.72 14.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.745 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.683 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.3 OUTLIER 41.0 27.05 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.81 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -52.24 134.8 33.22 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 111.253 -178.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.11 175.42 38.42 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.111 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -140.48 42.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.3 pt -50.26 148.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.522 -0.736 . . . . 0.0 111.165 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.857 HG22 ' HG2' ' A' ' 5' ' ' LYS . 76.0 p -111.97 141.04 46.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.051 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.537 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -138.37 134.75 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.738 . . . . 0.0 110.744 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.99 139.12 42.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.723 -0.611 . . . . 0.0 109.997 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.06 34.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 110.436 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -54.08 -39.55 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.511 -0.743 . . . . 0.0 110.325 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -160.02 -179.81 8.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.547 -0.721 . . . . 0.0 109.32 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.02 -31.17 72.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.731 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -54.15 -57.68 10.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 0.0 109.976 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -59.63 -40.91 89.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.63 -0.669 . . . . 0.0 109.783 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.73 . . . . 0.0 109.732 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 15.4 tt0 -60.54 -47.31 86.75 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.371 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -51.32 69.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.949 . . . . 0.0 109.958 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.51 -45.87 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.46 -0.775 . . . . 0.0 109.415 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.868 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -68.85 -37.49 79.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -76.03 1.95 14.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.777 -0.577 . . . . 0.0 111.441 179.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -107.08 -45.12 4.22 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 177.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 2.2 t80 -50.42 -38.28 42.33 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.838 176.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -63.86 -49.55 72.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.248 0.547 . . . . 0.0 109.825 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -60.22 -46.3 90.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.709 -0.619 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.99 -22.86 29.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.51 -0.744 . . . . 0.0 110.826 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -103.8 -24.35 13.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.675 -0.641 . . . . 0.0 110.468 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.33 44.03 1.65 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.797 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -104.18 135.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.908 . . . . 0.0 109.705 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -167.61 97.63 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.77 -65.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.645 ' HB2' HG22 ' A' ' 56' ' ' THR . 9.0 mt-10 -154.65 173.58 16.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.551 -0.97 . . . . 0.0 110.171 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 52.1 m95 -155.05 123.84 6.13 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.66 -0.65 . . . . 0.0 109.803 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -139.03 133.76 32.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.677 . . . . 0.0 109.289 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.4 t80 -96.15 136.92 35.96 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.851 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -105.15 99.58 9.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.666 . . . . 0.0 109.281 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.7 -4.51 23.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.606 . . . . 0.0 111.603 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.27 -26.58 17.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -126.55 7.82 6.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 110.135 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.6 mmtp 53.4 38.61 28.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.115 -0.99 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 7' ' ' ILE . 6.5 m -128.56 135.03 48.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.699 -0.626 . . . . 0.0 110.617 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 56.8 m-85 -87.52 -170.5 3.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.348 -0.845 . . . . 0.0 109.795 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.67 104.24 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.031 -1.043 . . . . 0.0 108.211 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.3 p -111.43 132.61 59.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.567 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -125.66 -177.41 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.268 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.245 0.545 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.8 m -90.23 112.16 23.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 49.7 m-85 -97.8 150.04 21.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.632 -0.668 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.942 ' CG ' HG22 ' A' ' 18' ' ' THR . 4.5 mptt -113.24 -167.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.706 -0.621 . . . . 0.0 109.83 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.736 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -167.33 100.38 0.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.487 -0.758 . . . . 0.0 110.145 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.2 mt -82.58 129.18 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.505 HG13 HD11 ' A' ' 13' ' ' LEU . 10.1 mm -99.91 115.93 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.234 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.491 ' OD1' HG22 ' A' ' 54' ' ' THR . 2.1 m-20 -80.75 -158.96 0.21 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.383 -0.823 . . . . 0.0 109.177 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.97 -129.19 47.72 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -148.07 25.54 1.01 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.909 . . . . 0.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 30.4 p -103.74 113.82 27.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.669 HD23 HG12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 67.43 -51.2 0.5 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.852 -0.53 . . . . 0.0 111.683 179.964 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 11.4 mmmt 49.17 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.616 -1.303 . . . . 0.0 111.543 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.79 170.13 43.24 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.38 55.94 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.77 -0.841 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.523 HG23 ' HE1' ' A' ' 31' ' ' PHE . 4.2 tp -59.32 133.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.519 -0.738 . . . . 0.0 110.373 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.942 HG22 ' CG ' ' A' ' 5' ' ' LYS . 53.0 p -98.94 140.13 33.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.647 -0.658 . . . . 0.0 110.079 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.449 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.1 147.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.532 -0.73 . . . . 0.0 110.469 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -90.96 153.36 20.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.592 -0.693 . . . . 0.0 110.152 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.48 164.05 14.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.484 -0.76 . . . . 0.0 110.58 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.3 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.542 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.5 p30 -162.28 174.33 12.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.92 -30.03 68.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.94 73.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.402 -0.811 . . . . 0.0 109.8 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.89 -40.22 91.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -55.89 -45.33 78.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.1 tt0 -58.45 -37.86 76.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.607 -0.683 . . . . 0.0 109.342 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -68.68 -50.64 49.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.27 -39.66 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.736 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.3 m-85 -73.36 -36.67 66.17 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 32.9 mtpt -75.62 -0.55 20.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.663 -0.648 . . . . 0.0 111.493 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -105.94 -45.58 4.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 177.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 1.2 t80 -52.81 -40.71 63.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.837 176.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -61.73 -47.52 84.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.825 -0.547 . . . . 0.0 109.942 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -59.0 -47.6 84.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.581 -0.7 . . . . 0.0 110.432 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -54.28 -25.15 21.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HB2' HD13 ' A' ' 40' ' ' ILE . 10.8 m120 -101.42 -24.59 14.16 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.784 -0.573 . . . . 0.0 110.535 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.47 36.27 3.11 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.777 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.39 116.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.614 -0.933 . . . . 0.0 109.489 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -158.06 101.71 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.13 -64.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.841 ' HB2' HG22 ' A' ' 56' ' ' THR . 68.8 mm-40 -129.56 169.03 15.53 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.48 -1.012 . . . . 0.0 110.952 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.9 m95 -162.85 118.78 1.83 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.44 132.78 21.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.399 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -93.56 144.52 25.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.9 97.8 6.61 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.88 -5.84 28.64 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.685 -0.634 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.77 -27.03 17.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -123.98 6.18 8.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.061 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 17.4 mmtt 54.18 39.93 31.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 110.077 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 5' ' ' LYS . 33.4 m -134.71 140.29 45.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 0.0 110.744 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' A' ' 6' ' ' LEU . 46.3 m-85 -93.62 -170.73 2.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.311 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.491 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.2 OUTLIER -157.04 102.95 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.485 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.4 p -116.1 144.71 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.92 -178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.841 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.7 t -143.22 -172.39 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.595 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.436 -0.79 . . . . 0.0 110.199 179.995 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 2' ' ' THR . 49.8 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.935 0.398 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.571 HG22 ' HB ' ' A' ' 18' ' ' THR . 21.6 m -60.12 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.415 -0.803 . . . . 0.0 109.841 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.528 ' CD2' HG22 ' A' ' 2' ' ' THR . 4.7 m-85 -85.49 147.51 26.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.715 -0.616 . . . . 0.0 110.129 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.847 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.46 -171.56 1.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.607 -0.683 . . . . 0.0 109.908 -179.907 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.733 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.7 tp -160.08 112.43 2.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.305 -0.872 . . . . 0.0 110.841 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mt -85.35 119.91 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 13' ' ' LEU . 5.4 mm -93.84 114.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.008 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -102.22 144.6 30.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.545 -0.722 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.68 -135.78 9.38 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -131.38 29.66 4.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.93 . . . . 0.0 110.191 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 14' ' ' LYS . 8.7 p -139.4 147.3 41.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.813 HD12 HG12 ' A' ' 40' ' ' ILE . 6.5 mt 60.9 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.784 -0.572 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' THR . 6.1 mtmm 54.72 98.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.47 -0.769 . . . . 0.0 110.56 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.92 177.36 40.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.88 55.76 1.88 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.655 -0.909 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 pt -58.19 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.5 p -128.81 138.76 52.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.531 -0.73 . . . . 0.0 110.188 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.51 138.84 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.734 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.61 128.58 33.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 109.538 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.45 -163.06 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.07 -59.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.29 -174.73 4.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.78 79.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.611 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.56 31.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.619 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -56.11 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.635 . . . . 0.0 109.868 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -49.81 -42.27 46.65 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.455 -0.778 . . . . 0.0 110.376 179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.4 tt0 -60.57 -35.15 75.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.56 -0.713 . . . . 0.0 109.236 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -72.57 -46.82 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 27' ' ' ALA . 61.6 mt -59.31 -36.94 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -76.96 -35.4 57.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 6.1 mtpt -77.3 0.93 20.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.773 -0.579 . . . . 0.0 111.357 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -107.31 -45.46 4.09 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.291 5.5 t80 -52.46 -35.24 52.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.783 176.211 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -71.02 -51.39 25.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.276 0.56 . . . . 0.0 109.946 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.31 -47.43 85.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.635 -0.666 . . . . 0.0 110.396 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -22.64 19.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.571 -0.706 . . . . 0.0 111.11 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -104.52 -31.8 9.28 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 118.7 34.64 1.05 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.813 HG12 HD12 ' A' ' 13' ' ' LEU . 1.6 mp -102.13 110.18 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.456 -1.026 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -143.36 111.76 6.31 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.25 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.64 -110.03 0.23 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tp10 -107.93 179.11 4.32 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.367 -1.078 . . . . 0.0 110.4 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -155.19 129.45 8.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.575 -0.703 . . . . 0.0 109.856 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.0 p -141.94 133.05 26.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.548 -0.72 . . . . 0.0 109.177 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.5 t80 -98.48 134.48 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.889 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -104.23 98.92 8.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -71.13 -3.81 21.97 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.612 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.75 -25.1 17.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.729 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 p -128.66 5.62 5.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.612 -0.68 . . . . 0.0 110.296 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 74.1 mmtt 55.89 42.81 28.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.164 -0.96 . . . . 0.0 109.679 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 124.89 32.92 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.869 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 82.8 m-85 -81.28 -171.3 3.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -0.75 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.6 90.42 1.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -92.64 100.25 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.005 0.907 . . . . 0.0 110.927 -178.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -80.12 171.39 15.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.67 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.6 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.074 0.464 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -73.3 109.56 6.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.877 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 2' ' ' THR . 78.7 m-85 -87.93 145.44 26.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.555 -0.716 . . . . 0.0 110.646 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.809 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.6 OUTLIER -108.94 -173.95 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.892 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.4 tp -167.65 110.14 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.285 -0.885 . . . . 0.0 110.681 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 52' ' ' THR . 3.6 mp -95.55 113.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' HA ' HG13 ' A' ' 55' ' ' VAL . 1.2 mm -84.13 104.05 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.94 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -86.52 144.6 27.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.554 -0.716 . . . . 0.0 110.17 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.55 -140.77 12.0 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.28 29.74 5.51 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.664 -0.904 . . . . 0.0 110.176 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' LYS . 10.4 p -138.05 138.02 38.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 40' ' ' ILE . 5.7 mt 60.9 -77.3 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.762 -0.586 . . . . 0.0 111.027 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' THR . 15.5 mtpt 54.37 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.339 -0.85 . . . . 0.0 110.738 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.62 -175.77 41.58 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -108.43 -57.88 2.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.577 -0.954 . . . . 0.0 110.367 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.9 mm 53.6 72.75 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.809 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.6 p -69.64 137.36 52.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.598 -0.689 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -145.51 147.4 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.562 -0.711 . . . . 0.0 110.572 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.73 162.08 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.605 -0.685 . . . . 0.0 109.936 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 26' ' ' GLU . . . -169.35 171.16 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.1 p -53.08 -39.06 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.494 -0.754 . . . . 0.0 110.401 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.5 p30 -160.67 -175.18 4.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -70.38 -31.23 68.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.19 -49.3 74.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.593 -0.692 . . . . 0.0 109.921 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tt0 -63.09 -43.64 97.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.403 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.35 -45.06 69.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -59.12 -36.27 74.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 109.348 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.72 -54.85 16.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.52 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.49 -40.34 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.892 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -72.07 -34.7 68.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -78.52 1.25 23.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.693 -0.629 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -104.22 -46.14 4.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 4.4 t80 -47.36 -51.98 17.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.906 175.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.721 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -67.74 -50.19 58.62 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.659 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.06 -49.92 72.41 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.72 . . . . 0.0 110.899 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.86 -21.46 29.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.603 -0.685 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -102.72 -27.76 12.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.572 -0.705 . . . . 0.0 110.576 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.67 29.25 3.67 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.721 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.41 106.01 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 108.756 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -141.71 114.89 8.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.35 0.595 . . . . 0.0 111.016 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.76 -100.78 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.7 tt0 -115.31 170.74 8.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -1.002 . . . . 0.0 110.035 179.54 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 40.6 m95 -152.6 122.95 7.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.505 -0.747 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 25.3 p -138.22 128.57 26.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.5 t80 -94.24 141.7 28.26 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.654 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -111.82 100.92 9.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.1 -2.68 16.46 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.616 -0.678 . . . . 0.0 111.745 -179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -28.69 21.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -136.69 15.39 3.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.695 . . . . 0.0 109.906 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER 48.28 45.34 20.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.487 179.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 7' ' ' ILE . 26.2 m -121.18 120.84 36.38 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.54 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.3 m-85 -85.35 172.81 10.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -139.78 97.16 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -97.68 107.53 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 122.007 0.908 . . . . 0.0 110.682 -178.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -92.02 170.1 10.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.286 -179.952 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.4 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.073 0.463 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.5 m 51.03 88.05 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.375 -0.828 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -90.04 149.46 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.228 178.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.899 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.5 OUTLIER -110.19 -173.93 2.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 110.389 -179.634 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.7 tp -160.98 108.97 1.54 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.634 -0.666 . . . . 0.0 109.986 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.5 mm -87.42 129.89 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' LEU . 2.1 mm -101.91 116.39 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.67 -179.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.637 HD21 HG22 ' A' ' 54' ' ' THR . 15.1 m-20 -76.05 -29.31 57.99 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.84 -175.91 4.92 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -114.85 25.55 10.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.618 -0.931 . . . . 0.0 110.486 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -96.04 -33.72 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.46 -0.775 . . . . 0.0 109.964 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 40' ' ' ILE . 9.7 mt -121.96 -54.09 1.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.696 -0.628 . . . . 0.0 109.772 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt 52.66 82.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.539 -0.726 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.99 -175.54 46.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.47 -50.07 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.797 -0.825 . . . . 0.0 109.966 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.0 mm 54.12 83.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.899 HG22 ' CG ' ' A' ' 5' ' ' LYS . 62.0 p -76.94 142.14 40.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.626 -0.671 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -143.69 131.5 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.488 -0.758 . . . . 0.0 111.187 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -66.93 131.15 45.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 110.068 179.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.32 150.11 31.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.0 p -53.26 -39.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.546 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.4 p30 -158.13 177.18 11.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.68 -33.11 74.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.415 -0.803 . . . . 0.0 109.642 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.581 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.71 -44.09 81.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.562 -0.711 . . . . 0.0 109.723 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' OE1' HD11 ' A' ' 30' ' ' ILE . 2.1 tt0 -70.62 -44.19 67.72 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.98 80.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.571 -0.706 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.8 tt0 -57.98 -37.54 74.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.648 -0.658 . . . . 0.0 109.401 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -51.57 32.62 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.513 HD11 ' OE1' ' A' ' 26' ' ' GLU . 22.3 mt -58.48 -35.56 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -77.24 -35.55 55.36 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -73.85 -2.9 25.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.75 -0.594 . . . . 0.0 111.211 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -103.24 -46.1 4.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.296 2.8 t80 -52.33 -32.43 38.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.692 175.627 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.49 -60.81 2.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.819 0.818 . . . . 0.0 108.896 178.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -57.19 -40.56 77.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.83 -0.544 . . . . 0.0 110.562 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.09 -27.95 3.78 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.616 -0.678 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -49.31 3.4 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.475 0.655 . . . . 0.0 109.861 179.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.53 64.95 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.753 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -118.81 129.3 75.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.949 -0.736 . . . . 0.0 110.389 -176.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.18 94.34 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.511 -0.743 . . . . 0.0 110.154 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.32 -44.95 0.02 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 56' ' ' THR . 15.0 tt0 -152.02 167.43 28.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.466 -1.02 . . . . 0.0 110.863 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 43.8 m95 -163.41 116.56 1.54 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -141.97 130.77 22.9 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.586 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -93.24 146.29 23.81 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.25 100.07 7.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.732 -0.605 . . . . 0.0 109.592 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -71.65 -2.78 18.43 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.668 -0.645 . . . . 0.0 111.505 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -25.82 18.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -131.54 8.74 4.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.482 -0.761 . . . . 0.0 110.174 179.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 54.41 45.11 27.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.193 -0.942 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.9 m -133.52 135.13 44.2 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.774 ' HB2' HD12 ' A' ' 6' ' ' LEU . 63.5 m-85 -90.74 -172.23 3.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.5 -0.75 . . . . 0.0 109.618 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 HD21 ' A' ' 9' ' ' ASN . 0.6 OUTLIER -156.16 97.68 1.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.98 -1.075 . . . . 0.0 108.712 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.3 p -112.5 146.31 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.138 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.84 HG22 ' HB3' ' A' ' 43' ' ' GLU . 6.2 t -145.28 -172.48 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.936 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.201 179.925 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.438 HG22 ' CE2' ' A' ' 4' ' ' PHE . 63.5 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.083 0.468 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.1 m -102.76 109.12 20.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.109 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.3 m-85 -93.16 141.92 27.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 110.301 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.836 ' HG3' HG22 ' A' ' 18' ' ' THR . 3.8 mptt -105.88 -166.21 1.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 0.0 109.35 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.861 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.4 tp -166.55 105.69 0.63 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.416 -0.803 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -81.34 118.43 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mm -89.86 101.3 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.609 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -76.1 -3.39 35.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.518 -0.739 . . . . 0.0 111.166 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.8 163.89 33.84 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.83 -27.42 68.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.478 -1.013 . . . . 0.0 110.64 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . 16.7 m -78.46 156.27 29.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.53 -0.731 . . . . 0.0 110.324 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.672 HD22 ' OH ' ' A' ' 34' ' ' TYR . 9.6 mt 59.71 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.865 -0.522 . . . . 0.0 111.188 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' THR . 1.0 OUTLIER 56.3 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.149 -0.969 . . . . 0.0 110.528 -179.766 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.53 -177.69 36.85 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -128.09 67.52 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -1.008 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 6.8 tp -62.72 126.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.735 . . . . 0.0 109.892 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.836 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.0 p -96.29 137.54 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.485 -0.76 . . . . 0.0 110.424 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -142.37 133.65 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.365 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -78.58 148.99 33.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.672 -0.643 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.63 163.97 32.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.604 -0.685 . . . . 0.0 110.246 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.8 -40.93 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.494 -0.753 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.42 172.55 18.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.28 -34.48 75.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.299 -0.875 . . . . 0.0 109.704 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.3 -49.47 69.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.62 -0.675 . . . . 0.0 109.796 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -40.87 96.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -56.11 -43.53 78.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.424 -0.797 . . . . 0.0 109.665 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 9.6 tt0 -59.82 -35.85 75.56 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -68.33 -51.13 47.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.3 mt -58.12 -40.96 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.861 ' CD1' HD22 ' A' ' 6' ' ' LEU . 14.3 m-85 -72.0 -36.66 69.82 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.5 mmmt -74.58 -2.44 25.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.615 -0.678 . . . . 0.0 111.182 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -105.41 -42.51 5.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.672 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.293 16.4 t80 -55.08 -19.47 7.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.734 175.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -89.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -53.06 -42.42 65.79 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.708 -0.62 . . . . 0.0 111.787 -178.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 39.5 p-10 -46.85 -27.54 1.27 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.461 -0.774 . . . . 0.0 111.612 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -108.74 -59.57 1.86 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.849 -0.532 . . . . 0.0 110.253 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.82 59.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.733 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.297 1.1 mm -116.49 130.52 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.742 -0.858 . . . . 0.0 109.532 -178.363 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -169.9 104.49 0.32 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.407 -0.808 . . . . 0.0 111.079 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.24 -63.22 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 32.7 mt-10 -152.7 171.37 18.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.567 -0.961 . . . . 0.0 110.143 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.9 m95 -155.03 124.89 6.57 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.669 -0.644 . . . . 0.0 110.009 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.2 p -144.45 132.82 21.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.627 -0.671 . . . . 0.0 109.532 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.1 t80 -93.08 148.73 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.67 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.68 100.08 6.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.742 -0.599 . . . . 0.0 109.879 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.79 -4.18 22.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.712 -0.617 . . . . 0.0 111.554 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.24 -28.0 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.9 p -128.82 8.33 5.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 110.083 179.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 15.9 mmtt 54.28 40.1 31.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.5 m -130.49 138.62 50.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 0.0 110.371 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 48.4 m-85 -91.33 -167.41 1.79 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -154.57 102.31 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.99 -1.069 . . . . 0.0 108.474 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.8 p -113.15 128.39 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.796 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -124.78 -178.69 4.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.769 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 2' ' ' THR . 60.8 m . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.111 0.482 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -71.27 93.31 1.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m-85 -81.98 139.5 34.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 110.178 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.811 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -105.08 -170.96 1.83 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.175 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.4 tp -165.04 108.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.601 -0.687 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -84.61 129.41 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.597 HD11 HD23 ' A' ' 6' ' ' LEU . 9.6 mm -93.22 114.31 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.082 -178.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.88 40.96 1.16 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.36 -151.17 6.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 12' ' ' THR . 10.2 ptmt -114.7 -28.82 6.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -1.013 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.1 p -79.88 113.71 18.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.25 144.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.277 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.4 ptpp? -151.27 140.16 20.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.225 -0.922 . . . . 0.0 111.073 -179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.53 -163.47 29.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 17' ' ' ILE . 5.4 mp0 -108.69 -42.76 4.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.883 . . . . 0.0 110.235 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.541 HD12 ' C ' ' A' ' 16' ' ' GLU . 5.3 mp 53.25 95.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.405 -0.809 . . . . 0.0 110.356 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' CG ' ' A' ' 5' ' ' LYS . 80.8 p -90.19 132.11 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.633 -0.667 . . . . 0.0 110.241 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.471 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.4 pp -143.42 130.22 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.512 -0.743 . . . . 0.0 110.478 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -71.22 157.72 37.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.55 161.4 11.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 110.165 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -53.75 -30.99 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.445 -0.785 . . . . 0.0 110.366 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.8 p30 -171.42 178.3 3.26 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.15 -30.61 71.55 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.612 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.67 81.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.502 -0.749 . . . . 0.0 109.704 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG3' HD11 ' A' ' 30' ' ' ILE . 19.9 tp10 -70.59 -44.64 66.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.63 -42.54 71.34 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.352 -0.842 . . . . 0.0 109.689 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -60.44 -41.13 93.41 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.044 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.11 -35.03 66.49 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.604 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 26' ' ' GLU . 52.8 mt -67.72 -40.78 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.639 ' HB3' HD13 ' A' ' 6' ' ' LEU . 12.7 m-85 -73.3 -38.3 65.91 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.7 mmmt -72.96 -4.98 35.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.602 -0.686 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -106.14 -45.12 4.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.29 5.5 t80 -51.62 -30.62 22.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.091 176.193 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -76.08 -50.11 15.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.608 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -57.54 -47.56 81.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 110.678 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -24.74 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB2' HD13 ' A' ' 40' ' ' ILE . 52.3 m-20 -102.75 -27.1 12.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.637 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 35.15 2.34 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.769 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.95 107.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.657 -0.908 . . . . 0.0 108.904 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.25 113.45 9.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.476 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.19 -109.77 0.22 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.9 tt0 -114.51 174.39 5.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -1.032 . . . . 0.0 110.347 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CE2' HG23 ' A' ' 55' ' ' VAL . 36.5 m95 -151.9 130.71 12.44 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.577 -0.702 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.2 p -142.89 133.17 24.66 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.298 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.4 t80 -95.12 145.37 25.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -117.8 98.11 6.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.792 -0.568 . . . . 0.0 109.488 179.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.63 -4.62 24.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.659 -0.65 . . . . 0.0 111.659 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -26.71 17.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 109.733 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -125.98 7.05 7.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.609 -0.682 . . . . 0.0 110.194 179.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 4' ' ' PHE . 3.9 mmtp 54.15 38.47 29.21 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.184 -0.947 . . . . 0.0 110.101 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.5 m -130.6 134.21 46.8 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.628 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' HD12 ' A' ' 6' ' ' LEU . 53.3 m-85 -88.27 -166.84 1.7 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.21 92.71 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.92 102.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.933 0.873 . . . . 0.0 111.316 -178.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -82.51 169.44 16.35 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 2' ' ' THR . 46.0 m . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 120.968 0.413 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 m -68.86 85.31 0.32 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.776 . . . . 0.0 109.983 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.6 m-85 -70.42 126.89 30.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.647 -0.658 . . . . 0.0 109.778 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 18' ' ' THR . 30.9 mttm -89.57 175.35 7.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.967 HD23 HD11 ' A' ' 8' ' ' ILE . 2.5 tp -156.54 112.5 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.643 -0.661 . . . . 0.0 109.839 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -90.8 114.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.967 HD11 HD23 ' A' ' 6' ' ' LEU . 2.3 mp -90.08 113.15 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.071 -178.829 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -92.61 149.93 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.432 -0.792 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.51 -108.52 1.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -166.28 47.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.584 -0.951 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.621 ' CG2' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -152.21 119.22 5.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 110.208 179.998 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 53.95 23.98 4.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.504 0.669 . . . . 0.0 110.312 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -46.97 109.0 0.16 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.007 -1.058 . . . . 0.0 111.468 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.79 -162.73 29.48 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -109.46 -33.58 6.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.617 -0.931 . . . . 0.0 110.719 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.463 ' C ' HG23 ' A' ' 18' ' ' THR . 28.2 mm 67.05 -61.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 O-C-N 121.699 -0.626 . . . . 0.0 110.834 -179.81 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 17' ' ' ILE . 1.3 p 62.37 112.63 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.344 -0.847 . . . . 0.0 110.427 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -143.24 132.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.765 -0.585 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.51 155.01 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 110.325 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.45 12.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.386 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.5 -39.65 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.535 -0.728 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.3 m-20 -159.27 177.05 11.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.646 -0.659 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.7 -32.16 73.71 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.383 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.3 82.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.632 -0.667 . . . . 0.0 109.807 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.41 -44.66 82.37 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -45.91 75.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 109.623 178.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 6.1 tt0 -59.26 -37.01 76.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.503 179.08 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -69.14 -51.26 40.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mt -58.26 -38.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.65 -39.36 62.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.145 0.498 . . . . 0.0 109.792 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -76.45 0.7 18.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.489 -0.757 . . . . 0.0 111.953 -179.393 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -110.14 -45.32 3.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.301 9.5 t80 -53.78 -39.0 65.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.249 176.558 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.814 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.22 -54.49 32.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -56.83 -48.35 78.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.679 -0.638 . . . . 0.0 110.712 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.82 -22.23 34.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.0 110.831 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -102.57 -29.02 11.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.681 -0.637 . . . . 0.0 110.217 179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 115.53 33.55 1.57 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.814 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -105.73 115.52 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -1.044 . . . . 0.0 109.229 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.17 105.55 2.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.433 -179.622 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.4 -97.12 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.51 127.55 46.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.334 -1.097 . . . . 0.0 111.067 -179.551 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' NE1' HG23 ' A' ' 55' ' ' VAL . 50.4 m95 -105.83 137.09 44.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.533 -0.729 . . . . 0.0 110.904 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.8 p -147.01 132.06 18.24 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.3 t80 -98.6 144.8 27.5 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.861 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -115.57 99.34 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.766 -0.584 . . . . 0.0 109.638 179.257 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.31 -6.09 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 111.306 -179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.82 -26.52 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.612 179.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -124.24 5.63 8.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.619 -0.676 . . . . 0.0 110.119 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 54.0 38.55 29.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.143 -0.973 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -128.06 143.53 51.07 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.811 -179.436 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.901 ' HB2' HD12 ' A' ' 6' ' ' LEU . 78.6 m-85 -98.34 -172.19 2.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.187 179.452 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -158.41 99.39 1.61 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.713 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.466 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -102.79 97.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.774 0.797 . . . . 0.0 111.155 -178.537 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.35 169.62 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.13 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.685 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.59 HG22 ' CE2' ' A' ' 4' ' ' PHE . 20.3 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 120.981 0.42 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' HB ' ' A' ' 18' ' ' THR . 20.4 m -67.16 91.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 110.143 179.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 2' ' ' THR . 34.2 m-85 -72.43 146.75 46.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.624 -0.672 . . . . 0.0 110.172 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 17.1 mtmt -109.84 -178.1 3.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.94 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 53' ' ' PHE . 6.4 tp -160.57 102.48 1.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.401 HG12 ' CG ' ' A' ' 16' ' ' GLU . 18.9 mt -90.71 117.0 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.045 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.766 ' CG1' HD11 ' A' ' 13' ' ' LEU . 2.0 mp -91.46 120.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.333 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.7 -31.15 59.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.34 -179.293 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 160.12 45.96 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.41 13.66 13.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.611 -0.935 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.625 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.2 p -63.05 -54.18 42.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.25 -0.906 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.766 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.6 pp -131.13 -29.08 1.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.677 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.697 ' N ' HD12 ' A' ' 13' ' ' LEU . 16.4 ptmt 37.35 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.68 -179.98 47.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HG12 ' A' ' 7' ' ' ILE . 2.1 mt-10 -129.76 72.54 1.48 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.834 -0.803 . . . . 0.0 109.786 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.66 112.56 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 109.974 -179.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 55.3 p -88.24 123.27 32.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.642 -0.661 . . . . 0.0 109.692 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.33 139.22 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.781 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -86.51 159.4 19.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.983 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.8 168.92 10.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.711 . . . . 0.0 110.203 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.89 -38.74 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -163.6 174.65 11.5 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.711 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.6 -30.61 70.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.31 -48.96 70.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.427 -0.796 . . . . 0.0 110.026 179.43 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.91 -43.43 83.39 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.617 -0.677 . . . . 0.0 109.749 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 17.9 tt0 -58.02 -40.45 80.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.709 -0.62 . . . . 0.0 109.508 179.175 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -50.12 56.22 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.331 178.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 27' ' ' ALA . 26.3 mt -58.01 -38.37 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -75.54 -35.28 60.72 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -79.78 3.97 17.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.64 . . . . 0.0 111.32 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -107.23 -45.27 4.15 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.413 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.288 6.1 t80 -52.9 -45.51 67.57 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.916 176.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.21 -51.56 69.05 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.322 0.582 . . . . 0.0 109.9 179.139 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.83 -49.62 76.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.802 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -57.55 -27.89 63.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.526 -0.733 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.7 -27.52 17.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.887 -0.508 . . . . 0.0 110.307 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 108.03 38.89 1.92 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.781 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.8 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -106.44 130.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.656 -0.908 . . . . 0.0 109.375 -179.714 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -168.1 106.61 0.5 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.01 -59.9 0.03 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.852 ' HB3' HG22 ' A' ' 56' ' ' THR . 7.0 tt0 -136.75 163.61 30.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.381 -1.07 . . . . 0.0 110.529 -179.479 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.4 m95 -162.65 116.06 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 p -145.64 131.57 19.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.604 -0.685 . . . . 0.0 109.495 179.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.3 t80 -89.05 152.3 21.75 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.821 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.32 102.18 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.721 -0.612 . . . . 0.0 109.643 179.367 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.47 -6.06 33.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.737 -0.602 . . . . 0.0 111.395 -179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.49 -28.13 21.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 p -125.22 6.12 7.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.614 -0.679 . . . . 0.0 109.973 179.103 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt 53.47 39.12 29.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.154 -0.966 . . . . 0.0 110.176 -179.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -133.55 145.87 50.5 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.015 -179.493 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 6' ' ' LEU . 49.6 m-85 -97.68 173.56 7.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.574 -0.704 . . . . 0.0 109.441 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.32 110.2 8.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.097 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.694 HG13 HG13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -117.94 152.89 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.704 -178.271 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -160.11 -169.44 2.5 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.7 179.242 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 2' ' ' THR . 53.5 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.131 0.491 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 m -62.75 86.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.531 -0.731 . . . . 0.0 110.074 179.926 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.787 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -71.75 137.0 47.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.602 -0.686 . . . . 0.0 109.95 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 15.9 mttt -99.37 179.72 4.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.635 -0.666 . . . . 0.0 110.269 -179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.823 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -163.14 118.58 1.74 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 110.464 -179.975 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.99 114.35 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.284 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -89.84 119.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.529 -179.142 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -102.64 56.76 0.78 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.41 174.2 22.67 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -70.15 -41.14 74.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.505 -0.997 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.672 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.3 p -76.31 115.44 16.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.469 -0.769 . . . . 0.0 109.946 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 60.28 156.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.356 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -171.67 126.19 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.25 -158.71 23.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -110.03 146.3 35.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.641 -0.917 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 49.5 mm -113.64 -16.96 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.669 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 65.0 p 45.33 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.678 -0.639 . . . . 0.0 112.006 179.845 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -126.81 141.04 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.803 . . . . 0.0 110.532 179.35 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.73 151.16 32.25 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.431 -179.835 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 2' ' ' THR . . . -167.82 158.55 10.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -55.95 -39.35 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 110.382 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 22' ' ' VAL . 52.6 p30 -159.36 178.81 9.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.677 -0.639 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.99 -29.18 70.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.609 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.4 71.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.71 . . . . 0.0 109.878 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -41.97 86.12 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.65 -46.42 77.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.632 -0.668 . . . . 0.0 109.583 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.8 tt0 -58.85 -37.27 76.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -51.44 39.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.515 -0.741 . . . . 0.0 109.046 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.0 mt -58.76 -38.02 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.823 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.5 m-85 -74.7 -37.98 62.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 179.198 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 9.1 mmmt -75.67 -0.89 22.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 111.448 179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -109.91 -45.49 3.62 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.59 -39.25 64.71 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.865 176.328 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.36 -54.0 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.344 0.592 . . . . 0.0 109.969 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.8 -47.36 77.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.631 -0.668 . . . . 0.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -51.63 -26.33 8.75 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.527 -0.733 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.7 -26.16 12.86 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.887 -0.508 . . . . 0.0 110.318 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.82 29.35 3.6 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' A' ' 12' ' ' THR . 2.1 mp -100.5 57.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.759 1.266 . . . . 0.0 108.173 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.54 101.75 11.63 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.37 -178.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . -160.38 -127.27 0.88 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.7 tt0 -71.28 168.38 17.45 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.136 -1.214 . . . . 0.0 110.325 -179.786 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 33.9 m95 -158.84 129.03 5.86 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.684 -0.635 . . . . 0.0 109.518 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.1 p -145.46 133.3 21.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.407 -0.808 . . . . 0.0 109.428 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.5 t80 -98.46 144.13 28.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.759 179.597 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.69 98.15 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.07 -7.05 32.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.69 -0.631 . . . . 0.0 111.378 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.24 -27.55 17.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 179.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.0 p -122.21 4.99 9.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.56 -0.713 . . . . 0.0 110.062 179.131 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt 54.41 39.26 30.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 109.938 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -129.87 142.39 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.804 -179.468 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.7 m-85 -97.66 -171.6 2.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -158.51 102.36 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.189 . . . . 0.0 108.088 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 40' ' ' ILE . 3.3 p -106.24 108.97 26.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.083 0.944 . . . . 0.0 110.93 -178.711 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.577 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -92.88 98.5 11.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.304 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.324 -179.551 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 2' ' ' THR . 29.8 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.101 0.476 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.1 m -69.59 87.6 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.723 . . . . 0.0 110.143 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -74.79 140.23 43.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.53 -0.731 . . . . 0.0 110.216 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.936 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.9 OUTLIER -107.21 -179.28 3.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.627 -0.67 . . . . 0.0 110.109 179.9 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -158.24 114.68 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.441 -0.787 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.36 122.69 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.777 HG21 ' HG ' ' A' ' 13' ' ' LEU . 6.3 mm -89.64 111.45 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.516 -177.957 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.47 152.38 19.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.736 179.249 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.67 -142.63 15.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -134.81 21.96 3.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.581 -0.952 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.497 HG22 HD11 ' A' ' 40' ' ' ILE . 3.9 m -131.12 111.53 12.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.777 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 61.77 137.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.369 0.604 . . . . 0.0 110.158 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptpt -141.83 138.27 32.07 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.65 -176.29 33.24 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.13 -41.49 6.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.701 -0.882 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 mt 53.86 73.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.435 -0.791 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.936 HG22 ' CG ' ' A' ' 5' ' ' LYS . 78.8 p -71.14 130.57 41.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -140.95 135.53 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.498 -0.752 . . . . 0.0 110.625 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.18 156.35 37.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.706 -0.621 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 2' ' ' THR . . . -169.8 162.28 9.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.552 -0.718 . . . . 0.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.97 -38.54 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.637 -0.665 . . . . 0.0 110.258 179.78 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.4 m-20 -160.49 178.98 9.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.8 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.52 -35.91 82.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.487 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.22 -49.28 67.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.412 -0.805 . . . . 0.0 109.948 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -45.8 91.19 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.121 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.07 -44.07 67.2 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.439 -0.788 . . . . 0.0 109.808 179.008 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.1 tt0 -57.96 -35.53 71.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.673 -0.642 . . . . 0.0 109.349 179.032 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -70.15 -53.54 16.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.47 -35.73 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.7 m-85 -76.26 -34.19 59.14 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.92 1.89 22.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.718 -0.614 . . . . 0.0 111.286 179.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -103.05 -46.47 4.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 176.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 8.3 t80 -45.48 -53.66 8.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.3 175.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.766 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.04 -49.92 74.34 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.36 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.83 -47.37 85.99 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.628 -0.67 . . . . 0.0 110.265 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.16 -23.89 15.98 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.595 -0.691 . . . . 0.0 111.16 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -105.21 -34.43 7.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.633 -0.667 . . . . 0.0 110.451 -179.924 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 121.21 37.23 0.7 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.766 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -102.99 110.85 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 0.0 109.12 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -141.43 109.21 5.69 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.826 -179.679 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.6 -106.63 0.2 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 tt0 -110.59 173.37 6.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -1.001 . . . . 0.0 110.791 -179.695 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.2 m95 -153.75 129.96 10.44 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.648 -0.658 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -143.13 133.84 25.18 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.504 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.5 t80 -98.73 146.67 25.65 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.881 179.712 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -116.78 100.0 7.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.24 -5.54 28.31 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.657 -0.652 . . . . 0.0 111.513 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.51 -27.61 18.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 179.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -126.06 6.83 7.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt 54.47 38.8 30.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.2 m -126.29 144.78 50.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.2 m-85 -99.15 -169.75 1.81 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 0.0 109.854 179.729 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.69 93.91 1.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.832 -1.167 . . . . 0.0 108.013 179.593 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -95.73 116.13 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.972 0.892 . . . . 0.0 110.879 -178.634 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -99.25 168.39 10.06 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.146 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 4' ' ' PHE . 27.6 m . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 120.949 0.404 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -68.93 106.23 2.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 109.962 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.3 m-85 -88.89 145.25 25.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.529 -0.732 . . . . 0.0 110.409 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.834 ' HG2' HG22 ' A' ' 18' ' ' THR . 26.1 mttt -112.55 -167.3 1.17 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.4 tp -166.44 108.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.41 -0.806 . . . . 0.0 110.463 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.28 119.81 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.793 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.867 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.1 mm -94.23 113.23 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.596 -179.178 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -105.07 57.9 0.69 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.819 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.94 -148.7 6.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 pttp -114.74 -25.07 8.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.598 -0.942 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -80.76 -38.82 27.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.867 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.5 mt -123.1 168.68 12.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.472 -0.768 . . . . 0.0 110.479 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.42 80.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.009 179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.36 -170.39 38.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.03 107.92 10.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.67 -0.9 . . . . 0.0 110.201 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 17' ' ' ILE . 5.3 mp -93.27 109.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.541 -0.725 . . . . 0.0 109.717 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.834 HG22 ' HG2' ' A' ' 5' ' ' LYS . 82.2 p -85.12 124.4 31.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.56 -0.713 . . . . 0.0 110.595 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.476 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -143.37 134.23 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -77.47 160.69 28.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.597 -0.689 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.46 165.2 10.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.239 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.3 p -55.13 -38.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.397 -0.814 . . . . 0.0 110.35 -179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.9 m-20 -162.31 174.88 12.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.629 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.29 -30.86 71.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.06 79.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 109.87 179.383 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' CD ' HG12 ' A' ' 22' ' ' VAL . 6.0 tt0 -71.79 -45.07 62.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.057 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.35 -39.74 76.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.567 -0.708 . . . . 0.0 109.362 178.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.1 tt0 -60.48 -40.23 90.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.012 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -67.53 -49.12 64.83 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.806 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.82 -44.13 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.7 m-85 -70.3 -38.92 75.1 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 4.6 mmmt -74.57 0.6 14.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 111.319 179.179 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -106.06 -45.58 4.3 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.298 17.4 t80 -49.02 -30.05 5.66 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.468 176.037 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -83.74 -48.63 9.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.669 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -68.47 -44.8 74.04 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.606 -0.684 . . . . 0.0 111.419 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -47.46 -28.74 2.3 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.501 -0.75 . . . . 0.0 111.139 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.46 -46.55 4.96 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.499 0.666 . . . . 0.0 109.375 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.3 63.54 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -179.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.27 1.1 mm -118.72 137.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 O-C-N 121.721 -0.87 . . . . 0.0 110.118 -177.359 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 -172.66 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.067 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 126.53 -177.16 17.38 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.736 179.109 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.89 128.13 36.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.976 -0.72 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 43.4 m95 -97.68 125.01 42.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.56 -0.713 . . . . 0.0 110.407 179.667 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.9 p -138.23 134.75 34.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -98.15 148.16 23.85 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.452 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.68 101.09 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.39 -4.96 24.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.588 -0.695 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.35 -28.1 18.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.563 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -128.79 8.63 5.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.593 -0.692 . . . . 0.0 110.149 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 7.7 mmtm 54.02 40.8 31.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.119 -0.988 . . . . 0.0 110.255 -179.698 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 5' ' ' LYS . 36.8 m -125.73 143.51 51.02 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.122 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.3 m-85 -100.18 -174.15 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 30.5 m -160.69 122.37 3.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 0.0 109.201 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.4 p -117.24 93.97 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -84.7 90.55 7.74 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.975 0.893 . . . . 0.0 110.008 -178.443 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 . . . . . 0 N--CA 1.499 2.011 0 O-C-N 120.849 -1.157 . . . . 0.0 110.147 -179.522 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 4' ' ' PHE . 48.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.946 0.403 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -69.67 103.51 2.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.491 -0.756 . . . . 0.0 110.011 179.799 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.623 ' CE2' HG22 ' A' ' 2' ' ' THR . 65.7 m-85 -83.0 149.65 26.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.649 -0.657 . . . . 0.0 110.31 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 13.6 mttt -119.33 179.23 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 31' ' ' PHE . 38.9 tp -155.22 112.52 3.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.459 -0.776 . . . . 0.0 110.143 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 98.3 mt -82.9 115.99 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.126 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.733 HG21 ' CB ' ' A' ' 13' ' ' LEU . 3.6 mm -94.75 119.9 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.794 -179.171 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -117.54 73.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.749 179.55 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.27 -106.32 0.65 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -149.97 -41.1 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.559 -0.965 . . . . 0.0 110.676 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -71.51 -28.9 64.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.733 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.6 mt -128.24 170.83 12.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 110.232 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 75.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.182 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.99 -168.87 34.6 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -121.22 135.9 55.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.644 -0.915 . . . . 0.0 110.181 -179.906 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 19' ' ' ILE . 16.4 tt -93.96 -15.65 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.738 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 8.9 p 54.58 110.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.56 0.695 . . . . 0.0 111.065 179.88 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -137.44 138.1 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.653 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.78 156.23 21.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.642 -0.661 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.15 168.99 14.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.673 . . . . 0.0 110.339 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 10.4 p -55.27 -38.5 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.512 -0.743 . . . . 0.0 110.393 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-20 -161.68 175.08 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.48 -32.39 73.82 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.675 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.771 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.38 -39.63 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.06 -42.69 86.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.614 -0.679 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.4 tt0 -59.94 -34.04 72.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.36 -49.74 46.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.45 -35.43 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -77.72 -40.67 40.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.628 179.384 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.0 mmmt -72.33 -3.24 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.0 111.261 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 -44.58 4.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CE2' HD23 ' A' ' 6' ' ' LEU 0.291 4.5 t80 -49.42 -30.38 7.86 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.326 176.062 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -82.35 -55.17 4.67 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.718 0.77 . . . . 0.0 108.952 178.602 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.88 -45.8 92.18 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.624 . . . . 0.0 111.457 -178.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.29 -29.23 1.55 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.599 -0.688 . . . . 0.0 111.256 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -46.08 5.08 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.286 178.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.02 64.41 0.1 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.607 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.2 133.9 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.837 -0.802 . . . . 0.0 110.29 -177.068 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.2 -175.16 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 127.63 -173.53 18.69 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.56 -1.305 . . . . 0.0 111.744 179.186 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.8 126.38 36.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.02 -0.694 . . . . 0.0 110.164 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 37.7 m95 -95.84 126.77 41.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.712 . . . . 0.0 110.259 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.2 p -141.71 134.96 29.33 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.598 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.6 t80 -97.53 141.97 29.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.516 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.49 100.09 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.614 179.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.69 -4.03 21.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.593 -0.692 . . . . 0.0 111.483 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.67 -26.93 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.707 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.2 p -128.53 7.73 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.661 -0.65 . . . . 0.0 110.201 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 54.87 41.95 31.5 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.172 -0.955 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 5' ' ' LYS . 61.3 m -130.05 138.58 50.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.587 -0.695 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.4 m-85 -94.46 -173.18 2.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 0.0 109.17 179.245 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 38.1 m -161.38 122.39 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.772 -1.205 . . . . 0.0 109.184 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.5 p -118.99 89.94 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER -86.27 99.12 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.957 0.884 . . . . 0.0 110.428 -178.267 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 18.8 tt0 . . . . . 0 N--CA 1.501 2.123 0 O-C-N 120.91 -1.119 . . . . 0.0 110.291 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 43.2 m . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 120.975 0.417 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 m -62.55 87.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.459 -0.776 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -72.53 128.12 34.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.735 -0.603 . . . . 0.0 110.228 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.756 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -95.23 171.53 8.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 109.479 179.535 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.9 tp -150.47 106.6 3.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.66 122.6 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -95.89 124.17 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.966 -179.388 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 54' ' ' THR . 3.8 m-20 -79.96 -30.33 39.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.262 -0.898 . . . . 0.0 110.181 -179.688 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.3 149.27 50.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -58.86 -20.26 49.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.56 -0.965 . . . . 0.0 110.61 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.462 ' HB ' HD11 ' A' ' 40' ' ' ILE . 7.1 p -65.45 116.62 6.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 110.553 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 65.77 -53.62 0.37 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.334 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.6 mtmt 43.79 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.779 -1.201 . . . . 0.0 112.682 179.091 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.91 -166.41 38.11 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.664 179.201 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -126.87 153.18 46.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.898 -0.766 . . . . 0.0 109.798 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 17' ' ' ILE . 5.2 mp -120.56 -14.37 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.426 -0.796 . . . . 0.0 111.242 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.756 HG22 ' CG ' ' A' ' 5' ' ' LYS . 40.7 p 44.14 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.575 -0.703 . . . . 0.0 111.875 -179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -128.07 138.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.52 -0.737 . . . . 0.0 110.665 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -81.69 147.89 29.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.9 179.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' HG21 ' A' ' 2' ' ' THR . . . -159.98 165.65 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -55.04 -39.65 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.677 . . . . 0.0 110.601 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -162.32 174.77 12.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.717 -0.614 . . . . 0.0 109.563 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.51 -32.32 72.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.403 -0.811 . . . . 0.0 109.789 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.0 -41.37 78.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.65 -44.05 57.85 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.131 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.24 80.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.566 -0.709 . . . . 0.0 109.545 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.8 tt0 -58.69 -37.74 76.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.255 178.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -68.62 -52.28 33.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.674 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 mt -56.61 -40.18 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.07 -35.72 66.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.881 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 44' ' ' TRP . 23.7 mttm -76.47 0.34 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.654 -0.654 . . . . 0.0 111.464 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.81 -45.28 3.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 177.455 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 8.3 t80 -55.51 -42.22 74.18 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.882 176.353 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.803 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.28 -50.97 71.95 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.261 0.553 . . . . 0.0 110.185 179.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.38 -46.51 89.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -54.51 -23.3 15.78 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -106.17 -34.88 7.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.631 -0.668 . . . . 0.0 110.623 -179.911 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 123.63 37.76 0.57 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.803 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -107.67 107.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -1.047 . . . . 0.0 108.733 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -157.62 104.41 1.98 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.271 -179.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.72 -50.37 0.04 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.869 ' CB ' HG22 ' A' ' 56' ' ' THR . 10.1 tt0 -138.0 167.28 22.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -1.064 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.7 m95 -161.49 123.94 3.03 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.841 -0.537 . . . . 0.0 109.886 179.514 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 15.0 p -146.65 132.23 18.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.501 -0.75 . . . . 0.0 109.36 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.9 t80 -96.37 133.08 41.21 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.85 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 100.3 10.44 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -2.63 16.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.726 -0.609 . . . . 0.0 111.939 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.7 22.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.274 179.406 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -138.34 16.01 2.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.716 -0.615 . . . . 0.0 110.0 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.5 mptt 49.02 42.53 21.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 111.339 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -118.55 110.64 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.936 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.882 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.5 m-85 -70.86 -175.4 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 9' ' ' ASN . 0.5 OUTLIER -156.01 105.61 2.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.947 -1.096 . . . . 0.0 108.369 -179.759 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 8.0 p -120.76 144.5 29.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 43' ' ' GLU . 5.7 t -141.3 -165.63 2.01 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.815 179.767 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.294 -179.762 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 2' ' ' THR . 57.9 m . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.186 0.517 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 78.5 m -67.79 93.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.459 -0.775 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 11.8 m-85 -76.65 159.17 30.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.0 109.707 179.773 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.916 ' HG2' HG22 ' A' ' 18' ' ' THR . 37.7 mtmt -121.36 -172.99 2.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.5 tp -165.32 104.86 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.263 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.7 126.17 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.642 HG13 HD11 ' A' ' 13' ' ' LEU . 8.7 mm -99.14 115.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.525 -178.394 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.693 HD21 HG22 ' A' ' 54' ' ' THR . 2.1 m-20 -81.68 -159.04 0.25 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.33 -152.94 5.11 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.943 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -107.44 -18.28 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.771 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.497 ' CG2' HD13 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -58.02 94.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 179.743 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 58.17 171.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.263 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.828 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -162.69 106.9 1.12 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.46 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.93 -166.16 35.62 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.191 -179.823 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.86 -39.12 4.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.798 -0.825 . . . . 0.0 110.517 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.1 mm 54.09 76.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.327 -0.858 . . . . 0.0 110.303 -179.797 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.916 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.8 p -76.0 129.11 36.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.008 -179.787 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.445 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.17 144.18 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.904 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -83.07 149.66 26.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 109.964 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -163.81 153.14 14.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.684 . . . . 0.0 110.388 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -52.12 -39.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.399 -0.813 . . . . 0.0 110.458 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.2 m-20 -159.37 173.78 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.749 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.03 -30.58 70.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.822 . . . . 0.0 109.82 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.89 82.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.813 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.07 -44.79 60.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.594 -0.691 . . . . 0.0 109.689 178.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.1 tt0 -59.79 -38.08 80.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.647 -0.658 . . . . 0.0 109.229 179.088 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -67.99 -51.53 46.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 178.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.26 -37.41 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.879 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.6 m-85 -75.18 -35.78 61.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.786 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 mmmt -78.32 2.52 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.835 -0.541 . . . . 0.0 111.232 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -106.76 -46.44 3.96 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 177.332 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 23.7 t80 -52.42 -31.79 36.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.938 175.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.47 -64.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.676 0.75 . . . . 0.0 109.014 178.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -55.59 -40.08 71.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.925 -0.484 . . . . 0.0 110.767 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -49.32 -27.86 4.33 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.65 -0.656 . . . . 0.0 110.837 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -106.82 -50.72 3.06 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.436 0.636 . . . . 0.0 109.94 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.74 63.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -179.712 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.747 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -119.31 130.7 73.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.805 -0.82 . . . . 0.0 109.967 -177.272 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -171.19 100.26 0.21 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 110.724 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.96 -57.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.858 ' HB2' HG22 ' A' ' 56' ' ' THR . 79.1 mm-40 -140.92 168.42 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.947 . . . . 0.0 110.609 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.6 m95 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.1 p -133.75 130.68 38.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.856 -179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.0 t80 -93.65 129.6 39.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.084 -0.647 . . . . 0.0 109.555 179.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -97.95 97.51 9.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.731 -0.606 . . . . 0.0 109.472 179.185 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.55 -6.32 30.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.561 -0.712 . . . . 0.0 111.527 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.29 -27.26 17.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 179.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 p -124.15 6.82 8.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.557 -0.714 . . . . 0.0 110.142 179.268 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 6.9 mmmt 54.4 38.92 30.48 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 -179.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -130.44 134.17 46.9 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.663 . . . . 0.0 110.761 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 61.1 m-85 -87.88 -173.29 4.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.519 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.693 HG22 HD21 ' A' ' 9' ' ' ASN . 0.8 OUTLIER -155.74 103.78 2.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.923 -1.111 . . . . 0.0 108.692 179.881 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 6.4 p -117.02 146.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.327 -178.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' HB2' ' A' ' 43' ' ' GLU . 5.9 t -148.06 -171.61 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.999 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.231 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.627 HG22 ' CE2' ' A' ' 4' ' ' PHE . 59.9 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.15 0.5 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -73.74 109.82 7.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.465 -0.772 . . . . 0.0 110.017 179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.627 ' CE2' HG22 ' A' ' 2' ' ' THR . 60.2 m-85 -90.56 119.35 30.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 110.391 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -85.84 169.77 13.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.655 -0.653 . . . . 0.0 109.514 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.878 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.5 tp -148.25 111.06 4.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.986 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -90.72 119.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.508 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.771 HD11 HD23 ' A' ' 6' ' ' LEU . 2.0 mp -93.13 121.05 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.606 -179.144 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.9 162.19 13.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.359 -0.838 . . . . 0.0 110.552 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.07 -168.11 31.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.5 5.54 23.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.503 -0.998 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.538 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -60.07 -164.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.19 -0.944 . . . . 0.0 110.117 179.822 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.833 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 pp -52.78 -33.81 50.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.26 -0.9 . . . . 0.0 110.874 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.563 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.2 mmtt 52.33 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.398 -0.814 . . . . 0.0 111.536 178.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.55 -165.85 38.81 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.401 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' THR . 8.2 mt-10 -148.08 77.56 1.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.821 -0.811 . . . . 0.0 109.334 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 34' ' ' TYR . 41.6 pt -57.82 -26.24 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.46 -0.775 . . . . 0.0 111.118 -179.123 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 16' ' ' GLU . 2.9 p 60.31 128.55 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.5 0.666 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.17 156.88 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.416 -0.802 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.42 159.59 15.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.684 179.432 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.82 168.46 8.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.83 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 110.676 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.5 m-20 -158.11 177.21 11.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -64.3 -34.59 78.47 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.471 -179.817 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.42 -52.45 61.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.377 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -59.29 -42.71 91.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.635 -0.665 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.15 -42.49 69.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.526 -0.734 . . . . 0.0 109.773 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.1 tt0 -59.07 -45.84 89.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.556 -0.715 . . . . 0.0 109.335 179.248 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -50.72 71.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.288 -0.883 . . . . 0.0 109.641 178.654 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.4 -45.86 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.416 -0.803 . . . . 0.0 109.23 179.081 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.6 m-85 -69.01 -34.03 74.61 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 3.9 mmmt -73.72 -4.26 33.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.85 -0.531 . . . . 0.0 111.314 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -107.3 -45.45 4.1 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.719 ' CE1' HD13 ' A' ' 17' ' ' ILE 0.291 9.4 t80 -51.1 -31.69 20.04 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.821 175.948 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -64.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.837 0.827 . . . . 0.0 108.825 178.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -54.52 -40.42 68.59 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.085 0.469 . . . . 0.0 110.655 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -49.81 -27.15 4.63 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.72 -0.613 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -107.28 -48.75 3.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.382 0.61 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.29 62.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.833 HD11 HD23 ' A' ' 13' ' ' LEU 0.299 1.1 mm -119.54 136.54 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.821 -0.811 . . . . 0.0 109.495 -177.346 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -169.74 106.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.246 -0.908 . . . . 0.0 111.59 -179.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -108.14 0.21 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 179.054 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.5 tt0 -109.2 178.96 4.3 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.414 -1.05 . . . . 0.0 110.4 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.7 m95 -155.17 128.79 8.53 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.667 -0.646 . . . . 0.0 109.539 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.8 p -145.17 132.78 20.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.397 -0.814 . . . . 0.0 109.628 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 19.6 t80 -96.56 131.28 43.34 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -99.98 99.63 10.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.659 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -70.97 -2.83 16.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.692 -0.63 . . . . 0.0 111.87 -179.3 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.66 -28.36 20.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -136.19 14.97 3.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 4.3 mptt 48.8 43.05 20.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 111.578 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -121.01 114.4 21.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.854 -0.529 . . . . 0.0 109.87 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.878 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.2 m-85 -73.69 -172.96 1.36 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -0.816 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.17 97.55 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.19 . . . . 0.0 107.988 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG1' HG13 ' A' ' 8' ' ' ILE . 2.7 p -99.89 98.88 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.003 0.906 . . . . 0.0 111.012 -178.492 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -76.88 170.47 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.697 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' CG ' HG23 ' A' ' 12' ' ' THR . 5.5 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.087 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.606 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.041 0.448 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.8 m -72.98 98.01 2.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.733 . . . . 0.0 110.033 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 43.3 m-85 -76.11 122.66 24.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 110.328 -179.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -92.2 169.94 10.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 179.658 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.903 HD22 ' CD1' ' A' ' 31' ' ' PHE . 9.6 tp -150.14 105.21 3.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.953 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -90.66 123.31 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.1 mp -97.5 122.86 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.884 -1.127 . . . . 0.0 109.423 -178.928 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 54' ' ' THR . 2.3 m-20 -83.14 -157.97 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.22 -134.52 45.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -144.65 25.71 1.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.688 -0.889 . . . . 0.0 110.413 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.6 ' CG2' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -62.82 -71.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.511 -0.743 . . . . 0.0 109.642 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.804 HD23 HD11 ' A' ' 40' ' ' ILE . 4.6 pp -129.25 -28.69 2.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.631 -0.668 . . . . 0.0 110.688 179.601 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER 54.28 100.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.24 -0.912 . . . . 0.0 111.117 179.538 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.95 48.25 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 21.4 mt-10 -117.08 -37.83 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.901 -0.764 . . . . 0.0 109.95 179.815 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 19' ' ' ILE . 2.4 mp 65.52 -58.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.979 -0.451 . . . . 0.0 111.868 179.617 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 5' ' ' LYS . 4.1 p 57.5 107.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.474 -0.766 . . . . 0.0 110.401 -179.51 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 17' ' ' ILE . 2.3 pp -139.08 138.25 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.556 -0.715 . . . . 0.0 110.715 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -84.29 153.49 23.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.36 168.75 19.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.509 -0.744 . . . . 0.0 110.401 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.45 -39.67 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.589 -0.694 . . . . 0.0 110.771 -179.869 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -162.23 175.41 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.09 -29.33 70.72 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.859 -179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -41.33 78.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.869 179.574 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' OE2' HG12 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -74.65 -45.44 44.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.66 -49.15 71.31 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.433 -0.792 . . . . 0.0 109.766 179.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.0 tt0 -58.81 -35.59 73.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.605 -0.685 . . . . 0.0 109.26 179.083 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.77 -50.85 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.722 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mt -59.06 -36.86 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.903 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -75.28 -39.29 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.159 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 7.4 mtpm? -76.66 1.73 16.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.58 -0.7 . . . . 0.0 111.535 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -105.81 -45.03 4.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 177.143 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 16.0 t80 -54.02 -34.0 58.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.604 175.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.27 -62.93 1.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.536 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -57.57 -40.68 79.49 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.891 -0.505 . . . . 0.0 110.614 -179.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.88 -27.95 3.43 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.682 -0.636 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.05 -48.87 3.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.406 0.622 . . . . 0.0 109.759 179.113 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.94 63.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.804 HD11 HD23 ' A' ' 13' ' ' LEU 0.291 1.1 mm -119.24 133.8 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.731 -0.864 . . . . 0.0 109.851 -177.386 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -172.18 103.58 0.17 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.353 -0.842 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.19 -49.04 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.884 ' HB3' HG22 ' A' ' 56' ' ' THR . 12.8 tt0 -154.6 169.03 24.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -1.062 . . . . 0.0 110.798 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 48.5 m95 -161.24 115.22 2.0 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.14 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.4 p -137.81 132.02 32.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.514 -0.741 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.4 t80 -96.68 129.66 44.05 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.854 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -96.94 101.9 13.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.589 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.21 0.09 10.69 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.729 -0.607 . . . . 0.0 111.95 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.23 -26.54 18.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.388 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -140.81 16.85 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.897 179.513 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 49.32 45.63 23.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 111.456 179.591 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 m -120.3 111.64 18.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.087 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -73.71 -176.72 2.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 109.464 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.506 HG22 HD21 ' A' ' 9' ' ' ASN . 1.4 m -157.1 110.84 2.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.82 -1.175 . . . . 0.0 108.525 -179.784 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -122.35 139.98 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.135 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.884 HG22 ' HB3' ' A' ' 43' ' ' GLU . 9.3 t -136.37 -171.21 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.212 179.854 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 94.9 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.083 0.468 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.6 m 49.69 76.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.316 -0.865 . . . . 0.0 111.277 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.738 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -73.54 144.63 46.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.535 -0.728 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 18' ' ' THR . 7.2 mttp -109.22 -176.01 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 110.158 -179.8 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 31' ' ' PHE . 57.2 tp -155.81 118.99 4.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.493 -0.755 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 mt -87.88 108.69 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.043 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.901 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.5 mm -84.64 107.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.643 -179.407 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 25.5 m-20 -76.04 -28.31 57.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.558 -0.713 . . . . 0.0 110.131 179.572 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 166.38 4.72 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.305 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -31.11 27.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.909 . . . . 0.0 110.795 -179.701 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 p -56.51 -31.43 64.07 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.401 -0.812 . . . . 0.0 110.213 -179.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.901 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.0 mt -138.37 144.0 40.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.679 -0.638 . . . . 0.0 109.512 179.669 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -146.47 87.68 1.73 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.486 -0.759 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.26 -164.35 31.9 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.652 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.82 149.08 44.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.763 -0.845 . . . . 0.0 110.213 -179.965 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 48.7 mm -103.4 -15.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.716 . . . . 0.0 110.663 179.927 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' HG2' ' A' ' 5' ' ' LYS . 17.2 p 52.67 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.567 0.699 . . . . 0.0 111.018 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.457 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -135.81 134.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.39 -0.819 . . . . 0.0 110.733 -179.966 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.47 142.43 40.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.597 -0.689 . . . . 0.0 110.219 179.985 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.48 38.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.705 . . . . 0.0 110.306 179.856 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.38 -39.21 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.511 -0.743 . . . . 0.0 110.694 -179.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.1 m-20 -160.2 178.33 9.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.689 -0.632 . . . . 0.0 109.469 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.738 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.75 -30.05 71.19 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.797 179.937 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.665 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -65.74 -38.71 89.87 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.79 -44.12 94.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.06 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 16.0 tt0 -59.16 -36.1 74.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.599 . . . . 0.0 109.437 179.085 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -71.88 -49.63 36.34 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 109.109 178.865 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.53 -32.77 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.708 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' CD1' HD22 ' A' ' 6' ' ' LEU . 6.4 m-85 -80.91 -37.72 29.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.057 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -76.61 1.82 15.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 111.108 179.169 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.23 -44.16 4.2 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.423 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.296 2.6 t80 -52.12 -43.96 64.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.914 176.252 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.38 -59.28 5.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.316 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.57 -44.09 80.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.759 -0.588 . . . . 0.0 110.882 -179.509 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -48.31 -28.4 3.11 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.903 -179.786 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -102.36 -43.82 5.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.572 0.701 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.39 59.17 0.1 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 107.391 -2.283 . . . . 0.0 107.391 -179.463 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.791 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.293 1.1 mm -120.75 159.41 22.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.95 -0.735 . . . . 0.0 109.563 -177.043 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -176.65 -165.99 0.14 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 -126.5 7.43 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.187 178.373 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.902 ' HB3' HG22 ' A' ' 56' ' ' THR . 41.4 tt0 -96.59 109.22 21.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.72 . . . . 0.0 111.973 -177.834 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' THR . 26.0 m95 -97.47 118.03 33.05 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.446 0.641 . . . . 0.0 109.538 178.242 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -131.78 162.03 31.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.329 -179.387 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.8 t80 -123.71 137.37 54.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.46 100.13 9.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.213 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.03 -3.56 20.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.699 -0.626 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.93 -26.29 17.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.96 . . . . 0.0 109.742 179.705 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -129.45 8.28 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.62 -0.675 . . . . 0.0 110.132 179.384 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt 54.24 41.72 31.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 -179.671 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.6 m -126.49 137.78 53.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.688 -0.632 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.1 m-85 -96.89 -165.7 1.3 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.467 -0.77 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 6.9 m -154.83 162.86 40.96 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.996 -1.065 . . . . 0.0 108.839 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 40' ' ' ILE . 2.5 p -164.35 96.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.738 -0.601 . . . . 0.0 109.523 -179.452 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.902 HG22 ' HB3' ' A' ' 43' ' ' GLU . 3.8 t -110.83 91.87 3.83 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.296 1.046 . . . . 0.0 111.673 -178.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.504 2.274 0 O-C-N 120.887 -1.133 . . . . 0.0 110.794 -179.666 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.618 HG22 ' CE2' ' A' ' 4' ' ' PHE . 29.8 m . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.934 0.397 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -68.35 100.03 1.01 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 109.925 179.751 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.0 m-85 -80.19 150.7 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.841 ' HG2' HG22 ' A' ' 18' ' ' THR . 16.3 mtmm -116.4 174.69 5.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.76 HD23 HD11 ' A' ' 8' ' ' ILE . 10.4 tp -151.54 114.1 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.24 112.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.76 HD11 HD23 ' A' ' 6' ' ' LEU . 3.2 mp -96.59 114.94 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.469 -179.132 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.69 103.21 12.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.747 . . . . 0.0 109.74 179.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.77 -103.13 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.955 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -154.64 30.39 0.42 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.946 . . . . 0.0 110.334 -179.968 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.494 ' OG1' HD13 ' A' ' 40' ' ' ILE . 1.2 p -142.74 118.72 10.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.619 -0.676 . . . . 0.0 110.545 -179.813 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 67.31 -52.45 0.48 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.986 -0.446 . . . . 0.0 111.57 179.85 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.8 mttt 48.83 91.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.712 -1.243 . . . . 0.0 111.473 179.569 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.57 -165.75 29.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.88 154.68 42.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.747 . . . . 0.0 110.02 -179.856 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 19' ' ' ILE . 15.8 tt -118.78 -4.7 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.467 -0.77 . . . . 0.0 111.252 179.861 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.841 HG22 ' HG2' ' A' ' 5' ' ' LYS . 42.9 p 47.01 102.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.524 -0.735 . . . . 0.0 112.04 179.584 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -127.56 145.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.406 -0.809 . . . . 0.0 110.541 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.84 155.68 18.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.22 167.49 12.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.595 -0.69 . . . . 0.0 110.445 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.77 -39.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.521 -0.737 . . . . 0.0 110.736 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.474 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -161.47 174.91 12.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.88 -31.93 72.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 109.931 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.6 82.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.728 . . . . 0.0 109.831 179.675 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.78 -39.66 84.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.099 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.67 -42.19 87.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.632 -0.667 . . . . 0.0 109.447 179.049 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.7 tt0 -59.83 -36.86 77.69 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.96 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -70.77 -48.23 55.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.685 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 27' ' ' ALA . 46.5 mt -59.92 -38.74 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.713 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.1 m-85 -74.63 -39.39 62.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.126 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 31.0 mtpt -71.97 -3.36 22.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 111.084 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -107.88 -44.6 4.18 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.903 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 27.5 t80 -52.2 -37.7 55.7 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.355 176.327 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.63 -65.65 0.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -56.25 -42.39 77.28 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.721 -0.612 . . . . 0.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.68 -29.35 2.96 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -102.79 -44.96 5.14 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 178.703 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 12' ' ' THR . . . 132.83 63.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.955 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.81 135.36 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.774 -0.839 . . . . 0.0 110.22 -177.34 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -131.02 170.08 14.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 139.97 177.83 16.21 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.994 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -81.31 115.89 20.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.95 -0.735 . . . . 0.0 109.896 179.657 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.411 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 42.1 m95 -79.37 129.34 34.37 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.515 0.674 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 18.3 p -144.44 133.7 23.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.865 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -96.32 145.75 25.32 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.584 179.593 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.52 100.57 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.671 -0.643 . . . . 0.0 109.546 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.4 -5.04 25.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.0 111.588 -179.704 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.68 -27.72 19.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.738 179.619 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -130.03 8.05 5.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.0 110.08 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 54.58 42.13 31.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.3 m -127.03 132.57 50.69 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.419 -179.238 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.0 m-85 -90.12 -179.46 5.67 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.65 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 62.0 m -162.5 126.38 3.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.772 -1.205 . . . . 0.0 109.95 -179.444 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.34 92.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.806 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -84.56 102.94 13.27 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.707 0.765 . . . . 0.0 110.182 -178.54 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 27.0 tt0 . . . . . 0 N--CA 1.504 2.243 0 O-C-N 121.079 -1.013 . . . . 0.0 110.943 -178.96 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.942 0.401 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 m -109.16 120.85 43.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.73 . . . . 0.0 109.789 179.283 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 35.6 m-85 -114.24 125.46 53.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.568 -0.708 . . . . 0.0 110.256 179.98 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.806 ' HG3' HG22 ' A' ' 18' ' ' THR . 1.2 mtmt -91.69 172.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.529 -0.732 . . . . 0.0 109.391 179.632 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.911 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -153.99 112.77 3.66 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.233 -179.724 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.2 mt -91.52 115.65 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.941 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.71 116.81 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.269 -0.973 . . . . 0.0 109.449 -179.229 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.96 60.62 2.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.08 -144.73 4.94 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.36 27.23 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -179.812 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -140.07 27.32 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.491 -0.756 . . . . 0.0 110.183 179.836 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -173.73 -74.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 110.01 179.669 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt 51.61 54.07 11.65 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.325 -0.859 . . . . 0.0 110.667 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.95 169.05 28.1 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.782 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.99 64.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.812 . . . . 0.0 110.265 -179.857 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -61.16 143.54 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.806 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.0 p -99.4 150.65 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -0.754 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -116.19 168.58 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.111 0.958 . . . . 0.0 110.963 -179.181 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 19' ' ' ILE . 2.7 tp10 -132.16 79.37 1.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.758 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.66 176.68 5.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.678 -0.639 . . . . 0.0 110.5 -177.248 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 14.7 p -75.3 -40.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.278 -179.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 5.9 p30 -149.36 172.5 14.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.367 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.38 -31.27 71.16 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.859 -179.511 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.76 -54.26 46.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.483 -0.761 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' OE1' HG12 ' A' ' 22' ' ' VAL . 1.5 mt-10 -62.17 -45.57 92.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.0 -45.46 61.15 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.268 -0.895 . . . . 0.0 110.371 179.399 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.82 -34.63 74.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.401 179.348 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.43 -53.39 23.93 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.371 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 19' ' ' ILE . 19.4 mt -59.57 -32.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.916 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD12 ' A' ' 6' ' ' LEU . 3.9 m-85 -78.89 -38.67 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.463 0.649 . . . . 0.0 109.266 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.3 mmmt -72.93 -4.06 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.796 -0.565 . . . . 0.0 111.429 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -107.84 -44.69 4.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.329 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.476 ' OH ' HD21 ' A' ' 13' ' ' LEU 0.293 17.6 t80 -52.62 -34.04 49.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.2 176.43 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.58 -49.92 64.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.731 -0.606 . . . . 0.0 109.936 179.253 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -57.85 -46.2 85.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.639 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -55.61 -23.65 28.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.43 -0.794 . . . . 0.0 110.758 179.985 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.538 ' O ' HG21 ' A' ' 12' ' ' THR . 1.8 m-80 -102.98 -26.65 13.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.739 -0.601 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.99 29.9 3.37 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.79 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -96.97 106.71 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.622 -0.928 . . . . 0.0 108.855 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -143.96 102.73 3.93 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.409 -179.215 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.42 -105.81 0.2 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.154 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tt0 -105.95 179.73 4.18 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.41 -1.053 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.47 ' NE1' HG23 ' A' ' 55' ' ' VAL . 40.3 m95 -157.17 131.04 8.2 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.654 -0.653 . . . . 0.0 109.757 -179.952 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.2 p -146.13 132.29 19.4 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.581 -0.699 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 19.9 t80 -97.42 121.97 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.667 179.272 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.2 98.82 11.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.554 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.93 -3.05 17.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.573 -0.704 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.08 -28.54 21.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.416 179.369 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -136.53 14.62 3.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.697 -0.627 . . . . 0.0 110.024 179.275 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.6 mptp? 49.46 43.65 23.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.88 . . . . 0.0 111.283 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -119.99 103.41 9.28 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.274 179.774 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 75.6 m-85 -62.3 -177.04 0.12 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.695 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.9 101.68 1.8 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.764 -1.21 . . . . 0.0 107.756 -179.654 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.6 p -106.13 115.27 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.209 1.004 . . . . 0.0 111.607 -178.148 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -89.69 171.78 9.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.793 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.216 179.968 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 m -108.0 114.43 28.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.541 -0.725 . . . . 0.0 110.027 179.435 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.7 m-85 -113.0 117.91 33.35 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG2' HG22 ' A' ' 18' ' ' THR . 24.4 mtmt -87.36 171.94 10.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -0.812 . . . . 0.0 110.108 -179.655 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.899 HD22 ' CD1' ' A' ' 31' ' ' PHE . 29.8 tp -148.48 105.14 3.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.727 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.35 118.36 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mm -95.35 119.47 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.988 -178.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' THR . 16.6 t30 -113.71 92.03 3.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.333 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.55 176.86 45.95 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -60.41 -34.25 73.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.486 -1.008 . . . . 0.0 110.353 -179.873 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.505 HG23 ' HG3' ' A' ' 11' ' ' LYS . 23.9 p -91.09 133.45 35.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.657 -0.652 . . . . 0.0 109.871 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 8' ' ' ILE . 4.9 mt 58.48 162.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.504 -0.748 . . . . 0.0 110.274 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -175.69 94.29 0.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.327 -0.858 . . . . 0.0 110.659 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.54 176.04 14.33 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.586 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -82.06 150.25 27.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.676 -0.896 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.652 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 57.7 mt -117.51 -19.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.571 -0.706 . . . . 0.0 110.757 -179.919 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.494 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.2 p 61.83 129.59 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.722 -0.611 . . . . 0.0 110.251 -179.636 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.681 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -120.53 167.25 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.967 0.889 . . . . 0.0 111.14 -179.445 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.02 71.56 1.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.61 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.1 179.34 4.13 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.797 -0.564 . . . . 0.0 110.403 -177.619 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 13.5 p -80.01 -41.5 21.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.893 -179.386 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 19.0 m-20 -147.11 171.66 14.97 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.831 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.667 -179.338 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.36 72.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.52 -0.737 . . . . 0.0 109.942 179.42 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.43 -49.69 58.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.84 61.64 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.544 -0.723 . . . . 0.0 110.121 179.009 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -60.22 -41.29 92.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.303 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -67.44 -49.85 61.89 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.784 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 19' ' ' ILE . 47.7 mt -59.14 -39.97 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.59 -0.694 . . . . 0.0 109.204 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.899 ' CD1' HD22 ' A' ' 6' ' ' LEU . 5.6 m-85 -73.78 -38.58 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.336 0.588 . . . . 0.0 109.476 179.25 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 0.8 OUTLIER -72.77 -3.35 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.664 -0.647 . . . . 0.0 111.44 -179.99 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -110.41 -45.1 3.6 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 177.721 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.652 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.296 3.6 t80 -54.41 -44.49 72.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.85 176.28 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.479 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.48 -58.64 5.84 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.196 0.522 . . . . 0.0 109.921 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -54.76 -47.6 73.69 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.595 -0.69 . . . . 0.0 110.916 -179.719 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.32 -28.71 63.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.402 -0.811 . . . . 0.0 110.421 -179.896 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -94.6 -27.8 15.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.809 -0.557 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 111.33 27.81 4.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.728 HG22 HG21 ' A' ' 55' ' ' VAL . 1.7 mp -99.77 76.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -1.05 . . . . 0.0 109.075 -179.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -172.3 3.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.042 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 126.11 -171.13 17.91 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.432 -1.366 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.24 132.14 34.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.983 -0.716 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.448 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 49.7 m95 -100.57 133.56 44.84 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.573 0.701 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.55 133.59 21.44 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 t80 -98.19 142.2 30.16 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.674 179.688 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -113.2 101.25 9.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.764 -0.585 . . . . 0.0 109.739 179.576 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.87 -5.15 28.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 0.0 111.428 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.8 -28.66 21.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 109.503 179.499 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -129.13 7.64 5.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.676 . . . . 0.0 110.096 179.269 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp 54.42 41.04 32.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.179 -0.951 . . . . 0.0 110.092 -179.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 m -127.98 132.77 49.16 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.044 -179.333 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.7 m-85 -86.92 -173.78 4.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.332 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 2.0 m -157.86 117.76 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.835 -1.166 . . . . 0.0 108.987 -179.878 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.728 HG21 HG22 ' A' ' 40' ' ' ILE . 1.7 p -115.81 93.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.735 0.778 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -87.72 96.78 10.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.892 0.853 . . . . 0.0 110.046 -178.618 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 10.9 tt0 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.131 . . . . 0.0 110.223 -179.131 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 2' ' ' THR . 70.6 m . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.1 m -69.68 91.93 0.64 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.9 m-85 -80.98 139.69 35.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.517 -0.739 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.858 ' HG2' HG22 ' A' ' 18' ' ' THR . 78.6 mttt -103.92 -172.31 2.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.528 -0.733 . . . . 0.0 110.208 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.7 tp -164.05 98.77 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 0.0 109.94 179.912 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.435 HG13 HG21 ' A' ' 52' ' ' THR . 89.6 mt -80.52 134.11 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.421 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.807 HG21 ' HG ' ' A' ' 13' ' ' LEU . 5.9 mm -99.03 117.67 44.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.215 -178.925 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -94.07 6.0 49.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.677 -0.639 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.84 -165.89 36.33 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -103.11 27.56 7.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.611 -0.935 . . . . 0.0 109.966 179.614 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.668 ' C ' HD23 ' A' ' 13' ' ' LEU . 2.8 m -153.92 175.53 13.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 40' ' ' ILE . 0.6 OUTLIER 38.74 28.57 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.694 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.44 118.67 2.88 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.198 -0.939 . . . . 0.0 111.7 -179.209 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.95 -174.18 44.71 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 9.6 mt-10 -118.56 -32.78 4.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.832 -0.805 . . . . 0.0 110.546 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 pt 36.98 83.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.762 0 CA-C-O 121.558 0.694 . . . . 0.0 112.291 -179.625 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' HG2' ' A' ' 5' ' ' LYS . 72.9 p -70.54 140.8 51.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.51 -0.744 . . . . 0.0 110.553 -179.584 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.596 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -148.22 134.28 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 179.548 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.68 156.03 35.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 179.974 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.7 158.54 7.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.563 -0.71 . . . . 0.0 110.24 179.968 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.9 p -54.0 -39.99 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.544 -0.722 . . . . 0.0 110.555 179.926 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -160.5 177.48 10.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.458 -0.776 . . . . 0.0 109.705 179.561 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.79 -34.52 77.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 109.785 -179.985 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.611 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.04 -44.73 74.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.494 -0.754 . . . . 0.0 109.77 179.442 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -69.41 -44.48 71.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.826 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -55.8 -39.92 72.0 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.405 -0.809 . . . . 0.0 109.596 178.871 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.8 tt0 -61.37 -40.1 93.08 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.209 -0.597 . . . . 0.0 110.039 179.595 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.51 -34.44 63.03 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.491 179.478 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.4 mt -67.99 -38.76 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.915 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -75.21 -37.1 61.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.44 2.2 19.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 110.948 179.201 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.19 -44.8 4.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 177.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 8.6 t80 -51.54 -39.59 58.05 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.313 176.22 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.19 -48.72 32.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.583 0.706 . . . . 0.0 109.583 179.413 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -67.11 -46.38 74.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.774 -0.579 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -48.86 -27.76 3.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 111.03 -179.43 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -100.62 -47.76 4.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.417 0.627 . . . . 0.0 110.007 179.4 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.35 61.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -179.506 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.954 ' CD1' HD22 ' A' ' 13' ' ' LEU 0.294 1.1 mm -117.02 141.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.914 -0.756 . . . . 0.0 109.067 -177.298 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -166.66 125.28 1.43 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.735 -179.155 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.4 -102.2 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.525 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 9.6 tt0 -127.98 173.57 9.92 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.455 -1.026 . . . . 0.0 109.582 178.675 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.462 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.5 m95 -150.43 131.35 14.23 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.379 -0.826 . . . . 0.0 110.091 -179.798 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.4 p -143.96 131.5 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.6 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -94.87 134.14 37.84 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.211 179.308 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.14 98.77 8.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.627 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.05 -5.31 25.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.655 -0.653 . . . . 0.0 111.425 -179.903 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.59 -27.96 17.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.712 179.616 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.9 p -124.3 7.37 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.655 -0.653 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt 54.56 38.78 30.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.128 -0.982 . . . . 0.0 110.18 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -130.34 140.9 50.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.606 -0.684 . . . . 0.0 110.463 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.873 ' HB2' HD12 ' A' ' 6' ' ' LEU . 57.2 m-85 -92.74 -170.4 2.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 109.609 179.669 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.03 92.84 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.855 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 8' ' ' ILE . 2.4 p -92.98 105.71 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.87 0.843 . . . . 0.0 110.458 -178.91 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 43' ' ' GLU . 1.1 m -84.17 171.6 12.68 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.581 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.253 179.732 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.769 HG21 ' O ' ' A' ' 21' ' ' ALA . 61.7 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.835 0.35 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 22.6 m 52.39 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.28 -0.888 . . . . 0.0 110.875 -178.784 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -105.03 123.42 47.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.17 174.55 7.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.759 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.828 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -151.34 113.51 4.54 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.256 -179.997 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -80.98 119.81 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.969 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.855 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.9 mm -96.14 122.64 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.307 -178.738 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -108.84 52.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 109.956 179.458 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.09 -151.72 8.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.808 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 -23.6 9.37 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.598 -0.942 . . . . 0.0 110.722 -179.793 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -82.36 -30.4 30.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.563 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.855 ' HB2' HG21 ' A' ' 8' ' ' ILE . 8.5 mt -119.66 171.66 8.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.723 -0.61 . . . . 0.0 109.358 179.72 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.04 76.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.636 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.23 179.58 27.06 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.512 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.06 -154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.699 -0.883 . . . . 0.0 109.913 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 31' ' ' PHE . 7.0 tp -175.07 -32.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.501 -0.749 . . . . 0.0 110.25 179.913 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p 63.49 137.0 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.367 0.603 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -130.77 166.8 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 121.671 0.748 . . . . 0.0 111.057 -178.869 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.41 78.52 1.21 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.305 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.769 ' O ' HG21 ' A' ' 2' ' ' THR . . . -122.08 149.43 43.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.577 -0.702 . . . . 0.0 110.381 -177.533 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -58.55 -39.75 76.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.374 0.607 . . . . 0.0 110.75 -179.63 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' N ' HG13 ' A' ' 22' ' ' VAL . 49.1 p-10 -149.8 178.61 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.801 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.57 -29.99 70.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.606 -179.574 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.73 79.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.524 -0.735 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HG3' HG12 ' A' ' 22' ' ' VAL . 1.3 mm-40 -68.29 -47.87 66.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.639 -0.663 . . . . 0.0 109.394 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.26 -48.01 62.31 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.438 -0.789 . . . . 0.0 110.434 179.486 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.2 tt0 -58.6 -36.45 74.05 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.609 179.423 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -54.13 15.99 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.29 -35.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.527 -0.733 . . . . 0.0 109.184 178.753 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 6' ' ' LEU . 4.5 m-85 -74.65 -39.13 62.24 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.91 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -72.97 -2.79 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 111.442 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -109.28 -44.63 3.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 177.444 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 12.3 t80 -51.44 -33.77 32.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.746 175.954 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.95 -57.98 10.52 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.659 0.743 . . . . 0.0 109.118 178.573 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -58.55 -44.4 89.66 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -49.44 -27.19 3.92 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.593 -0.692 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -104.12 -50.07 3.45 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 0.0 110.135 179.402 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.88 62.64 0.05 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -179.653 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.307 1.1 mm -120.3 136.8 56.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.877 -0.778 . . . . 0.0 109.875 -177.042 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -170.07 101.97 0.29 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.325 -0.86 . . . . 0.0 111.237 -179.851 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.01 -104.38 0.18 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.445 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 8.6 tt0 -114.73 174.4 5.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.537 -0.978 . . . . 0.0 110.64 -179.923 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.447 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.1 m95 -152.87 128.67 10.19 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.709 -0.619 . . . . 0.0 109.615 179.854 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.43 132.06 23.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 109.309 179.587 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.5 t80 -96.97 128.25 43.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.53 179.589 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -96.22 98.66 10.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.656 -0.652 . . . . 0.0 109.407 179.207 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -70.59 -4.09 21.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.654 -0.654 . . . . 0.0 111.692 -179.598 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.22 -26.34 17.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.613 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -127.64 7.53 6.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.579 -0.701 . . . . 0.0 110.132 179.333 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 46.8 mmtt 54.53 40.43 31.83 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.21 -0.932 . . . . 0.0 110.134 -179.618 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -127.66 129.82 47.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.728 -0.608 . . . . 0.0 110.425 -179.638 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.5 m-85 -85.29 -171.17 3.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 109.497 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -155.83 95.28 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -98.8 107.5 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.982 0.896 . . . . 0.0 111.18 -178.357 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -88.4 163.72 15.86 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.796 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.305 -179.959 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 88.4 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.112 0.482 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.9 m -84.23 88.61 7.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.158 179.701 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.747 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 m-85 -76.9 137.72 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -102.48 -172.6 2.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.436 -179.533 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.0 tp -165.25 107.7 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.659 -0.65 . . . . 0.0 109.939 179.926 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -89.9 115.57 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.264 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 HD23 ' A' ' 6' ' ' LEU . 3.0 mp -97.67 120.55 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.483 -179.499 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -109.24 98.02 7.52 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.499 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.45 -135.02 1.97 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.937 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -32.94 4.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.968 . . . . 0.0 110.325 179.799 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 p -87.29 107.55 18.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 179.512 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.09 148.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.521 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.67 ' N ' HD12 ' A' ' 13' ' ' LEU . 15.2 ptmt -162.91 128.38 3.22 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.236 -0.915 . . . . 0.0 110.647 -179.724 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.07 -174.73 18.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.29 147.89 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.902 . . . . 0.0 110.836 -179.647 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.8 mm -113.12 -26.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.511 -0.743 . . . . 0.0 110.243 179.729 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 3.2 p 56.79 112.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.344 0.592 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.534 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -141.97 135.44 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.327 179.188 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.27 149.34 47.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.609 -0.682 . . . . 0.0 110.148 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.67 156.04 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.3 p -53.42 -40.53 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.557 -0.715 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -159.94 -179.81 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.706 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.92 -32.49 74.24 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.559 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.95 76.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.828 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -68.59 -45.46 71.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.891 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -42.05 76.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.042 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.5 tt0 -61.62 -41.34 97.33 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.447 179.083 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -69.32 -44.27 72.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.408 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 87.7 mt -63.21 -42.09 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.839 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -70.41 -40.5 73.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.199 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 34.1 mtpt -71.56 -4.06 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 110.963 179.299 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -98.3 -45.6 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.127 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 5.9 t80 -44.36 -54.15 6.11 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.79 175.572 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.78 -51.41 68.41 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.53 -47.3 79.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.641 -0.662 . . . . 0.0 111.364 -178.958 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -48.92 -30.82 6.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.476 -0.765 . . . . 0.0 110.985 -179.275 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -96.01 -46.08 6.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.564 0.697 . . . . 0.0 109.553 179.124 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 62.89 0.16 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -179.373 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.284 1.0 OUTLIER -118.67 139.67 45.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.863 -0.786 . . . . 0.0 110.489 -176.725 . . . . . . . . 4 4 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.98 -178.21 4.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.21 -178.74 17.36 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.716 179.2 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.98 123.1 31.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.982 -0.717 . . . . 0.0 110.328 179.888 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' THR . 37.8 m95 -88.62 128.1 35.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -141.04 132.9 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -96.62 143.44 27.59 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.532 179.714 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.77 99.15 7.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.681 -0.637 . . . . 0.0 109.405 179.233 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.74 -3.84 20.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.664 . . . . 0.0 111.593 -179.641 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.27 -27.05 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.736 179.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -130.17 8.9 5.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.632 -0.668 . . . . 0.0 110.128 179.372 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 53.82 44.22 29.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 0.0 110.154 -179.589 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.2 m -130.07 129.93 44.25 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.113 -179.411 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.794 ' HB2' HD12 ' A' ' 6' ' ' LEU . 69.9 m-85 -89.69 -176.65 5.05 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.934 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 34.5 m -162.39 124.58 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.793 -1.192 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 8' ' ' ILE . 1.2 p -118.13 93.27 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.059 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -82.93 96.44 8.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.026 0.917 . . . . 0.0 110.157 -178.237 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 O-C-N 120.978 -1.076 . . . . 0.0 110.448 -179.243 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.143 0.497 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 m -104.78 74.69 1.15 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.552 -0.718 . . . . 0.0 110.306 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.5 m -97.83 104.27 16.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.734 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.4 m-85 -90.58 152.21 20.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.843 ' HG2' HG22 ' A' ' 18' ' ' THR . 33.7 mttt -112.96 -171.85 1.94 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.669 -0.645 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.799 HD22 ' CD1' ' A' ' 31' ' ' PHE . 14.8 tp -164.25 107.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.771 . . . . 0.0 110.142 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.0 mt -83.68 124.89 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.7 mm -89.82 116.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.77 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -103.51 67.74 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 0.0 110.468 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.97 167.92 39.47 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -59.82 -33.84 72.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -1.012 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 p -80.44 133.73 35.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 58.32 163.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.468 -0.77 . . . . 0.0 110.284 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -177.24 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.55 -163.45 33.99 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -133.41 70.67 1.46 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.932 . . . . 0.0 110.377 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 17' ' ' ILE . 1.9 tp -62.31 114.53 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.461 -0.774 . . . . 0.0 109.712 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.843 HG22 ' HG2' ' A' ' 5' ' ' LYS . 75.6 p -83.61 138.47 33.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.651 -0.656 . . . . 0.0 110.499 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.465 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.48 149.98 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.573 -0.704 . . . . 0.0 110.369 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 148.68 23.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.18 159.64 23.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.553 -0.717 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -53.68 -38.83 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.511 -0.743 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.5 m-20 -159.96 175.83 12.57 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.55 -33.81 75.68 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.713 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.82 63.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.455 -0.778 . . . . 0.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.09 -40.47 96.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.35 -46.36 72.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.529 -0.732 . . . . 0.0 109.479 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -58.29 -36.26 73.04 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -69.11 -50.81 44.66 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.69 -37.76 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.799 ' CD1' HD22 ' A' ' 6' ' ' LEU . 12.0 m-85 -74.32 -37.34 63.61 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.6 mmmt -76.3 0.23 20.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.738 -0.601 . . . . 0.0 111.563 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -109.24 -45.25 3.77 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 10.7 t80 -53.07 -34.61 57.33 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.028 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -69.68 -48.14 60.75 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.193 0.52 . . . . 0.0 110.0 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.41 -46.7 85.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.526 -0.734 . . . . 0.0 110.342 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -54.58 -23.32 16.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.54 -0.725 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB3' HD13 ' A' ' 40' ' ' ILE . 1.7 m120 -105.51 -25.86 12.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.627 -0.67 . . . . 0.0 110.557 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.76 30.68 3.4 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.71 106.07 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.979 . . . . 0.0 108.788 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.73 111.68 6.75 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.427 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.27 -108.72 0.21 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -109.81 173.37 6.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.396 -1.061 . . . . 0.0 110.39 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.476 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.8 m95 -152.06 130.33 12.02 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.543 -0.723 . . . . 0.0 110.26 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 6.7 p -142.26 134.18 27.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.63 -0.669 . . . . 0.0 109.253 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.6 t80 -97.61 143.7 28.02 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.93 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -113.92 97.97 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.817 -0.552 . . . . 0.0 109.536 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -69.69 -6.84 34.41 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.661 -0.649 . . . . 0.0 111.478 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.15 -27.47 17.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.702 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -122.84 5.71 9.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.648 -0.658 . . . . 0.0 110.079 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp 54.19 36.63 25.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.7 m -127.97 143.2 51.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.629 -0.669 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HB2' HD12 ' A' ' 6' ' ' LEU . 64.2 m-85 -95.99 -168.04 1.69 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 109.698 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 92.16 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.18 108.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.902 0.858 . . . . 0.0 110.915 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -89.52 169.68 11.15 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.159 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.101 0.477 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m -118.28 34.8 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.559 -0.713 . . . . 0.0 110.294 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.1 m -61.16 95.17 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.575 -0.703 . . . . 0.0 110.179 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.7 m-85 -83.68 142.53 30.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.662 . . . . 0.0 109.895 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.811 ' HG2' HG22 ' A' ' 18' ' ' THR . 45.1 mtmt -103.34 -177.24 3.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.591 -0.693 . . . . 0.0 110.584 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.896 HD12 ' HB2' ' A' ' 53' ' ' PHE . 4.9 tp -163.26 110.17 1.17 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.653 -0.654 . . . . 0.0 109.967 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.6 mt -85.8 117.63 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.617 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.8 mm -85.72 116.9 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.031 -1.067 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -102.93 63.64 0.83 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.88 -132.68 3.26 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -131.32 -40.84 1.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.935 . . . . 0.0 110.465 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -69.89 -47.29 63.12 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.449 -0.782 . . . . 0.0 109.62 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.617 ' CB ' HG21 ' A' ' 8' ' ' ILE . 11.4 mt -110.81 156.89 20.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.811 -0.556 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -172.34 86.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.432 -0.793 . . . . 0.0 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.55 161.46 27.43 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.71 73.75 9.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.727 -0.867 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.646 HD13 ' CE2' ' A' ' 34' ' ' TYR . 7.2 mt -56.22 120.79 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' HG2' ' A' ' 5' ' ' LYS . 74.2 p -99.09 133.47 43.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -146.28 142.1 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.626 -0.671 . . . . 0.0 110.375 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.02 141.21 34.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.619 -0.676 . . . . 0.0 110.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.72 160.14 41.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 110.236 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 26' ' ' GLU . 8.6 p -56.9 -32.99 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.242 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 6.5 p30 -166.13 -176.51 3.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 0.0 109.429 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -68.82 -30.29 68.82 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.665 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.65 -46.19 87.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.576 -0.702 . . . . 0.0 109.706 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' CB ' HG12 ' A' ' 22' ' ' VAL . 8.2 tp10 -70.33 -39.8 74.52 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.79 85.14 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.528 -0.732 . . . . 0.0 109.533 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.3 tt0 -58.61 -35.97 73.29 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -71.27 -51.33 25.09 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.0 -36.2 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.9 m-85 -75.72 -36.28 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 12.9 mtpp -80.12 4.61 16.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.792 -0.567 . . . . 0.0 111.449 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -110.89 -45.49 3.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.646 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.291 12.2 t80 -55.48 -43.5 75.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.933 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.73 -47.26 85.21 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.35 -49.51 75.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.554 -0.716 . . . . 0.0 110.746 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.36 -23.52 38.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.7 m120 -100.8 -24.05 14.47 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.729 -0.607 . . . . 0.0 110.719 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.87 30.89 4.67 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.749 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.51 106.21 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.679 -0.894 . . . . 0.0 108.785 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.53 110.0 5.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.117 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.94 -106.32 0.2 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.2 tt0 -108.63 174.82 5.7 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.483 -1.01 . . . . 0.0 110.524 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.473 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.9 m95 -153.53 130.63 11.09 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.638 -0.664 . . . . 0.0 109.99 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.0 p -142.48 133.18 25.39 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -99.84 144.24 29.13 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.882 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -114.97 98.56 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.769 -0.582 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.16 -4.94 23.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.713 -0.617 . . . . 0.0 111.664 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.94 -27.13 18.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.677 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.1 p -127.9 7.38 6.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.658 -0.651 . . . . 0.0 110.175 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt 54.17 40.62 31.85 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -125.83 135.9 52.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.656 -0.652 . . . . 0.0 110.54 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.896 ' HB2' HD12 ' A' ' 6' ' ' LEU . 74.8 m-85 -94.36 -170.36 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.579 -0.701 . . . . 0.0 109.525 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -157.3 94.15 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.853 -1.154 . . . . 0.0 107.89 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 44' ' ' TRP . 3.0 p -96.66 107.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.02 0.914 . . . . 0.0 111.173 -178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -89.07 169.72 11.26 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.132 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptm . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 2' ' ' THR . 58.7 m -131.63 49.1 2.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.518 -0.739 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.654 HG22 ' HB ' ' A' ' 18' ' ' THR . 2.7 m -71.0 81.93 0.67 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 110.132 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -66.41 144.49 56.49 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.93 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.04 179.81 4.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.575 -0.703 . . . . 0.0 110.162 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.866 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.0 tp -157.36 112.15 2.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -89.57 122.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 HD13 ' CG1' ' A' ' 55' ' ' VAL . 3.2 mm -89.06 117.79 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.664 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -104.95 67.06 0.78 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.474 -0.767 . . . . 0.0 110.091 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.02 166.05 36.76 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 12' ' ' THR . 15.8 pttm -59.89 -28.76 67.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.443 -1.034 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 11' ' ' LYS . 19.2 p -92.45 129.59 38.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.622 -0.674 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 34' ' ' TYR . 8.6 mt 60.33 127.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.378 0.609 . . . . 0.0 110.586 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -148.75 93.6 2.15 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.15 -172.72 45.7 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -121.22 96.36 5.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.817 -0.813 . . . . 0.0 109.947 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.9 mp -86.72 115.51 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 109.95 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.93 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.7 p -89.44 126.9 35.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.704 -0.622 . . . . 0.0 110.282 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.87 135.28 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.615 -0.678 . . . . 0.0 110.491 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -73.87 153.1 40.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.592 -0.692 . . . . 0.0 110.134 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -167.66 160.22 12.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.1 p -53.14 -39.46 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.556 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -162.01 176.83 10.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.671 -0.643 . . . . 0.0 109.575 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.75 -33.35 74.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.48 -0.763 . . . . 0.0 109.746 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.2 -43.54 78.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 109.984 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 1.6 tp10 -70.4 -44.18 68.51 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.75 -46.29 74.29 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.484 -0.76 . . . . 0.0 109.686 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 2.7 tt0 -58.16 -37.65 75.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.747 -0.596 . . . . 0.0 109.412 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 -51.2 43.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -57.62 -40.39 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.2 m-85 -71.8 -34.85 69.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 9.5 mttm -77.15 0.17 22.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.647 -0.658 . . . . 0.0 111.5 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -108.06 -45.41 3.96 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.58 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.292 2.6 t80 -54.02 -35.89 62.42 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.139 176.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -71.0 -45.76 63.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.81 -0.556 . . . . 0.0 110.343 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.75 -50.23 73.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 111.018 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.82 -21.92 32.61 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.455 -0.778 . . . . 0.0 110.978 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' HD13 ' A' ' 40' ' ' ILE . 6.4 m120 -101.19 -23.71 14.39 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.686 -0.634 . . . . 0.0 110.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.3 31.09 4.78 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.746 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.49 105.34 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.595 -0.944 . . . . 0.0 108.92 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -144.29 112.22 6.27 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.074 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.46 -104.81 0.18 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.3 tt0 -112.19 173.78 6.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -1.022 . . . . 0.0 110.184 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CE2' HG23 ' A' ' 55' ' ' VAL . 38.9 m95 -151.97 128.62 10.8 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.535 -0.728 . . . . 0.0 109.815 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.11 132.51 28.46 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.227 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.2 t80 -98.62 147.54 24.72 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.592 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.46 99.94 7.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.724 -0.61 . . . . 0.0 109.626 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.8 -4.9 26.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.724 -0.61 . . . . 0.0 111.579 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.36 -26.74 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.1 p -129.11 7.54 5.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.6 -0.687 . . . . 0.0 110.17 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.2 mmtp 54.59 40.29 31.75 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.234 -0.916 . . . . 0.0 110.287 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 m -124.7 139.72 53.6 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.866 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.0 m-85 -97.29 -172.09 2.35 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.556 -0.715 . . . . 0.0 109.741 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.32 91.85 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.0 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.486 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.0 105.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 121.897 0.856 . . . . 0.0 110.895 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -88.03 171.75 10.05 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mtt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.136 0.494 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 78.2 m -112.17 69.3 0.69 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.55 -0.719 . . . . 0.0 110.373 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.8 m -93.34 103.67 15.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.553 -0.717 . . . . 0.0 110.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 28.4 m-85 -88.5 151.33 22.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.808 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.5 mptt -115.04 -168.35 1.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.671 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.0 tp -166.2 107.37 0.71 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.82 105.16 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.626 HD13 ' CG1' ' A' ' 55' ' ' VAL . 1.2 mm -75.95 106.06 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.523 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 56' ' ' THR . 43.7 t30 -82.04 4.16 24.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.505 -0.747 . . . . 0.0 111.192 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.82 -148.05 1.58 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -137.21 32.23 2.61 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.61 -0.936 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 p -147.23 17.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.574 -0.704 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.6 mt -170.81 36.61 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.63 97.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 110.994 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.57 177.59 43.63 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -44.33 4.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.702 -0.881 . . . . 0.0 110.181 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.0 mm 53.95 87.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.449 -0.782 . . . . 0.0 110.547 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.808 HG22 ' HG3' ' A' ' 5' ' ' LYS . 70.9 p -84.29 134.36 34.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.523 -0.736 . . . . 0.0 110.13 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.49 147.85 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.621 -0.674 . . . . 0.0 110.401 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.17 151.93 22.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.259 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.49 160.71 18.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.342 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.4 p -53.69 -40.17 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.511 -0.743 . . . . 0.0 110.541 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.0 m-20 -160.87 174.71 13.45 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.18 -27.45 67.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.373 -0.829 . . . . 0.0 109.953 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 -47.45 84.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.445 -0.785 . . . . 0.0 109.748 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE1' HG12 ' A' ' 22' ' ' VAL . 8.1 tt0 -69.88 -41.28 75.0 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.55 -46.76 80.52 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.579 -0.701 . . . . 0.0 109.57 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -57.26 -39.88 76.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.632 -0.667 . . . . 0.0 109.235 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -65.62 -53.1 46.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.508 -0.745 . . . . 0.0 109.379 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -56.29 -39.39 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.523 -0.736 . . . . 0.0 109.102 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -73.67 -36.62 65.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 4.0 mtmp? -79.48 3.32 18.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.701 -0.625 . . . . 0.0 111.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -45.21 3.73 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.495 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.289 9.4 t80 -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.974 176.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -62.53 -48.08 81.1 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.867 -0.521 . . . . 0.0 110.181 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.98 -48.52 78.22 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.539 -0.725 . . . . 0.0 110.622 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.37 -25.55 35.87 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.566 -0.709 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.4 m-20 -99.82 -25.56 14.32 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.709 -0.619 . . . . 0.0 110.667 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.17 30.42 4.18 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.752 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 105.82 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.686 -0.891 . . . . 0.0 108.862 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -148.64 102.84 3.34 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.728 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.06 -73.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 56' ' ' THR . 29.4 mt-10 -136.0 171.64 14.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.498 -1.001 . . . . 0.0 110.042 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.7 m95 -155.26 126.91 7.41 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.65 -0.656 . . . . 0.0 110.045 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.6 p -144.39 132.79 21.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.4 t80 -95.26 141.65 28.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.803 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -111.26 100.08 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.736 -0.603 . . . . 0.0 109.739 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.5 -2.79 18.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.686 -0.634 . . . . 0.0 111.657 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.01 -25.93 17.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 109.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.9 p -130.58 8.77 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.644 -0.66 . . . . 0.0 110.229 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 56.7 mmtt 54.3 41.65 31.88 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.175 -0.953 . . . . 0.0 110.27 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 5' ' ' LYS . 35.4 m -130.56 134.86 47.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.49 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' HB2' HD12 ' A' ' 6' ' ' LEU . 59.1 m-85 -89.28 -168.74 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.521 -0.737 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -155.92 105.3 2.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 108.172 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.626 ' CG1' HD13 ' A' ' 8' ' ' ILE . 5.9 p -115.82 129.86 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.299 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -126.09 -172.04 2.53 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 56' ' ' THR . 8.9 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.185 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.626 0.251 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 2' ' ' THR . 52.8 m -104.81 41.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.078 -1.014 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 m -63.54 85.8 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.713 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.751 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 5.3 m-85 -71.21 140.77 50.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.675 -0.641 . . . . 0.0 109.66 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.802 ' HG2' HG22 ' A' ' 18' ' ' THR . 9.5 mtmt -104.67 168.01 9.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.762 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.8 tp -141.9 105.57 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.8 mt -76.89 110.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HD23 ' A' ' 6' ' ' LEU . 6.8 mm -84.21 112.94 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.121 -1.032 . . . . 0.0 109.79 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -97.86 155.49 17.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.476 -0.765 . . . . 0.0 110.064 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.7 -138.97 15.32 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -129.07 28.9 5.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.523 -0.986 . . . . 0.0 110.424 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' LYS . 19.2 p -136.09 145.26 45.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.623 -0.673 . . . . 0.0 109.905 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 40' ' ' ILE . 6.2 mt 60.9 -76.69 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.733 -0.604 . . . . 0.0 111.16 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' THR . 24.6 mtpt 54.99 99.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.343 -0.848 . . . . 0.0 110.708 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.94 -174.22 31.75 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 18' ' ' THR . 7.6 mt-10 -136.03 86.3 2.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.895 . . . . 0.0 109.729 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -59.39 -25.88 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.552 -0.717 . . . . 0.0 110.789 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.802 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.6 p 60.69 125.91 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 121.43 0.634 . . . . 0.0 110.669 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -142.58 146.04 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.426 -0.796 . . . . 0.0 110.799 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -81.55 152.95 27.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.33 158.52 9.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.535 -0.728 . . . . 0.0 110.398 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 HG12 ' OE1' ' A' ' 26' ' ' GLU . 8.2 p -53.95 -38.92 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.3 m-20 -161.26 -177.92 6.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.751 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.77 -28.11 68.78 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.46 69.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' OE1' HG12 ' A' ' 22' ' ' VAL . 2.5 mt-10 -66.23 -41.68 89.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.677 -0.639 . . . . 0.0 109.377 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.23 73.42 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.529 -0.732 . . . . 0.0 109.856 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.453 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.5 tt0 -57.94 -38.17 75.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -70.15 -51.91 27.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.0 mt -58.04 -34.91 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.7 m-85 -77.66 -36.6 51.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -74.34 -2.0 23.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.698 -0.626 . . . . 0.0 111.402 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -108.56 -45.38 3.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.289 8.9 t80 -52.41 -35.44 51.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.936 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.761 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.11 -47.01 69.33 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.201 0.524 . . . . 0.0 109.987 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.7 -49.31 76.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.556 -0.715 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -54.97 -23.32 18.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.524 -0.735 . . . . 0.0 111.081 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' HD13 ' A' ' 40' ' ' ILE . 8.4 m-20 -102.34 -26.84 13.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.658 -0.651 . . . . 0.0 110.624 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 109.19 30.9 3.46 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.807 HG12 HD12 ' A' ' 13' ' ' LEU . 1.7 mp -96.85 107.07 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.647 -0.913 . . . . 0.0 108.928 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -145.12 109.47 4.9 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.162 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -107.2 0.2 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -107.18 176.64 5.1 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.454 -1.027 . . . . 0.0 110.45 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.458 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -154.37 130.35 10.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.598 -0.689 . . . . 0.0 109.79 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.2 p -143.88 132.25 22.08 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.337 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.57 147.61 24.11 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.851 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.44 98.68 6.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.715 -0.615 . . . . 0.0 109.746 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.97 -5.65 27.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.636 -0.665 . . . . 0.0 111.419 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.96 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.555 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -126.59 8.01 6.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.655 . . . . 0.0 110.069 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp 53.57 40.03 30.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.146 -0.971 . . . . 0.0 110.281 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 m -127.65 142.96 51.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.597 -0.689 . . . . 0.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HD12 ' A' ' 6' ' ' LEU . 72.0 m-85 -98.9 -170.14 1.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.626 -0.671 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.11 94.58 1.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -97.43 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.915 0.864 . . . . 0.0 111.173 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 166.25 20.06 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.257 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.045 0.45 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.1 m -136.61 -71.07 0.45 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.597 -0.689 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 18' ' ' THR . 43.6 m 49.86 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.313 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.718 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -87.36 142.49 27.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.638 -0.664 . . . . 0.0 109.654 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.781 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.1 mtmt -100.1 -176.45 3.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.492 -0.755 . . . . 0.0 109.767 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 53' ' ' PHE . 1.2 tp -164.43 112.65 1.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.443 -0.786 . . . . 0.0 110.342 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.45 118.12 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.882 HD11 HD23 ' A' ' 6' ' ' LEU . 2.4 mp -90.21 116.38 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.013 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -92.88 151.99 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.0 110.254 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.52 -155.41 16.27 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.11 31.48 6.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.924 . . . . 0.0 110.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -93.34 -147.58 0.25 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.674 -0.642 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.71 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.3 pp -53.91 -36.48 62.78 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 111.309 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.692 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.6 mtpt 50.9 99.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 111.538 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.12 -167.55 37.78 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.334 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -115.74 -64.84 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.814 -0.815 . . . . 0.0 110.055 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.729 HD12 ' OH ' ' A' ' 34' ' ' TYR . 83.1 mt 52.36 74.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.372 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 5' ' ' LYS . 68.3 p -59.27 150.19 26.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -143.32 134.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.519 -0.738 . . . . 0.0 110.89 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.99 138.37 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.618 -0.676 . . . . 0.0 110.216 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -155.94 154.65 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 110.242 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.44 -38.67 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -159.78 179.92 8.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.664 . . . . 0.0 109.429 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.718 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.29 -34.42 78.29 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.749 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.65 -42.95 75.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -70.91 -44.61 65.85 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.06 74.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.553 -0.717 . . . . 0.0 109.773 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -59.65 -39.16 83.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.626 -0.671 . . . . 0.0 109.275 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -68.37 -50.06 55.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.184 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.98 -37.49 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.44 -0.788 . . . . 0.0 109.161 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.77 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -75.97 -38.29 57.66 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.413 0.625 . . . . 0.0 109.321 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 6.9 mmtp -71.62 -5.09 31.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.777 -0.577 . . . . 0.0 111.479 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.97 -45.16 4.23 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.729 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.284 0.7 OUTLIER -51.22 -38.04 50.25 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.039 176.293 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.89 -47.95 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.252 0.549 . . . . 0.0 110.246 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -56.53 -51.28 69.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.521 -0.737 . . . . 0.0 110.919 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -57.11 -21.13 29.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.548 -0.72 . . . . 0.0 111.082 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' HD13 ' A' ' 40' ' ' ILE . 4.3 m120 -101.61 -25.57 13.83 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 106.81 28.7 4.94 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.751 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.54 105.85 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.653 -0.91 . . . . 0.0 108.581 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -143.24 108.94 5.12 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.53 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.22 -109.89 0.23 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -103.31 177.75 4.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.41 -1.053 . . . . 0.0 110.499 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.453 ' NE1' HG23 ' A' ' 55' ' ' VAL . 39.8 m95 -155.83 130.52 9.09 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.538 -0.726 . . . . 0.0 109.687 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -145.45 134.89 23.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.454 -0.779 . . . . 0.0 109.202 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.6 t80 -98.81 148.28 24.06 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.28 96.72 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -69.05 -6.68 29.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.699 -0.626 . . . . 0.0 111.403 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.78 20.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 109.605 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -124.76 7.5 8.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.758 -0.589 . . . . 0.0 110.121 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt 53.99 38.57 29.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.18 -0.95 . . . . 0.0 110.321 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.2 m -128.54 134.76 48.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.595 -0.691 . . . . 0.0 110.751 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.922 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.0 m-85 -90.9 -168.97 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.92 97.42 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.2 p -101.42 103.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.121 0.962 . . . . 0.0 111.253 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 57' ' ' GLU . 1.2 m -82.35 171.62 13.99 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 56' ' ' THR . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.033 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mtp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.006 0.431 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 2' ' ' THR . 80.6 m -93.76 54.54 2.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -84.13 104.29 14.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.76 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.3 m-85 -88.83 151.32 22.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.805 ' HG2' HG22 ' A' ' 18' ' ' THR . 42.4 mttt -113.19 -170.83 1.76 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.1 tp -163.69 99.97 0.9 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 110.233 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.78 115.35 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 13' ' ' LEU . 15.6 mm -82.64 103.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.745 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.8 t30 -71.24 167.06 20.23 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.496 -0.752 . . . . 0.0 110.238 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.2 -153.17 26.32 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.76 36.03 4.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.954 . . . . 0.0 109.917 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.677 HG21 HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -82.63 -151.07 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.635 -0.666 . . . . 0.0 110.097 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.677 HD11 HG13 ' A' ' 8' ' ' ILE . 2.5 pp -48.75 -26.95 2.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 111.027 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.66 103.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.637 -0.664 . . . . 0.0 111.576 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.41 153.36 8.18 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.437 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -108.77 54.73 0.65 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.834 -0.804 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.663 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.5 tt -50.99 128.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.303 -0.873 . . . . 0.0 110.779 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.805 HG22 ' HG2' ' A' ' 5' ' ' LYS . 47.5 p -99.13 141.05 32.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.332 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.7 pp -142.99 143.14 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.63 -0.669 . . . . 0.0 110.548 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -83.85 146.36 28.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.88 159.01 29.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.531 -0.731 . . . . 0.0 110.454 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.14 -39.32 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.754 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-20 -159.76 176.65 11.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.76 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.53 -29.96 70.94 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.738 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.75 80.58 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.819 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.99 -41.35 77.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.08 -44.25 82.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.634 -0.666 . . . . 0.0 109.529 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -59.33 -37.9 78.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.71 -0.619 . . . . 0.0 109.368 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -50.7 46.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.268 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.81 -36.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.739 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -77.06 -37.09 55.36 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 6.2 mmmt -77.68 1.69 19.11 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.662 -0.649 . . . . 0.0 111.351 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -108.8 -45.17 3.87 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE2' HD13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.08 -38.47 62.54 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.068 176.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.47 -49.36 71.7 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -57.5 -48.51 79.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.513 -0.742 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.24 -23.55 36.65 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.395 -0.816 . . . . 0.0 110.956 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' CB ' HD13 ' A' ' 40' ' ' ILE . 15.3 m-80 -101.34 -25.28 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.691 -0.631 . . . . 0.0 110.599 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.63 32.39 3.65 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.751 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.21 106.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.69 -0.888 . . . . 0.0 108.765 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -148.65 103.2 3.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.749 -0.594 . . . . 0.0 110.948 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.77 -58.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HB2' HG22 ' A' ' 56' ' ' THR . 2.5 tp10 -152.19 174.8 13.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.576 -0.955 . . . . 0.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 43.3 m95 -158.42 127.54 5.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.67 -0.644 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.6 p -145.03 132.43 20.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.627 -0.671 . . . . 0.0 109.521 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.4 t80 -96.2 146.64 24.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -117.95 98.43 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.774 -0.579 . . . . 0.0 109.533 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -70.18 -6.06 31.67 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 111.345 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.95 -27.07 18.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -124.77 5.81 8.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.603 -0.686 . . . . 0.0 110.05 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.9 mmtt 54.39 40.72 31.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -132.63 137.79 47.13 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.124 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 65.2 m-85 -92.36 -172.94 3.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.578 -0.701 . . . . 0.0 109.353 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.62 105.12 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 108.548 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 5.9 p -115.22 133.37 61.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.658 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -120.88 -174.35 2.8 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.774 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.144 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.085 0.469 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 2' ' ' THR . 28.8 m -106.4 42.93 1.2 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.265 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -66.94 85.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.474 -0.766 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.736 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -70.2 142.01 52.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.685 -0.634 . . . . 0.0 109.817 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.512 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -108.3 177.22 4.86 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.541 -0.724 . . . . 0.0 110.198 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.813 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.6 tp -152.53 109.71 3.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.37 108.44 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.757 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.3 mm -84.92 118.78 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.957 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -110.95 140.66 45.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.69 -149.66 21.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -121.58 14.64 11.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.005 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -113.57 -56.68 2.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.757 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.7 mt -115.01 167.55 10.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.795 -0.566 . . . . 0.0 109.501 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.46 92.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 110.701 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.28 173.99 24.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -100.71 156.76 17.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.799 -0.824 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.77 -16.65 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.601 -0.687 . . . . 0.0 110.53 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.512 HG22 ' CG ' ' A' ' 5' ' ' LYS . 48.7 p 46.32 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.579 -0.701 . . . . 0.0 111.842 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -132.26 132.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.476 -0.765 . . . . 0.0 110.372 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -75.14 150.45 38.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.644 -0.66 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.17 163.01 28.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.636 . . . . 0.0 110.4 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.4 p -55.55 -34.24 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.2 p30 -166.93 176.26 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.729 -0.607 . . . . 0.0 109.376 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.736 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.76 -29.88 71.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.347 -0.845 . . . . 0.0 109.761 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.89 87.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 109.822 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' CD ' HG12 ' A' ' 22' ' ' VAL . 17.9 tt0 -70.95 -42.71 69.44 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.29 84.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.617 -0.677 . . . . 0.0 109.558 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.5 tt0 -59.08 -34.18 71.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 109.487 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -71.09 -52.35 19.93 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.4 mt -57.91 -35.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.813 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.8 m-85 -75.55 -38.95 58.9 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 40.9 mtpt -79.84 5.25 14.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 111.49 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -110.04 -45.4 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.292 2.0 t80 -54.05 -43.72 70.44 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.177 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.0 -49.11 78.95 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.834 -0.541 . . . . 0.0 110.197 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -56.91 -48.39 78.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.727 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.56 -21.57 39.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.599 -0.688 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 40' ' ' ILE . 2.1 m120 -103.09 -27.87 12.31 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.599 -0.688 . . . . 0.0 110.596 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.25 29.63 3.65 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.763 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.76 110.49 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.918 . . . . 0.0 109.035 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.22 110.22 3.9 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.335 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.43 -97.69 0.13 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.5 tt0 -123.78 129.01 50.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.39 -1.065 . . . . 0.0 111.483 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' NE1' HG23 ' A' ' 55' ' ' VAL . 48.1 m95 -107.6 135.9 48.27 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.428 -0.795 . . . . 0.0 110.405 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -145.63 131.83 19.45 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -99.19 141.05 32.46 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.774 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -110.9 100.9 9.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.641 -0.662 . . . . 0.0 109.596 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.99 -4.26 23.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.664 -0.648 . . . . 0.0 111.637 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.77 19.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -131.9 8.47 4.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 110.13 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp 54.03 42.94 31.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.216 -0.928 . . . . 0.0 110.233 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -125.75 129.74 50.08 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.626 -0.671 . . . . 0.0 110.787 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.534 ' HB2' HD12 ' A' ' 6' ' ' LEU . 84.2 m-85 -87.46 -173.41 4.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.502 -0.749 . . . . 0.0 109.705 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.32 99.01 1.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -101.77 101.43 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.869 0.843 . . . . 0.0 111.105 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.62 171.96 14.36 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.135 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.108 0.48 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.485 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.8 m -85.07 -72.88 0.46 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.573 -0.704 . . . . 0.0 110.297 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.7 m 50.1 72.23 0.34 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.275 -0.891 . . . . 0.0 111.075 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.726 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.3 m-85 -67.86 139.61 56.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 -178.84 3.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.731 . . . . 0.0 110.459 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.794 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -159.52 109.39 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.664 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.07 124.89 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.802 HG21 ' CB ' ' A' ' 13' ' ' LEU . 1.7 mm -98.71 115.38 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.089 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -93.12 152.58 19.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.517 -0.74 . . . . 0.0 109.54 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.18 -151.84 18.31 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -116.85 -24.48 7.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.543 -0.975 . . . . 0.0 110.89 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -58.87 -60.52 3.72 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.348 -0.845 . . . . 0.0 110.374 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.802 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.7 mt -120.32 174.52 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.117 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -175.38 75.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.613 -0.679 . . . . 0.0 109.817 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -162.68 -176.33 34.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 38.8 mt-10 -108.61 -28.16 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.779 -0.836 . . . . 0.0 110.381 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 16' ' ' GLU . 3.7 mt 65.93 -60.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.538 0 O-C-N 121.879 -0.513 . . . . 0.0 111.568 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.439 ' C ' HG23 ' A' ' 19' ' ' ILE . 1.9 p 61.49 118.63 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.477 -0.764 . . . . 0.0 110.546 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -148.99 133.93 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.573 -0.704 . . . . 0.0 110.286 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.68 145.22 36.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.595 -0.691 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.03 165.69 34.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.745 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.78 -39.62 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.545 -0.722 . . . . 0.0 110.447 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 50.9 p30 -161.17 177.26 10.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.728 -0.608 . . . . 0.0 109.375 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.63 -29.5 70.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.397 -0.814 . . . . 0.0 109.731 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.72 -52.49 63.73 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.02 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -64.13 -42.77 96.7 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.19 -48.85 75.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 109.601 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 23.6 tt0 -58.73 -37.31 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.315 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -52.64 36.98 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.83 -40.53 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.794 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -72.1 -38.83 69.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 5.9 mmtp -73.88 -2.43 23.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.669 -0.644 . . . . 0.0 111.522 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -107.2 -44.94 4.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 1.4 t80 -52.44 -36.81 55.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.206 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -68.12 -50.98 51.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.758 -0.589 . . . . 0.0 110.23 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -56.25 -49.88 72.91 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.582 -0.699 . . . . 0.0 110.903 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -23.97 41.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.402 -0.811 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.489 HD22 HD11 ' A' ' 13' ' ' LEU . 3.8 m-20 -99.16 -26.89 14.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.776 -0.577 . . . . 0.0 110.395 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 30.0 4.0 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.746 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.39 107.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.584 -0.95 . . . . 0.0 109.007 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -151.78 100.62 2.69 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.647 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.93 -55.27 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 29.3 tt0 -145.47 169.56 18.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.479 -1.012 . . . . 0.0 110.535 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.6 m95 -159.95 125.62 4.13 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.849 -0.532 . . . . 0.0 109.687 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.81 131.68 19.11 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 109.371 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.4 t80 -96.63 151.19 19.85 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.702 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -124.73 99.45 6.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.676 -0.64 . . . . 0.0 109.592 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.77 -4.25 22.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.654 . . . . 0.0 111.523 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.94 -27.79 19.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -127.92 7.53 6.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.498 -0.751 . . . . 0.0 110.069 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp 54.82 42.13 31.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.9 m -130.22 141.79 50.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.597 -0.689 . . . . 0.0 110.91 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.5 m-85 -98.44 -173.97 2.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.523 -0.736 . . . . 0.0 109.104 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.45 102.29 2.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.863 -1.148 . . . . 0.0 108.688 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.486 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.6 p -117.19 146.24 21.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.165 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.451 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -138.12 177.9 7.53 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.231 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.17 0.51 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 2' ' ' THR . 46.3 m -110.28 28.08 8.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.739 . . . . 0.0 110.217 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -62.91 94.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.591 -0.693 . . . . 0.0 110.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.5 m-85 -78.05 149.25 33.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.067 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 52' ' ' THR . 12.1 ttpt -108.71 -174.45 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.525 -0.735 . . . . 0.0 110.389 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.849 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.7 tp -163.13 97.92 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.16 117.06 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' CB ' ' A' ' 13' ' ' LEU . 9.9 mm -85.03 110.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.861 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 41.4 t30 -85.41 7.28 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.72 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.88 -174.67 41.15 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -110.77 26.67 10.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.928 . . . . 0.0 110.379 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 p -125.94 24.51 6.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.617 -0.677 . . . . 0.0 110.284 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.609 HD12 HG12 ' A' ' 40' ' ' ILE . 1.5 mt -172.69 -67.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.76 . . . . 0.0 110.034 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.16 97.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.742 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.67 144.1 3.99 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -102.14 61.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.645 -0.914 . . . . 0.0 110.738 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -57.42 148.08 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.208 -0.932 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 3' ' ' THR . 7.3 p -115.72 136.07 53.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.888 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.07 145.78 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.556 -0.715 . . . . 0.0 110.314 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.49 155.83 24.37 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.609 -0.682 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.36 159.2 8.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.62 -39.26 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.464 -0.773 . . . . 0.0 110.563 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.7 m-20 -159.25 173.35 16.47 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.55 -35.78 76.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.405 -0.809 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.18 -46.76 72.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.467 -0.771 . . . . 0.0 109.925 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.763 ' OE1' HD11 ' A' ' 30' ' ' ILE . 1.6 tm-20 -66.67 -45.19 79.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.31 -39.48 69.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.419 -0.8 . . . . 0.0 109.819 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -62.12 -39.54 92.89 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.43 -34.48 65.46 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.353 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.763 HD11 ' OE1' ' A' ' 26' ' ' GLU . 98.0 mt -68.59 -39.66 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.849 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.31 -36.89 66.31 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 30.1 mttt -75.74 -2.44 29.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.732 -0.605 . . . . 0.0 111.301 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -104.13 -44.97 4.85 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.293 8.8 t80 -53.56 -42.14 67.23 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.731 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -64.72 -52.16 58.59 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.813 -0.555 . . . . 0.0 110.135 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.19 -49.14 74.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.725 . . . . 0.0 110.679 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.77 -23.48 18.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.58 -0.7 . . . . 0.0 111.005 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -102.31 -28.14 12.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.733 -0.604 . . . . 0.0 110.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 30.08 2.96 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.754 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.77 106.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.985 . . . . 0.0 109.002 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -150.17 105.82 3.41 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.27 0.557 . . . . 0.0 110.715 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.8 -57.82 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' CB ' HG22 ' A' ' 56' ' ' THR . 15.1 tt0 -148.55 171.97 15.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.564 -0.963 . . . . 0.0 110.224 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 45.9 m95 -157.22 128.56 6.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.69 -0.631 . . . . 0.0 109.859 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -145.8 131.96 19.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.615 -0.678 . . . . 0.0 109.409 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.1 t80 -97.49 127.17 43.24 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.59 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.65 98.88 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.651 -0.655 . . . . 0.0 109.316 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.88 -5.41 25.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.65 -0.656 . . . . 0.0 111.583 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.39 -29.46 21.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 109.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -128.4 8.06 5.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.636 -0.665 . . . . 0.0 110.171 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt 54.95 40.38 31.99 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.233 -0.917 . . . . 0.0 110.268 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.611 HG23 ' HB3' ' A' ' 5' ' ' LYS . 57.6 m -125.11 125.48 43.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.717 ' HB2' HD12 ' A' ' 6' ' ' LEU . 83.2 m-85 -80.26 -176.12 5.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.359 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.13 106.67 2.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.939 -1.1 . . . . 0.0 108.235 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 6.3 p -117.09 133.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.101 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.605 HG22 ' CB ' ' A' ' 43' ' ' GLU . 1.3 t -124.41 -170.04 2.08 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.908 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.195 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.064 0.459 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 95.3 m -125.49 -74.42 0.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 110.227 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.597 HG22 ' HB ' ' A' ' 18' ' ' THR . 22.1 m 50.24 79.77 0.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.258 -0.901 . . . . 0.0 111.252 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.9 m-85 -78.45 147.82 33.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.88 ' CG ' HG22 ' A' ' 18' ' ' THR . 7.2 mptt -112.45 -172.25 2.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.511 -0.743 . . . . 0.0 110.17 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.729 HD22 ' CD1' ' A' ' 31' ' ' PHE . 19.3 tp -163.08 105.68 1.02 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.444 -0.785 . . . . 0.0 110.204 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.55 114.86 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.801 HG13 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -89.95 113.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.722 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 54' ' ' THR . 2.3 m-20 -83.37 -161.68 0.54 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.229 -0.919 . . . . 0.0 109.285 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -163.1 13.65 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 pttt -114.58 28.18 8.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.607 -0.937 . . . . 0.0 110.406 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -66.25 -78.21 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.801 HD11 HG13 ' A' ' 8' ' ' ILE . 4.5 pp -132.21 -27.26 1.82 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.536 -0.728 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' N ' HD12 ' A' ' 13' ' ' LEU . 70.2 mttt 56.69 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.452 -0.78 . . . . 0.0 111.492 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.37 161.33 20.73 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -130.6 58.31 1.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.884 -0.774 . . . . 0.0 109.711 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.99 110.97 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.549 -0.72 . . . . 0.0 109.755 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.88 HG22 ' CG ' ' A' ' 5' ' ' LYS . 81.7 p -75.84 144.84 41.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -147.33 133.11 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.6 153.6 35.16 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.522 -0.736 . . . . 0.0 110.162 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.14 162.3 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.65 -0.656 . . . . 0.0 110.31 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -53.8 -39.1 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.692 . . . . 0.0 110.387 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' HG13 ' A' ' 22' ' ' VAL . 40.5 p30 -163.51 177.19 9.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 109.526 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.43 -29.66 70.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 110.005 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.05 -49.77 72.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 0.0 110.008 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.33 -43.36 81.8 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.12 -47.49 71.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.57 -0.706 . . . . 0.0 109.856 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.7 tt0 -58.29 -36.75 73.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.64 -0.663 . . . . 0.0 109.332 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.01 -52.24 25.73 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -57.53 -37.58 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.729 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.99 -36.69 62.0 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -77.86 2.28 17.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.665 -0.647 . . . . 0.0 111.371 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -105.7 -45.83 4.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 1.4 t80 -53.38 -46.7 69.73 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.928 176.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.85 -49.25 77.32 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.635 -0.665 . . . . 0.0 110.139 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -57.81 -50.59 72.78 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.647 -0.658 . . . . 0.0 110.661 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -56.46 -24.56 46.52 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.483 -0.761 . . . . 0.0 110.69 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -98.44 -26.55 14.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.694 -0.628 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.64 33.69 3.26 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.754 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -99.11 114.47 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -157.58 104.44 1.99 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.308 0.575 . . . . 0.0 110.945 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.53 -47.15 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.908 ' HB3' HG22 ' A' ' 56' ' ' THR . 45.0 tt0 -142.2 164.97 28.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.47 -1.017 . . . . 0.0 110.75 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.489 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 41.4 m95 -164.1 112.33 1.15 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 19.0 p -137.9 131.05 30.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.496 -0.753 . . . . 0.0 109.738 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.9 t80 -93.84 143.66 26.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.78 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -114.7 98.28 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.786 -0.571 . . . . 0.0 109.522 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -70.17 -4.76 23.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.584 -0.697 . . . . 0.0 111.598 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.81 -27.76 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -126.14 7.62 7.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.734 -0.604 . . . . 0.0 110.087 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp 53.85 41.53 32.02 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.185 -0.947 . . . . 0.0 110.192 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.698 HG23 ' HB2' ' A' ' 5' ' ' LYS . 7.3 m -132.31 137.23 47.37 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.68 -0.637 . . . . 0.0 110.762 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.2 m-85 -92.0 -172.74 3.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.745 . . . . 0.0 109.697 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.697 HG22 HD21 ' A' ' 9' ' ' ASN . 0.2 OUTLIER -155.41 103.57 2.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 108.478 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 ' CG1' HD13 ' A' ' 8' ' ' ILE . 7.7 p -118.63 152.95 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.198 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.908 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -156.16 -162.44 1.29 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.904 -0.497 . . . . 0.0 109.986 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.049 179.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.05 0.452 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 2' ' ' THR . 72.1 m -115.17 55.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.585 -0.697 . . . . 0.0 110.188 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.9 m -77.42 92.99 4.02 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.544 -0.722 . . . . 0.0 110.2 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 14.2 m-85 -76.74 144.77 39.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.688 -0.633 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.829 ' HG2' HG22 ' A' ' 18' ' ' THR . 35.7 mtmt -106.6 -179.2 3.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 0.0 110.041 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.865 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -158.09 110.11 2.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.574 -0.704 . . . . 0.0 109.823 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.43 124.81 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.431 HD11 ' HE2' ' A' ' 34' ' ' TYR . 7.0 mm -89.95 108.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.83 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -92.92 54.6 2.22 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.465 -0.772 . . . . 0.0 110.121 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.05 -131.65 2.92 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.43 50.59 0.89 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.945 . . . . 0.0 110.393 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 p -138.72 -59.91 0.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.571 -0.705 . . . . 0.0 110.12 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 21.8 mt -95.26 -54.58 3.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.367 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.96 82.62 0.07 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.432 -0.792 . . . . 0.0 110.599 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.88 -167.82 37.78 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.42 -50.88 2.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.644 -0.915 . . . . 0.0 110.545 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.4 mm 53.7 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.356 -0.84 . . . . 0.0 110.188 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.829 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.2 p -76.55 133.81 39.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.623 -0.673 . . . . 0.0 110.555 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.451 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -137.32 140.86 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.571 -0.705 . . . . 0.0 110.276 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.32 150.4 28.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.609 -0.682 . . . . 0.0 110.328 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.58 161.56 23.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.676 -0.64 . . . . 0.0 110.248 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.66 -39.61 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.557 -0.714 . . . . 0.0 110.57 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.0 m-20 -158.77 175.99 12.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.0 -33.27 75.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.21 -50.24 69.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.0 109.852 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -63.53 -43.11 98.09 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.67 -45.36 70.25 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.467 -0.77 . . . . 0.0 109.84 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.2 tt0 -58.71 -36.56 74.47 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.37 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -67.53 -52.97 32.6 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.21 -38.83 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.865 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.3 m-85 -74.31 -34.57 63.53 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 18.2 mmmt -74.92 -3.25 31.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.75 -0.594 . . . . 0.0 111.22 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -105.74 -45.65 4.34 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.88 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.29 6.7 t80 -50.84 -32.46 20.28 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.809 175.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.711 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.58 -63.93 0.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.74 0.781 . . . . 0.0 109.277 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -55.46 -41.68 73.24 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.111 0.481 . . . . 0.0 110.914 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.5 -27.2 4.04 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.706 . . . . 0.0 110.935 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.4 -56.21 2.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.371 0.605 . . . . 0.0 110.049 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.67 61.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.711 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -117.97 134.93 59.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.838 -0.801 . . . . 0.0 109.816 -177.536 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.31 106.42 0.57 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.36 -0.837 . . . . 0.0 111.195 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.08 -107.46 0.2 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -115.84 176.23 5.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.467 -1.019 . . . . 0.0 110.166 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.2 m95 -151.72 129.18 11.37 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.638 -0.664 . . . . 0.0 109.881 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.5 p -140.74 134.28 30.05 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.301 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.6 t80 -99.41 148.84 23.79 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -120.71 98.25 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 -6.32 30.83 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.646 -0.659 . . . . 0.0 111.478 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.84 -27.6 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 109.557 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 6.54 8.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.624 -0.672 . . . . 0.0 110.073 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.3 mmtp 54.07 38.25 28.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.194 -0.941 . . . . 0.0 110.123 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 5' ' ' LYS . 8.0 m -126.39 143.13 51.28 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.038 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.832 ' HB2' HD12 ' A' ' 6' ' ' LEU . 66.9 m-85 -99.54 -169.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.533 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -157.27 90.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.803 -1.186 . . . . 0.0 108.254 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.485 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -90.4 97.94 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.794 0.806 . . . . 0.0 110.688 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -78.25 170.89 15.89 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.327 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 4' ' ' PHE . 38.0 m -134.48 34.05 3.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.617 -0.677 . . . . 0.0 110.145 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.62 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.6 m -69.2 105.7 2.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 110.085 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.619 ' CE2' HG22 ' A' ' 2' ' ' THR . 43.9 m-85 -88.31 140.26 29.65 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.672 -0.643 . . . . 0.0 110.443 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.822 ' CG ' HG22 ' A' ' 18' ' ' THR . 5.9 mptt -104.98 -174.81 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.867 HD22 ' CD1' ' A' ' 31' ' ' PHE . 7.6 tp -161.21 110.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.86 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' GLY . 74.3 mt -97.64 133.41 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.512 HD13 ' CG1' ' A' ' 55' ' ' VAL . 21.7 mm -87.66 107.48 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.95 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.631 ' HB2' HG22 ' A' ' 54' ' ' THR . 8.3 t30 -75.61 66.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.762 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.62 -135.98 1.95 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -171.19 50.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.518 -0.989 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 13' ' ' LEU . 52.3 m -140.2 23.8 2.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.518 -0.739 . . . . 0.0 110.957 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 12' ' ' THR . 0.4 OUTLIER -177.61 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.48 -0.762 . . . . 0.0 111.066 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 55.68 110.19 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.331 -0.855 . . . . 0.0 110.752 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -145.43 135.93 6.23 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.405 -1.378 . . . . 0.0 110.255 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -162.67 28.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 122.08 -0.659 . . . . 0.0 109.67 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 pt -73.0 -171.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.822 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.1 p -138.61 129.12 26.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -135.56 136.09 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 110.82 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.18 160.17 20.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.613 -0.679 . . . . 0.0 110.043 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.41 171.25 7.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.103 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG12 ' OE1' ' A' ' 26' ' ' GLU . 7.7 p -53.77 -36.43 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.533 -0.729 . . . . 0.0 110.424 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -166.93 173.38 9.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.67 -0.644 . . . . 0.0 109.336 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -60.58 -31.39 70.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.48 -46.83 76.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.682 ' OE1' HG12 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -66.76 -45.69 77.76 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.423 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.03 -45.02 67.81 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.495 -0.753 . . . . 0.0 109.759 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.28 -38.09 76.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.656 -0.652 . . . . 0.0 109.383 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -68.61 -52.83 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.612 -0.68 . . . . 0.0 109.182 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.3 mt -55.66 -40.38 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.867 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -72.29 -32.64 66.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -80.4 4.41 18.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.761 -0.587 . . . . 0.0 111.102 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -104.56 -45.51 4.61 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.299 1.1 t80 -50.34 -40.66 49.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.15 -1.387 . . . . 0.0 108.827 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -44.68 86.15 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.039 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.25 -48.1 82.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.389 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.0 -23.61 20.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.57 -0.706 . . . . 0.0 110.866 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.66 -20.68 13.9 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.688 -0.632 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 100.56 36.55 4.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.776 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -99.03 119.44 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.91 . . . . 0.0 109.186 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -152.16 71.63 0.97 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.373 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -112.22 2.34 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -108.65 174.13 6.01 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.489 -1.006 . . . . 0.0 110.533 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.1 m95 -151.11 134.46 16.15 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.632 -0.667 . . . . 0.0 110.0 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.2 p -142.94 133.0 24.32 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.369 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.7 t80 -97.52 147.29 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.608 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -119.05 102.0 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.617 -0.677 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.4 -5.64 29.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.718 -0.614 . . . . 0.0 111.411 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.59 -28.76 20.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.9 p -127.2 7.17 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.703 . . . . 0.0 110.06 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 54.44 38.26 29.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.188 -0.945 . . . . 0.0 110.203 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 5' ' ' LYS . 18.6 m -124.49 149.69 46.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.791 ' HB2' HD12 ' A' ' 6' ' ' LEU . 68.0 m-85 -102.17 -169.33 1.66 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.515 -0.741 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -157.7 92.6 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.7 p -91.64 104.8 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 121.907 0.861 . . . . 0.0 110.649 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -78.13 156.55 29.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.137 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.065 0.46 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 59.6 m -104.26 40.57 1.44 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.642 -0.661 . . . . 0.0 110.077 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 18' ' ' THR . 16.2 m -72.04 103.04 3.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.568 -0.708 . . . . 0.0 110.18 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.691 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 25.9 m-85 -88.44 149.01 23.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.868 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -113.63 -173.84 2.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.616 -0.677 . . . . 0.0 110.099 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.787 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.9 tp -160.47 109.14 1.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.526 -0.734 . . . . 0.0 110.16 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.28 120.12 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 55' ' ' VAL . 6.2 mm -84.84 114.79 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.401 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -101.49 53.47 0.83 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.529 -0.732 . . . . 0.0 110.132 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.1 1.9 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -166.34 47.52 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.585 -0.95 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.7 m -140.54 -45.7 0.41 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.67 -0.644 . . . . 0.0 109.995 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 12.3 mt -106.88 -57.71 2.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? 52.84 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.481 -0.762 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.16 172.2 43.14 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -127.58 59.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.69 -0.888 . . . . 0.0 110.098 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tp -59.89 136.4 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.824 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.868 HG22 ' CG ' ' A' ' 5' ' ' LYS . 77.8 p -103.35 136.69 42.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.246 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.456 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.3 135.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -78.3 154.31 31.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.571 -0.706 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.37 164.15 17.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.388 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.82 -39.49 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.48 -0.762 . . . . 0.0 110.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 22' ' ' VAL . 3.8 m-20 -161.44 173.53 14.76 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.67 -29.09 69.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -0.867 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 -45.86 85.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 109.631 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.84 -42.24 77.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.75 -45.51 81.97 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.611 -0.68 . . . . 0.0 109.488 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.4 tt0 -58.63 -37.22 75.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.289 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -68.73 -51.56 40.12 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.93 -40.34 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.787 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -71.63 -36.96 70.91 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -77.78 1.9 18.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.62 -0.675 . . . . 0.0 111.43 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -106.5 -45.41 4.26 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.747 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.292 8.7 t80 -52.97 -31.74 42.35 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.743 175.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.26 -63.24 1.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.705 0.764 . . . . 0.0 109.234 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -55.31 -40.99 71.77 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.082 0.468 . . . . 0.0 110.72 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.82 -27.06 4.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.672 -0.642 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -107.15 -53.26 2.64 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.367 0.603 . . . . 0.0 110.192 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.83 62.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.305 1.0 OUTLIER -119.24 134.73 61.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.896 -0.767 . . . . 0.0 109.898 -177.352 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -169.68 100.03 0.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.324 -0.86 . . . . 0.0 111.242 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.57 -101.44 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 4.1 tt0 -125.23 134.65 52.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.463 -1.022 . . . . 0.0 110.941 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.468 ' NE1' HG23 ' A' ' 55' ' ' VAL . 43.7 m95 -112.98 132.52 55.32 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.9 p -144.43 132.53 21.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.0 t80 -97.92 137.77 36.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.731 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -107.75 98.72 8.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.69 -0.631 . . . . 0.0 109.524 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -69.07 -6.69 29.82 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.652 -0.655 . . . . 0.0 111.558 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.46 -29.25 19.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.74 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.9 p -124.62 6.81 8.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.627 -0.67 . . . . 0.0 110.121 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt 54.41 38.98 30.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.178 -0.952 . . . . 0.0 110.086 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 5' ' ' LYS . 6.5 m -126.84 138.39 53.33 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.582 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.593 ' HB2' HD12 ' A' ' 6' ' ' LEU . 70.9 m-85 -92.45 -171.53 2.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.475 -0.766 . . . . 0.0 109.574 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.92 98.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.7 p -99.31 90.38 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.697 0.761 . . . . 0.0 111.062 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.58 170.97 9.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.305 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mtt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.141 0.496 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 2' ' ' THR . 55.8 m -130.96 35.66 3.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.588 -0.695 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.666 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.3 m -63.27 95.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.444 -0.785 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 12.5 m-85 -79.7 140.53 36.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 110.23 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.858 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.7 OUTLIER -104.06 179.64 4.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.571 -0.706 . . . . 0.0 110.071 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.856 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.3 tp -154.11 108.22 3.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.446 -0.784 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.7 mt -84.31 120.96 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.5 mm -90.06 112.6 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.087 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -95.27 148.63 22.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -138.62 14.18 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -132.42 42.74 3.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.976 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 14' ' ' LYS . 1.5 m -150.02 147.22 27.57 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.603 -0.686 . . . . 0.0 109.702 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.637 HD12 HG12 ' A' ' 40' ' ' ILE . 6.3 mt 61.59 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.864 -0.522 . . . . 0.0 111.003 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' THR . 57.7 mttt 55.4 97.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.311 -0.868 . . . . 0.0 110.51 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.51 -176.42 44.74 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -109.54 -53.14 2.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.513 -0.992 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.9 mm 52.94 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.351 -0.843 . . . . 0.0 110.486 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' CG ' ' A' ' 5' ' ' LYS . 63.9 p -79.75 133.8 36.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 110.164 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.49 137.26 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.56 154.77 32.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.657 -0.652 . . . . 0.0 110.488 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.83 162.82 16.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.623 -0.673 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -54.99 -38.93 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.592 -0.693 . . . . 0.0 110.425 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -161.61 174.56 13.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -60.26 -28.86 68.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.445 -0.784 . . . . 0.0 109.827 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.65 72.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 109.83 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.3 -43.38 98.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.69 -46.78 80.99 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.645 -0.659 . . . . 0.0 109.553 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.1 tt0 -59.73 -33.74 72.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.704 -0.622 . . . . 0.0 109.48 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -75.98 -45.25 35.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 66.8 mt -62.7 -38.26 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.856 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -73.23 -37.99 66.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -73.64 -2.87 24.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 111.378 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -104.1 -45.33 4.75 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.611 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.292 4.4 t80 -50.41 -37.14 36.15 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.103 176.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.53 -47.17 76.84 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.276 0.56 . . . . 0.0 110.161 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -58.98 -47.17 86.12 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.584 -0.697 . . . . 0.0 110.546 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -59.47 -19.49 48.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.614 -0.679 . . . . 0.0 110.811 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -104.41 -27.68 11.8 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.559 -0.713 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.3 31.5 3.26 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.75 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.17 120.91 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.654 -0.909 . . . . 0.0 109.402 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -152.47 108.1 3.32 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.317 0.579 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.69 -110.5 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -109.33 177.04 4.87 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -1.012 . . . . 0.0 110.672 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' CE2' HG23 ' A' ' 55' ' ' VAL . 43.8 m95 -153.15 132.8 13.05 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.605 -0.684 . . . . 0.0 109.803 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.3 p -144.15 132.72 22.23 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.469 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.2 t80 -98.56 138.92 35.06 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.848 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -108.15 100.67 9.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.619 -0.675 . . . . 0.0 109.561 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.12 -5.36 26.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.586 -0.696 . . . . 0.0 111.549 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.28 -28.01 18.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.553 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -126.21 6.89 7.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.665 -0.647 . . . . 0.0 110.213 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 54.3 39.35 30.8 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.125 -0.984 . . . . 0.0 109.946 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.4 m -124.7 140.99 52.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.655 -0.653 . . . . 0.0 110.549 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.785 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -95.79 -171.53 2.37 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.516 -0.74 . . . . 0.0 109.538 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.28 93.27 1.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -94.16 106.73 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.917 0.865 . . . . 0.0 111.019 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -86.11 170.39 12.25 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.218 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttm . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.097 0.475 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.468 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.3 m -104.23 -75.31 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.528 -0.732 . . . . 0.0 110.301 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.6 m 50.17 78.01 0.11 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.14 -0.975 . . . . 0.0 111.111 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.743 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.5 m-85 -75.52 144.57 41.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.552 -0.718 . . . . 0.0 109.851 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -106.39 -174.4 2.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.615 -0.678 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.829 HD22 ' CD1' ' A' ' 31' ' ' PHE . 17.9 tp -160.77 102.79 1.33 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' CD1' HG21 ' A' ' 52' ' ' THR . 22.1 mt -84.47 133.32 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mm -101.85 119.33 49.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.986 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 54' ' ' THR . 32.4 m-20 -67.85 -52.15 40.08 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.35 -0.844 . . . . 0.0 110.255 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -156.08 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.07 15.39 4.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.907 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -60.02 -69.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.212 -0.93 . . . . 0.0 109.438 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' C ' HD12 ' A' ' 13' ' ' LEU . 1.5 pp -122.47 43.45 2.89 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 20.5 ptmt -33.74 137.25 0.1 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.13 30.44 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.598 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -140.82 47.57 1.74 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 17' ' ' ILE . 4.6 tp -51.4 115.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.807 HG22 ' HG2' ' A' ' 5' ' ' LYS . 60.4 p -83.76 144.91 29.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.636 -0.665 . . . . 0.0 110.009 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.512 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -143.19 134.74 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.56 137.8 39.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.7 -0.625 . . . . 0.0 110.14 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.39 37.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.63 -0.669 . . . . 0.0 110.228 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -53.77 -39.95 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.0 110.586 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.1 m-20 -159.62 179.47 8.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.622 . . . . 0.0 109.398 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.29 -29.15 70.24 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.679 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.0 70.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.19 -41.93 85.04 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.53 -48.32 72.09 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.541 -0.724 . . . . 0.0 109.881 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.3 tt0 -58.22 -37.32 74.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.566 -0.709 . . . . 0.0 109.368 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -69.04 -52.44 28.57 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -58.49 -36.58 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.4 m-85 -75.28 -38.93 60.15 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -76.14 0.4 19.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.0 111.657 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -105.96 -45.27 4.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CE1' HD22 ' A' ' 13' ' ' LEU 0.287 2.2 t80 -51.12 -38.8 54.02 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.933 176.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -65.62 -48.85 70.83 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -60.47 -48.17 82.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.617 -0.677 . . . . 0.0 110.517 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -55.69 -25.29 39.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.51 -0.743 . . . . 0.0 110.799 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -99.51 -27.68 13.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.722 -0.611 . . . . 0.0 110.287 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 107.36 45.27 1.17 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.788 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -107.87 126.59 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.668 -0.901 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -162.33 101.97 1.08 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.545 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.48 -57.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.805 ' HB2' HG22 ' A' ' 56' ' ' THR . 62.5 mt-10 -149.49 169.19 21.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.465 -1.02 . . . . 0.0 110.634 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.521 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 50.1 m95 -159.76 121.0 3.18 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.4 p -143.08 132.13 23.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.593 -0.692 . . . . 0.0 109.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.507 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.1 t80 -96.8 144.32 26.88 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.042 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.15 99.76 7.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.0 -5.32 25.63 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.651 -0.655 . . . . 0.0 111.499 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.54 -28.86 20.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.175 -0.953 . . . . 0.0 109.61 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.1 p -129.01 8.22 5.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.625 -0.672 . . . . 0.0 110.131 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 15.9 mmtm 53.78 41.57 32.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 5' ' ' LYS . 4.2 m -126.44 130.91 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.596 -0.69 . . . . 0.0 110.69 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 6' ' ' LEU . 69.6 m-85 -88.32 -173.61 4.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.503 -0.748 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.5 OUTLIER -154.14 102.57 2.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.99 -1.069 . . . . 0.0 108.664 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.521 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 5.9 p -115.91 141.81 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 111.19 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.9 t -141.08 -174.23 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.961 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.242 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 ' CE2' ' A' ' 4' ' ' PHE . 24.7 m -132.95 34.52 3.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.522 -0.736 . . . . 0.0 110.383 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.3 m -75.85 103.8 6.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.517 -0.739 . . . . 0.0 110.078 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 57.0 m-85 -86.99 140.46 29.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.615 -0.678 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.919 ' CG ' HG22 ' A' ' 18' ' ' THR . 1.1 mptt -107.23 -168.01 1.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.729 -0.607 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 53' ' ' PHE . 11.8 tp -163.56 100.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 110.158 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CD1' HG21 ' A' ' 52' ' ' THR . 16.4 mt -83.54 132.46 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 55' ' ' VAL . 7.1 mm -102.48 119.28 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.141 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.445 HD21 HG22 ' A' ' 54' ' ' THR . 21.5 m-20 -69.16 -26.68 64.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.449 -0.782 . . . . 0.0 110.307 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.19 37.49 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -102.56 -23.96 13.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.59 -0.947 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' HD11 ' A' ' 40' ' ' ILE . 70.1 p -59.04 124.7 20.82 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.354 -0.841 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 50.63 27.21 2.82 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 110.133 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 1.7 ptmm? -46.3 124.56 5.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.217 -0.927 . . . . 0.0 111.873 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.17 -165.92 30.91 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' CG ' ' HB3' ' A' ' 5' ' ' LYS . 29.0 tt0 -132.99 67.53 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.727 -0.867 . . . . 0.0 110.049 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.6 mt -60.25 138.48 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.422 -0.799 . . . . 0.0 109.849 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 5' ' ' LYS . 71.5 p -110.54 138.5 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.663 -0.648 . . . . 0.0 110.833 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -144.18 142.47 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.39 157.01 18.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.551 -0.718 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.57 167.15 11.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.534 -0.729 . . . . 0.0 110.55 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.41 -39.29 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 110.42 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.1 m-20 -162.31 174.62 12.57 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.67 -29.17 69.9 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.44 81.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.03 -42.97 72.25 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.12 -43.91 78.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.648 -0.657 . . . . 0.0 109.528 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.2 tt0 -58.12 -39.66 79.26 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -50.83 48.27 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.2 -39.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.631 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.2 m-85 -73.55 -37.5 65.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 11.8 mtpp -81.49 8.16 10.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.676 -0.64 . . . . 0.0 111.367 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -111.65 -46.86 3.21 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.442 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.301 9.2 t80 -52.99 -41.1 64.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.146 175.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.804 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -58.25 -49.15 78.12 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.783 -0.573 . . . . 0.0 109.753 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.65 -47.46 81.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.764 -0.585 . . . . 0.0 110.267 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -23.46 29.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.578 -0.701 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.88 -30.21 10.97 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.731 -0.606 . . . . 0.0 110.004 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 112.68 50.7 0.55 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.804 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.3 mp -115.34 132.63 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.453 -1.028 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -168.12 98.16 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.722 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.31 -56.3 0.01 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.8 ' HB2' HG22 ' A' ' 56' ' ' THR . 37.2 mt-10 -149.01 169.22 21.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.458 -1.025 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.556 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 49.6 m95 -160.39 121.99 3.12 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -145.42 131.61 19.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.507 -0.746 . . . . 0.0 109.564 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 28.5 t80 -93.24 144.25 25.48 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.748 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 100.08 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.752 -0.592 . . . . 0.0 109.775 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.24 -4.81 23.56 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.657 -0.652 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.84 -28.94 18.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.509 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -126.77 8.34 6.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.69 -0.631 . . . . 0.0 110.169 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.6 mmtt 53.91 38.6 29.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.146 -0.971 . . . . 0.0 110.318 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.43 HG21 ' CD1' ' A' ' 7' ' ' ILE . 45.5 m -127.53 143.63 51.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.67 -0.644 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' HD12 ' A' ' 6' ' ' LEU . 60.3 m-85 -96.37 -171.64 2.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.48 -0.763 . . . . 0.0 109.74 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.445 HG22 HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER -153.32 102.42 2.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.05 -1.031 . . . . 0.0 108.497 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.579 HG11 HD21 ' A' ' 6' ' ' LEU . 5.7 p -116.34 142.56 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.114 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.8 HG22 ' HB2' ' A' ' 43' ' ' GLU . 3.7 t -140.15 -177.28 4.93 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.283 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.121 0.486 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 78.6 m -134.22 143.06 47.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.555 -0.715 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.3 m -153.06 102.24 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.763 -0.586 . . . . 0.0 109.632 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 55.6 m-85 -93.38 154.03 18.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.681 -0.637 . . . . 0.0 110.291 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.879 ' HG2' HG22 ' A' ' 18' ' ' THR . 34.6 mttt -113.96 -171.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 16.7 tp -163.42 108.41 1.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.463 -0.773 . . . . 0.0 110.235 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -85.59 120.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 HD13 ' CG1' ' A' ' 55' ' ' VAL . 8.6 mm -86.97 109.43 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.784 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -96.65 50.77 1.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.504 -0.747 . . . . 0.0 110.22 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.59 -118.59 1.99 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.47 47.12 0.19 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.572 -0.957 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -136.45 -62.31 0.66 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.146 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 22.2 mt -91.88 -52.64 4.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.214 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.99 81.85 0.07 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.496 -0.753 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -173.55 46.33 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.51 66.82 1.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.618 -0.931 . . . . 0.0 110.2 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' HE1' ' A' ' 31' ' ' PHE . 3.3 tt -60.34 119.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 109.921 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.879 HG22 ' HG2' ' A' ' 5' ' ' LYS . 64.1 p -89.34 140.16 29.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 110.435 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -145.52 149.54 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.723 . . . . 0.0 110.421 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.7 155.19 19.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.666 -0.646 . . . . 0.0 110.415 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.05 162.47 13.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.577 -0.702 . . . . 0.0 110.208 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.92 -38.11 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.289 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -162.44 176.88 10.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.36 -29.55 70.55 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.852 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -52.35 65.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.819 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -63.66 -38.87 92.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.39 78.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.9 tt0 -58.62 -36.25 73.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.638 -0.664 . . . . 0.0 109.355 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -67.71 -52.58 35.99 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.52 -38.5 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.1 m-85 -74.04 -35.77 64.34 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.2 mmmt -75.98 -1.03 23.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.767 -0.583 . . . . 0.0 111.462 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -109.01 -45.43 3.78 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' CZ ' HD13 ' A' ' 13' ' ' LEU 0.294 12.7 t80 -51.33 -31.97 23.76 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.931 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.52 -62.34 1.65 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.874 0.845 . . . . 0.0 108.88 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -55.35 -41.55 72.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.822 -0.549 . . . . 0.0 110.797 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.39 -26.83 5.39 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.626 -0.672 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -106.5 -54.3 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.98 62.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.311 1.0 OUTLIER -119.09 134.96 61.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 0.0 109.84 -177.275 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -167.17 104.44 0.54 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.836 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.11 -107.91 0.21 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.6 tp10 -113.24 175.58 5.38 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -1.029 . . . . 0.0 110.398 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.464 ' CE2' HG23 ' A' ' 55' ' ' VAL . 37.9 m95 -152.55 129.04 10.68 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.654 -0.654 . . . . 0.0 109.825 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.79 133.65 25.49 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.371 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.3 t80 -97.4 135.15 39.69 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.658 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -103.18 98.96 8.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.356 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.6 -6.1 28.9 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.663 -0.648 . . . . 0.0 111.648 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.94 -27.47 17.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.7 p -123.53 5.97 8.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt 54.57 36.31 25.57 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.166 -0.959 . . . . 0.0 110.162 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 5' ' ' LYS . 17.1 m -126.35 140.54 52.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 62.6 m-85 -93.24 -169.0 2.04 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -156.37 94.63 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 2.8 p -95.87 100.12 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.908 0.861 . . . . 0.0 111.023 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -80.44 169.4 17.75 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.188 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 tmm? . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.988 0.423 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 2' ' ' THR . 59.9 m -98.26 45.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.548 -0.72 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.611 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.2 m -76.42 91.0 3.26 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 24.2 m-85 -76.98 143.94 39.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.688 -0.632 . . . . 0.0 110.073 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.724 ' HG3' HG22 ' A' ' 18' ' ' THR . 5.0 mptt -110.51 -171.22 1.79 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.628 -0.67 . . . . 0.0 109.88 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.773 HD22 ' CD1' ' A' ' 31' ' ' PHE . 37.3 tp -162.21 112.35 1.53 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -0.87 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.63 106.99 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 13' ' ' LEU . 1.6 mm -82.87 110.72 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.153 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -96.32 147.66 23.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.53 -0.731 . . . . 0.0 110.1 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.97 -144.07 14.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 12' ' ' THR . 22.3 pttm -120.02 -33.0 4.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.583 -0.951 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 2.6 m -75.15 110.83 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.442 -0.786 . . . . 0.0 110.038 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 59.36 159.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.18 0.514 . . . . 0.0 109.966 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.922 ' N ' HD12 ' A' ' 13' ' ' LEU . 7.5 ptmt -169.99 127.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.88 179.13 37.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.74 69.37 1.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.704 -0.88 . . . . 0.0 109.941 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.4 pt -61.68 177.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.563 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.724 HG22 ' HG3' ' A' ' 5' ' ' LYS . 67.0 p -139.48 133.1 30.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.529 -0.732 . . . . 0.0 110.509 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -141.97 131.17 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.539 -0.726 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.89 156.08 32.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.683 -0.636 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.11 163.79 13.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.649 -0.657 . . . . 0.0 110.207 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.6 -39.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.44 -0.787 . . . . 0.0 110.521 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -162.35 174.87 12.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.724 -0.61 . . . . 0.0 109.369 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.54 -27.71 66.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.466 -0.771 . . . . 0.0 110.024 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -53.3 59.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HG3' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.67 -42.81 98.0 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.28 -49.29 72.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.624 -0.672 . . . . 0.0 109.618 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -58.13 -36.24 72.65 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.523 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -69.73 -53.75 16.98 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.7 -36.35 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.773 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.1 m-85 -75.44 -35.76 60.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -80.69 4.56 18.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.705 -0.622 . . . . 0.0 111.401 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -109.95 -45.38 3.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 3.9 t80 -53.51 -43.25 68.16 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.092 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.82 -49.31 78.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.816 -0.553 . . . . 0.0 110.178 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -57.21 -47.83 80.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.548 -0.72 . . . . 0.0 110.68 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -56.81 -22.6 37.51 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.646 -0.659 . . . . 0.0 110.987 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -102.9 -26.72 13.01 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.566 -0.709 . . . . 0.0 110.504 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.48 29.37 3.68 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.757 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -96.08 104.92 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -142.53 106.33 4.69 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.251 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.3 -103.15 0.18 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -107.46 176.29 5.21 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.615 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.44 ' CE2' ' CG2' ' A' ' 55' ' ' VAL . 44.1 m95 -156.92 128.79 7.19 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.71 -0.619 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.36 132.56 21.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 t80 -95.84 142.24 28.33 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.696 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -112.69 99.56 8.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.69 -0.632 . . . . 0.0 109.775 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -70.64 -4.6 24.21 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.611 -0.681 . . . . 0.0 111.456 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.67 -27.87 18.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 109.579 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -127.92 7.71 6.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 110.179 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp 54.53 40.68 32.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.165 -0.96 . . . . 0.0 110.194 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.3 m -129.81 139.92 51.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.663 -0.648 . . . . 0.0 110.335 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 62.2 m-85 -93.42 -168.39 1.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.894 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.13 98.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.5 p -102.49 119.43 50.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 122.035 0.921 . . . . 0.0 111.015 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -100.24 169.84 8.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.33 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ptt? . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 2' ' ' THR . 87.3 m -133.43 59.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.588 -0.695 . . . . 0.0 110.388 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.3 m -77.26 90.1 3.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.0 m-85 -74.11 141.12 45.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.619 -0.675 . . . . 0.0 109.956 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' THR . 21.3 mtmt -104.64 -177.54 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.62 -0.675 . . . . 0.0 110.238 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -164.34 118.16 1.4 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 110.826 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.9 mt -89.77 118.14 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mm -86.47 108.23 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.692 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.39 144.11 26.12 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.548 -0.72 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.78 163.02 18.37 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -60.53 -26.65 67.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.647 -0.914 . . . . 0.0 110.379 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -76.16 125.62 29.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.595 -0.691 . . . . 0.0 110.074 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.795 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.0 mt 56.09 169.04 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.569 -0.707 . . . . 0.0 110.561 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -179.64 90.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.77 -166.86 34.49 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -105.14 -42.23 5.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.713 -0.875 . . . . 0.0 110.441 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt 53.65 85.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.343 -0.848 . . . . 0.0 110.376 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.2 p -84.1 126.23 32.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.601 -0.687 . . . . 0.0 110.338 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -134.91 143.92 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.493 -0.754 . . . . 0.0 110.668 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.86 152.32 25.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.65 7.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.612 -0.68 . . . . 0.0 110.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.32 -39.3 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.357 -0.839 . . . . 0.0 110.582 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -159.29 178.8 9.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.39 -27.31 69.22 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.806 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.25 -54.93 39.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.552 -0.718 . . . . 0.0 109.854 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.14 -42.92 99.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.726 -0.609 . . . . 0.0 109.371 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.11 -46.01 68.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.359 -0.838 . . . . 0.0 109.836 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.09 -38.21 82.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.665 . . . . 0.0 109.284 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -64.77 -56.51 13.11 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -54.94 -42.29 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 109.391 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.1 m-85 -70.52 -37.94 74.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 0.0 109.573 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 44' ' ' TRP . 11.1 mmtt -76.78 1.09 18.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.658 -0.651 . . . . 0.0 111.49 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -104.28 -46.54 4.38 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.307 8.1 t80 -46.1 -50.85 14.87 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.206 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.744 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.37 -54.16 47.27 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.64 -46.54 77.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.608 -0.682 . . . . 0.0 110.739 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.45 -16.92 51.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.631 -0.668 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' HB3' HD13 ' A' ' 40' ' ' ILE . 20.9 t-20 -108.43 -27.87 9.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.464 -0.773 . . . . 0.0 110.691 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 114.24 30.82 2.37 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.744 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -101.62 113.49 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.473 -1.016 . . . . 0.0 109.031 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.49 109.19 3.46 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.27 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.82 -95.59 0.11 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.2 tt0 -126.04 123.07 37.62 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -1.073 . . . . 0.0 111.55 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.55 ' NE1' HG23 ' A' ' 55' ' ' VAL . 37.3 m95 -103.5 137.1 42.04 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.583 -0.698 . . . . 0.0 110.403 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -147.38 131.87 17.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.634 -0.666 . . . . 0.0 109.245 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 33.8 t80 -95.75 143.43 27.0 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.773 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -113.92 101.52 9.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.647 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.36 -3.81 22.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.619 -0.676 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.36 -27.59 20.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.5 p -130.96 9.5 4.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.617 -0.677 . . . . 0.0 110.162 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 16.2 mmtt 53.6 41.89 32.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -127.8 140.05 52.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.637 -0.664 . . . . 0.0 110.294 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 67.2 m-85 -93.67 -170.82 2.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 109.708 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.86 99.48 1.54 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.9 p -102.61 109.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.999 0.904 . . . . 0.0 111.195 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.49 172.94 9.41 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.032 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.088 0.47 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 2' ' ' THR . 79.5 m -104.56 54.25 0.72 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.707 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.653 HG22 ' HB ' ' A' ' 18' ' ' THR . 6.3 m -72.8 89.39 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.48 -0.763 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -76.83 143.18 39.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.658 -0.651 . . . . 0.0 109.943 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.845 ' HG2' HG22 ' A' ' 18' ' ' THR . 32.0 mtmt -104.53 -176.41 3.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 31' ' ' PHE . 2.2 tp -166.8 108.92 0.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.522 -0.736 . . . . 0.0 109.992 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.0 mt -89.06 117.5 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.8 mp -87.32 119.6 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.253 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -96.61 149.58 21.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.11 -127.65 7.06 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.2 -41.23 0.9 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.549 -0.971 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.8 m -63.16 99.61 0.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 0.0 109.571 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.57 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.269 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.68 ' N ' HD12 ' A' ' 13' ' ' LEU . 3.5 ptpt -162.69 105.91 1.09 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -177.7 161.94 29.43 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.08 58.45 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.717 -0.872 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 11.2 pt -52.49 145.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.149 -0.969 . . . . 0.0 110.382 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.845 HG22 ' HG2' ' A' ' 5' ' ' LYS . 81.4 p -113.59 139.66 48.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.537 -0.727 . . . . 0.0 110.956 -178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.583 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -146.72 132.64 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.602 -0.686 . . . . 0.0 110.456 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -70.47 154.66 41.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.579 -0.701 . . . . 0.0 110.186 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.06 157.73 9.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.669 . . . . 0.0 110.354 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 26' ' ' GLU . 8.9 p -54.89 -34.21 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.549 -0.72 . . . . 0.0 110.502 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 22' ' ' VAL . 53.0 p30 -165.72 178.43 6.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.39 -29.74 70.8 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.569 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -47.24 84.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 109.811 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HG2' HD11 ' A' ' 30' ' ' ILE . 30.8 tt0 -68.1 -41.32 81.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -46.19 81.12 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.52 -0.738 . . . . 0.0 109.546 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.5 tt0 -58.69 -35.78 73.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.353 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.74 26.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 26' ' ' GLU . 34.3 mt -58.18 -34.77 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.882 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.6 m-85 -77.48 -36.22 52.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HG3' ' CH2' ' A' ' 44' ' ' TRP . 22.4 mttt -78.04 1.79 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.778 -0.576 . . . . 0.0 111.219 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -108.56 -45.4 3.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 177.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.294 10.9 t80 -53.76 -42.96 68.78 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.753 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.22 -47.34 86.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.183 0.516 . . . . 0.0 109.902 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.67 -48.8 78.51 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.634 -0.666 . . . . 0.0 110.549 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.06 -22.47 27.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.571 -0.705 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.414 ' CB ' HD13 ' A' ' 40' ' ' ILE . 25.5 m-80 -103.29 -25.42 13.33 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.639 -0.663 . . . . 0.0 110.671 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.05 30.62 4.13 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.9 107.23 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.68 -0.894 . . . . 0.0 109.004 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -146.08 100.52 3.4 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.23 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.68 -105.48 0.24 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tp10 -105.28 177.61 4.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.399 -1.059 . . . . 0.0 110.507 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 43.4 m95 -155.68 130.94 9.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.656 -0.653 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -144.85 132.2 20.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 109.264 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.7 t80 -98.49 138.1 36.19 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.93 99.82 9.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.652 -0.655 . . . . 0.0 109.551 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.31 -4.89 24.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.693 -0.629 . . . . 0.0 111.533 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.86 -28.4 19.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.654 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -128.76 8.5 5.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 110.234 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 31.6 mmtt 54.08 40.77 31.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.263 -0.898 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -125.17 133.67 52.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.553 -0.717 . . . . 0.0 110.628 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' HD12 ' A' ' 6' ' ' LEU . 75.1 m-85 -90.57 -172.39 3.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.425 -0.797 . . . . 0.0 109.613 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.12 98.29 1.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.6 p -102.02 109.46 26.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 122.122 0.963 . . . . 0.0 111.376 -178.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 169.17 12.45 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.156 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ttt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.077 0.465 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.524 HG22 ' CE2' ' A' ' 4' ' ' PHE . 62.9 m -139.34 58.46 1.63 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.531 -0.731 . . . . 0.0 110.25 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.619 HG22 ' HB ' ' A' ' 18' ' ' THR . 11.5 m -90.55 103.85 16.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.581 -0.699 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 59.8 m-85 -86.32 152.19 22.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.678 -0.639 . . . . 0.0 110.262 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.943 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -115.9 -164.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.653 -0.655 . . . . 0.0 109.502 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 31' ' ' PHE . 58.4 tp -168.12 108.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 110.336 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 105.55 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CG1' ' A' ' 55' ' ' VAL . 2.7 mm -77.52 99.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.087 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -85.05 63.39 8.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.982 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.7 -129.01 2.63 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 23.66 0.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.636 -0.92 . . . . 0.0 110.553 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 10.38 3.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.344 -0.847 . . . . 0.0 110.737 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.559 HD12 ' CD1' ' A' ' 40' ' ' ILE . 1.1 mt -172.32 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.324 -0.86 . . . . 0.0 110.415 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -52.6 103.82 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.229 -0.92 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.81 -177.83 48.15 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -137.0 64.8 1.52 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.636 -0.92 . . . . 0.0 110.173 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 HD12 ' OH ' ' A' ' 34' ' ' TYR . 95.1 mt -62.88 136.41 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.44 -0.787 . . . . 0.0 109.55 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.943 HG22 ' CG ' ' A' ' 5' ' ' LYS . 64.3 p -103.42 136.89 42.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.228 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -137.29 136.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.48 -0.762 . . . . 0.0 110.367 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.78 152.49 33.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.131 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -166.53 159.64 14.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.473 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.8 p -54.57 -40.11 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.576 -0.703 . . . . 0.0 110.568 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.4 173.08 17.2 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -62.43 -29.87 70.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -44.57 84.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.519 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 2.5 tp10 -69.97 -43.68 71.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -56.98 -41.12 77.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.667 . . . . 0.0 109.605 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.0 tt0 -60.27 -39.0 85.29 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.398 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -68.96 -48.84 62.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.58 -37.02 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.517 -0.739 . . . . 0.0 109.018 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.3 m-85 -76.89 -38.24 53.93 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.203 0.525 . . . . 0.0 109.652 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 24.5 mtpt -76.79 0.7 19.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.582 -0.699 . . . . 0.0 111.305 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -108.68 -44.72 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 17' ' ' ILE 0.283 6.6 t80 -53.0 -45.53 67.94 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.979 176.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -65.65 -57.53 7.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.775 -0.578 . . . . 0.0 109.871 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -58.32 -46.48 86.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.709 -0.619 . . . . 0.0 110.795 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -54.12 -23.93 15.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.5 -0.75 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.439 ' HB3' HD13 ' A' ' 40' ' ' ILE . 23.6 t-20 -105.64 -30.37 9.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 110.155 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 117.09 32.67 1.48 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.731 HG22 HG21 ' A' ' 55' ' ' VAL . 1.8 mp -102.41 74.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.401 -1.058 . . . . 0.0 108.617 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.95 -164.43 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . 114.41 -173.8 15.09 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.885 -1.15 . . . . 0.0 111.546 179.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.2 tt0 -73.57 -178.09 2.95 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.794 -0.827 . . . . 0.0 109.512 179.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.415 ' CE2' ' HG2' ' A' ' 32' ' ' LYS . 24.6 m95 -151.74 128.56 10.92 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.655 -0.653 . . . . 0.0 109.67 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.5 p -142.3 137.36 30.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.7 -0.625 . . . . 0.0 109.442 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.2 t80 -97.37 147.29 24.33 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.548 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -116.35 100.64 8.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.2 -4.65 26.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.613 -0.679 . . . . 0.0 111.33 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.22 -26.81 18.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -128.03 7.02 6.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.66 -0.65 . . . . 0.0 110.13 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 54.74 39.74 31.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.2 -0.937 . . . . 0.0 110.165 -179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 63.9 m -130.27 143.38 50.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 0.0 110.714 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 49.8 m-85 -96.75 -168.14 1.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -160.96 117.76 2.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.77 -1.206 . . . . 0.0 108.966 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 40' ' ' ILE . 1.4 p -110.62 110.77 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.135 0.969 . . . . 0.0 109.169 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.635 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -96.36 87.69 4.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.823 0.821 . . . . 0.0 110.125 -178.078 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.501 2.12 0 O-C-N 120.782 -1.199 . . . . 0.0 110.193 -179.636 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.161 0.505 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.586 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.3 m -115.56 41.34 2.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.567 -0.708 . . . . 0.0 110.235 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -76.8 103.47 6.77 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.564 -0.71 . . . . 0.0 110.245 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.8 m-85 -84.56 130.5 34.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.597 -0.689 . . . . 0.0 110.182 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CG ' HG22 ' A' ' 18' ' ' THR . 6.6 mptt -98.83 172.66 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 109.603 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.837 HD22 ' CD1' ' A' ' 31' ' ' PHE . 34.7 tp -143.76 106.06 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.428 -0.795 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.3 mt -81.64 115.04 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.62 HG13 HD11 ' A' ' 13' ' ' LEU . 2.1 mm -87.62 113.66 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.461 -178.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -101.21 75.94 1.68 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.453 -0.779 . . . . 0.0 110.544 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.33 -152.02 6.91 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -110.39 -27.25 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.573 -0.957 . . . . 0.0 110.262 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 7.8 p -79.73 102.24 8.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 109.824 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.8 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.168 0.508 . . . . 0.0 109.635 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 3.0 mtpm? -142.55 137.24 30.0 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.258 -0.901 . . . . 0.0 111.057 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.06 -165.41 22.45 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.26 158.19 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.87 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.8 mp -116.57 -16.28 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' CG ' ' A' ' 5' ' ' LYS . 60.2 p 45.53 96.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.557 -0.714 . . . . 0.0 111.655 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.453 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -130.14 132.99 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -77.53 157.46 30.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.531 -0.731 . . . . 0.0 109.937 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.8 168.84 12.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.553 -0.717 . . . . 0.0 110.289 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.37 -35.51 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 0.0 110.487 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 22' ' ' VAL . 32.1 p30 -166.5 172.81 10.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.294 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.74 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.98 -31.18 71.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.317 -0.864 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.0 81.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.715 . . . . 0.0 109.745 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -69.16 -43.17 74.82 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.95 77.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.45 -0.782 . . . . 0.0 109.717 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.5 tt0 -59.16 -36.82 75.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.581 -0.699 . . . . 0.0 109.334 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -69.53 -51.4 36.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.7 -39.42 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.837 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.5 m-85 -72.95 -37.47 67.11 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.52 1.95 17.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.694 -0.629 . . . . 0.0 111.377 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -109.19 -45.54 3.73 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.29 4.4 t80 -53.21 -40.31 64.37 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.151 176.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -61.08 -55.13 36.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.846 -0.534 . . . . 0.0 110.191 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -58.89 -48.79 80.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.709 -0.619 . . . . 0.0 110.662 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.14 -22.8 18.33 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -0.784 . . . . 0.0 111.06 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -103.1 -35.19 8.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.553 -0.717 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 122.33 36.32 0.7 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.788 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -103.72 119.77 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -1.066 . . . . 0.0 109.06 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -149.1 108.48 3.96 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.264 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.01 -109.64 0.22 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.9 tt0 -111.06 176.58 4.97 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.489 -1.006 . . . . 0.0 110.526 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.9 m95 -154.29 130.54 10.41 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.61 -0.682 . . . . 0.0 109.838 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.8 p -144.28 132.58 21.9 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.485 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.2 t80 -97.57 132.79 42.91 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.75 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -102.07 99.31 9.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.685 -0.635 . . . . 0.0 109.361 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.21 -7.15 33.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.0 111.309 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.02 -28.9 18.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -122.02 5.6 9.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.676 -0.64 . . . . 0.0 110.183 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 54.76 35.96 25.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 5' ' ' LYS . 38.4 m -126.61 143.76 51.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.614 -0.679 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.9 m-85 -94.93 -170.35 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.419 -0.8 . . . . 0.0 110.036 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -155.72 92.66 1.4 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.611 ' CG1' HD13 ' A' ' 8' ' ' ILE . 2.9 p -95.89 104.82 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.888 0.852 . . . . 0.0 111.053 -178.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -85.14 169.73 13.6 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 178.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.202 -179.92 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.21 0.529 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 99.8 m -103.13 -82.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.564 -0.71 . . . . 0.0 110.318 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 m 50.24 90.64 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.112 -0.992 . . . . 0.0 111.082 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 16.2 m-85 -89.14 139.17 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.089 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.857 ' HG2' HG22 ' A' ' 18' ' ' THR . 23.2 mttt -99.22 -173.7 2.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.775 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.868 HD22 ' CD1' ' A' ' 31' ' ' PHE . 12.6 tp -158.99 105.56 1.77 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.374 -0.829 . . . . 0.0 110.015 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 52' ' ' THR . 12.8 mt -85.9 130.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.683 HG21 ' HG ' ' A' ' 13' ' ' LEU . 14.5 mm -95.54 113.83 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.711 -179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -70.69 -23.84 62.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.175 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.28 149.12 46.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.52 -25.01 66.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.685 -0.891 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -86.82 166.72 14.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.745 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.683 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.3 OUTLIER 41.0 27.05 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 179.81 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -52.24 134.8 33.22 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 111.253 -178.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.11 175.42 38.42 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.111 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -140.48 42.42 1.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.3 pt -50.26 148.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.522 -0.736 . . . . 0.0 111.165 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.857 HG22 ' HG2' ' A' ' 5' ' ' LYS . 76.0 p -111.97 141.04 46.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.051 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.537 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -138.37 134.75 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.738 . . . . 0.0 110.744 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.99 139.12 42.71 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.723 -0.611 . . . . 0.0 109.997 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.06 34.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 110.436 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.8 p -54.08 -39.55 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.511 -0.743 . . . . 0.0 110.325 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.6 p30 -160.02 -179.81 8.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.547 -0.721 . . . . 0.0 109.32 179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.02 -31.17 72.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.731 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -54.15 -57.68 10.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 0.0 109.976 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -59.63 -40.91 89.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.63 -0.669 . . . . 0.0 109.783 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.4 75.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.73 . . . . 0.0 109.732 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 15.4 tt0 -60.54 -47.31 86.75 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.371 179.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -51.32 69.37 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.181 -0.949 . . . . 0.0 109.958 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.51 -45.87 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.46 -0.775 . . . . 0.0 109.415 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.868 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -68.85 -37.49 79.14 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -76.03 1.95 14.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.777 -0.577 . . . . 0.0 111.441 179.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -107.08 -45.12 4.22 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 177.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 2.2 t80 -50.42 -38.28 42.33 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.838 176.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.797 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -63.86 -49.55 72.31 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.248 0.547 . . . . 0.0 109.825 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -60.22 -46.3 90.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.709 -0.619 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.99 -22.86 29.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.51 -0.744 . . . . 0.0 110.826 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -103.8 -24.35 13.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.675 -0.641 . . . . 0.0 110.468 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.33 44.03 1.65 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.797 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -104.18 135.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.656 -0.908 . . . . 0.0 109.705 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -167.61 97.63 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.77 -65.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.645 ' HB2' HG22 ' A' ' 56' ' ' THR . 9.0 mt-10 -154.65 173.58 16.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.551 -0.97 . . . . 0.0 110.171 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 52.1 m95 -155.05 123.84 6.13 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.66 -0.65 . . . . 0.0 109.803 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.9 p -139.03 133.76 32.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.618 -0.677 . . . . 0.0 109.289 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.4 t80 -96.15 136.92 35.96 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.851 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -105.15 99.58 9.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.666 . . . . 0.0 109.281 179.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.7 -4.51 23.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.606 . . . . 0.0 111.603 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.27 -26.58 17.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -126.55 7.82 6.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 110.135 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 11.6 mmtp 53.4 38.61 28.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.115 -0.99 . . . . 0.0 110.385 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 7' ' ' ILE . 6.5 m -128.56 135.03 48.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.699 -0.626 . . . . 0.0 110.617 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 56.8 m-85 -87.52 -170.5 3.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.348 -0.845 . . . . 0.0 109.795 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.67 104.24 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.031 -1.043 . . . . 0.0 108.211 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.3 p -111.43 132.61 59.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.567 -178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -125.66 -177.41 3.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.268 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.132 0.491 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 2' ' ' THR . 41.4 m -86.44 57.09 4.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.601 -0.687 . . . . 0.0 110.2 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.8 m -90.23 112.16 23.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 49.7 m-85 -97.8 150.04 21.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.632 -0.668 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.942 ' CG ' HG22 ' A' ' 18' ' ' THR . 4.5 mptt -113.24 -167.53 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.706 -0.621 . . . . 0.0 109.83 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.736 HD22 ' CD1' ' A' ' 31' ' ' PHE . 13.0 tp -167.33 100.38 0.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.487 -0.758 . . . . 0.0 110.145 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.2 mt -82.58 129.18 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.505 HG13 HD11 ' A' ' 13' ' ' LEU . 10.1 mm -99.91 115.93 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.234 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.491 ' OD1' HG22 ' A' ' 54' ' ' THR . 2.1 m-20 -80.75 -158.96 0.21 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.383 -0.823 . . . . 0.0 109.177 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.97 -129.19 47.72 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -148.07 25.54 1.01 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.655 -0.909 . . . . 0.0 110.285 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 30.4 p -103.74 113.82 27.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.573 -0.704 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.669 HD23 HG12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 67.43 -51.2 0.5 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.852 -0.53 . . . . 0.0 111.683 179.964 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 11.4 mmmt 49.17 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.616 -1.303 . . . . 0.0 111.543 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.79 170.13 43.24 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.38 55.94 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.77 -0.841 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.523 HG23 ' HE1' ' A' ' 31' ' ' PHE . 4.2 tp -59.32 133.0 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.519 -0.738 . . . . 0.0 110.373 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.942 HG22 ' CG ' ' A' ' 5' ' ' LYS . 53.0 p -98.94 140.13 33.56 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.647 -0.658 . . . . 0.0 110.079 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.449 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -141.1 147.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.532 -0.73 . . . . 0.0 110.469 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -90.96 153.36 20.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.592 -0.693 . . . . 0.0 110.152 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.48 164.05 14.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.484 -0.76 . . . . 0.0 110.58 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.3 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.542 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.5 p30 -162.28 174.33 12.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -59.92 -30.03 68.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.94 73.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.402 -0.811 . . . . 0.0 109.8 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.89 -40.22 91.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -55.89 -45.33 78.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 179.139 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.1 tt0 -58.45 -37.86 76.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.607 -0.683 . . . . 0.0 109.342 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -68.68 -50.64 49.45 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.27 -39.66 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.736 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.3 m-85 -73.36 -36.67 66.17 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 32.9 mtpt -75.62 -0.55 20.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.663 -0.648 . . . . 0.0 111.493 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -105.94 -45.58 4.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 177.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 1.2 t80 -52.81 -40.71 63.5 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.837 176.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -61.73 -47.52 84.85 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.825 -0.547 . . . . 0.0 109.942 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -59.0 -47.6 84.59 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.581 -0.7 . . . . 0.0 110.432 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -54.28 -25.15 21.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HB2' HD13 ' A' ' 40' ' ' ILE . 10.8 m120 -101.42 -24.59 14.16 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.784 -0.573 . . . . 0.0 110.535 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 104.47 36.27 3.11 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.777 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -97.39 116.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.614 -0.933 . . . . 0.0 109.489 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -158.06 101.71 1.77 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.13 -64.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.841 ' HB2' HG22 ' A' ' 56' ' ' THR . 68.8 mm-40 -129.56 169.03 15.53 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.48 -1.012 . . . . 0.0 110.952 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.9 m95 -162.85 118.78 1.83 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.7 p -144.44 132.78 21.89 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.399 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -93.56 144.52 25.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.901 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -113.9 97.8 6.61 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -69.88 -5.84 28.64 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.685 -0.634 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.77 -27.03 17.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -123.98 6.18 8.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.061 179.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 17.4 mmtt 54.18 39.93 31.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 110.077 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 5' ' ' LYS . 33.4 m -134.71 140.29 45.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 0.0 110.744 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' HD12 ' A' ' 6' ' ' LEU . 46.3 m-85 -93.62 -170.73 2.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.311 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.491 HG22 ' OD1' ' A' ' 9' ' ' ASN . 0.2 OUTLIER -157.04 102.95 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.485 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 7.4 p -116.1 144.71 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.92 -178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.841 HG22 ' HB2' ' A' ' 43' ' ' GLU . 2.7 t -143.22 -172.39 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.595 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.436 -0.79 . . . . 0.0 110.199 179.995 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.058 0.456 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 2' ' ' THR . 49.8 m -107.48 37.95 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 110.369 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.571 HG22 ' HB ' ' A' ' 18' ' ' THR . 21.6 m -60.12 92.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.415 -0.803 . . . . 0.0 109.841 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.528 ' CD2' HG22 ' A' ' 2' ' ' THR . 4.7 m-85 -85.49 147.51 26.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.715 -0.616 . . . . 0.0 110.129 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.847 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -109.46 -171.56 1.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.607 -0.683 . . . . 0.0 109.908 -179.907 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.733 HD22 ' CD1' ' A' ' 31' ' ' PHE . 25.7 tp -160.08 112.43 2.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.305 -0.872 . . . . 0.0 110.841 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.1 mt -85.35 119.91 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.631 HG21 ' HB2' ' A' ' 13' ' ' LEU . 5.4 mm -93.84 114.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.008 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -102.22 144.6 30.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.545 -0.722 . . . . 0.0 110.176 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.68 -135.78 9.38 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -131.38 29.66 4.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.62 -0.93 . . . . 0.0 110.191 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 14' ' ' LYS . 8.7 p -139.4 147.3 41.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.813 HD12 HG12 ' A' ' 40' ' ' ILE . 6.5 mt 60.9 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.784 -0.572 . . . . 0.0 111.204 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' THR . 6.1 mtmm 54.72 98.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.47 -0.769 . . . . 0.0 110.56 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.92 177.36 40.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.88 55.76 1.88 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.655 -0.909 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 pt -58.19 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' CG ' ' A' ' 5' ' ' LYS . 82.5 p -128.81 138.76 52.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.531 -0.73 . . . . 0.0 110.188 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.6 pp -139.51 138.84 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.734 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.61 128.58 33.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 109.538 179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.45 -163.06 1.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 110.527 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.07 -59.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.29 -174.73 4.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.78 79.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.611 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.56 31.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.619 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -56.11 22.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.685 -0.635 . . . . 0.0 109.868 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -49.81 -42.27 46.65 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.455 -0.778 . . . . 0.0 110.376 179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.4 tt0 -60.57 -35.15 75.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.56 -0.713 . . . . 0.0 109.236 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -72.57 -46.82 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 27' ' ' ALA . 61.6 mt -59.31 -36.94 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.733 ' CD1' HD22 ' A' ' 6' ' ' LEU . 7.3 m-85 -76.96 -35.4 57.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 44' ' ' TRP . 6.1 mtpt -77.3 0.93 20.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.773 -0.579 . . . . 0.0 111.357 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -107.31 -45.46 4.09 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.291 5.5 t80 -52.46 -35.24 52.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.783 176.211 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -71.02 -51.39 25.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.276 0.56 . . . . 0.0 109.946 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.31 -47.43 85.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.635 -0.666 . . . . 0.0 110.396 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -22.64 19.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.571 -0.706 . . . . 0.0 111.11 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -104.52 -31.8 9.28 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 118.7 34.64 1.05 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.813 HG12 HD12 ' A' ' 13' ' ' LEU . 1.6 mp -102.13 110.18 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.456 -1.026 . . . . 0.0 108.999 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -143.36 111.76 6.31 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.25 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.64 -110.03 0.23 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tp10 -107.93 179.11 4.32 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.367 -1.078 . . . . 0.0 110.4 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' CE2' HG23 ' A' ' 55' ' ' VAL . 41.2 m95 -155.19 129.45 8.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.575 -0.703 . . . . 0.0 109.856 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 7.0 p -141.94 133.05 26.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.548 -0.72 . . . . 0.0 109.177 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 30.5 t80 -98.48 134.48 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.889 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -104.23 98.92 8.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -71.13 -3.81 21.97 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.722 -0.612 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.75 -25.1 17.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.729 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 p -128.66 5.62 5.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.612 -0.68 . . . . 0.0 110.296 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 74.1 mmtt 55.89 42.81 28.42 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.164 -0.96 . . . . 0.0 109.679 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -130.53 124.89 32.92 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.979 -0.689 . . . . 0.0 110.869 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 6' ' ' LEU . 82.8 m-85 -81.28 -171.3 3.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.499 -0.75 . . . . 0.0 109.548 179.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.6 90.42 1.16 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -92.64 100.25 10.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.005 0.907 . . . . 0.0 110.927 -178.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -80.12 171.39 15.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.072 0.463 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.67 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.6 m -99.25 29.55 3.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.489 -0.757 . . . . 0.0 110.321 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -73.3 109.56 6.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 0.0 109.877 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 2' ' ' THR . 78.7 m-85 -87.93 145.44 26.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.555 -0.716 . . . . 0.0 110.646 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.809 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.6 OUTLIER -108.94 -173.95 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.892 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.4 tp -167.65 110.14 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.285 -0.885 . . . . 0.0 110.681 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 52' ' ' THR . 3.6 mp -95.55 113.47 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' HA ' HG13 ' A' ' 55' ' ' VAL . 1.2 mm -84.13 104.05 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.94 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -86.52 144.6 27.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.554 -0.716 . . . . 0.0 110.17 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.55 -140.77 12.0 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.28 29.74 5.51 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.664 -0.904 . . . . 0.0 110.176 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' LYS . 10.4 p -138.05 138.02 38.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 40' ' ' ILE . 5.7 mt 60.9 -77.3 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.762 -0.586 . . . . 0.0 111.027 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' THR . 15.5 mtpt 54.37 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.339 -0.85 . . . . 0.0 110.738 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.62 -175.77 41.58 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -108.43 -57.88 2.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.577 -0.954 . . . . 0.0 110.367 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.9 mm 53.6 72.75 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.809 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.6 p -69.64 137.36 52.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.598 -0.689 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -145.51 147.4 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.562 -0.711 . . . . 0.0 110.572 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.73 162.08 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.605 -0.685 . . . . 0.0 109.936 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 26' ' ' GLU . . . -169.35 171.16 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.1 p -53.08 -39.06 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.494 -0.754 . . . . 0.0 110.401 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.5 p30 -160.67 -175.18 4.83 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -70.38 -31.23 68.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.19 -49.3 74.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.593 -0.692 . . . . 0.0 109.921 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tt0 -63.09 -43.64 97.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.403 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -53.35 -45.06 69.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.354 -0.841 . . . . 0.0 109.752 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 3.8 tt0 -59.12 -36.27 74.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.599 -0.688 . . . . 0.0 109.348 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.72 -54.85 16.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.52 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.49 -40.34 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.892 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -72.07 -34.7 68.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -78.52 1.25 23.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.693 -0.629 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -104.22 -46.14 4.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.301 4.4 t80 -47.36 -51.98 17.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.906 175.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.721 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -67.74 -50.19 58.62 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.659 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.06 -49.92 72.41 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.72 . . . . 0.0 110.899 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.86 -21.46 29.46 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.603 -0.685 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -102.72 -27.76 12.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.572 -0.705 . . . . 0.0 110.576 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.67 29.25 3.67 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.721 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.41 106.01 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 108.756 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -141.71 114.89 8.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.35 0.595 . . . . 0.0 111.016 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.76 -100.78 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.7 tt0 -115.31 170.74 8.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -1.002 . . . . 0.0 110.035 179.54 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.43 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 40.6 m95 -152.6 122.95 7.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.505 -0.747 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 25.3 p -138.22 128.57 26.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.578 -0.701 . . . . 0.0 109.56 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 20.5 t80 -94.24 141.7 28.26 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.654 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -111.82 100.92 9.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.1 -2.68 16.46 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.616 -0.678 . . . . 0.0 111.745 -179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -28.69 21.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -136.69 15.39 3.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.695 . . . . 0.0 109.906 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER 48.28 45.34 20.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.359 -0.838 . . . . 0.0 111.487 179.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 7' ' ' ILE . 26.2 m -121.18 120.84 36.38 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.54 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 6' ' ' LEU . 76.3 m-85 -85.35 172.81 10.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -139.78 97.16 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -97.68 107.53 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-O 122.007 0.908 . . . . 0.0 110.682 -178.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -92.02 170.1 10.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.286 -179.952 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.122 0.487 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 91.4 m -141.37 -69.24 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.5 m 51.03 88.05 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.375 -0.828 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 m-85 -90.04 149.46 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 109.228 178.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.899 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.5 OUTLIER -110.19 -173.93 2.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 110.389 -179.634 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' A' ' 53' ' ' PHE . 7.7 tp -160.98 108.97 1.54 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.634 -0.666 . . . . 0.0 109.986 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.5 mm -87.42 129.89 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' LEU . 2.1 mm -101.91 116.39 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.67 -179.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.637 HD21 HG22 ' A' ' 54' ' ' THR . 15.1 m-20 -76.05 -29.31 57.99 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.84 -175.91 4.92 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -114.85 25.55 10.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.618 -0.931 . . . . 0.0 110.486 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -96.04 -33.72 12.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.46 -0.775 . . . . 0.0 109.964 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.684 HD12 HD11 ' A' ' 40' ' ' ILE . 9.7 mt -121.96 -54.09 1.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.696 -0.628 . . . . 0.0 109.772 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt 52.66 82.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.539 -0.726 . . . . 0.0 110.844 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.99 -175.54 46.1 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -108.47 -50.07 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.797 -0.825 . . . . 0.0 109.966 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.0 mm 54.12 83.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.899 HG22 ' CG ' ' A' ' 5' ' ' LYS . 62.0 p -76.94 142.14 40.17 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.626 -0.671 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -143.69 131.5 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.488 -0.758 . . . . 0.0 111.187 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -66.93 131.15 45.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 110.068 179.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.32 150.11 31.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.0 p -53.26 -39.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.6 -0.687 . . . . 0.0 110.546 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.4 p30 -158.13 177.18 11.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.386 179.406 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.68 -33.11 74.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.415 -0.803 . . . . 0.0 109.642 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.581 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.71 -44.09 81.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.562 -0.711 . . . . 0.0 109.723 179.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' OE1' HD11 ' A' ' 30' ' ' ILE . 2.1 tt0 -70.62 -44.19 67.72 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.4 -44.98 80.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.571 -0.706 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.8 tt0 -57.98 -37.54 74.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.648 -0.658 . . . . 0.0 109.401 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -51.57 32.62 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.513 HD11 ' OE1' ' A' ' 26' ' ' GLU . 22.3 mt -58.48 -35.56 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -77.24 -35.55 55.36 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -73.85 -2.9 25.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.75 -0.594 . . . . 0.0 111.211 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -103.24 -46.1 4.71 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 13' ' ' LEU 0.296 2.8 t80 -52.33 -32.43 38.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.692 175.627 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.49 -60.81 2.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.819 0.818 . . . . 0.0 108.896 178.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -57.19 -40.56 77.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.83 -0.544 . . . . 0.0 110.562 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.09 -27.95 3.78 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.616 -0.678 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.15 -49.31 3.4 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.475 0.655 . . . . 0.0 109.861 179.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.53 64.95 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.753 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -118.81 129.3 75.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.949 -0.736 . . . . 0.0 110.389 -176.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.18 94.34 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.511 -0.743 . . . . 0.0 110.154 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.32 -44.95 0.02 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.84 ' HB3' HG22 ' A' ' 56' ' ' THR . 15.0 tt0 -152.02 167.43 28.45 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.466 -1.02 . . . . 0.0 110.863 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 43.8 m95 -163.41 116.56 1.54 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.0 p -141.97 130.77 22.9 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.586 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -93.24 146.29 23.81 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.25 100.07 7.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.732 -0.605 . . . . 0.0 109.592 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -71.65 -2.78 18.43 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.668 -0.645 . . . . 0.0 111.505 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -25.82 18.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -131.54 8.74 4.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.482 -0.761 . . . . 0.0 110.174 179.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 54.41 45.11 27.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.193 -0.942 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.9 m -133.52 135.13 44.2 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.794 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.774 ' HB2' HD12 ' A' ' 6' ' ' LEU . 63.5 m-85 -90.74 -172.23 3.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.5 -0.75 . . . . 0.0 109.618 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.637 HG22 HD21 ' A' ' 9' ' ' ASN . 0.6 OUTLIER -156.16 97.68 1.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.98 -1.075 . . . . 0.0 108.712 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.3 p -112.5 146.31 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.138 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.84 HG22 ' HB3' ' A' ' 43' ' ' GLU . 6.2 t -145.28 -172.48 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.936 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.201 179.925 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.186 0.517 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.438 HG22 ' CE2' ' A' ' 4' ' ' PHE . 63.5 m -120.84 75.55 1.15 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.611 -0.68 . . . . 0.0 110.26 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.1 m -102.76 109.12 20.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.594 -0.691 . . . . 0.0 110.109 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 53.3 m-85 -93.16 141.92 27.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 110.301 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.836 ' HG3' HG22 ' A' ' 18' ' ' THR . 3.8 mptt -105.88 -166.21 1.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.671 -0.643 . . . . 0.0 109.35 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.861 HD22 ' CD1' ' A' ' 31' ' ' PHE . 21.4 tp -166.55 105.69 0.63 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.416 -0.803 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -81.34 118.43 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mm -89.86 101.3 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.609 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -76.1 -3.39 35.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.518 -0.739 . . . . 0.0 111.166 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.8 163.89 33.84 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.83 -27.42 68.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.478 -1.013 . . . . 0.0 110.64 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . 16.7 m -78.46 156.27 29.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.53 -0.731 . . . . 0.0 110.324 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.672 HD22 ' OH ' ' A' ' 34' ' ' TYR . 9.6 mt 59.71 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.865 -0.522 . . . . 0.0 111.188 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 12' ' ' THR . 1.0 OUTLIER 56.3 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.149 -0.969 . . . . 0.0 110.528 -179.766 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.53 -177.69 36.85 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -128.09 67.52 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -1.008 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 6.8 tp -62.72 126.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.524 -0.735 . . . . 0.0 109.892 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.836 HG22 ' HG3' ' A' ' 5' ' ' LYS . 75.0 p -96.29 137.54 35.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.485 -0.76 . . . . 0.0 110.424 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -142.37 133.65 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.365 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -78.58 148.99 33.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.672 -0.643 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.63 163.97 32.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.604 -0.685 . . . . 0.0 110.246 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.4 p -54.8 -40.93 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.494 -0.753 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m-20 -158.42 172.55 18.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.646 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.28 -34.48 75.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.299 -0.875 . . . . 0.0 109.704 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.3 -49.47 69.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.62 -0.675 . . . . 0.0 109.796 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -40.87 96.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -56.11 -43.53 78.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.424 -0.797 . . . . 0.0 109.665 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 9.6 tt0 -59.82 -35.85 75.56 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -68.33 -51.13 47.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.3 mt -58.12 -40.96 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.861 ' CD1' HD22 ' A' ' 6' ' ' LEU . 14.3 m-85 -72.0 -36.66 69.82 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.5 mmmt -74.58 -2.44 25.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.615 -0.678 . . . . 0.0 111.182 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -105.41 -42.51 5.22 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.672 ' OH ' HD22 ' A' ' 13' ' ' LEU 0.293 16.4 t80 -55.08 -19.47 7.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.734 175.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -89.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 179.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -53.06 -42.42 65.79 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.708 -0.62 . . . . 0.0 111.787 -178.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 39.5 p-10 -46.85 -27.54 1.27 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.461 -0.774 . . . . 0.0 111.612 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -108.74 -59.57 1.86 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.849 -0.532 . . . . 0.0 110.253 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.82 59.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.733 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.297 1.1 mm -116.49 130.52 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.742 -0.858 . . . . 0.0 109.532 -178.363 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -169.9 104.49 0.32 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.407 -0.808 . . . . 0.0 111.079 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.24 -63.22 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 32.7 mt-10 -152.7 171.37 18.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.567 -0.961 . . . . 0.0 110.143 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 47.9 m95 -155.03 124.89 6.57 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.669 -0.644 . . . . 0.0 110.009 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.2 p -144.45 132.82 21.92 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.627 -0.671 . . . . 0.0 109.532 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.1 t80 -93.08 148.73 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.67 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -120.68 100.08 6.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.742 -0.599 . . . . 0.0 109.879 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.79 -4.18 22.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.712 -0.617 . . . . 0.0 111.554 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.24 -28.0 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.9 p -128.82 8.33 5.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 110.083 179.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 15.9 mmtt 54.28 40.1 31.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.5 m -130.49 138.62 50.34 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.628 -0.67 . . . . 0.0 110.371 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 48.4 m-85 -91.33 -167.41 1.79 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 m -154.57 102.31 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.99 -1.069 . . . . 0.0 108.474 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.8 p -113.15 128.39 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.796 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -124.78 -178.69 4.24 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.157 179.769 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 2' ' ' THR . 60.8 m -115.85 44.86 1.83 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.568 -0.707 . . . . 0.0 110.157 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 18' ' ' THR . 3.4 m -71.27 93.31 1.09 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m-85 -81.98 139.5 34.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.659 -0.651 . . . . 0.0 110.178 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.811 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -105.08 -170.96 1.83 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.175 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.4 tp -165.04 108.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.601 -0.687 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -84.61 129.41 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.597 HD11 HD23 ' A' ' 6' ' ' LEU . 9.6 mm -93.22 114.31 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.082 -178.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.88 40.96 1.16 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.36 -151.17 6.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 12' ' ' THR . 10.2 ptmt -114.7 -28.82 6.98 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.477 -1.013 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.1 p -79.88 113.71 18.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 40' ' ' ILE . 0.2 OUTLIER 62.25 144.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.277 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' N ' HD12 ' A' ' 13' ' ' LEU . 9.4 ptpp? -151.27 140.16 20.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.225 -0.922 . . . . 0.0 111.073 -179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.53 -163.47 29.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 17' ' ' ILE . 5.4 mp0 -108.69 -42.76 4.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.699 -0.883 . . . . 0.0 110.235 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.541 HD12 ' C ' ' A' ' 16' ' ' GLU . 5.3 mp 53.25 95.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.405 -0.809 . . . . 0.0 110.356 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.811 HG22 ' CG ' ' A' ' 5' ' ' LYS . 80.8 p -90.19 132.11 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.633 -0.667 . . . . 0.0 110.241 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.471 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.4 pp -143.42 130.22 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.512 -0.743 . . . . 0.0 110.478 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -71.22 157.72 37.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 110.127 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' O ' HG21 ' A' ' 2' ' ' THR . . . -168.55 161.4 11.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 110.165 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -53.75 -30.99 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.445 -0.785 . . . . 0.0 110.366 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.8 p30 -171.42 178.3 3.26 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.15 -30.61 71.55 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.612 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.88 -43.67 81.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.502 -0.749 . . . . 0.0 109.704 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG3' HD11 ' A' ' 30' ' ' ILE . 19.9 tp10 -70.59 -44.64 66.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.63 -42.54 71.34 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.352 -0.842 . . . . 0.0 109.689 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.4 tt0 -60.44 -41.13 93.41 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.044 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -73.11 -35.03 66.49 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.604 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 26' ' ' GLU . 52.8 mt -67.72 -40.78 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.639 ' HB3' HD13 ' A' ' 6' ' ' LEU . 12.7 m-85 -73.3 -38.3 65.91 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 5.7 mmmt -72.96 -4.98 35.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.602 -0.686 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -106.14 -45.12 4.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 177.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.29 5.5 t80 -51.62 -30.62 22.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.091 176.193 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -76.08 -50.11 15.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.728 -0.608 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -57.54 -47.56 81.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 110.678 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -24.74 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.476 -0.765 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB2' HD13 ' A' ' 40' ' ' ILE . 52.3 m-20 -102.75 -27.1 12.9 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.637 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 35.15 2.34 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.769 ' CG2' ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -95.95 107.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.657 -0.908 . . . . 0.0 108.904 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.25 113.45 9.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.476 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.19 -109.77 0.22 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 5.9 tt0 -114.51 174.39 5.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.445 -1.032 . . . . 0.0 110.347 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CE2' HG23 ' A' ' 55' ' ' VAL . 36.5 m95 -151.9 130.71 12.44 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.577 -0.702 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 8.2 p -142.89 133.17 24.66 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.298 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 25.4 t80 -95.12 145.37 25.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -117.8 98.11 6.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.792 -0.568 . . . . 0.0 109.488 179.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.63 -4.62 24.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.659 -0.65 . . . . 0.0 111.659 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.75 -26.71 17.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 109.733 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -125.98 7.05 7.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.609 -0.682 . . . . 0.0 110.194 179.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 4' ' ' PHE . 3.9 mmtp 54.15 38.47 29.21 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.184 -0.947 . . . . 0.0 110.101 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.5 m -130.6 134.21 46.8 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.628 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' HD12 ' A' ' 6' ' ' LEU . 53.3 m-85 -88.27 -166.84 1.7 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.21 92.71 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.8 p -93.92 102.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.933 0.873 . . . . 0.0 111.316 -178.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -82.51 169.44 16.35 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.051 0.453 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 2' ' ' THR . 46.0 m -124.29 47.16 2.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.294 -179.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 m -68.86 85.31 0.32 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.459 -0.776 . . . . 0.0 109.983 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.6 m-85 -70.42 126.89 30.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.647 -0.658 . . . . 0.0 109.778 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HG2' HG22 ' A' ' 18' ' ' THR . 30.9 mttm -89.57 175.35 7.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.967 HD23 HD11 ' A' ' 8' ' ' ILE . 2.5 tp -156.54 112.5 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.643 -0.661 . . . . 0.0 109.839 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -90.8 114.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.967 HD11 HD23 ' A' ' 6' ' ' LEU . 2.3 mp -90.08 113.15 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.071 -178.829 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -92.61 149.93 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.432 -0.792 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.51 -108.52 1.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -166.28 47.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.584 -0.951 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.621 ' CG2' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -152.21 119.22 5.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.428 -0.795 . . . . 0.0 110.208 179.998 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 53.95 23.98 4.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.504 0.669 . . . . 0.0 110.312 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -46.97 109.0 0.16 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.007 -1.058 . . . . 0.0 111.468 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.79 -162.73 29.48 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -109.46 -33.58 6.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.617 -0.931 . . . . 0.0 110.719 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.463 ' C ' HG23 ' A' ' 18' ' ' THR . 28.2 mm 67.05 -61.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 O-C-N 121.699 -0.626 . . . . 0.0 110.834 -179.81 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 17' ' ' ILE . 1.3 p 62.37 112.63 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.344 -0.847 . . . . 0.0 110.427 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -143.24 132.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.765 -0.585 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -70.51 155.01 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 110.325 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.45 12.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.386 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.5 -39.65 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.535 -0.728 . . . . 0.0 110.617 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.3 m-20 -159.27 177.05 11.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.646 -0.659 . . . . 0.0 109.501 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.7 -32.16 73.71 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.383 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.3 82.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.632 -0.667 . . . . 0.0 109.807 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.41 -44.66 82.37 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -45.91 75.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.603 -0.686 . . . . 0.0 109.623 178.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 6.1 tt0 -59.26 -37.01 76.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.503 179.08 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -69.14 -51.26 40.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 178.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.3 mt -58.26 -38.71 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.4 m-85 -74.65 -39.36 62.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.145 0.498 . . . . 0.0 109.792 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -76.45 0.7 18.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.489 -0.757 . . . . 0.0 111.953 -179.393 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -110.14 -45.32 3.61 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 177.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' OH ' HD13 ' A' ' 13' ' ' LEU 0.301 9.5 t80 -53.78 -39.0 65.04 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.249 176.558 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.814 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.22 -54.49 32.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.628 . . . . 0.0 109.948 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -56.83 -48.35 78.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.679 -0.638 . . . . 0.0 110.712 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.82 -22.23 34.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.0 110.831 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -102.57 -29.02 11.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.681 -0.637 . . . . 0.0 110.217 179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 115.53 33.55 1.57 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.814 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -105.73 115.52 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -1.044 . . . . 0.0 109.229 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.17 105.55 2.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.433 -179.622 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -154.4 -97.12 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -125.51 127.55 46.61 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.334 -1.097 . . . . 0.0 111.067 -179.551 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' NE1' HG23 ' A' ' 55' ' ' VAL . 50.4 m95 -105.83 137.09 44.31 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.533 -0.729 . . . . 0.0 110.904 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.8 p -147.01 132.06 18.24 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 29.3 t80 -98.6 144.8 27.5 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.861 179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -115.57 99.34 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.766 -0.584 . . . . 0.0 109.638 179.257 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.31 -6.09 32.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 111.306 -179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.82 -26.52 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 109.612 179.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -124.24 5.63 8.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.619 -0.676 . . . . 0.0 110.119 179.211 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 54.0 38.55 29.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.143 -0.973 . . . . 0.0 110.051 -179.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 m -128.06 143.53 51.07 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.811 -179.436 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.901 ' HB2' HD12 ' A' ' 6' ' ' LEU . 78.6 m-85 -98.34 -172.19 2.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.689 . . . . 0.0 109.187 179.452 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -158.41 99.39 1.61 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.713 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG23 ' NE1' ' A' ' 44' ' ' TRP . 2.8 p -102.79 97.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.774 0.797 . . . . 0.0 111.155 -178.537 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.35 169.62 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.13 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.194 -179.685 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.122 0.487 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.59 HG22 ' CE2' ' A' ' 4' ' ' PHE . 20.3 m -117.64 33.58 5.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.551 -0.718 . . . . 0.0 110.199 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' HB ' ' A' ' 18' ' ' THR . 20.4 m -67.16 91.31 0.22 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 110.143 179.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 2' ' ' THR . 34.2 m-85 -72.43 146.75 46.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.624 -0.672 . . . . 0.0 110.172 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 17.1 mtmt -109.84 -178.1 3.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.94 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 53' ' ' PHE . 6.4 tp -160.57 102.48 1.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.442 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG12 ' CG ' ' A' ' 16' ' ' GLU . 18.9 mt -90.71 117.0 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.045 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.766 ' CG1' HD11 ' A' ' 13' ' ' LEU . 2.0 mp -91.46 120.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.333 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.7 -31.15 59.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 110.34 -179.293 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.06 160.12 45.96 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.41 13.66 13.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.611 -0.935 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.625 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.2 p -63.05 -54.18 42.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.25 -0.906 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.766 HD11 ' CG1' ' A' ' 8' ' ' ILE . 4.6 pp -131.13 -29.08 1.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.677 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.697 ' N ' HD12 ' A' ' 13' ' ' LEU . 16.4 ptmt 37.35 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.68 -179.98 47.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HG12 ' A' ' 7' ' ' ILE . 2.1 mt-10 -129.76 72.54 1.48 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.834 -0.803 . . . . 0.0 109.786 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.0 mm -65.66 112.56 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 109.974 -179.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 55.3 p -88.24 123.27 32.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.642 -0.661 . . . . 0.0 109.692 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -139.33 139.22 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.781 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -86.51 159.4 19.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.983 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.8 168.92 10.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.711 . . . . 0.0 110.203 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -53.89 -38.74 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 110.447 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -163.6 174.65 11.5 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.711 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.6 -30.61 70.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -0.815 . . . . 0.0 109.806 -179.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.31 -48.96 70.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.427 -0.796 . . . . 0.0 110.026 179.43 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.91 -43.43 83.39 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -54.2 -44.44 71.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.617 -0.677 . . . . 0.0 109.749 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 17.9 tt0 -58.02 -40.45 80.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.709 -0.62 . . . . 0.0 109.508 179.175 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.22 -50.12 56.22 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.331 178.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 27' ' ' ALA . 26.3 mt -58.01 -38.37 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.75 ' CD1' HD22 ' A' ' 6' ' ' LEU . 11.5 m-85 -75.54 -35.28 60.72 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -79.78 3.97 17.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.64 . . . . 0.0 111.32 179.565 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -107.23 -45.27 4.15 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 177.413 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.288 6.1 t80 -52.9 -45.51 67.57 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.916 176.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -60.21 -51.56 69.05 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.322 0.582 . . . . 0.0 109.9 179.139 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.83 -49.62 76.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.802 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -57.55 -27.89 63.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.526 -0.733 . . . . 0.0 110.593 -179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.7 -27.52 17.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.887 -0.508 . . . . 0.0 110.307 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 108.03 38.89 1.92 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.781 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.8 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.5 mp -106.44 130.19 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.656 -0.908 . . . . 0.0 109.375 -179.714 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -168.1 106.61 0.5 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.01 -59.9 0.03 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.852 ' HB3' HG22 ' A' ' 56' ' ' THR . 7.0 tt0 -136.75 163.61 30.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.381 -1.07 . . . . 0.0 110.529 -179.479 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 48.4 m95 -162.65 116.06 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.8 p -145.64 131.57 19.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.604 -0.685 . . . . 0.0 109.495 179.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 32.3 t80 -89.05 152.3 21.75 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.821 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.32 102.18 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.721 -0.612 . . . . 0.0 109.643 179.367 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.47 -6.06 33.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.737 -0.602 . . . . 0.0 111.395 -179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.49 -28.13 21.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 p -125.22 6.12 7.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.614 -0.679 . . . . 0.0 109.973 179.103 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt 53.47 39.12 29.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.154 -0.966 . . . . 0.0 110.176 -179.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -133.55 145.87 50.5 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.015 -179.493 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 6' ' ' LEU . 49.6 m-85 -97.68 173.56 7.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.574 -0.704 . . . . 0.0 109.441 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.32 110.2 8.74 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.097 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.694 HG13 HG13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -117.94 152.89 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.704 -178.271 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 43' ' ' GLU . 5.6 t -160.11 -169.44 2.5 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.296 -0.561 . . . . 0.0 109.7 179.242 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.26 -179.841 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 2' ' ' THR . 53.5 m -118.73 37.75 3.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 m -62.75 86.89 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.531 -0.731 . . . . 0.0 110.074 179.926 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.787 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m-85 -71.75 137.0 47.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.602 -0.686 . . . . 0.0 109.95 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 15.9 mttt -99.37 179.72 4.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.635 -0.666 . . . . 0.0 110.269 -179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.823 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -163.14 118.58 1.74 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 110.464 -179.975 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 80.3 mt -91.99 114.35 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.284 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -89.84 119.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.529 -179.142 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -102.64 56.76 0.78 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.41 174.2 22.67 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -70.15 -41.14 74.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.505 -0.997 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.672 ' HB ' HD11 ' A' ' 40' ' ' ILE . 3.3 p -76.31 115.44 16.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.469 -0.769 . . . . 0.0 109.946 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 60.28 156.33 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.356 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -171.67 126.19 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 110.375 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.25 -158.71 23.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -110.03 146.3 35.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.641 -0.917 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 49.5 mm -113.64 -16.96 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.669 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 65.0 p 45.33 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.678 -0.639 . . . . 0.0 112.006 179.845 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -126.81 141.04 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.803 . . . . 0.0 110.532 179.35 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.73 151.16 32.25 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.431 -179.835 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 2' ' ' THR . . . -167.82 158.55 10.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.667 -0.646 . . . . 0.0 110.065 -179.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -55.95 -39.35 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 110.382 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 22' ' ' VAL . 52.6 p30 -159.36 178.81 9.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.677 -0.639 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.787 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.99 -29.18 70.09 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.609 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 -50.4 71.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.71 . . . . 0.0 109.878 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -41.97 86.12 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.65 -46.42 77.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.632 -0.668 . . . . 0.0 109.583 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.8 tt0 -58.85 -37.27 76.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -51.44 39.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.515 -0.741 . . . . 0.0 109.046 178.73 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.0 mt -58.76 -38.02 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.823 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.5 m-85 -74.7 -37.98 62.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.289 0.566 . . . . 0.0 109.539 179.198 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 9.1 mmmt -75.67 -0.89 22.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 111.448 179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -109.91 -45.49 3.62 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.289 1.5 t80 -53.59 -39.25 64.71 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.865 176.328 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.436 ' CA ' ' HB ' ' A' ' 40' ' ' ILE . . . -65.36 -54.0 35.2 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.344 0.592 . . . . 0.0 109.969 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.8 -47.36 77.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.631 -0.668 . . . . 0.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -51.63 -26.33 8.75 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.527 -0.733 . . . . 0.0 110.844 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' CB ' HD13 ' A' ' 40' ' ' ILE . 4.8 m120 -103.7 -26.16 12.86 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.887 -0.508 . . . . 0.0 110.318 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.82 29.35 3.6 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' A' ' 12' ' ' THR . 2.1 mp -100.5 57.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.759 1.266 . . . . 0.0 108.173 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.54 101.75 11.63 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.37 -178.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 56' ' ' THR . . . -160.38 -127.27 0.88 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.263 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.7 tt0 -71.28 168.38 17.45 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.136 -1.214 . . . . 0.0 110.325 -179.786 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.439 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 33.9 m95 -158.84 129.03 5.86 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.684 -0.635 . . . . 0.0 109.518 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 12.1 p -145.46 133.3 21.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.407 -0.808 . . . . 0.0 109.428 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.515 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.5 t80 -98.46 144.13 28.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.759 179.597 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -114.69 98.15 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.07 -7.05 32.18 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.69 -0.631 . . . . 0.0 111.378 -179.829 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.24 -27.55 17.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 179.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.0 p -122.21 4.99 9.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.56 -0.713 . . . . 0.0 110.062 179.131 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt 54.41 39.26 30.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 109.938 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -129.87 142.39 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.804 -179.468 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.7 m-85 -97.66 -171.6 2.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -158.51 102.36 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.189 . . . . 0.0 108.088 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 40' ' ' ILE . 3.3 p -106.24 108.97 26.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.083 0.944 . . . . 0.0 110.93 -178.711 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.577 ' O ' HG22 ' A' ' 56' ' ' THR . 0.9 OUTLIER -92.88 98.5 11.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.304 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.324 -179.551 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.132 0.492 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 2' ' ' THR . 29.8 m -126.85 40.74 3.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.541 -0.724 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 18' ' ' THR . 5.1 m -69.59 87.6 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.544 -0.723 . . . . 0.0 110.143 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -74.79 140.23 43.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.53 -0.731 . . . . 0.0 110.216 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.936 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.9 OUTLIER -107.21 -179.28 3.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.627 -0.67 . . . . 0.0 110.109 179.9 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -158.24 114.68 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.441 -0.787 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.36 122.69 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.777 HG21 ' HG ' ' A' ' 13' ' ' LEU . 6.3 mm -89.64 111.45 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.516 -177.957 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.47 152.38 19.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.578 -0.701 . . . . 0.0 109.736 179.249 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.67 -142.63 15.35 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -134.81 21.96 3.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.581 -0.952 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.497 HG22 HD11 ' A' ' 40' ' ' ILE . 3.9 m -131.12 111.53 12.05 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.777 ' HG ' HG21 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 61.77 137.05 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.369 0.604 . . . . 0.0 110.158 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptpt -141.83 138.27 32.07 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.65 -176.29 33.24 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.13 -41.49 6.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.701 -0.882 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 mt 53.86 73.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.435 -0.791 . . . . 0.0 110.408 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.936 HG22 ' CG ' ' A' ' 5' ' ' LYS . 78.8 p -71.14 130.57 41.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.543 -0.723 . . . . 0.0 110.122 179.956 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -140.95 135.53 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.498 -0.752 . . . . 0.0 110.625 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -74.18 156.35 37.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.706 -0.621 . . . . 0.0 109.963 179.797 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 2' ' ' THR . . . -169.8 162.28 9.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.552 -0.718 . . . . 0.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.7 p -54.97 -38.54 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.637 -0.665 . . . . 0.0 110.258 179.78 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.462 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.4 m-20 -160.49 178.98 9.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.8 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.52 -35.91 82.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.487 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.22 -49.28 67.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.412 -0.805 . . . . 0.0 109.948 179.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.61 -45.8 91.19 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.121 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.07 -44.07 67.2 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.439 -0.788 . . . . 0.0 109.808 179.008 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.1 tt0 -57.96 -35.53 71.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.673 -0.642 . . . . 0.0 109.349 179.032 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -70.15 -53.54 16.77 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.47 -35.73 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CD1' HD12 ' A' ' 6' ' ' LEU . 8.7 m-85 -76.26 -34.19 59.14 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.92 1.89 22.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.718 -0.614 . . . . 0.0 111.286 179.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -103.05 -46.47 4.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 176.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 8.3 t80 -45.48 -53.66 8.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.3 175.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.766 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -57.04 -49.92 74.34 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.36 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.83 -47.37 85.99 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.628 -0.67 . . . . 0.0 110.265 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -54.16 -23.89 15.98 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.595 -0.691 . . . . 0.0 111.16 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -105.21 -34.43 7.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.633 -0.667 . . . . 0.0 110.451 -179.924 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 121.21 37.23 0.7 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.766 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -102.99 110.85 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 0.0 109.12 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -141.43 109.21 5.69 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.826 -179.679 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.6 -106.63 0.2 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 tt0 -110.59 173.37 6.36 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -1.001 . . . . 0.0 110.791 -179.695 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' CE2' HG23 ' A' ' 55' ' ' VAL . 40.2 m95 -153.75 129.96 10.44 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.648 -0.658 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -143.13 133.84 25.18 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.504 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.5 t80 -98.73 146.67 25.65 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.881 179.712 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -116.78 100.0 7.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.24 -5.54 28.31 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.657 -0.652 . . . . 0.0 111.513 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.51 -27.61 18.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.606 179.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -126.06 6.83 7.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.649 -0.657 . . . . 0.0 110.157 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt 54.47 38.8 30.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.2 m -126.29 144.78 50.67 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 70.2 m-85 -99.15 -169.75 1.81 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.485 -0.76 . . . . 0.0 109.854 179.729 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.69 93.91 1.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.832 -1.167 . . . . 0.0 108.013 179.593 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 44' ' ' TRP . 2.9 p -95.73 116.13 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.972 0.892 . . . . 0.0 110.879 -178.634 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -99.25 168.39 10.06 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.146 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mtt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.031 0.443 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 4' ' ' PHE . 27.6 m -122.13 27.28 8.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.579 -0.701 . . . . 0.0 110.425 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -68.93 106.23 2.66 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 109.962 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.3 m-85 -88.89 145.25 25.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.529 -0.732 . . . . 0.0 110.409 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.834 ' HG2' HG22 ' A' ' 18' ' ' THR . 26.1 mttt -112.55 -167.3 1.17 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.4 tp -166.44 108.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.41 -0.806 . . . . 0.0 110.463 179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.28 119.81 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.793 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.867 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.1 mm -94.23 113.23 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.596 -179.178 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -105.07 57.9 0.69 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.819 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.94 -148.7 6.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 pttp -114.74 -25.07 8.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.598 -0.942 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 p -80.76 -38.82 27.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.538 -0.726 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.867 ' CB ' HG21 ' A' ' 8' ' ' ILE . 6.5 mt -123.1 168.68 12.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.472 -0.768 . . . . 0.0 110.479 -179.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.42 80.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.009 179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.36 -170.39 38.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.03 107.92 10.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.67 -0.9 . . . . 0.0 110.201 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 17' ' ' ILE . 5.3 mp -93.27 109.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.541 -0.725 . . . . 0.0 109.717 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.834 HG22 ' HG2' ' A' ' 5' ' ' LYS . 82.2 p -85.12 124.4 31.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.56 -0.713 . . . . 0.0 110.595 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.476 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -143.37 134.23 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 179.498 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -77.47 160.69 28.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.597 -0.689 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.46 165.2 10.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 110.239 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.3 p -55.13 -38.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.397 -0.814 . . . . 0.0 110.35 -179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.9 m-20 -162.31 174.88 12.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.629 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.29 -30.86 71.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.06 79.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 109.87 179.383 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' CD ' HG12 ' A' ' 22' ' ' VAL . 6.0 tt0 -71.79 -45.07 62.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.057 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.35 -39.74 76.58 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.567 -0.708 . . . . 0.0 109.362 178.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 19.1 tt0 -60.48 -40.23 90.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.012 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -67.53 -49.12 64.83 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.806 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.82 -44.13 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.755 ' CD1' HD22 ' A' ' 6' ' ' LEU . 13.7 m-85 -70.3 -38.92 75.1 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 4.6 mmmt -74.57 0.6 14.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.505 -0.747 . . . . 0.0 111.319 179.179 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -106.06 -45.58 4.3 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 177.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.298 17.4 t80 -49.02 -30.05 5.66 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.468 176.037 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -83.74 -48.63 9.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.669 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -68.47 -44.8 74.04 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.606 -0.684 . . . . 0.0 111.419 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -47.46 -28.74 2.3 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.501 -0.75 . . . . 0.0 111.139 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.46 -46.55 4.96 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.499 0.666 . . . . 0.0 109.375 178.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.3 63.54 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 -179.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.27 1.1 mm -118.72 137.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 O-C-N 121.721 -0.87 . . . . 0.0 110.118 -177.359 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 -172.66 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.067 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 126.53 -177.16 17.38 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.736 179.109 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.89 128.13 36.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.976 -0.72 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.457 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 43.4 m95 -97.68 125.01 42.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.56 -0.713 . . . . 0.0 110.407 179.667 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.9 p -138.23 134.75 34.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.3 t80 -98.15 148.16 23.85 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.452 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.68 101.09 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.708 -0.62 . . . . 0.0 109.572 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.39 -4.96 24.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.588 -0.695 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.35 -28.1 18.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.596 179.563 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -128.79 8.63 5.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.593 -0.692 . . . . 0.0 110.149 179.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 7.7 mmtm 54.02 40.8 31.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.119 -0.988 . . . . 0.0 110.255 -179.698 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 5' ' ' LYS . 36.8 m -125.73 143.51 51.02 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.122 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.3 m-85 -100.18 -174.15 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 30.5 m -160.69 122.37 3.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 0.0 109.201 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.4 p -117.24 93.97 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -84.7 90.55 7.74 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.975 0.893 . . . . 0.0 110.008 -178.443 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 . . . . . 0 N--CA 1.499 2.011 0 O-C-N 120.849 -1.157 . . . . 0.0 110.147 -179.522 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 4' ' ' PHE . 48.4 m -116.21 25.86 10.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.525 -0.735 . . . . 0.0 110.537 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -69.67 103.51 2.15 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.491 -0.756 . . . . 0.0 110.011 179.799 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.623 ' CE2' HG22 ' A' ' 2' ' ' THR . 65.7 m-85 -83.0 149.65 26.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.649 -0.657 . . . . 0.0 110.31 -179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 18' ' ' THR . 13.6 mttt -119.33 179.23 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 31' ' ' PHE . 38.9 tp -155.22 112.52 3.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.459 -0.776 . . . . 0.0 110.143 -179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 98.3 mt -82.9 115.99 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.126 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.733 HG21 ' CB ' ' A' ' 13' ' ' LEU . 3.6 mm -94.75 119.9 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.794 -179.171 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -117.54 73.31 0.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.749 179.55 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.27 -106.32 0.65 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -149.97 -41.1 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.559 -0.965 . . . . 0.0 110.676 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -71.51 -28.9 64.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.733 ' CB ' HG21 ' A' ' 8' ' ' ILE . 5.6 mt -128.24 170.83 12.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.537 -0.727 . . . . 0.0 110.232 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 75.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.182 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.99 -168.87 34.6 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -121.22 135.9 55.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.644 -0.915 . . . . 0.0 110.181 -179.906 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 19' ' ' ILE . 16.4 tt -93.96 -15.65 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.738 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.89 HG22 ' HG2' ' A' ' 5' ' ' LYS . 8.9 p 54.58 110.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.56 0.695 . . . . 0.0 111.065 179.88 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -137.44 138.1 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.653 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.78 156.23 21.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.642 -0.661 . . . . 0.0 110.147 179.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.15 168.99 14.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.673 . . . . 0.0 110.339 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 23' ' ' ASP . 10.4 p -55.27 -38.5 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.512 -0.743 . . . . 0.0 110.393 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.468 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.5 m-20 -161.68 175.08 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.752 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -63.48 -32.39 73.82 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.675 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.495 -0.753 . . . . 0.0 109.771 179.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.38 -39.63 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.06 -42.69 86.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.614 -0.679 . . . . 0.0 109.598 179.013 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 11.4 tt0 -59.94 -34.04 72.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -70.36 -49.74 46.07 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.45 -35.43 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -77.72 -40.67 40.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.827 -0.546 . . . . 0.0 109.628 179.384 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.0 mmmt -72.33 -3.24 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.0 111.261 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -105.06 -44.58 4.75 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.449 ' CE2' HD23 ' A' ' 6' ' ' LEU 0.291 4.5 t80 -49.42 -30.38 7.86 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.326 176.062 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -82.35 -55.17 4.67 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.718 0.77 . . . . 0.0 108.952 178.602 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -61.88 -45.8 92.18 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.701 -0.624 . . . . 0.0 111.457 -178.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.29 -29.23 1.55 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.599 -0.688 . . . . 0.0 111.256 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.57 -46.08 5.08 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.286 178.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.02 64.41 0.1 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -179.607 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.2 133.9 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.837 -0.802 . . . . 0.0 110.29 -177.068 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.2 -175.16 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 56' ' ' THR . . . 127.63 -173.53 18.69 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.56 -1.305 . . . . 0.0 111.744 179.186 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.8 126.38 36.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 122.02 -0.694 . . . . 0.0 110.164 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 32' ' ' LYS . 37.7 m95 -95.84 126.77 41.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.712 . . . . 0.0 110.259 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.2 p -141.71 134.96 29.33 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.598 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 23.6 t80 -97.53 141.97 29.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.516 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -109.49 100.09 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.614 179.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.69 -4.03 21.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.593 -0.692 . . . . 0.0 111.483 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.67 -26.93 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.707 179.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.2 p -128.53 7.73 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.661 -0.65 . . . . 0.0 110.201 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt 54.87 41.95 31.5 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.172 -0.955 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 5' ' ' LYS . 61.3 m -130.05 138.58 50.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.587 -0.695 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 66.4 m-85 -94.46 -173.18 2.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 0.0 109.17 179.245 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 38.1 m -161.38 122.39 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.772 -1.205 . . . . 0.0 109.184 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.5 p -118.99 89.94 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER -86.27 99.12 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.957 0.884 . . . . 0.0 110.428 -178.267 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 18.8 tt0 . . . . . 0 N--CA 1.501 2.123 0 O-C-N 120.91 -1.119 . . . . 0.0 110.291 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.017 0.437 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 2' ' ' THR . 43.2 m -123.49 29.71 6.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 0.0 110.387 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 m -62.55 87.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.459 -0.776 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 13.5 m-85 -72.53 128.12 34.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.735 -0.603 . . . . 0.0 110.228 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.756 ' CG ' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -95.23 171.53 8.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.57 -0.706 . . . . 0.0 109.479 179.535 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.9 tp -150.47 106.6 3.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.66 122.6 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -95.89 124.17 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.966 -179.388 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 54' ' ' THR . 3.8 m-20 -79.96 -30.33 39.8 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.262 -0.898 . . . . 0.0 110.181 -179.688 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.3 149.27 50.11 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HA ' ' HG3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -58.86 -20.26 49.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.56 -0.965 . . . . 0.0 110.61 179.937 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.462 ' HB ' HD11 ' A' ' 40' ' ' ILE . 7.1 p -65.45 116.62 6.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 110.553 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 8' ' ' ILE . 0.2 OUTLIER 65.77 -53.62 0.37 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.334 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.6 mtmt 43.79 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.779 -1.201 . . . . 0.0 112.682 179.091 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.91 -166.41 38.11 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.664 179.201 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -126.87 153.18 46.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.898 -0.766 . . . . 0.0 109.798 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 17' ' ' ILE . 5.2 mp -120.56 -14.37 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.426 -0.796 . . . . 0.0 111.242 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.756 HG22 ' CG ' ' A' ' 5' ' ' LYS . 40.7 p 44.14 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.575 -0.703 . . . . 0.0 111.875 -179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.2 pp -128.07 138.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.52 -0.737 . . . . 0.0 110.665 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -81.69 147.89 29.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.9 179.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' HG21 ' A' ' 2' ' ' THR . . . -159.98 165.65 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.0 110.336 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.9 p -55.04 -39.65 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.616 -0.677 . . . . 0.0 110.601 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -162.32 174.77 12.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.717 -0.614 . . . . 0.0 109.563 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.51 -32.32 72.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.403 -0.811 . . . . 0.0 109.789 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.0 -41.37 78.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 109.736 179.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.65 -44.05 57.85 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.131 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.41 -46.24 80.27 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.566 -0.709 . . . . 0.0 109.545 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.47 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.8 tt0 -58.69 -37.74 76.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.255 178.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -68.62 -52.28 33.16 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.674 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.4 mt -56.61 -40.18 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.829 ' CD1' HD22 ' A' ' 6' ' ' LEU . 9.9 m-85 -73.07 -35.72 66.73 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.881 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 44' ' ' TRP . 23.7 mttm -76.47 0.34 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.654 -0.654 . . . . 0.0 111.464 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.81 -45.28 3.84 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 177.455 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 8.3 t80 -55.51 -42.22 74.18 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.882 176.353 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.803 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -59.28 -50.97 71.95 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.261 0.553 . . . . 0.0 110.185 179.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.38 -46.51 89.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.372 -179.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -54.51 -23.3 15.78 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' HD13 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -106.17 -34.88 7.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.631 -0.668 . . . . 0.0 110.623 -179.911 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 123.63 37.76 0.57 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.803 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.7 mp -107.67 107.76 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -1.047 . . . . 0.0 108.733 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -157.62 104.41 1.98 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.271 -179.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.72 -50.37 0.04 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.869 ' CB ' HG22 ' A' ' 56' ' ' THR . 10.1 tt0 -138.0 167.28 22.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.391 -1.064 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 46.7 m95 -161.49 123.94 3.03 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.841 -0.537 . . . . 0.0 109.886 179.514 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 15.0 p -146.65 132.23 18.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.501 -0.75 . . . . 0.0 109.36 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.9 t80 -96.37 133.08 41.21 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.85 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.35 100.3 10.44 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -2.63 16.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.726 -0.609 . . . . 0.0 111.939 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.7 22.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 109.274 179.406 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -138.34 16.01 2.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.716 -0.615 . . . . 0.0 110.0 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.5 mptt 49.02 42.53 21.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 111.339 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -118.55 110.64 17.61 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.936 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.882 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.5 m-85 -70.86 -175.4 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.045 179.808 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 9' ' ' ASN . 0.5 OUTLIER -156.01 105.61 2.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.947 -1.096 . . . . 0.0 108.369 -179.759 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 8.0 p -120.76 144.5 29.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 43' ' ' GLU . 5.7 t -141.3 -165.63 2.01 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.815 179.767 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.294 -179.762 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.072 0.463 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 2' ' ' THR . 57.9 m -117.42 43.56 2.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.586 -0.696 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 78.5 m -67.79 93.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.459 -0.775 . . . . 0.0 110.126 179.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 11.8 m-85 -76.65 159.17 30.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.0 109.707 179.773 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.916 ' HG2' HG22 ' A' ' 18' ' ' THR . 37.7 mtmt -121.36 -172.99 2.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.821 HD22 ' CD1' ' A' ' 31' ' ' PHE . 27.5 tp -165.32 104.86 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.263 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.7 126.17 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.642 HG13 HD11 ' A' ' 13' ' ' LEU . 8.7 mm -99.14 115.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.525 -178.394 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.693 HD21 HG22 ' A' ' 54' ' ' THR . 2.1 m-20 -81.68 -159.04 0.25 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.33 -152.94 5.11 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.943 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -107.44 -18.28 13.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.936 . . . . 0.0 110.771 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.497 ' CG2' HD13 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -58.02 94.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 179.743 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 58.17 171.03 0.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.263 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.828 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -162.69 106.9 1.12 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.46 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.93 -166.16 35.62 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.191 -179.823 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.86 -39.12 4.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.798 -0.825 . . . . 0.0 110.517 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.1 mm 54.09 76.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.327 -0.858 . . . . 0.0 110.303 -179.797 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.916 HG22 ' HG2' ' A' ' 5' ' ' LYS . 71.8 p -76.0 129.11 36.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.635 -0.666 . . . . 0.0 110.008 -179.787 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.4 pp -141.17 144.18 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.904 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -83.07 149.66 26.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 109.964 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -163.81 153.14 14.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.684 . . . . 0.0 110.388 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -52.12 -39.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.399 -0.813 . . . . 0.0 110.458 179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.2 m-20 -159.37 173.78 15.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.749 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.03 -30.58 70.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.384 -0.822 . . . . 0.0 109.82 179.917 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.89 82.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.813 179.564 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.07 -44.79 60.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.594 -0.691 . . . . 0.0 109.689 178.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 21.1 tt0 -59.79 -38.08 80.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.647 -0.658 . . . . 0.0 109.229 179.088 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -67.99 -51.53 46.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.591 -0.693 . . . . 0.0 109.135 178.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -58.26 -37.41 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.879 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.821 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.6 m-85 -75.18 -35.78 61.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.786 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 4.5 mmmt -78.32 2.52 18.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.835 -0.541 . . . . 0.0 111.232 179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -106.76 -46.44 3.96 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 177.332 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.294 23.7 t80 -52.42 -31.79 36.11 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.938 175.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.47 -64.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.676 0.75 . . . . 0.0 109.014 178.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -55.59 -40.08 71.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.925 -0.484 . . . . 0.0 110.767 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -49.32 -27.86 4.33 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.65 -0.656 . . . . 0.0 110.837 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -106.82 -50.72 3.06 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.436 0.636 . . . . 0.0 109.94 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.74 63.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -179.712 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.747 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.295 1.1 mm -119.31 130.7 73.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.805 -0.82 . . . . 0.0 109.967 -177.272 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -171.19 100.26 0.21 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 110.724 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.96 -57.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.858 ' HB2' HG22 ' A' ' 56' ' ' THR . 79.1 mm-40 -140.92 168.42 19.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.947 . . . . 0.0 110.609 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 40.6 m95 -163.92 108.53 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 17.1 p -133.75 130.68 38.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.856 -179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.0 t80 -93.65 129.6 39.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.084 -0.647 . . . . 0.0 109.555 179.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -97.95 97.51 9.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.731 -0.606 . . . . 0.0 109.472 179.185 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -69.55 -6.32 30.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.561 -0.712 . . . . 0.0 111.527 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.29 -27.26 17.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 179.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 p -124.15 6.82 8.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.557 -0.714 . . . . 0.0 110.142 179.268 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 6.9 mmmt 54.4 38.92 30.48 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.248 -0.908 . . . . 0.0 110.263 -179.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -130.44 134.17 46.9 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.663 . . . . 0.0 110.761 -179.683 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 61.1 m-85 -87.88 -173.29 4.22 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.519 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.693 HG22 HD21 ' A' ' 9' ' ' ASN . 0.8 OUTLIER -155.74 103.78 2.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.923 -1.111 . . . . 0.0 108.692 179.881 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 6.4 p -117.02 146.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.327 -178.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' HB2' ' A' ' 43' ' ' GLU . 5.9 t -148.06 -171.61 3.87 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.999 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.231 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.02 0.438 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.627 HG22 ' CE2' ' A' ' 4' ' ' PHE . 59.9 m -129.41 34.68 4.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.576 -0.702 . . . . 0.0 110.169 -179.884 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.9 m -73.74 109.82 7.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.465 -0.772 . . . . 0.0 110.017 179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.627 ' CE2' HG22 ' A' ' 2' ' ' THR . 60.2 m-85 -90.56 119.35 30.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 110.391 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -85.84 169.77 13.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.655 -0.653 . . . . 0.0 109.514 179.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.878 HD12 ' HB2' ' A' ' 53' ' ' PHE . 2.5 tp -148.25 111.06 4.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.986 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -90.72 119.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.508 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.771 HD11 HD23 ' A' ' 6' ' ' LEU . 2.0 mp -93.13 121.05 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.606 -179.144 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.9 162.19 13.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.359 -0.838 . . . . 0.0 110.552 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.07 -168.11 31.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.5 5.54 23.56 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.503 -0.998 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.538 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -60.07 -164.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.19 -0.944 . . . . 0.0 110.117 179.822 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.833 HD23 HD11 ' A' ' 40' ' ' ILE . 3.9 pp -52.78 -33.81 50.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.26 -0.9 . . . . 0.0 110.874 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.2 mmtt 52.33 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.398 -0.814 . . . . 0.0 111.536 178.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.55 -165.85 38.81 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.401 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' THR . 8.2 mt-10 -148.08 77.56 1.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.821 -0.811 . . . . 0.0 109.334 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 34' ' ' TYR . 41.6 pt -57.82 -26.24 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.46 -0.775 . . . . 0.0 111.118 -179.123 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 16' ' ' GLU . 2.9 p 60.31 128.55 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.5 0.666 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 2.5 pp -147.17 156.88 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.416 -0.802 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.42 159.59 15.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.634 -0.666 . . . . 0.0 109.684 179.432 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.82 168.46 8.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.2 p -54.22 -39.83 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 110.676 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.5 m-20 -158.11 177.21 11.55 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -64.3 -34.59 78.47 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.471 -179.817 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.42 -52.45 61.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.55 -0.719 . . . . 0.0 109.954 179.377 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -59.29 -42.71 91.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.635 -0.665 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.15 -42.49 69.62 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.526 -0.734 . . . . 0.0 109.773 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.1 tt0 -59.07 -45.84 89.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.556 -0.715 . . . . 0.0 109.335 179.248 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -50.72 71.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.288 -0.883 . . . . 0.0 109.641 178.654 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.4 -45.86 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.416 -0.803 . . . . 0.0 109.23 179.081 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.781 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.6 m-85 -69.01 -34.03 74.61 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HG2' ' CH2' ' A' ' 44' ' ' TRP . 3.9 mmmt -73.72 -4.26 33.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.85 -0.531 . . . . 0.0 111.314 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -107.3 -45.45 4.1 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.719 ' CE1' HD13 ' A' ' 17' ' ' ILE 0.291 9.4 t80 -51.1 -31.69 20.04 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.821 175.948 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.731 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.65 -64.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.837 0.827 . . . . 0.0 108.825 178.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -54.52 -40.42 68.59 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.085 0.469 . . . . 0.0 110.655 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -49.81 -27.15 4.63 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.72 -0.613 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -107.28 -48.75 3.39 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.382 0.61 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.29 62.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.699 -2.16 . . . . 0.0 107.699 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.833 HD11 HD23 ' A' ' 13' ' ' LEU 0.299 1.1 mm -119.54 136.54 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.821 -0.811 . . . . 0.0 109.495 -177.346 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -169.74 106.05 0.36 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.246 -0.908 . . . . 0.0 111.59 -179.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -108.14 0.21 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 179.054 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 1.5 tt0 -109.2 178.96 4.3 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.414 -1.05 . . . . 0.0 110.4 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 41.7 m95 -155.17 128.79 8.53 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.667 -0.646 . . . . 0.0 109.539 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.8 p -145.17 132.78 20.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.397 -0.814 . . . . 0.0 109.628 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 19.6 t80 -96.56 131.28 43.34 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -99.98 99.63 10.41 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.659 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -70.97 -2.83 16.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.692 -0.63 . . . . 0.0 111.87 -179.3 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.66 -28.36 20.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.8 p -136.19 14.97 3.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 4.3 mptt 48.8 43.05 20.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.88 . . . . 0.0 111.578 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -121.01 114.4 21.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.854 -0.529 . . . . 0.0 109.87 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.878 ' HB2' HD12 ' A' ' 6' ' ' LEU . 65.2 m-85 -73.69 -172.96 1.36 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -0.816 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -156.17 97.55 1.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.19 . . . . 0.0 107.988 -179.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.49 ' CG1' HG13 ' A' ' 8' ' ' ILE . 2.7 p -99.89 98.88 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.003 0.906 . . . . 0.0 111.012 -178.492 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -76.88 170.47 16.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.697 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' CG ' HG23 ' A' ' 12' ' ' THR . 5.5 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.087 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.08 0.467 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.606 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m -136.64 42.52 2.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.618 -0.676 . . . . 0.0 110.215 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.8 m -72.98 98.01 2.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.733 . . . . 0.0 110.033 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 43.3 m-85 -76.11 122.66 24.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 0.0 110.328 -179.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HG3' HG22 ' A' ' 18' ' ' THR . 0.1 OUTLIER -92.2 169.94 10.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.62 -0.675 . . . . 0.0 109.765 179.658 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.903 HD22 ' CD1' ' A' ' 31' ' ' PHE . 9.6 tp -150.14 105.21 3.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.953 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -90.66 123.31 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.1 mp -97.5 122.86 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.884 -1.127 . . . . 0.0 109.423 -178.928 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 54' ' ' THR . 2.3 m-20 -83.14 -157.97 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.22 -134.52 45.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.213 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -144.65 25.71 1.46 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.688 -0.889 . . . . 0.0 110.413 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.6 ' CG2' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -62.82 -71.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.511 -0.743 . . . . 0.0 109.642 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.804 HD23 HD11 ' A' ' 40' ' ' ILE . 4.6 pp -129.25 -28.69 2.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.631 -0.668 . . . . 0.0 110.688 179.601 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.721 ' N ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER 54.28 100.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.24 -0.912 . . . . 0.0 111.117 179.538 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.95 48.25 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 21.4 mt-10 -117.08 -37.83 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.901 -0.764 . . . . 0.0 109.95 179.815 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 19' ' ' ILE . 2.4 mp 65.52 -58.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 O-C-N 121.979 -0.451 . . . . 0.0 111.868 179.617 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 5' ' ' LYS . 4.1 p 57.5 107.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.474 -0.766 . . . . 0.0 110.401 -179.51 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 17' ' ' ILE . 2.3 pp -139.08 138.25 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.556 -0.715 . . . . 0.0 110.715 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -84.29 153.49 23.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.36 168.75 19.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.509 -0.744 . . . . 0.0 110.401 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.45 -39.67 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.589 -0.694 . . . . 0.0 110.771 -179.869 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.7 m-20 -162.23 175.41 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' CA ' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.09 -29.33 70.72 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.859 -179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.95 -41.33 78.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.723 . . . . 0.0 109.869 179.574 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' OE2' HG12 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -74.65 -45.44 44.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -54.66 -49.15 71.31 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.433 -0.792 . . . . 0.0 109.766 179.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 14.0 tt0 -58.81 -35.59 73.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.605 -0.685 . . . . 0.0 109.26 179.083 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.77 -50.85 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.722 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mt -59.06 -36.86 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.903 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -75.28 -39.29 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.159 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 7.4 mtpm? -76.66 1.73 16.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.58 -0.7 . . . . 0.0 111.535 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -105.81 -45.03 4.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 177.143 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 16.0 t80 -54.02 -34.0 58.73 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.604 175.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.27 -62.93 1.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.536 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -57.57 -40.68 79.49 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.891 -0.505 . . . . 0.0 110.614 -179.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.88 -27.95 3.43 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.682 -0.636 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.05 -48.87 3.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.406 0.622 . . . . 0.0 109.759 179.113 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.94 63.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.804 HD11 HD23 ' A' ' 13' ' ' LEU 0.291 1.1 mm -119.24 133.8 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.731 -0.864 . . . . 0.0 109.851 -177.386 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -172.18 103.58 0.17 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.353 -0.842 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.19 -49.04 0.02 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.884 ' HB3' HG22 ' A' ' 56' ' ' THR . 12.8 tt0 -154.6 169.03 24.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -1.062 . . . . 0.0 110.798 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.494 ' CZ2' HG21 ' A' ' 55' ' ' VAL . 48.5 m95 -161.24 115.22 2.0 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.14 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.4 p -137.81 132.02 32.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.514 -0.741 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 22.4 t80 -96.68 129.66 44.05 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.854 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -96.94 101.9 13.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.589 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -72.21 0.09 10.69 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.729 -0.607 . . . . 0.0 111.95 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.23 -26.54 18.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.388 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.4 p -140.81 16.85 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.614 -0.679 . . . . 0.0 109.897 179.513 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB3' ' CD1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 49.32 45.63 23.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 111.456 179.591 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 m -120.3 111.64 18.03 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.087 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HB2' HD12 ' A' ' 6' ' ' LEU . 73.8 m-85 -73.71 -176.72 2.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 109.464 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.506 HG22 HD21 ' A' ' 9' ' ' ASN . 1.4 m -157.1 110.84 2.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.82 -1.175 . . . . 0.0 108.525 -179.784 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 7.7 p -122.35 139.98 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.135 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.884 HG22 ' HB3' ' A' ' 43' ' ' GLU . 9.3 t -136.37 -171.21 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.212 179.854 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.483 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 94.9 m -82.74 -71.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.64 -0.663 . . . . 0.0 110.22 -179.978 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.6 m 49.69 76.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.316 -0.865 . . . . 0.0 111.277 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.738 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 m-85 -73.54 144.63 46.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.535 -0.728 . . . . 0.0 109.677 179.617 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 18' ' ' THR . 7.2 mttp -109.22 -176.01 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 110.158 -179.8 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 31' ' ' PHE . 57.2 tp -155.81 118.99 4.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.493 -0.755 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 mt -87.88 108.69 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.043 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.901 HG21 ' CB ' ' A' ' 13' ' ' LEU . 4.5 mm -84.64 107.19 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.643 -179.407 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 25.5 m-20 -76.04 -28.31 57.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.558 -0.713 . . . . 0.0 110.131 179.572 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.76 166.38 4.72 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.305 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -31.11 27.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.909 . . . . 0.0 110.795 -179.701 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 p -56.51 -31.43 64.07 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.401 -0.812 . . . . 0.0 110.213 -179.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.901 ' CB ' HG21 ' A' ' 8' ' ' ILE . 4.0 mt -138.37 144.0 40.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.679 -0.638 . . . . 0.0 109.512 179.669 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -146.47 87.68 1.73 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.486 -0.759 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.26 -164.35 31.9 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.652 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.82 149.08 44.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.763 -0.845 . . . . 0.0 110.213 -179.965 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CZ ' ' A' ' 34' ' ' TYR . 48.7 mm -103.4 -15.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.554 -0.716 . . . . 0.0 110.663 179.927 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.82 HG22 ' HG2' ' A' ' 5' ' ' LYS . 17.2 p 52.67 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.567 0.699 . . . . 0.0 111.018 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.457 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.5 pp -135.81 134.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.39 -0.819 . . . . 0.0 110.733 -179.966 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.47 142.43 40.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.597 -0.689 . . . . 0.0 110.219 179.985 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.48 38.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.705 . . . . 0.0 110.306 179.856 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.6 p -54.38 -39.21 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.511 -0.743 . . . . 0.0 110.694 -179.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 4.1 m-20 -160.2 178.33 9.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.689 -0.632 . . . . 0.0 109.469 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.738 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -63.75 -30.05 71.19 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.797 179.937 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.665 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -65.74 -38.71 89.87 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.79 -44.12 94.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.614 -0.679 . . . . 0.0 109.39 179.06 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 16.0 tt0 -59.16 -36.1 74.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.599 . . . . 0.0 109.437 179.085 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -71.88 -49.63 36.34 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.578 -0.701 . . . . 0.0 109.109 178.865 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.53 -32.77 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.708 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' CD1' HD22 ' A' ' 6' ' ' LEU . 6.4 m-85 -80.91 -37.72 29.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.057 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -76.61 1.82 15.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.718 -0.614 . . . . 0.0 111.108 179.169 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.23 -44.16 4.2 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.423 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.436 ' CZ ' HG13 ' A' ' 17' ' ' ILE 0.296 2.6 t80 -52.12 -43.96 64.25 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.914 176.252 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.791 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.38 -59.28 5.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.316 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.57 -44.09 80.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.759 -0.588 . . . . 0.0 110.882 -179.509 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -48.31 -28.4 3.11 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.903 -179.786 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -102.36 -43.82 5.57 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.572 0.701 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.39 59.17 0.1 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 107.391 -2.283 . . . . 0.0 107.391 -179.463 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.791 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.293 1.1 mm -120.75 159.41 22.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.95 -0.735 . . . . 0.0 109.563 -177.043 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -176.65 -165.99 0.14 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 -126.5 7.43 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.187 178.373 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.902 ' HB3' HG22 ' A' ' 56' ' ' THR . 41.4 tt0 -96.59 109.22 21.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.977 -0.72 . . . . 0.0 111.973 -177.834 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' THR . 26.0 m95 -97.47 118.03 33.05 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.446 0.641 . . . . 0.0 109.538 178.242 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.8 p -131.78 162.03 31.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.329 -179.387 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 21.8 t80 -123.71 137.37 54.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.46 100.13 9.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.213 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.03 -3.56 20.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.699 -0.626 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.93 -26.29 17.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.96 . . . . 0.0 109.742 179.705 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -129.45 8.28 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.62 -0.675 . . . . 0.0 110.132 179.384 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt 54.24 41.72 31.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 -179.671 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' LYS . 5.6 m -126.49 137.78 53.42 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.688 -0.632 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 64.1 m-85 -96.89 -165.7 1.3 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.467 -0.77 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 6.9 m -154.83 162.86 40.96 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.996 -1.065 . . . . 0.0 108.839 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG21 HG22 ' A' ' 40' ' ' ILE . 2.5 p -164.35 96.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.738 -0.601 . . . . 0.0 109.523 -179.452 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.902 HG22 ' HB3' ' A' ' 43' ' ' GLU . 3.8 t -110.83 91.87 3.83 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.296 1.046 . . . . 0.0 111.673 -178.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 N--CA 1.504 2.274 0 O-C-N 120.887 -1.133 . . . . 0.0 110.794 -179.666 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.618 HG22 ' CE2' ' A' ' 4' ' ' PHE . 29.8 m -129.13 25.83 5.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -68.35 100.03 1.01 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 109.925 179.751 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 2' ' ' THR . 58.0 m-85 -80.19 150.7 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.576 -0.702 . . . . 0.0 110.325 -179.764 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.841 ' HG2' HG22 ' A' ' 18' ' ' THR . 16.3 mtmm -116.4 174.69 5.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.679 -0.638 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.76 HD23 HD11 ' A' ' 8' ' ' ILE . 10.4 tp -151.54 114.1 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.24 112.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.851 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.76 HD11 HD23 ' A' ' 6' ' ' LEU . 3.2 mp -96.59 114.94 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.469 -179.132 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.69 103.21 12.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.747 . . . . 0.0 109.74 179.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.77 -103.13 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.955 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -154.64 30.39 0.42 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.946 . . . . 0.0 110.334 -179.968 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.494 ' OG1' HD13 ' A' ' 40' ' ' ILE . 1.2 p -142.74 118.72 10.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.619 -0.676 . . . . 0.0 110.545 -179.813 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 67.31 -52.45 0.48 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.986 -0.446 . . . . 0.0 111.57 179.85 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 8.8 mttt 48.83 91.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.712 -1.243 . . . . 0.0 111.473 179.569 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.57 -165.75 29.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.581 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -125.88 154.68 42.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.93 -0.747 . . . . 0.0 110.02 -179.856 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 19' ' ' ILE . 15.8 tt -118.78 -4.7 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.467 -0.77 . . . . 0.0 111.252 179.861 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.841 HG22 ' HG2' ' A' ' 5' ' ' LYS . 42.9 p 47.01 102.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.524 -0.735 . . . . 0.0 112.04 179.584 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' ILE . 2.5 pp -127.56 145.5 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.406 -0.809 . . . . 0.0 110.541 179.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.84 155.68 18.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -168.22 167.49 12.21 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.595 -0.69 . . . . 0.0 110.445 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.5 p -54.77 -39.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.521 -0.737 . . . . 0.0 110.736 -179.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.474 ' N ' HG13 ' A' ' 22' ' ' VAL . 1.3 m-20 -161.47 174.91 12.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.713 . . . . 0.0 109.751 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 4' ' ' PHE . . . -61.88 -31.93 72.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 109.931 -179.936 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.6 82.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.728 . . . . 0.0 109.831 179.675 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.78 -39.66 84.07 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.099 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.67 -42.19 87.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.632 -0.667 . . . . 0.0 109.447 179.049 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 4.7 tt0 -59.83 -36.86 77.69 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.96 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -70.77 -48.23 55.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.685 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 27' ' ' ALA . 46.5 mt -59.92 -38.74 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.713 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.1 m-85 -74.63 -39.39 62.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.126 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 31.0 mtpt -71.97 -3.36 22.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 111.084 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -107.88 -44.6 4.18 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.903 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 27.5 t80 -52.2 -37.7 55.7 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.355 176.327 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.63 -65.65 0.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -56.25 -42.39 77.28 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.721 -0.612 . . . . 0.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.68 -29.35 2.96 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.546 -0.721 . . . . 0.0 110.987 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -102.79 -44.96 5.14 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 178.703 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 12' ' ' THR . . . 132.83 63.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.955 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.273 1.1 mm -119.81 135.36 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.774 -0.839 . . . . 0.0 110.22 -177.34 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -131.02 170.08 14.97 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 139.97 177.83 16.21 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.994 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -81.31 115.89 20.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.95 -0.735 . . . . 0.0 109.896 179.657 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.411 ' CE2' ' HB ' ' A' ' 55' ' ' VAL . 42.1 m95 -79.37 129.34 34.37 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.515 0.674 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 18.3 p -144.44 133.7 23.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.865 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 26.2 t80 -96.32 145.75 25.32 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.584 179.593 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.52 100.57 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.671 -0.643 . . . . 0.0 109.546 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.4 -5.04 25.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.0 111.588 -179.704 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.68 -27.72 19.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.738 179.619 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.0 p -130.03 8.05 5.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.654 -0.654 . . . . 0.0 110.08 179.212 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 54.58 42.13 31.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.3 m -127.03 132.57 50.69 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.419 -179.238 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 83.0 m-85 -90.12 -179.46 5.67 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.65 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 62.0 m -162.5 126.38 3.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.772 -1.205 . . . . 0.0 109.95 -179.444 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.34 92.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.806 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -84.56 102.94 13.27 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.707 0.765 . . . . 0.0 110.182 -178.54 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 27.0 tt0 . . . . . 0 N--CA 1.504 2.243 0 O-C-N 121.079 -1.013 . . . . 0.0 110.943 -178.96 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.165 0.507 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.3 m -115.62 87.39 2.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.512 -0.743 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 m -109.16 120.85 43.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.73 . . . . 0.0 109.789 179.283 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 35.6 m-85 -114.24 125.46 53.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.568 -0.708 . . . . 0.0 110.256 179.98 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.806 ' HG3' HG22 ' A' ' 18' ' ' THR . 1.2 mtmt -91.69 172.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.529 -0.732 . . . . 0.0 109.391 179.632 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.911 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -153.99 112.77 3.66 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.233 -179.724 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.2 mt -91.52 115.65 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.941 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.705 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.71 116.81 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.269 -0.973 . . . . 0.0 109.449 -179.229 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.96 60.62 2.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.08 -144.73 4.94 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.36 27.23 5.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -179.812 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -140.07 27.32 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.491 -0.756 . . . . 0.0 110.183 179.836 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -173.73 -74.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 110.01 179.669 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt 51.61 54.07 11.65 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.325 -0.859 . . . . 0.0 110.667 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.95 169.05 28.1 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.782 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.99 64.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.812 . . . . 0.0 110.265 -179.857 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.0 tt -61.16 143.54 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 109.763 179.687 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.806 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.0 p -99.4 150.65 21.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -0.754 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -116.19 168.58 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.111 0.958 . . . . 0.0 110.963 -179.181 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 19' ' ' ILE . 2.7 tp10 -132.16 79.37 1.86 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 176.758 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.66 176.68 5.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.678 -0.639 . . . . 0.0 110.5 -177.248 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 23' ' ' ASP . 14.7 p -75.3 -40.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.278 -179.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.587 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 5.9 p30 -149.36 172.5 14.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.367 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -61.38 -31.27 71.16 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.859 -179.511 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.76 -54.26 46.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.483 -0.761 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' OE1' HG12 ' A' ' 22' ' ' VAL . 1.5 mt-10 -62.17 -45.57 92.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 109.437 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.0 -45.46 61.15 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.268 -0.895 . . . . 0.0 110.371 179.399 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 7.7 tt0 -60.82 -34.63 74.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.401 179.348 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -68.43 -53.39 23.93 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.371 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 19' ' ' ILE . 19.4 mt -59.57 -32.67 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.916 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.911 ' CD1' HD12 ' A' ' 6' ' ' LEU . 3.9 m-85 -78.89 -38.67 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.463 0.649 . . . . 0.0 109.266 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD3' ' CD2' ' A' ' 44' ' ' TRP . 2.3 mmmt -72.93 -4.06 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.796 -0.565 . . . . 0.0 111.429 -179.941 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -107.84 -44.69 4.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 177.329 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.476 ' OH ' HD21 ' A' ' 13' ' ' LEU 0.293 17.6 t80 -52.62 -34.04 49.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.2 176.43 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -66.58 -49.92 64.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.731 -0.606 . . . . 0.0 109.936 179.253 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -57.85 -46.2 85.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.678 -0.639 . . . . 0.0 110.581 -179.767 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -55.61 -23.65 28.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.43 -0.794 . . . . 0.0 110.758 179.985 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.538 ' O ' HG21 ' A' ' 12' ' ' THR . 1.8 m-80 -102.98 -26.65 13.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.739 -0.601 . . . . 0.0 110.453 179.883 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 110.99 29.9 3.37 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.79 HG22 ' HB1' ' A' ' 35' ' ' ALA . 1.6 mp -96.97 106.71 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.622 -0.928 . . . . 0.0 108.855 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -143.96 102.73 3.93 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.409 -179.215 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.42 -105.81 0.2 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.154 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.2 tt0 -105.95 179.73 4.18 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.41 -1.053 . . . . 0.0 110.654 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.47 ' NE1' HG23 ' A' ' 55' ' ' VAL . 40.3 m95 -157.17 131.04 8.2 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.654 -0.653 . . . . 0.0 109.757 -179.952 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 13.2 p -146.13 132.29 19.4 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.581 -0.699 . . . . 0.0 109.557 179.631 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 19.9 t80 -97.42 121.97 39.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.667 179.272 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -89.2 98.82 11.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.554 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.93 -3.05 17.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.573 -0.704 . . . . 0.0 111.561 -179.49 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.08 -28.54 21.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.416 179.369 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.3 p -136.53 14.62 3.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.697 -0.627 . . . . 0.0 110.024 179.275 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 51' ' ' LYS . 1.6 mptp? 49.46 43.65 23.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.291 -0.88 . . . . 0.0 111.283 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.7 m -119.99 103.41 9.28 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.274 179.774 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 28' ' ' GLU . 75.6 m-85 -62.3 -177.04 0.12 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.695 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.9 101.68 1.8 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.764 -1.21 . . . . 0.0 107.756 -179.654 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 4.6 p -106.13 115.27 47.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.209 1.004 . . . . 0.0 111.607 -178.148 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -89.69 171.78 9.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.793 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.216 179.968 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.219 0.533 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.2 m -87.05 89.98 8.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.95 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 m -108.0 114.43 28.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.541 -0.725 . . . . 0.0 110.027 179.435 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.675 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 27.7 m-85 -113.0 117.91 33.35 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG2' HG22 ' A' ' 18' ' ' THR . 24.4 mtmt -87.36 171.94 10.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.402 -0.812 . . . . 0.0 110.108 -179.655 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.899 HD22 ' CD1' ' A' ' 31' ' ' PHE . 29.8 tp -148.48 105.14 3.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.727 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -80.35 118.36 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mm -95.35 119.47 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.988 -178.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' THR . 16.6 t30 -113.71 92.03 3.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.333 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.55 176.86 45.95 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -60.41 -34.25 73.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.486 -1.008 . . . . 0.0 110.353 -179.873 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.505 HG23 ' HG3' ' A' ' 11' ' ' LYS . 23.9 p -91.09 133.45 35.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.657 -0.652 . . . . 0.0 109.871 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 8' ' ' ILE . 4.9 mt 58.48 162.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.504 -0.748 . . . . 0.0 110.274 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -175.69 94.29 0.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.327 -0.858 . . . . 0.0 110.659 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.54 176.04 14.33 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.586 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -82.06 150.25 27.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.676 -0.896 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.652 HD13 ' CZ ' ' A' ' 34' ' ' TYR . 57.7 mt -117.51 -19.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.571 -0.706 . . . . 0.0 110.757 -179.919 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.494 HG22 ' HG2' ' A' ' 5' ' ' LYS . 2.2 p 61.83 129.59 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.722 -0.611 . . . . 0.0 110.251 -179.636 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.681 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -120.53 167.25 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.967 0.889 . . . . 0.0 111.14 -179.445 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.02 71.56 1.26 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.61 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.1 179.34 4.13 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.797 -0.564 . . . . 0.0 110.403 -177.619 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 23' ' ' ASP . 13.5 p -80.01 -41.5 21.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.893 -179.386 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 22' ' ' VAL . 19.0 m-20 -147.11 171.66 14.97 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.831 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.85 -38.33 90.39 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.667 -179.338 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.36 72.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.52 -0.737 . . . . 0.0 109.942 179.42 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.43 -49.69 58.12 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.84 61.64 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.544 -0.723 . . . . 0.0 110.121 179.009 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 8.0 tt0 -60.22 -41.29 92.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.608 -0.682 . . . . 0.0 109.303 179.158 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -67.44 -49.85 61.89 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.784 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' HD11 ' A' ' 19' ' ' ILE . 47.7 mt -59.14 -39.97 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.59 -0.694 . . . . 0.0 109.204 179.023 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.899 ' CD1' HD22 ' A' ' 6' ' ' LEU . 5.6 m-85 -73.78 -38.58 64.62 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.336 0.588 . . . . 0.0 109.476 179.25 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HD3' ' CG ' ' A' ' 44' ' ' TRP . 0.8 OUTLIER -72.77 -3.35 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.664 -0.647 . . . . 0.0 111.44 -179.99 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -110.41 -45.1 3.6 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 177.721 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.652 ' CZ ' HD13 ' A' ' 17' ' ' ILE 0.296 3.6 t80 -54.41 -44.49 72.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.85 176.28 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.479 ' HB1' HG22 ' A' ' 40' ' ' ILE . . . -64.48 -58.64 5.84 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.196 0.522 . . . . 0.0 109.921 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -54.76 -47.6 73.69 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.595 -0.69 . . . . 0.0 110.916 -179.719 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.32 -28.71 63.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.402 -0.811 . . . . 0.0 110.421 -179.896 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -94.6 -27.8 15.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.809 -0.557 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' C ' HD12 ' A' ' 40' ' ' ILE . . . 111.33 27.81 4.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.908 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.728 HG22 HG21 ' A' ' 55' ' ' VAL . 1.7 mp -99.77 76.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -1.05 . . . . 0.0 109.075 -179.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -172.3 3.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.042 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' HA3' ' C ' ' A' ' 56' ' ' THR . . . 126.11 -171.13 17.91 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.432 -1.366 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.24 132.14 34.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.983 -0.716 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.448 ' CG ' ' HD3' ' A' ' 32' ' ' LYS . 49.7 m95 -100.57 133.56 44.84 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.573 0.701 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.9 p -145.55 133.59 21.44 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 t80 -98.19 142.2 30.16 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.674 179.688 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -113.2 101.25 9.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.764 -0.585 . . . . 0.0 109.739 179.576 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.87 -5.15 28.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 0.0 111.428 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.8 -28.66 21.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 109.503 179.499 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -129.13 7.64 5.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.676 . . . . 0.0 110.096 179.269 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp 54.42 41.04 32.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.179 -0.951 . . . . 0.0 110.092 -179.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 m -127.98 132.77 49.16 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.044 -179.333 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 78.7 m-85 -86.92 -173.78 4.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.332 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 2.0 m -157.86 117.76 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.835 -1.166 . . . . 0.0 108.987 -179.878 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.728 HG21 HG22 ' A' ' 40' ' ' ILE . 1.7 p -115.81 93.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.735 0.778 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -87.72 96.78 10.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.892 0.853 . . . . 0.0 110.046 -178.618 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 10.9 tt0 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.131 . . . . 0.0 110.223 -179.131 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 2' ' ' THR . 70.6 m -114.39 48.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.639 -0.663 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.1 m -69.68 91.93 0.64 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.57 -0.706 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 7.9 m-85 -80.98 139.69 35.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.517 -0.739 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.858 ' HG2' HG22 ' A' ' 18' ' ' THR . 78.6 mttt -103.92 -172.31 2.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.528 -0.733 . . . . 0.0 110.208 -179.526 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 53' ' ' PHE . 3.7 tp -164.05 98.77 0.85 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 0.0 109.94 179.912 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG13 HG21 ' A' ' 52' ' ' THR . 89.6 mt -80.52 134.11 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.421 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.807 HG21 ' HG ' ' A' ' 13' ' ' LEU . 5.9 mm -99.03 117.67 44.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.636 -1.226 . . . . 0.0 110.215 -178.925 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -94.07 6.0 49.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.677 -0.639 . . . . 0.0 110.954 -179.965 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.84 -165.89 36.33 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -103.11 27.56 7.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.611 -0.935 . . . . 0.0 109.966 179.614 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.668 ' C ' HD23 ' A' ' 13' ' ' LEU . 2.8 m -153.92 175.53 13.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 40' ' ' ILE . 0.6 OUTLIER 38.74 28.57 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.694 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.44 118.67 2.88 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.198 -0.939 . . . . 0.0 111.7 -179.209 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.95 -174.18 44.71 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 9.6 mt-10 -118.56 -32.78 4.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.832 -0.805 . . . . 0.0 110.546 -179.788 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.2 pt 36.98 83.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.762 0 CA-C-O 121.558 0.694 . . . . 0.0 112.291 -179.625 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.858 HG22 ' HG2' ' A' ' 5' ' ' LYS . 72.9 p -70.54 140.8 51.86 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.51 -0.744 . . . . 0.0 110.553 -179.584 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.596 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -148.22 134.28 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.395 -0.816 . . . . 0.0 110.425 179.548 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.68 156.03 35.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.557 -0.715 . . . . 0.0 110.306 179.974 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 26' ' ' GLU . . . -169.7 158.54 7.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.563 -0.71 . . . . 0.0 110.24 179.968 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 23' ' ' ASP . 7.9 p -54.0 -39.99 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.544 -0.722 . . . . 0.0 110.555 179.926 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -160.5 177.48 10.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.458 -0.776 . . . . 0.0 109.705 179.561 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -62.79 -34.52 77.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 109.785 -179.985 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.611 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.04 -44.73 74.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.494 -0.754 . . . . 0.0 109.77 179.442 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -69.41 -44.48 71.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.826 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -55.8 -39.92 72.0 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.405 -0.809 . . . . 0.0 109.596 178.871 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.8 tt0 -61.37 -40.1 93.08 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.209 -0.597 . . . . 0.0 110.039 179.595 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.51 -34.44 63.03 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.491 179.478 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 27' ' ' ALA . 49.4 mt -67.99 -38.76 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.915 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.641 ' CD1' HD22 ' A' ' 6' ' ' LEU . 10.9 m-85 -75.21 -37.1 61.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.44 2.2 19.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 0.0 110.948 179.201 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -104.19 -44.8 4.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 177.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.291 8.6 t80 -51.54 -39.59 58.05 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.313 176.22 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.19 -48.72 32.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.583 0.706 . . . . 0.0 109.583 179.413 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -67.11 -46.38 74.34 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.774 -0.579 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -48.86 -27.76 3.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 111.03 -179.43 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -100.62 -47.76 4.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.417 0.627 . . . . 0.0 110.007 179.4 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.35 61.16 0.1 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -179.506 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.954 ' CD1' HD22 ' A' ' 13' ' ' LEU 0.294 1.1 mm -117.02 141.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.914 -0.756 . . . . 0.0 109.067 -177.298 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -166.66 125.28 1.43 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.735 -179.155 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.4 -102.2 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.525 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 9.6 tt0 -127.98 173.57 9.92 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.455 -1.026 . . . . 0.0 109.582 178.675 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.462 ' CZ2' ' CG2' ' A' ' 55' ' ' VAL . 38.5 m95 -150.43 131.35 14.23 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.379 -0.826 . . . . 0.0 110.091 -179.798 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 11.4 p -143.96 131.5 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.6 179.507 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -94.87 134.14 37.84 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.211 179.308 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -104.14 98.77 8.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.627 179.442 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -70.05 -5.31 25.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.655 -0.653 . . . . 0.0 111.425 -179.903 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.59 -27.96 17.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.712 179.616 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.9 p -124.3 7.37 8.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.655 -0.653 . . . . 0.0 110.085 179.128 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt 54.56 38.78 30.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.128 -0.982 . . . . 0.0 110.18 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 5' ' ' LYS . 13.0 m -130.34 140.9 50.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.606 -0.684 . . . . 0.0 110.463 -179.776 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.873 ' HB2' HD12 ' A' ' 6' ' ' LEU . 57.2 m-85 -92.74 -170.4 2.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 109.609 179.669 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.03 92.84 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.855 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 8' ' ' ILE . 2.4 p -92.98 105.71 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.87 0.843 . . . . 0.0 110.458 -178.91 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 43' ' ' GLU . 1.1 m -84.17 171.6 12.68 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.581 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.253 179.732 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.047 0.451 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.769 HG21 ' O ' ' A' ' 21' ' ' ALA . 61.7 m -110.57 -80.85 0.58 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.65 -0.656 . . . . 0.0 110.571 -179.963 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 22.6 m 52.39 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.28 -0.888 . . . . 0.0 110.875 -178.784 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 9.5 m-85 -105.03 123.42 47.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -91.17 174.55 7.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.759 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.828 HD12 ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -151.34 113.51 4.54 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.256 -179.997 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mm -80.98 119.81 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.969 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.855 HG21 ' HB2' ' A' ' 13' ' ' LEU . 7.9 mm -96.14 122.64 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.307 -178.738 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -108.84 52.29 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 109.956 179.458 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.09 -151.72 8.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.808 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.22 -23.6 9.37 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.598 -0.942 . . . . 0.0 110.722 -179.793 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -82.36 -30.4 30.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.563 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.855 ' HB2' HG21 ' A' ' 8' ' ' ILE . 8.5 mt -119.66 171.66 8.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.723 -0.61 . . . . 0.0 109.358 179.72 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.04 76.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.636 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.23 179.58 27.06 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.512 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -67.06 -154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.699 -0.883 . . . . 0.0 109.913 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 31' ' ' PHE . 7.0 tp -175.07 -32.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.501 -0.749 . . . . 0.0 110.25 179.913 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p 63.49 137.0 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.367 0.603 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -130.77 166.8 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 121.671 0.748 . . . . 0.0 111.057 -178.869 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.41 78.52 1.21 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.305 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.769 ' O ' HG21 ' A' ' 2' ' ' THR . . . -122.08 149.43 43.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.577 -0.702 . . . . 0.0 110.381 -177.533 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 23' ' ' ASP . 9.0 p -58.55 -39.75 76.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.374 0.607 . . . . 0.0 110.75 -179.63 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' N ' HG13 ' A' ' 22' ' ' VAL . 49.1 p-10 -149.8 178.61 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.801 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -65.57 -29.99 70.67 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.606 -179.574 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.73 79.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.524 -0.735 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.465 ' HG3' HG12 ' A' ' 22' ' ' VAL . 1.3 mm-40 -68.29 -47.87 66.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.639 -0.663 . . . . 0.0 109.394 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' A' ' 19' ' ' ILE . . . -51.26 -48.01 62.31 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.438 -0.789 . . . . 0.0 110.434 179.486 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 10.2 tt0 -58.6 -36.45 74.05 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.609 179.423 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -54.13 15.99 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.0 mt -58.29 -35.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.527 -0.733 . . . . 0.0 109.184 178.753 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 6' ' ' LEU . 4.5 m-85 -74.65 -39.13 62.24 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.91 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -72.97 -2.79 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 111.442 179.958 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -109.28 -44.63 3.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 177.444 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.295 12.3 t80 -51.44 -33.77 32.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.746 175.954 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.729 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.95 -57.98 10.52 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.659 0.743 . . . . 0.0 109.118 178.573 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -58.55 -44.4 89.66 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -49.44 -27.19 3.92 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.593 -0.692 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -104.12 -50.07 3.45 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.277 0.56 . . . . 0.0 110.135 179.402 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.88 62.64 0.05 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -179.653 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.729 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.307 1.1 mm -120.3 136.8 56.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.877 -0.778 . . . . 0.0 109.875 -177.042 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -170.07 101.97 0.29 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.325 -0.86 . . . . 0.0 111.237 -179.851 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.01 -104.38 0.18 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.445 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 8.6 tt0 -114.73 174.4 5.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.537 -0.978 . . . . 0.0 110.64 -179.923 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.447 ' NE1' HG23 ' A' ' 55' ' ' VAL . 36.1 m95 -152.87 128.67 10.19 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.709 -0.619 . . . . 0.0 109.615 179.854 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 10.5 p -142.43 132.06 23.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 109.309 179.587 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 27.5 t80 -96.97 128.25 43.75 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.53 179.589 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -96.22 98.66 10.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.656 -0.652 . . . . 0.0 109.407 179.207 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -70.59 -4.09 21.42 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.654 -0.654 . . . . 0.0 111.692 -179.598 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.22 -26.34 17.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 109.723 179.613 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -127.64 7.53 6.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.579 -0.701 . . . . 0.0 110.132 179.333 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 46.8 mmtt 54.53 40.43 31.83 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.21 -0.932 . . . . 0.0 110.134 -179.618 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -127.66 129.82 47.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.728 -0.608 . . . . 0.0 110.425 -179.638 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 71.5 m-85 -85.29 -171.17 3.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.554 -0.716 . . . . 0.0 109.497 179.664 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -155.83 95.28 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLU . 3.0 p -98.8 107.5 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.982 0.896 . . . . 0.0 111.18 -178.357 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -88.4 163.72 15.86 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.796 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.305 -179.959 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.032 0.444 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 88.4 m -120.11 67.21 0.83 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.675 . . . . 0.0 110.336 -179.848 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.9 m -84.23 88.61 7.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.158 179.701 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.747 ' CZ ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 m-85 -76.9 137.72 39.29 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.567 -0.708 . . . . 0.0 109.775 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.782 ' HG2' HG22 ' A' ' 18' ' ' THR . 31.1 mttt -102.48 -172.6 2.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.602 -0.686 . . . . 0.0 110.436 -179.533 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 31' ' ' PHE . 6.0 tp -165.25 107.7 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.659 -0.65 . . . . 0.0 109.939 179.926 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -89.9 115.57 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.264 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.8 HD11 HD23 ' A' ' 6' ' ' LEU . 3.0 mp -97.67 120.55 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.483 -179.499 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -109.24 98.02 7.52 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.499 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.45 -135.02 1.97 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.937 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -32.94 4.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.968 . . . . 0.0 110.325 179.799 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 p -87.29 107.55 18.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 179.512 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER 61.09 148.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.521 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.67 ' N ' HD12 ' A' ' 13' ' ' LEU . 15.2 ptmt -162.91 128.38 3.22 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.236 -0.915 . . . . 0.0 110.647 -179.724 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.07 -174.73 18.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.29 147.89 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.902 . . . . 0.0 110.836 -179.647 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.8 mm -113.12 -26.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.511 -0.743 . . . . 0.0 110.243 179.729 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.782 HG22 ' HG2' ' A' ' 5' ' ' LYS . 3.2 p 56.79 112.54 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.344 0.592 . . . . 0.0 111.206 179.57 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.534 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.6 pp -141.97 135.44 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.327 179.188 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.27 149.34 47.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.609 -0.682 . . . . 0.0 110.148 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.67 156.04 9.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 23' ' ' ASP . 8.3 p -53.42 -40.53 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.557 -0.715 . . . . 0.0 110.832 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -159.94 -179.81 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.706 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' CZ ' ' A' ' 4' ' ' PHE . . . -64.92 -32.49 74.24 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.559 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.95 76.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.828 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' HG12 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -68.59 -45.46 71.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.891 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -42.05 76.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.042 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 12.5 tt0 -61.62 -41.34 97.33 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.447 179.083 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -69.32 -44.27 72.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.408 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 87.7 mt -63.21 -42.09 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.839 ' CD1' HD22 ' A' ' 6' ' ' LEU . 8.7 m-85 -70.41 -40.5 73.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.199 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 44' ' ' TRP . 34.1 mtpt -71.56 -4.06 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 110.963 179.299 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -98.3 -45.6 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.127 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.306 5.9 t80 -44.36 -54.15 6.11 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.79 175.572 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.78 -51.41 68.41 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 110.052 179.951 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.53 -47.3 79.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.641 -0.662 . . . . 0.0 111.364 -178.958 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -48.92 -30.82 6.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.476 -0.765 . . . . 0.0 110.985 -179.275 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -96.01 -46.08 6.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.564 0.697 . . . . 0.0 109.553 179.124 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 62.89 0.16 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 107.0 -2.44 . . . . 0.0 107.0 -179.373 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 35' ' ' ALA 0.284 1.0 OUTLIER -118.67 139.67 45.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.863 -0.786 . . . . 0.0 110.489 -176.725 . . . . . . . . 4 4 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.98 -178.21 4.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.331 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.21 -178.74 17.36 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.716 179.2 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.98 123.1 31.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.982 -0.717 . . . . 0.0 110.328 179.888 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' THR . 37.8 m95 -88.62 128.1 35.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 16.1 p -141.04 132.9 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 53' ' ' PHE . 24.5 t80 -96.62 143.44 27.59 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.532 179.714 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.77 99.15 7.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.681 -0.637 . . . . 0.0 109.405 179.233 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.74 -3.84 20.75 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.664 . . . . 0.0 111.593 -179.641 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.27 -27.05 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.736 179.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -130.17 8.9 5.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.632 -0.668 . . . . 0.0 110.128 179.372 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 53.82 44.22 29.86 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 0.0 110.154 -179.589 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.2 m -130.07 129.93 44.25 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.113 -179.411 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.794 ' HB2' HD12 ' A' ' 6' ' ' LEU . 69.9 m-85 -89.69 -176.65 5.05 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.934 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' TRP . 34.5 m -162.39 124.58 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.793 -1.192 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 8' ' ' ILE . 1.2 p -118.13 93.27 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.059 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 56' ' ' THR . 0.3 OUTLIER -82.93 96.44 8.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.026 0.917 . . . . 0.0 110.157 -178.237 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 O-C-N 120.978 -1.076 . . . . 0.0 110.448 -179.243 . . . . . . . . 0 0 . 1 stop_ save_